"PROJ_ID"	"SITE_ID"	"SUBID"	"STATE"	"EVENT_NO"	"EVENT_ID"	"ID"	"AETERM"	"AESTDT_"	"AEENDT_"	"AEONGO"	"AETOXGR"	"AEPACN"	"AEPACN_A"	"AEPACN_B"	"AEACN"	"AEACN_A"	"AEACN_B"	"AEDACN"	"AEDACN_A"	"AEDACN_B"	"AEACOTH"	"AEACOTH1"	"AEACOTH2"	"AEACOTH3"	"AEACO3OT"	"AEOUT"	"AERELP"	"AERELA"	"AERELD"	"AESER"	"AESCONG"	"AESDISAB"	"AESDTH"	"AESHOSP"	"AESLIFE"	"AESINTER"	"AESOTH"	"AESOTHC"	"SAEIRDT_"	"SAEDDT_"	"SAEAUTOP"	"SAEHADT_"	"SAEHDDT_"	"SAECOM1"	"SAECOM2"	"SAECOM3"	"SAEPRED"	"SAEDRED"	"SAEPST"	"SAEST"	"SAEDST"	"SAEPRR"	"SAERR"	"SAEDRR"	"SAEDESC1"	"SAEDESC2"	"SAEDESC3"	"SAEDESC4"	"SAEDESC5"	"SAEDESC6"	"M_HLGT"	"M_LLT"	"M_USER"	"M_PT"	"M_SOURCE"	"M_SCORE"	"M_MTIME"	"M_SOC"	"M_TIME"	"M_DICT"	"M_HLT"	"M_PROD"	"M_IS_P"	"llt"	"SOC"	"HLGT"	"HLT"	"PT"	"Level_5_Type"	"Level_5_Text"	"Level_6_Type"	"Level_6_Text"	"Level_7_Type"	"Level_7_Text"	"Level_8_Type"	"Level_8_Text"	"Level_9_Type"	"Level_9_Text"	"Level_10_Type"	"Level_10_Text"
"1"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	2603014003	"anemia"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471792346	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	2822916001	"anemia"	119	126	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"2 units packed red blood cells given ,"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481663560	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	2680725001	"arthralgia knees"	37	187	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473883911	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	3727671001	"dyspnea with exertion"	168	420	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505938042	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"5"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	2645865001	"fatigue"	15	248	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471791774	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"6"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	2682100001	"hot flashes"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473961741	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"7"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	2823244001	"hyperglycemia"	14	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481666275	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"8"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	2823258001	"hyperglycemia"	77	98	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481666380	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"9"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	3310803001	"Hyperglycemia"	98	266	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498058500	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"10"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	5263169002	"Hypertension"	266	585	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522933692	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"11"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	2680743001	"numbness tingling fingertips"	51	162	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473884062	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"12"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	2823222001	"numbness tingling fingertips"	162	357	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481666063	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"13"	"DN-101 Protocol No. 011-007"	"001"	"001-0003"	5	9	"Adverse Event/Serious Adverse Event"	3310772001	"numbness,tingling of fingers"	357	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498058214	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"14"	"DN-101 Protocol No. 011-007"	"001"	"001-0004"	5	9	"Adverse Event/Serious Adverse Event"	2642913003	"alopecia"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474297127	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"15"	"DN-101 Protocol No. 011-007"	"001"	"001-0004"	5	9	"Adverse Event/Serious Adverse Event"	5263207002	"Anemia"	154	154	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522933886	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"16"	"DN-101 Protocol No. 011-007"	"001"	"001-0004"	5	9	"Adverse Event/Serious Adverse Event"	3805116001	"Back pain"	321	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507055765	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"17"	"DN-101 Protocol No. 011-007"	"001"	"001-0004"	5	9	"Adverse Event/Serious Adverse Event"	5263247002	"Constipation"	253	495	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522934186	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"18"	"DN-101 Protocol No. 011-007"	"001"	"001-0004"	5	9	"Adverse Event/Serious Adverse Event"	3804674001	"Fatigue"	328	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507054618	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"19"	"DN-101 Protocol No. 011-007"	"001"	"001-0004"	5	9	"Adverse Event/Serious Adverse Event"	2685693001	"indigestion"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474297274	""	""	""	NA	"Indigestion"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"20"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	5	9	"Adverse Event/Serious Adverse Event"	2683452003	"acute renal failure"	153	167	NA	4	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"dialysis"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519662336	""	""	""	NA	"Acute renal failure"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure acute"	""	""	""	""	""	""	""	""	""	""	""	""
"21"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	5	9	"Adverse Event/Serious Adverse Event"	4963512002	"arrythmia"	153	167	NA	4	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519665958	""	""	""	NA	"Arrhythmia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Arrhythmia"	""	""	""	""	""	""	""	""	""	""	""	""
"22"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	5	9	"Adverse Event/Serious Adverse Event"	4966462002	"bowel perforation"	167	167	NA	4	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519672048	""	""	""	NA	"Bowel perforation"	"Gastrointestinal disorders"	"Gastrointestinal ulceration and perforation"	"Intestinal ulcers and perforation NEC"	"Intestinal perforation"	""	""	""	""	""	""	""	""	""	""	""	""
"23"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	5	9	"Adverse Event/Serious Adverse Event"	4963587002	"cardiomyopathy"	153	167	NA	4	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519666062	""	""	""	NA	"Cardiomyopathy"	"Cardiac disorders"	"Myocardial disorders"	"Cardiomyopathies"	"Cardiomyopathy"	""	""	""	""	""	""	""	""	""	""	""	""
"24"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	5	9	"Adverse Event/Serious Adverse Event"	2866467001	"edema lower legs"	109	167	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484161298	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"25"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	5	9	"Adverse Event/Serious Adverse Event"	2925802001	"hemorrhage GI"	153	167	NA	5	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	4	0	NA	0	28	NA	NA	1	1	1	NA	NA	""	154	167	2	153	167	"CT scan of abdomen on day of admission 2/7/07 shows evidence of sigmoid diverticulosis, no evidence to suggest abcess or free air."	""	""	2	2	0	NA	0	2	NA	2	"I have very little information today, patient is on a ventilator in ICU. I have been verbally told the patient had a GI hemorrhage, had severely low BP, cardiac arrest. Now he is comatose on a"	"ventilator with possible congestive heart failure. I will be able to get more information over the next few days.;2/14/07 Update- The patient has been extubated and is eating. He has been undergoing"	"dialysis for renal failure.;2/21/07 The patient developed a bowel perforation from his diverticulosis and expired on 2/21/07. He did not undergo any surgical procedure for the bowel perforation."	""	""	""	""	""	""	""	""	NA	NA	""	1486581002	""	""	""	NA	"GI hemorrhage"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"26"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	5	9	"Adverse Event/Serious Adverse Event"	4962627002	"hypotension"	153	167	NA	4	0	NA	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519664390	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"27"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	5	9	"Adverse Event/Serious Adverse Event"	2866454001	"insomnia"	54	167	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484161120	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"28"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	5	9	"Adverse Event/Serious Adverse Event"	2866476001	"low hemoglobin"	98	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484161428	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"29"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	5	9	"Adverse Event/Serious Adverse Event"	4962110002	"metabolic acidosis"	153	167	NA	4	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519663381	""	""	""	NA	"Metabolic acidosis"	"Metabolism and nutrition disorders"	"Acid-base disorders"	"Metabolic acidoses (excl diabetic acidoses)"	"Metabolic acidosis"	""	""	""	""	""	""	""	""	""	""	""	""
"30"	"DN-101 Protocol No. 011-007"	"001"	"001-0005"	5	9	"Adverse Event/Serious Adverse Event"	4960903002	"sepsis"	153	167	NA	3	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519660710	""	""	""	NA	"Sepsis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Sepsis, bacteraemia and viraemia"	"Sepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"31"	"DN-101 Protocol No. 011-007"	"001"	"001-0008"	5	9	"Adverse Event/Serious Adverse Event"	2746568003	"alopecia"	34	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481056500	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"32"	"DN-101 Protocol No. 011-007"	"001"	"001-0008"	5	9	"Adverse Event/Serious Adverse Event"	2806329001	"anemia"	20	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481056679	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"33"	"DN-101 Protocol No. 011-007"	"001"	"001-0008"	5	9	"Adverse Event/Serious Adverse Event"	2806402001	"anxiety"	29	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481057261	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"34"	"DN-101 Protocol No. 011-007"	"001"	"001-0008"	5	9	"Adverse Event/Serious Adverse Event"	2806314001	"fever"	29	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481056570	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"35"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	2752143003	"abdomenal pain/cramping"	178	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495478651	""	""	""	NA	"Abdominal crampy pains"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"36"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183464002	"acholic stools"	182	197	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521663120	""	""	""	NA	"Acholic stool"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Faecal abnormalities NEC"	"Faeces pale"	""	""	""	""	""	""	""	""	""	""	""	""
"37"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	3231929001	"alopecia"	17	155	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495478362	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"38"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	3232046001	"arthalgia"	165	240	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495479110	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"39"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183499002	"biliary colic"	182	197	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521663203	""	""	""	NA	"Biliary colic"	"Hepatobiliary disorders"	"Bile duct disorders"	"Bile duct infections and inflammations"	"Biliary colic"	""	""	""	""	""	""	""	""	""	""	""	""
"40"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183203002	"bone pain"	11	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521662648	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"41"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183543002	"darkening of urine"	178	197	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521663286	""	""	""	NA	"Discoloration urine"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Chromaturia"	""	""	""	""	""	""	""	""	""	""	""	""
"42"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183359002	"dizziness"	51	134	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521662908	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"43"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	2903581001	"dyspnea"	51	NA	1	3	2	NA	1	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485881315	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"44"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	2903587001	"fatigue"	53	74	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485881571	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"45"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	3232033001	"fatigue"	164	NA	1	3	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"study treatment terminated"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495479021	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"46"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183650002	"hematuria"	86	86	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521663557	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"47"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183569002	"hot flashes"	182	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521663342	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"48"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183301002	"insomnia"	44	162	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521662810	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"49"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183423002	"memory impairment"	164	164	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521663054	""	""	""	NA	"Memory impairment"	"Nervous system disorders"	"Mental impairment disorders"	"Memory loss (excl dementia)"	"Memory impairment"	""	""	""	""	""	""	""	""	""	""	""	""
"50"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183607002	"ocular discharge"	178	192	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521663411	""	""	""	NA	"Discharge eye"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Ocular infections, inflammations and associated manifestations"	"Eye discharge"	""	""	""	""	""	""	""	""	""	""	""	""
"51"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183170002	"OD blurring"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521662576	""	""	""	NA	"Blurring of vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"52"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183270002	"rash on both arms"	29	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521662737	""	""	""	NA	"Rash over arms"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"53"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	4526991002	"taste alteration"	73	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516203709	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"54"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	5183625002	"urinary obstruction"	211	212	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"catheter put in"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521663487	""	""	""	NA	"Urinary obstruction unspecified"	"Renal and urinary disorders"	"Genitourinary tract disorders NEC"	"Genital and urinary tract disorders NEC"	"Urinary tract obstruction"	""	""	""	""	""	""	""	""	""	""	""	""
"55"	"DN-101 Protocol No. 011-007"	"001"	"001-0009"	5	9	"Adverse Event/Serious Adverse Event"	2903593001	"weakness"	53	NA	1	3	3	1	1	NA	NA	NA	3	1	1	4	NA	NA	1	"study treatment terminated"	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485881732	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"56"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	5	9	"Adverse Event/Serious Adverse Event"	2799091003	"acid reflux"	106	158	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516810986	""	""	""	NA	"Acid reflux (oesophageal)"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Gastrooesophageal reflux disease"	""	""	""	""	""	""	""	""	""	""	""	""
"57"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	5	9	"Adverse Event/Serious Adverse Event"	2903875001	"anemia"	32	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485894933	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"58"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	5	9	"Adverse Event/Serious Adverse Event"	3087981001	"bone pain"	129	136	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492353779	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"59"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	5	9	"Adverse Event/Serious Adverse Event"	4624880002	"Bone Pain"	167	247	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516809700	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"60"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	5	9	"Adverse Event/Serious Adverse Event"	2903854001	"fatigue"	14	123	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485894652	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"61"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	5	9	"Adverse Event/Serious Adverse Event"	4624265002	"Fatigue"	123	144	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516806317	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"62"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	5	9	"Adverse Event/Serious Adverse Event"	2903872001	"olfactory alteration"	16	226	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485894853	""	""	""	NA	"Smell alteration"	"Nervous system disorders"	"Cranial nerve disorders (excl neoplasms)"	"Olfactory nerve disorders"	"Parosmia"	""	""	""	""	""	""	""	""	""	""	""	""
"63"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	5	9	"Adverse Event/Serious Adverse Event"	3088059001	"spinal cord compression"	93	106	NA	2	2	NA	1	NA	NA	NA	2	NA	1	4	NA	NA	1	"radiation therapy to involved area"	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492354663	""	""	""	NA	"Spinal cord compression"	"Nervous system disorders"	"Spinal cord and nerve root disorders"	"Spinal cord and nerve root disorders NEC"	"Spinal cord compression"	""	""	""	""	""	""	""	""	""	""	""	""
"64"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	5	9	"Adverse Event/Serious Adverse Event"	3088049001	"taste alterations"	39	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492354513	""	""	""	NA	"Taste altered"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"65"	"DN-101 Protocol No. 011-007"	"001"	"001-0012"	5	9	"Adverse Event/Serious Adverse Event"	4625164002	"weakness"	218	228	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516810684	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"66"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	2958069003	"alopecia"	28	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498052439	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"67"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3309963001	"anemia"	86	101	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"received 2 units of blood"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498052861	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"68"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3307630001	"C-DIFF ENTEROCOLITIS"	103	114	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	124	NA	NA	103	109	"5/30/07 FECAL SPECIMEN WAS POSITIVE FOR C-DIFF prolonging hospitalization until 06/05/2007.  NO FURTHUR TESTING DONE AS SYMPTOMS HAD SUBSIDED AS THE PATIENT COMPLETED HIS ANTIBIOTIC REGIMEN."	""	""	2	2	2	NA	2	2	NA	2	"DURING THE PATIENT'S HOSPITALIZATION, HE CONTRACTED C-DIFF ENTEROCOLITIS THAT PROLONGED HIS HOSPITALIZATION"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497990144	""	""	""	NA	"C.difficile colitis"	"Infections and infestations"	"Bacterial infectious disorders"	"Clostridia infections"	"Clostridium difficile colitis"	""	""	""	""	""	""	""	""	""	""	""	""
"69"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3670493001	"congestive heart failure"	195	195	NA	5	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	4	0	NA	0	4	NA	NA	1	NA	NA	NA	NA	""	207	195	0	NA	NA	"no testing was performed"	""	""	0	0	0	NA	0	0	NA	0	"The patient was found unresponsive by his spouse, the life squad was summoned and determined the patient DOA.  The body was taken directly to the funeral home, and no autopsy was performed."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505225329	""	""	""	NA	"Congestive heart failure"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"70"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3310356001	"constipation"	87	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498054932	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"71"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3310340001	"depression"	104	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498054839	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"72"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3310117001	"dysuria"	98	102	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498054041	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"73"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3310051001	"elevated creatinine"	86	89	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"received hydrating fluids while hospitalized"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498053518	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"74"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3310106001	"fatigue"	86	189	NA	3	2	NA	1	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498053951	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"75"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3309916001	"fatigue"	50	52	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498052587	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"76"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3310266001	"fever"	86	106	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"documented at time of hospitalization"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498054386	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"77"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3016926001	"hyperglycemia"	7	195	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490128001	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"78"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3310388001	"hypotension"	86	87	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498055060	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"79"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	4021524001	"indigestion"	105	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510168919	""	""	""	NA	"Indigestion"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"80"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3310077001	"mid/lower back pain"	88	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498053683	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"81"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	5263431002	"Pain in lumbar spine"	168	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522935401	""	""	""	NA	"Pain in spine"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"82"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3310028001	"pleural effusions"	96	130	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498053342	""	""	""	NA	"Pleural effusion"	"Respiratory, thoracic and mediastinal disorders"	"Pleural disorders"	"Pneumothorax and pleural effusions NEC"	"Pleural effusion"	""	""	""	""	""	""	""	""	""	""	""	""
"83"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3231654001	"pneumonia"	86	109	NA	3	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	95	NA	NA	86	109	"5/13/07 CXR SHOWED PNEUMONIA IN LEFT MID LUNG FIELD; 5/13/07 BLOOD CULTURE WAS POSITIVE FOR STREPTOCOCCUS PNEUMONIAE"	""	""	2	2	2	NA	2	2	NA	2	"ON 5/13/07 THE PT PRESENTED TO THE ER WITH 1 WEEK HX OF CHILLS AND LOW GRADE FEVER (99.5F), AND 3 DAY HX OF WORSENINF SHORTNESS OF BREATH.  CXR SHOWED MID LEFT LUNG OPACITY CONSISTENT WITH PNEUMONIA."	"PT WAS ADMITTED AND TREATED WITH IV FLUIDS, IV ANTIBIOTICS, LEVOPHED INFUSION, BIPAP AT NIGHT.  AS OF 5/22/05 THE PT CONTINUES HOSPITALIZED WHILE RECOVERING."	""	""	""	""	""	""	""	""	""	NA	NA	""	1495476477	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"84"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3578108001	"rectal bleeding"	169	170	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503843842	""	""	""	NA	"Rectal bleeding"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Intestinal haemorrhages"	"Rectal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"85"	"DN-101 Protocol No. 011-007"	"001"	"001-0013"	5	9	"Adverse Event/Serious Adverse Event"	3310183001	"Weakness"	86	106	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"event partially percipated hospitalization"	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498054231	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"86"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3026850003	"Allergey symptoms"	217	245	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1527088130	""	""	""	NA	"Allergy NOS"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"87"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3488026001	"anemia"	147	168	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501770387	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"88"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3108009001	"anemia"	34	147	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492635352	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"89"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3563070001	"anemia"	168	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503418043	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"90"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	4424468002	"Bone pain"	308	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515519722	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"91"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3427165001	"constipation"	98	103	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500315912	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"92"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	5216896002	"dehydration"	208	208	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hospitalization, patient given 1000 cc of normal saline in the hospital"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522171116	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"93"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	4273346001	"dehydration"	240	243	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Pt was already off study treatment. He was admitted to the hospital for IV fluid replacement"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	282	NA	NA	240	243	"CBC & BUN 11-1-2007"	""	""	2	2	2	2	2	2	2	2	"The patient had grade 3 nausea and diarrhea after starting radiation therapy ,He had 6 treatments when this SAE occurred. It was during his first 48 wk follow-up period. He wasn't able to take any"	"fluids due to nause and with concurrent diarrhea he became dehydrated.The patient improved with IV fluid therapy  in the hospital and was discharged home after 3 days ."	""	""	""	""	""	""	""	""	""	NA	NA	""	1513203631	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"94"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3107993001	"dizziness with movements"	41	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492635239	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"95"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3183621001	"dry skin"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494535860	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"96"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3427079001	"dyspnea on exertion"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500315343	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"97"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3427283001	"edema of left ankle"	123	126	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500316539	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"98"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	4079365001	"elevated BUN"	147	189	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510845538	""	""	""	NA	"Blood urea nitrogen increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood urea increased"	""	""	""	""	""	""	""	""	""	""	""	""
"99"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	4079392001	"elevated creatinine"	147	189	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510845632	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"100"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	5217189002	"elevated creatinine"	168	273	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522171957	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"101"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3107986001	"facial rash"	42	45	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492635114	""	""	""	NA	"Facial rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"102"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3488032001	"facial swelling-moonface"	147	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501770662	""	""	""	NA	"Moon face"	"Endocrine disorders"	"Adrenal gland disorders"	"Adrenal cortical hyperfunctions"	"Cushingoid"	""	""	""	""	""	""	""	""	""	""	""	""
"103"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3724847001	"fatigue"	180	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505930923	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"104"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3724815001	"Fatigue"	145	179	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505930814	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"105"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3107978001	"fatigue"	21	127	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492634994	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"106"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3488023001	"Fatigue"	127	144	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501770290	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"107"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3183602001	"fatigue"	43	50	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494535615	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"108"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	5384682002	"generalized pain"	217	245	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1527088329	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"109"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3107939001	"hot flashes"	21	75	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492634633	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"110"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	5214997002	"Hot Flashes"	273	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522164439	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"111"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3257170001	"hot flashes"	75	236	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496340930	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"112"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3493766001	"hyperglycemia"	147	189	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502048119	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"113"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3107959001	"hyperglycemia"	34	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492634782	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"114"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3493798001	"hypocalcemia"	147	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502048335	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"115"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	4424949002	"Left shoulder dislocated"	308	308	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515520603	""	""	""	NA	"Dislocated shoulder"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Fractures and dislocations NEC"	"Joint dislocation"	""	""	""	""	""	""	""	""	""	""	""	""
"116"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3725403001	"nail changes"	152	179	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505931981	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"117"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3725464001	"nail changes"	180	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505932103	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"118"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3427100001	"numbness tingling of fingertips"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500315431	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"119"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3107814001	"right buttock pain"	21	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492633309	""	""	""	NA	"Buttock pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Buttock pain"	""	""	""	""	""	""	""	""	""	""	""	""
"120"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3107966001	"right hip pain"	24	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492634873	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"121"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	4424664002	"Shoulder pain"	308	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515520070	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"122"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	5216806002	"syncope"	208	208	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hospitalization"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522170859	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"123"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	4424869002	"Taste alteration"	244	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515520419	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"124"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3183616001	"taste alteration"	43	243	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494535788	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"125"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3725151001	"watery eyes"	162	179	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505931529	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"126"	"DN-101 Protocol No. 011-007"	"001"	"001-0014"	5	9	"Adverse Event/Serious Adverse Event"	3725308001	"watery eyes"	180	240	NA	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505931834	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"127"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2558403003	"Alopecia"	448	596	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509397381	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"128"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2575205001	"Alopecia"	24	243	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463518017	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"129"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3968974001	"Altered taste"	476	596	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509397213	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"130"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2581139001	"Altered taste"	40	213	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464808155	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"131"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2660380001	"Cold sore outer aspect right side of mouth"	76	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472659411	""	""	""	NA	"Cold sore mouth"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes simplex"	""	""	""	""	""	""	""	""	""	""	""	""
"132"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2778490001	"Constipation"	147	149	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479312447	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"133"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2660389001	"Cushingoid appearance"	124	285	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472659602	""	""	""	NA	"Cushingoid"	"Endocrine disorders"	"Adrenal gland disorders"	"Adrenal cortical hyperfunctions"	"Cushingoid"	""	""	""	""	""	""	""	""	""	""	""	""
"134"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3683019001	"Dry Cough"	NA	596	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505318975	""	""	""	NA	"Dry cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"135"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3278670001	"Edema left upper leg"	376	433	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497215956	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"136"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3278664001	"Edema to right lower leg"	376	433	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497215859	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"137"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2601739001	"Eye tearing"	61	212	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467654399	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"138"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3969036001	"Eye tearing"	492	596	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509397469	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"139"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2878561001	"Eyes tearing"	213	285	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484686122	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"140"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2878492001	"Fatigue"	82	NA	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484685541	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"141"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3968952001	"Fatigue"	NA	596	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509397100	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"142"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2640162001	"Fingernail changes"	103	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471289037	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"143"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2707601001	"Fingernail changes"	162	387	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475612204	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"144"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3278640001	"Fingernail changes"	388	596	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497215536	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"145"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3057233001	"Intermittent lower abdominal pain"	331	375	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491323599	""	""	""	NA	"Lower abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain lower"	""	""	""	""	""	""	""	""	""	""	""	""
"146"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2878511001	"Knee pain"	NA	596	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484685766	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"147"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2877411001	"Left eyelid blepharitis"	194	245	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484668672	""	""	""	NA	"Blepharitis"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Lid, lash and lacrimal infections, irritations and inflammations"	"Blepharitis"	""	""	""	""	""	""	""	""	""	""	""	""
"148"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3683368001	"Left iliac vein thrombosis"	432	596	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505319982	""	""	""	NA	"Iliac vein thrombosis"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Pelvic venous thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"149"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	4984560002	"Low platelets"	468	475	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519768592	""	""	""	NA	"Low platelets"	"Investigations"	"Haematology investigations (incl blood groups)"	"Platelet analyses"	"Platelet count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"150"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3278790001	"Lower abdominal pain"	376	433	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497217016	""	""	""	NA	"Lower abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain lower"	""	""	""	""	""	""	""	""	""	""	""	""
"151"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3057260001	"Lower back pain with ambulation"	320	433	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491323947	""	""	""	NA	"Low back ache"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"152"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3682817001	"Myocardial infarction"	428	441	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	525	NA	NA	428	441	"U/S confirmed Left common iliac DVT."	""	""	2	2	2	NA	2	2	NA	0	"Pt was on standard chemo.  After his first cycle he developed cardiac problems and was brought into hospital.  He was found to have had a myocardial infarction and developed atrial fibrillation.  Pt"	"stabilized on oral Coumadin and discharged."	""	""	""	""	""	""	""	""	""	NA	NA	""	1505318056	""	""	""	NA	"Myocardial infarction"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Myocardial infarction"	""	""	""	""	""	""	""	""	""	""	""	""
"153"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2601733001	"Neuropathy"	54	331	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467653983	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"154"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3969110001	"Neuropathy lower extremities"	511	596	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509397795	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"155"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2878533001	"Numbness in fingertips"	NA	331	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484685942	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"156"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2660365001	"Pain in fingertips with pressure"	117	213	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472659293	""	""	""	NA	"Pain in fingers"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"157"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2880172001	"Right eye catract"	194	278	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484757677	""	""	""	NA	"Right cataract"	"Eye disorders"	"Anterior eye structural change, deposit and degeneration"	"Cataract conditions"	"Cataract"	""	""	""	""	""	""	""	""	""	""	""	""
"158"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2660386001	"Right eye red-from rubbing"	111	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472659517	""	""	""	NA	"Red eye"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Ocular infections, inflammations and associated manifestations"	"Ocular hyperaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"159"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	2707631001	"Right middle finger infected"	175	184	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475613224	""	""	""	NA	"Infected finger"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Localised infection"	""	""	""	""	""	""	""	""	""	""	""	""
"160"	"DN-101 Protocol No. 011-007"	"002"	"002-0001"	5	9	"Adverse Event/Serious Adverse Event"	3968890001	"Shortness of breath on exertion"	NA	596	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509396758	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"161"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	2777567003	"Alopecia"	41	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484175855	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"162"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3426619001	"Bilateral ankle edema"	196	207	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500313614	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"163"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3486005001	"Bilateral ankle edema"	237	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501707451	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"164"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3426649001	"Bilateral ankle edema"	208	236	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500313699	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"165"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3002455001	"Bruising on forearms"	83	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489605071	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"166"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	2821506001	"Constipation"	10	10	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481651062	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"167"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3002470001	"Cracked skin of fingers"	83	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489605198	""	""	""	NA	"Chapped skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Skin injuries and mechanical dermatoses"	"Skin chapped"	""	""	""	""	""	""	""	""	""	""	""	""
"168"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3002462001	"Dry skin"	83	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489605140	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"169"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3054477001	"Eye tearing"	132	234	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491239880	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"170"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	2922962001	"Fatigue"	62	233	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486497711	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"171"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3486288001	"Fatigue"	234	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501709246	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"172"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3176693001	"Left hip muscle weakness"	174	234	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494436651	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"173"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	2922951001	"Left knee muscle weakness"	69	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486497586	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"174"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3426561001	"Left knee muscle weakness"	184	233	NA	2	3	1	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500313420	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"175"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3486308001	"Left knee muscle weakness"	234	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501709467	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"176"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3176702001	"Left knee muscle weakness"	142	183	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494436728	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"177"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3666908001	"Left upper arm pain"	251	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505161799	""	""	""	NA	"Painful L arm"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"178"	"DN-101 Protocol No. 011-007"	"002"	"002-0008"	5	9	"Adverse Event/Serious Adverse Event"	3426594001	"Right knee muscle weakness"	208	234	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500313509	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"179"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	2862051003	"Alopecia"	24	273	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486500157	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"180"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3214752001	"Cushingoid syndrome"	99	179	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495056698	""	""	""	NA	"Cushingoid"	"Endocrine disorders"	"Adrenal gland disorders"	"Adrenal cortical hyperfunctions"	"Cushingoid"	""	""	""	""	""	""	""	""	""	""	""	""
"181"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3009118001	"Fatigue"	26	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489955922	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"182"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3214777001	"Fatigue"	116	272	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495056872	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"183"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3361504001	"Fingernail changes"	165	467	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499202724	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"184"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3271460001	"Fingernail changes"	132	164	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496863440	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"185"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3214799001	"Fingernail changes"	81	131	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495057029	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"186"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	5469608002	"Left ankle stiffness"	NA	69	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1530037064	""	""	""	NA	"Ankle stiffness"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint stiffness"	""	""	""	""	""	""	""	""	""	""	""	""
"187"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3214812001	"Left hand blister"	123	179	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495057137	""	""	""	NA	"Blister"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Bullous conditions"	"Blister"	""	""	""	""	""	""	""	""	""	""	""	""
"188"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3214732001	"Lower back pain"	108	467	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495056461	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"189"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3214739001	"Neuropathy in feet"	95	467	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495056529	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"190"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3271480001	"Numbness in fingers"	131	467	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496863717	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"191"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3271492001	"Right anterior chest muscle pain"	148	154	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496863804	""	""	""	NA	"Muscle pain"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"192"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3214762001	"Sinus congestion"	111	467	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495056799	""	""	""	NA	"Sinus congestion"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Sinus congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"193"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3214727001	"Toe nail changes"	81	115	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495056408	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"194"	"DN-101 Protocol No. 011-007"	"002"	"002-0011"	5	9	"Adverse Event/Serious Adverse Event"	3214806001	"Toenail changes"	116	467	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495057081	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"195"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3096945003	"Alopecia"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496857165	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"196"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3666803001	"Anemia"	137	139	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505161289	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"197"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3697607001	"Bilateral ankle and lower leg edema"	152	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505685228	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"198"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3270949001	"Bilateral ankle, lower leg edema"	29	151	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496857262	""	""	""	NA	"Peripheral edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"199"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3697586001	"Dry cough"	138	215	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505684951	""	""	""	NA	"Dry cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"200"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3697577001	"Dry cough"	133	137	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505684885	""	""	""	NA	"Dry cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"201"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3697463001	"Dyspnea"	133	137	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505684181	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"202"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	4311624001	"Dyspnea"	215	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513704488	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"203"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3958509001	"Dyspnea"	189	214	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"CXR done 24 Oct 07"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509311453	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"204"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3199982001	"Hyperglycemia"	7	7	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494945996	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"205"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3640229001	"Hyperglycemia"	154	175	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504723940	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"206"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3361435001	"Hyperglycemia"	69	70	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499201540	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"207"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3422991001	"Hyperglycemia"	90	91	NA	3	1	1	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500238215	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"208"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3199997001	"Hyperglycemia-sporadic"	8	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494946064	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"209"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	4311694001	"Hypotension"	135	137	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513704711	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"210"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3640212001	"Nail changes"	97	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504723831	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"211"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3958539001	"Productive cough"	182	215	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509311763	""	""	""	NA	"Productive cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"212"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	4311543001	"Right flank pain"	195	201	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513704301	""	""	""	NA	"Flank pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Flank pain"	""	""	""	""	""	""	""	""	""	""	""	""
"213"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3640312001	"Right lower leg muscle weakness"	96	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504724203	""	""	""	NA	"Weakness of limbs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"214"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3640200001	"Right lower leg neuropathy"	96	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504723690	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"215"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3199963001	"Scalp tenderness"	23	59	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494945853	""	""	""	NA	"Scalp tenderness"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Pain of skin"	""	""	""	""	""	""	""	""	""	""	""	""
"216"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3592155001	"Sepsis"	135	140	NA	4	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	140	NA	NA	136	140	"Right leg ultrasound-showed no signs of DVT.Blood and urine cultures were negative.  CXR was clear."	""	""	2	2	2	2	2	2	2	0	"Pt. had been feeling unwell for about a week he presented to ER with febrile neutropenia, acute-on-chronic renal failure, hyperglycemia and hypotension. Pt was treated with volume resuscitation as"	"well as empiric Piperacillin/Tazobactam and Vancomycin; however he had no obvious source of infection.	His creatinine was elevated at 267 and his lactate at above 10.  He stabilized quickly with"	"resuscitation.	Pt was transferred to the Cross cancer and admitted. Pt. was never neutropenic so not technically febrile neutropenia, but rather, true sepsis with a normal white blood cell count and"	"unknown focus of infection.  During the admission, we monitored his blood sugars and provided him with a sliding scale of insulin.  With increased oral intake and resolution of his hypotension, as"	"well as IV support, his creatinine dramatically improved, such that it was normal at 123 on the day of discharge.  He was dischargeed on oral antibiotics."	""	""	""	""	""	""	NA	NA	""	1504021411	""	""	""	NA	"Sepsis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Sepsis, bacteraemia and viraemia"	"Sepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"217"	"DN-101 Protocol No. 011-007"	"002"	"002-0014"	5	9	"Adverse Event/Serious Adverse Event"	3640277001	"Vision changes"	107	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504724089	""	""	""	NA	"Visual disturbances"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Visual disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"218"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3357292003	"Abdominal pain"	15	15	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504044157	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"219"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596581001	"Alopecia"	21	NA	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504042024	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"220"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3595647001	"Anemia"	15	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504038159	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"221"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3837024001	"Bruising skin"	78	NA	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507586580	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"222"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3958038001	"Eye tearing"	105	NA	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509307071	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"223"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3837021001	"Eye tearing"	85	104	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507586518	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"224"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3655663001	"Fatigue"	51	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505062590	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"225"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596317001	"Fatigue"	10	12	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504041191	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"226"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596667001	"Fatigue"	38	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504042415	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"227"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596356001	"Fatigue"	17	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504041316	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"228"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596652001	"Fatigue"	31	37	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504042315	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"229"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3837008001	"Fatigue"	83	183	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507586394	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"230"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3837004001	"Fatigue"	74	82	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507586347	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"231"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596338001	"Fatigue"	14	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504041252	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"232"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3405134001	"Febrile neutropenia"	14	16	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	15	NA	NA	14	18	"Blood culture was negative."	""	""	2	2	2	2	2	0	2	0	"Pt phoned in to say he had a fever and was advised to go to his local emerg. Pt's temperature was down within 48 hrs.  Discharged in stable condition."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499807534	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"233"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596730001	"Fever"	34	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504042767	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"234"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596374001	"Headache"	11	15	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504041388	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"235"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3837015001	"Headache"	74	76	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507586451	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"236"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596683001	"Headache"	31	37	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504042488	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"237"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596408001	"Headache"	16	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504041474	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"238"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	4883595002	"Heartburn"	78	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518646351	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"239"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596790001	"Insomnia"	45	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504043197	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"240"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596610001	"Insomnia"	7	44	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504042128	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"241"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3958168001	"Intermittent left hip pain"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509307831	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"242"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3958177001	"Intermittent numbness fingertips"	73	165	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509308075	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"243"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596164001	"Joint pain"	11	13	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504040610	""	""	""	NA	"Joint pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"244"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	4883568002	"Left hip pain"	NA	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518646269	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"245"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3837031001	"Lower back pain"	95	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507586650	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"246"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3958061001	"Mood alteration-agitation"	93	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509307140	""	""	""	NA	"Agitation"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Agitation"	""	""	""	""	""	""	""	""	""	""	""	""
"247"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596525001	"Mouth sores"	13	17	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504041866	""	""	""	NA	"Sores mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"248"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3655701001	"Nail changes"	57	164	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505062792	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"249"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	4883411002	"Nail changes"	165	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518645616	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"250"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596716001	"Nail lifting"	37	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504042670	""	""	""	NA	"Onycholysis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onycholysis"	""	""	""	""	""	""	""	""	""	""	""	""
"251"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3655644001	"Pain right foot 4th toe"	49	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505062483	""	""	""	NA	"Pain in toe"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"252"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3837040001	"Posterior thigh pain"	95	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507586753	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"253"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3958201001	"Rash webbing of hands"	113	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509308539	""	""	""	NA	"Hand rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"254"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596742001	"Rectal irritation"	31	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504042844	""	""	""	NA	"Discomfort rectal"	"Gastrointestinal disorders"	"Anal and rectal conditions NEC"	"Anal and rectal disorders NEC"	"Anal discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"255"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3958174001	"Right knee pain"	118	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509307968	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"256"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3958171001	"Right knee pain"	117	117	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509307907	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"257"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596759001	"Scrotal irritation"	31	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504043007	""	""	""	NA	"Scrotal irritation"	"Reproductive system and breast disorders"	"Penile and scrotal disorders (excl infections and inflammations)"	"Scrotal disorders NEC"	"Scrotal irritation"	""	""	""	""	""	""	""	""	""	""	""	""
"258"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3655830001	"Shakes"	47	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505063397	""	""	""	NA	"Tremor"	"Nervous system disorders"	"Movement disorders (incl Parkinsonism)"	"Tremor (excl congenital)"	"Tremor"	""	""	""	""	""	""	""	""	""	""	""	""
"259"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3655820001	"Shakes"	45	46	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505063343	""	""	""	NA	"Tremor"	"Nervous system disorders"	"Movement disorders (incl Parkinsonism)"	"Tremor (excl congenital)"	"Tremor"	""	""	""	""	""	""	""	""	""	""	""	""
"260"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3836992001	"Stabbing pain lower limbs"	74	82	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507586272	""	""	""	NA	"Pain in limb"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"261"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3655867001	"Sweats"	47	142	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505063537	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"262"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3655849001	"Sweats"	45	46	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505063467	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"263"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3958185001	"Taste change"	111	165	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509308216	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"264"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596700001	"Taste change"	31	37	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504042581	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"265"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3655681001	"Taste change"	53	57	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505062672	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"266"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3958180001	"Taste changes"	104	110	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509308162	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"267"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3596963001	"Thrush"	14	15	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504044074	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"268"	"DN-101 Protocol No. 011-007"	"002"	"002-0016"	5	9	"Adverse Event/Serious Adverse Event"	3958204001	"Toenail changes"	105	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509308594	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"269"	"DN-101 Protocol No. 011-007"	"002"	"002-0019"	5	9	"Adverse Event/Serious Adverse Event"	3835492003	"Alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509567609	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"270"	"DN-101 Protocol No. 011-007"	"002"	"002-0019"	5	9	"Adverse Event/Serious Adverse Event"	3984608001	"Body aches"	8	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509567484	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"271"	"DN-101 Protocol No. 011-007"	"002"	"002-0019"	5	9	"Adverse Event/Serious Adverse Event"	3984741001	"Dyspepsia"	10	10	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509567980	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"272"	"DN-101 Protocol No. 011-007"	"002"	"002-0019"	5	9	"Adverse Event/Serious Adverse Event"	3984619001	"Fatigue"	10	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509567545	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"273"	"DN-101 Protocol No. 011-007"	"002"	"002-0020"	5	9	"Adverse Event/Serious Adverse Event"	3956474003	"Alopecia"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513632693	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"274"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	5	9	"Adverse Event/Serious Adverse Event"	2628807003	"Benign Systolic Murmur"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486236453	""	""	""	NA	"Systolic murmur"	"Investigations"	"Cardiac and vascular investigations (excl enzyme tests)"	"Cardiac auscultatory investigations"	"Cardiac murmur"	""	""	""	""	""	""	""	""	""	""	""	""
"275"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	5	9	"Adverse Event/Serious Adverse Event"	3004015001	"Bilateral Leg Edema"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489673170	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"276"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	5	9	"Adverse Event/Serious Adverse Event"	2689633001	"Constipation"	42	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474409725	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"277"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	5	9	"Adverse Event/Serious Adverse Event"	2919996001	"Disturbed Sleep"	71	132	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486421908	""	""	""	NA	"Sleep disturbed"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Sleep disorders NEC"	"Sleep disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"278"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	5	9	"Adverse Event/Serious Adverse Event"	2826141001	"Dizziness"	117	120	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481821423	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"279"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	5	9	"Adverse Event/Serious Adverse Event"	2921711001	"Dyspnea"	172	197	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486487194	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"280"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	5	9	"Adverse Event/Serious Adverse Event"	2712263001	"fatigue"	132	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475789027	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"281"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	5	9	"Adverse Event/Serious Adverse Event"	2910555001	"Heart Palpitation"	155	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"ECHOCARDIOGRAM - NORMAL REPORT"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486237001	""	""	""	NA	"Palpitation"	"Cardiac disorders"	"Cardiac disorder signs and symptoms"	"Cardiac signs and symptoms NEC"	"Palpitations"	""	""	""	""	""	""	""	""	""	""	""	""
"282"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	5	9	"Adverse Event/Serious Adverse Event"	2910524001	"Nail Changes"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486234837	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"283"	"DN-101 Protocol No. 011-007"	"003"	"003-0001"	5	9	"Adverse Event/Serious Adverse Event"	2920028001	"Nocturia"	71	132	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486422414	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"284"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	5	9	"Adverse Event/Serious Adverse Event"	2659202003	"allopecia"	28	270	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483487206	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"285"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	5	9	"Adverse Event/Serious Adverse Event"	2908608001	"Constipation"	13	270	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486057682	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"286"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	5	9	"Adverse Event/Serious Adverse Event"	2851162001	"fatigue"	21	270	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483487088	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"287"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	5	9	"Adverse Event/Serious Adverse Event"	2774891001	"Febrile Neutropenia"	54	63	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479160264	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"288"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	5	9	"Adverse Event/Serious Adverse Event"	2908472001	"Nail Changes"	84	270	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486055439	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"289"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	5	9	"Adverse Event/Serious Adverse Event"	2908461001	"Neutropenia"	72	84	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486055371	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"290"	"DN-101 Protocol No. 011-007"	"003"	"003-0002"	5	9	"Adverse Event/Serious Adverse Event"	2908479001	"Restlessness"	128	270	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486055536	""	""	""	NA	"Restlessness"	"Psychiatric disorders"	"Changes in physical activity"	"Increased physical activity levels"	"Restlessness"	""	""	""	""	""	""	""	""	""	""	""	""
"291"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	2680128003	"Allopecia"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481495783	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"292"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	4514034002	"cough"	450	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516133364	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"293"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	3023124001	"Cough"	182	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490288306	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"294"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	2817401001	"Emphysematous Cholecystitis"	87	121	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	1	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	89	NA	NA	87	91	"CT Scan performed 09 Dec 06 indicated Emphysematous cholecystitis, likely with small amount of portal venous air.  Significant pericholecystic fluid and fluid in the region of the head of the"	"pancreas and hepatoduodenal ligament all consistent with acute inflammation."	""	2	2	2	NA	2	2	NA	2	"Patient presented to the Foothills Medical Centre on morning of 09 Dec 06 after collapsing at his home.  EMS was called and patient presented with significant abdominal pain, weakness and was"	"diaphoretic.  Family member stated that patient was mildly SOB on 08 DEC 06.  Family member also states that patient appears to have a mild facial droop and dysarthria.  Patient was assessed by CT"	"scan to confirm the presence of Emphysematous Cholecystitis.  Patient underwent a laparoscopic cholecytectomy the morning of 10 Dec 06.  At time of this SAE report, Patient is presently stable and"	"admitted to surgical ward at Foothills Medical Centre.;Patient fully recovered from surgery on 12 Jan 06.  Pt. was saw Dr. Eigl on 27 Dec 06 and was assessed and improving but still recovering from"	"surg.  Pt. then seen in surg. clinic on 05 Jan 07 and given ok by the surgeon to cont. with chemo.  Patient returned to TBCC on 12 jan 07 W/Dr. Eigl and was restarted on chemo reduced to dose of 60"	"mg/m2  15 jan 07."	""	""	""	""	""	NA	NA	""	1481480678	""	""	""	NA	"Emphysematous cholecystitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Hepatobiliary and spleen infections"	"Emphysematous cholecystitis"	""	""	""	""	""	""	""	""	""	""	""	""
"295"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	2818249001	"Fatigue"	12	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481495638	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"296"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	2909052001	"Fatigue"	125	135	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486068838	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"297"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	3023132001	"Fever"	182	184	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490288417	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"298"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	3116052001	"Leg Edema"	189	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492958994	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"299"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	3023142001	"Nasal Discharge"	184	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490288502	""	""	""	NA	"Nasal discharge"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"300"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	3853642001	"non-small cell lung cancer - lung lesion"	373	NA	1	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507741766	""	""	""	NA	"Non-small cell lung cancer"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Respiratory and mediastinal neoplasms malignant and unspecified"	"Non-small cell neoplasms malignant of the respiratory tract cell type specified"	"Non-small cell lung cancer"	""	""	""	""	""	""	""	""	""	""	""	""
"301"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	3186156001	"Shortness of breath"	232	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494779816	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"302"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	4513996002	"Upper Respiratory Infection"	450	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516133289	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"303"	"DN-101 Protocol No. 011-007"	"003"	"003-0003"	5	9	"Adverse Event/Serious Adverse Event"	4514054002	"yellow sputum"	450	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516133413	""	""	""	NA	"Sputum discolored"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Sputum discoloured"	""	""	""	""	""	""	""	""	""	""	""	""
"304"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	2753066003	"Alopecia"	48	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483570492	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"305"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	5288387002	"Anxiety"	402	402	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523466157	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"306"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	3116133001	"Bilateral Peripheral Edema- lower legs"	153	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"Treatment stopped, patient off study."	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492960965	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"307"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	5282592002	"Constipation"	287	308	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523378209	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"308"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	5288333002	"Difficulty breathing"	403	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523465814	""	""	""	NA	"Difficulty breathing"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"309"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	4420295002	"Elevated Creatinine"	272	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515512716	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"310"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	2854964001	"Fatigue"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483570058	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"311"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	4414518002	"heart perfusion noted per thallium scan - small vol infarct & ischemia, apical"	400	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515453401	""	""	""	NA	"Myocardial infarct"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Myocardial infarction"	""	""	""	""	""	""	""	""	""	""	""	""
"312"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	2854979001	"Insomnia"	36	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483570359	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"313"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	2992537001	"Nail Changes"	132	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489337887	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"314"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	2914814001	"Nocturia"	73	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486332463	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"315"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	4163270001	"Obstructive Uropathy"	272	287	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	6	NA	1	1	"Catheter placed on July 25th. Patient was referred for a TURP procedure which happened on August 8th."	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	403	NA	NA	286	309	"Patient has always had Grade 1 elevated creatinine. On July 25 his creatinine raised up to 380umol/L (grade 3). Patient also had urinary obstruction requiring TURP procedure.;Creatinine at admission:"	"183umol/L;Creatinine at discharge: 175 umol/L;Urea levels normal except on August 22/07 when elevated to 9.2mmol/L;CBCs and electrolytes monitored throughout hospitalisation"	""	2	2	2	2	2	2	2	2	"Patient was admitted to hospital on August 8th for a TURP to help with his Obstructive Uropathy. The procedure was performed on the 9th of August. There were complications after TURP (post-op"	"bleeding, hematuria and further TURP procedures).;;All medications during hospitalisation will be captured on conmeds log (this will take some time)."	""	""	""	""	""	""	""	""	""	NA	NA	""	1512071771	""	""	""	NA	"Obstructive uropathy"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal obstructive disorders"	"Obstructive uropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"316"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	2854973001	"Peripheral Edema"	42	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Dexamethasone Reduced"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483570214	""	""	""	NA	"Peripheral edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"317"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	4163322001	"Post procedure bleeding following TURP"	287	307	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	403	NA	NA	286	309	"CBCs and electrolytes monitored throughout hospitalisation.;On August 17/07 HGB level dropped to 68g/L, requiring transfusion. He also received transfusions on the 22nd, 24th, 26th and 27th.;Patients"	"CBCs showed recovering after cauterisation occurred."	""	2	2	2	NA	2	2	NA	2	"After initial TURP on August 9th, patient experienced bleeding requiring 4 blood transfusions. Due to the persistent bleeding and Hematuria patient underwent another TURP on August 21st for"	"cauterisation. Patient was still bleeding and had a third TURP to cauterise on August 29. Bleeding and hematuria resolved after the 3rd procedure."	""	""	""	""	""	""	""	""	""	NA	NA	""	1512072270	""	""	""	NA	"Post procedural bleeding"	"Injury, poisoning and procedural complications"	"Procedural and device related injuries and complications NEC"	"Non-site specific procedural complications"	"Post procedural haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"318"	"DN-101 Protocol No. 011-007"	"003"	"003-0004"	5	9	"Adverse Event/Serious Adverse Event"	4175634001	"Sepsis"	397	414	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	403	NA	NA	397	424	"November 27:;microbiology of urine - enterococcus;November 28:;blood, gram positive cocci resembling Staph;November 30:;blood culture. gram positive resembling staphylococcus.;anaerobic culture of"	"abscess. gram positive resembling staphylococcus.;December 14:;anaerobic culture of abscess. no organisms found"	""	2	2	2	NA	2	2	NA	2	"Patient admitted to Rockyview Hospital on November 27th due to Sepsis. Was given IV antibiotics. All meds give while in hospital will be captured on the conmeds forms (I will try to do this as"	"quickly as I can).;;On a side note patient had a heart condition identified while in hospital. This has been captured as an AE (not SAE) as it did not prolong his hospitalisation."	""	""	""	""	""	""	""	""	""	NA	NA	""	1512338008	""	""	""	NA	"Sepsis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Sepsis, bacteraemia and viraemia"	"Sepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"319"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	5	9	"Adverse Event/Serious Adverse Event"	2861156003	"Abscess in right groin (ingrown hair)"	43	51	NA	2	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488726347	""	""	""	NA	"Abscess"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Abscess"	""	""	""	""	""	""	""	""	""	""	""	""
"320"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	5	9	"Adverse Event/Serious Adverse Event"	2907946001	"Allergic Reaction"	3	3	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486047905	""	""	""	NA	"Allergic reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"321"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	5	9	"Adverse Event/Serious Adverse Event"	3153571001	"Edema (both ankles)"	72	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493730434	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"322"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	5	9	"Adverse Event/Serious Adverse Event"	2922017001	"Fever"	12	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486489988	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"323"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	5	9	"Adverse Event/Serious Adverse Event"	3124967001	"Infected Sebaceous cyst on back of neck"	105	192	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493070683	""	""	""	NA	"Infected sebaceous cyst"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Infected sebaceous cyst"	""	""	""	""	""	""	""	""	""	""	""	""
"324"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	5	9	"Adverse Event/Serious Adverse Event"	3019783001	"Infected Sebaceous cyst on back of neck"	65	104	NA	2	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490205888	""	""	""	NA	"Infected sebaceous cyst"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Infected sebaceous cyst"	""	""	""	""	""	""	""	""	""	""	""	""
"325"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	5	9	"Adverse Event/Serious Adverse Event"	2907962001	"Myalgia"	4	9	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486048007	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"326"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	5	9	"Adverse Event/Serious Adverse Event"	2977406001	"Myalgia"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488726443	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"327"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	5	9	"Adverse Event/Serious Adverse Event"	4021138001	"Pneumonia"	298	301	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalisation on Friday November 2nd."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	304	NA	NA	298	301	"Not available"	""	""	2	2	2	2	2	2	2	2	"Patient was admitted to Rockyview hospital on November 2nd because of pneumonia. Patient was discharged on November 5."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510167019	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"328"	"DN-101 Protocol No. 011-007"	"003"	"003-0006"	5	9	"Adverse Event/Serious Adverse Event"	3740269001	"Rectal Bleeding"	247	261	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506021199	""	""	""	NA	"Rectal bleeding"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Intestinal haemorrhages"	"Rectal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"329"	"DN-101 Protocol No. 011-007"	"003"	"003-0007"	5	9	"Adverse Event/Serious Adverse Event"	2878819003	"Alopecia"	117	349	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494770245	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"330"	"DN-101 Protocol No. 011-007"	"003"	"003-0007"	5	9	"Adverse Event/Serious Adverse Event"	4384569001	"Constipation"	313	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515087507	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"331"	"DN-101 Protocol No. 011-007"	"003"	"003-0007"	5	9	"Adverse Event/Serious Adverse Event"	4384631001	"increased right sciatic pain (right buttock)"	313	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515087740	""	""	""	NA	"Sciatica"	"Nervous system disorders"	"Spinal cord and nerve root disorders"	"Lumbar spinal cord and nerve root disorders"	"Sciatica"	""	""	""	""	""	""	""	""	""	""	""	""
"332"	"DN-101 Protocol No. 011-007"	"003"	"003-0007"	5	9	"Adverse Event/Serious Adverse Event"	3048496001	"Nail Changes"	77	349	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490901451	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"333"	"DN-101 Protocol No. 011-007"	"003"	"003-0007"	5	9	"Adverse Event/Serious Adverse Event"	3467380001	"Peripheral neuropathy at fingertips"	140	349	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501449997	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"334"	"DN-101 Protocol No. 011-007"	"003"	"003-0007"	5	9	"Adverse Event/Serious Adverse Event"	3115313001	"Tenderness in fingertips"	78	88	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492949111	""	""	""	NA	"Pain in fingers"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"335"	"DN-101 Protocol No. 011-007"	"003"	"003-0007"	5	9	"Adverse Event/Serious Adverse Event"	2992602001	"Transient Numbness in fingertips"	48	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489338813	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"336"	"DN-101 Protocol No. 011-007"	"003"	"003-0007"	5	9	"Adverse Event/Serious Adverse Event"	4384708001	"Urinary Tract Infection"	313	318	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515087958	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"337"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	2894198003	"Alopecia"	23	330	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939071	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"338"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	3463641001	"Anemia"	161	330	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Transfusion"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501188248	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"339"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	3463653001	"Bruising Left Forearm"	170	330	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501188312	""	""	""	NA	"Bruising of arm"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"340"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	3007704001	"Decreased Hemoglobin"	28	182	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939432	""	""	""	NA	"Decreased hemoglobin"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"341"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	3463678001	"Excess Lacrimation"	161	330	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501188460	""	""	""	NA	"Lacrimation"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"342"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	3463696001	"Excess Saliva"	161	330	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501188521	""	""	""	NA	"Saliva secretion excessive"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Salivary gland disorders NEC"	"Salivary hypersecretion"	""	""	""	""	""	""	""	""	""	""	""	""
"343"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	3007715001	"Fatigue"	49	330	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939588	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"344"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	3144484001	"Left Leg Edema"	67	330	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient had Doppler Ultrasound"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493575713	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"345"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	3007710001	"Muscle Aches"	49	330	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939523	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"346"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	3007691001	"Nail Changes"	28	330	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939266	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"347"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	3202675001	"Right femoral head and neck fracture - pathologic"	112	132	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"Patient Hospitalised"	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	112	NA	NA	112	118	"Fracture was pinned while in hospital. Pins removed 2 weeks after discharge (June 5). Conmeds have been updated with medication taken while in hospital."	""	""	2	2	2	NA	2	2	NA	2	"notified patient was admitted to unit 47 of FMC with fractured hip. No other information available;;fracture was unrelated to the drug but was related to disease. He was admitted, had the fracture"	"pinned and released once he had recovered. All medications and imaging were related to identifying the fracture and managing the pain."	""	""	""	""	""	""	""	""	""	NA	NA	""	1494961334	""	""	""	NA	"Pathologic fracture of neck of femur"	"Musculoskeletal and connective tissue disorders"	"Fractures"	"Pathological fractures and complications"	"Pathological fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"348"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	3007674001	"Sensory Neuropathy (fingertips of both hands)"	28	330	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939168	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"349"	"DN-101 Protocol No. 011-007"	"003"	"003-0009"	5	9	"Adverse Event/Serious Adverse Event"	3305827001	"Weight Loss"	NA	330	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497972841	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"350"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	5	9	"Adverse Event/Serious Adverse Event"	2901157003	"Anhedonia"	49	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492086979	""	""	""	NA	"Anhedonia"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Mood alterations with depressive symptoms"	"Anhedonia"	""	""	""	""	""	""	""	""	""	""	""	""
"351"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	5	9	"Adverse Event/Serious Adverse Event"	3151177001	"Decrease in muscle strength"	90	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493666910	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"352"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	5	9	"Adverse Event/Serious Adverse Event"	3007747001	"Fatigue"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489939907	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"353"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	5	9	"Adverse Event/Serious Adverse Event"	3007755001	"generalized achiness"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489940095	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"354"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	5	9	"Adverse Event/Serious Adverse Event"	3007762001	"Nail Changes"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489940201	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"355"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	5	9	"Adverse Event/Serious Adverse Event"	3083660001	"Pain in Right Hip"	13	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492087243	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"356"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	5	9	"Adverse Event/Serious Adverse Event"	2962729001	"Pain in sternum"	13	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487855784	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"357"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	5	9	"Adverse Event/Serious Adverse Event"	3151169001	"Peripheral Edema- Bilateral (feet)"	80	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493666846	""	""	""	NA	"Foot edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"358"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	5	9	"Adverse Event/Serious Adverse Event"	2962726001	"sensory neuropathy"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487855714	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"359"	"DN-101 Protocol No. 011-007"	"003"	"003-0010"	5	9	"Adverse Event/Serious Adverse Event"	3186287001	"Sweats (diaphoresis)"	90	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494780325	""	""	""	NA	"Diaphoresis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"360"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	2926334003	"Abdominal Pain"	NA	126	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497460414	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"361"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	3506122001	"Alopecia"	82	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502214425	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"362"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	3122339001	"Edema- lower limbs"	79	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493045444	""	""	""	NA	"Edema lower limb"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"363"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	3289763001	"Fatigue"	106	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497460278	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"364"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	4951927002	"Hematuria"	NA	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519587224	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"365"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	3154270001	"Hydronephrosis"	87	95	NA	3	2	NA	1	NA	NA	NA	2	NA	1	7	1	1	1	"Patient had a right retrograde pyelogram, uretheroscopy and strent placement on 04/27/2007"	0	0	NA	0	104	NA	NA	NA	1	NA	1	1	"Patient required to have a right retrograde pyelogram, an uretheroscopy and a stent placement."	98	NA	NA	87	95	"CT of Abdomen, Right Ureteroscopy on 04/27/2007, Stent inserted on 04/27/2007. Patient given cipro and Tylenol #3. Patient discharged 04/29/2007."	""	""	2	2	2	NA	1	2	NA	0	"Patient being dealyed one week from treatment but still contuning to take prednisone. Patient now has been re-introduced. No problems thus far."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493744326	""	""	""	NA	"Hydronephrosis"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal obstructive disorders"	"Hydronephrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"366"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	4952236002	"Hypertension"	300	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519589981	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"367"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	4189467001	"Orhtostatic hypotension"	311	311	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Prolonged hospitalisation. Code 66."	0	0	NA	0	24	NA	NA	NA	1	1	NA	NA	""	314	NA	NA	300	362	"Troponin levels:; December 1 - 0.14ug/L; PTT:; December 1 - 65.9 sec; INR:; December 1 - 1.3; Hemoglobin:; December 1 - 88g/L; Hematocrit:; December 1 - 0.26 L/L; RBC:; December 1 - 3.1"	""	""	2	2	2	NA	2	2	NA	2	"While patient was in hospital for increased creatinine (November 20th) he suffered a PE on November 28th and then had suspected hypertension and had a fainting spell on December 1 resulting in a"	"'Code 66', which is what is called before full Cardiac Arrest. He also had elevated troponin levels.;;He had continued bleeding, dizziness, edema and hematuria after starting anticoagulant treatment"	"for the PE and hypotensive problems. This was suspended temporarily to control the bleeding. He underwent a TURP procedure, which helped with the hematuria. Once this was under control he re-started"	"on anticoagulants. Hospitalisation continued until the edema reduced and he was able to be discharged."	""	""	""	""	""	""	""	NA	NA	""	1512425167	""	""	""	NA	"Hypotension orthostatic"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Orthostatic hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"368"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	3506183001	"Peripheral Neuropathy"	177	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502214637	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"369"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	4189368001	"Pulmonary Embolism"	308	NA	1	4	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	2	0	NA	0	24	NA	NA	NA	1	1	NA	NA	""	314	NA	NA	300	362	"Abnormal results from November 28:; Hemoglobin 103 g/L; Hematocrit 0.31 L/L; RBC 3.6; RDW 16.2%; INR 1.2; PTT 53.9 sec; Albumin 28 g/L; Radiologist confirmed Pumonary Embolism (V/Q Scan)"	""	""	2	2	2	NA	2	2	NA	2	"Patient was in hospital for elevated creatinine. While there he suffered a PE on Novmeber 28th from a blood clot and went into Code Blue. He has had an IVC placed on December 30th. He also has been"	"given anticoagulants to treat this.;;Anticoagulant treatment was complitated by hematuria. He temporarily suspended his anticoagulants until the bleeding was resolved by a TURP in December. He now"	"continues on anticoagulants."	""	""	""	""	""	""	""	""	NA	NA	""	1512424835	""	""	""	NA	"Pulmonary embolism"	"Respiratory, thoracic and mediastinal disorders"	"Pulmonary vascular disorders"	"Pulmonary thrombotic and embolic conditions"	"Pulmonary embolism"	""	""	""	""	""	""	""	""	""	""	""	""
"370"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	4189223001	"Urinary tension"	300	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalisation"	2	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	314	NA	NA	300	362	"Creatinine levels:;November 20 - 602 umol/L;November 21 - 463 umol/L;November 22 - 408 umol/L;Novmeber 23 - 351 umol/L;Novmeber 24 - 263 umol/L;November 25 - 254 umol/L;November 26 - 232"	"umol/L;Novmeber 30 - 244 umol/L;December 1 - 214 umol/L;December 5 - 177 umol/L"	""	2	2	2	NA	2	2	NA	2	"Patient advised to go to ER for elevated creatinine. Was admitted to Rockyview General Hospital on November 20th for treatment. Had a catheter placed and underwent a TURP.;;While there he had a"	"Pulmonary Embolism on the 28th of November and a hypotensive crisis on December 1."	""	""	""	""	""	""	""	""	""	NA	NA	""	1512424539	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"371"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	2992588001	"Vesicular Rash (left hand)"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489338636	""	""	""	NA	"Rash vesicular"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash vesicular"	""	""	""	""	""	""	""	""	""	""	""	""
"372"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	2992569001	"Vesicular rash (left hand)"	21	33	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489338454	""	""	""	NA	"Rash vesicular"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash vesicular"	""	""	""	""	""	""	""	""	""	""	""	""
"373"	"DN-101 Protocol No. 011-007"	"003"	"003-0011"	5	9	"Adverse Event/Serious Adverse Event"	3289767001	"Weight Loss"	126	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497460341	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"374"	"DN-101 Protocol No. 011-007"	"003"	"003-0012"	5	9	"Adverse Event/Serious Adverse Event"	3144701003	"Breast Tenderness"	49	226	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498483450	""	""	""	NA	"Breast tenderness"	"Reproductive system and breast disorders"	"Breast disorders"	"Breast signs and symptoms"	"Breast tenderness"	""	""	""	""	""	""	""	""	""	""	""	""
"375"	"DN-101 Protocol No. 011-007"	"003"	"003-0012"	5	9	"Adverse Event/Serious Adverse Event"	3463738001	"Peripheral Neuropathy - fingertips"	76	226	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501188898	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"376"	"DN-101 Protocol No. 011-007"	"003"	"003-0012"	5	9	"Adverse Event/Serious Adverse Event"	3324217001	"Sweats"	49	226	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498483381	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"377"	"DN-101 Protocol No. 011-007"	"003"	"003-0013"	5	9	"Adverse Event/Serious Adverse Event"	3185622003	"Alopecia"	43	243	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505064695	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"378"	"DN-101 Protocol No. 011-007"	"003"	"003-0013"	5	9	"Adverse Event/Serious Adverse Event"	3467453001	"Bilateral Ankle Edema"	62	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501450854	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"379"	"DN-101 Protocol No. 011-007"	"003"	"003-0013"	5	9	"Adverse Event/Serious Adverse Event"	3541404001	"Fatigue"	53	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502918066	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"380"	"DN-101 Protocol No. 011-007"	"003"	"003-0013"	5	9	"Adverse Event/Serious Adverse Event"	3541408001	"Lacrimation"	84	205	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502918146	""	""	""	NA	"Lacrimation"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"381"	"DN-101 Protocol No. 011-007"	"003"	"003-0013"	5	9	"Adverse Event/Serious Adverse Event"	3275205001	"Myalgia"	10	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496950728	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"382"	"DN-101 Protocol No. 011-007"	"003"	"003-0013"	5	9	"Adverse Event/Serious Adverse Event"	3656101001	"Nail Changes"	112	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505064648	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"383"	"DN-101 Protocol No. 011-007"	"003"	"003-0013"	5	9	"Adverse Event/Serious Adverse Event"	3467445001	"Peripheral Neuropathy"	62	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501450757	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"384"	"DN-101 Protocol No. 011-007"	"003"	"003-0013"	5	9	"Adverse Event/Serious Adverse Event"	3541416001	"Taste Disturbance"	84	243	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502918216	""	""	""	NA	"Taste disturbance"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"385"	"DN-101 Protocol No. 011-007"	"003"	"003-0014"	5	9	"Adverse Event/Serious Adverse Event"	3185796003	"Atrial Fibrillation"	183	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1525183860	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"386"	"DN-101 Protocol No. 011-007"	"003"	"003-0014"	5	9	"Adverse Event/Serious Adverse Event"	3344286001	"Bilateral Lower Leg Edema"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498753619	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"387"	"DN-101 Protocol No. 011-007"	"003"	"003-0014"	5	9	"Adverse Event/Serious Adverse Event"	3274898001	"Constipation"	11	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496947747	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"388"	"DN-101 Protocol No. 011-007"	"003"	"003-0014"	5	9	"Adverse Event/Serious Adverse Event"	3344280001	"Fatigue"	32	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498753458	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"389"	"DN-101 Protocol No. 011-007"	"003"	"003-0014"	5	9	"Adverse Event/Serious Adverse Event"	3274879001	"Myalgia"	9	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496947616	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"390"	"DN-101 Protocol No. 011-007"	"003"	"003-0014"	5	9	"Adverse Event/Serious Adverse Event"	3752461001	"Peripheral Neuropathy, both feet"	133	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506290868	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"391"	"DN-101 Protocol No. 011-007"	"003"	"003-0014"	5	9	"Adverse Event/Serious Adverse Event"	3938810001	"Peripheral Neuropathy, both feet"	145	NA	1	3	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"Patient has stopped treatment as of 10 OCT 2007."	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508956983	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"392"	"DN-101 Protocol No. 011-007"	"003"	"003-0014"	5	9	"Adverse Event/Serious Adverse Event"	3655755001	"Peripheral Neuropathy, both feet"	112	133	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505062979	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"393"	"DN-101 Protocol No. 011-007"	"003"	"003-0014"	5	9	"Adverse Event/Serious Adverse Event"	3467520001	"Peripheral Neuropathy, Both Feet"	62	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501451404	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"394"	"DN-101 Protocol No. 011-007"	"003"	"003-0014"	5	9	"Adverse Event/Serious Adverse Event"	3344283001	"Skin Lesion on Left Shoulder"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Consutation with dermatologist"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498753548	""	""	""	NA	"Skin lesion"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin lesion"	""	""	""	""	""	""	""	""	""	""	""	""
"395"	"DN-101 Protocol No. 011-007"	"003"	"003-0014"	5	9	"Adverse Event/Serious Adverse Event"	3274924001	"Urinary Retention"	14	15	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496947941	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"396"	"DN-101 Protocol No. 011-007"	"003"	"003-0015"	5	9	"Adverse Event/Serious Adverse Event"	3271840003	"Alopecia"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501449785	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"397"	"DN-101 Protocol No. 011-007"	"003"	"003-0015"	5	9	"Adverse Event/Serious Adverse Event"	3553499001	"Bruising"	78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503257503	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"398"	"DN-101 Protocol No. 011-007"	"003"	"003-0015"	5	9	"Adverse Event/Serious Adverse Event"	3553534001	"constipation"	78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503257779	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"399"	"DN-101 Protocol No. 011-007"	"003"	"003-0015"	5	9	"Adverse Event/Serious Adverse Event"	3656464001	"Fatigue"	90	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505066163	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"400"	"DN-101 Protocol No. 011-007"	"003"	"003-0015"	5	9	"Adverse Event/Serious Adverse Event"	4117597001	"Febrile Neutropenia"	175	190	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Patient was admitted to hospital for IV antibiotics."	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	183	NA	NA	176	180	"Fingernail removed by Plastics. White cell count of 2.2 with neutrophils at 0.3. Patient received Tazocin and Vancomycin initially and then switched to Levofloxacin and Vancomycin. Patient was"	"discharged with 5 days worth of Levofloxacin."	""	2	2	0	2	0	0	2	0	"Patient came in on the 15th of November regarding an infection on his hand and a fever. He was sent for bloodwork. He was found to be neuropenic due to the infection and admitted to hospital for IV"	"antibiotic treatment on the 16th of November. He is recovering and was discharged on the 20th."	""	""	""	""	""	""	""	""	""	NA	NA	""	1511473348	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"401"	"DN-101 Protocol No. 011-007"	"003"	"003-0015"	5	9	"Adverse Event/Serious Adverse Event"	3656522001	"Headache"	90	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"will be seeing a cardiologist"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505066376	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"402"	"DN-101 Protocol No. 011-007"	"003"	"003-0015"	5	9	"Adverse Event/Serious Adverse Event"	3553521001	"Mucositis - Oral"	78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503257698	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"403"	"DN-101 Protocol No. 011-007"	"003"	"003-0015"	5	9	"Adverse Event/Serious Adverse Event"	4352463001	"Nail Bed Infection (nail changes)"	175	190	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514475373	""	""	""	NA	"Nail bed infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Nail bed infection"	""	""	""	""	""	""	""	""	""	""	""	""
"404"	"DN-101 Protocol No. 011-007"	"003"	"003-0015"	5	9	"Adverse Event/Serious Adverse Event"	3553505001	"Nail changes"	78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503257557	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"405"	"DN-101 Protocol No. 011-007"	"003"	"003-0015"	5	9	"Adverse Event/Serious Adverse Event"	3656483001	"Non-fasting hyperglycemia"	99	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505066244	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"406"	"DN-101 Protocol No. 011-007"	"003"	"003-0015"	5	9	"Adverse Event/Serious Adverse Event"	3656543001	"Peripheral Neuropathy"	90	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient will be seeing a cardiologist"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505066437	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"407"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2467135004	"Anemia"	399	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506271288	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"408"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2535888001	"Anemia"	27	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"409"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608670001	"anemia"	99	237	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468412223	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"410"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	5308949002	"back pain"	407	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1524066560	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"411"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	4904574002	"Cellulitis of the left foot"	532	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519055304	""	""	""	NA	"Cellulitis of foot"	"Infections and infestations"	"Bacterial infectious disorders"	"Bacterial infections NEC"	"Cellulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"412"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608706001	"chest pain, cardiac"	30	34	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468414541	""	""	""	NA	"Chest pain - cardiac"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"413"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608695001	"constipation"	35	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468413384	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"414"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	4904829002	"constipation"	386	407	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519056202	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"415"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2590317001	"Cough"	71	87	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465738044	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"416"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608661001	"cough"	92	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468411831	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"417"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608709001	"dyspnea"	137	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468414850	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"418"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608655001	"erythematous left leg"	113	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468411641	""	""	""	NA	"Erythema"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"419"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608658001	"fatigue"	120	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468411764	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"420"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2534342001	"Fatigue"	13	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"421"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2584247001	"Fatigue"	93	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465223061	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"422"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2574325001	"Fatigue"	71	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463496026	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"423"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2584255001	"Frequency of urination intermittent"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465223202	""	""	""	NA	"Frequency urinary"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"424"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2535823001	"Hypotension"	8	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"425"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2534352001	"Insomnia"	11	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"426"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608664001	"peripheral neuropathy"	148	244	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468411923	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"427"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608698001	"phlebitis r fore arm"	44	46	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"ice pack to affected area 3 x day"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468413759	""	""	""	NA	"Phlebitis arm"	"Vascular disorders"	"Vascular inflammations"	"Phlebitis NEC"	"Phlebitis"	""	""	""	""	""	""	""	""	""	""	""	""
"428"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608667001	"steroid myopathy"	148	244	NA	2	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468412122	""	""	""	NA	"Steroid myopathy"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Myopathies"	"Myopathy steroid"	""	""	""	""	""	""	""	""	""	""	""	""
"429"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2535844001	"Tachycardia"	8	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"430"	"DN-101 Protocol No. 011-007"	"005"	"005-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608673001	"thrombocytopenia"	118	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468412303	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"431"	"DN-101 Protocol No. 011-007"	"006"	"006-0001"	5	9	"Adverse Event/Serious Adverse Event"	2532056003	"Acute DVT of the left lower extremity"	180	183	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	286	NA	NA	180	183	"DVT ultrasound 8/22/06 which showed left sided common DVT and a superficial venous thrombosis on th right."	""	""	2	2	2	NA	2	2	NA	2	"Patient was seen by his urologist on the day of admissions to schedule cystoscopy and ureteral stent change. The physician noticed an increased left lower extremity swelling. Patient was admitted to"	"the hospital for management of anticoagulation. The patient was placed on heparin at first pending his stent replacement. Once stent replacement was complete, the patient was instructed on Lovenox"	"injections and coumadin. Patient was discharged."	""	""	""	""	""	""	""	""	NA	NA	""	1481040292	""	""	""	NA	"DVT"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"432"	"DN-101 Protocol No. 011-007"	"006"	"006-0001"	5	9	"Adverse Event/Serious Adverse Event"	2567297001	"Blood in urine"	53	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481121149	""	""	""	NA	"Blood in urine"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Urinalysis NEC"	"Blood urine present"	""	""	""	""	""	""	""	""	""	""	""	""
"433"	"DN-101 Protocol No. 011-007"	"006"	"006-0001"	5	9	"Adverse Event/Serious Adverse Event"	5292197002	"Constipation"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523545730	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"434"	"DN-101 Protocol No. 011-007"	"006"	"006-0001"	5	9	"Adverse Event/Serious Adverse Event"	2809275001	"Neutropenia"	43	50	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481121403	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"435"	"DN-101 Protocol No. 011-007"	"006"	"006-0001"	5	9	"Adverse Event/Serious Adverse Event"	2545415001	"Syncopal episode"	18	20	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	27	NA	NA	18	20	"3/13/06 EKG with normal sinus rhythm; 3/13/06 Basic metabolic panel with BUN 32, Creatinine 1.0, sodium 131; 3/13/06 Hgb 11.4; and 3/13/06 chest x-ray normal."	""	""	2	2	2	2	2	2	2	2	"Patient was at home when he fainted. He presented to the emergency room without chest pain, palpitations or shortness of breath. Patient was admitted to the cardiac floor for monitoring. Patient"	"discharged on 3/15/06."	""	""	""	""	""	""	""	""	""	NA	NA	""	1521041626	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"436"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	5	9	"Adverse Event/Serious Adverse Event"	2551328003	"Bone Pain from Prostate Cancer"	203	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481129033	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"437"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	5	9	"Adverse Event/Serious Adverse Event"	2658236001	"Dizziness"	46	67	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472574810	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"438"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	5	9	"Adverse Event/Serious Adverse Event"	2658148001	"Intermittent Constipation"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472573314	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"439"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	5	9	"Adverse Event/Serious Adverse Event"	2658208001	"Left Leg Edema"	109	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472574487	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"440"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	5	9	"Adverse Event/Serious Adverse Event"	2658222001	"Lightheaded"	46	67	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472574591	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"441"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	5	9	"Adverse Event/Serious Adverse Event"	2567192001	"Lower Left Back Pain"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"442"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	5	9	"Adverse Event/Serious Adverse Event"	2658203001	"Neutropenia"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472574433	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"443"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	5	9	"Adverse Event/Serious Adverse Event"	2567224001	"skin rash"	10	46	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469017955	""	""	""	NA	"Skin rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"444"	"DN-101 Protocol No. 011-007"	"006"	"006-0002"	5	9	"Adverse Event/Serious Adverse Event"	2616287001	"Swelling in both legs"	82	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469041585	""	""	""	NA	"Swelling of legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"445"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	2877452003	"Allergies-seasonal"	91	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523460352	""	""	""	NA	"Seasonal allergy"	"Immune system disorders"	"Allergic conditions"	"Atopic disorders"	"Seasonal allergy"	""	""	""	""	""	""	""	""	""	""	""	""
"446"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	3627613001	"Arthritis"	20	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504629413	""	""	""	NA	"Arthritis"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Arthropathies NEC"	"Arthritis"	""	""	""	""	""	""	""	""	""	""	""	""
"447"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	3627631001	"Back Pain"	6	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504629556	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"448"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	4868696002	"Bad taste in mouth"	207	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518545434	""	""	""	NA	"Bad taste"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"449"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	4868634002	"Dry eyes"	207	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518545293	""	""	""	NA	"Dry eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Dry eye"	""	""	""	""	""	""	""	""	""	""	""	""
"450"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	4868450002	"edema in ankle"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518544909	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"451"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	3626839001	"Fatigue"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504626579	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"452"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	5287042002	"Heart burn"	153	399	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523460708	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"453"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	3628012001	"Increased Pain"	132	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504630832	""	""	""	NA	"Pain exacerbated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"454"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	3189652001	"Intermittant Constipation"	8	96	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient was hydrated"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494794409	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"455"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	4868365002	"Mouth sores"	NA	NA	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518544558	""	""	""	NA	"Sores mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"456"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	3627667001	"Neuropathy"	91	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504629760	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"457"	"DN-101 Protocol No. 011-007"	"008"	"008-0001"	5	9	"Adverse Event/Serious Adverse Event"	4868790002	"weakness"	237	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Reduced dose of Ketoconazole"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518545711	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"458"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	5	9	"Adverse Event/Serious Adverse Event"	2833683003	"Dermatology/Skin-other: peeling, cracking"	80	150	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489949708	""	""	""	NA	"Skin peeling"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Exfoliative conditions"	"Skin exfoliation"	""	""	""	""	""	""	""	""	""	""	""	""
"459"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	5	9	"Adverse Event/Serious Adverse Event"	2917463001	"hypersensitive reaction"	45	45	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient c/o flushing and lightheadedness 10 min. after docetaxel started.  Docetaxel infusion stopped for 15 min.  Symptoms resolved.  Docetaxel resumed and completed without any further symptoms."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486397438	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"460"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	5	9	"Adverse Event/Serious Adverse Event"	2970643001	"increased frequency of headache"	50	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488306291	""	""	""	NA	"Frequent headaches"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"461"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	5	9	"Adverse Event/Serious Adverse Event"	2871064001	"low neutrophils"	10	17	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484495592	""	""	""	NA	"Neutrophil count low"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"462"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	5	9	"Adverse Event/Serious Adverse Event"	3271833001	"peripheral sensory neuropathy"	150	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496866434	""	""	""	NA	"Peripheral sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"463"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	5	9	"Adverse Event/Serious Adverse Event"	3271883001	"urinary retention"	162	162	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496866668	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"464"	"DN-101 Protocol No. 011-007"	"009"	"009-0004"	5	9	"Adverse Event/Serious Adverse Event"	3271855001	"urinary urgency"	147	162	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496866541	""	""	""	NA	"Urinary urgency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Micturition urgency"	""	""	""	""	""	""	""	""	""	""	""	""
"465"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	2909829003	"1/6 systolic flow murmur"	47	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495467994	""	""	""	NA	"Systolic murmur"	"Investigations"	"Cardiac and vascular investigations (excl enzyme tests)"	"Cardiac auscultatory investigations"	"Cardiac murmur"	""	""	""	""	""	""	""	""	""	""	""	""
"466"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	4954533002	"aphasia"	197	197	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519597666	""	""	""	NA	"Aphasia"	"Nervous system disorders"	"Neurological disorders NEC"	"Cortical dysfunction NEC"	"Aphasia"	""	""	""	""	""	""	""	""	""	""	""	""
"467"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3807627001	"bilateral carotid atherosclerosis"	196	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507065548	""	""	""	NA	"Atherosclerosis"	"Vascular disorders"	"Arteriosclerosis, stenosis, vascular insufficiency and necrosis"	"Non-site specific necrosis and vascular insufficiency NEC"	"Arteriosclerosis"	""	""	""	""	""	""	""	""	""	""	""	""
"468"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	2944206001	"bladder obstruction secondary to hematuria"	13	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	7	1	1	1	"ultrasound; catheterization w/ continuous bladder irrigation"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	14	NA	NA	13	16	"2/13/07:  Urinalysis showing gross hematuria; 2/14/07:	Catheterization for continuous bladder irrigation.  02/14/07:  Ultrasound prior to catheterization"	""	""	2	2	2	NA	2	2	NA	2	"2/13/07--Pt in office for routine hematology.  Used restroom after arrival; afterward stated had just urinated blood; had not had this prior.  Collected urine specimen; result gross hematuria. Cipro"	"ordered.  Patient instructed to call office if new or worsening symptoms.  2/14/07 a.m. patient called office with complaint of unable to urinate since he was in our office the previous day.	Dr."	"Mark Hutchins instructed patient to go to hospital ER for examination, catheterization.  BryanLGH West hospital called re: patient's impending arrival.  In the ER, patient catheterized, bladder"	"irrigated; quite a few blood clots irrigated.  Ultrasound performed showing no hydronephrosis; 5mm known calculus lower pole left kidney unchanged; small clot in bladder; good-sized intravesical"	"component of bladder with prostate cancer protuding into bladder.  Patient admitted and 3-way Foley catheter placed for continuous bladder irrigation.	Patient to be re-evaluted on 2/15/07; further"	"reports to follow."	""	""	""	""	""	NA	NA	""	1487169896	""	""	""	NA	"Bladder obstruction"	"Renal and urinary disorders"	"Bladder and bladder neck disorders (excl calculi)"	"Bladder disorders NEC"	"Bladder obstruction"	""	""	""	""	""	""	""	""	""	""	""	""
"469"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3230833001	"bruising"	89	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495468532	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"470"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3810986001	"chronic obstructive pulmonary disease"	187	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507128914	""	""	""	NA	"Chronic obstructive pulmonary disease"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Chronic obstructive pulmonary disease"	""	""	""	""	""	""	""	""	""	""	""	""
"471"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3807688001	"congestive heart failure"	176	NA	1	3	2	NA	1	NA	NA	NA	1	1	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507065836	""	""	""	NA	"Congestive heart failure"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"472"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3810896001	"diabetes mellitus"	187	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507128447	""	""	""	NA	"Diabetes mellitus"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Diabetes mellitus (incl subtypes)"	"Diabetes mellitus"	""	""	""	""	""	""	""	""	""	""	""	""
"473"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3807613001	"dyspnea"	244	279	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507065437	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"474"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	2944233001	"hematuria"	12	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487170581	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"475"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3230787001	"hematuria"	36	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495467585	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"476"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3230790001	"hematuria"	76	81	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495467665	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"477"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3230796001	"hypersensitivity reaction"	26	26	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495467860	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"478"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3230822001	"intermittent heartburn"	29	152	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495468331	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"479"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3230830001	"intermittent tearing"	89	279	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495468460	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"480"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3230815001	"mild epistaxis"	33	47	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495468266	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"481"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	4324378001	"myocardial infarction"	175	175	NA	4	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	176	NA	NA	175	187	"Lab 7/26/07: BNP elevated at 679. Echo 7/27/07: EF 30%."	""	""	2	2	2	NA	2	2	NA	2	"Patient called in a.m. with complaint of shortness of breath and increasing muscle pain.  Was asked to come to office to be examined.  After examination, he was sent for admission to hospital to rule"	"out pulmonary emboli vs pneumonia.  More details will be reported as received.;UPDATE:	Discharge diagnosis: acute myocardial infarction; congestive heart failure; right lower lobe pneumonia."	"Symptomatically improved and stable upon discharge to home on 08/07/07."	""	""	""	""	""	""	""	""	NA	NA	""	1513780860	""	""	""	NA	"Myocardial infarction"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Myocardial infarction"	""	""	""	""	""	""	""	""	""	""	""	""
"482"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	4954408002	"onycholysis"	131	175	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519597249	""	""	""	NA	"Onycholysis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onycholysis"	""	""	""	""	""	""	""	""	""	""	""	""
"483"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	4960456002	"onycholysis"	175	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519658952	""	""	""	NA	"Onycholysis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onycholysis"	""	""	""	""	""	""	""	""	""	""	""	""
"484"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3230793001	"oral mucositis"	28	202	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495467733	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"485"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3810919001	"pneumonia"	175	236	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507128651	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"486"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3807727001	"renal insufficiency"	197	199	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507066023	""	""	""	NA	"Renal insufficiency"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure"	""	""	""	""	""	""	""	""	""	""	""	""
"487"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3807574001	"sinus congestion"	202	279	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507065315	""	""	""	NA	"Sinus congestion"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Sinus congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"488"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3551027001	"transient ischemic attack"	197	197	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	200	NA	NA	197	199	"negative CT head on 8/16/07 (ER prior to admission); negative MRI head on 8/17/07; carotid duplex exam 8/17/07showing carotid atherosclerosis.	Neurologist recommended anticoagulation with Lovenox"	"and Coumadin."	""	2	2	2	NA	2	2	NA	2	"Patient went to ER after developing sudden onset aphasia the night of 8/17/07.	Denied weakness, facial droop, dizziness, but did have slurred speech.	Patient was admitted for further tests.  Those"	"reports have been requested.  Updated information will be reported as received.  Patient was discharged 8/19/07."	""	""	""	""	""	""	""	""	""	NA	NA	""	1503238487	""	""	""	NA	"Transient ischemic attacks"	"Nervous system disorders"	"Central nervous system vascular disorders"	"Transient cerebrovascular events"	"Transient ischaemic attack"	""	""	""	""	""	""	""	""	""	""	""	""
"489"	"DN-101 Protocol No. 011-007"	"009"	"009-0005"	5	9	"Adverse Event/Serious Adverse Event"	3230803001	"worsening sinus congestion"	33	202	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495468074	""	""	""	NA	"Sinus congestion"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Sinus congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"490"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	3505650003	"anemia"	9	86	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503612406	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"491"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	4197021001	"anemia"	86	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512498810	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"492"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	4196650001	"balanitis"	111	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512497865	""	""	""	NA	"Balanitis"	"Reproductive system and breast disorders"	"Male reproductive tract infections and inflammations"	"Penile and scrotal infections and inflammations"	"Balanitis"	""	""	""	""	""	""	""	""	""	""	""	""
"493"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	3741777001	"intermittent insomnia"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506029099	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"494"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	4343443001	"intermittent worsening constipation"	115	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514326998	""	""	""	NA	"Constipation aggravated"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"495"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	4334783001	"iron deficiency anemia"	119	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513878581	""	""	""	NA	"Iron deficiency anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemia deficiencies"	"Iron deficiency anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"496"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	3741760001	"mucositis/symptomatic/oral cavity"	36	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506028938	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"497"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	3918049001	"nail bed discoloration"	45	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508765300	""	""	""	NA	"Discoloration nail"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"498"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	3918042001	"nail changes-break easier"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508765225	""	""	""	NA	"Brittle nails"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onychoclasis"	""	""	""	""	""	""	""	""	""	""	""	""
"499"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	3535609001	"nausea"	2	9	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hospitalization"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	8	NA	NA	6	10	"Abdominal series x-ray on 8/13/07 showed no GI abnormalities."	""	""	2	2	2	NA	2	2	NA	2	"Patient historically had intermittent nausea and vomiting. He was taking oral Zofran prior to his first dose of study drug.He started the prednisone 5mg bid on 8/8/07 and received his first dose of"	"docetaxel on 8/9/07.  On 8/13/07 the patient was admitted to the hospital for worsening nausea and vomiting.  The hospital records state the worsening nausea and vomiting started since his docetaxel"	"on 8/9/07.  Per hospital records, the patient was started on IV fluids, was continuing his Reglan 10mg po before meals and at HS, and was started on a proton-pump inhibitor."	""	""	""	""	""	""	""	""	NA	NA	""	1502821100	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"500"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	3575935001	"neutropenia"	9	13	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503612307	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"501"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	4196616001	"oral candidal infection"	111	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512497785	""	""	""	NA	"Oral candida"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"502"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	4196004001	"urinary tract infection"	97	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512495679	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"503"	"DN-101 Protocol No. 011-007"	"009"	"009-0008"	5	9	"Adverse Event/Serious Adverse Event"	4285831001	"vomiting"	2	9	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hospitalization"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	8	NA	NA	6	10	"abdominal x-rays showed no evidence of obstruction"	""	""	2	2	2	NA	2	2	NA	2	"Patient historically had intermittent nausea and vomiting. He was taking oral Zofran prior to his first dose of study drug.He started the prednisone 5mg bid on 8/8/07 and received his first dose of"	"docetaxel on 8/9/07.  On 8/13/07 the patient was admitted to the hospital for worsening nausea and vomiting.  The hospital records state the worsening nausea and vomiting started since his docetaxel"	"on 8/9/07.  Per hospital records, the patient was started on IV fluids, was continuing his Reglan 10mg po before meals and at HS, and was started on a proton-pump inhibitor."	""	""	""	""	""	""	""	""	NA	NA	""	1513523098	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"504"	"DN-101 Protocol No. 011-007"	"009"	"009-0009"	5	9	"Adverse Event/Serious Adverse Event"	3521082003	"hand/foot syndrome"	96	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513095761	""	""	""	NA	"Hand and foot syndrome"	"Skin and subcutaneous tissue disorders"	"Skin and subcutaneous tissue disorders NEC"	"Skin and subcutaneous conditions NEC"	"Palmar-plantar erythrodysaesthesia syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"505"	"DN-101 Protocol No. 011-007"	"009"	"009-0009"	5	9	"Adverse Event/Serious Adverse Event"	3915360001	"intermittent constipation"	15	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508710643	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"506"	"DN-101 Protocol No. 011-007"	"009"	"009-0009"	5	9	"Adverse Event/Serious Adverse Event"	4252621001	"intermittent dizziness"	99	101	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513095645	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"507"	"DN-101 Protocol No. 011-007"	"009"	"009-0009"	5	9	"Adverse Event/Serious Adverse Event"	4252609001	"intermittent fatigue"	96	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513095582	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"508"	"DN-101 Protocol No. 011-007"	"009"	"009-0009"	5	9	"Adverse Event/Serious Adverse Event"	3770928001	"intermittent headache"	35	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506462012	""	""	""	NA	"Intermittent headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"509"	"DN-101 Protocol No. 011-007"	"009"	"009-0009"	5	9	"Adverse Event/Serious Adverse Event"	3705546001	"neurology other-intermittent tooth cold sensitivitiy"	29	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505766948	""	""	""	NA	"Sensitivity of teeth"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Dental pain and sensation disorders"	"Sensitivity of teeth"	""	""	""	""	""	""	""	""	""	""	""	""
"510"	"DN-101 Protocol No. 011-007"	"009"	"009-0010"	5	9	"Adverse Event/Serious Adverse Event"	3978455003	"back pain"	11	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516722461	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"511"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	2844494003	"Alopecia"	107	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493919850	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"512"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3864371001	"Anemia"	76	146	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507831897	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"513"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3864402001	"Anemia"	146	269	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507831966	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"514"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3160671001	"Constipation"	108	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493920689	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"515"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	4514570002	"constitutional Weakness"	63	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516134488	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"516"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	4514296002	"contitutional weight loss"	146	269	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516133913	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"517"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	4514624002	"dehydration"	63	66	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516134604	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"518"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3865246001	"dyspnea"	176	269	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507835468	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"519"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	4514508002	"ESOPHAGITIS"	63	76	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516134358	""	""	""	NA	"Esophagitis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Oesophagitis (excl infective)"	"Oesophagitis"	""	""	""	""	""	""	""	""	""	""	""	""
"520"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3160617001	"Fatigue"	107	269	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493919937	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"521"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	4514368002	"HEMATURIA"	66	76	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516134088	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"522"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3160667001	"Hematuria"	79	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493920581	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"523"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	4514685002	"Hemorhoids"	146	164	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516134707	""	""	""	NA	"Hemorrhoids"	"Gastrointestinal disorders"	"Gastrointestinal vascular conditions"	"Haemorrhoids and gastrointestinal varices (excl oesophageal)"	"Haemorrhoids"	""	""	""	""	""	""	""	""	""	""	""	""
"524"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3864986001	"hyperglycemia"	55	63	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507833883	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"525"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3865014001	"Hyperglycemia"	164	269	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507834023	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"526"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3864997001	"Hyperglycemia"	63	115	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507833956	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"527"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3068999001	"Infection-Select  Renal/Genitourinary   Urinary tract infection"	63	70	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"IV Fluid hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491510405	""	""	""	NA	"Genitourinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Genitourinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"528"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3864337001	"Infusion Reaction"	76	76	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507831699	""	""	""	NA	"Infusion related reaction"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion related reaction"	""	""	""	""	""	""	""	""	""	""	""	""
"529"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3864865001	"Leukopenia"	146	164	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507833431	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"530"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3864897001	"Leukopenia"	164	269	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507833534	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"531"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3864841001	"Leukopenia"	63	76	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507833366	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"532"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3864919001	"Neutropenia"	63	76	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507833621	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"533"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3864936001	"Neutropenia"	164	269	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507833685	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"534"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3865183001	"pain select Musculoskeleal bone"	176	269	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507835014	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"535"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3160625001	"Taste Alteration"	107	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493920026	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"536"	"DN-101 Protocol No. 011-007"	"011"	"011-0002"	5	9	"Adverse Event/Serious Adverse Event"	3160661001	"Weight Loss"	107	146	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493920459	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"537"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2653623003	"Anemia"	83	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479834220	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"538"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2785422001	"Anemia"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479834315	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"539"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2707148001	"chest pain-non cardiac"	32	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475603378	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"540"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2785372001	"Decrease total WBC"	78	83	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479833833	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"541"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2761340001	"Decubitus Ulcer"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"duoderm gel dressing"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478187864	""	""	""	NA	"Decubitus ulcer"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Skin injuries and mechanical dermatoses"	"Decubitus ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"542"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2785452001	"Deep venous thrombosis- left leg"	81	86	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"Admitted to hospital and found to have DVT left leg. reported initially as PE  and Dehydration. Need to add DVT"	83	NA	NA	81	86	"doppler ultrasound positive for acute thrombosis left leg on 11/12/2006"	""	""	2	2	2	NA	2	2	NA	2	"DVT left leg  and was admitted for anticoagulation"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479834652	""	""	""	NA	"Deep vein thrombosis leg"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"543"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2771349001	"Dehydration"	81	86	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV Fluids"	0	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"required admission for IV fluids"	83	NA	NA	81	86	"11/11/2006 clinical physical assessment by MD. no labs to support."	""	""	2	2	2	NA	2	0	NA	2	"Pt admitted to Kettering hospital on saturday Nov. 11, 2006 with clinical signs and symptoms of dehydration including weakness, somnolence, dry mouth.	To receive IV fluids to hydrate."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479048587	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"544"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2761312001	"hypoglycemia"	48	69	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478187447	""	""	""	NA	"Hypoglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hypoglycaemic conditions NEC"	"Hypoglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"545"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2761326001	"Irregular heart rate"	64	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"decreased dose of current conmed--Capoten"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478187571	""	""	""	NA	"Heart rate irregular"	"Investigations"	"Cardiac and vascular investigations (excl enzyme tests)"	"Heart rate and pulse investigations"	"Heart rate irregular"	""	""	""	""	""	""	""	""	""	""	""	""
"546"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690826001	"neuropathy"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474487596	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"547"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2761297001	"Neutropenia"	43	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478187340	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"548"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2785375001	"Neutropenia"	78	83	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479833948	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"549"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2707153001	"prolonged pt/inr"	32	34	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hold coumadin"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475603504	""	""	""	NA	"PT prolonged"	"Investigations"	"Haematology investigations (incl blood groups)"	"Coagulation and bleeding analyses"	"Prothrombin time prolonged"	""	""	""	""	""	""	""	""	""	""	""	""
"550"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2771386001	"Pulmonary Embolism"	81	86	NA	4	0	NA	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"Pulmonary embolism"	83	NA	NA	81	86	"D.Dimer 2520,  INR 1.3, PTT 29 drawn on 11/11/2006 Ultrasound and CT PE protocol positive for PE"	""	""	2	2	2	NA	2	2	NA	2	"Pt admitted to hospital on 11/11/06 with weakness, dyspnea, and dehydration and was found to have a very high D. Dimer and Pulmonary embolism.	Placed on anticoagulant therapy."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479049298	""	""	""	NA	"Pulmonary embolism"	"Respiratory, thoracic and mediastinal disorders"	"Pulmonary vascular disorders"	"Pulmonary thrombotic and embolic conditions"	"Pulmonary embolism"	""	""	""	""	""	""	""	""	""	""	""	""
"551"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690822001	"thrush"	14	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474487488	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"552"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2785389001	"Thrush"	78	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479834038	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"553"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2707134001	"weakness"	32	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475603274	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"554"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2785398001	"Weakness"	81	86	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479834141	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"555"	"DN-101 Protocol No. 011-007"	"012"	"012-0001"	5	9	"Adverse Event/Serious Adverse Event"	2761337001	"Weakness"	62	70	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478187754	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"556"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3328260003	"anemia"	75	82	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504702701	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"557"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3605723001	"anemia"	43	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504123680	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"558"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3605711001	"anemia"	15	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504123549	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"559"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3991075001	"anemia"	57	70	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509646816	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"560"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3991152001	"anemia"	36	42	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509647068	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"561"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3991624001	"anxiety"	15	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509648437	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"562"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3992018001	"arthralgias"	50	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509650036	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"563"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3991399001	"constipation"	8	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509647583	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"564"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3991710001	"dehydration"	15	15	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"iv fluid"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509648732	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"565"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	4342182001	"fatigue"	158	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514313855	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"566"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3991908001	"fatigue"	36	43	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509649348	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"567"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3720338001	"fever"	87	87	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505917128	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"568"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3992078001	"hypokalemia"	87	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509650453	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"569"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3991773001	"jaw pain"	36	158	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509648978	""	""	""	NA	"Jaw pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Pain in jaw"	""	""	""	""	""	""	""	""	""	""	""	""
"570"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3991883001	"left shoulder pain"	32	50	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509649227	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"571"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3992093001	"left upper shoulder abcess"	91	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"warm compresses"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509650535	""	""	""	NA	"Abscess"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Abscess"	""	""	""	""	""	""	""	""	""	""	""	""
"572"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3991803001	"loss of taste"	15	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509649059	""	""	""	NA	"Loss of taste"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Ageusia"	""	""	""	""	""	""	""	""	""	""	""	""
"573"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3991458001	"oral tenderness"	15	158	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509647931	""	""	""	NA	"Oral pain"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Oral soft tissue pain and paraesthesia"	"Oral pain"	""	""	""	""	""	""	""	""	""	""	""	""
"574"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3992029001	"palpitations"	67	70	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509650111	""	""	""	NA	"Palpitations"	"Cardiac disorders"	"Cardiac disorder signs and symptoms"	"Cardiac signs and symptoms NEC"	"Palpitations"	""	""	""	""	""	""	""	""	""	""	""	""
"575"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3991921001	"palpitations"	36	43	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509649514	""	""	""	NA	"Palpitations"	"Cardiac disorders"	"Cardiac disorder signs and symptoms"	"Cardiac signs and symptoms NEC"	"Palpitations"	""	""	""	""	""	""	""	""	""	""	""	""
"576"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3992044001	"right upper quadrant pain abdominal"	70	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509650234	""	""	""	NA	"Pain right upper quadrant"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"577"	"DN-101 Protocol No. 011-007"	"013"	"013-0001"	5	9	"Adverse Event/Serious Adverse Event"	3991431001	"shortness of breath with exertion"	15	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509647754	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"578"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	2624953003	"edema-pedal"	188	202	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505262967	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"579"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3678144001	"fatigue"	146	412	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505262829	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"580"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	2729885001	"hyperglycemia"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476381546	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"581"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3678113001	"nailbed changes"	286	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505262392	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"582"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3678148001	"neuropathy"	167	202	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505262898	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"583"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3678138001	"neuropathy"	83	139	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505262603	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"584"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3013433001	"Neutropenia"	83	97	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054445	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"585"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3013455001	"Neutropenia"	209	225	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054931	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"586"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3013436001	"Neutropenia"	104	118	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054529	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"587"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	2674610001	"neutropenia"	41	55	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473551998	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"588"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3013439001	"Neutropenia"	126	139	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054620	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"589"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3013423001	"Neutropenia"	63	76	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054284	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"590"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3013444001	"Neutropenia"	146	161	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490054705	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"591"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	2674607001	"neutropenia"	20	34	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473551931	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"592"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3678130001	"pedal edema"	55	146	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505262526	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"593"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	2889470001	"prostatitis"	188	225	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485198005	""	""	""	NA	"Prostatitis"	"Reproductive system and breast disorders"	"Male reproductive tract infections and inflammations"	"Prostate and seminal vesicles infections and inflammations"	"Prostatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"594"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3973792001	"prostititis"	344	350	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509467636	""	""	""	NA	"Prostatitis"	"Reproductive system and breast disorders"	"Male reproductive tract infections and inflammations"	"Prostate and seminal vesicles infections and inflammations"	"Prostatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"595"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3678141001	"syncope"	118	118	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505262757	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"596"	"DN-101 Protocol No. 011-007"	"014"	"014-0001"	5	9	"Adverse Event/Serious Adverse Event"	3013470001	"URI"	209	213	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490055401	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"597"	"DN-101 Protocol No. 011-007"	"014"	"014-0002"	5	9	"Adverse Event/Serious Adverse Event"	2840459003	"Arthralgias"	209	237	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501182321	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"598"	"DN-101 Protocol No. 011-007"	"014"	"014-0002"	5	9	"Adverse Event/Serious Adverse Event"	2951913001	"fatigue"	72	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487282086	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"599"	"DN-101 Protocol No. 011-007"	"014"	"014-0002"	5	9	"Adverse Event/Serious Adverse Event"	3220349001	"R lower leg fluid reetention"	135	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495133491	""	""	""	NA	"Edema lower limb"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"600"	"DN-101 Protocol No. 011-007"	"014"	"014-0002"	5	9	"Adverse Event/Serious Adverse Event"	2951919001	"rash to bilateral arms"	72	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487282238	""	""	""	NA	"Rash over arms"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"601"	"DN-101 Protocol No. 011-007"	"014"	"014-0003"	5	9	"Adverse Event/Serious Adverse Event"	2998949003	"anemia"	42	NA	1	4	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517782410	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"602"	"DN-101 Protocol No. 011-007"	"014"	"014-0003"	5	9	"Adverse Event/Serious Adverse Event"	3024116001	"Bone Pain"	27	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490297633	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"603"	"DN-101 Protocol No. 011-007"	"014"	"014-0003"	5	9	"Adverse Event/Serious Adverse Event"	4767145002	"confusion"	42	NA	1	1	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517782233	""	""	""	NA	"Confusion"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Confusion and disorientation"	"Confusional state"	""	""	""	""	""	""	""	""	""	""	""	""
"604"	"DN-101 Protocol No. 011-007"	"014"	"014-0003"	5	9	"Adverse Event/Serious Adverse Event"	5113755002	"enterococcal uti"	42	53	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521057794	""	""	""	NA	"Enterococcal urinary tract infection"	"Infections and infestations"	"Bacterial infectious disorders"	"Enterococcal infections"	"Urinary tract infection enterococcal"	""	""	""	""	""	""	""	""	""	""	""	""
"605"	"DN-101 Protocol No. 011-007"	"014"	"014-0003"	5	9	"Adverse Event/Serious Adverse Event"	4767176002	"hypotension"	42	NA	1	3	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"antihypertensives held"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517782350	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"606"	"DN-101 Protocol No. 011-007"	"014"	"014-0003"	5	9	"Adverse Event/Serious Adverse Event"	4766380002	"neutropenia"	30	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517779768	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"607"	"DN-101 Protocol No. 011-007"	"014"	"014-0003"	5	9	"Adverse Event/Serious Adverse Event"	4767044002	"peptic ulcer disease/gastric ulcers"	42	53	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	349	NA	NA	42	53	"ekg, kub, cardiac enzymes, coags, cbc, chemistries, endoscopy, portable cxr, urinalysis, holding antihypertensive meds."	""	""	2	2	2	NA	2	2	NA	2	"Pt went to the ER with c/o bloody bowel movements for the last 2 days."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517781973	""	""	""	NA	"Gastric ulcer"	"Gastrointestinal disorders"	"Gastrointestinal ulceration and perforation"	"Gastric ulcers and perforation"	"Gastric ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"608"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3701392003	"constipation"	29	34	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509564573	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"609"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4303483001	"cough"	14	17	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513629384	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"610"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3984039001	"decubitus ulcer-buttocks"	35	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"encouraged not to sit/sleep in same position too long"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509564954	""	""	""	NA	"Decubitus ulcer"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Skin injuries and mechanical dermatoses"	"Decubitus ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"611"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3790851001	"dehydration"	14	17	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV fluids"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	17	NA	NA	14	17	"none"	""	""	2	2	2	2	2	2	2	2	"Patient presented to clinic 9/28/07 with day and a half history of fever upt to 101.5, diarrhea up to 6 times/day.  Labs reveals ANC 0.3. Patient admitted to hospital."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506883118	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"612"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4063075001	"dehydration"	59	62	NA	3	0	NA	NA	NA	NA	NA	NA	NA	NA	4	NA	NA	1	"Patient received IV fluids to treat."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	61	NA	NA	59	62	"none"	""	""	2	2	2	NA	2	2	NA	2	"Patient admitted for dehydration secondary to decreased oral intake due to oral thrush.  Patient taken off treatment 11/5/07, so patient was no longer taking Prednisone or Taxotere, thus the above"	"questions are not applicable regarding drug action taken."	""	""	""	""	""	""	""	""	""	NA	NA	""	1510700212	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"613"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4303997001	"depression"	49	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513630826	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"614"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3790819001	"diarrhea"	13	17	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV fluids"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	17	NA	NA	14	17	"none"	""	""	2	2	2	2	2	2	2	2	"Patient presented to clinic 9/28/07 with day and a half hisotry of fever up to 101.5, diarrhea up to 6 times/day.  Labs revealed ANC 0.3. Patient admitted to hospital."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506882854	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"615"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4304112001	"edema"	68	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513631127	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"616"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3904763001	"edema-legs"	21	55	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508421244	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"617"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	5266546002	"Epigastric Pain"	28	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522955794	""	""	""	NA	"Epigastric pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"618"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3904743001	"fatigue"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508421002	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"619"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4668036002	"hemorrhoids"	59	62	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517182131	""	""	""	NA	"Hemorrhoids"	"Gastrointestinal disorders"	"Gastrointestinal vascular conditions"	"Haemorrhoids and gastrointestinal varices (excl oesophageal)"	"Haemorrhoids"	""	""	""	""	""	""	""	""	""	""	""	""
"620"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4303607001	"hyponatremia"	32	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513629790	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"621"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4657311002	"hyponatremia"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517158597	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"622"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4303890001	"hyponatremia"	68	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513630550	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"623"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4303756001	"hyponatremia"	48	68	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513630198	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"624"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4304029001	"muscle weakness; neck"	49	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"physical therapy"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513630919	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"625"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4303579001	"neutropenia"	35	48	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513629705	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"626"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3790794001	"neutropenic fever"	14	17	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	17	NA	NA	14	17	"9/28/07 ANC 0.3"	""	""	2	2	2	2	2	2	2	2	"patient presented to clinic 9/28/07 with day and a half history of fever up to 101.5, diarrhea up to 6 times/day.  Labs revealed ANC 0.3.  Patient admitted to hopsital."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506882635	""	""	""	NA	"Neutropenic fever"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"627"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3983966001	"neutropenic fever"	35	49	NA	4	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509564793	""	""	""	NA	"Neutropenic fever"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"628"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3904770001	"oral mucositis"	21	26	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508421317	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"629"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3983891001	"oral mucositis"	34	68	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509564634	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"630"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4200025001	"oral thrush"	59	62	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	61	NA	NA	59	62	"None"	""	""	2	2	2	2	2	2	2	2	"Patient admitted for dehydration secondary to decreased oral intake, found to be due to extensive oral thrush.	Patient taken off treatment 11/5/07, so was not taking Prednisone or Taxotere, and thus"	"the above questions regarding action taken of drugs is not applicable."	""	""	""	""	""	""	""	""	""	NA	NA	""	1512507122	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"631"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3904784001	"pain-neck"	19	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Increased dose of Vicodin"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508421482	""	""	""	NA	"Pain neck"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Neck pain"	""	""	""	""	""	""	""	""	""	""	""	""
"632"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4304139001	"palmar erythrodyesthesia"	68	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"lotion"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513631210	""	""	""	NA	"Palmar-plantar erythrodysesthesia syndrome"	"Skin and subcutaneous tissue disorders"	"Skin and subcutaneous tissue disorders NEC"	"Skin and subcutaneous conditions NEC"	"Palmar-plantar erythrodysaesthesia syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"633"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4667748002	"tachycardia"	14	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517180719	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"634"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4304054001	"thrush; oral"	55	59	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513630987	""	""	""	NA	"Thrush oral"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"635"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4667867002	"transaminitis"	21	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV fluids"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517181205	""	""	""	NA	"Transaminitis"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Transaminases increased"	""	""	""	""	""	""	""	""	""	""	""	""
"636"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3983914001	"urinary tract infection"	35	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509564698	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"637"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4303518001	"urinary tract infection"	59	68	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513629554	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"638"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	3904725001	"weakness-generalized"	19	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508420778	""	""	""	NA	"Weakness generalized"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"639"	"DN-101 Protocol No. 011-007"	"014"	"014-0006"	5	9	"Adverse Event/Serious Adverse Event"	4667974002	"weight loss"	55	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517181930	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"640"	"DN-101 Protocol No. 011-007"	"016"	"016-0001"	5	9	"Adverse Event/Serious Adverse Event"	3188994003	"bilateral ankle edema"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499714794	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"641"	"DN-101 Protocol No. 011-007"	"016"	"016-0001"	5	9	"Adverse Event/Serious Adverse Event"	4453493002	"Eczyma"	12	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515617951	""	""	""	NA	"Eczema"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermatitis and eczema"	"Eczema"	""	""	""	""	""	""	""	""	""	""	""	""
"642"	"DN-101 Protocol No. 011-007"	"016"	"016-0001"	5	9	"Adverse Event/Serious Adverse Event"	4453450002	"fatigue"	26	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515617856	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"643"	"DN-101 Protocol No. 011-007"	"016"	"016-0001"	5	9	"Adverse Event/Serious Adverse Event"	3253976001	"febrile neutropenia"	12	15	NA	4	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"hospitalization"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	20	NA	NA	12	14	"5/23/2007, WBC=0.78, ANC =.08"	""	""	2	2	2	2	2	2	2	2	"fever with neutropenia,admitted for  IV antibiotics along with neupogen. Pt was discharged with recovery."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496259004	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"644"	"DN-101 Protocol No. 011-007"	"016"	"016-0001"	5	9	"Adverse Event/Serious Adverse Event"	3541118001	"fever"	63	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502910706	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"645"	"DN-101 Protocol No. 011-007"	"016"	"016-0001"	5	9	"Adverse Event/Serious Adverse Event"	3390696001	"fever undetermined origin"	59	60	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499713702	""	""	""	NA	"Fever of unknown origin"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"646"	"DN-101 Protocol No. 011-007"	"016"	"016-0001"	5	9	"Adverse Event/Serious Adverse Event"	4453392002	"Hair Loss"	26	207	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515617647	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"647"	"DN-101 Protocol No. 011-007"	"016"	"016-0001"	5	9	"Adverse Event/Serious Adverse Event"	3428784001	"left upper mouth/tooth infection"	12	19	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Culture of tooth infection collected"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500328157	""	""	""	NA	"Tooth infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Dental and oral soft tissue infections"	"Tooth infection"	""	""	""	""	""	""	""	""	""	""	""	""
"648"	"DN-101 Protocol No. 011-007"	"016"	"016-0001"	5	9	"Adverse Event/Serious Adverse Event"	3541140001	"pneumonia"	63	69	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502911222	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"649"	"DN-101 Protocol No. 011-007"	"016"	"016-0001"	5	9	"Adverse Event/Serious Adverse Event"	3541207001	"pneumonitis"	69	154	NA	2	0	NA	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	3	0	NA	1	96	NA	NA	NA	NA	NA	1	1	"taxotere induced interstitial pneumonitis"	97	NA	NA	NA	NA	"CXR done 7/19/07, 7/25/07, and8/1/07. Pt continues with \"bilateral interstital pattern\""	""	""	2	2	2	2	0	2	2	2	"Pt presented to clinic 7/18/07. C/O Fever/cough. CXR obtained. Due to good response on Docetaxel, Treatment was given 7/19/07 and pt started on Z-pack.  CXR repeated one week later on 7/25/07, with"	"no intervention.  On 8/1/07, Pt returned to clinic. Prednisone was increased to 30 mg po daily. Pnumonitis considered taxotere induced. Pt to come off study."	""	""	""	""	""	""	""	""	""	NA	NA	""	1502912607	""	""	""	NA	"Pneumonitis"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Lower respiratory tract inflammatory and immunologic conditions"	"Pneumonitis"	""	""	""	""	""	""	""	""	""	""	""	""
"650"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	3696390003	"bruising"	73	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512074948	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"651"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163535001	"change of taste in food"	73	84	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512074036	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"652"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163692001	"change of taste of food"	84	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512075191	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"653"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4162764001	"Chest Pain - angina"	69	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512069331	""	""	""	NA	"Chest pain - cardiac"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"654"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163424001	"daytime sleeping"	69	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512073268	""	""	""	NA	"Daytime sleepiness"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Somnolence"	""	""	""	""	""	""	""	""	""	""	""	""
"655"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163624001	"dehydration"	73	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512074522	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"656"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163564001	"dry mouth"	73	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512074226	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"657"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163416001	"dry skin"	69	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512073172	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"658"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163607001	"dysuria"	73	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512074429	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"659"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4162273001	"Fatigue"	69	84	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512067164	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"660"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163683001	"fatigue"	84	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512075124	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"661"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163585001	"generalized pain"	73	84	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512074349	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"662"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4162618001	"Generalized pain"	69	73	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512068550	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"663"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163703001	"hair loss"	84	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512075313	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"664"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4162727001	"Headache"	69	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512069177	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"665"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163316001	"heartburn"	84	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512072202	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"666"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163294001	"Heartburn"	73	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512072016	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"667"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163269001	"heartburn"	69	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512071765	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"668"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163377001	"joint pain"	73	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512072754	""	""	""	NA	"Joint pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"669"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163362001	"joint pains"	69	73	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512072626	""	""	""	NA	"Joint ache"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"670"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163384001	"muscle aches"	69	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512072831	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"671"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4469952002	"netropenia"	69	72	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515710314	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"672"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163485001	"psychiatric issues"	69	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512073801	""	""	""	NA	"Psychiatric disorder NOS"	"Psychiatric disorders"	"Psychiatric disorders NEC"	"Mental disorders NEC"	"Mental disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"673"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163467001	"rectal bleeding"	73	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512073639	""	""	""	NA	"Rectal bleeding"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Intestinal haemorrhages"	"Rectal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"674"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163444001	"sexual problems"	69	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512073455	""	""	""	NA	"Sexual problem"	"Reproductive system and breast disorders"	"Sexual function and fertility disorders"	"Sexual function and fertility disorders NEC"	"Sexual dysfunction"	""	""	""	""	""	""	""	""	""	""	""	""
"675"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163523001	"trouble seeing"	73	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512073957	""	""	""	NA	"Visual disturbance"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Visual disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"676"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163455001	"trouble sleeping at night"	73	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512073555	""	""	""	NA	"Difficulty sleeping"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"677"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163432001	"trouble sleeping at night"	69	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512073355	""	""	""	NA	"Difficulty sleeping"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"678"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163551001	"trouble swallowing"	73	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512074146	""	""	""	NA	"Swallowing difficult"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Dysphagia"	""	""	""	""	""	""	""	""	""	""	""	""
"679"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163349001	"weakness of body parts"	84	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512072484	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"680"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163336001	"weakness of body parts"	69	73	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512072365	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"681"	"DN-101 Protocol No. 011-007"	"016"	"016-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163498001	"weight loss"	73	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512073872	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"682"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2562368003	"acute bronchitis"	502	506	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	525	NA	NA	502	506	"8-28-07 - CBC, CMP, EKG, CT scan - planning echocardiogram"	""	""	2	2	2	2	2	2	2	2	"Pt woke up with shortness of breath.  He was admitted to hospital for treatment of his shortness of breath, determined to be a symptom of acute bronchitis.  He was treated with IV antibiotics and"	"nebulized bronchodilators.  He was discharged to home on 9-1-07."	""	""	""	""	""	""	""	""	""	NA	NA	""	1505932713	""	""	""	NA	"Acute bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis acute"	""	""	""	""	""	""	""	""	""	""	""	""
"683"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690019001	"anxiety"	15	15	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474465655	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"684"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690009001	"chest pain - non cardiac"	15	15	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474465351	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"685"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2864409001	"compression fracture T9 & T10 -NOT SRE -see notes"	268	320	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"admitted to evaluate for kyphoplasty; immobilization"	0	1	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	272	NA	NA	268	272	"Thoracic spine x-ray on 1-6-07 finds \"approximate 30-50% compression fracture deformities of T9 & T10\";MRI of thoracic spine on 1-8-07 finds \"compression fractures at T9 & T10 secondary to"	"osteoporosis\""	""	2	2	2	2	2	2	2	2	"pt went to ER on 1-6-07 with back pain.  DX of compression fractures of T9 & T10.  Pt was admitted to evaluate for possible kyphoplasty.;pt was fitted for a turtle brace, discharged home to follow up"	"with neurosurgeon for possible kyphoplasty in the future if needed for pain not controlled by brace.;Not considered a SRE therefore this will not be documented in the SRE pages.;**5-17-07** According"	"to Dr. Craig Berman at Novacea, the determination of osteoporosis etiology for the compression fracture does not qualify as a SRE."	""	""	""	""	""	""	""	""	NA	NA	""	1484082572	""	""	""	NA	"Compression fracture"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Fractures and dislocations NEC"	"Compression fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"686"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2620051001	"dizziness"	85	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469386422	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"687"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2619995001	"dizziness"	42	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469385089	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"688"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690068001	"dysguesia"	92	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467012	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"689"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2864933001	"eczema"	236	260	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484085378	""	""	""	NA	"Eczema"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermatitis and eczema"	"Eczema"	""	""	""	""	""	""	""	""	""	""	""	""
"690"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690071001	"fatigue"	36	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467081	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"691"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2619983001	"headache"	15	22	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"lower Kytril dose"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469384808	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"692"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	4483267002	"hyperglycemia"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515963855	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"693"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2619979001	"intermittant heartburn"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469384666	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"694"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2800213001	"nail changes"	162	320	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480883782	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"695"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2620043001	"neutropenia"	42	50	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"neutropenic precautions"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469386257	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"696"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690083001	"neutropenia"	127	134	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467432	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"697"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2620035001	"neutropenia"	22	29	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469386056	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"698"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690089001	"neutropenia"	148	162	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467576	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"699"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2623935001	"NEUTROPENIA"	63	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"NEUTROPENIC PRECAUTIONS"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469561807	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"700"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2620056001	"neutropenia"	85	92	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"neutropenic precautions"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469386591	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"701"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690049001	"orthostatic hypotension"	120	183	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474466166	""	""	""	NA	"Orthostatic hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Orthostatic hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"702"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	3344287001	"osteoporosis"	260	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498753620	""	""	""	NA	"Osteoporosis"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Metabolic bone disorders"	"Osteoporosis"	""	""	""	""	""	""	""	""	""	""	""	""
"703"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	3017194001	"pedal edema"	236	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490129713	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"704"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690040001	"pedal edema"	120	141	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474466039	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"705"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690080001	"productive cough with white sputum"	120	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467345	""	""	""	NA	"Productive cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"706"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690077001	"productive cough with yellow sputum"	74	120	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474467248	""	""	""	NA	"Productive cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"707"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	3695963001	"pulmonary infiltrates"	469	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505672034	""	""	""	NA	"Pulmonary infiltration"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Parenchymal lung disorders NEC"	"Lung infiltration"	""	""	""	""	""	""	""	""	""	""	""	""
"708"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	3017175001	"right rib fracture due to osteoporosis"	236	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490129539	""	""	""	NA	"Fracture due to osteoporosis"	"Musculoskeletal and connective tissue disorders"	"Fractures"	"Pathological fractures and complications"	"Osteoporotic fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"709"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2619986001	"scalp tenderness"	36	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469384949	""	""	""	NA	"Scalp tenderness"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Pain of skin"	""	""	""	""	""	""	""	""	""	""	""	""
"710"	"DN-101 Protocol No. 011-007"	"017"	"017-0001"	5	9	"Adverse Event/Serious Adverse Event"	2690032001	"viral URI"	74	78	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474465936	""	""	""	NA	"Upper respiratory tract infection viral NOS"	"Infections and infestations"	"Viral infectious disorders"	"Viral infections NEC"	"Viral upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"711"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2752242003	"Decreased Mobility"	164	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"MRI L/S ordered for 4-05-07"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491407007	""	""	""	NA	"Mobility decreased"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Mobility decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"712"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2818665001	"Dizziness"	36	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481558313	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"713"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2797912001	"fatigue"	17	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480620676	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"714"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3238650001	"Fatigue"	207	220	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495640323	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"715"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2798158001	"fever"	37	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480622135	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"716"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3923600001	"Generalized Weakness"	318	337	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508793472	""	""	""	NA	"Weakness generalized"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"717"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3187055001	"Headache"	178	199	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494783085	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"718"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3118035001	"Hyperglycemia"	178	179	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492974008	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"719"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2799387001	"Hyperglycemia"	40	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480867934	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"720"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2799246001	"Hyperglycemia"	39	40	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Sent to Endocrinologist for diabetes management and insulin addition . Does have hx of diabetes which was well-controlled however has increased in grade."	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480866599	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"721"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2797989001	"hyperglycemia"	28	29	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"already on oral hyperglycemic agents for hx of diabetes/reported the hyperglycemia since grade has increased"	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480621164	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"722"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2818662001	"Hyperglycemia"	49	59	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481558243	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"723"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2798084001	"infection;blood gram negative rods"	37	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480621677	""	""	""	NA	"Gram-negative rod infection"	"Infections and infestations"	"Bacterial infectious disorders"	"Bacterial infections NEC"	"Bacterial infection"	""	""	""	""	""	""	""	""	""	""	""	""
"724"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	4900114002	"Inguinal Hernia with Testicular Swelling"	443	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518987642	""	""	""	NA	"Hernia inguinal"	"Gastrointestinal disorders"	"Abdominal hernias and other abdominal wall conditions"	"Inguinal hernias"	"Inguinal hernia"	""	""	""	""	""	""	""	""	""	""	""	""
"725"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3238756001	"Intermittant Hematuria"	92	201	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495640732	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"726"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3062280001	"Leukopenia"	164	178	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491407223	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"727"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3138083001	"Leukopenia"	186	199	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493314744	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"728"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2797956001	"leukopenia"	17	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480620916	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"729"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2799349001	"Lymphopenia"	39	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480867364	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"730"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2798055001	"lymphopenia"	37	39	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480621537	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"731"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2798141001	"malaise"	37	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480622004	""	""	""	NA	"Malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"732"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2797939001	"neutropenia"	17	28	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480620839	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"733"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3138098001	"Neutropenia"	186	199	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493314858	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"734"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2907135001	"Neutropenia"	101	112	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485980767	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"735"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3062289001	"Neutropenia"	164	178	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491407309	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"736"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3002549001	"Neutropenia"	143	154	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489606487	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"737"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2839311001	"neutropenia"	59	71	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482360079	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"738"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3498482001	"pain back of both legs (thighs)"	287	318	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502133176	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"739"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3238725001	"Pain back of both legs (thighs)"	207	287	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495640583	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"740"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3740708001	"Pain: Low back pain (buttocks area)"	318	337	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506022985	""	""	""	NA	"Buttock pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Buttock pain"	""	""	""	""	""	""	""	""	""	""	""	""
"741"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3740728001	"Pain: pain back of both legs (thighs)"	318	337	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506023073	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"742"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2895971001	"Pain:Low back pain (buttocks area)"	30	318	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485376143	""	""	""	NA	"Buttock pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Buttock pain"	""	""	""	""	""	""	""	""	""	""	""	""
"743"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2895959001	"Pain:Pain to back of both legs( thighs )"	30	207	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485376041	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"744"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	4102137001	"Posterior lower back pain"	334	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511206765	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"745"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3066219001	"Spinal Stenosis"	86	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491485820	""	""	""	NA	"Spinal stenosis NOS"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)"	"Spine and neck deformities"	"Spinal column stenosis"	""	""	""	""	""	""	""	""	""	""	""	""
"746"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2797965001	"sweating"	23	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480620991	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"747"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2798167001	"sweating"	37	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480622236	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"748"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2989543001	"Taste Alteration"	122	204	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489080460	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"749"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3238693001	"Taste Alteration"	204	220	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495640459	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"750"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2799322001	"Taste Alteration"	39	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480867188	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"751"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3238781001	"Urinary Tract Infection"	210	217	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495640838	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"752"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2798105001	"urinary tract infection"	37	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480621825	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"753"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	3238642001	"Weakness"	207	220	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495640252	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"754"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2798124001	"weakness"	37	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480621903	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"755"	"DN-101 Protocol No. 011-007"	"019"	"019-0001"	5	9	"Adverse Event/Serious Adverse Event"	2797924001	"weakness"	17	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480620760	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"756"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	2779287003	"alopecia"	20	330	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481145234	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"757"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	3306894001	"decreased Hct"	218	246	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497982915	""	""	""	NA	"Hematocrit decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haematocrit decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"758"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	3600687001	"decreased HCT"	246	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504108067	""	""	""	NA	"Hematocrit decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haematocrit decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"759"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	3306863001	"decreased Hgb"	218	246	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497982800	""	""	""	NA	"Decreased hemoglobin"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"760"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	3600651001	"decreased HgB"	246	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504107848	""	""	""	NA	"Decreased hemoglobin"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"761"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	3306845001	"Dizziness"	211	213	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497982731	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"762"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	2989374001	"Dizziness"	110	134	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489077917	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"763"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	4764427002	"Edema around both eyes"	416	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"DES was stopped"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517775372	""	""	""	NA	"Eye edema"	"Eye disorders"	"Eye disorders NEC"	"Ocular disorders NEC"	"Eye oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"764"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	4764397002	"Edema to both feet"	416	419	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"DES was stopped"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517775310	""	""	""	NA	"Foot edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"765"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	3176539001	"Fatigue"	176	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494434438	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"766"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	3600745001	"Infection L upper jaw (area of tooth extraction)"	252	261	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504108303	""	""	""	NA	"Tooth infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Dental and oral soft tissue infections"	"Tooth infection"	""	""	""	""	""	""	""	""	""	""	""	""
"767"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	3600791001	"L upper jaw pain"	252	318	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"consult to oral surgeon on 8-27-07"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504108433	""	""	""	NA	"Jaw pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Pain in jaw"	""	""	""	""	""	""	""	""	""	""	""	""
"768"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	2813465001	"leukopenia"	15	22	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481143952	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"769"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	2813577001	"neutropenia"	15	22	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481144971	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"770"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	2813737001	"neutropenia"	22	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481146063	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"771"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	3600840001	"Osteonecrosis L upper jaw"	286	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"consult with oral surgery"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504108661	""	""	""	NA	"Osteonecrosis of jaw"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone disorders NEC"	"Osteonecrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"772"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	3600703001	"Pain to tooth L upper jaw"	242	252	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504108144	""	""	""	NA	"Tooth pain"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Dental pain and sensation disorders"	"Toothache"	""	""	""	""	""	""	""	""	""	""	""	""
"773"	"DN-101 Protocol No. 011-007"	"019"	"019-0003"	5	9	"Adverse Event/Serious Adverse Event"	4764497002	"Rash around both eyes"	416	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"DES was stopped"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517775482	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"774"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	5	9	"Adverse Event/Serious Adverse Event"	2658742003	"alopecia"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474311359	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"775"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	5	9	"Adverse Event/Serious Adverse Event"	4289058001	"anemia"	40	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513538838	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"776"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	5	9	"Adverse Event/Serious Adverse Event"	2730570001	"dysuria"	48	53	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476386068	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"777"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	5	9	"Adverse Event/Serious Adverse Event"	2731305001	"fatigue"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476389952	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"778"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	5	9	"Adverse Event/Serious Adverse Event"	2686505001	"leukopenia"	23	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474311279	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"779"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	5	9	"Adverse Event/Serious Adverse Event"	2730727001	"leukopenia"	51	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476387253	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"780"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	5	9	"Adverse Event/Serious Adverse Event"	2730954001	"neutropenia"	51	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476388674	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"781"	"DN-101 Protocol No. 011-007"	"022"	"022-0002"	5	9	"Adverse Event/Serious Adverse Event"	2731002001	"thrombocytopenia"	56	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476388755	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"782"	"DN-101 Protocol No. 011-007"	"022"	"022-0004"	5	9	"Adverse Event/Serious Adverse Event"	3529685003	"Anemia"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508704476	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"783"	"DN-101 Protocol No. 011-007"	"022"	"022-0004"	5	9	"Adverse Event/Serious Adverse Event"	3913957001	"Chest Pain-non cardiac"	27	27	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"infusion interrupted"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508704206	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"784"	"DN-101 Protocol No. 011-007"	"022"	"022-0004"	5	9	"Adverse Event/Serious Adverse Event"	3581618001	"leukopenia"	13	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503881409	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"785"	"DN-101 Protocol No. 011-007"	"022"	"022-0004"	5	9	"Adverse Event/Serious Adverse Event"	3581621001	"neutropenia"	13	20	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503881483	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"786"	"DN-101 Protocol No. 011-007"	"022"	"022-0004"	5	9	"Adverse Event/Serious Adverse Event"	3913997001	"worsening Hypertension"	27	27	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508704306	""	""	""	NA	"Hypertension worsened"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"787"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	2711709003	"anemia"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486649044	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"788"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	4745421002	"Bowel incontinence"	168	197	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517513277	""	""	""	NA	"Bowel incontinence"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Faecal incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"789"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	2773044001	"constipation"	22	37	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479140906	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"790"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	2856003001	"fatigue"	51	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483638499	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"791"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	2927860001	"hair loss"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486648854	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"792"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	2856037001	"hoarseness"	28	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483638826	""	""	""	NA	"Hoarseness"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dysphonia"	""	""	""	""	""	""	""	""	""	""	""	""
"793"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	2927871001	"neutropenia"	56	63	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486648967	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"794"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	2927849001	"sleeplessness"	28	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486648783	""	""	""	NA	"Sleeplessness"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"795"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	2773037001	"urinary infection"	9	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479140815	""	""	""	NA	"Urinary infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"796"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	4734533002	"Urinary tract infection"	175	184	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517432105	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"797"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	2856023001	"urinary tract infection"	78	85	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483638692	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"798"	"DN-101 Protocol No. 011-007"	"024"	"024-0002"	5	9	"Adverse Event/Serious Adverse Event"	3292227001	"Urinary Tract Infection"	161	175	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497527592	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"799"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	2782142003	"Constipation"	117	121	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490815411	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"800"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3044611001	"Dehydration"	37	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"increased PO fluids"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490813350	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"801"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3044994001	"Dehydration - Xerostomia"	119	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"encourage increased PO fluids"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490815551	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"802"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3044842001	"Dehydration - Xerostomia"	99	113	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"ecnouraged increased PO fluids"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490814448	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"803"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3139423001	"Dehydration - Xerostomia"	140	147	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"encouraged increased po fluids"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493324602	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"804"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3044581001	"Dysgeusia"	37	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490813245	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"805"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3139410001	"Fatigue"	140	142	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493324462	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"806"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3044649001	"Hand Foot Syndrome"	56	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490813462	""	""	""	NA	"Hand and foot syndrome"	"Skin and subcutaneous tissue disorders"	"Skin and subcutaneous tissue disorders NEC"	"Skin and subcutaneous conditions NEC"	"Palmar-plantar erythrodysaesthesia syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"807"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	2824412001	"Hand-Foot Syndrome"	15	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481738785	""	""	""	NA	"Hand and foot syndrome"	"Skin and subcutaneous tissue disorders"	"Skin and subcutaneous tissue disorders NEC"	"Skin and subcutaneous conditions NEC"	"Palmar-plantar erythrodysaesthesia syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"808"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3044513001	"Intermittent Fatigue"	36	233	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490812850	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"809"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	2995374001	"Mucositis - oral cavity"	15	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Magic Mouthwash prn"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489423721	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"810"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3044533001	"Mucositis - oral cavity"	37	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Magic Mouthwash"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490812978	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"811"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3178048001	"Nail Changes"	141	404	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494446057	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"812"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3044973001	"Pain - Bilateral thighs to hips"	139	182	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490815322	""	""	""	NA	"Painful hips"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"813"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3044870001	"Pain - lt. Hip"	109	140	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490814604	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"814"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	4465349002	"pain-left thigh to hip"	182	404	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515698926	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"815"	"DN-101 Protocol No. 011-007"	"024"	"024-0003"	5	9	"Adverse Event/Serious Adverse Event"	3044550001	"Rectal Irritation"	37	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490813065	""	""	""	NA	"Discomfort rectal"	"Gastrointestinal disorders"	"Anal and rectal conditions NEC"	"Anal and rectal disorders NEC"	"Anal discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"816"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	3397777003	"acute infusion reaction"	25	25	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517430054	""	""	""	NA	"Infusion related reaction"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion related reaction"	""	""	""	""	""	""	""	""	""	""	""	""
"817"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	3755954001	"Alopecia"	24	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506351732	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"818"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	3755916001	"Fever"	5	5	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506351466	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"819"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	3755932001	"Fever"	8	8	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506351555	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"820"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	3756128001	"Hypersensitivity reaction"	70	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506352363	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"821"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	3756098001	"Hypersensitivity reaction"	53	53	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506352280	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"822"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	4025128001	"Hypersensitivity Reaction"	113	113	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Docetaxel stopped, con meds given, and docetaxel was restarted."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510241140	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"823"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	3603964001	"Hypersensitivity reaction"	25	25	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Infusion stopped and restarted; Infusion completed on 8/6/07"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504118128	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"824"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	3756068001	"Hypersensitivity reaction"	28	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506352170	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"825"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	4025101001	"Hypersensitivity Reaction"	92	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Docetaxel stopped, con meds given, and Docetaxel restarted"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510240915	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"826"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	3756155001	"Left Lower Leg Edema"	68	69	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506352462	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"827"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	3756179001	"Rectal Irritation"	69	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506352555	""	""	""	NA	"Discomfort rectal"	"Gastrointestinal disorders"	"Anal and rectal conditions NEC"	"Anal and rectal disorders NEC"	"Anal discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"828"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	4452015002	"Right Leg Edema"	92	113	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515614764	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"829"	"DN-101 Protocol No. 011-007"	"024"	"024-0006"	5	9	"Adverse Event/Serious Adverse Event"	3621719001	"Urinary Tract Infection"	8	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504549752	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"830"	"DN-101 Protocol No. 011-007"	"024"	"024-0009"	5	9	"Adverse Event/Serious Adverse Event"	3723147003	"Alopecia"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510502207	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"831"	"DN-101 Protocol No. 011-007"	"024"	"024-0009"	5	9	"Adverse Event/Serious Adverse Event"	3939814001	"Back Pain"	11	31	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508960675	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"832"	"DN-101 Protocol No. 011-007"	"024"	"024-0009"	5	9	"Adverse Event/Serious Adverse Event"	4374271001	"Constipation"	73	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515002448	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"833"	"DN-101 Protocol No. 011-007"	"024"	"024-0009"	5	9	"Adverse Event/Serious Adverse Event"	4034488001	"Fatigue"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510502264	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"834"	"DN-101 Protocol No. 011-007"	"024"	"024-0009"	5	9	"Adverse Event/Serious Adverse Event"	4746435002	"Hyperglycemia"	10	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517516148	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"835"	"DN-101 Protocol No. 011-007"	"024"	"024-0009"	5	9	"Adverse Event/Serious Adverse Event"	3939778001	"Insomnia"	11	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508960350	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"836"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2695940003	"alopecia"	28	451	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488158557	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"837"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967826001	"anemia"	28	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488160247	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"838"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	3372012001	"Bone Pain"	7	451	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499372823	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"839"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967820001	"change in taste of food"	118	451	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488159997	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"840"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967787001	"constipation"	49	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488158870	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"841"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967800001	"decreased appetite"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488159256	""	""	""	NA	"Appetite decreased NOS"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"842"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967809001	"dry eyes"	98	160	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488159690	""	""	""	NA	"Dry eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Dry eye"	""	""	""	""	""	""	""	""	""	""	""	""
"843"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967823001	"dry mouth"	118	160	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488160101	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"844"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	3358317001	"fatigue"	6	451	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499113897	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"845"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967803001	"fatigue"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488159352	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"846"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967773001	"hematuria"	28	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488158730	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"847"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967839001	"hyperglycemia"	98	139	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488160974	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"848"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967842001	"hyperglycemia"	139	181	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488161090	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"849"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967836001	"hyperglycemia"	77	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488160791	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"850"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	3358269001	"hyperglycemia"	223	236	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499113681	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"851"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967806001	"insomnia"	7	9	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488159535	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"852"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967790001	"night sweats"	7	8	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488158985	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"853"	"DN-101 Protocol No. 011-007"	"025"	"025-0002"	5	9	"Adverse Event/Serious Adverse Event"	2967761001	"urinary incontinence"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488158368	""	""	""	NA	"Urinary incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"854"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	2560687003	"ACUTE DVT OF RIGHT LOWER EXTREMITY"	35	36	NA	3	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	35	NA	NA	35	36	"PT/PTT 05/15, 05/16; CBC W/DIFF 05/15/2006; DIGOXIN LEVEL 05/15/2006; PT/PTT/INR 05/15/2006"	""	""	2	2	2	NA	2	2	NA	2	"75 YEAR OLD MALE WITH COMPLAINTS OF RIGHT LOWER EXTREMITY AND RIGHT THIGH SWELLING THAT HAS BEEN ONGOING SINCE PREVIOUS HOSPITALIZATION ON 05/08/2006. ;;THE SYMPTOMS RIGHT LOWER EXTREMITY AND RIGHT"	"THIGH SWELLING IN ADDITION TO PAIN INCREASED WITH STANDING OR WALKING.	;;PATIENT DENIED SYMPTOMS OF CHEST PAIN, SHORTNESS OF BREATH."	""	""	""	""	""	""	""	""	""	NA	NA	""	1463671885	""	""	""	NA	"DVT"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"855"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	2965627001	"anemia"	35	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488130367	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"856"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	2965196001	"fatigue"	14	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488122574	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"857"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	2576292001	"GROUP G STREPTOCOCCUS SEPTICEMIA"	23	28	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	35	NA	NA	23	28	"BLOOD CULTURE 05/03/2006;CBC W/DIFF 05/03/2006, 05/05/2006, 05/06/2006, 05/07/2006, 05/08/2006;URINE CULTURE 05/03/2006;STOOL CULTURE 05/03/2006;CT of ABDOMEN 05/UNK/2006;CT OF PELVIS"	"05/UNK/2006;BONE MARROW BIOPSY 05/UNK/2006;CHEST X-RAY 05/04/2006"	""	2	2	2	NA	2	2	NA	2	"75 YEAR OLD MALE WITH COMPLAINTS OF GENERALIZED WEAKNESS, NAUSEA AND FEVER.; ; ON 05/03/2006 ADMITTED WITH TEMPERATURE OF 101, BLOOD PRESSURE OF 68/30 mmHg."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463669987	""	""	""	NA	"Streptococcal septicemia"	"Infections and infestations"	"Bacterial infectious disorders"	"Streptococcal infections"	"Streptococcal sepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"858"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	2600635001	"HYPOKALEMIA"	25	25	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467214027	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"859"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	2600632001	"HYPOMAGNESEMIA"	25	25	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467213946	""	""	""	NA	"Hypomagnesemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Magnesium metabolism disorders"	"Hypomagnesaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"860"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	3386158001	"left arm edema"	35	56	NA	1	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499699931	""	""	""	NA	"Edema arms"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"861"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	2583626001	"NEUTROPENIC FEVER"	23	28	NA	4	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	53	NA	NA	23	28	"CBC WITH DIFF 05/03/2006, BLOOD CULTURE 05/03/2005"	""	""	2	2	2	NA	1	2	NA	2	")N 05/03/2006 PT. ADMITTED WITH COMPLAINTS OF GENERALIZED WEAKNESS, NAUSEA AND FEVER OF 101 F. ON DAY OF  WBC 400. PATIENT WAS PLACED ON NEUPOGEN 300 MG SQ QD AS WELL AS IV ANTIBIOTIC THERAPY.  ON"	"05/08/2006 PT WAS DISCHARGED HOME WITH HOME HEALTH SERVICE FOR CONTINUED IV ROCEPHIN QD X 14 DAYS."	""	""	""	""	""	""	""	""	""	NA	NA	""	1465160678	""	""	""	NA	"Neutropenic fever"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"862"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	3385468001	"Nocturia"	56	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499697663	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"863"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	2583576001	"PAROXYSMAL ATRIAL FIBRILLATION"	23	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465159996	""	""	""	NA	"Paroxysmal atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"864"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	3385555001	"shoulder discomfort"	168	192	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499698183	""	""	""	NA	"Shoulder discomfort"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"865"	"DN-101 Protocol No. 011-007"	"027"	"027-0001"	5	9	"Adverse Event/Serious Adverse Event"	5276588002	"Thrush"	24	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523278740	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"866"	"DN-101 Protocol No. 011-007"	"027"	"027-0003"	5	9	"Adverse Event/Serious Adverse Event"	2848095003	"alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487700984	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"867"	"DN-101 Protocol No. 011-007"	"027"	"027-0003"	5	9	"Adverse Event/Serious Adverse Event"	2958629001	"fatigue"	38	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487701432	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"868"	"DN-101 Protocol No. 011-007"	"027"	"027-0003"	5	9	"Adverse Event/Serious Adverse Event"	2958620001	"fatigue"	26	37	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487701194	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"869"	"DN-101 Protocol No. 011-007"	"027"	"027-0003"	5	9	"Adverse Event/Serious Adverse Event"	2958626001	"Insomnia"	38	41	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487701325	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"870"	"DN-101 Protocol No. 011-007"	"027"	"027-0003"	5	9	"Adverse Event/Serious Adverse Event"	3195712001	"sore throat"	70	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494876979	""	""	""	NA	"Sore throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"871"	"DN-101 Protocol No. 011-007"	"028"	"028-0002"	5	9	"Adverse Event/Serious Adverse Event"	3185937003	"alopecia"	47	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503248195	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"872"	"DN-101 Protocol No. 011-007"	"028"	"028-0002"	5	9	"Adverse Event/Serious Adverse Event"	3697196001	"congestion sinus"	106	108	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505682393	""	""	""	NA	"Sinus congestion"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Sinus congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"873"	"DN-101 Protocol No. 011-007"	"028"	"028-0002"	5	9	"Adverse Event/Serious Adverse Event"	3881690001	"dysguesia"	138	141	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508181519	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"874"	"DN-101 Protocol No. 011-007"	"028"	"028-0002"	5	9	"Adverse Event/Serious Adverse Event"	3552082001	"fatigue"	53	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503247945	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"875"	"DN-101 Protocol No. 011-007"	"028"	"028-0002"	5	9	"Adverse Event/Serious Adverse Event"	3697182001	"fever"	107	108	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505682147	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"876"	"DN-101 Protocol No. 011-007"	"028"	"028-0002"	5	9	"Adverse Event/Serious Adverse Event"	4080598001	"hot flashes"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510851736	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"877"	"DN-101 Protocol No. 011-007"	"028"	"028-0002"	5	9	"Adverse Event/Serious Adverse Event"	3280685001	"Leukopenia"	15	22	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497283516	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"878"	"DN-101 Protocol No. 011-007"	"028"	"028-0002"	5	9	"Adverse Event/Serious Adverse Event"	4121949001	"nail changes"	183	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511710915	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"879"	"DN-101 Protocol No. 011-007"	"028"	"028-0002"	5	9	"Adverse Event/Serious Adverse Event"	3280763001	"Neutropenia"	15	22	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497284554	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"880"	"DN-101 Protocol No. 011-007"	"028"	"028-0002"	5	9	"Adverse Event/Serious Adverse Event"	4080550001	"phlebitis right leg"	152	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510851543	""	""	""	NA	"Phlebitis"	"Vascular disorders"	"Vascular inflammations"	"Phlebitis NEC"	"Phlebitis"	""	""	""	""	""	""	""	""	""	""	""	""
"881"	"DN-101 Protocol No. 011-007"	"028"	"028-0002"	5	9	"Adverse Event/Serious Adverse Event"	3691701001	"umbilical hernia"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505420977	""	""	""	NA	"Umbilical hernia"	"Gastrointestinal disorders"	"Abdominal hernias and other abdominal wall conditions"	"Umbilical hernias"	"Umbilical hernia"	""	""	""	""	""	""	""	""	""	""	""	""
"882"	"DN-101 Protocol No. 011-007"	"028"	"028-0002"	5	9	"Adverse Event/Serious Adverse Event"	4121931001	"worsening neuropathy"	183	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511710814	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"883"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	2557593003	"alopecia"	100	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467741541	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"884"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	2562956001	"dry mouth"	18	121	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469553753	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"885"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	2595161001	"dypsnea"	82	100	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"had 2-view chest x-ray/came out negative"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466439457	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"886"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	2578964001	"dysguesia"	58	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464124789	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"887"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	2592712001	"fatigue"	61	615	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466005655	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"888"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	2578967001	"fatigue"	40	51	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464125118	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"889"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	2562947001	"fatigue"	19	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"890"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	3284928001	"herpetic neuralgia"	387	444	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497374836	""	""	""	NA	"Post herpetic neuralgia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Post herpetic neuralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"891"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	2562952001	"intermittent constipation"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"892"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	3284891001	"left lower extremity edema"	162	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497374564	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"893"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	2578958001	"neuropathy"	58	121	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464124685	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"894"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	3284884001	"right hip pain"	162	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497374510	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"895"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	3284921001	"shingles"	393	401	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497374791	""	""	""	NA	"Shingles"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes zoster"	""	""	""	""	""	""	""	""	""	""	""	""
"896"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	2602480001	"vertigo-intermittent"	97	121	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467741446	""	""	""	NA	"Vertigo"	"Ear and labyrinth disorders"	"Inner ear and VIIIth cranial nerve disorders"	"Inner ear signs and symptoms"	"Vertigo"	""	""	""	""	""	""	""	""	""	""	""	""
"897"	"DN-101 Protocol No. 011-007"	"030"	"030-0001"	5	9	"Adverse Event/Serious Adverse Event"	3284910001	"worsening in hearing"	304	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497374714	""	""	""	NA	"Hearing decreased"	"Ear and labyrinth disorders"	"Hearing disorders"	"Hearing losses"	"Hypoacusis"	""	""	""	""	""	""	""	""	""	""	""	""
"898"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2719549003	"abdominal bloating"	70	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482252104	""	""	""	NA	"Abdominal bloating"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Abdominal distension"	""	""	""	""	""	""	""	""	""	""	""	""
"899"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	3943905001	"altered taste"	15	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509027546	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"900"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2748063001	"asthenia"	4	7	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477344551	""	""	""	NA	"Asthenia"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"901"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2950081001	"dehydration"	126	130	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487263817	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"902"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2950192001	"diaphoresis"	124	131	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487264370	""	""	""	NA	"Diaphoresis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"903"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2834019001	"dypsnea"	70	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482252276	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"904"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2748071001	"dyspepsia"	14	25	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477344810	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"905"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2763783001	"erectile dysfunction"	25	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478472121	""	""	""	NA	"Erectile dysfunction"	"Reproductive system and breast disorders"	"Sexual function and fertility disorders"	"Erection and ejaculation conditions and disorders"	"Erectile dysfunction"	""	""	""	""	""	""	""	""	""	""	""	""
"906"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	3500842001	"fatigue"	164	165	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502143192	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"907"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2950200001	"fatigue"	126	130	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487264762	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"908"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	3769791001	"fatigue"	49	126	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506456239	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"909"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2949944001	"fever"	124	128	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487263075	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"910"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2763765001	"flatus"	15	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478471817	""	""	""	NA	"Flatus"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Flatulence"	""	""	""	""	""	""	""	""	""	""	""	""
"911"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2949998001	"generalized arthalgia"	126	144	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487263303	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"912"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2950197001	"headache"	126	128	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487264658	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"913"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2763771001	"hot flashes-intermittent"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478471899	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"914"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2950021001	"intermittent abdominal pain/cramping"	124	131	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487263435	""	""	""	NA	"Abdominal crampy pains"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"915"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	3500870001	"left neck pain"	274	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"MRI performed"	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502143272	""	""	""	NA	"Neck pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Neck pain"	""	""	""	""	""	""	""	""	""	""	""	""
"916"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2949964001	"muscle weakness"	126	130	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487263169	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"917"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2833963001	"right jaw pain/post herpetic neuralgia intermittent"	63	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482251915	""	""	""	NA	"Post herpetic neuralgia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Post herpetic neuralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"918"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2748060001	"right jaw pain/post herpetic neuralgia-intermittent"	6	8	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477344472	""	""	""	NA	"Post herpetic neuralgia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Post herpetic neuralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"919"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2967890001	"salmonella infection"	133	140	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488167481	""	""	""	NA	"Salmonella infection NOS"	"Infections and infestations"	"Bacterial infectious disorders"	"Salmonella infections"	"Salmonellosis"	""	""	""	""	""	""	""	""	""	""	""	""
"920"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2748066001	"scrotal pain post tx"	4	6	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477344647	""	""	""	NA	"Scrotal pain"	"Reproductive system and breast disorders"	"Penile and scrotal disorders (excl infections and inflammations)"	"Scrotal disorders NEC"	"Scrotal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"921"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2942389001	"sinusitis"	91	114	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487110372	""	""	""	NA	"Sinusitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Sinusitis"	""	""	""	""	""	""	""	""	""	""	""	""
"922"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	3500361001	"testicular pain"	164	165	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502140355	""	""	""	NA	"Testicular pain"	"Reproductive system and breast disorders"	"Testicular and epididymal disorders"	"Testicular and epididymal disorders NEC"	"Testicular pain"	""	""	""	""	""	""	""	""	""	""	""	""
"923"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	3500887001	"urinary hesistancy"	288	291	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502143332	""	""	""	NA	"Urinary hesitancy"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary hesitation"	""	""	""	""	""	""	""	""	""	""	""	""
"924"	"DN-101 Protocol No. 011-007"	"030"	"030-0003"	5	9	"Adverse Event/Serious Adverse Event"	2834004001	"Weight Gain"	70	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482252195	""	""	""	NA	"Weight gain"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight increased"	""	""	""	""	""	""	""	""	""	""	""	""
"925"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	2754380003	"cough"	218	246	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497367795	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"926"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	3480186001	"dyspnea"	241	241	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501623959	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"927"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	3480007001	"hypokalemia"	246	260	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501621791	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"928"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	2772434001	"hypotension"	21	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"held Toprol"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479100752	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"929"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	3765240001	"increased rt leg pain"	309	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506440581	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"930"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	2772440001	"leukopenia"	21	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479100837	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"931"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	2772443001	"neutropenia"	21	36	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479100892	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"932"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	2863298001	"pruritis"	60	72	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484068851	""	""	""	NA	"Pruritis"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Pruritus NEC"	"Pruritus"	""	""	""	""	""	""	""	""	""	""	""	""
"933"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	2784212001	"rash- lower abdomen"	28	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479749628	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"934"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	2784206001	"rash-axilla bilateral"	28	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479749573	""	""	""	NA	"Localised rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"935"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	3480174001	"sinus tachycardia"	241	242	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501623710	""	""	""	NA	"Sinus tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Sinus tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"936"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	2772449001	"teeth pain-intermittent"	14	79	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479101192	""	""	""	NA	"Tooth pain"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Dental pain and sensation disorders"	"Toothache"	""	""	""	""	""	""	""	""	""	""	""	""
"937"	"DN-101 Protocol No. 011-007"	"030"	"030-0004"	5	9	"Adverse Event/Serious Adverse Event"	2772446001	"vertigo"	21	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479100971	""	""	""	NA	"Vertigo"	"Ear and labyrinth disorders"	"Inner ear and VIIIth cranial nerve disorders"	"Inner ear signs and symptoms"	"Vertigo"	""	""	""	""	""	""	""	""	""	""	""	""
"938"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	5	9	"Adverse Event/Serious Adverse Event"	2888854003	"alopecia"	26	154	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487101990	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"939"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	5	9	"Adverse Event/Serious Adverse Event"	3479755001	"arthalgia"	25	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501619559	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"940"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	5	9	"Adverse Event/Serious Adverse Event"	2983164001	"constipation"	42	43	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"disimpaction"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488910542	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"941"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	5	9	"Adverse Event/Serious Adverse Event"	3479764001	"dysguesia"	172	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501619683	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"942"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	5	9	"Adverse Event/Serious Adverse Event"	2906075001	"dysguesia"	12	17	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485964779	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"943"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	5	9	"Adverse Event/Serious Adverse Event"	2940981001	"fatigue"	17	217	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487101879	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"944"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	5	9	"Adverse Event/Serious Adverse Event"	2905982001	"halluciniations"	11	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485964044	""	""	""	NA	"Hallucinations"	"Psychiatric disorders"	"Disturbances in thinking and perception"	"Perception disturbances"	"Hallucination"	""	""	""	""	""	""	""	""	""	""	""	""
"945"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	5	9	"Adverse Event/Serious Adverse Event"	3778639001	"increased intermittent fatigue"	217	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Taxotere cycle changed to every 4 weeks"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506546223	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"946"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	5	9	"Adverse Event/Serious Adverse Event"	3778646001	"insomnia intermittent"	195	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506546321	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"947"	"DN-101 Protocol No. 011-007"	"030"	"030-0005"	5	9	"Adverse Event/Serious Adverse Event"	2901361001	"intermittent constipation"	8	17	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485803037	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"948"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	3109940003	"alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502051321	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"949"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	3146500001	"arthalgia hands-intermittent"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493585795	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"950"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	3146511001	"fatigue"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493585838	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"951"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	3197789001	"intermittent vertigo"	13	17	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494897988	""	""	""	NA	"Vertigo"	"Ear and labyrinth disorders"	"Inner ear and VIIIth cranial nerve disorders"	"Inner ear signs and symptoms"	"Vertigo"	""	""	""	""	""	""	""	""	""	""	""	""
"952"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	3172727001	"leukopenia"	17	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494355659	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"953"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	3841219001	"lightheadedness"	169	169	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507651767	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"954"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	4027473001	"mild diaphoresis"	169	169	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510251724	""	""	""	NA	"Diaphoresis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"955"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	3172766001	"neutropenia"	17	27	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494355997	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"956"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	3278980001	"tenia capitis"	45	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497218363	""	""	""	NA	"Scalp tinea"	"Infections and infestations"	"Fungal infectious disorders"	"Tinea infections"	"Tinea capitis"	""	""	""	""	""	""	""	""	""	""	""	""
"957"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	4330186001	"upper respiratory infection"	206	223	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513806282	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"958"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	4421888002	"URI"	206	223	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515515324	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"959"	"DN-101 Protocol No. 011-007"	"030"	"030-0009"	5	9	"Adverse Event/Serious Adverse Event"	4421850002	"weakness"	206	223	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515515253	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"960"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3319814003	"alopecia"	72	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507652535	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"961"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3595261001	"conjunctivitis"	72	93	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504035915	""	""	""	NA	"Conjunctivitis"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Conjunctival infections, irritations and inflammations"	"Conjunctivitis"	""	""	""	""	""	""	""	""	""	""	""	""
"962"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3595213001	"fatigue"	55	58	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504035767	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"963"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3841508001	"general malaise"	74	79	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507652596	""	""	""	NA	"General malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"964"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3841531001	"hyperlacrimation"	112	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507652659	""	""	""	NA	"Lacrimation increased"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"965"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3595291001	"intermittent diaphoresis"	71	93	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504036043	""	""	""	NA	"Diaphoresis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"966"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3845793001	"intermittent fatigue"	93	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507671709	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"967"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3845762001	"intermittent hand tremors"	93	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507671655	""	""	""	NA	"Tremor of hands"	"Nervous system disorders"	"Movement disorders (incl Parkinsonism)"	"Tremor (excl congenital)"	"Tremor"	""	""	""	""	""	""	""	""	""	""	""	""
"968"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3845738001	"intermittent pain-fingernails"	93	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507671583	""	""	""	NA	"Nail pain"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onychalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"969"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3545700001	"Malaise"	10	12	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502995403	""	""	""	NA	"Malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"970"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3545713001	"Malaise"	31	33	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502995462	""	""	""	NA	"Malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"971"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3380193001	"neutropenia"	21	29	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499632449	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"972"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	4355218001	"upper respiratory infection"	147	153	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514499172	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"973"	"DN-101 Protocol No. 011-007"	"030"	"030-0012"	5	9	"Adverse Event/Serious Adverse Event"	3595202001	"vertigo"	58	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504035712	""	""	""	NA	"Vertigo"	"Ear and labyrinth disorders"	"Inner ear and VIIIth cranial nerve disorders"	"Inner ear signs and symptoms"	"Vertigo"	""	""	""	""	""	""	""	""	""	""	""	""
"974"	"DN-101 Protocol No. 011-007"	"030"	"030-0013"	5	9	"Adverse Event/Serious Adverse Event"	3319854003	"alopecia"	51	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504037015	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"975"	"DN-101 Protocol No. 011-007"	"030"	"030-0013"	5	9	"Adverse Event/Serious Adverse Event"	3380217001	"dysguesia"	20	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499632568	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"976"	"DN-101 Protocol No. 011-007"	"030"	"030-0013"	5	9	"Adverse Event/Serious Adverse Event"	3380241001	"insomnia"	20	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499632737	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"977"	"DN-101 Protocol No. 011-007"	"030"	"030-0013"	5	9	"Adverse Event/Serious Adverse Event"	3737562001	"myopathy-upper and lower extremities"	93	113	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Dexamethasone decreased as well"	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506013265	""	""	""	NA	"Myopathy"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Myopathies"	"Myopathy"	""	""	""	""	""	""	""	""	""	""	""	""
"978"	"DN-101 Protocol No. 011-007"	"030"	"030-0013"	5	9	"Adverse Event/Serious Adverse Event"	4221384001	"pain right femur"	135	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512681843	""	""	""	NA	"Pain femoral"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"979"	"DN-101 Protocol No. 011-007"	"030"	"030-0013"	5	9	"Adverse Event/Serious Adverse Event"	3844616001	"weakness"	93	NA	1	2	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507667926	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"980"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2536465003	"abdomen pain"	350	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502388952	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"981"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518203001	"anemia"	391	445	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502389644	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"982"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2629920001	"anemia"	77	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470175775	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"983"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518118001	"back pain"	350	507	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502389011	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"984"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2571031001	"constipation"	15	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1462986528	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"985"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3489127001	"Deep Vein Thrombosis"	321	327	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	511	NA	NA	321	327	"doppler scan of the lower extremities showed extensive superior vein clot"	""	""	2	2	2	NA	0	2	NA	2	"The patient was hospitalized 1/25/07 with right lower extremity edema and dyspnea.  A dopple scan showed deep venous thrombosis."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501783757	""	""	""	NA	"Deep vein thrombosis"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"986"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518266001	"dizziness"	312	314	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502390395	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"987"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2556832001	"dizziness"	11	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"988"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2571038001	"dry skin"	48	158	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1462986655	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"989"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518069001	"dyspnea"	312	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502388591	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"990"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518139001	"fatigue"	350	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502389129	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"991"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2556819001	"fatigue"	11	350	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502387838	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"992"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2629905001	"feet tingling"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470175578	""	""	""	NA	"Tingling feet/hands"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"993"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518160001	"flatulence"	370	375	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502389332	""	""	""	NA	"Flatulence"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Flatulence"	""	""	""	""	""	""	""	""	""	""	""	""
"994"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3205233001	"groin pain"	291	497	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494969466	""	""	""	NA	"Groin pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Soft tissue disorders NEC"	"Groin pain"	""	""	""	""	""	""	""	""	""	""	""	""
"995"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	5288421002	"hyperglycemia"	127	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523466330	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"996"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518188001	"leukopenia"	391	445	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502389504	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"997"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2581677001	"leukopenia"	77	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464887155	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"998"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2629914001	"leukopenia"	98	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470175720	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"999"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2556810001	"leukopenia"	14	28	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1000"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518057001	"lower extremity edema"	304	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502388468	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1001"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2556839001	"lower extremity myalgias"	11	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Myalgia of lower extremities"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1002"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2629911001	"nail changes"	133	231	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470175664	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1003"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2556816001	"neutropenia"	14	28	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	NA	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1004"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518081001	"obstructive uropathy"	321	327	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502388803	""	""	""	NA	"Obstructive uropathy"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal obstructive disorders"	"Obstructive uropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1005"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518310001	"right hip pain"	313	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502390707	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1006"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518339001	"right leg pain"	313	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502390954	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1007"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518282001	"suprapubic pain"	313	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502390505	""	""	""	NA	"Suprapubic pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Suprapubic pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1008"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	2571028001	"thrombocytopenia"	35	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1462986439	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1009"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518164001	"urinary hesitancy"	376	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502389385	""	""	""	NA	"Urinary hesitancy"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary hesitation"	""	""	""	""	""	""	""	""	""	""	""	""
"1010"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518089001	"urinary tract infection"	321	327	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502388874	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1011"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518373001	"weight loss"	454	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502391250	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1012"	"DN-101 Protocol No. 011-007"	"031"	"031-0001"	5	9	"Adverse Event/Serious Adverse Event"	3518259001	"wheezing"	312	314	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502390296	""	""	""	NA	"Wheezing"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Wheezing"	""	""	""	""	""	""	""	""	""	""	""	""
"1013"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	5	9	"Adverse Event/Serious Adverse Event"	2663284003	"Allergic Rhinitis"	28	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476890757	""	""	""	NA	"Allergic rhinitis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal congestion and inflammations"	"Rhinitis allergic"	""	""	""	""	""	""	""	""	""	""	""	""
"1014"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	5	9	"Adverse Event/Serious Adverse Event"	2723711001	"Anemia"	14	63	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476288508	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1015"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	5	9	"Adverse Event/Serious Adverse Event"	4515121002	"Decreased Hemoglobin"	64	64	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"2 Units of Packed Red Blood Cells"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516135613	""	""	""	NA	"Decreased hemoglobin"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1016"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	5	9	"Adverse Event/Serious Adverse Event"	3033443001	"Deep Vein Thrombosis"	90	92	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	90	NA	NA	90	92	"Left leg Ultrasound on 11/28/2006"	""	""	2	2	2	2	2	2	2	2	"Ultrasound showed Acute deep vein thrombosis.  He was admitted and treated with Lovenox and Coumadin."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490631109	""	""	""	NA	"Deep vein thrombosis"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1017"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	5	9	"Adverse Event/Serious Adverse Event"	2753971001	"febrile neutropenia"	57	60	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	40	NA	NA	NA	1	NA	1	NA	""	58	NA	NA	57	65	"WBC- 900-  Manual diff= Bands .02 Neut .25 = ; AGC of 243"	""	""	2	2	2	NA	2	2	NA	2	"ON 10/26/06 patient went to ER with a 101 fever and weakness.  Mild diarrhea.; Grade 4 neutropenia"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477598809	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1018"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	5	9	"Adverse Event/Serious Adverse Event"	2723880001	"hypocalcemia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289962	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1019"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	5	9	"Adverse Event/Serious Adverse Event"	2773428001	"hypokalemia"	64	65	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479146268	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1020"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	5	9	"Adverse Event/Serious Adverse Event"	2723797001	"hyponatremia"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289459	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1021"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	5	9	"Adverse Event/Serious Adverse Event"	2723774001	"neutropenia"	14	21	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289147	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1022"	"DN-101 Protocol No. 011-007"	"034"	"034-0001"	5	9	"Adverse Event/Serious Adverse Event"	2723566001	"Pain port placement"	28	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476287550	""	""	""	NA	"Catheter site pain"	"General disorders and administration site conditions"	"Administration site reactions"	"Implant and catheter site reactions"	"Catheter site pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1023"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	5	9	"Adverse Event/Serious Adverse Event"	2951765003	"Anemia"	175	223	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Blood Transfusion"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505073500	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1024"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	5	9	"Adverse Event/Serious Adverse Event"	3222746001	"Bone Pain"	94	223	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495139112	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1025"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	5	9	"Adverse Event/Serious Adverse Event"	3138187001	"Constipation"	67	223	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493315730	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1026"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	5	9	"Adverse Event/Serious Adverse Event"	3658908001	"Decubitus Ulcer-Coccyx"	203	223	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Local wound care"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505074838	""	""	""	NA	"Decubitus ulcer"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Skin injuries and mechanical dermatoses"	"Decubitus ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"1027"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	5	9	"Adverse Event/Serious Adverse Event"	3093463001	"Edema of Right Ankle"	29	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Venous Doppler Ultrasound Right Lower Limb"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492436786	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1028"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	5	9	"Adverse Event/Serious Adverse Event"	3357760001	"Neropathy (Motor) both arms"	NA	223	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499108261	""	""	""	NA	"Peripheral motor neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral motor neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1029"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	5	9	"Adverse Event/Serious Adverse Event"	3658133001	"Neuropathy (Motor) Legs"	NA	223	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505071769	""	""	""	NA	"Motor peripheral neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral motor neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1030"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	5	9	"Adverse Event/Serious Adverse Event"	3096552001	"Swelling of both ankles"	46	223	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492459755	""	""	""	NA	"Ankles swelling"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint swelling"	""	""	""	""	""	""	""	""	""	""	""	""
"1031"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	5	9	"Adverse Event/Serious Adverse Event"	3138143001	"Syncope"	58	58	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient was taken by ambulance to the Emergency department, assessed and released after determining that the Syncope was caused by an episode of Hypotension"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493315344	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"1032"	"DN-101 Protocol No. 011-007"	"036"	"036-0003"	5	9	"Adverse Event/Serious Adverse Event"	3658451001	"Thrombocytopenia"	152	223	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Blood Transfusion"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505073074	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1033"	"DN-101 Protocol No. 011-007"	"037"	"037-0002"	5	9	"Adverse Event/Serious Adverse Event"	3163250003	"shortness of breath"	247	254	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520450004	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1034"	"DN-101 Protocol No. 011-007"	"037"	"037-0003"	5	9	"Adverse Event/Serious Adverse Event"	3404267003	"Anemia"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508776356	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1035"	"DN-101 Protocol No. 011-007"	"037"	"037-0003"	5	9	"Adverse Event/Serious Adverse Event"	3920697001	"Anemia"	14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508776112	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1036"	"DN-101 Protocol No. 011-007"	"037"	"037-0003"	5	9	"Adverse Event/Serious Adverse Event"	5057849002	"chest pain (non-cardiac)"	172	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520447609	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1037"	"DN-101 Protocol No. 011-007"	"037"	"037-0003"	5	9	"Adverse Event/Serious Adverse Event"	3637317001	"Cold"	56	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504708223	""	""	""	NA	"Cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1038"	"DN-101 Protocol No. 011-007"	"037"	"037-0003"	5	9	"Adverse Event/Serious Adverse Event"	4070988001	"Elevated Alkaline Phosphate"	56	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510771935	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1039"	"DN-101 Protocol No. 011-007"	"037"	"037-0003"	5	9	"Adverse Event/Serious Adverse Event"	4070920001	"Elevated ALT"	56	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510771731	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1040"	"DN-101 Protocol No. 011-007"	"037"	"037-0003"	5	9	"Adverse Event/Serious Adverse Event"	4070966001	"Elevated AST"	56	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510771849	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1041"	"DN-101 Protocol No. 011-007"	"037"	"037-0003"	5	9	"Adverse Event/Serious Adverse Event"	3565799001	"Elevated Glucose Level"	16	NA	1	3	1	1	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503435223	""	""	""	NA	"Glucose increased"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1042"	"DN-101 Protocol No. 011-007"	"037"	"037-0003"	5	9	"Adverse Event/Serious Adverse Event"	4317557001	"Exacerbation fo chronic obstructive pulmonary disease"	142	146	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	174	NA	NA	142	146	"CBC was significant for high WBC, low RBC, low HGB, low HCT, and high platelets. Coagulation profile demonstrated high activated PTT. High glucose, and low calcium. Chest x-ray = ok. V/Q scan showed"	"decreased ventilation and perfusion to right lung. CT scan showed small cavitary nodule in left apex."	""	2	2	2	2	2	2	2	2	"Patient presented with respiratory isufficiency, and the recommendations at the time included oxygen support with nebulizer treatment as well as bronchodialators."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513716504	""	""	""	NA	"Chronic obstructive airways disease exacerbated"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Chronic obstructive pulmonary disease"	""	""	""	""	""	""	""	""	""	""	""	""
"1043"	"DN-101 Protocol No. 011-007"	"037"	"037-0003"	5	9	"Adverse Event/Serious Adverse Event"	4317722001	"Exacerbation of chronic obstructive pulmonary disease"	165	170	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	174	NA	NA	165	170	"PSA was 483.8; Ferritin 543; Blood Sugar 157; Alkaline Phosphate 234; AST 82 ; BUN 26; Creatinine 1.1"	""	""	2	2	2	2	2	2	2	2	"Patient was giving the \"usual breathing treatments\" and also given IV steroids in addition to his home medications.  CT scan revealed liver nodules, ultrasound confirmed to be most likely metastatic"	"disease."	""	""	""	""	""	""	""	""	""	NA	NA	""	1513716925	""	""	""	NA	"Chronic obstructive airways disease exacerbated"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Chronic obstructive pulmonary disease"	""	""	""	""	""	""	""	""	""	""	""	""
"1044"	"DN-101 Protocol No. 011-007"	"037"	"037-0003"	5	9	"Adverse Event/Serious Adverse Event"	5058164002	"liver nodules"	165	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520448689	""	""	""	NA	"Liver nodule"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Hepatobiliary neoplasms malignant and unspecified"	"Hepatobiliary neoplasms malignancy unspecified"	"Hepatic neoplasm"	""	""	""	""	""	""	""	""	""	""	""	""
"1045"	"DN-101 Protocol No. 011-007"	"037"	"037-0003"	5	9	"Adverse Event/Serious Adverse Event"	5058023002	"shortness of breath"	172	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520448237	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1046"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2609204003	"Alopecia"	27	251	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470755914	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1047"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2654644001	"Constipation"	30	31	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472420167	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1048"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2859573001	"dyspnea on exertion"	148	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906638	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"1049"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2631780001	"Edema - Right Lower extremity"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470338883	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1050"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2859531001	"edema bilateral feet"	91	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906267	""	""	""	NA	"Foot edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1051"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2859594001	"edema left upper extremity"	148	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906880	""	""	""	NA	"Edema extremity upper"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1052"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2859588001	"edema lower extremities"	148	176	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906792	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1053"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2702212001	"Epistaxis"	80	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Stop taking Ansaid"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475183364	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"1054"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2702107001	"Fatigue"	80	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475181897	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1055"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2687330001	"Fatigue"	51	61	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474318984	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1056"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2687324001	"Generalized myalgia's"	51	61	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474318743	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1057"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2859516001	"generalized pain"	91	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906182	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1058"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2654650001	"Hot flashes"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472420411	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"1059"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2656938001	"Inadequate venous access"	10	10	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472501913	""	""	""	NA	"Poor venous access"	"Vascular disorders"	"Vascular disorders NEC"	"Non-site specific vascular disorders NEC"	"Poor venous access"	""	""	""	""	""	""	""	""	""	""	""	""
"1060"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2705230001	"Neutropenia"	83	91	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475516209	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1061"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2631774001	"Neutropenia"	14	20	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470338792	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1062"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2631786001	"Neutropenia"	20	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470338993	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1063"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2672772001	"Neutropenia"	56	69	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473354409	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1064"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2859548001	"onychosis hands and feet"	148	370	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906426	""	""	""	NA	"Onycholysis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onycholysis"	""	""	""	""	""	""	""	""	""	""	""	""
"1065"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2859562001	"orbital edema"	148	251	NA	1	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483906551	""	""	""	NA	"Orbital edema"	"Eye disorders"	"Ocular structural change, deposit and degeneration NEC"	"Orbital structural change, deposit and degeneration"	"Orbital oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1066"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2702118001	"Pain - knees bilaterally"	80	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475182092	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1067"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	3326300001	"Pain - right foot"	251	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498503363	""	""	""	NA	"Foot pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1068"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	3189742001	"pain bilateral legs"	251	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494794855	""	""	""	NA	"Pain legs"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1069"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664003001	"Rash - bilaterally axilla"	53	59	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473096517	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1070"	"DN-101 Protocol No. 011-007"	"039"	"039-0001"	5	9	"Adverse Event/Serious Adverse Event"	3326396001	"rectal bleeding"	252	259	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Discontinued naproxen"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498503976	""	""	""	NA	"Rectal bleeding"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Intestinal haemorrhages"	"Rectal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1071"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	5	9	"Adverse Event/Serious Adverse Event"	2559571003	"constipation"	147	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475787708	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1072"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	5	9	"Adverse Event/Serious Adverse Event"	2840022001	"constipation"	161	182	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482423069	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1073"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	5	9	"Adverse Event/Serious Adverse Event"	2840019001	"elevated creatinine"	154	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482423009	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1074"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	5	9	"Adverse Event/Serious Adverse Event"	2587629001	"Fatigue"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465404316	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1075"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	5	9	"Adverse Event/Serious Adverse Event"	2839936001	"fatigue"	147	182	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482421341	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1076"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	5	9	"Adverse Event/Serious Adverse Event"	2567350001	"Fever"	10	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465418605	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1077"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	5	9	"Adverse Event/Serious Adverse Event"	2818822001	"hyperalkaline phosphatase"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481560701	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1078"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	5	9	"Adverse Event/Serious Adverse Event"	2567342001	"Hyperglycemia"	7	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465151757	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1079"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	5	9	"Adverse Event/Serious Adverse Event"	2840003001	"loss of appetite"	154	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482422753	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1080"	"DN-101 Protocol No. 011-007"	"041"	"041-0001"	5	9	"Adverse Event/Serious Adverse Event"	2839986001	"neuropathy"	147	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482422616	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1081"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	2576896003	"Albumin, low"	131	132	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492704976	""	""	""	NA	"Albumin low"	"Investigations"	"Protein and chemistry analyses NEC"	"Protein analyses NEC"	"Blood albumin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1082"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	4061436001	"alopecia"	233	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510694524	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1083"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	3110838001	"Anemia"	7	180	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492704610	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1084"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	4061310001	"bad taste in mouth"	201	233	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510694147	""	""	""	NA	"Bad taste"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1085"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	3110895001	"elevated Alkaline Phosphatase"	7	159	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705026	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1086"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	2611430001	"Fatigue"	26	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468782013	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1087"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	3110936001	"Glucose, high"	7	308	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705295	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1088"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	4061106001	"increased lacrimation"	112	341	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510693164	""	""	""	NA	"Lacrimation increased"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1089"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	4061205001	"Intermittent elevated liver enzymes"	47	201	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510693479	""	""	""	NA	"Elevated liver enzymes"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Hepatic enzyme increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1090"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	3110850001	"Lymphopenia"	130	130	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492704676	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1091"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	4061329001	"nailbed changes"	201	233	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510694198	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1092"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	2683626001	"numbness and tingling"	68	233	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474212767	""	""	""	NA	"Numbness"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1093"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	3110941001	"Phosphate, low"	131	132	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705384	""	""	""	NA	"Phosphate low"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood phosphorus decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1094"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	2693955001	"pneumonia"	130	140	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	131	NA	NA	130	132	"9/24/06 Chest Xray: Left lower lobe pneumonia; 9/24/06 CBC w/diff; chem panel; UA performed"	""	""	2	1	2	NA	2	0	NA	0	"Pt called Urgent Care Center reporting a fever of 102.8 and generalized aches, but no localizing symptoms.  He was asked to come in and later admitted with pnuemonia, confirmed on chest x-ray."	"Discharged in stable condition."	""	""	""	""	""	""	""	""	""	NA	NA	""	1474830699	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1095"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	4061450001	"right rotator cuff injury"	273	273	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	6	NA	1	1	"arthroplasty"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510694589	""	""	""	NA	"Rotator cuff injury"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related disorders NEC"	"Rotator cuff syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"1096"	"DN-101 Protocol No. 011-007"	"041"	"041-0005"	5	9	"Adverse Event/Serious Adverse Event"	4061357001	"URI"	231	233	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510694288	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1097"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	2576905003	"anemia"	112	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510758405	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1098"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	2582295001	"Anemia"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464896497	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1099"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	3696337001	"anemia"	308	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505675106	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1100"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	3696229001	"constipation"	144	217	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505674588	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1101"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	3696210001	"dysuria"	91	113	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505674448	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1102"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	4066698001	"ecchymosis: L anticubital fossa"	434	483	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510758774	""	""	""	NA	"Ecchymosis"	"Skin and subcutaneous tissue disorders"	"Skin vascular abnormalities"	"Purpura and related conditions"	"Ecchymosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1103"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	3110990001	"elevated AST, SGOT"	133	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705841	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1104"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	3696366001	"fatigue"	350	371	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505675256	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1105"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	2707911001	"Fatigue"	125	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475619012	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1106"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	2582304001	"Hyperglycemia"	7	329	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464896597	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1107"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	4066647001	"lower tooth pain"	152	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510758544	""	""	""	NA	"Tooth pain"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Dental pain and sensation disorders"	"Toothache"	""	""	""	""	""	""	""	""	""	""	""	""
"1108"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	3696345001	"numbness/tingling in feet"	329	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505675164	""	""	""	NA	"Numbness in feet"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1109"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	3110994001	"Potassium, high"	133	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705892	""	""	""	NA	"Potassium high"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood potassium increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1110"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	3111001001	"Sodium, low"	196	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492705961	""	""	""	NA	"Sodium low"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood sodium decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1111"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	4066720001	"URI"	532	542	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510758859	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1112"	"DN-101 Protocol No. 011-007"	"041"	"041-0006"	5	9	"Adverse Event/Serious Adverse Event"	3696308001	"weakness"	287	308	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505675018	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1113"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	2650456003	"ALT, SGPT elevated"	7	156	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492718485	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1114"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	3112245001	"AST, SGOT elevated"	7	156	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492718530	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1115"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	4593513002	"Edema"	345	413	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516648728	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1116"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	4593090002	"Fatigue"	135	156	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516647964	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1117"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	4592860002	"fever"	77	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516647483	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1118"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	2822253001	"hyperglycemia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481658799	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1119"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	2685569001	"hyperglycemia"	7	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474294787	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1120"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	2822287001	"hyperkalemia (high potassium)"	70	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481659108	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1121"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	2822273001	"hyperkalemia (high potassium)"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481659003	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1122"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	2835863001	"LDH (elevated)"	49	313	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482271877	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1123"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	2822267001	"Leukocytes (Total WBC), low"	77	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481658927	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1124"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	2822260001	"Low Hemoglobin"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481658862	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1125"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	4593449002	"Neuropathy"	156	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516648587	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1126"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	2835853001	"neutropenia"	7	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482271790	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1127"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	2827089001	"nocturia"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481837658	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1128"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	2827098001	"nocturia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481837774	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1129"	"DN-101 Protocol No. 011-007"	"041"	"041-0009"	5	9	"Adverse Event/Serious Adverse Event"	3062217001	"Tongue Ulceration"	102	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	6	NA	1	1	"patient seen by Head and Neck MD, biopsy benign"	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491406606	""	""	""	NA	"Tongue ulceration"	"Gastrointestinal disorders"	"Tongue conditions"	"Tongue disorders"	"Tongue ulceration"	""	""	""	""	""	""	""	""	""	""	""	""
"1130"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	2728478003	"alopecia"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522856556	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1131"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	5254210002	"atrial fibrillation"	235	235	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522857331	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"1132"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	5253996002	"bilateral rib pain"	23	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522856500	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1133"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	2750702001	"Cardiac Chest Pain"	15	15	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	15	15	"10/24/06:  WBC*=0.5 K/mcL; RBC*=3.87 M/mcL; HGB*=11.6 g/dl; HCT*=34.9%; MCV=90 fl; MCH=30.1 pg; MCHC=33.3%; Platelet=199 K/mcL; RDW*=16.7%; Pro Time=13.2 sec; Pro Time=0.96 inr; APTT=28.1 sec; Na=141"	"mEq/L; K=4.4 mEq/L; Cl=106 mEq/L; Gluc*=144 mg/dl; BUN=11 mg/dl; Creat=0.8 mg/dl; Calcium=9.2 mg/dl; Magnesium=1.8 mEq/L; CPK=48 Units/L; Troponin=<0.06 ng/mL;* indicates values outside normal range"	""	2	2	2	NA	2	2	NA	2	"Pt admitted to Urgent Care Center at MSKCC on 10/24/06 complaining of pain in shoulders and chest tightness.  Urgent Care Center reports chest pain, pain in limb, and neutropenia.  Pt discharged same"	"day. Neutropenia is a known side-effect of the docetaxel.  The chest pain is unlikely related to the docetaxel or the prednisone."	""	""	""	""	""	""	""	""	""	NA	NA	""	1477424340	""	""	""	NA	"Chest pain - cardiac"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"1134"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	2776236001	"Cardiac Chest pain"	36	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Pt had ECHO performed"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	37	NA	NA	36	36	"Myocardial Infarction was ruled and. And Echocardiogran weas reviewd and appeared unchanged from previous records"	""	""	2	2	2	NA	2	2	2	2	"Pt was admitted to Monmouth Medical Center on 11/14 with chest pain.  Myocardial Infarction was ruled out.  Echocardiogram was reviewed by dr. McAleer and appears unchanged from previous records. Pt"	"was discharged on 11/14, same day."	""	""	""	""	""	""	""	""	""	NA	NA	""	1479227735	""	""	""	NA	"Chest pain - cardiac"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"1135"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	2819769001	"elevated Alkaline phosphatase"	30	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481574358	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1136"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	5254131002	"extravasation at chemo site"	70	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522857055	""	""	""	NA	"Infusion site extravasation"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion site extravasation"	""	""	""	""	""	""	""	""	""	""	""	""
"1137"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	2754314001	"Febrile neutropenia"	17	20	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"hosptialized"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	18	20	"10/27/06 (to 11/8/06): hypoalbuminemia Grade 1;10/26/06: hyperglycemia Grade 2;10/27/06-10/28/06: Hemoglobin Grade 2;10/27/06: INR Grade 1;10/26/06-10/27/06: WBC Grade 3;10/28/06: WBC Grade"	"1;10/26/06-10/27/06: Neutrophils Grade 4;10/27/06: PTT Grade 1;10/26/06: hyponatremia (low sodium): Grade 1;10/27/06: lymphopenia grade 3;10/26/06: hyperglycemia Grade 2"	""	2	1	2	NA	2	2	NA	0	"Thursday 10/26 pt reported \"scratchy throat and runny nose\" w temp 99.5.  Temp rose to 100.6 at 8pm on 10/26, pt was admitted 10/27 for"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477842334	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1138"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	2819273001	"hemoglobin (low)"	18	19	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481569968	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1139"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	2819261001	"hyperglycemia (high glucose)"	17	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Glycosylated HGB performed on 11/12/06. Result was within normal limits."	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481569736	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1140"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	2819276001	"Hypoalbuminemia (low albumin)"	18	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481570095	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1141"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	5253967002	"increased back pain"	18	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522856336	""	""	""	NA	"Back pain aggravated"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1142"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	2819793001	"INR (elevated)"	18	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481574556	""	""	""	NA	"INR increased"	"Investigations"	"Haematology investigations (incl blood groups)"	"Coagulation and bleeding analyses"	"International normalised ratio increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1143"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	2819946001	"Lymphopenia"	8	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481576266	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1144"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	3161341001	"Pneumonia"	200	219	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Hospitalized"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	207	NA	NA	200	219	"4/27- WBC: 3.7 K/CUMM, RBC: 3.26 M/CUMM; 5/5- WBC: 4.0 K/CUMM, RBC: 4.65 M/CUMM"	""	""	2	2	2	NA	0	2	NA	0	"Patient AIP was admitted to a local local hospital on 4/27/07. He was septic and hypotensive.  His blood pressure was 90 over 37. He has right and left pneumonia, with a temperature of 102 F and was"	"neutropenic (although exact counts are not yet available). Patient received two blood transfusions to bring his oxygen level up.  He is on dopamine.  Patient was dicharged on Friday 5/4/07.  However,"	"he was readmitted Saturday night 5/5/07 when he became hypotensive and septic again."	""	""	""	""	""	""	""	""	NA	NA	""	1493930359	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1145"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	5253978002	"rhinorrhea"	20	20	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522856390	""	""	""	NA	"Rhinorrhea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1146"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	5254108002	"Right hip hematoma"	50	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522856987	""	""	""	NA	"Hematoma"	"Vascular disorders"	"Vascular haemorrhagic disorders"	"Haemorrhages NEC"	"Haematoma"	""	""	""	""	""	""	""	""	""	""	""	""
"1147"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	5254177002	"sinusitis"	133	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522857184	""	""	""	NA	"Sinusitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Sinusitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1148"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	5254097002	"stomach virus"	49	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522856924	""	""	""	NA	"Stomach virus"	"Infections and infestations"	"Viral infectious disorders"	"Viral infections NEC"	"Gastroenteritis viral"	""	""	""	""	""	""	""	""	""	""	""	""
"1149"	"DN-101 Protocol No. 011-007"	"041"	"041-0010"	5	9	"Adverse Event/Serious Adverse Event"	5254148002	"subconjunctival hemorrhaging"	70	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522857125	""	""	""	NA	"Subconjunctival hemorrhage"	"Eye disorders"	"Ocular haemorrhages and vascular disorders NEC"	"Conjunctival and corneal bleeding and vascular disorders"	"Conjunctival haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1150"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	2741939003	"Fatigue"	147	392	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490811125	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1151"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	3064748001	"Fever"	107	108	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491421361	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1152"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	3112319001	"Glucose, high"	7	122	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492718973	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1153"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	3112305001	"High Alkaline Phosphatase"	7	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492718926	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1154"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	3112291001	"Low Hemoglobin"	122	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492718880	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1155"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	3390561001	"lower back pain"	217	221	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	266	NA	NA	217	221	"Values normal except: Hgb 12.3, Hct 35.3, CO2 23."	""	""	2	2	2	NA	2	2	NA	2	"Patient admitted to UCC with lower back pain, radiating down the legs. His pain medication was adjusted as necessary."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499713252	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1156"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	4399681002	"lower back pain"	251	254	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	447	NA	NA	251	254	"Values normal except: HGB 12.0, Hct 35.4, Ca 8.4, Glu 133"	""	""	2	2	2	NA	2	2	NA	2	"Patient admitted for pain. MRI confirmed progression of bony spinal metastases with epidural disease but no clear indication of cord compression or vertebral collapse.  Patient began XRT to T6-T8."	"There was improvement in pain control at discharge on 6/28/07."	""	""	""	""	""	""	""	""	""	NA	NA	""	1515362076	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1157"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	4556339002	"neuropathy"	206	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516309399	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1158"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	5201489002	"Progressive Weakness"	122	392	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522000226	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1159"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	5201435002	"right hip pain"	147	392	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522000044	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1160"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	4931984002	"tension-type headache"	14	192	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519243541	""	""	""	NA	"Headache tension"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Tension headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1161"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	4556271002	"Weight Loss"	147	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516309234	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1162"	"DN-101 Protocol No. 011-007"	"041"	"041-0011"	5	9	"Adverse Event/Serious Adverse Event"	3044036001	"wound infection"	98	112	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490810585	""	""	""	NA	"Wound infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Wound infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1163"	"DN-101 Protocol No. 011-007"	"041"	"041-0013"	5	9	"Adverse Event/Serious Adverse Event"	2756487003	"cough"	10	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520347285	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1164"	"DN-101 Protocol No. 011-007"	"041"	"041-0013"	5	9	"Adverse Event/Serious Adverse Event"	3112507001	"elevated ALT, SGPT"	31	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492720138	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1165"	"DN-101 Protocol No. 011-007"	"041"	"041-0013"	5	9	"Adverse Event/Serious Adverse Event"	2818930001	"hyperkalemia (high potassium)"	31	115	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481561550	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1166"	"DN-101 Protocol No. 011-007"	"041"	"041-0013"	5	9	"Adverse Event/Serious Adverse Event"	4459951002	"Increased fatigue"	157	227	NA	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515683190	""	""	""	NA	"Fatigue aggravated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1167"	"DN-101 Protocol No. 011-007"	"041"	"041-0013"	5	9	"Adverse Event/Serious Adverse Event"	4460018002	"Increased lacrimation"	199	227	NA	1	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515683455	""	""	""	NA	"Lacrimation increased"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1168"	"DN-101 Protocol No. 011-007"	"041"	"041-0013"	5	9	"Adverse Event/Serious Adverse Event"	2831471001	"nocturia"	10	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482167835	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1169"	"DN-101 Protocol No. 011-007"	"041"	"041-0018"	5	9	"Adverse Event/Serious Adverse Event"	2870728003	"Dyspnea"	147	157	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516138873	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1170"	"DN-101 Protocol No. 011-007"	"041"	"041-0018"	5	9	"Adverse Event/Serious Adverse Event"	3090277001	"Elevated AST SGOT"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492374715	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1171"	"DN-101 Protocol No. 011-007"	"041"	"041-0018"	5	9	"Adverse Event/Serious Adverse Event"	3090302001	"Glucose, high"	35	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492374841	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1172"	"DN-101 Protocol No. 011-007"	"041"	"041-0018"	5	9	"Adverse Event/Serious Adverse Event"	3090264001	"hemoglobin, low"	35	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492374647	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1173"	"DN-101 Protocol No. 011-007"	"041"	"041-0018"	5	9	"Adverse Event/Serious Adverse Event"	3090320001	"Potassium, high"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492374930	""	""	""	NA	"Potassium high"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood potassium increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1174"	"DN-101 Protocol No. 011-007"	"041"	"041-0018"	5	9	"Adverse Event/Serious Adverse Event"	3029895001	"Rash"	15	NA	1	1	1	1	NA	NA	NA	NA	1	1	NA	5	1	NA	1	"skin biopsy performed by local dermatologist"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490553821	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1175"	"DN-101 Protocol No. 011-007"	"041"	"041-0018"	5	9	"Adverse Event/Serious Adverse Event"	4516326002	"Weight loss"	126	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516138720	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1176"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	2923710003	"Adrenal Insufficieny"	259	361	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522018711	""	""	""	NA	"Adrenal insufficiency"	"Endocrine disorders"	"Adrenal gland disorders"	"Adrenal cortical hypofunctions"	"Adrenal insufficiency"	""	""	""	""	""	""	""	""	""	""	""	""
"1177"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	3735408001	"back discomfort"	149	191	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506006356	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1178"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	4213869001	"cardiac arrhythmia"	41	41	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512595283	""	""	""	NA	"Cardiac arrhythmia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Arrhythmia"	""	""	""	""	""	""	""	""	""	""	""	""
"1179"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	4213950001	"constipation"	224	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512595720	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1180"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	4388452001	"Constitutional Symptoms, Other: Failure to thrive"	267	362	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	331	NA	NA	267	308	"Reportedly a CNS workup was unremarkable and there were no clear objective findings to attribute to his symptoms."	""	""	2	2	2	NA	2	2	NA	2	"The patient was admitted to a local hospital for failure to thrive.  Reportedly a CNS workup was unremarkable and there were no clear objective findings to attribute to his symptoms. ;As per nursing"	"phone conversation on 12/12/07, the patient is receiving home hospice care."	""	""	""	""	""	""	""	""	""	NA	NA	""	1515103086	""	""	""	NA	"Failure to thrive"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"General nutritional disorders NEC"	"Failure to thrive"	""	""	""	""	""	""	""	""	""	""	""	""
"1181"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	3735388001	"depression"	86	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506006257	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"1182"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	4814826002	"elevated AST"	2	2	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518029410	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1183"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	4213978001	"generalized weakness"	224	259	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512595848	""	""	""	NA	"Weakness generalized"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1184"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	3099189001	"hyperglycemia"	2	224	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492525625	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1185"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	4814856002	"hyperkalemia"	2	2	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518029640	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1186"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	4213922001	"hyperkalemia"	168	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512595556	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1187"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	4814906002	"night sweats"	259	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518029864	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"1188"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	4213910001	"peripheral neuropathy"	84	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512595480	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1189"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	4213896001	"pleural effusion"	77	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512595374	""	""	""	NA	"Pleural effusion"	"Respiratory, thoracic and mediastinal disorders"	"Pleural disorders"	"Pneumothorax and pleural effusions NEC"	"Pleural effusion"	""	""	""	""	""	""	""	""	""	""	""	""
"1190"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	3099205001	"Potassium, high"	2	2	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492525740	""	""	""	NA	"Potassium high"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood potassium increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1191"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	3024524001	"Right hand rash/dry skin"	23	170	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490301054	""	""	""	NA	"Skin rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1192"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	4214166001	"syncope"	208	213	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"fluids"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	302	NA	NA	208	213	""	""	""	2	2	2	NA	2	2	NA	2	"Patient was admitted for a syncopal episode on 9/3/07."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512596833	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"1193"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	3735353001	"urinary frequency"	2	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506006070	""	""	""	NA	"Urinary frequency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1194"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	3024554001	"Urinary incontinence"	23	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490301336	""	""	""	NA	"Urinary incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"1195"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	3735343001	"worsening fatigue"	168	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506006005	""	""	""	NA	"Fatigue aggravated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1196"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	3845879001	"worsening memory impairment"	107	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507672076	""	""	""	NA	"Memory impairment"	"Nervous system disorders"	"Mental impairment disorders"	"Memory loss (excl dementia)"	"Memory impairment"	""	""	""	""	""	""	""	""	""	""	""	""
"1197"	"DN-101 Protocol No. 011-007"	"041"	"041-0020"	5	9	"Adverse Event/Serious Adverse Event"	4213940001	"worsening nocturia"	259	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512595671	""	""	""	NA	"Nocturia aggravated"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1198"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	2965027003	"Anemia (low Hemoglobin)"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492527561	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1199"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	4667811002	"Constipation"	153	180	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517181005	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1200"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	5204794002	"depression"	55	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522011769	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"1201"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	3099476001	"elevated Alkaline Phosphatase"	7	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492527767	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1202"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	3099502001	"elevated AST, SGOT"	14	14	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492528098	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1203"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	3039254001	"Fatigue"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490726584	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1204"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	3090566001	"fever"	52	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492377637	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1205"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	4645356002	"generalized weakness"	14	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516917809	""	""	""	NA	"Weakness generalized"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1206"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	3099514001	"Glucose, high"	7	52	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492528172	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1207"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	5204565002	"insomnia"	49	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522010746	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1208"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	3099463001	"Lymphopenia"	52	52	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492527657	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1209"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	5204530002	"numbness/tingling in fingers"	49	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522010648	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1210"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	3112817001	"Pneumonitis"	57	62	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	57	NA	NA	57	62	"4/19/2007 WBC: 3.1, HGB: 9.7, PLT: 228, electrocardiogram: normal"	""	""	2	2	2	NA	2	0	NA	2	"Patient HNH reported malaise, cough and temperature of 101.2F on 4/14/07.  He was prescribed Levaquin 500 mg daily for 7 days.	Patient was seen in UCC and admitted on 4/19/07 with concern for viral"	"pneumonia.  Appears to have docetaxel induced pulmonary toxicity and is responding to steroids."	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723492	""	""	""	NA	"Pneumonitis"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Lower respiratory tract inflammatory and immunologic conditions"	"Pneumonitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1211"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	5204770002	"skin rash"	49	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522011660	""	""	""	NA	"Skin rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1212"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	5204724002	"viral syndrome"	55	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522011423	""	""	""	NA	"Viral syndrome"	"Infections and infestations"	"Viral infectious disorders"	"Viral infections NEC"	"Viral infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1213"	"DN-101 Protocol No. 011-007"	"041"	"041-0022"	5	9	"Adverse Event/Serious Adverse Event"	4645455002	"Weight Loss"	49	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516919153	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1214"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	2992343003	"constipation"	118	138	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506020503	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1215"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	3740078001	"constipation"	189	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506020718	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1216"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	4668396002	"Dyspnea"	189	189	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517184007	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1217"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	3740019001	"fatigue"	189	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506020610	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1218"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	3099637001	"Glucose, High"	7	40	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492529485	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1219"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	3099625001	"High Alkaline Phosphatase"	7	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492529151	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1220"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	3099633001	"High ALT"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492529446	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1221"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	3099629001	"High AST"	7	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492529190	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1222"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	3739935001	"Left side chin numbness"	70	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506020429	""	""	""	NA	"Numbness facial"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Hypoaesthesia facial"	""	""	""	""	""	""	""	""	""	""	""	""
"1223"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	3739914001	"nocturia"	27	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506020381	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1224"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	3739992001	"oral mucositis"	189	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506020558	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1225"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	3099641001	"Sodium, low"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492529520	""	""	""	NA	"Sodium low"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood sodium decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1226"	"DN-101 Protocol No. 011-007"	"041"	"041-0024"	5	9	"Adverse Event/Serious Adverse Event"	3740043001	"weight loss"	189	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506020661	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1227"	"DN-101 Protocol No. 011-007"	"041"	"041-0025"	5	9	"Adverse Event/Serious Adverse Event"	3009149003	"Glucose, high"	28	93	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492526258	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1228"	"DN-101 Protocol No. 011-007"	"041"	"041-0025"	5	9	"Adverse Event/Serious Adverse Event"	5290499002	"increased insomnia"	6	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523479862	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1229"	"DN-101 Protocol No. 011-007"	"041"	"041-0025"	5	9	"Adverse Event/Serious Adverse Event"	3099255001	"Low Hemoglobin"	5	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492526094	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1230"	"DN-101 Protocol No. 011-007"	"041"	"041-0025"	5	9	"Adverse Event/Serious Adverse Event"	5290488002	"worsening hand tremor"	49	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523479797	""	""	""	NA	"Tremor of hands"	"Nervous system disorders"	"Movement disorders (incl Parkinsonism)"	"Tremor (excl congenital)"	"Tremor"	""	""	""	""	""	""	""	""	""	""	""	""
"1231"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	3079968003	"Bleeding from rectum"	74	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517183899	""	""	""	NA	"Bleeding rectal"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Intestinal haemorrhages"	"Rectal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1232"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4044474001	"c. difficile colitis"	94	105	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510593325	""	""	""	NA	"C.difficile colitis"	"Infections and infestations"	"Bacterial infectious disorders"	"Clostridia infections"	"Clostridium difficile colitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1233"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4764155002	"cold like symptoms"	154	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517774898	""	""	""	NA	"Cold symptoms"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1234"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	3728347001	"constipation"	84	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505939746	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1235"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4764142002	"cystitis"	172	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517774864	""	""	""	NA	"Cystitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Cystitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1236"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	3734173001	"dyspnea"	63	140	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506001758	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1237"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4764129002	"dysuria"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517774807	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1238"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4764181002	"Erythemia"	96	105	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517774951	""	""	""	NA	"Erythema"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"1239"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	3728115001	"fatigue"	42	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505939160	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1240"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	3728177001	"fatigue"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505939408	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1241"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	3728145001	"fatigue"	63	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505939298	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1242"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4044444001	"febrile neutropenia"	93	96	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510593254	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1243"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4044651001	"hyperglycemia"	21	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510593794	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1244"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4044580001	"hypersensitivity reaction"	21	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510593610	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"1245"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4764088002	"Hypokalemia"	97	103	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517774671	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1246"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4044378001	"leukopenia"	93	96	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510593067	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1247"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4764044002	"lower extremity pain"	84	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517774442	""	""	""	NA	"Pain of lower extremities"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1248"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4764076002	"nail bed changes"	63	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517774558	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1249"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4044487001	"nocturia"	42	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510593374	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1250"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	3728519001	"numbness/tingling"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505940343	""	""	""	NA	"Numbness"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1251"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	3417334001	"pneumonia"	93	105	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	95	NA	NA	93	105	"fever 7/11/07 was 101.1 F, with a neutrophil count of 0.6 K/mcL. ; 7/13/07, his neutrophil count is 1.1 K/mcL."	""	""	2	2	2	NA	2	2	NA	2	"Patient MBL was admitted to MSKCC UCC on 7/11/07 with febrile neutropenia and severe diarrhea.	His fever on 7/11/07 was 101.1 F, with a neutrophil count of 0.6 K/mcL. He is diagnosed with pneumonia."	"As of today, 7/13/07, his neutrophil count is 1.1 K/mcL."	""	""	""	""	""	""	""	""	""	NA	NA	""	1499979264	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1252"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4764121002	"sensitive gums"	63	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517774780	""	""	""	NA	"Sensitivity of gums"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Gingival pains"	"Gingival pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1253"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4007426001	"Shortness of Breath"	205	207	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	211	NA	NA	205	207	"No relevent lab results"	""	""	2	2	2	2	2	2	2	2	"The patient was admitted to a local hospital for 3 days after presenting with shortness of breath and possible pneumonia.  He was afebrile and there was no documented pneumonia.  He was discharged on"	"11/2/07 and was prescibed Augmentin.  He was dose reduced but taken off study prior to resuming treatment at the lower dose.  He resports feeling better and will follow up in clinic on 11/21."	""	""	""	""	""	""	""	""	""	NA	NA	""	1510004651	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1254"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4044743001	"tachycardia"	84	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510594100	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"1255"	"DN-101 Protocol No. 011-007"	"041"	"041-0029"	5	9	"Adverse Event/Serious Adverse Event"	4044675001	"wheezing"	84	119	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510593906	""	""	""	NA	"Wheezing"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Wheezing"	""	""	""	""	""	""	""	""	""	""	""	""
"1256"	"DN-101 Protocol No. 011-007"	"041"	"041-0033"	5	9	"Adverse Event/Serious Adverse Event"	3274008003	"abdominal pain"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510678433	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1257"	"DN-101 Protocol No. 011-007"	"041"	"041-0033"	5	9	"Adverse Event/Serious Adverse Event"	4699050002	"blood in stool"	70	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517322421	""	""	""	NA	"Blood in stool"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Haematochezia"	""	""	""	""	""	""	""	""	""	""	""	""
"1258"	"DN-101 Protocol No. 011-007"	"041"	"041-0033"	5	9	"Adverse Event/Serious Adverse Event"	4698638002	"cardiac chest pain"	29	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517320907	""	""	""	NA	"Chest pain - cardiac"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"1259"	"DN-101 Protocol No. 011-007"	"041"	"041-0033"	5	9	"Adverse Event/Serious Adverse Event"	4055284001	"constipation"	49	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510678223	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1260"	"DN-101 Protocol No. 011-007"	"041"	"041-0033"	5	9	"Adverse Event/Serious Adverse Event"	4055306001	"dyspnea"	70	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510678379	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1261"	"DN-101 Protocol No. 011-007"	"041"	"041-0033"	5	9	"Adverse Event/Serious Adverse Event"	4699364002	"edema"	29	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517323373	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1262"	"DN-101 Protocol No. 011-007"	"041"	"041-0033"	5	9	"Adverse Event/Serious Adverse Event"	4055231001	"LLQ abdominal tenderness"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510678020	""	""	""	NA	"Abdominal tenderness"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal tenderness"	""	""	""	""	""	""	""	""	""	""	""	""
"1263"	"DN-101 Protocol No. 011-007"	"041"	"041-0033"	5	9	"Adverse Event/Serious Adverse Event"	4699418002	"lower extremity pain"	91	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517323499	""	""	""	NA	"Pain of lower extremities"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1264"	"DN-101 Protocol No. 011-007"	"041"	"041-0033"	5	9	"Adverse Event/Serious Adverse Event"	4055258001	"UTI"	7	14	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510678122	""	""	""	NA	"UTI"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1265"	"DN-101 Protocol No. 011-007"	"041"	"041-0033"	5	9	"Adverse Event/Serious Adverse Event"	4699325002	"weakness"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517323271	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1266"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	3350005003	"Anemia"	125	NA	1	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"multiple blood transfusions"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521566152	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1267"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	4717032002	"constipation"	130	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517354444	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1268"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	4733371002	"cough"	48	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Chest X-Ray performed locally to rule out pneumonia"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517429327	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1269"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	4723330002	"depression"	109	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517406189	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"1270"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	3644703001	"headaches"	25	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504802735	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1271"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	4717044002	"hematuria"	130	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517354511	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1272"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	3644548001	"hyperglycemia"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"will follow up with endocrinologist to adjust glucovance"	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504801459	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1273"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	5162363002	"Increase Fatigue"	109	NA	1	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"multiple blood transfusions"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521565921	""	""	""	NA	"Fatigue aggravated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1274"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	3644699001	"leg cramps"	25	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504802674	""	""	""	NA	"Leg cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1275"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	5162502002	"Melyosupression"	130	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521566315	""	""	""	NA	"Myelosuppression"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Marrow depression and hypoplastic anaemias"	"Bone marrow failure"	""	""	""	""	""	""	""	""	""	""	""	""
"1276"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	4717079002	"pain in fingertips"	130	137	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517354593	""	""	""	NA	"Pain in fingers"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1277"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	4007527001	"shortness of breath"	125	127	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"received 3 units of RBCs"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	131	NA	NA	125	127	"patient was admitted due to chest discomfort.  He received 3 units of red blood cells and a myocardial infarction was ruled out.  Of note, the patient's hematacrit was 22.5."	""	""	2	2	2	NA	1	0	NA	0	"The patient was admitted to NYU hospital on 10/31/07 for shortness of breath.  On examination the patient was not found to have sustained a cardiac episode, however, on admission his hematocrit was"	"noted to be 22.5 which is a decline from the test performed on 10/15/07 which indicated his hematocrit was 30.7.  The patient was transfused and a Guaiac test was performed and found to be negative."	"The patient was discharged on 11/2/07 and returned to clinic on 11/05/07 for a follow up appointment.  This event is possibly related to the cumulative effects in the marrow of treatment but a"	"possible GI source will be monitored as well."	""	""	""	""	""	""	""	NA	NA	""	1510005058	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1278"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	5162552002	"Thromybocytopenia"	130	NA	1	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521566485	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1279"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	5162335002	"Upper Respiratory Infection"	88	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521565812	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1280"	"DN-101 Protocol No. 011-007"	"041"	"041-0035"	5	9	"Adverse Event/Serious Adverse Event"	3644721001	"upper respiratory infection"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504803054	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1281"	"DN-101 Protocol No. 011-007"	"041"	"041-0036"	5	9	"Adverse Event/Serious Adverse Event"	3437278003	"Blurred vision"	73	81	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Fentanyl patch increased from 50 to 100 micrograms"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516817576	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"1282"	"DN-101 Protocol No. 011-007"	"041"	"041-0036"	5	9	"Adverse Event/Serious Adverse Event"	4626713002	"Chest pain (non cardiac)"	73	81	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"Fentanyl patch increased from 50 to 100 micrograms"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516815877	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1283"	"DN-101 Protocol No. 011-007"	"041"	"041-0036"	5	9	"Adverse Event/Serious Adverse Event"	4629688002	"decreased sodium"	11	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516822849	""	""	""	NA	"Sodium decreased"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood sodium decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1284"	"DN-101 Protocol No. 011-007"	"041"	"041-0036"	5	9	"Adverse Event/Serious Adverse Event"	4628886002	"Dyspnea"	99	144	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516821010	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1285"	"DN-101 Protocol No. 011-007"	"041"	"041-0036"	5	9	"Adverse Event/Serious Adverse Event"	4629984002	"elevated ALT"	11	81	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516823642	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1286"	"DN-101 Protocol No. 011-007"	"041"	"041-0036"	5	9	"Adverse Event/Serious Adverse Event"	4629943002	"elevated AST"	11	81	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516823551	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1287"	"DN-101 Protocol No. 011-007"	"041"	"041-0036"	5	9	"Adverse Event/Serious Adverse Event"	4007291001	"Fatigue"	100	105	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"hospitalized"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	116	NA	NA	100	105	"no relevent tests"	""	""	0	2	2	NA	2	2	2	2	"On 10/21/2007 the patient was admitted to the Urgent Care Center due to Grade II fever, Grade III fatigue, Grade III generalized pain which the patient characterized as \"all over soreness\", and"	"Failure to Thrive.  The patient was discharged on 10/26/07 and returned to clinic for a follow up appointment on 11/02/07 at which time he was taken off study.  This is considered an unexpected event"	"that is most likely unrelated to drug.	."	""	""	""	""	""	""	""	""	NA	NA	""	1510003940	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1288"	"DN-101 Protocol No. 011-007"	"041"	"041-0036"	5	9	"Adverse Event/Serious Adverse Event"	4628674002	"Fever"	99	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"this AE occurred during hospitalization for SAE (pain, fatigue)"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516820652	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1289"	"DN-101 Protocol No. 011-007"	"041"	"041-0036"	5	9	"Adverse Event/Serious Adverse Event"	5189037002	"Gastric Reflux"	112	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521732350	""	""	""	NA	"Reflux gastritis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Gastritis (excl infective)"	"Reflux gastritis"	""	""	""	""	""	""	""	""	""	""	""	""
"1290"	"DN-101 Protocol No. 011-007"	"041"	"041-0036"	5	9	"Adverse Event/Serious Adverse Event"	4628389002	"Generalized pain"	100	105	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"hospitalized, fentanyl patch increased to 200 micrograms, Lyrica 50 mg initiated."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	116	NA	NA	100	105	"no relevant tests"	""	""	2	2	2	NA	2	2	NA	2	"On 10/21/2007 the patient was admitted to the Urgent Care Center due to Grade II fever, Grade III fatigue, Grade III generalized pain which the patient characterized as \"all over soreness\", and"	"Failure to Thrive.  The patient was discharged on 10/26/07 and returned to clinic for a follow up appointment on 11/02/07 at which time he was taken off study.  This is considered an unexpected event"	"that is most likely unrelated to drug.	."	""	""	""	""	""	""	""	""	NA	NA	""	1516820196	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1291"	"DN-101 Protocol No. 011-007"	"041"	"041-0036"	5	9	"Adverse Event/Serious Adverse Event"	4627193002	"Lower extremity pain"	73	81	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"Fentanyl patch increased from 50 to 100 micrograms"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516817445	""	""	""	NA	"Pain of lower extremities"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1292"	"DN-101 Protocol No. 011-007"	"041"	"041-0036"	5	9	"Adverse Event/Serious Adverse Event"	4629211002	"Neuropathy"	112	144	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516821685	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1293"	"DN-101 Protocol No. 011-007"	"041"	"041-0037"	5	9	"Adverse Event/Serious Adverse Event"	3461994003	"anemia"	56	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517237102	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1294"	"DN-101 Protocol No. 011-007"	"041"	"041-0037"	5	9	"Adverse Event/Serious Adverse Event"	5161774002	"conjunctivitis"	119	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521563926	""	""	""	NA	"Conjunctivitis"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Conjunctival infections, irritations and inflammations"	"Conjunctivitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1295"	"DN-101 Protocol No. 011-007"	"041"	"041-0037"	5	9	"Adverse Event/Serious Adverse Event"	4633772002	"constipation"	77	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516839915	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1296"	"DN-101 Protocol No. 011-007"	"041"	"041-0037"	5	9	"Adverse Event/Serious Adverse Event"	4676142002	"edema"	80	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517235432	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1297"	"DN-101 Protocol No. 011-007"	"041"	"041-0037"	5	9	"Adverse Event/Serious Adverse Event"	5063074002	"fatigue"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520459017	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1298"	"DN-101 Protocol No. 011-007"	"041"	"041-0037"	5	9	"Adverse Event/Serious Adverse Event"	4677266002	"hypokalemia"	104	104	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517238457	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1299"	"DN-101 Protocol No. 011-007"	"041"	"041-0037"	5	9	"Adverse Event/Serious Adverse Event"	4677679002	"hyponatremia"	104	127	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517239098	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1300"	"DN-101 Protocol No. 011-007"	"041"	"041-0037"	5	9	"Adverse Event/Serious Adverse Event"	4633562002	"Insomnia"	56	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516838495	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1301"	"DN-101 Protocol No. 011-007"	"041"	"041-0037"	5	9	"Adverse Event/Serious Adverse Event"	4676250002	"leg cramps"	98	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517235970	""	""	""	NA	"Leg cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1302"	"DN-101 Protocol No. 011-007"	"041"	"041-0037"	5	9	"Adverse Event/Serious Adverse Event"	5161792002	"Lightheadness"	122	126	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521564028	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1303"	"DN-101 Protocol No. 011-007"	"041"	"041-0037"	5	9	"Adverse Event/Serious Adverse Event"	4633834002	"Neuropathy"	77	NA	1	1	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516840173	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1304"	"DN-101 Protocol No. 011-007"	"041"	"041-0037"	5	9	"Adverse Event/Serious Adverse Event"	4676324002	"oral mucositis"	126	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517236330	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1305"	"DN-101 Protocol No. 011-007"	"041"	"041-0038"	5	9	"Adverse Event/Serious Adverse Event"	3497244003	"nocturia"	49	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505923785	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1306"	"DN-101 Protocol No. 011-007"	"041"	"041-0038"	5	9	"Adverse Event/Serious Adverse Event"	4686154002	"skull abrasion secondary to fall"	133	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517255048	""	""	""	NA	"Abrasion NOS"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Non-site specific injuries NEC"	"Excoriation"	""	""	""	""	""	""	""	""	""	""	""	""
"1307"	"DN-101 Protocol No. 011-007"	"041"	"041-0039"	5	9	"Adverse Event/Serious Adverse Event"	3740893003	"Bilateral intermittent cramps in legs"	24	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517260057	""	""	""	NA	"Cramps legs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1308"	"DN-101 Protocol No. 011-007"	"041"	"041-0039"	5	9	"Adverse Event/Serious Adverse Event"	4724769002	"elevated AST"	51	72	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517410506	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1309"	"DN-101 Protocol No. 011-007"	"041"	"041-0039"	5	9	"Adverse Event/Serious Adverse Event"	4724889002	"Lymphopenia"	51	93	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517410880	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1310"	"DN-101 Protocol No. 011-007"	"041"	"041-0039"	5	9	"Adverse Event/Serious Adverse Event"	4688880002	"Nocturia"	30	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517260475	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1311"	"DN-101 Protocol No. 011-007"	"043"	"043-0002"	5	9	"Adverse Event/Serious Adverse Event"	2561688003	"Abdominal Cramps"	76	80	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473353943	""	""	""	NA	"Abdominal cramps"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1312"	"DN-101 Protocol No. 011-007"	"043"	"043-0002"	5	9	"Adverse Event/Serious Adverse Event"	2735355001	"Asthenia"	114	269	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476706886	""	""	""	NA	"Asthenia"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1313"	"DN-101 Protocol No. 011-007"	"043"	"043-0002"	5	9	"Adverse Event/Serious Adverse Event"	2672698001	"Dehydration"	80	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV Fluids- Normal Saline"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473353179	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1314"	"DN-101 Protocol No. 011-007"	"043"	"043-0002"	5	9	"Adverse Event/Serious Adverse Event"	2735361001	"Dysgeusia"	114	209	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476707751	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1315"	"DN-101 Protocol No. 011-007"	"043"	"043-0002"	5	9	"Adverse Event/Serious Adverse Event"	2672778001	"Muscle strain right anterior chest"	99	102	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473354933	""	""	""	NA	"Muscle strain"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Muscle, tendon and ligament injuries"	"Muscle strain"	""	""	""	""	""	""	""	""	""	""	""	""
"1316"	"DN-101 Protocol No. 011-007"	"043"	"043-0002"	5	9	"Adverse Event/Serious Adverse Event"	4135844001	"Upper Respiratory Infection"	249	254	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511815175	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1317"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2582405003	"Abdominal Pain"	41	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473686721	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1318"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2626225001	"Anemia"	41	48	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469730220	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1319"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2626200001	"Asthenia"	34	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469729598	""	""	""	NA	"Asthenia"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1320"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2877146001	"Constipation"	200	201	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484664825	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1321"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2735830001	"Edema of Bilateral Ankles"	119	161	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476716473	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1322"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2874477001	"Fatigue"	182	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484589743	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1323"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2676873001	"Fatigue"	48	181	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473687328	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1324"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2602234001	"GI bleed"	40	47	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalized"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	43	NA	NA	41	47	"Hgb 7.3 on 7/3/2006; Endoscopy done 7/5/06 showed bleeding ulcers; erosive esophagitis; small hiatal hernia; 1 cm Mallory-Weiss tear"	""	""	2	2	2	2	2	2	2	2	"Patient presented to office c/o hematemesis, epigastric abdominal pain and bleeding per rectum.  Hgb 7.3"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467733706	""	""	""	NA	"GI bleed"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1325"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2674875001	"GI Bleed Stool"	41	77	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473603007	""	""	""	NA	"GI bleed"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"1326"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2626300001	"Hematemesis"	41	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469732142	""	""	""	NA	"Hematemesis"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Haematemesis"	""	""	""	""	""	""	""	""	""	""	""	""
"1327"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2674878001	"Hiatal Hernia"	41	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473603372	""	""	""	NA	"Hiatal hernia"	"Gastrointestinal disorders"	"Abdominal hernias and other abdominal wall conditions"	"Diaphragmatic hernias"	"Hiatus hernia"	""	""	""	""	""	""	""	""	""	""	""	""
"1328"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2877170001	"Hot Flashes"	182	203	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484665734	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"1329"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2877091001	"Hyperglycemia"	182	233	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484663483	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1330"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2877082001	"Hyperglycemia"	140	160	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484663381	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1331"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2877073001	"Hyperglycemia"	77	97	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484661896	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1332"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2626210001	"Hyperglycemia"	14	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469729917	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1333"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2676809001	"Insomnia"	41	47	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473686608	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1334"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2877159001	"Right Frozen Shoulder"	181	NA	1	4	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"MRI = Torn Rotator Cuff, Patient refused Surgery."	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484665369	""	""	""	NA	"Frozen shoulder"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related disorders NEC"	"Periarthritis"	""	""	""	""	""	""	""	""	""	""	""	""
"1335"	"DN-101 Protocol No. 011-007"	"043"	"043-0003"	5	9	"Adverse Event/Serious Adverse Event"	2877121001	"Right Shoulder Pain"	181	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484664395	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1336"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	2585220003	"Alopecia"	11	493	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468154985	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1337"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	3036247001	"Anemia"	176	493	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490706908	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1338"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	3036199001	"Left hip pain"	124	133	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490704329	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1339"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	3036237001	"Left hip pain"	134	186	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490706314	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1340"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	3036266001	"Left hip replacement"	186	186	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490707574	""	""	""	NA	"Hip replacement"	"Surgical and medical procedures"	"Bone and joint therapeutic procedures"	"Joint therapeutic procedures"	"Hip arthroplasty"	""	""	""	""	""	""	""	""	""	""	""	""
"1341"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	2604533001	"Leg Cramping"	35	493	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468155049	""	""	""	NA	"Leg cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1342"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	3036234001	"Lower leg extremities swelling"	124	493	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490706185	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1343"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	3036326001	"Pain in shoulders"	211	493	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490708859	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1344"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	2604522001	"Rash"	8	11	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468154817	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1345"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	2604525001	"Rash"	12	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468154896	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1346"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	2674423001	"Sinus discharge"	84	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473536890	""	""	""	NA	"Nasal sinus discharge"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Paranasal sinus hypersecretion"	""	""	""	""	""	""	""	""	""	""	""	""
"1347"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	3036231001	"Taste change"	12	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490706044	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1348"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	2674409001	"Toe nail change"	70	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473536586	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1349"	"DN-101 Protocol No. 011-007"	"043"	"043-0004"	5	9	"Adverse Event/Serious Adverse Event"	3036240001	"Toe nail change"	176	493	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490706406	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1350"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2655001003	"Alopecia"	22	458	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477406792	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1351"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2749172001	"Anemia"	22	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477403885	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1352"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2812314001	"Anemia"	78	458	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481137322	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1353"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2693003001	"Bilateral soles of feet numbness"	22	458	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474817267	""	""	""	NA	"Numbness in feet"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1354"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2980630001	"Bone Pain"	162	281	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488831379	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1355"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	3493246001	"Carbuncle Right eyebrow"	321	352	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502045217	""	""	""	NA	"Carbuncle"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Carbuncle"	""	""	""	""	""	""	""	""	""	""	""	""
"1356"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2831296001	"Cold Symptoms"	109	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482165381	""	""	""	NA	"Cold symptoms"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1357"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2693007001	"Constipation"	10	458	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474817391	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1358"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2812446001	"Dehydration"	75	78	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV Normal Saline  1000mg 11/6/2006; IV Normal Saline 1500 mg 11/8/2006"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481138374	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1359"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2693030001	"Dysgeusia"	24	458	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474818008	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1360"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2670558001	"Fatigue"	10	458	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473268887	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1361"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2693123001	"Leukocytosis"	29	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474818664	""	""	""	NA	"Leukocytosis"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukocytoses NEC"	"Leukocytosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1362"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2980637001	"Leukopenia"	155	162	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488831459	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1363"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2812136001	"Leukopenia"	57	65	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481135815	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1364"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2812158001	"Leukopenia"	65	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481135932	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1365"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2749438001	"Leukopenia"	22	50	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477404762	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1366"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2980651001	"Neutropenia"	155	162	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488831584	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1367"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2749595001	"Neutropenia"	43	50	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477407206	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1368"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2692996001	"Neutropenia"	22	29	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474816552	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1369"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2670618001	"Neutropenia"	15	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473269470	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1370"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2812244001	"Neutropenia"	65	71	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481136744	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1371"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2812298001	"Right Arm Bone Pain"	65	458	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481137229	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1372"	"DN-101 Protocol No. 011-007"	"043"	"043-0005"	5	9	"Adverse Event/Serious Adverse Event"	2812096001	"weakness in lower extremities"	57	458	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481135638	""	""	""	NA	"Lower extremities weakness of"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"1373"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3084338003	"Anemia"	32	167	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496686373	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1374"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	4145379001	"Cardiac arrest"	167	167	NA	5	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	4	0	NA	0	30	NA	1	1	1	1	NA	NA	""	247	167	0	164	167	"Subject had CBC, Chem panel, Chest Xray, IV Antibiotics & Oxygen support.  However was a DNR; subject died 9/9/07."	""	""	2	2	2	2	2	2	NA	2	"Pt. hospitaized on 9/6/07 with Dx pneumonia. Was tx with IVF and IV antibiotics. Pt. had a cardiac arrest on 9/9/07. He had a DNR order if he should arrest. Date of death 9-9-07. Contacted Hospital"	"for discharge summary.	Informed per Medical Rec's. dept. that DS was not done as of 11-28-07. Have requested a DS to be completed for Hospitalization."	""	""	""	""	""	""	""	""	""	NA	NA	""	1511900094	""	""	""	NA	"Cardiac arrest"	"Cardiac disorders"	"Cardiac arrhythmias"	"Ventricular arrhythmias and cardiac arrest"	"Cardiac arrest"	""	""	""	""	""	""	""	""	""	""	""	""
"1375"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3264158001	"Constipation"	32	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496686715	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1376"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3632112001	"Dehydrdation"	141	144	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504642831	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1377"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3321013001	"Depression"	73	167	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498411538	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"1378"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3631428001	"Dizziness"	122	129	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504640149	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1379"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3264175001	"Fatigue"	38	167	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496686857	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1380"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3631455001	"Hyperglycemia"	108	167	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504640279	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1381"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3264149001	"Leukopenia"	32	38	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496686590	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1382"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3631310001	"Leukopenia"	122	129	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504639797	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1383"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3403827001	"Leukopenia"	94	101	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499803302	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1384"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3632068001	"Leukopenia"	144	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504642665	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1385"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3403855001	"Neutropenia"	94	101	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499803483	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1386"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3631376001	"Neutropenia"	122	129	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504640002	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1387"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3553804001	"Pneumonia"	144	157	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	147	NA	NA	144	147	"ECG, CXR, Blood Culture- 8-17-07; Urinaylsis- 8-18-07; Type 8-18-07; CBC-8-19-07; BMP, GFR, PTT, PT/INR, CBC-8-20-07"	""	""	2	2	2	NA	2	2	NA	2	"Patient admitted to hospital due to rigors.  Upon admission patient diagnosed with pneumonia."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503260010	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1388"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3644863001	"Pneumonia"	164	167	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	165	NA	NA	164	167	"Chest X-Ray 09-06-2007, 09-07-07.Labs done 9-6-07, 9-7-07.U/A & culture"	""	""	2	2	0	NA	2	2	NA	2	"Patient was admitted to the Hospital with Pneumonia on September 6th, 2007.  Patient receiving IV antibiotics and resp. treatments.WBC 2.6, HGB 9.8, IV Cefepime q12, Rocephin 1gm q 24h, Ns 60ml per"	"H, Albuterol nebulizer 2.5mg q 4 h, Atrovent 0.5mg nebulizer q4 h, Inapsine 1mg IV q4 h prn.."	""	""	""	""	""	""	""	""	""	NA	NA	""	1504804479	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1389"	"DN-101 Protocol No. 011-007"	"043"	"043-0007"	5	9	"Adverse Event/Serious Adverse Event"	3403887001	"Upper Respiratory Infection"	94	101	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499803610	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1390"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	3804718003	"Alopecia"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511810062	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1391"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4133628001	"Bilat leg and arm pain"	21	40	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511809433	""	""	""	NA	"Pain of extremities"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1392"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4133878001	"Fatigue"	26	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511810145	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1393"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4133700001	"Headache"	21	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511809628	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1394"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4342810001	"insomia"	91	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514320424	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1395"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4133765001	"Intermittant productive cough"	26	72	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511809867	""	""	""	NA	"Productive cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1396"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4342687001	"Intermittent back ache"	86	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514319040	""	""	""	NA	"Back ache"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1397"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4342705001	"Intermittent dyspnea with exertion"	40	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514319289	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"1398"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4133811001	"Leukopenia"	26	33	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511809996	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1399"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4133589001	"Neutropenia"	26	33	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511809291	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1400"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4133656001	"Oral Mucositis"	26	40	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511809532	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1401"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4133904001	"Thrush"	26	32	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511810224	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"1402"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4342732001	"Thrush"	88	95	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514319546	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"1403"	"DN-101 Protocol No. 011-007"	"043"	"043-0010"	5	9	"Adverse Event/Serious Adverse Event"	4133950001	"Thrush"	46	53	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511810372	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"1404"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	2963408003	"abdominal pain"	292	292	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517429027	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1405"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	3185470001	"Alopecia"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494772286	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1406"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	3373690001	"Anemia"	123	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499441332	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1407"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4740995002	"bilateral pedal edema"	242	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517494891	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1408"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4733165002	"Chills"	292	293	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517428726	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"1409"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4741126002	"cough"	62	80	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517495891	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1410"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4740951002	"dry skin, fingertips"	123	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517494709	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"1411"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4741750002	"dyspnea"	292	295	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	292	295	"Blood cultures drawn. Came back sterile. Started on antibiotics."	""	""	2	2	2	2	2	2	2	2	"Presented to emergency department with acure worsening of shortness of breath. Has been having some SOB for about a week. Woke up on 12/1 with an episode of diarrhea and shortly afterwards developing"	"chills and difficulty breathing. Denies precipitating factors like exertion or position changes, no associated light headedness, dizziness, palpitations, or cough. On arrival, had abdominal pain and"	"nausea, which has subsequently resolved. A repeat CT scan of the chest as also negative."	""	""	""	""	""	""	""	""	NA	NA	""	1517498306	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1412"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4740884002	"edema, left lower leg"	285	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517493251	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1413"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4741150002	"fatigue"	39	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517495960	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1414"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4741228002	"fever"	292	295	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517496172	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1415"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4733676002	"finger injury from fall"	165	186	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517430188	""	""	""	NA	"Injury to finger NOS"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Limb injuries NEC (incl traumatic amputation)"	"Limb injury"	""	""	""	""	""	""	""	""	""	""	""	""
"1416"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	5176057002	"groin abcess/cellulitis"	287	295	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Lower extremity doppler (12/1) was notable for a mass lesion. Diagnosed as cellulitis"	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	402	NA	NA	292	295	"Lower extreity doppler.  Abcess drained by interventional radiology. Antibiotic given to help resolve abcess."	""	""	0	0	2	NA	1	0	NA	0	"J-O came to clinic complaining of groin pain.  Antibiotic helped decrease size of mass, but did not resolve. Was admitted for fever and dyspnea, at which point abcess was drained.  There was not"	"enough fluid to obtain a diagnosis. Antibiotics appeared to relieve some of the pain associated with abcess.  Ultrasound on 1/16/08 showed possible seroma.  One treatment of taxotere was held due to"	"multiple AE's. Abcess improving, but still present."	""	""	""	""	""	""	""	""	NA	NA	""	1521641359	""	""	""	NA	"Groin abscess"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Groin abscess"	""	""	""	""	""	""	""	""	""	""	""	""
"1417"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4758032002	"hiatel hernia"	260	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517752627	""	""	""	NA	"Hernia hiatal"	"Gastrointestinal disorders"	"Abdominal hernias and other abdominal wall conditions"	"Diaphragmatic hernias"	"Hiatus hernia"	""	""	""	""	""	""	""	""	""	""	""	""
"1418"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4156351001	"neuropathy"	207	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Neurology consult"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511987075	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1419"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4740868002	"neuropathy, right lower leg"	207	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517493160	""	""	""	NA	"Peripheral neuropathy NOS"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1420"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4741047002	"pain, behind left knee"	242	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517495450	""	""	""	NA	"Aching (l) knee"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1421"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4733963002	"Pain, right eye"	80	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517430739	""	""	""	NA	"Eye pain"	"Eye disorders"	"Eye disorders NEC"	"Ocular disorders NEC"	"Eye pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1422"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4733556002	"pinched nerve, left leg"	288	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517429914	""	""	""	NA	"Crushed nerve"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Nerve injuries NEC"	"Nerve injury"	""	""	""	""	""	""	""	""	""	""	""	""
"1423"	"DN-101 Protocol No. 011-007"	"044"	"044-0001"	5	9	"Adverse Event/Serious Adverse Event"	4758046002	"streptococcus Salivarius infection"	336	340	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517752818	""	""	""	NA	"Streptococcal infection"	"Infections and infestations"	"Bacterial infectious disorders"	"Streptococcal infections"	"Streptococcal infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1424"	"DN-101 Protocol No. 011-007"	"044"	"044-0002"	5	9	"Adverse Event/Serious Adverse Event"	3528607003	"Anemia"	67	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1526910191	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1425"	"DN-101 Protocol No. 011-007"	"044"	"044-0002"	5	9	"Adverse Event/Serious Adverse Event"	5375459002	"Anemia"	71	77	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1526910276	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1426"	"DN-101 Protocol No. 011-007"	"044"	"044-0002"	5	9	"Adverse Event/Serious Adverse Event"	5375484002	"Anemia"	78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1526910415	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1427"	"DN-101 Protocol No. 011-007"	"044"	"044-0002"	5	9	"Adverse Event/Serious Adverse Event"	4705611002	"Anorexia"	51	132	NA	2	0	NA	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517337958	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1428"	"DN-101 Protocol No. 011-007"	"044"	"044-0002"	5	9	"Adverse Event/Serious Adverse Event"	4709542002	"dehydration"	51	51	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV fluids at home."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517344490	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1429"	"DN-101 Protocol No. 011-007"	"044"	"044-0002"	5	9	"Adverse Event/Serious Adverse Event"	4747084002	"Edema -- left ankle"	25	46	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517517569	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1430"	"DN-101 Protocol No. 011-007"	"044"	"044-0002"	5	9	"Adverse Event/Serious Adverse Event"	4746773002	"Lethargy"	46	132	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517516778	""	""	""	NA	"Lethargy"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Lethargy"	""	""	""	""	""	""	""	""	""	""	""	""
"1431"	"DN-101 Protocol No. 011-007"	"044"	"044-0002"	5	9	"Adverse Event/Serious Adverse Event"	4704563002	"Mood Alteration -- Depression"	67	132	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517335431	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"1432"	"DN-101 Protocol No. 011-007"	"044"	"044-0002"	5	9	"Adverse Event/Serious Adverse Event"	4704684002	"Neuropathy - feet, bilateral"	11	132	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517335632	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1433"	"DN-101 Protocol No. 011-007"	"044"	"044-0002"	5	9	"Adverse Event/Serious Adverse Event"	4746811002	"neuropathy -- hands"	11	132	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517516874	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1434"	"DN-101 Protocol No. 011-007"	"044"	"044-0002"	5	9	"Adverse Event/Serious Adverse Event"	4705327002	"Pain -- right scapula"	25	132	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517337179	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1435"	"DN-101 Protocol No. 011-007"	"044"	"044-0002"	5	9	"Adverse Event/Serious Adverse Event"	4705522002	"weakness"	51	132	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517337777	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1436"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2590563003	"alopecia"	80	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474323331	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1437"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2687370001	"bone pain"	-61	NA	1	2	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474322878	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1438"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2687376001	"fatigue"	17	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474323114	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1439"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2687379001	"insomnia"	24	45	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474323221	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1440"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2902652001	"lower extremity edema"	178	198	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485812975	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1441"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2902708001	"nail changes"	234	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485813726	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1442"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2902674001	"nasal drainage"	126	136	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485813217	""	""	""	NA	"Nasal discharge"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1443"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2902698001	"nasal stuffiness"	185	198	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485813629	""	""	""	NA	"Nasal stuffiness"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal congestion and inflammations"	"Nasal congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"1444"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2902726001	"neuropathy motor-weakness"	52	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485813919	""	""	""	NA	"Peripheral motor neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral motor neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1445"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2687398001	"neuropathy-sensory"	87	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474323518	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1446"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2902758001	"pain-back"	73	94	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485814285	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1447"	"DN-101 Protocol No. 011-007"	"045"	"045-0001"	5	9	"Adverse Event/Serious Adverse Event"	2687373001	"upper extemity pain"	10	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474323001	""	""	""	NA	"Pain in extremity"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"1448"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2604584003	"abdominal pain, nonspecific,secondary to partial ileus"	225	230	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	229	NA	NA	225	230	"2/15-EKG-sinus tachy(R=108, K-2.8; Abd series- nonspecific bowel gas pattern which could be due to ileus, no obstruction or performation;Right Rib xray- suspicious for metastatic disease::2/16- GB"	"sonogram- neg, 2/29- CXR-no chg"	""	2	2	2	NA	2	2	NA	2	"The patients wife called the Hope Center to report the patient's condition. After discussiion with Dr. Reddy, she was advised to take him to the ER for evaluation of RUQ Abdominal pain, nausea,"	"anorexia for the past 10 days and poor intake. The patient was in a holding bed overnight and admitted as an inpatient. Prednisone was >20 mg BID, Megace and Lexapro were added and TPN was started. A"	"pulmonologist consult was requested.Blood sugars were monitored and insulin coverage was added.;Potassium dropped to 2.9 and was corrected with TPN. sputum culture was + for pseudomonas. Patient"	"experience some diarrhea which resolved by D/C."	""	""	""	""	""	""	""	NA	NA	""	1487530233	""	""	""	NA	"Ileus"	"Gastrointestinal disorders"	"Gastrointestinal stenosis and obstruction"	"Gastrointestinal stenosis and obstruction NEC"	"Ileus"	""	""	""	""	""	""	""	""	""	""	""	""
"1449"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2924782001	"Acute Bronchitis and Pneumonia"	204	217	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	3	1	1	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486569780	""	""	""	NA	"Bronchial pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchopneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1450"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2900000001	"Acute Exacerbation of Chronic Obstructive Pulmonary Disease"	204	212	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	208	NA	NA	204	212	"WBC-20.7 (2 weeks post Neulasta), chest per auscultation-scattered wheezes and rales; per patient, CXR was negative for Pneumonia; 1/29-CXR showed resolution of infiltrate in the right costophrenic"	"angle.sputum culture was normal, micro on 2/1 was neg so far"	""	2	2	2	NA	2	2	2	2	"Patients presented to the Pulmonologists office with severe Shortness of Breath, cough, wheezing and rattling. No improvement despite outpatient treatment. Patient was then hospitalized for IV"	"steroids(Solumedrol) and IV antibiotics(Zosyn3.375gm q6hours), oxygen PRN, Pulmonary toilet,and mucomyst. On d/c, he had no distress, good air entry, no rales no wheezes, and was sent home in stable"	"condition"	""	""	""	""	""	""	""	""	NA	NA	""	1485732378	""	""	""	NA	"Chronic obstructive airways disease exacerbated"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Chronic obstructive pulmonary disease"	""	""	""	""	""	""	""	""	""	""	""	""
"1451"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2738518001	"anemia"	1	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476815862	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1452"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	3080567001	"Aspergillus lung infection"	233	268	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492021582	""	""	""	NA	"Aspergillus infection NOS"	"Infections and infestations"	"Fungal infectious disorders"	"Aspergillus infections"	"Aspergillosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1453"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2628599001	"Bronchitis"	20	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470079319	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1454"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2682366001	"Chronic Obstructive Pulmonary Disease, Exacerbation"	72	76	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"hospitalized for IV steroids and IV antibiotics/per patient will do bronchoscopy on Tuesday if no improvement over the weekend."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	72	NA	NA	72	76	"Patient was just admitted. No specific information is available at this time"	""	""	2	2	2	NA	2	2	NA	2	"Patient has Chronic Bronchitis with COPD. He has been treated with oral antibiotics and steroids as an outpatient. Patient was assessed by his pulmonologist today and it was felt patient needed to be"	"hospitalized for high dose antibiotics and steroids. No specific information is available at this time"	""	""	""	""	""	""	""	""	""	NA	NA	""	1473965727	""	""	""	NA	"Chronic obstructive airways disease exacerbated"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Chronic obstructive pulmonary disease"	""	""	""	""	""	""	""	""	""	""	""	""
"1455"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2696412001	"Clinical Pneumonia"	72	76	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	72	NA	NA	72	76	"9/15/06- CXR- negative;blood culture- negative;sputum culture showed pseudomonas aeruginosa;wbc-4.4, Hgb-11.6;chemistry was unremarkable"	""	""	2	2	2	NA	2	2	2	2	"Patient was treated as an outpatient with oral antibiotics and steroids. He had a productive cough with increasing shortness of breath and was hospitalized for IV antibiotics and IV steroids. On"	"9/19/06 he was discharged to home with continued IV Tobramycin QD as an outpatient x 10 days and Levaquin po x 7 days"	""	""	""	""	""	""	""	""	""	NA	NA	""	1474919827	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1456"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2801836001	"Clinical Pneumonia"	153	157	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Direct admit to Hospital"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	153	NA	NA	153	157	"CBC, CMP, Blood Cultures, CXR, EKG were ordered for 12/5/06; (no results at this time)"	""	""	2	2	2	NA	2	2	2	2	"Patient came to clinic for Follow-up visit , labs and Aranesp.Patient reported he was feeling weak and was chilling. He had a increased amount of phlegm and had vomited this A.M. mostly phlegm."	"T-100.6, BP-178/88, R-24, P-76. Patient was examined by Dr. Bolla and was sent to the hospital for a direct admit: Dx-Clinical Pneumonia;Patient was to start on Solumedrol 80 mg IV Q8H and Levaquin"	"500 mg IV QD and nebulizer treatments."	""	""	""	""	""	""	""	""	NA	NA	""	1480963237	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1457"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	3080548001	"Cough, Bronchitis"	186	204	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492021342	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1458"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	3080602001	"Depression"	226	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492021838	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"1459"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	3080557001	"Dizziness"	189	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492021455	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1460"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2638653001	"Febrile Neutropenia"	36	39	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Oxygen @ 2 liters per nasal cannula"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	40	NA	NA	36	39	"8/10/06- WBC=1.6, neuts=42%, ANC=.6,hgb=11.1, chemistry unremarkable except of Glucose =152,; Chest X-ray unremarkable but felt to have clinical pneumonia with fever and cough with productive sputum."	""	""	2	2	2	2	2	2	2	2	"Patient was seen in the clinic on 8/8/06, stated he had Bronchitis and	was on day 3 of 10 days of antibiotics(dicloxacillin).	noted some nausea  no vomiting, has had temp on and off as high as"	"102.5. It was 98.5 in the clinic on 8/8/06. Patient also noted some increase in SOB. Patient was to continue his antibiotics and call if symptoms persist.  WBC was 1.5 and ANC =0.7. chemistry"	"OK.;Patient's wife called on 8/10/06 and reported his worsening condition. Patient was admitted as an inpatient. Temperature on asmission was 101.1, P=112, R=24, BP=129/60.Blood cultures and sputum"	"cultures were drawn. .	Patient was started on Solu-medrol 60 mg IV BID, IV fluids of NS @ 50cc/hr, Rocephin 1 gm IV qd, Levaquin 500 mg IV qd, DuoNeb nebulizers QID,	Oxygen was on at 2 liters per"	"nasal cannula. Patient was given Neupogen 300 mcg qd x 3 for neutropenia. Patient was discharged on 8/13/2006 and to continue Levaquin 500 mg po qd x 7 days, Xopenex 1.25 via nebulizer 4 times a day"	"as needed.  ;."	""	""	""	""	""	NA	NA	""	1471205088	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1461"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2653472001	"fever"	32	32	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472164914	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1462"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2679678001	"hypertension"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473804921	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"1463"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	3080615001	"hypokalemia"	225	230	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492021998	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1464"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2923003001	"Leukoplakia above supraglottis area"	208	235	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486497959	""	""	""	NA	"Leukoplakia"	"Skin and subcutaneous tissue disorders"	"Cornification and dystrophic skin disorders"	"Skin preneoplastic conditions NEC"	"Leukoplakia"	""	""	""	""	""	""	""	""	""	""	""	""
"1465"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2738502001	"neutropenia"	104	111	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Infection precautions"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476815546	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1466"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2924826001	"Pseudomonas Pneumonia"	217	222	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	218	NA	NA	217	222	"2/7/;07- Na-133, K-3.0, CL-92, Glucose-197, BUN-31, WBC-11.9, neuts-88%(H), lymphs-1%(L)"	""	""	2	2	2	NA	2	2	NA	2	"Patient had been discharged from the hospital on 2/2/07 and was evaluated in the Pulmonist's office on 2/7/07. He was sent to the office with the Diagnosis of Pseudomonas Pneumonia."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486570646	""	""	""	NA	"Pneumonia due to Pseudomonas"	"Infections and infestations"	"Bacterial infectious disorders"	"Pseudomonal infections"	"Lung infection pseudomonal"	""	""	""	""	""	""	""	""	""	""	""	""
"1467"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	3080635001	"Pseudomonos Pneumonia"	225	230	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492022168	""	""	""	NA	"Pneumonia due to Pseudomonas"	"Infections and infestations"	"Bacterial infectious disorders"	"Pseudomonal infections"	"Lung infection pseudomonal"	""	""	""	""	""	""	""	""	""	""	""	""
"1468"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	3081404001	"rash"	218	222	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492028917	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1469"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2923098001	"Steroid induced hyperglycemia"	188	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486498695	""	""	""	NA	"Hyperglycemia steroid-induced"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1470"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2679684001	"sweating"	49	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473805370	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1471"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2869011001	"swelling- left arm"	181	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484244972	""	""	""	NA	"Swelling arm"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1472"	"DN-101 Protocol No. 011-007"	"046"	"046-0001"	5	9	"Adverse Event/Serious Adverse Event"	2722093001	"Thrush"	76	86	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476223901	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"1473"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	2572447003	"Anemia"	237	267	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513715937	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1474"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3074429001	"cough"	195	216	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491850782	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1475"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	2600952001	"decreased taste"	43	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467300625	""	""	""	NA	"Taste diminished"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Hypogeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1476"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	4317304001	"diplopia"	475	475	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513716036	""	""	""	NA	"Diplopia"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Diplopia"	""	""	""	""	""	""	""	""	""	""	""	""
"1477"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	4317370001	"dizziness"	475	475	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513716175	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1478"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3074410001	"dyspnea"	174	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491850597	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1479"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3074458001	"eye tearing"	195	216	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491851311	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1480"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3072596001	"fatigue"	71	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491828971	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1481"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3074472001	"left shoulder pain"	244	253	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491851609	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1482"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3074420001	"lightheadedness"	174	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491850687	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1483"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	2600939001	"muscle aches"	15	19	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467300013	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1484"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3072618001	"nail toxicity"	132	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491829307	""	""	""	NA	"Nail toxicity"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail toxicity"	""	""	""	""	""	""	""	""	""	""	""	""
"1485"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3072611001	"nasal drainage"	195	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491829219	""	""	""	NA	"Nasal discharge"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1486"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	2861545001	"neutroenia"	120	132	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483988685	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1487"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3070029001	"neutropenia"	223	237	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491752958	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1488"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	2662186001	"neutropenia"	99	102	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472755438	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1489"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3070019001	"neutropenia"	160	167	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491752676	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1490"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	2662181001	"neutropenia"	78	81	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472755349	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1491"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	2600942001	"neutropenia"	36	39	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467300166	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1492"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	2600936001	"neutropenia"	15	19	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1467299853	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1493"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3070038001	"neutropenia"	286	293	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491753282	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1494"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3070032001	"neutropenia"	244	253	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491753060	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1495"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	2662173001	"neutropenia"	56	60	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472755259	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1496"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3070007001	"neutropenia"	139	141	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491752538	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1497"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3070035001	"neutropenia"	265	272	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491753174	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1498"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3072584001	"neutropenia"	307	309	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491828814	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1499"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3070022001	"neutropenia"	181	183	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491752782	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1500"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3070026001	"neutropenia"	202	204	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491752862	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1501"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	4317338001	"pleural effusion"	442	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513716116	""	""	""	NA	"Pleural effusion"	"Respiratory, thoracic and mediastinal disorders"	"Pleural disorders"	"Pneumothorax and pleural effusions NEC"	"Pleural effusion"	""	""	""	""	""	""	""	""	""	""	""	""
"1502"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3074465001	"red, itchy, edematous hands"	223	225	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491851477	""	""	""	NA	"Erythema edematous"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"1503"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3074497001	"unable to void"	244	244	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491852113	""	""	""	NA	"Urination difficulty"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1504"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3074438001	"urinary tract infection"	177	194	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491850936	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1505"	"DN-101 Protocol No. 011-007"	"047"	"047-0001"	5	9	"Adverse Event/Serious Adverse Event"	3072601001	"weakness"	174	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491829113	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1506"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	2580267003	"alopecia"	27	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477877549	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1507"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	2756338001	"alopecia"	34	371	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477877631	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1508"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	3413887001	"chronic renal insufficiency"	355	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499902164	""	""	""	NA	"Chronic renal insufficiency"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure chronic"	""	""	""	""	""	""	""	""	""	""	""	""
"1509"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	2756384001	"constipation, intermittant"	99	224	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477878971	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1510"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	3413921001	"degenerative joint disease"	371	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499902341	""	""	""	NA	"Degenerative joint disease"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Osteoarthropathies"	"Osteoarthritis"	""	""	""	""	""	""	""	""	""	""	""	""
"1511"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	2756341001	"desquamation on palms of hands"	34	57	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477877816	""	""	""	NA	"Desquamation"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Exfoliative conditions"	"Skin exfoliation"	""	""	""	""	""	""	""	""	""	""	""	""
"1512"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	3195583001	"diverticulitis"	179	203	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494876330	""	""	""	NA	"Diverticulitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Diverticulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1513"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	2756344001	"fatigue"	69	203	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477877892	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1514"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	2756399001	"increased INR"	94	95	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477879418	""	""	""	NA	"INR increased"	"Investigations"	"Haematology investigations (incl blood groups)"	"Coagulation and bleeding analyses"	"International normalised ratio increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1515"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	4803900002	"Mouth Sores"	98	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517960056	""	""	""	NA	"Sores mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1516"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	2756367001	"nail changes"	119	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477878369	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1517"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	3413906001	"neck pain"	364	439	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499902253	""	""	""	NA	"Neck pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Neck pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1518"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	2756331001	"neuropathy -numbness & tingling of hands & feet"	15	57	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477877444	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1519"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	3195606001	"taste alteration"	224	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494876534	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1520"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	2756353001	"thrush"	97	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477878118	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"1521"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	2657412001	"viral gastroenteritis"	94	97	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	103	NA	NA	94	97	"On 8/20/06 WBC of 10.8, protime 50.7, protime INR 4.8, and hemoglobin 12.8.  On 8/23/06, WBC of 5.1, protime 14.8, protime INR 1.4 and hemoglobin 10.7.  Blood culture X 2 was no growth after 5 days,"	"clostridium difficile toxin assay was no clostridium difficile toxin detected by EIA method, UA was WNL."	""	2	2	2	2	2	0	2	0	"(taken from discharge summary);Patient was admitted with fever, diarrhea, nausea, vomiting, and occasional bright red blood per rectum.  His INR was 4.8 upon admission, so he was given a 0/5mg of IV"	"vitamin K, which brought his INR down to 1.4.  His GI bleeding has been much, much less since then.;He has a pre-existing diagnosis of radiation proctitis from seeds for his prostate cancer several"	"years ago.  The patient was just observed.;The patient's fever was assessed with panculturing, and he was placed upon intravenous Levaquin upon admission.  He had no further fever.  His C.difficile"	"toxin titer was negative.  His white count was normal throughout the admission.  He is anticoagulated already for pre-existing atrial fibrillation.  He has been instructed to take 10 mg of Coumadin"	"and will check his protime on 8/24.  He does has thrush and will go home on Nystatin along with Levaquin for about 5 days."	""	""	""	""	""	""	NA	NA	""	1472528214	""	""	""	NA	"Viral gastroenteritis"	"Infections and infestations"	"Viral infectious disorders"	"Viral infections NEC"	"Gastroenteritis viral"	""	""	""	""	""	""	""	""	""	""	""	""
"1522"	"DN-101 Protocol No. 011-007"	"049"	"049-0002"	5	9	"Adverse Event/Serious Adverse Event"	2756357001	"watery eyes"	119	315	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1477878251	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1523"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	2594920003	"alopecic"	51	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501438979	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1524"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3472630001	"anemia"	391	423	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501533613	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1525"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3472561001	"anemia"	296	324	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501533143	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1526"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3381152001	"Atrial Fibrillation Flutter"	391	419	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	391	NA	NA	391	419	"ECG 7/9/07,"	""	""	2	2	2	NA	2	2	NA	2	"The pt. felt weak with malaise, low-grade fever, and not feeling well.	He does not have any chest pain or SOB.  He did not have much palpitations but he was brought in today for eval and found to be"	"tachycardia at 160s and hypotensive with a b/p of 80/50.  ECG shows atrial flutter with rapid ventricular response and right bundle branch block."	""	""	""	""	""	""	""	""	""	NA	NA	""	1499639049	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"1527"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466467001	"bruisability"	72	93	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501439332	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"1528"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3470334001	"cough"	8	23	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501522276	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1529"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	5425466002	"cough w/ yellow sputum"	489	503	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1528313522	""	""	""	NA	"Productive cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1530"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3467629001	"dyspnea"	100	114	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501455770	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1531"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3467626001	"fatigue"	43	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501455672	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1532"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3467635001	"fever"	118	156	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501456355	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1533"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466929001	"hyperglycemia"	8	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501445308	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1534"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	5425440002	"Hyperkalemia"	345	380	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1528313341	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1535"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3467620001	"hyperkalemia"	8	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501455442	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1536"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3467623001	"hyperkalemia"	114	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501455563	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1537"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466599001	"hypotension"	72	93	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501440560	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"1538"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466582001	"intermittent dyspnea"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501440218	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1539"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	5425351002	"Intermittent hypocalcemia"	128	NA	1	1	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1528312786	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1540"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3381164001	"interstitial lung infiltrate/pneumonia"	391	419	NA	3	0	NA	NA	NA	NA	NA	3	1	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	391	NA	NA	391	419	"CT Chest-7/12/2007; CXR 7/10/07;CT Thorax 7/18/07;ultrasound guided thoracentesis 7/20/07; single chest 7/19/07; CXR 7/23/07; Chest CT 7/26/07; CXR 7/27/07;"	""	""	2	2	2	NA	2	2	NA	2	"Pt. became extremely tired and fatigued.  He had beenrelatively bedbound.  He has been having low-grade temps between 99 and 100.4.  He was brought in for a clinic evaluation.  B/P 80/50 with"	"saturaton of 85% and HR of 160 and pulse of 80.  The pt. is admitted to the hosp. for eval of likely atrial fib flutter along with the etiology of such. CXR's were unremarkable for infiltrates or"	"effusions.  Subsequent CT scan of the chest showed evidence of fluffy bilateral infiltrates.  Pulmonary consult suggested poss. pneumocystis.  bronchoscopy showed no evidence of bacterial pneumonia."	"He was continued on abx's.  He was diuresed over 20kg.	breathing improved.  It was felt that it was likely a combination of vol,. overload, pneumonia vs. possible contribution from Taxotere."	""	""	""	""	""	""	""	NA	NA	""	1499639175	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1541"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3470022001	"knee pain d/t arthritis"	93	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501520395	""	""	""	NA	"Arthritic pains"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1542"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3470127001	"Left shoulder pain"	8	93	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501521122	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1543"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	5425345002	"Leg edema"	43	NA	1	3	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1528312705	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1544"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3472456001	"leukocytosis"	296	296	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501532571	""	""	""	NA	"Leukocytosis"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukocytoses NEC"	"Leukocytosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1545"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3472711001	"leukopenia"	212	219	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501534016	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1546"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3472699001	"leukopenia"	191	198	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501533942	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1547"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3472681001	"leukopenia"	170	177	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501533853	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1548"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	5425425002	"Leukopenia"	253	262	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1528313265	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1549"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	5425477002	"Leukopenia"	534	628	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1528313606	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1550"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466742001	"leukopenia"	43	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501443096	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1551"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466745001	"leukopenia"	86	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501443230	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1552"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466758001	"leukopenia"	100	114	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501443376	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1553"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3472653001	"leukopenia"	149	156	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501533730	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1554"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3472510001	"lymphopenia"	233	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501532823	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1555"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	5425411002	"Lymphopenia"	212	219	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1528313190	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1556"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466814001	"lymphopenia"	51	198	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501444429	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1557"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466792001	"lymphopenia"	8	23	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501443852	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1558"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3470569001	"nail changes and onychomycosis"	219	352	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501523546	""	""	""	NA	"Onychomycosis"	"Infections and infestations"	"Fungal infectious disorders"	"Fungal infections NEC"	"Onychomycosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1559"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3472757001	"neutropenia"	233	240	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501534354	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1560"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	5425398002	"Neutropenia"	212	219	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1528313106	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1561"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466766001	"neutropenia"	100	107	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501443509	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1562"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3472732001	"neutropenia"	170	177	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501534172	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1563"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3473214001	"neutropenia"	253	262	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501537689	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1564"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	5425382002	"Neutropenia"	191	198	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1528313038	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1565"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466588001	"numbness in fingers"	72	86	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501440322	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1566"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	5424984002	"Pneumonia"	536	550	NA	3	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	723	NA	NA	536	550	"data not available"	""	""	2	2	2	2	2	2	2	2	"The pt was admitted to the hospital for fever and chills.  He developed pneumonia during the hospitalization."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1528310333	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1567"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3467632001	"rib pain"	114	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501455956	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1568"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	5425459002	"Rt side posterior pelvic pain"	477	503	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1528313444	""	""	""	NA	"Pelvic pain"	"Reproductive system and breast disorders"	"Reproductive tract disorders NEC"	"Reproductive tract signs and symptoms NEC"	"Pelvic pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1569"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	5425368002	"Sinus drainage"	135	NA	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1528312942	""	""	""	NA	"Nasal sinus discharge"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Paranasal sinus hypersecretion"	""	""	""	""	""	""	""	""	""	""	""	""
"1570"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3471569001	"tachycardia"	380	380	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501528870	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"1571"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3469983001	"URI"	128	156	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501520145	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1572"	"DN-101 Protocol No. 011-007"	"049"	"049-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466363001	"weight loss"	72	72	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501438594	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1573"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	5	9	"Adverse Event/Serious Adverse Event"	2647488003	"Abdominal cramping"	115	136	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486341027	""	""	""	NA	"Abdominal cramp"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1574"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	5	9	"Adverse Event/Serious Adverse Event"	2717857001	"alopecia"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476140911	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1575"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	5	9	"Adverse Event/Serious Adverse Event"	2717851001	"cold sore"	34	42	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476140731	""	""	""	NA	"Cold sores"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes simplex"	""	""	""	""	""	""	""	""	""	""	""	""
"1576"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	5	9	"Adverse Event/Serious Adverse Event"	2836022001	"Constipation"	94	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482273850	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1577"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	5	9	"Adverse Event/Serious Adverse Event"	2864721001	"Dizzyness"	98	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484083969	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1578"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	5	9	"Adverse Event/Serious Adverse Event"	2835964001	"Fatigue"	73	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482273142	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1579"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	5	9	"Adverse Event/Serious Adverse Event"	2915383001	"herpes"	129	135	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486341104	""	""	""	NA	"Herpes NOS"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes virus infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1580"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	5	9	"Adverse Event/Serious Adverse Event"	2864805001	"Neuropathy"	115	136	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484084424	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1581"	"DN-101 Protocol No. 011-007"	"050"	"050-0004"	5	9	"Adverse Event/Serious Adverse Event"	2836028001	"Upper Respiratory Tract infection"	94	115	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482274035	""	""	""	NA	"Upper respiratory tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1582"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2659471003	"abdominal pain"	30	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475080299	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1583"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	5284421002	"Anemia - chemo inducted"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523400314	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1584"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	3942346001	"Belching"	29	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508971209	""	""	""	NA	"Belching"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Eructation"	""	""	""	""	""	""	""	""	""	""	""	""
"1585"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2835871001	"Bilateral hip pain"	105	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482271928	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1586"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2699641001	"confusion"	33	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475080797	""	""	""	NA	"Confusion"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Confusion and disorientation"	"Confusional state"	""	""	""	""	""	""	""	""	""	""	""	""
"1587"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	3942404001	"Constipation"	315	356	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508971698	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1588"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	3942388001	"Dehydration"	155	155	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508971514	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1589"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2684949001	"dehydration"	32	36	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Pt given IV fluids given in the clinic x 2 days...pt ultimately admitted to hospital for hydration"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	40	NA	NA	34	36	"None"	""	""	2	1	2	NA	2	2	NA	0	"Hopitalized for dehydration due to nausea and vomiting"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474238542	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1590"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2926863001	"Ecchymosis"	181	223	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486598949	""	""	""	NA	"Ecchymosis"	"Skin and subcutaneous tissue disorders"	"Skin vascular abnormalities"	"Purpura and related conditions"	"Ecchymosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1591"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2699701001	"edema - extrermities"	33	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475081141	""	""	""	NA	"Edema extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1592"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2709688001	"Electolyte imbalance"	34	40	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475694654	""	""	""	NA	"Electrolyte imbalance"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Electrolyte imbalance NEC"	"Electrolyte imbalance"	""	""	""	""	""	""	""	""	""	""	""	""
"1593"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2699608001	"Fatigue"	43	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475080606	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1594"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2699596001	"generalized weakness"	33	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475080460	""	""	""	NA	"Weakness generalized"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1595"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2864315001	"Hypercholesteralemia"	34	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484081653	""	""	""	NA	"Hypercholesteraemia"	"Metabolism and nutrition disorders"	"Lipid metabolism disorders"	"Elevated cholesterol"	"Hypercholesterolaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1596"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2699547001	"Hyperglycemia"	23	40	NA	2	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475079775	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1597"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2717624001	"Neutropenia"	33	43	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476137792	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1598"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2765007001	"Neutropenia"	57	64	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478537531	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1599"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	4703013002	"Peripheral edema"	447	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517331791	""	""	""	NA	"Peripheral edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1600"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	3942364001	"Restless sleep"	34	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508971345	""	""	""	NA	"Sleep restless"	"Nervous system disorders"	"Sleep disturbances (incl subtypes)"	"Sleep disturbances NEC"	"Poor quality sleep"	""	""	""	""	""	""	""	""	""	""	""	""
"1601"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2717597001	"Shortness of breath"	33	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476137069	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1602"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2699678001	"shortness of breath"	33	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475080969	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1603"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2869473001	"Spinal stenosis"	155	174	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	155	NA	NA	155	174	"Please see source documentation included in report"	""	""	2	2	2	NA	2	2	NA	2	"Patient fell at home twice due to lower extremity weakness with crumpling of the knees and hips, but no loss of consiousness.  He is also neutropenic and is complaining about pain in his lumbar"	"spine."	""	""	""	""	""	""	""	""	""	NA	NA	""	1484251404	""	""	""	NA	"Spinal stenosis NOS"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)"	"Spine and neck deformities"	"Spinal column stenosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1604"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	4456416002	"Tachycardia"	64	85	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515627030	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"1605"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	3942375001	"Tachycardia"	155	155	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508971412	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"1606"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2765001001	"taste disturbances"	64	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478537401	""	""	""	NA	"Taste disturbance"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1607"	"DN-101 Protocol No. 011-007"	"050"	"050-0005"	5	9	"Adverse Event/Serious Adverse Event"	2717609001	"Weakness"	43	64	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476137226	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1608"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	5	9	"Adverse Event/Serious Adverse Event"	2685007003	"Alopecia"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478654400	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1609"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	5	9	"Adverse Event/Serious Adverse Event"	2719783001	"Anemia"	26	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476205257	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1610"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	5	9	"Adverse Event/Serious Adverse Event"	2986976001	"Facial edema"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488996354	""	""	""	NA	"Face edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Face oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1611"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	5	9	"Adverse Event/Serious Adverse Event"	2767994001	"Fatigue"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478654243	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1612"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	5	9	"Adverse Event/Serious Adverse Event"	2836217001	"Fever"	83	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482278557	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1613"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	5	9	"Adverse Event/Serious Adverse Event"	2719729001	"Leukopenia"	26	36	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476205053	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1614"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	5	9	"Adverse Event/Serious Adverse Event"	2719766001	"Neutropenia"	26	36	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476205191	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1615"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	5	9	"Adverse Event/Serious Adverse Event"	2962260001	"Tearing"	119	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487809178	""	""	""	NA	"Lacrimation"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1616"	"DN-101 Protocol No. 011-007"	"050"	"050-0006"	5	9	"Adverse Event/Serious Adverse Event"	2767991001	"Trace bipedal edema"	36	57	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478654173	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1617"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	5	9	"Adverse Event/Serious Adverse Event"	2693767003	"Cough"	53	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482276578	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1618"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	5	9	"Adverse Event/Serious Adverse Event"	2710644001	"Dehydration"	20	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475709506	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1619"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	5	9	"Adverse Event/Serious Adverse Event"	2836065001	"Fatigue"	15	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482275873	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1620"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	5	9	"Adverse Event/Serious Adverse Event"	2836125001	"Leukopenia"	48	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482277216	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1621"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	5	9	"Adverse Event/Serious Adverse Event"	2710650001	"leukopenia"	20	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475709609	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1622"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	5	9	"Adverse Event/Serious Adverse Event"	2836147001	"Neutropenia"	48	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482277447	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1623"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	5	9	"Adverse Event/Serious Adverse Event"	2710655001	"Neutropenia"	20	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475709761	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1624"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	5	9	"Adverse Event/Serious Adverse Event"	2836111001	"Pneumonitis"	84	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482276722	""	""	""	NA	"Pneumonitis"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Lower respiratory tract inflammatory and immunologic conditions"	"Pneumonitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1625"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	5	9	"Adverse Event/Serious Adverse Event"	4727727002	"Right Hip Pain"	430	456	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517417094	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1626"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	5	9	"Adverse Event/Serious Adverse Event"	2836097001	"Upper Respiratory Infection"	63	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482276422	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1627"	"DN-101 Protocol No. 011-007"	"050"	"050-0007"	5	9	"Adverse Event/Serious Adverse Event"	2836108001	"Weakness"	63	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482276647	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1628"	"DN-101 Protocol No. 011-007"	"050"	"050-0012"	5	9	"Adverse Event/Serious Adverse Event"	3248625003	"Back pain"	146	150	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509493027	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1629"	"DN-101 Protocol No. 011-007"	"050"	"050-0012"	5	9	"Adverse Event/Serious Adverse Event"	3687681001	"Body aches"	100	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505337978	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1630"	"DN-101 Protocol No. 011-007"	"050"	"050-0012"	5	9	"Adverse Event/Serious Adverse Event"	3333115001	"Leukopenia"	21	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498602047	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1631"	"DN-101 Protocol No. 011-007"	"050"	"050-0012"	5	9	"Adverse Event/Serious Adverse Event"	3559630001	"Neutropenia"	48	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503360648	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1632"	"DN-101 Protocol No. 011-007"	"050"	"050-0012"	5	9	"Adverse Event/Serious Adverse Event"	3333121001	"Neutropenia"	21	31	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498602119	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1633"	"DN-101 Protocol No. 011-007"	"050"	"050-0012"	5	9	"Adverse Event/Serious Adverse Event"	3581452001	"Shortness of breath"	83	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503877587	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1634"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	2798245003	"alopecia"	19	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487803371	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1635"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4306724001	"anasarca"	348	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513643974	""	""	""	NA	"Anasarca"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Generalised oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1636"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4306705001	"congestive heart failure"	346	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513643861	""	""	""	NA	"Congestive heart failure"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"1637"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	2893808001	"constipation"	5	5	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"prune juice"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485288955	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1638"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	2962001001	"decreased appetite"	12	19	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487802922	""	""	""	NA	"Appetite decreased NOS"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"1639"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	2962029001	"dry desquamation fingertips"	26	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"udderly smooth cream, tea tree oil"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487803275	""	""	""	NA	"Desquamation"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Exfoliative conditions"	"Skin exfoliation"	""	""	""	""	""	""	""	""	""	""	""	""
"1640"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	3019707001	"edema bilateral lower extremities"	110	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490205579	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1641"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	2962019001	"epistaxis"	19	19	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487803090	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"1642"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	2893837001	"fatigue"	5	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485289279	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1643"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4059277001	"Hepatitis"	298	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Discontinued Ketaconazole"	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510688552	""	""	""	NA	"Hepatitis"	"Hepatobiliary disorders"	"Hepatic and hepatobiliary disorders"	"Hepatocellular damage and hepatitis NEC"	"Hepatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1644"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4848038002	"hypokalemia"	350	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518392099	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1645"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	2962045001	"increase lacrimentation"	53	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487803479	""	""	""	NA	"Lacrimation increased"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1646"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4058765001	"Infection left lower tooth"	275	285	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510687482	""	""	""	NA	"Tooth infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Dental and oral soft tissue infections"	"Tooth infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1647"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4847807002	"Left Lower Gum infection"	368	380	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518390725	""	""	""	NA	"Gum infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Dental and oral soft tissue infections"	"Gingival infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1648"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4058688001	"Left lower tooth pain"	194	257	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510687326	""	""	""	NA	"Tooth pain"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Dental pain and sensation disorders"	"Toothache"	""	""	""	""	""	""	""	""	""	""	""	""
"1649"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4306756001	"lower extremity edema"	348	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513644173	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1650"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	2962055001	"nail changes"	26	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487803646	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1651"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	5152288002	"neuropathy"	47	165	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521491206	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1652"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4059036001	"nocturia"	257	320	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510688041	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1653"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	3704705001	"nueropathy"	166	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505762632	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1654"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	2962080001	"nuetropenia"	12	26	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487804323	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1655"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4847819002	"Numbness left lower mandible"	383	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518390807	""	""	""	NA	"Numbness localized"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1656"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	2961986001	"oral mucositis"	12	201	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"salt and soda rinse"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487802769	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1657"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4306690001	"pleural effusion"	346	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513643747	""	""	""	NA	"Pleural effusion"	"Respiratory, thoracic and mediastinal disorders"	"Pleural disorders"	"Pneumothorax and pleural effusions NEC"	"Pleural effusion"	""	""	""	""	""	""	""	""	""	""	""	""
"1658"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	3019673001	"pneumonia"	105	112	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490205473	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1659"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4058539001	"Right Achilles Tear"	124	166	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510686934	""	""	""	NA	"Achilles tendon rupture"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Muscle, tendon and ligament injuries"	"Tendon rupture"	""	""	""	""	""	""	""	""	""	""	""	""
"1660"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4847784002	"SCLERA ICTERUS"	383	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518390526	""	""	""	NA	"Scleral icterus"	"Eye disorders"	"Eye disorders NEC"	"Ocular disorders NEC"	"Ocular icterus"	""	""	""	""	""	""	""	""	""	""	""	""
"1661"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4306636001	"shortness of breath"	346	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513643288	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1662"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	2961971001	"Taste Changes"	12	201	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487802536	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1663"	"DN-101 Protocol No. 011-007"	"051"	"051-0001"	5	9	"Adverse Event/Serious Adverse Event"	4058946001	"unsteady gait"	285	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Uses a cane"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510687733	""	""	""	NA	"Unsteady gait"	"General disorders and administration site conditions"	"General system disorders NEC"	"Gait disturbances"	"Gait disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"1664"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	2554263003	"Alopecia"	25	445	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463510973	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1665"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	3725633001	"Anemia"	282	372	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505932484	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1666"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	2574884001	"Chills"	26	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463509005	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"1667"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	3725330001	"depression"	53	445	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505931873	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"1668"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	3725944001	"Dyspnea"	360	372	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505933215	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1669"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	2624455001	"Ear Congestion"	32	115	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469628247	""	""	""	NA	"Ear congestion"	"Ear and labyrinth disorders"	"Aural disorders NEC"	"Ear disorders NEC"	"Ear congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"1670"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	2624461001	"Fatigue - intermittent"	11	445	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469628753	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1671"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	2624812001	"Hypersensitivity to Zometa"	24	445	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Zometa dose reduced."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469637703	""	""	""	NA	"Drug hypersensitivity"	"Immune system disorders"	"Allergic conditions"	"Allergies to foods, food additives, drugs and other chemicals"	"Drug hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"1672"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	3725745001	"Increased creatinine"	282	312	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505932737	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1673"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	3725849001	"Lower extremity edema"	355	445	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505932968	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1674"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	2574916001	"myalgias"	26	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463509775	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1675"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	2630942001	"Nasal Congestion"	32	445	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470254801	""	""	""	NA	"Nasal congestion"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal congestion and inflammations"	"Nasal congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"1676"	"DN-101 Protocol No. 011-007"	"052"	"052-0001"	5	9	"Adverse Event/Serious Adverse Event"	2689313001	"Sty - intermittent"	136	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474402364	""	""	""	NA	"Sty"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Eye and eyelid infections"	"Hordeolum"	""	""	""	""	""	""	""	""	""	""	""	""
"1677"	"DN-101 Protocol No. 011-007"	"052"	"052-0004"	5	9	"Adverse Event/Serious Adverse Event"	3242213003	"Blurred Vision"	16	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498579125	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"1678"	"DN-101 Protocol No. 011-007"	"052"	"052-0004"	5	9	"Adverse Event/Serious Adverse Event"	3329618001	"Body Aches"	16	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498579214	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1679"	"DN-101 Protocol No. 011-007"	"052"	"052-0004"	5	9	"Adverse Event/Serious Adverse Event"	3888677001	"Cardiac Chest Pain"	57	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508255017	""	""	""	NA	"Chest pain - cardiac"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"1680"	"DN-101 Protocol No. 011-007"	"052"	"052-0004"	5	9	"Adverse Event/Serious Adverse Event"	3329660001	"Chest Pain non cardiac"	16	44	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498579413	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1681"	"DN-101 Protocol No. 011-007"	"052"	"052-0004"	5	9	"Adverse Event/Serious Adverse Event"	3779608001	"edema"	120	141	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506553223	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1682"	"DN-101 Protocol No. 011-007"	"052"	"052-0004"	5	9	"Adverse Event/Serious Adverse Event"	4073834001	"fingertip neuropathy"	57	57	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510783402	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1683"	"DN-101 Protocol No. 011-007"	"052"	"052-0004"	5	9	"Adverse Event/Serious Adverse Event"	3779557001	"intermitted neuropathy"	120	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506552822	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1684"	"DN-101 Protocol No. 011-007"	"052"	"052-0004"	5	9	"Adverse Event/Serious Adverse Event"	3329714001	"Leg Cramps"	16	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498579580	""	""	""	NA	"Leg cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1685"	"DN-101 Protocol No. 011-007"	"052"	"052-0004"	5	9	"Adverse Event/Serious Adverse Event"	3888067001	"Neuropathy"	141	NA	1	2	1	1	NA	NA	NA	NA	3	1	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508252830	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1686"	"DN-101 Protocol No. 011-007"	"052"	"052-0004"	5	9	"Adverse Event/Serious Adverse Event"	3329686001	"Shortness of Breath"	16	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498579480	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1687"	"DN-101 Protocol No. 011-007"	"052"	"052-0004"	5	9	"Adverse Event/Serious Adverse Event"	3585855001	"Urinary Tract Infection"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503937505	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1688"	"DN-101 Protocol No. 011-007"	"052"	"052-0004"	5	9	"Adverse Event/Serious Adverse Event"	3493188001	"Urinary Tract Infection"	35	51	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502044779	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1689"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	5	9	"Adverse Event/Serious Adverse Event"	2548656003	"Blurred Vision"	175	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476051299	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"1690"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	5	9	"Adverse Event/Serious Adverse Event"	2714725001	"Bruising"	91	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476050843	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"1691"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	5	9	"Adverse Event/Serious Adverse Event"	2717277001	"Fatigue"	175	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476133744	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1692"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	5	9	"Adverse Event/Serious Adverse Event"	2717251001	"Insomnia"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476133250	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1693"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	5	9	"Adverse Event/Serious Adverse Event"	2714743001	"Neuropathy - Feet"	91	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476051163	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1694"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	5	9	"Adverse Event/Serious Adverse Event"	2714779001	"Neuropathy - hands and feet"	175	376	NA	1	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476051457	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1695"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	5	9	"Adverse Event/Serious Adverse Event"	2714733001	"Rash"	111	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476050953	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1696"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	5	9	"Adverse Event/Serious Adverse Event"	5151691002	"right eye erythema"	260	441	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521489857	""	""	""	NA	"Eye red"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Ocular infections, inflammations and associated manifestations"	"Ocular hyperaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1697"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	5	9	"Adverse Event/Serious Adverse Event"	2714651001	"Trace Right pretibial edema"	28	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476050191	""	""	""	NA	"Pretibial edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1698"	"DN-101 Protocol No. 011-007"	"053"	"053-0001"	5	9	"Adverse Event/Serious Adverse Event"	2714671001	"Urinary Frequency"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476050318	""	""	""	NA	"Urinary frequency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1699"	"DN-101 Protocol No. 011-007"	"053"	"053-0002"	5	9	"Adverse Event/Serious Adverse Event"	2595732003	"Alopecia"	45	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476136916	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1700"	"DN-101 Protocol No. 011-007"	"053"	"053-0002"	5	9	"Adverse Event/Serious Adverse Event"	2717593001	"Bruising"	45	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476136985	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"1701"	"DN-101 Protocol No. 011-007"	"053"	"053-0002"	5	9	"Adverse Event/Serious Adverse Event"	5155307002	"Cardiac Chest Pain"	294	371	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	638	NA	NA	366	371	"missed this initially because we received no reports about event and this occurred several months after treatment completion.  ;Patient underwent CABGx5 on 6/21/07.  Left internal mammary artery to"	"the left anterior descending...only have discharge summary (finally!) for our report."	""	2	2	2	NA	2	2	NA	2	"Patient had been complaining of chest pain with walking back in April, 2007.  Unclear to us what prompted hospitalization other than an increase in cardiac chest pain.  Patient admitted on 6/20/07,"	"surgery (CABGx5) on 6/21/07.  Experienced some constipation during hospitalization, managed with Senna (1-2 tab po qd). Discharged 6/25/07, stable, with cardiac comment \"regular rate and rhythm,"	"normal S1, S2.\""	""	""	""	""	""	""	""	""	NA	NA	""	1521500263	""	""	""	NA	"Chest pain - cardiac"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"1702"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	5	9	"Adverse Event/Serious Adverse Event"	3056995003	"abrasion left elbow"	132	175	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502890901	""	""	""	NA	"Skin abrasion"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Non-site specific injuries NEC"	"Excoriation"	""	""	""	""	""	""	""	""	""	""	""	""
"1703"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	5	9	"Adverse Event/Serious Adverse Event"	3539299001	"blisters on lips"	133	146	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502891095	""	""	""	NA	"Lip blister"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Oral soft tissue disorders NEC"	"Lip blister"	""	""	""	""	""	""	""	""	""	""	""	""
"1704"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	5	9	"Adverse Event/Serious Adverse Event"	3453305001	"eyes tearing"	42	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500992425	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1705"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	5	9	"Adverse Event/Serious Adverse Event"	3200614001	"fatigue"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494950259	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1706"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	5	9	"Adverse Event/Serious Adverse Event"	3200663001	"fever"	38	39	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494950550	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1707"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	5	9	"Adverse Event/Serious Adverse Event"	3453333001	"oral thrush"	74	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500992714	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"1708"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	5	9	"Adverse Event/Serious Adverse Event"	3453340001	"rash on arms"	74	80	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500992790	""	""	""	NA	"Rash over arms"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1709"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	5	9	"Adverse Event/Serious Adverse Event"	3200648001	"sore throat"	35	68	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494950415	""	""	""	NA	"Sore throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1710"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	5	9	"Adverse Event/Serious Adverse Event"	3796539001	"staff infection"	142	161	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506964650	""	""	""	NA	"Staphylococcal infection"	"Infections and infestations"	"Bacterial infectious disorders"	"Staphylococcal infections"	"Staphylococcal infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1711"	"DN-101 Protocol No. 011-007"	"055"	"055-0002"	5	9	"Adverse Event/Serious Adverse Event"	3796565001	"swelling on head from trauma"	173	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506964723	""	""	""	NA	"Head injury"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Site specific injuries NEC"	"Head injury"	""	""	""	""	""	""	""	""	""	""	""	""
"1712"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	2830738003	"Abdominal aortic aneurysm"	197	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516563151	""	""	""	NA	"Abdominal aortic aneurysm"	"Vascular disorders"	"Aneurysms and artery dissections"	"Aortic aneurysms and dissections"	"Aortic aneurysm"	""	""	""	""	""	""	""	""	""	""	""	""
"1713"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4557465002	"Alopecia"	50	155	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516312356	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1714"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4558213002	"Bone Pain"	134	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516314886	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1715"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4557629002	"Compression fracture spine"	84	113	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516312829	""	""	""	NA	"Spinal cord compression"	"Nervous system disorders"	"Spinal cord and nerve root disorders"	"Spinal cord and nerve root disorders NEC"	"Spinal cord compression"	""	""	""	""	""	""	""	""	""	""	""	""
"1716"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4573898002	"decreased energy level"	238	273	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516563284	""	""	""	NA	"Energy decreased"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1717"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4557768002	"Diarrhea"	98	99	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516313385	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1718"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4557528002	"Fatigue"	71	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516312534	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1719"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4557750002	"Fatigue"	98	112	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516313299	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1720"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	5049319002	"heartburn"	273	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520375210	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1721"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	5265940002	"insomnia"	394	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522950498	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1722"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4558155002	"Intermittent nose bleeds"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516314625	""	""	""	NA	"Nose bleeds"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"1723"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4558291002	"Left foot drop"	177	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"brace for left foot"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516315120	""	""	""	NA	"Foot drop"	"Nervous system disorders"	"Peripheral neuropathies"	"Mononeuropathies"	"Peroneal nerve palsy"	""	""	""	""	""	""	""	""	""	""	""	""
"1724"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4557807002	"Left Ribcage fracture due to injury"	97	113	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516313513	""	""	""	NA	"Fracture"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Fractures and dislocations NEC"	"Fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"1725"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4557592002	"lightheadedness"	92	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516312703	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1726"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	5049174002	"neutropenia"	63	65	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520374878	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1727"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4573959002	"Sinus congestion"	238	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516563421	""	""	""	NA	"Sinus congestion"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Sinus congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"1728"	"DN-101 Protocol No. 011-007"	"056"	"056-0003"	5	9	"Adverse Event/Serious Adverse Event"	4557910002	"Viral Infection"	127	134	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516313875	""	""	""	NA	"Viral infection"	"Infections and infestations"	"Viral infectious disorders"	"Viral infections NEC"	"Viral infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1729"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	2889388003	"Anemia"	112	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504742057	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1730"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3642237001	"Arthralgias"	112	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504742278	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1731"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3112728001	"Back Pain"	-202	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492722343	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1732"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3112828001	"Back Pain"	53	76	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723745	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1733"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3112757001	"Back Pain"	17	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492722698	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1734"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3112778001	"Dizziness"	20	20	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723007	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1735"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3642246001	"Erectile Dysfunction"	63	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504742391	""	""	""	NA	"Erectile dysfunction"	"Reproductive system and breast disorders"	"Sexual function and fertility disorders"	"Erection and ejaculation conditions and disorders"	"Erectile dysfunction"	""	""	""	""	""	""	""	""	""	""	""	""
"1736"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3112809001	"Fatigue"	20	20	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723356	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1737"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3112825001	"Knee Pain"	28	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723655	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1738"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3112815001	"Myalgias"	20	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723457	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1739"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3642229001	"Myalgias"	112	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504742219	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1740"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3112821001	"Myalgias"	28	37	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723545	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1741"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3642226001	"Nausea"	112	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504742166	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1742"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3642212001	"Neutropenia"	112	150	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504741913	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1743"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3642243001	"Pancytopenia"	150	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504742337	""	""	""	NA	"Pancytopenia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Marrow depression and hypoplastic anaemias"	"Pancytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1744"	"DN-101 Protocol No. 011-007"	"056"	"056-0004"	5	9	"Adverse Event/Serious Adverse Event"	3112792001	"Pelvic Pain"	-202	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492723164	""	""	""	NA	"Pelvic pain"	"Reproductive system and breast disorders"	"Reproductive tract disorders NEC"	"Reproductive tract signs and symptoms NEC"	"Pelvic pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1745"	"DN-101 Protocol No. 011-007"	"059"	"059-0002"	5	9	"Adverse Event/Serious Adverse Event"	2906857003	"fractured ribs from fall"	75	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493602677	""	""	""	NA	"Fractured ribs"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Thoracic cage fractures and dislocations"	"Rib fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"1746"	"DN-101 Protocol No. 011-007"	"059"	"059-0002"	5	9	"Adverse Event/Serious Adverse Event"	3347002001	"hemo-pneumothorax"	75	95	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498787743	""	""	""	NA	"Pneumothorax"	"Respiratory, thoracic and mediastinal disorders"	"Pleural disorders"	"Pneumothorax and pleural effusions NEC"	"Pneumothorax"	""	""	""	""	""	""	""	""	""	""	""	""
"1747"	"DN-101 Protocol No. 011-007"	"059"	"059-0002"	5	9	"Adverse Event/Serious Adverse Event"	4618695002	"near syncopal episode"	329	332	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	362	NA	NA	329	332	"Chest X-ray 12/21/2007; CT of Brain without contrast 12/21/2007; Echocardiogram with Doppler 12/22/2007; CT of Chest with and without contrast 12/23/2007; mra of head 12/23/2007; mri of brain"	"12/23/2007"	""	2	2	2	NA	2	2	NA	2	"Patient was at a holiday party and states that he was simply standing up when he became suddenly lightheaded and felt like he was going to pass out.  No loss of consciousness, the entire episode"	"lasted seconds."	""	""	""	""	""	""	""	""	""	NA	NA	""	1516746690	""	""	""	NA	"Pre-syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1748"	"DN-101 Protocol No. 011-007"	"059"	"059-0002"	5	9	"Adverse Event/Serious Adverse Event"	4782886002	"nocturia"	52	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517866378	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"1749"	"DN-101 Protocol No. 011-007"	"059"	"059-0002"	5	9	"Adverse Event/Serious Adverse Event"	4804088002	"Residual Pleural Fluid Right Lung"	95	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517961202	""	""	""	NA	"Pleural effusion"	"Respiratory, thoracic and mediastinal disorders"	"Pleural disorders"	"Pneumothorax and pleural effusions NEC"	"Pleural effusion"	""	""	""	""	""	""	""	""	""	""	""	""
"1750"	"DN-101 Protocol No. 011-007"	"059"	"059-0002"	5	9	"Adverse Event/Serious Adverse Event"	3611660001	"thrombus left lower leg"	202	203	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	208	NA	NA	202	203	"doppler 08/16/07"	""	""	2	2	2	NA	2	2	NA	2	"patient had some swelling below right knee which was noticed by tech nician during his scheduled bone scan 8/16/07. went to the ER, and was admitted for an overnight stay to initiate lovenox. was"	"sent home the next day, after receiving instructions on how to give his own subq injections."	""	""	""	""	""	""	""	""	""	NA	NA	""	1504198209	""	""	""	NA	"Thrombosis leg"	"Vascular disorders"	"Embolism and thrombosis"	"Non-site specific embolism and thrombosis"	"Thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1751"	"DN-101 Protocol No. 011-007"	"060"	"060-0001"	5	9	"Adverse Event/Serious Adverse Event"	3239648003	"Alopecia"	40	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498679575	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1752"	"DN-101 Protocol No. 011-007"	"060"	"060-0001"	5	9	"Adverse Event/Serious Adverse Event"	4103669001	"Constipation"	166	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511216489	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1753"	"DN-101 Protocol No. 011-007"	"060"	"060-0001"	5	9	"Adverse Event/Serious Adverse Event"	3339294001	"Fatigue"	21	61	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498679794	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1754"	"DN-101 Protocol No. 011-007"	"060"	"060-0001"	5	9	"Adverse Event/Serious Adverse Event"	4802039002	"gastric reflux"	221	263	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517952428	""	""	""	NA	"Reflux gastritis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Gastritis (excl infective)"	"Reflux gastritis"	""	""	""	""	""	""	""	""	""	""	""	""
"1755"	"DN-101 Protocol No. 011-007"	"060"	"060-0001"	5	9	"Adverse Event/Serious Adverse Event"	4800488002	"Infection Ear"	184	214	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517949681	""	""	""	NA	"Ear infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Ear infections"	"Ear infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1756"	"DN-101 Protocol No. 011-007"	"060"	"060-0001"	5	9	"Adverse Event/Serious Adverse Event"	5113608002	"Nausea"	184	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521057273	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"1757"	"DN-101 Protocol No. 011-007"	"060"	"060-0001"	5	9	"Adverse Event/Serious Adverse Event"	3404882001	"Pelvic pain"	54	82	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499806504	""	""	""	NA	"Pelvic pain"	"Reproductive system and breast disorders"	"Reproductive tract disorders NEC"	"Reproductive tract signs and symptoms NEC"	"Pelvic pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1758"	"DN-101 Protocol No. 011-007"	"060"	"060-0001"	5	9	"Adverse Event/Serious Adverse Event"	4800385002	"pulmonary/upper respiratory infection"	184	214	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517949492	""	""	""	NA	"Infection upper respiratory"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1759"	"DN-101 Protocol No. 011-007"	"060"	"060-0001"	5	9	"Adverse Event/Serious Adverse Event"	4535718002	"Vomiting"	184	221	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	251	NA	NA	214	221	"hgb was 13.5, wbc 6600, plts 179,000. cmp was normal except for an alk phos 3070 and sgot 72."	""	""	2	2	2	2	2	2	2	2	"pt has been off tx since 08/23/2007 for progression. he was then followed with tx of mitozantrone. He did not respond and cont. with rising psa and was placed or oral ketaconazole and prednisone. pt"	"developed severe nausea/vomiting for appr. 1 month till hospitilization."	""	""	""	""	""	""	""	""	""	NA	NA	""	1516219544	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"1760"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2610802003	"Anasarca"	519	548	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	627	NA	NA	500	548	"Clinical diagnosis 12/11/07"	""	""	2	2	2	NA	2	2	NA	2	"Patient was hospitalized on 11/22/07 with hemorrhage, GI (duodenal ulcer) and taken to surgery on 11/24/07 for repair of perforated, bleeding ulcer. On 12/11/07 he developed grade 3 anasarca which"	"prolonged his hospital stay. He was put on fluid restrictions and given lasix and zaroxolyn. Dr Prakash does not believe the anasarca was related to the study drugs but rather to his underlying"	"hypoalbuminemia, renal insufficiency and chronic heart failure."	""	""	""	""	""	""	""	""	NA	NA	""	1522330938	""	""	""	NA	"Anasarca"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Generalised oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1761"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	4157624001	"anemia"	491	500	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511993488	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1762"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5233719002	"Anemia"	521	524	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522354705	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1763"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5227165002	"Anemia"	500	504	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	626	NA	NA	500	548	"hemoglobin 6.5"	""	""	2	2	2	NA	2	2	NA	2	"WLF was admitted to the hospital on 11/22/07 after vomiting blood since early that morning and his hemoglobin was found to be 6.5. He initially refused transfer to a larger facility with"	"Gastrointestinal MD coverage was available, so packed red blood cells were given over the next 2 days until he consented to transfer. Upon arrival to East Texas Medical Center  an emergent"	"esophagastroduodenoscopy was done and a pumping duodenal ulcer was found. He was taken to surgery where a contained duodenal perforation into the liver was also found and repaired. He received a"	"total of 17 units of packed red blood cells, a 10 pack unit of platelets and 11 units of fresh frozen plasma during this time. Dr Prakash does not believe the anemia is related to the study drugs but"	"rather to his hemorrhage, GI (duodenal ulcer) and conmed warfarin."	""	""	""	""	""	""	NA	NA	""	1522268101	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1764"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2626752001	"arthralgia"	11	212	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469970309	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1765"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2948226001	"Bilateral deep vein thrombosis"	172	178	NA	3	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	220	NA	NA	172	178	"Bilateral lower extremity venous doppler diagnostic of bilateral deep vein thrombosis."	""	""	2	2	2	NA	2	2	NA	2	"Patient was in the hospital with the diagnosis of bilateral pulmonary emboli when a bilateral venous doppler done on 12/29/06 also showed bilateral deep vein thrombosis."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487196202	""	""	""	NA	"Deep vein thrombosis"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1766"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2846918001	"bilateral pulmonary emboli"	172	178	NA	3	3	1	1	NA	NA	NA	3	1	1	5	1	NA	1	"hospitalization"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	172	NA	NA	172	178	"CT of chest with contrast on 12/29/06."	""	""	2	2	2	NA	2	2	NA	2	"Patient was found to have bilateral pulmonary emboli on a routine chest CT done today. He denies worsening dyspnea and states has been feeling quite well the past 5 days. He was admitted under the"	"care of his primary physician and will be receiving medication to dissolve the emboli.	Dr Wilcox does not believe this AE is related to the study drugs Taxotere or Prednisone but rather to his"	"underlying prostate cancer."	""	""	""	""	""	""	""	""	NA	NA	""	1483053606	""	""	""	NA	"Embolism pulmonary"	"Respiratory, thoracic and mediastinal disorders"	"Pulmonary vascular disorders"	"Pulmonary thrombotic and embolic conditions"	"Pulmonary embolism"	""	""	""	""	""	""	""	""	""	""	""	""
"1767"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5230864002	"Cardiomegaly"	500	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522336167	""	""	""	NA	"Cardiomegaly"	"Cardiac disorders"	"Myocardial disorders"	"Myocardial disorders NEC"	"Cardiomegaly"	""	""	""	""	""	""	""	""	""	""	""	""
"1768"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5231057002	"Chronic obstructive pulmonary disease"	500	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522336879	""	""	""	NA	"Chronic obstructive pulmonary disease"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Chronic obstructive pulmonary disease"	""	""	""	""	""	""	""	""	""	""	""	""
"1769"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	3416922001	"Congestive heart failure"	365	367	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	368	NA	NA	365	367	"echocardiogram 07/10/07, cardiac catheterization 07/11/07"	""	""	2	2	2	NA	2	2	NA	2	"Patient was admitted on 07/10/07 with the severe dyspnea and question of congestive heart failure. And echocardiogram was performed showing multiple wall motion abnormalities, hypokinesis and"	"ejection fraction of 40%. It was then felt this was probably an ischemic cardiomyopathy. A cardiac cath was performed on 07/11/07 which revealed an ejection fraction of 35% and no significant"	"coronary artery disease. Dr Prakash does not believe the congestive heart failure was related to the study drugs Taxotere and Prednisone but rather to the underlying hypertention and ischemic"	"cardiomyopathy."	""	""	""	""	""	""	""	NA	NA	""	1499977283	""	""	""	NA	"Congestive heart failure"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"1770"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5230085002	"Congestive heart failure"	520	548	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	627	NA	NA	500	548	"Echocardiogram 12/12/07 shows ejection fraction of 45%, BNP on 12/13/07 was 172"	""	""	2	2	2	NA	2	2	NA	2	"Patient was hospitalized on 11/22/07 with hemorrhage, GI (duodenal ulcer) and taken to surgery on 11/24/07 for repair of perforated, bleeding ulcer. On 12/12/07 he was diagnosised with severe"	"congestive heart failure which prolonged his hospital stay. He was put on fluid restrictions, given lasix and monitored closely. Dr Prakash believes this was an acute exacerbation of his chronic"	"congestive heart failure condition and was not related to the study drugs."	""	""	""	""	""	""	""	""	NA	NA	""	1522332193	""	""	""	NA	"Congestive heart failure"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"1771"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	4206150001	"CONSTIPATION"	427	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512573400	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1772"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2626742001	"constipation"	11	241	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469969720	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1773"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	3416815001	"dizziness"	366	375	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499976272	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1774"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5231776002	"dry eyes"	501	502	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522343017	""	""	""	NA	"Dry eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Dry eye"	""	""	""	""	""	""	""	""	""	""	""	""
"1775"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5231805002	"dry nostrils"	501	502	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522343099	""	""	""	NA	"Nasal dryness"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Nasal dryness"	""	""	""	""	""	""	""	""	""	""	""	""
"1776"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	3964394001	"dyspepsia"	431	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509379945	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1777"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	4147619001	"dyspnea"	458	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511908826	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1778"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2949660001	"dyspnea"	184	458	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487261075	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1779"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2691681001	"dyspnea"	52	178	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474552260	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1780"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	4147663001	"fatigue"	444	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511909136	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1781"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5231150002	"Fever"	518	518	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522337201	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1782"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	4937565002	"flaccid (r) arm"	63	63	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519313894	""	""	""	NA	"Muscle flaccid"	"Nervous system disorders"	"Neuromuscular disorders"	"Muscle tone abnormal"	"Hypotonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1783"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5230904002	"hematemesis"	500	502	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522336269	""	""	""	NA	"Hematemesis"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Haematemesis"	""	""	""	""	""	""	""	""	""	""	""	""
"1784"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2801224001	"hematuria"	98	102	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480953347	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1785"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	4147642001	"hematuria"	426	428	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511908983	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1786"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5230932002	"hydronephrosis (right kidney)"	500	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522336367	""	""	""	NA	"Hydronephrosis"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal obstructive disorders"	"Hydronephrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1787"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5231026002	"hyperglycemia"	503	508	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522336628	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1788"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5231104002	"hypoalbuminemia"	519	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522337107	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1789"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5230965002	"hypocalcemia"	500	502	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522336451	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1790"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5231046002	"hypokalemia (intermittent)"	503	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522336729	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1791"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5227826002	"hyponatremia"	512	528	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	626	NA	NA	500	548	"Sodium levels ranging from 125-131 from 12/04/07 through 12/20/07."	""	""	2	2	2	NA	2	2	NA	2	"Patient was hospitalized on 11/22/07 for GI hemorrhage and perforation of duodenal ulcer. On 12/04/07 he developed grade 3 hyponatremia prolonging his hospital stay. Dr Prakash does not believe the"	"hyponatremia was related to the study drugs but rather to underlying volume depletion related to his blood loss."	""	""	""	""	""	""	""	""	""	NA	NA	""	1522272226	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1792"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5231006002	"ileus (post-operative)"	502	508	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522336559	""	""	""	NA	"Postoperative ileus"	"Injury, poisoning and procedural complications"	"Procedural and device related injuries and complications NEC"	"Gastrointestinal and hepatobiliary procedural complications"	"Postoperative ileus"	""	""	""	""	""	""	""	""	""	""	""	""
"1793"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2626768001	"indigestion"	14	212	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469971132	""	""	""	NA	"Indigestion"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"1794"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5233605002	"insomnia"	520	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522353867	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1795"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2639283001	"LEUKOPENIA"	18	30	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471269693	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1796"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2728507001	"lymphedema bilateral extremities"	83	114	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476368050	""	""	""	NA	"Lymphedema"	"Vascular disorders"	"Lymphatic vessel disorders"	"Lymphoedemas"	"Lymphoedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1797"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2801240001	"mood alteration - anxiety"	97	212	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480953612	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"1798"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2691684001	"muscle weakness lower extremities"	52	430	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474552396	""	""	""	NA	"Lower extremities weakness of"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"1799"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	4147575001	"muscle weakness-lower extremities"	499	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511908672	""	""	""	NA	"Lower extremities weakness of"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"1800"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	4147542001	"muscle weakness-lower extremities"	430	499	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511908545	""	""	""	NA	"Lower extremities weakness of"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"1801"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2626762001	"myalgia"	11	212	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469970859	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1802"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2639307001	"NEUTROPENIA"	18	30	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471270272	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1803"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	4937602002	"numb (r) arm"	63	63	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519314060	""	""	""	NA	"Numbness of upper arm"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"1804"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5231760002	"pain-generalized"	500	505	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522342941	""	""	""	NA	"Generalized aching"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1805"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5230837002	"Peptic ulcer disease"	500	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522336081	""	""	""	NA	"Peptic ulcer disease"	"Gastrointestinal disorders"	"Gastrointestinal ulceration and perforation"	"Peptic ulcers and perforation"	"Peptic ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"1806"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5227012002	"Perforation GI (duodenal ulcer)"	500	514	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	626	NA	NA	500	548	"A contained perforation into the liver was found and repaired during surgery to stop pumping hemorrhage of duodenal ulcer."	""	""	2	2	2	NA	2	2	NA	2	"On 11/22/07 patient was hospitalized for hemorrhage, GI (duodenal ulcer) and taken to surgery on 11/24/07 to gain control of the bleeding. During surgery a contained perforation of the duodenal ulcer"	"into the liver was found and repaired as well. Dr Prakash does not believe the perforation is related to the study drugs but rather to his peptic ulcer disease."	""	""	""	""	""	""	""	""	""	NA	NA	""	1522267102	""	""	""	NA	"Gastrointestinal ulcer perforation"	"Gastrointestinal disorders"	"Gastrointestinal ulceration and perforation"	"Gastrointestinal ulcers and perforation, site unspecified"	"Gastrointestinal ulcer perforation"	""	""	""	""	""	""	""	""	""	""	""	""
"1807"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2922900001	"peripheral neuropathy"	156	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486497159	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1808"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5228168002	"pneumonia"	502	520	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	626	NA	NA	500	548	"11/24/07 CXR Bibasilar infiltrate or atelectasis, lung volumes low."	""	""	2	2	2	NA	2	2	NA	2	"Patient was admitted on 11/22/07 with hemorrhage, GI (duodenal ulcer) and taken to surgery on 11/24/07 for repair of a perforated, bleeding ulcer. Consequently he developed post operative pneumonia"	"and was treated with Augmentin and IV Zosyn which prolonged his hospital stay. Dr Prakash does not believe the pneumonia was related to the study drugs but rather to his compromised pulmonary statis"	"post surgery."	""	""	""	""	""	""	""	""	NA	NA	""	1522273277	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"1809"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	3613137001	"Pulmonary congestion"	295	375	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504205312	""	""	""	NA	"Pulmonary congestion"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Pulmonary oedemas"	"Pulmonary congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"1810"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5230806002	"Renal insufficiency"	493	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522335868	""	""	""	NA	"Renal insufficiency"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure"	""	""	""	""	""	""	""	""	""	""	""	""
"1811"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5230619002	"Septicemia"	520	548	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	627	NA	NA	500	548	"12/12/07 blood culture showed gram positive staphylococcus aureus"	""	""	2	2	2	NA	2	2	NA	2	"Patient was hospitalized on 11/22/07 with hemorrhage, GI (duodenal ulcer) and taken to surgery on 11/24/07 for repair of a perforated, bleeding ulcer. On 12/12/07 he was diagnosised with grade 3"	"septicemia and was treated with IV Levaquin and Vancomycin which prolonged his hospital stay. Dr Prakash believes the septicemia was related to his compromised immune statis and the organism"	"staphylococcus aureus and not related to the study drugs."	""	""	""	""	""	""	""	""	NA	NA	""	1522334968	""	""	""	NA	"Septicemia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Sepsis, bacteraemia and viraemia"	"Sepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"1812"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2639325001	"TASTE ALTERATION"	30	212	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471270576	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1813"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	3964412001	"taste alterations"	431	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509380077	""	""	""	NA	"Taste altered"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1814"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2801244001	"tremor"	100	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480953689	""	""	""	NA	"Tremor"	"Nervous system disorders"	"Movement disorders (incl Parkinsonism)"	"Tremor (excl congenital)"	"Tremor"	""	""	""	""	""	""	""	""	""	""	""	""
"1815"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	5230155002	"Urinary tract infection"	520	548	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	627	NA	NA	500	548	"12/12/07 urine culture showed \"enterobacter cloacae\""	""	""	2	2	2	NA	2	2	NA	2	"Patient was hospitalized on 11/22/07 with hemorrhage, GI (duodenal ulcer) and taken to surgery on 11/24/07 for repair of perforated bleeding ulcer. On 12/12/07 he developed a grade 3 urinary tract"	"infection which prolonged his hospital stay. He was treated with IV Levaquin, Vancomycin and Primaxcin. Dr Prakash does not believe the urinary tract infection was related to the study drugs but"	"rather to his compromised immune statis and the organism enterobacter cloacae."	""	""	""	""	""	""	""	""	NA	NA	""	1522333154	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1816"	"DN-101 Protocol No. 011-007"	"061"	"061-0002"	5	9	"Adverse Event/Serious Adverse Event"	2801232001	"watery eye"	51	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480953499	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1817"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2645852003	"Anemia"	250	279	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511805137	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1818"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	3077974001	"anemia"	117	139	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491936811	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1819"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2898271001	"atrial fibrillation"	140	NA	1	2	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485697772	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"1820"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2949290001	"bruising"	180	223	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487258471	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"1821"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	3077147001	"bruising"	223	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491923502	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"1822"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2898256001	"cellulitis (r) foot"	121	182	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485697091	""	""	""	NA	"Cellulitis of foot"	"Infections and infestations"	"Bacterial infectious disorders"	"Bacterial infections NEC"	"Cellulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1823"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	3077122001	"chest congestion"	195	226	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491923240	""	""	""	NA	"Pulmonary congestion"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Pulmonary oedemas"	"Pulmonary congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"1824"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2798868001	"cold-pulmonary"	96	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480857814	""	""	""	NA	"Cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1825"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2728770001	"confusion"	45	45	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476370137	""	""	""	NA	"Confusion"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Confusion and disorientation"	"Confusional state"	""	""	""	""	""	""	""	""	""	""	""	""
"1826"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2898284001	"congestive heart failure"	156	NA	1	2	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485698075	""	""	""	NA	"Congestive heart failure"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"1827"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	3077951001	"degenerative disc disease"	232	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491936682	""	""	""	NA	"Intervertebral disc degeneration NOS"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)"	"Intervertebral disc disorders NEC"	"Intervertebral disc degeneration"	""	""	""	""	""	""	""	""	""	""	""	""
"1828"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2798865001	"dizziness"	88	88	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480857684	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1829"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	3077991001	"dizziness"	186	186	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491936946	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1830"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2898310001	"dizziness"	145	160	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485698648	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1831"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	3953840001	"dizziness"	390	395	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509286458	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1832"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2728616001	"dizziness"	45	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476368762	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1833"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2691714001	"dizzness"	20	20	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474553092	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1834"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2691717001	"dizzness"	27	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474553171	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"1835"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2949243001	"dyspnea"	140	161	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487258238	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1836"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	3953855001	"dyspnea"	390	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509286675	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1837"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2728746001	"dyspnea"	45	46	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476369979	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1838"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2949270001	"dyspnea"	161	384	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487258380	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"1839"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2898263001	"edema lower extremities"	119	384	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485697406	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1840"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2728659001	"fever"	46	49	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476369266	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1841"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2898299001	"generalized anasarca"	140	161	NA	2	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485698387	""	""	""	NA	"Anasarca"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Generalised oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1842"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2949218001	"generalized anasarca"	161	384	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487258039	""	""	""	NA	"Anasarca"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Generalised oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"1843"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2669434001	"hypertension"	7	7	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473256913	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"1844"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2898322001	"insomnia"	145	160	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485699038	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1845"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2669471001	"muscle spasms"	17	18	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473257321	""	""	""	NA	"Muscle spasms"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1846"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2949301001	"muscle weakness"	174	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487258586	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"1847"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2949179001	"neutropenia"	169	180	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487257749	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1848"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2669464001	"neutropenia"	16	26	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473257154	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1849"	"DN-101 Protocol No. 011-007"	"061"	"061-0003"	5	9	"Adverse Event/Serious Adverse Event"	2728696001	"non-cardiac chest pain"	45	46	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476369623	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1850"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2741544003	"ACUTE RENAL FAILURE"	43	45	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484749863	""	""	""	NA	"Acute renal failure"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure acute"	""	""	""	""	""	""	""	""	""	""	""	""
"1851"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	4141067001	"anemia"	196	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511882851	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1852"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2883305001	"anemia"	66	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484832300	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1853"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	3209078001	"anemia"	35	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495031201	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1854"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879821001	"ANEMIA"	43	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484750692	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1855"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	4140986001	"anorexia"	319	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511882121	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1856"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2883332001	"anxiety"	66	72	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484835672	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"1857"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879847001	"AORTIC STENOSIS"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484751578	""	""	""	NA	"Aortic stenosis"	"Vascular disorders"	"Arteriosclerosis, stenosis, vascular insufficiency and necrosis"	"Aortic necrosis and vascular insufficiency"	"Aortic stenosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1858"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879799001	"ATRIAL FIBRILLATION"	43	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484750089	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"1859"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879834001	"CARDIOMYOPATHY"	44	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484751243	""	""	""	NA	"Cardiomyopathy"	"Cardiac disorders"	"Myocardial disorders"	"Cardiomyopathies"	"Cardiomyopathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1860"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2764829001	"chills"	21	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478529419	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"1861"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	5263519002	"clostridium difficile"	54	66	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522935946	""	""	""	NA	"Clostridium difficile infection"	"Infections and infestations"	"Bacterial infectious disorders"	"Clostridia infections"	"Clostridial infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1862"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879881001	"CONGESTIVE HEART FAILURE"	44	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484752736	""	""	""	NA	"Congestive heart failure"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"1863"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2780695001	"constipation"	25	172	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479396807	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1864"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	3209004001	"constipation"	204	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495030907	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"1865"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879805001	"CORONARY ARTERY DISEASE"	43	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484750206	""	""	""	NA	"Coronary artery disease"	"Cardiac disorders"	"Coronary artery disorders"	"Coronary artery disorders NEC"	"Coronary artery disease"	""	""	""	""	""	""	""	""	""	""	""	""
"1866"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879774001	"DEHYDRATION"	43	44	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484749572	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1867"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	3208956001	"depression"	176	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495030768	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"1868"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2883298001	"epitaxis"	66	70	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484832172	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"1869"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2764820001	"facial flushing"	15	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478529089	""	""	""	NA	"Facial flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"1870"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879918001	"FEVER"	55	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484753929	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1871"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	3209030001	"hemorrhoids"	205	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495031038	""	""	""	NA	"Hemorrhoids"	"Gastrointestinal disorders"	"Gastrointestinal vascular conditions"	"Haemorrhoids and gastrointestinal varices (excl oesophageal)"	"Haemorrhoids"	""	""	""	""	""	""	""	""	""	""	""	""
"1872"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879812001	"HYPOCALCEMIA"	43	46	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484750372	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1873"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2883347001	"hypokalemia"	69	70	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484835887	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1874"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879943001	"HYPOKALEMIA"	56	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484754263	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1875"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879961001	"HYPOKALEMIA"	57	58	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484754416	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1876"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2883363001	"hypokalemia"	70	72	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484836045	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1877"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879986001	"HYPOKALEMIA"	58	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484754741	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1878"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879892001	"HYPOKALEMIA"	45	52	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484753060	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1879"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879976001	"HYPOMAGNESEMIA"	58	69	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484754612	""	""	""	NA	"Hypomagnesemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Magnesium metabolism disorders"	"Hypomagnesaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1880"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879760001	"HYPOTENSON"	43	45	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484749292	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"1881"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2883315001	"hypoxia"	66	71	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484835251	""	""	""	NA	"Hypoxia"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Conditions associated with abnormal gas exchange"	"Hypoxia"	""	""	""	""	""	""	""	""	""	""	""	""
"1882"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879740001	"insomnia"	43	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484748862	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1883"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879854001	"LEFT ATRIAL ENLARGEMENT"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484751753	""	""	""	NA	"Left atrial enlargement"	"Cardiac disorders"	"Myocardial disorders"	"Myocardial disorders NEC"	"Dilatation atrial"	""	""	""	""	""	""	""	""	""	""	""	""
"1884"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879861001	"LEFT VENTRICULAR ENLARGEMENT"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484751990	""	""	""	NA	"Left ventricular enlargement"	"Cardiac disorders"	"Myocardial disorders"	"Myocardial disorders NEC"	"Dilatation ventricular"	""	""	""	""	""	""	""	""	""	""	""	""
"1885"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879733001	"leukopenia"	43	44	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484748658	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1886"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879874001	"MALAISE"	44	73	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484752459	""	""	""	NA	"Malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"1887"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2780708001	"neutropenia"	22	35	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479396996	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1888"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879727001	"neutropenia"	43	45	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484748461	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1889"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	4141037001	"non-occlusive thrombosis, left extremity"	352	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511882572	""	""	""	NA	"Thrombosis"	"Vascular disorders"	"Embolism and thrombosis"	"Non-site specific embolism and thrombosis"	"Thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"1890"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	3534177001	"peripheral neuropathy"	240	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502813850	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1891"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2784818001	"sepsis"	43	73	NA	4	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	43	NA	NA	43	73	"11/21/06 WBC 0.9, ANC 0.1, 11/22/06 Blood cultures show gram negative rods-Escherichia coli"	""	""	2	2	0	NA	1	2	NA	2	"TLM became anorexic on Sunday, November 19, and then began experiencing nausea and vomiting Monday afternoon, November 20. He states he started feeling really bad during the evening and night hours"	"and came to clinic this morning where he was found to have a WBC of 0.9 and ANC of 0.1. His vital signs were BP 64/50, Temp 97, HR 112, Resp 36 and O2 Sat 89% on room air. He initially received a"	"liter bolus of NS and was then hospitalized with the diagnosis of Sepsis. IV Levaquin and Zosyn were started upon hospital arrival. Dr Prakash believes the sepsis was directly related to the"	"docetaxel and not related to the predisone."	""	""	""	""	""	""	""	NA	NA	""	1479762198	""	""	""	NA	"Sepsis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Sepsis, bacteraemia and viraemia"	"Sepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"1892"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879868001	"SINUS TACHYCARDIA"	44	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484752257	""	""	""	NA	"Sinus tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Sinus tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"1893"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2883326001	"sinus tachycardia"	66	112	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484835418	""	""	""	NA	"Sinus tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Sinus tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"1894"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879898001	"skin irritation-BUTTOCKS"	57	115	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484753369	""	""	""	NA	"Irritation skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermatitis and eczema"	"Skin irritation"	""	""	""	""	""	""	""	""	""	""	""	""
"1895"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879909001	"THRUSH"	52	86	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484753649	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"1896"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879840001	"TRICUSPID REGURGITATION"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484751357	""	""	""	NA	"Tricuspid regurgitation"	"Cardiac disorders"	"Cardiac valve disorders"	"Tricuspid valvular disorders"	"Tricuspid valve incompetence"	""	""	""	""	""	""	""	""	""	""	""	""
"1897"	"DN-101 Protocol No. 011-007"	"061"	"061-0004"	5	9	"Adverse Event/Serious Adverse Event"	2879828001	"VENTRICULAR TACHYCARDIA"	44	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484751090	""	""	""	NA	"Ventricular tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Ventricular arrhythmias and cardiac arrest"	"Ventricular tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"1898"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	3336013003	"Alopecia"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504218683	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1899"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	5258947002	"anemia (intermittent)"	126	144	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522871905	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1900"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	3948316001	"bilateral lower extremity edema"	89	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509052251	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"1901"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	5258741002	"chilling"	154	164	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522871177	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"1902"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	3948374001	"dehydration"	119	120	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509052726	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"1903"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	4173918001	"hematuria"	159	161	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hospitalization with bladder irrigation"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	161	NA	NA	159	161	"no relevant tests or laboratory data"	""	""	2	2	2	NA	2	2	NA	2	"This is a SAE report on WER, pt # 061-0005, on USOncology protocol 05113. WER had been experiencing grade 2 hematuria since 11/27/07 which progressed to grade 3 on 12/01/07. He was admitted to the"	"hospital for bladder irrigation to stop the bleeding. The SAE resolved and he was discharged this morning in stable condition. Dr Cochran does not believe the hematuria was related to the predisone"	"or docetaxel but rather to disease progression."	""	""	""	""	""	""	""	""	NA	NA	""	1512332679	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1904"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	5258801002	"hematuria"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522871364	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1905"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	4175257001	"hematuria"	155	159	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512336385	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"1906"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	3425182001	"leg cramps"	8	8	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500303288	""	""	""	NA	"Leg cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"1907"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	3948290001	"myalgias"	72	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509052080	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1908"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	3425213001	"myalgias"	9	72	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500303494	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1909"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	3964614001	"neutropenia"	119	126	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509381215	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1910"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	4175332001	"pain lower abdomen"	153	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512336573	""	""	""	NA	"Abdominal pain lower"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain lower"	""	""	""	""	""	""	""	""	""	""	""	""
"1911"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	4175360001	"pain lower back"	159	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512336680	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1912"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	4175296001	"rash"	141	144	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512336472	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1913"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	3948336001	"respiratory infection"	106	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509052430	""	""	""	NA	"Respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1914"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	3948356001	"respiratory infection"	119	126	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509052577	""	""	""	NA	"Respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1915"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	3948238001	"taste changes"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509051893	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1916"	"DN-101 Protocol No. 011-007"	"061"	"061-0005"	5	9	"Adverse Event/Serious Adverse Event"	4175449001	"urinary tract infection"	133	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512337135	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1917"	"DN-101 Protocol No. 011-007"	"062"	"062-0006"	5	9	"Adverse Event/Serious Adverse Event"	3522366003	"alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506298766	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1918"	"DN-101 Protocol No. 011-007"	"062"	"062-0006"	5	9	"Adverse Event/Serious Adverse Event"	3753594001	"Anxiety"	6	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506298436	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"1919"	"DN-101 Protocol No. 011-007"	"062"	"062-0006"	5	9	"Adverse Event/Serious Adverse Event"	4109139001	"cold symptoms"	69	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511288304	""	""	""	NA	"Cold symptoms"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1920"	"DN-101 Protocol No. 011-007"	"062"	"062-0006"	5	9	"Adverse Event/Serious Adverse Event"	4177008001	"Mild Headache"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512349145	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1921"	"DN-101 Protocol No. 011-007"	"062"	"062-0006"	5	9	"Adverse Event/Serious Adverse Event"	4109166001	"Rhinitis after eating"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511288488	""	""	""	NA	"Rhinitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Rhinitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1922"	"DN-101 Protocol No. 011-007"	"063"	"063-0001"	5	9	"Adverse Event/Serious Adverse Event"	2864012003	"Acute respiratory distress syndrome"	4	4	NA	5	1	1	NA	NA	NA	NA	1	1	NA	7	1	1	1	"ventilated"	4	0	NA	0	28	NA	NA	1	1	1	NA	NA	""	6	4	1	4	4	"WBC 4.3, abs. grans 3.5 in morning. WBC 1.8, abs. grans 1.3 in afternoon.;Troponin normal;CT negative for PE, but significant bibasilar consolidation consistent with aspiration. All tests done Jan"	"13/07"	""	2	2	2	2	2	2	2	2	"Presented to ER Jan 13/07 @ 5:00 am, c/o neck pain. Patient became acutely hypoxic, tachycardic, moderately hypotensive. Decreased LOC, sats poor, SBP in 80's. Intubated, started on pressors. Expired"	"6:00 pm Jan 13/07. Autopsy to be done Jan 15. Actual diagnosis and causality to be determined after autopsy.;Jan 18/07-autopsy not done as coroner determined it was not necessary. Physician feels"	"cause of death is respiratory failure probably secondary to ARDS, which possibly resulted from aspiration pneumonia, which possibly resulted from depression of level of consciousness stemming from"	"hypernarcosis. Causality not related to prednisone or docetaxel. Hospital discharge summary faxed to Novacea Safety Group; Investigators Assessment and Discharge summary faxed to Lesley Beals"	"Pharmacovigilance this morning, as requested.-Jan Barclay RN/Dr Hotte"	""	""	""	""	""	""	NA	NA	""	1484492604	""	""	""	NA	"Acute respiratory distress syndrome"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Pulmonary oedemas"	"Acute respiratory distress syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"1923"	"DN-101 Protocol No. 011-007"	"063"	"063-0001"	5	9	"Adverse Event/Serious Adverse Event"	3048904001	"infection documented clinically (oral candidiasis)"	3	4	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490908754	""	""	""	NA	"Oral candidiasis"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"1924"	"DN-101 Protocol No. 011-007"	"063"	"063-0001"	5	9	"Adverse Event/Serious Adverse Event"	3048918001	"orthostatic hypotension"	3	4	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"instructed to push fluids"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490908917	""	""	""	NA	"Orthostatic hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Orthostatic hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"1925"	"DN-101 Protocol No. 011-007"	"063"	"063-0001"	5	9	"Adverse Event/Serious Adverse Event"	3048925001	"pain - bone - neck"	4	4	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	6	NA	NA	4	4	"CT neg for PE - CT showed bilateral basilar consolidation"	""	""	2	2	2	NA	2	2	NA	2	"-presented to ER complaining of posterior neck pain, developed respiratory distress, became obtunded, expired"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490909342	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1926"	"DN-101 Protocol No. 011-007"	"063"	"063-0001"	5	9	"Adverse Event/Serious Adverse Event"	3918410001	"Pain, LLQ"	3	4	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508767729	""	""	""	NA	"Left lower quadrant pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain lower"	""	""	""	""	""	""	""	""	""	""	""	""
"1927"	"DN-101 Protocol No. 011-007"	"063"	"063-0001"	5	9	"Adverse Event/Serious Adverse Event"	3048936001	"pain-pulmonary-chest/thorax NOS"	4	4	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490909808	""	""	""	NA	"Thorax pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1928"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	2894459003	"allergic reaction/hypersensitivity"	35	36	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491415427	""	""	""	NA	"Allergic reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"1929"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	3133886001	"alopecia"	78	273	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493234094	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1930"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	3296320001	"creatinine serum high"	49	77	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497793463	""	""	""	NA	"Raised serum creatinine"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1931"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	3064484001	"decreased leukocytes"	49	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491419219	""	""	""	NA	"Leukocyte count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1932"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	3657191001	"Dermatology- other/ facial flushing"	98	233	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505068599	""	""	""	NA	"Facial flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"1933"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	3593056001	"Dermatology/ other/ Skin Tears"	203	257	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504026573	""	""	""	NA	"Skin tear"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Skin laceration"	""	""	""	""	""	""	""	""	""	""	""	""
"1934"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	2981933001	"fatigue"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488899719	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1935"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	3063432001	"infection-upper respiratory"	49	59	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491415280	""	""	""	NA	"Infection upper respiratory"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1936"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	4279539001	"lymphopenia"	255	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513277669	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1937"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	3047462001	"lymphopenia"	35	255	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490889517	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1938"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	3657252001	"Pulmonary/ head cold"	161	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505068767	""	""	""	NA	"Head cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1939"	"DN-101 Protocol No. 011-007"	"063"	"063-0003"	5	9	"Adverse Event/Serious Adverse Event"	3155095001	"rash"	50	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493754271	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"1940"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3008117003	"Bil. mid back pain"	113	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502291151	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"1941"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3320879001	"Dry cough"	63	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498410627	""	""	""	NA	"Dry cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1942"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	4593220002	"Facial Flushing"	50	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516648185	""	""	""	NA	"Facial flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"1943"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3162776001	"facial flushing"	29	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494166087	""	""	""	NA	"Facial flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"1944"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3511675001	"Fatigue"	120	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502287054	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1945"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	4594119002	"Hyperglycemia"	176	184	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516649652	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1946"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	4826597002	"Hyperglycemia"	155	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518108956	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1947"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	4593464002	"Hyperglycemia"	92	134	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516648612	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1948"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3245712001	"hyperglycemia"	50	92	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496084020	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1949"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	4593929002	"Hypocalcemia"	184	190	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516649318	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1950"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	4593869002	"Hypocalcemia"	134	184	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516649222	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1951"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3372528001	"Insomnia"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499374694	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"1952"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	5326202002	"Left Tendonitis"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1524772353	""	""	""	NA	"Tendonitis"	"Musculoskeletal and connective tissue disorders"	"Tendon, ligament and cartilage disorders"	"Tendon disorders"	"Tendonitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1953"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3162805001	"low hemoglobin"	29	274	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494166468	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1954"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	4594009002	"Low lymphocytes"	155	184	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516649496	""	""	""	NA	"Lymphocyte count low"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Lymphocyte count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1955"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3302244001	"Low lymphocytes"	71	92	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497898118	""	""	""	NA	"Lymphocyte count low"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Lymphocyte count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1956"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3245698001	"Low lymphocytes"	8	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496083874	""	""	""	NA	"Lymphocyte count low"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Lymphocyte count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1957"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3245715001	"Low lymphocytes"	50	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496084081	""	""	""	NA	"Lymphocyte count low"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Lymphocyte count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1958"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	4593686002	"Low Lymphocytes"	92	113	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516649006	""	""	""	NA	"Lymphocyte count low"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Lymphocyte count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1959"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3511632001	"Mood alteration"	114	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502286701	""	""	""	NA	"Mood alteration NOS"	"Psychiatric disorders"	"Mood disorders and disturbances NEC"	"Emotional and mood disturbances NEC"	"Mood altered"	""	""	""	""	""	""	""	""	""	""	""	""
"1960"	"DN-101 Protocol No. 011-007"	"063"	"063-0004"	5	9	"Adverse Event/Serious Adverse Event"	3511868001	"Right hip pain"	144	155	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502289687	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1961"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3018139003	"alopecia"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492544989	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1962"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3965811001	"Bruising/ Left calf"	NA	132	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509385382	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"1963"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3476374001	"Cough"	100	103	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501601095	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"1964"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3253315001	"epistaxis"	6	6	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496255526	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"1965"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3253352001	"epistaxis"	18	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496255826	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"1966"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3388556001	"Fatigue"	89	153	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499707732	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1967"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3656820001	"Fatigue"	153	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505067337	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1968"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3118418001	"fatigue"	3	10	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492976312	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1969"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3476390001	"Headache"	101	101	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501601185	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"1970"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3118397001	"hypersensitivity reaction"	24	24	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492976238	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"1971"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3297073001	"injection site reaction"	66	102	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497804794	""	""	""	NA	"Injection site reaction"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Injection site reaction"	""	""	""	""	""	""	""	""	""	""	""	""
"1972"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3965940001	"Low grade fever"	99	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509385852	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"1973"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3302097001	"low hemoglobin"	87	108	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497897159	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1974"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	4765943002	"Low Hemoglobin"	244	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517778626	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1975"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3965475001	"Low Hemoglobin"	150	192	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509384546	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1976"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3201517001	"lymphocytopenia"	3	192	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494955032	""	""	""	NA	"Lymphocytopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1977"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	4585001002	"Lymphocytopenia"	192	244	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516628860	""	""	""	NA	"Lymphocytopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"1978"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3579479001	"Nail changes"	131	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503858173	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"1979"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	4584918002	"Neuropathy"	101	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516628684	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1980"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3579399001	"Neuropathy- sensory"	49	101	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503857844	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"1981"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3102683001	"pain musculoskeletal-joint"	7	10	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492545177	""	""	""	NA	"Joint pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"1982"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3118354001	"proctitis"	6	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492976029	""	""	""	NA	"Proctitis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Rectal inflammations NEC"	"Proctitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1983"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3386948001	"Pruritis"	88	95	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499702196	""	""	""	NA	"Pruritis"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Pruritus NEC"	"Pruritus"	""	""	""	""	""	""	""	""	""	""	""	""
"1984"	"DN-101 Protocol No. 011-007"	"063"	"063-0005"	5	9	"Adverse Event/Serious Adverse Event"	3476272001	"Throat infection"	99	108	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501600638	""	""	""	NA	"Throat infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Pharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"1985"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3145075003	"alopecia"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496243834	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"1986"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3297977001	"dysguesia"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497812417	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"1987"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3302261001	"Elevated ALT"	28	70	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497898508	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"1988"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3975115001	"fatigue"	84	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509473457	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1989"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3297990001	"fatigue"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497812589	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"1990"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3297985001	"hot flashes"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497812502	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"1991"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3368155001	"Hypercalcemia"	70	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499354031	""	""	""	NA	"Hypercalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypercalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1992"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	4587700002	"Hyperglycemia"	91	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516636497	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1993"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3245813001	"hyperglycemia"	7	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496085714	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1994"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3368175001	"Hypophosphatemia"	70	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499354125	""	""	""	NA	"Hypophosphatemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Phosphorus metabolism disorders"	"Hypophosphataemia"	""	""	""	""	""	""	""	""	""	""	""	""
"1995"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3297996001	"infection- right toe"	37	62	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497812693	""	""	""	NA	"Infected toe"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Localised infection"	""	""	""	""	""	""	""	""	""	""	""	""
"1996"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3251934001	"intestinal gas"	12	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496243256	""	""	""	NA	"Gas"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Flatulence"	""	""	""	""	""	""	""	""	""	""	""	""
"1997"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3245800001	"lymphocytes"	7	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496085529	""	""	""	NA	"Lymphocyte count low"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Lymphocyte count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1998"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	4597515002	"Lymphocytes"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516656110	""	""	""	NA	"Lymphocyte count low"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Lymphocyte count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"1999"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3252023001	"mood changes"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496243690	""	""	""	NA	"Mood swings"	"Psychiatric disorders"	"Mood disorders and disturbances NEC"	"Fluctuating mood symptoms"	"Mood swings"	""	""	""	""	""	""	""	""	""	""	""	""
"2000"	"DN-101 Protocol No. 011-007"	"063"	"063-0006"	5	9	"Adverse Event/Serious Adverse Event"	3298008001	"oral candida"	35	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497812769	""	""	""	NA	"Oral candida"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"2001"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	3369188003	"Bone pain"	28	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504014941	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2002"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	4346378001	"Elevated Alk Phos"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514392493	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2003"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	3591697001	"Elevated Alk Phos"	7	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504017835	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2004"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	3975857001	"Elevated Alk Phos"	28	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509476057	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2005"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	4589279002	"Elevated AST"	112	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516639429	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2006"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	4346444001	"elevated AST"	153	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514392706	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2007"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	3944360001	"elevated AST"	112	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509031476	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2008"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	4346308001	"elevated AST"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514392289	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2009"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	3686601001	"Heartburn"	50	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505333502	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2010"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	3975828001	"High GGT"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509475935	""	""	""	NA	"GGT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Gamma-glutamyltransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2011"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	3591686001	"High GGT"	7	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504017678	""	""	""	NA	"GGT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Gamma-glutamyltransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2012"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	4346394001	"Hypocalcemia"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514392566	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2013"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	4589241002	"Low Lymphocytes"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516639318	""	""	""	NA	"Lymphocyte count low"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Lymphocyte count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2014"	"DN-101 Protocol No. 011-007"	"063"	"063-0007"	5	9	"Adverse Event/Serious Adverse Event"	3843419001	"Runny nose"	91	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507660812	""	""	""	NA	"Runny nose"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2015"	"DN-101 Protocol No. 011-007"	"063"	"063-0010"	5	9	"Adverse Event/Serious Adverse Event"	3782847003	"Allergic reation"	70	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514899886	""	""	""	NA	"Allergic reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"2016"	"DN-101 Protocol No. 011-007"	"063"	"063-0010"	5	9	"Adverse Event/Serious Adverse Event"	3980158001	"Alopecia"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509550190	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2017"	"DN-101 Protocol No. 011-007"	"063"	"063-0010"	5	9	"Adverse Event/Serious Adverse Event"	3989877001	"Arthralgia"	8	8	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509641906	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2018"	"DN-101 Protocol No. 011-007"	"063"	"063-0010"	5	9	"Adverse Event/Serious Adverse Event"	3989859001	"Fever\ suspected infection"	8	8	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509641717	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"2019"	"DN-101 Protocol No. 011-007"	"063"	"063-0010"	5	9	"Adverse Event/Serious Adverse Event"	4801601002	"Heartburn"	NA	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517951664	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2020"	"DN-101 Protocol No. 011-007"	"063"	"063-0010"	5	9	"Adverse Event/Serious Adverse Event"	4363698001	"Hyperglycemia"	7	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514899593	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2021"	"DN-101 Protocol No. 011-007"	"063"	"063-0010"	5	9	"Adverse Event/Serious Adverse Event"	4363710001	"Hyperglycemia"	49	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514899703	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2022"	"DN-101 Protocol No. 011-007"	"063"	"063-0010"	5	9	"Adverse Event/Serious Adverse Event"	4801753002	"Low Lymphocytes"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517951954	""	""	""	NA	"Lymphocyte count low"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Lymphocyte count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2023"	"DN-101 Protocol No. 011-007"	"063"	"063-0010"	5	9	"Adverse Event/Serious Adverse Event"	3989870001	"Myalgia"	8	8	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509641852	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2024"	"DN-101 Protocol No. 011-007"	"063"	"063-0012"	5	9	"Adverse Event/Serious Adverse Event"	3832432003	"Alopecia"	16	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509551760	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2025"	"DN-101 Protocol No. 011-007"	"063"	"063-0012"	5	9	"Adverse Event/Serious Adverse Event"	3981801001	"Altered taste"	2	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509556110	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2026"	"DN-101 Protocol No. 011-007"	"063"	"063-0012"	5	9	"Adverse Event/Serious Adverse Event"	4117372001	"Hyperglycemia"	23	44	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511465712	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2027"	"DN-101 Protocol No. 011-007"	"063"	"063-0012"	5	9	"Adverse Event/Serious Adverse Event"	4812489002	"Low Lymphocytes"	2	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518021212	""	""	""	NA	"Lymphocyte count low"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Lymphocyte count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2028"	"DN-101 Protocol No. 011-007"	"063"	"063-0012"	5	9	"Adverse Event/Serious Adverse Event"	3981952001	"Neuropathy sensory"	2	4	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509556651	""	""	""	NA	"Sensory peripheral neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2029"	"DN-101 Protocol No. 011-007"	"063"	"063-0012"	5	9	"Adverse Event/Serious Adverse Event"	3980532001	"Urinary frequency/urgency"	11	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509551902	""	""	""	NA	"Urinary frequency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"2030"	"DN-101 Protocol No. 011-007"	"064"	"064-0002"	5	9	"Adverse Event/Serious Adverse Event"	3052754003	"febrile neutropenia"	39	39	NA	5	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	4	0	NA	1	12	NA	NA	1	1	NA	NA	NA	""	39	39	0	39	39	"WBC 500;Other test results pending or not available at time of this report. When pt was seen 15 minutes later, the O2 saturation was 45 %, and at that time, it was decided that the probability of"	"improvement was so remote that palliative care remained appropriate."	""	2	2	2	2	2	2	2	2	"On 04/04/07, patient started Cycle 1, day 1 Prednisone, and on 4/5/07 (day 2), patient received Docetaxel. Patient was on the Control Arm.;On 4/13/07, patient was admitted to hospital after"	"complaining of severe abdominal pain and was found to have febrile neutropenia/sepsis during admission. ;He was put in intensive care and later expired that day.;Death Summary and Death Certificate"	"were faxed to USON Safety Office in Dallas on 5/25/2007."	""	""	""	""	""	""	""	""	NA	NA	""	1492119466	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2031"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	3422958003	"Abdominal Cramping"	28	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503610495	""	""	""	NA	"Abdominal cramp"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2032"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	3575536001	"Alopecia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503609211	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2033"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	4611075002	"Back Pain"	161	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516728516	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2034"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	3575768001	"Constipation"	28	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503610402	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2035"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	4274146001	"Cough"	119	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513207229	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2036"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	4274182001	"Dyspepsia"	134	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513207334	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2037"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	4023691001	"Dyspnea"	119	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510185613	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2038"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	3575784001	"Dyspnea"	49	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503610605	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2039"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	4023709001	"Fatigue"	133	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Frequent rest periods"	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510185687	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2040"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	4023638001	"Fatigue"	112	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510185357	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2041"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	4023755001	"Hot Flashes"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510185907	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"2042"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	4023734001	"Left Hand Edema"	112	114	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510185804	""	""	""	NA	"Edema hands"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2043"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	3642160001	"leukopenia"	34	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504740938	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2044"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	3642180001	"Myalgias"	30	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504741434	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2045"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	3642151001	"neutropenia"	41	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504740738	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2046"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	3575793001	"Taste Alterations"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503610684	""	""	""	NA	"Taste altered"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2047"	"DN-101 Protocol No. 011-007"	"064"	"064-0004"	5	9	"Adverse Event/Serious Adverse Event"	4023668001	"Wrist Edema"	92	102	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510185495	""	""	""	NA	"Swollen wrists"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint swelling"	""	""	""	""	""	""	""	""	""	""	""	""
"2048"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	2563389003	"alopecia"	464	559	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509987390	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2049"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	3015505001	"Constipation"	143	171	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118289	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2050"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	2644110001	"Dry Skin"	24	45	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471529525	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"2051"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	3015537001	"Edema Lower Extremity"	143	171	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118399	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2052"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	3015600001	"eyes tearing"	108	559	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118701	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2053"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	2644113001	"Fatigue"	45	241	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471529630	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2054"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	4003647001	"Increased anemia"	415	559	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509986997	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2055"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	4003681001	"Increased dyspnea"	436	559	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509987239	""	""	""	NA	"Increased shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exacerbated"	""	""	""	""	""	""	""	""	""	""	""	""
"2056"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	4003662001	"increased fatigue"	415	559	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509987114	""	""	""	NA	"Fatigue aggravated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2057"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	2644116001	"Infection nephrostomy tube"	71	79	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471530148	""	""	""	NA	"Infection localised"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Localised infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2058"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	3015669001	"mild parethesia of finger tips"	66	559	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118974	""	""	""	NA	"Paresthesia of fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"2059"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	3015459001	"Onycholysis"	129	559	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118090	""	""	""	NA	"Onycholysis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onycholysis"	""	""	""	""	""	""	""	""	""	""	""	""
"2060"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	3015488001	"Pain Left Buttock"	142	363	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118213	""	""	""	NA	"Buttock pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Buttock pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2061"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	3015575001	"Papular Lesions Right Foot"	155	171	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118583	""	""	""	NA	"Papular rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Papulosquamous conditions"	"Rash papular"	""	""	""	""	""	""	""	""	""	""	""	""
"2062"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	3015636001	"Peri-rectal abcess"	130	506	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490118825	""	""	""	NA	"Rectal abscess"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Rectal abscess"	""	""	""	""	""	""	""	""	""	""	""	""
"2063"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	4003686001	"right flank pain"	436	559	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509987302	""	""	""	NA	"Flank pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Flank pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2064"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	4298227001	"Shoulder Pain"	332	559	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513616186	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2065"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	4298130001	"Thrombocytopenia"	492	559	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513615827	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2066"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	4298113001	"UTI"	510	517	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513615735	""	""	""	NA	"UTI"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2067"	"DN-101 Protocol No. 011-007"	"065"	"065-0001"	5	9	"Adverse Event/Serious Adverse Event"	4003773001	"UTI"	450	460	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509987642	""	""	""	NA	"UTI"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2068"	"DN-101 Protocol No. 011-007"	"065"	"065-0002"	5	9	"Adverse Event/Serious Adverse Event"	3245996003	"Anemia"	28	147	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511123626	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2069"	"DN-101 Protocol No. 011-007"	"065"	"065-0002"	5	9	"Adverse Event/Serious Adverse Event"	3351584001	"Chest Pain non-cardiac"	7	9	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	9	NA	NA	7	9	"All heart monitoring normal patient was dehydrated.  After patient recieved IV fluids and pain medication he was stablized."	""	""	2	2	2	2	2	0	2	0	"Patient called our office on 05/31/2007 with complaints of chest pain, he was instructed to go to the ED.  There he was found to be hypotensive and in pain.  Hypotension resolved with IV fluids and"	"pain was controlled with morphine.  All heart exams were normal after 2 days of observation the patient was discharged with no residual problems."	""	""	""	""	""	""	""	""	""	NA	NA	""	1499018309	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2070"	"DN-101 Protocol No. 011-007"	"065"	"065-0002"	5	9	"Adverse Event/Serious Adverse Event"	3351620001	"Constipation"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499018524	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2071"	"DN-101 Protocol No. 011-007"	"065"	"065-0002"	5	9	"Adverse Event/Serious Adverse Event"	4302688001	"decrease in taste"	28	147	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513627226	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2072"	"DN-101 Protocol No. 011-007"	"065"	"065-0002"	5	9	"Adverse Event/Serious Adverse Event"	4093292001	"decreased Appetite"	49	147	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511124787	""	""	""	NA	"Appetite decreased NOS"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"2073"	"DN-101 Protocol No. 011-007"	"065"	"065-0002"	5	9	"Adverse Event/Serious Adverse Event"	4093034001	"dyspnea on exertion"	28	147	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511123951	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"2074"	"DN-101 Protocol No. 011-007"	"065"	"065-0002"	5	9	"Adverse Event/Serious Adverse Event"	3351691001	"Hypotension"	7	7	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV Hydration"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499019022	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"2075"	"DN-101 Protocol No. 011-007"	"065"	"065-0002"	5	9	"Adverse Event/Serious Adverse Event"	4093363001	"increased pedal edema"	77	147	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511125025	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2076"	"DN-101 Protocol No. 011-007"	"065"	"065-0002"	5	9	"Adverse Event/Serious Adverse Event"	4093109001	"increased weakness"	35	62	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Transfusion"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511124162	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2077"	"DN-101 Protocol No. 011-007"	"065"	"065-0002"	5	9	"Adverse Event/Serious Adverse Event"	3470395001	"increased weakness"	63	71	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	3	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	68	NA	NA	63	71	"There were no test performed in the hospital of relevance, he was admitted for hydration and some strengthening therapy."	""	""	2	2	2	NA	2	2	2	2	"Pt went to hospital and requested admission on 07/26/2007 secondary to weakness and loss of appetite.  Pt remains hospitalized at this time with no further information available."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501522604	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2078"	"DN-101 Protocol No. 011-007"	"065"	"065-0002"	5	9	"Adverse Event/Serious Adverse Event"	4093184001	"pancytopenia"	35	49	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Transfusion"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511124409	""	""	""	NA	"Pancytopenia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Marrow depression and hypoplastic anaemias"	"Pancytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2079"	"DN-101 Protocol No. 011-007"	"065"	"065-0002"	5	9	"Adverse Event/Serious Adverse Event"	4093052001	"pedal edema"	28	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511124016	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2080"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2556619003	"Alopecia"	24	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463418953	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2081"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	3923115001	"Anemia"	133	136	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Blood transfusion - 2U PRBC"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508787294	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2082"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688805001	"Anemia"	17	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474397357	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2083"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688832001	"Anemia"	122	129	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474397700	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2084"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688782001	"Ankle edema"	133	143	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474396967	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2085"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688634001	"Constipation"	99	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474395700	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2086"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688770001	"Fatigue"	150	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474396786	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2087"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688758001	"Fatigue"	133	150	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474396653	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2088"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	4309088001	"hyperglycemia"	8	NA	1	2	1	1	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513698178	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2089"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2573431001	"Hyperglycemia"	7	8	NA	3	1	1	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Insulin given iv, and prednisone held"	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463419425	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2090"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2573438001	"Hyperkalemia"	17	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463419595	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2091"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2573391001	"Leukocytopenia"	17	24	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463419124	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2092"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688835001	"Neutropenia"	17	24	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474397909	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2093"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688972001	"Neutropenia"	163	176	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399267	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2094"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688946001	"Neutropenia"	143	150	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399163	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2095"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688864001	"Neutropenia"	129	133	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474398648	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2096"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688899001	"Neutropenia"	133	143	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474398852	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2097"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688787001	"Pallor"	133	143	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474397096	""	""	""	NA	"Pallor"	"Vascular disorders"	"Vascular disorders NEC"	"Site specific vascular disorders NEC"	"Pallor"	""	""	""	""	""	""	""	""	""	""	""	""
"2098"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2573352001	"Sinus drainage"	7	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463418705	""	""	""	NA	"Nasal sinus discharge"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Paranasal sinus hypersecretion"	""	""	""	""	""	""	""	""	""	""	""	""
"2099"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2689052001	"Thrombocytopenia"	143	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399823	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2100"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2689004001	"Thrombocytopenia"	122	129	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399513	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2101"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2689027001	"Thrombocytopenia"	129	133	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399645	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2102"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2689041001	"Thrombocytopenia"	133	143	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399743	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2103"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688991001	"Thrombocytopenia"	92	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474399383	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2104"	"DN-101 Protocol No. 011-007"	"067"	"067-0001"	5	9	"Adverse Event/Serious Adverse Event"	2688607001	"Urinary incontinence"	50	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474395470	""	""	""	NA	"Urinary incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"2105"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	3177863003	"alopecia"	58	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503943000	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2106"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4630384002	"bilateral hand pain"	-2	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516825280	""	""	""	NA	"Hand pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2107"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4495283002	"fatigue"	150	211	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516041005	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2108"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	3227691001	"fatigue"	15	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495390117	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2109"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4495324002	"fatigue"	211	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516041073	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2110"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4495193002	"fatigue"	137	149	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516040863	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2111"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4495110002	"fatigue"	105	137	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516040718	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2112"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	3587146001	"fatigue"	97	104	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503942919	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2113"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4494667002	"fatigue"	78	83	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516039875	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2114"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4494706002	"fatigue"	84	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516039972	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2115"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4495062002	"hyperglycemia"	53	74	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516040636	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2116"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4494991002	"hyperglycemia"	12	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516040515	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2117"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4495019002	"hyperglycemia"	29	53	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516040580	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2118"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4630689002	"hyperlachrymation"	176	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516826061	""	""	""	NA	"Lacrimation increased"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2119"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4630663002	"left hand cramping"	184	211	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516825971	""	""	""	NA	"Cramp in hand"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"2120"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4494627002	"leukopenia - intermittent"	21	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516039701	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2121"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4495146002	"nail changes"	43	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516040771	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2122"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4630286002	"pedal edema"	-2	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516825032	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2123"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4495532002	"shortness of breath"	176	211	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516041421	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2124"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4630639002	"weakness"	184	211	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516825905	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2125"	"DN-101 Protocol No. 011-007"	"068"	"068-0006"	5	9	"Adverse Event/Serious Adverse Event"	4495392002	"weakness"	211	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516041166	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2126"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	5	9	"Adverse Event/Serious Adverse Event"	2768806003	"ALT, SGPT elevation"	238	259	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513184673	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2127"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	5	9	"Adverse Event/Serious Adverse Event"	4866895002	"AST, SGOT elevation"	238	308	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518540761	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2128"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	5	9	"Adverse Event/Serious Adverse Event"	3032980001	"fatigue"	78	79	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490628695	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2129"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	5	9	"Adverse Event/Serious Adverse Event"	3144179001	"fatigue"	121	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493574245	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2130"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	5	9	"Adverse Event/Serious Adverse Event"	3144203001	"fatigue"	142	143	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493574349	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2131"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	5	9	"Adverse Event/Serious Adverse Event"	3033044001	"fatigue"	99	101	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490628925	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2132"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	5	9	"Adverse Event/Serious Adverse Event"	2875007001	"fatigue"	39	40	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484592715	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2133"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	5	9	"Adverse Event/Serious Adverse Event"	3037032001	"intermittent knee pain"	98	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490714511	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2134"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	5	9	"Adverse Event/Serious Adverse Event"	4866962002	"nail change (due to trauma)"	266	287	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518540926	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2135"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	5	9	"Adverse Event/Serious Adverse Event"	3144227001	"nail changes"	105	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493574446	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2136"	"DN-101 Protocol No. 011-007"	"069"	"069-0001"	5	9	"Adverse Event/Serious Adverse Event"	4867112002	"neuropathy-upper extremities"	287	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518541252	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2137"	"DN-101 Protocol No. 011-007"	"069"	"069-0002"	5	9	"Adverse Event/Serious Adverse Event"	2871140003	"Dehydration"	56	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV Fluids administered"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489100942	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"2138"	"DN-101 Protocol No. 011-007"	"069"	"069-0002"	5	9	"Adverse Event/Serious Adverse Event"	3975425001	"elective surgery for hernia repair"	168	168	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509474391	""	""	""	NA	"Hernia repair"	"Surgical and medical procedures"	"Gastrointestinal therapeutic procedures"	"Hernia repairs"	"Hernia repair"	""	""	""	""	""	""	""	""	""	""	""	""
"2139"	"DN-101 Protocol No. 011-007"	"069"	"069-0004"	5	9	"Adverse Event/Serious Adverse Event"	3372322003	"Edema"	109	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513131766	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"2140"	"DN-101 Protocol No. 011-007"	"069"	"069-0004"	5	9	"Adverse Event/Serious Adverse Event"	3494120001	"Infected Mediport with redness, drainage and fever"	45	49	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	6	NA	1	1	"inpatient antibiotic therapy; removal of mediport"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	46	NA	NA	45	49	"Blood Cultures 8-5-07; removal of mediport 8-5-07"	""	""	2	2	2	NA	2	2	NA	2	"Presented to Emergency department with infected mediport with drainage, redness and fever on 08-05-2007. Admitted for inpatient IV antibiotic therapy and immediate removal of mediport."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502052758	""	""	""	NA	"Catheter site infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Catheter site infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2141"	"DN-101 Protocol No. 011-007"	"069"	"069-0004"	5	9	"Adverse Event/Serious Adverse Event"	3837630001	"Insomnia"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507598190	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"2142"	"DN-101 Protocol No. 011-007"	"069"	"069-0004"	5	9	"Adverse Event/Serious Adverse Event"	4262200001	"Nailbed changes"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513132769	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2143"	"DN-101 Protocol No. 011-007"	"069"	"069-0004"	5	9	"Adverse Event/Serious Adverse Event"	3517682001	"perineal Furuncle"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Ordered antiobiotic therapy and epsom salts sitz bath"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502384788	""	""	""	NA	"Furuncle"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Furuncle"	""	""	""	""	""	""	""	""	""	""	""	""
"2144"	"DN-101 Protocol No. 011-007"	"069"	"069-0004"	5	9	"Adverse Event/Serious Adverse Event"	3958546001	"Peripheral Neuropathy"	130	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509311852	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2145"	"DN-101 Protocol No. 011-007"	"069"	"069-0004"	5	9	"Adverse Event/Serious Adverse Event"	4262159001	"PICC line infection"	88	95	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513131101	""	""	""	NA	"Catheter infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Catheter related infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2146"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	3580256003	"allergic rhinitis"	21	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518530679	""	""	""	NA	"Allergic rhinitis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal congestion and inflammations"	"Rhinitis allergic"	""	""	""	""	""	""	""	""	""	""	""	""
"2147"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4864439002	"alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518530870	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2148"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4864531002	"anemia"	35	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518531347	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2149"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4864457002	"bladder spasm"	28	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518531007	""	""	""	NA	"Bladder spasm"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Bladder spasm"	""	""	""	""	""	""	""	""	""	""	""	""
"2150"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4433997002	"constipation"	14	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515534918	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2151"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4434100002	"fatigue"	9	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515535069	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2152"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4434762002	"fungal infection"	70	85	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515536056	""	""	""	NA	"Fungal infection"	"Infections and infestations"	"Fungal infectious disorders"	"Fungal infections NEC"	"Fungal infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2153"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4864308002	"Incontinent urination"	14	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518530482	""	""	""	NA	"Incontinence urinary"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"2154"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4434199002	"joint pain"	9	14	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515535215	""	""	""	NA	"Joint pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2155"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4882274002	"leukopenia"	42	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518640562	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2156"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4864642002	"leukopenia"	35	41	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518531702	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2157"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4864562002	"neutropenia"	35	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518531440	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2158"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4434261002	"neutropenia"	21	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515535334	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2159"	"DN-101 Protocol No. 011-007"	"069"	"069-0006"	5	9	"Adverse Event/Serious Adverse Event"	4864497002	"seasonal allergies"	35	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518531215	""	""	""	NA	"Seasonal allergy"	"Immune system disorders"	"Allergic conditions"	"Atopic disorders"	"Seasonal allergy"	""	""	""	""	""	""	""	""	""	""	""	""
"2160"	"DN-101 Protocol No. 011-007"	"069"	"069-0007"	5	9	"Adverse Event/Serious Adverse Event"	3913059003	"cold symptoms"	10	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512574658	""	""	""	NA	"Cold symptoms"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2161"	"DN-101 Protocol No. 011-007"	"069"	"069-0007"	5	9	"Adverse Event/Serious Adverse Event"	4206045001	"flushed ( dermatology)"	9	9	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512572874	""	""	""	NA	"Flushed"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"2162"	"DN-101 Protocol No. 011-007"	"069"	"069-0007"	5	9	"Adverse Event/Serious Adverse Event"	4206639001	"hyperglycemia"	10	NA	1	2	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512575561	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2163"	"DN-101 Protocol No. 011-007"	"069"	"069-0007"	5	9	"Adverse Event/Serious Adverse Event"	4206526001	"leg/hip bone pain"	10	13	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512574997	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2164"	"DN-101 Protocol No. 011-007"	"069"	"069-0007"	5	9	"Adverse Event/Serious Adverse Event"	4206700001	"neutropenia"	20	30	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512575821	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2165"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	5	9	"Adverse Event/Serious Adverse Event"	2754585003	"cough"	144	202	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494787324	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2166"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	5	9	"Adverse Event/Serious Adverse Event"	3188204001	"fingernail changes"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494787578	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2167"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	5	9	"Adverse Event/Serious Adverse Event"	4514754002	"Hot Flashes"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516134819	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"2168"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	5	9	"Adverse Event/Serious Adverse Event"	2802690001	"insomnia"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480972779	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"2169"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	5	9	"Adverse Event/Serious Adverse Event"	3188227001	"lower back pain"	182	206	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494787660	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2170"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	5	9	"Adverse Event/Serious Adverse Event"	4683860002	"Pain--left hip"	NA	NA	1	NA	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Radiation Therapy"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517249857	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2171"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	5	9	"Adverse Event/Serious Adverse Event"	3188118001	"respiratory congestion"	144	153	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494787189	""	""	""	NA	"Respiratory tract congestion"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Respiratory tract disorders NEC"	"Respiratory tract congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"2172"	"DN-101 Protocol No. 011-007"	"071"	"071-0003"	5	9	"Adverse Event/Serious Adverse Event"	3317525001	"sensory neuropathy--toes and fingers"	218	330	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498231459	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2173"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	5	9	"Adverse Event/Serious Adverse Event"	2787996003	"alopecia"	49	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485808796	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2174"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	5	9	"Adverse Event/Serious Adverse Event"	3210351001	"chemo induced anemia"	56	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495037677	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2175"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	5	9	"Adverse Event/Serious Adverse Event"	3210369001	"dyspnea"	72	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495037753	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2176"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	5	9	"Adverse Event/Serious Adverse Event"	2902168001	"eye tearing"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485808693	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2177"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	5	9	"Adverse Event/Serious Adverse Event"	2902208001	"fatigue"	57	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485808930	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2178"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	5	9	"Adverse Event/Serious Adverse Event"	2902109001	"pain in feet bilaterally"	24	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485808380	""	""	""	NA	"Pain in foot"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2179"	"DN-101 Protocol No. 011-007"	"071"	"071-0004"	5	9	"Adverse Event/Serious Adverse Event"	2902233001	"pain right arm from chemo infiltration"	35	78	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485809052	""	""	""	NA	"Administration site pain"	"General disorders and administration site conditions"	"Administration site reactions"	"Administration site reactions NEC"	"Administration site pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2180"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	3173495003	"Allergic reaction"	159	159	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Infusion temporarily stopped, then restarted at slower rate."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516053917	""	""	""	NA	"Allergic reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"2181"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	3837077001	"allergic reaction"	28	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507587251	""	""	""	NA	"Allergic reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"2182"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	3837074001	"alopecia"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507587103	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2183"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	3325135001	"back pain"	28	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498493588	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2184"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	3837014001	"Constipation"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507586447	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2185"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	3836999001	"fatigue"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507586309	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2186"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	3837030001	"infection with grade 3-4 neutropenia"	102	112	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507586645	""	""	""	NA	"Neutropenic infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Neutropenic infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2187"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	3836977001	"Nail changes"	90	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507586134	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2188"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	3325123001	"Rash"	11	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498493430	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"2189"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	3836939001	"Restless legs"	71	159	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507585846	""	""	""	NA	"Restless legs"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Restless legs syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"2190"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	3873528001	"sensory neuropathy"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508098165	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2191"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	4509450002	"Syncope"	184	185	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	6	NA	1	1	"Patient admitted to hospital, cardiac workup done."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	257	NA	NA	184	185	"Labs 11/04/2007: cbc, electrolytes,troponins, myoglobin, UA. Chest XRay 11/04/2007: normal result. Head CT 11/04/2007: normal results. Chest CT 11/04/2007: negative for pulmonary embolus. Carotid"	"ultrasound 11/05/2007 revealing less than 50% dianeter carotid stenosis. Cardiac echo 11/05/2007 : normal LVEF.Cardiology consult 11/04/2007."	""	2	2	2	2	2	2	2	2	"Patient brought to hospital following syncopal episode which occurred in church on 11/04/2007. Patient has a long hsitory of syncopal episodes since childhood. MI ruled out with serial troponins;"	"electrolytes, kidney funciton , and BNP also within normal limits. CT of chest negative for PE. CT of head normal. Carotid US revealed less than 50% diameter stenosis. Cardiac echo normal. Cardiology"	"consulted and determined event likely attributable to  neurocardiogenic syncope; recommended increasing fluids and sodium intake, as well as compression stockings. Patient discharged from hospital"	"11/05/2007 and to follow up with cardiology in 6-8 weeks. No further information received to date."	""	""	""	""	""	""	""	NA	NA	""	1516123856	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"2192"	"DN-101 Protocol No. 011-007"	"071"	"071-0009"	5	9	"Adverse Event/Serious Adverse Event"	3325128001	"urinary incontinence"	9	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498493504	""	""	""	NA	"Urinary incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"2193"	"DN-101 Protocol No. 011-007"	"071"	"071-0010"	5	9	"Adverse Event/Serious Adverse Event"	3307032003	"blurred vision"	115	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508100632	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"2194"	"DN-101 Protocol No. 011-007"	"071"	"071-0010"	5	9	"Adverse Event/Serious Adverse Event"	4909504002	"dehydration"	14	14	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519073674	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"2195"	"DN-101 Protocol No. 011-007"	"071"	"071-0010"	5	9	"Adverse Event/Serious Adverse Event"	3874153001	"facial edema"	115	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508100805	""	""	""	NA	"Face edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Face oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"2196"	"DN-101 Protocol No. 011-007"	"071"	"071-0010"	5	9	"Adverse Event/Serious Adverse Event"	3647908001	"neutropenia"	14	17	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504822543	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2197"	"DN-101 Protocol No. 011-007"	"071"	"071-0010"	5	9	"Adverse Event/Serious Adverse Event"	3647876001	"sensory neuropathy"	11	27	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504822204	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2198"	"DN-101 Protocol No. 011-007"	"071"	"071-0011"	5	9	"Adverse Event/Serious Adverse Event"	3569427003	"alopecia"	55	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507497283	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2199"	"DN-101 Protocol No. 011-007"	"071"	"071-0011"	5	9	"Adverse Event/Serious Adverse Event"	3828948001	"alopecia"	22	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507497211	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2200"	"DN-101 Protocol No. 011-007"	"071"	"071-0011"	5	9	"Adverse Event/Serious Adverse Event"	3828925001	"fatigue"	14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507497130	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2201"	"DN-101 Protocol No. 011-007"	"071"	"071-0011"	5	9	"Adverse Event/Serious Adverse Event"	3954155001	"insomnia"	56	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509288663	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"2202"	"DN-101 Protocol No. 011-007"	"071"	"071-0011"	5	9	"Adverse Event/Serious Adverse Event"	3828909001	"rash"	18	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507497025	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"2203"	"DN-101 Protocol No. 011-007"	"071"	"071-0011"	5	9	"Adverse Event/Serious Adverse Event"	4659203002	"skin irritation"	118	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517162643	""	""	""	NA	"Skin irritation"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermatitis and eczema"	"Skin irritation"	""	""	""	""	""	""	""	""	""	""	""	""
"2204"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2594676003	"Alopecia"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471445275	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2205"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2706296001	"Anemia"	64	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475585820	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2206"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2899226001	"Bone Pain"	151	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485715713	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2207"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2760170001	"Bone Pain"	130	134	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478119108	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2208"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2899223001	"Fatigue"	158	326	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485715655	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2209"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2706304001	"Fatigue"	66	69	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475586002	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2210"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2760131001	"Fatigue"	129	134	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478118901	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2211"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2760144001	"Fatigue"	134	153	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478118966	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2212"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2706286001	"Fatigue"	47	66	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475585339	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2213"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2706317001	"Fatigue"	87	90	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475587508	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2214"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2642333001	"Fatigue"	44	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471445438	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2215"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2706326001	"Fatigue"	90	129	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475587660	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2216"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2899220001	"Fatigue"	153	158	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485715605	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2217"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2706307001	"Fatigue"	69	87	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475586060	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2218"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2706292001	"Hyperglycemia"	21	248	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475585491	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2219"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	3781468001	"Hyperglycemia"	270	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506611572	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2220"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	3011350001	"hyperglycemia"	249	269	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490028532	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2221"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2899240001	"Muscle Aches"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Encouraged Weight Loss"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485715890	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2222"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	2706329001	"Sensory Neuropathy"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475587730	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2223"	"DN-101 Protocol No. 011-007"	"072"	"072-0001"	5	9	"Adverse Event/Serious Adverse Event"	4537631002	"Tearing - Eyes"	228	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516223599	""	""	""	NA	"Tearing eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2224"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	2679177003	"Anemia"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522942783	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2225"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	3200535001	"Cough"	182	206	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494949678	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2226"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	2836962001	"Hyperglycemia"	98	161	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482333189	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2227"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	3200480001	"Hyperglycemia"	182	227	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494949216	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2228"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	2836947001	"Hyperglycemia"	35	77	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482332481	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2229"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	2836959001	"Hyperglycemia"	77	98	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482333087	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2230"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	2955672001	"Hyperglycemia"	161	182	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487615039	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2231"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	3357429001	"Hyperglycemia"	270	389	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499105767	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2232"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	3357403001	"Hyperglycemia"	248	270	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499105496	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2233"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	2689840001	"Hypergycemia"	14	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474457178	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2234"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	3200574001	"Nail Changes"	227	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494949937	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2235"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	2836950001	"Neutropenia"	21	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482332561	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2236"	"DN-101 Protocol No. 011-007"	"072"	"072-0002"	5	9	"Adverse Event/Serious Adverse Event"	3200563001	"Pain - Left inguinal - intermittent"	182	227	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494949849	""	""	""	NA	"Groin pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Soft tissue disorders NEC"	"Groin pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2237"	"DN-101 Protocol No. 011-007"	"072"	"072-0007"	5	9	"Adverse Event/Serious Adverse Event"	3794090003	"Depression"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515949818	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"2238"	"DN-101 Protocol No. 011-007"	"072"	"072-0007"	5	9	"Adverse Event/Serious Adverse Event"	4479045002	"Impotence"	31	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Referred to Urology"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515949653	""	""	""	NA	"Impotence"	"Reproductive system and breast disorders"	"Sexual function and fertility disorders"	"Erection and ejaculation conditions and disorders"	"Erectile dysfunction"	""	""	""	""	""	""	""	""	""	""	""	""
"2239"	"DN-101 Protocol No. 011-007"	"072"	"072-0007"	5	9	"Adverse Event/Serious Adverse Event"	4479057002	"Leukocytosis"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515949743	""	""	""	NA	"Leukocytosis"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukocytoses NEC"	"Leukocytosis"	""	""	""	""	""	""	""	""	""	""	""	""
"2240"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2615046003	"alopecia"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471795279	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2241"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	3900461001	"basal cell carcinoma of Left ear"	267	295	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508350794	""	""	""	NA	"Basal cell carcinoma"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Skin neoplasms malignant and unspecified"	"Skin neoplasms malignant and unspecified (excl melanoma)"	"Basal cell carcinoma"	""	""	""	""	""	""	""	""	""	""	""	""
"2242"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2851907001	"cardiac arrhythmia"	178	180	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"cardizem drip"	0	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	178	NA	NA	178	180	"EKG - 1/4/07; transthoracic ECHO - 1/4/07; telemetry monitoring; serial troponins; serial INR monitoring; duplex doppler of bilateral lower extremities; chest x-ray; blood cultures and sensitivity"	""	""	2	2	2	NA	2	2	NA	2	"Patient was admitted with atrial fib with a rapid ventricular response rate. He was monitored with serial troponins and telemetry. Rate control was achieved with a cardizem drip. INR monitoring"	"showed low therapeutic INR (1.12) resulting in anticoagulation with Lovenox. The atrial fib responded to the Cardizem drip. Drip was titrated and discontinued accordingly. Oral Cardizem was"	"prescribed and routine HCTZ and Norvasc were held.  A bilateral lower extremity doppler was performed showing no evidence of DVT.  At discharge, the Cardizem was controlling the patient's heart rate"	"and blood pressure so the HCTZ and Norvasc were discontinued with Cardizem CD 360 mg QD prescribed. Therapeutic INR was 0.98, so Lovenox 90 mg SC every 12 hours and Coumadin 5 mg QD was prescribed"	"for anticoagulation. The patient's study treatment was delayed due to this event. The Investigator considers this event unrelated to study therapy. The patient will receive treatment this week with"	"no dose changes."	""	""	""	""	""	NA	NA	""	1483546735	""	""	""	NA	"Cardiac arrhythmia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Arrhythmia"	""	""	""	""	""	""	""	""	""	""	""	""
"2243"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2768185001	"constipation"	59	60	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478704089	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2244"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2711184001	"constipation"	80	81	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475766611	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2245"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2646068001	"constipation"	15	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471794632	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2246"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2666879001	"cough"	53	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473168939	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2247"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	3900209001	"cough"	247	289	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508349791	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2248"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2768453001	"fatigue"	78	268	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478710300	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2249"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2666855001	"fatigue"	36	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473168656	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2250"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2918430001	"hematuria"	178	247	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486408737	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"2251"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2816709001	"increased bruising"	135	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481468691	""	""	""	NA	"Increased tendency to bruise"	"Skin and subcutaneous tissue disorders"	"Skin vascular abnormalities"	"Purpura and related conditions"	"Increased tendency to bruise"	""	""	""	""	""	""	""	""	""	""	""	""
"2252"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2806798001	"insomnia"	120	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481060291	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"2253"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2768229001	"Left thigh pain"	73	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478706082	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2254"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2768449001	"leg cramps"	31	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478709829	""	""	""	NA	"Leg cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"2255"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	3900147001	"Pain lower extremity"	170	337	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508349538	""	""	""	NA	"Pain of lower extremities"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2256"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2768441001	"rectal bleeding r/t pre-existing hemorrhoids"	95	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478709541	""	""	""	NA	"Hemorrhoidal bleeding"	"Gastrointestinal disorders"	"Gastrointestinal vascular conditions"	"Haemorrhoids and gastrointestinal varices (excl oesophageal)"	"Haemorrhoidal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"2257"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	5039727002	"Right leg edema"	141	157	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"Discontinued Norvasc"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520351569	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2258"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2977428001	"Right leg pain"	226	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488727514	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2259"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2768282001	"taste disturbance"	88	268	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478706778	""	""	""	NA	"Taste disturbance"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2260"	"DN-101 Protocol No. 011-007"	"074"	"074-0001"	5	9	"Adverse Event/Serious Adverse Event"	2666827001	"taste disturbance"	37	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473168502	""	""	""	NA	"Taste disturbance"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2261"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	2996186003	"alopecia"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493662922	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2262"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3863947001	"anemia"	71	336	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507829813	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2263"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3864355001	"bronchitis"	85	92	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507831800	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2264"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3150770001	"constipation"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493663599	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2265"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3298423001	"cough"	85	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497815286	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2266"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	5166969002	"dehydration"	217	217	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"normal saline given"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521576166	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"2267"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3298414001	"dyspnea"	71	197	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497815182	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2268"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3483127001	"fatigue"	29	217	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501688147	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2269"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3027624001	"fever"	14	15	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490541249	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"2270"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3864547001	"heartburn"	71	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507832344	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2271"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3864708001	"nail changes"	155	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507832999	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2272"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3483373001	"neuropathy (motor)"	134	176	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501690251	""	""	""	NA	"Motor peripheral neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral motor neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2273"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3483370001	"neuropathy (sensory)"	134	217	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501690188	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2274"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3027486001	"neutropenia"	15	17	NA	4	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	3	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	18	NA	NA	15	17	"3/23/07 ANC = 320 WBC = 1.1; 3/24/2007 ANC = 290  WBC = 2.1; 3/25/2007 ANC = 592  WBC = 4.2; 3/23/2007 CXR = slight opacity R lung; 3/23/2007 blood cultures = no growth in 24 hours"	""	""	2	2	2	NA	2	2	NA	2	"Docetaxel given (cycle 1) 3/16/2007.  Pt. presented in ER 3/23/2007 evening with c/o productive cough x 3 days and fever spike of 101.5 (f) 3/22.  Temperature in ER = 99.7. Pt  admitted to hospital"	"for emperic Cefipime 2 grams Q 8 hours started immediately.  Blood cultures and sputum cultures were obtained with no growth after 24 hours.  Neupogen 300 mcg was given for neutrophil recovery.  Pt."	"discharged home 3/25/2007 morning.  The investigator considers this event related to Docetaxel."	""	""	""	""	""	""	""	""	NA	NA	""	1490540188	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2275"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3863924001	"nosebleeds"	60	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507829651	""	""	""	NA	"Nosebleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"2276"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3864764001	"oral mucositis"	152	159	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507833157	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2277"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3483296001	"pain-calf/leg"	71	217	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501689253	""	""	""	NA	"Calf pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2278"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3298387001	"sensory neuropathy"	71	92	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497814967	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2279"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3864451001	"sinus infection"	113	124	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507832103	""	""	""	NA	"Sinus infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Sinusitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2280"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3483217001	"sweats/hot flashes"	29	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501688783	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"2281"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3298295001	"taste alteration"	8	217	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497814347	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2282"	"DN-101 Protocol No. 011-007"	"074"	"074-0003"	5	9	"Adverse Event/Serious Adverse Event"	3298377001	"watery eyes"	71	252	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497814863	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2283"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	3478647003	"acute exacerbation of congestive heart failure"	126	130	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	233	NA	NA	126	130	"CBC, CMP, Cardiac enzymes, Chest X-ray, EKG, Renal Ultrasound, CT Chest,"	""	""	2	2	2	NA	2	2	NA	2	"Subject 074-0004 to ER 12/5/07 with increasing SOB, nonproductive cough, weakness, and decreased urine output.	A chest x-ray showed exacerbation of congestive heart failure and pneumonia. CMP showed"	"hyponatremia. IV Lasix and Avelox were started. EKG showed atrial fibrillation. Renal U/S showed mild to moderate bilateral hydronephrosis. Cystoscopy performed for urethral stricture, dilating"	"urethra and insertion of foley catheter. Cardiac enzymes were negative. CT chest showed no pulmonary emboli. Subject improved with antibiotics and diuretic Lasix.  He was discharged 12/9/07. Reason"	"for admission is noted as \"exacerbation of CHF\". None of the other findings, pneumonia, hyponatremia, atrial fibrillation or hydronephrosis, prolonged hospitalization. They are entered as separate"	"AE's. Subject received last study chemotherapy 10/4/07, and last study Prednisone 10/26/07.Patient officially removed from study 11/5/07. Investigator considers event unrelated to study treatment."	""	""	""	""	""	""	NA	NA	""	1521746199	""	""	""	NA	"Congestive cardiac failure aggravated"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"2284"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	3853205001	"alopecia"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507740645	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2285"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	3796174001	"congestive heart failure"	58	61	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	62	NA	NA	58	61	"Chest x-ray - 09/28/07; Troponin levels-9/28/07; CT scan chest-9/29/07;"	""	""	2	2	2	NA	2	2	NA	2	"Subject ECS/074-0004 presented to the Emergency room 9/28/07 with complaints of increasing shortness of breath and lower extremity edema.  A chest x-ray was performed which showed evidence of"	"congestive heart failure.  (Pt. has history of CHF)  He was subsequently admitted to the hospital telemetry unit on strict intake and output.  Troponin levels were drawn and were negative times two."	"CT scan of the chest showed fluid overload and \"swiss cheese pulmonary edema\". He was given 80mg Lasix intravenous followed by 40mg IV daily thereafter during hospitalization.  Pt. was started on"	"Lasix 80mg/day and Zaroxolyn 5mg orally at discharge.  Pt discharged on 10/1/07 with marked reduction of shortness of breath and bipedal edema."	""	""	""	""	""	""	""	NA	NA	""	1506962495	""	""	""	NA	"Congestive heart failure"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"2286"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	4209890001	"cough"	58	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512584974	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2287"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	4210185001	"edema: limb"	23	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512585925	""	""	""	NA	"Edema limbs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2288"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	5179905002	"Edema: limb-lower extremity"	106	139	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521655060	""	""	""	NA	"Edema lower limb"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2289"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	3795344001	"elevated alkaline phosphatase"	44	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506957933	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2290"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	3795382001	"elevated ALT"	44	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506958109	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2291"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	3794915001	"elevated AST"	44	58	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506956343	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2292"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	3853644001	"fatigue"	58	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507741770	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2293"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	3795049001	"hyperglycemia"	23	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506956964	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2294"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	3795296001	"hypoalbuminemia"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506957826	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2295"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	3855269001	"hypoxia"	58	61	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507746538	""	""	""	NA	"Hypoxia"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Conditions associated with abnormal gas exchange"	"Hypoxia"	""	""	""	""	""	""	""	""	""	""	""	""
"2296"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	5191779002	"Infection with normal ANC - pneumonia"	126	130	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521742164	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"2297"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	5179834002	"Lower extremity weakness"	106	139	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521654872	""	""	""	NA	"Lower extremities weakness of"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"2298"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	5179702002	"Shortness of Breath"	106	117	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521654327	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2299"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	5191891002	"urethral stricture"	126	127	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	6	NA	1	1	"Cystoscopy performed and foley catheter placed."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521742506	""	""	""	NA	"Urethral stricture"	"Renal and urinary disorders"	"Urethral disorders (excl calculi)"	"Structural and obstructive urethral disorders (excl congenital)"	"Urethral stenosis"	""	""	""	""	""	""	""	""	""	""	""	""
"2300"	"DN-101 Protocol No. 011-007"	"074"	"074-0004"	5	9	"Adverse Event/Serious Adverse Event"	3853561001	"wheezing"	59	61	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507741443	""	""	""	NA	"Wheezing"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Wheezing"	""	""	""	""	""	""	""	""	""	""	""	""
"2301"	"DN-101 Protocol No. 011-007"	"075"	"075-0002"	5	9	"Adverse Event/Serious Adverse Event"	2995498003	"alopecia"	55	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498657126	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2302"	"DN-101 Protocol No. 011-007"	"075"	"075-0002"	5	9	"Adverse Event/Serious Adverse Event"	3654594001	"dysgeusia"	117	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505058096	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2303"	"DN-101 Protocol No. 011-007"	"075"	"075-0002"	5	9	"Adverse Event/Serious Adverse Event"	3335680001	"hyperglycemia"	34	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498657830	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2304"	"DN-101 Protocol No. 011-007"	"075"	"075-0002"	5	9	"Adverse Event/Serious Adverse Event"	3335632001	"nail changes"	76	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498657342	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2305"	"DN-101 Protocol No. 011-007"	"075"	"075-0002"	5	9	"Adverse Event/Serious Adverse Event"	3654513001	"neuropathy, sensory"	160	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505057833	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2306"	"DN-101 Protocol No. 011-007"	"075"	"075-0002"	5	9	"Adverse Event/Serious Adverse Event"	4121630001	"watery eye"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511708694	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2307"	"DN-101 Protocol No. 011-007"	"075"	"075-0002"	5	9	"Adverse Event/Serious Adverse Event"	4121593001	"weight loss"	220	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511708154	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2308"	"DN-101 Protocol No. 011-007"	"077"	"077-0001"	5	9	"Adverse Event/Serious Adverse Event"	3326202003	"Alopecia"	27	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516567360	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2309"	"DN-101 Protocol No. 011-007"	"077"	"077-0001"	5	9	"Adverse Event/Serious Adverse Event"	3904984001	"Constipation"	109	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508423215	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2310"	"DN-101 Protocol No. 011-007"	"077"	"077-0001"	5	9	"Adverse Event/Serious Adverse Event"	3904949001	"Fatigue"	111	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508423017	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2311"	"DN-101 Protocol No. 011-007"	"077"	"077-0001"	5	9	"Adverse Event/Serious Adverse Event"	4575640002	"Nail bed changes"	153	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516567602	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2312"	"DN-101 Protocol No. 011-007"	"077"	"077-0001"	5	9	"Adverse Event/Serious Adverse Event"	3720138001	"Neuropathy/sensory"	39	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505916455	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2313"	"DN-101 Protocol No. 011-007"	"077"	"077-0001"	5	9	"Adverse Event/Serious Adverse Event"	3720723001	"Pain/musculoskelatal/joint"	83	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505918532	""	""	""	NA	"Musculoskeletal pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2314"	"DN-101 Protocol No. 011-007"	"077"	"077-0001"	5	9	"Adverse Event/Serious Adverse Event"	4575602002	"Pedal edema"	132	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516567514	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2315"	"DN-101 Protocol No. 011-007"	"077"	"077-0002"	5	9	"Adverse Event/Serious Adverse Event"	3452972003	"Alopecia"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516636262	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2316"	"DN-101 Protocol No. 011-007"	"077"	"077-0002"	5	9	"Adverse Event/Serious Adverse Event"	4587416002	"Constipation"	28	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516636015	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2317"	"DN-101 Protocol No. 011-007"	"077"	"077-0002"	5	9	"Adverse Event/Serious Adverse Event"	4587351002	"Dizziness"	7	8	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516635818	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"2318"	"DN-101 Protocol No. 011-007"	"077"	"077-0002"	5	9	"Adverse Event/Serious Adverse Event"	4587309002	"Dyspnea"	7	66	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516635676	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2319"	"DN-101 Protocol No. 011-007"	"077"	"077-0002"	5	9	"Adverse Event/Serious Adverse Event"	4587381002	"Intermittent fatigue"	3	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516635917	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2320"	"DN-101 Protocol No. 011-007"	"077"	"077-0002"	5	9	"Adverse Event/Serious Adverse Event"	4587755002	"Neuropathy fingers"	66	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516636585	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2321"	"DN-101 Protocol No. 011-007"	"077"	"077-0002"	5	9	"Adverse Event/Serious Adverse Event"	4587676002	"Rash on legs"	46	53	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516636461	""	""	""	NA	"Rash both legs"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"2322"	"DN-101 Protocol No. 011-007"	"077"	"077-0002"	5	9	"Adverse Event/Serious Adverse Event"	4592836002	"worsening hypertension"	85	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516647429	""	""	""	NA	"Hypertension worsened"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"2323"	"DN-101 Protocol No. 011-007"	"077"	"077-0003"	5	9	"Adverse Event/Serious Adverse Event"	3545315003	"anemia"	47	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508271591	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2324"	"DN-101 Protocol No. 011-007"	"077"	"077-0003"	5	9	"Adverse Event/Serious Adverse Event"	3891733001	"dehydration"	11	12	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508267369	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"2325"	"DN-101 Protocol No. 011-007"	"077"	"077-0003"	5	9	"Adverse Event/Serious Adverse Event"	3891845001	"Fatigue"	11	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508267642	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2326"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	3023528003	"abdominal cramping"	5	6	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496848023	""	""	""	NA	"Abdominal cramp"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2327"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4160986001	"abdominal cramps"	202	230	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512059376	""	""	""	NA	"Abdominal cramps"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2328"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	3270134001	"alopecia"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496848086	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2329"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	3703354001	"anemia"	132	167	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505757853	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2330"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4160980001	"anemia"	147	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512059321	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2331"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	3270169001	"chest tightness"	47	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496848361	""	""	""	NA	"Chest tightness"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Chest discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"2332"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4250574001	"CNS cerebrovascular ischemia"	264	268	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	265	NA	NA	264	268	"CT Head negative for metastatic disease"	""	""	2	2	2	NA	2	2	NA	2	"Presented to office with 1 hour history of poor recall and mixed words.  History over past week of headache, wavy vision, and nausea and vomiting.;Admitted to hospital.  All scan negative for clot."	"Started with ASA and Heparin SQ.  Symptoms resolved.  Transfered to rehab with resolution of symptoms."	""	""	""	""	""	""	""	""	""	NA	NA	""	1513088673	""	""	""	NA	"Ischemia cerebrovascular"	"Nervous system disorders"	"Central nervous system vascular disorders"	"Central nervous system haemorrhages and cerebrovascular accidents"	"Cerebral ischaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2333"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	3270127001	"constipation"	5	6	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496847953	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2334"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4160999001	"constipation"	202	230	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512059429	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2335"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	3270155001	"cough"	47	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496848270	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2336"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	3270177001	"dyspepsia"	68	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496848462	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2337"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4387076001	"elevated creatinine"	264	267	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515097919	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2338"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4160970001	"fatigue"	130	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512059261	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2339"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	3703297001	"fatigue"	125	132	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505757660	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2340"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4160922001	"fever"	174	189	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512058893	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"2341"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	3270148001	"flu-like syndrome; post zometa"	47	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496848216	""	""	""	NA	"Flu-like symptoms"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Influenza like illness"	""	""	""	""	""	""	""	""	""	""	""	""
"2342"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	3703336001	"infection- upper respiratory tract"	125	176	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505757787	""	""	""	NA	"Upper respiratory tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2343"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4160909001	"infection- upper respiratory tract"	209	216	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512058790	""	""	""	NA	"Upper respiratory tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2344"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4160877001	"infection-upper respiratory tract"	164	174	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512058629	""	""	""	NA	"Upper respiratory tract infection NOS"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2345"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4161043001	"night sweats"	209	216	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512059713	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"2346"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4160935001	"night sweats"	193	195	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512058965	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"2347"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	3703280001	"nocturia"	110	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505757598	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"2348"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4160957001	"pain-abdominal"	239	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512059152	""	""	""	NA	"Pain abdominal"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2349"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4160951001	"pain-lower back"	216	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512059097	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2350"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4161049001	"pain-right thigh"	216	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512059769	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2351"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	3711255001	"Right Hydronephrosis"	173	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505839450	""	""	""	NA	"Hydronephrosis"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal obstructive disorders"	"Hydronephrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"2352"	"DN-101 Protocol No. 011-007"	"078"	"078-0001"	5	9	"Adverse Event/Serious Adverse Event"	4160964001	"syncope"	243	244	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512059206	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"2353"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	2634760003	"Alteration in taste"	13	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475701316	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2354"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	4328802001	"Cold Symptoms"	134	141	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513799107	""	""	""	NA	"Cold symptoms"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2355"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	2890512001	"Constipation"	173	174	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	174	NA	NA	174	175	"Pending"	""	""	2	2	2	NA	2	2	NA	2	"Patient experienced constipation not responsive to remedies from home. Was admitted to hospital 23 Jan 07 by on-call physician. Records pending"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485209705	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2356"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	2958363001	"Constipation"	154	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487692890	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2357"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	4226174001	"Decreased Appetite"	183	337	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512915343	""	""	""	NA	"Appetite decreased NOS"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"2358"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	3979798001	"Eyes- Excessive Tearing"	162	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509545708	""	""	""	NA	"Eyes tearing"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2359"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	3404039001	"Facial Flushing (Infusion Reaction)"	12	12	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499804092	""	""	""	NA	"Facial flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"2360"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	3398067001	"Facial Flushing(Infusion Reaction)"	8	8	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499783818	""	""	""	NA	"Facial flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"2361"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	2821631001	"Fatigue"	78	81	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481652975	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2362"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	4328871001	"Increased Alteration in Taste"	78	81	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513799418	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2363"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	3398037001	"Increased Blood Pressure"	8	8	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499783705	""	""	""	NA	"Increased blood pressure"	"Investigations"	"Cardiac and vascular investigations (excl enzyme tests)"	"Vascular tests NEC (incl blood pressure)"	"Blood pressure increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2364"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	3404080001	"Increased Blood Pressure (Infusion Reaction)"	12	12	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499804206	""	""	""	NA	"Blood pressure increased"	"Investigations"	"Cardiac and vascular investigations (excl enzyme tests)"	"Vascular tests NEC (incl blood pressure)"	"Blood pressure increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2365"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	2958333001	"Nail Chnages"	120	337	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487692630	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2366"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	4328885001	"Neutropenia"	153	162	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513799555	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2367"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	2710215001	"Pain - right lower extremity"	57	79	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475701743	""	""	""	NA	"Pain of lower extremities"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2368"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	3398091001	"Pain-Neck/Back (Infusion Reaction)"	8	8	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499783922	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2369"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	3889014001	"Recurrent Basal Cell Carcinoma"	236	254	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508257350	""	""	""	NA	"Basal cell carcinoma"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Skin neoplasms malignant and unspecified"	"Skin neoplasms malignant and unspecified (excl melanoma)"	"Basal cell carcinoma"	""	""	""	""	""	""	""	""	""	""	""	""
"2370"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	2710229001	"Sensory neuropathy"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475701827	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2371"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	2821610001	"Shortness of breath"	119	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481652743	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2372"	"DN-101 Protocol No. 011-007"	"081"	"081-0002"	5	9	"Adverse Event/Serious Adverse Event"	4226167001	"Weight Loss"	183	274	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512915223	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2373"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	2658044003	"Atrial Fibrillation"	237	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516916079	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"2374"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	2960640001	"Bronchitis"	129	133	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487780072	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2375"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	3056563001	"Candidiasis"	202	209	NA	2	0	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491316274	""	""	""	NA	"Candidiasis"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"2376"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	2960668001	"Dizziness"	173	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Told patient to increase fluid intake; monitor BP at home"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487780289	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"2377"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	2960679001	"Dizziness"	177	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487780418	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"2378"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	4644197002	"Dizziness - Episodic"	173	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Increased oral fluid intake at home"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516912838	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"2379"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	4644246002	"Dizziness - Episodic"	177	224	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516913024	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"2380"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	2960737001	"Fatigue"	152	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487781007	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2381"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	2732293001	"Fatigue"	45	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476399956	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2382"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	4643979002	"Fatigue"	74	76	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516912049	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2383"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	2732286001	"Fatigue"	25	32	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476399850	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2384"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	2732303001	"indigestion"	45	46	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476400163	""	""	""	NA	"Indigestion"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2385"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	2960768001	"Mucositis - Oral cavity"	196	202	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487781339	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2386"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	3056586001	"Pain - Bone"	215	NA	1	2	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"New treatment will be started"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491316533	""	""	""	NA	"Pain bone"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2387"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	4644309002	"Post nasal drip"	129	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516913288	""	""	""	NA	"Postnasal drip"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Postnasal drip"	""	""	""	""	""	""	""	""	""	""	""	""
"2388"	"DN-101 Protocol No. 011-007"	"081"	"081-0004"	5	9	"Adverse Event/Serious Adverse Event"	4645119002	"Tachycardia"	231	238	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516915993	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"2389"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	5	9	"Adverse Event/Serious Adverse Event"	2609735003	"bilateral ankle edema"	148	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483905188	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2390"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	5	9	"Adverse Event/Serious Adverse Event"	4279238001	"easy bruising of skin"	442	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513275872	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"2391"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	5	9	"Adverse Event/Serious Adverse Event"	2859444001	"fatigue"	176	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483905596	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2392"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	5	9	"Adverse Event/Serious Adverse Event"	2737552001	"insomnia"	71	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476736467	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"2393"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	5	9	"Adverse Event/Serious Adverse Event"	4279279001	"intermittent constipation"	470	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513276108	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2394"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	5	9	"Adverse Event/Serious Adverse Event"	2859429001	"intermittent non-cardiac chest pain"	148	149	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"cardiac workup, EKG and CT angio all proved negative."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483905355	""	""	""	NA	"Non-cardiac chest pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2395"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	5	9	"Adverse Event/Serious Adverse Event"	4762841002	"intermittent spasm, left calf"	568	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517770969	""	""	""	NA	"Muscle spasm"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"2396"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	5	9	"Adverse Event/Serious Adverse Event"	2644776001	"swollen olecranon"	31	32	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"antibiotics given for 24 hours in the hospital and following discharge."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	38	NA	NA	31	32	"CBC within normal limits, x-ray of left elbow showing swelling at the olecranon"	""	""	2	2	2	2	2	2	NA	2	"Patient admitted to Jefferson Memorial Hospital for 24 hours. Received IV antibiotics for swollen elbow. No decrease or discontinuation of study treatment occurred. The patient recovered"	"uneventfully."	""	""	""	""	""	""	""	""	""	NA	NA	""	1471545590	""	""	""	NA	"Swollen elbows"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint swelling"	""	""	""	""	""	""	""	""	""	""	""	""
"2397"	"DN-101 Protocol No. 011-007"	"082"	"082-0001"	5	9	"Adverse Event/Serious Adverse Event"	3254665001	"Upper Respiratory Infection"	71	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496264795	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2398"	"DN-101 Protocol No. 011-007"	"084"	"084-0001"	5	9	"Adverse Event/Serious Adverse Event"	2843463003	"dark urine"	16	126	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499709996	""	""	""	NA	"Discoloration urine"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Chromaturia"	""	""	""	""	""	""	""	""	""	""	""	""
"2399"	"DN-101 Protocol No. 011-007"	"084"	"084-0001"	5	9	"Adverse Event/Serious Adverse Event"	3389355001	"fatigue"	105	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499710077	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2400"	"DN-101 Protocol No. 011-007"	"084"	"084-0001"	5	9	"Adverse Event/Serious Adverse Event"	2951373001	"fatigue"	24	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487274598	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2401"	"DN-101 Protocol No. 011-007"	"084"	"084-0001"	5	9	"Adverse Event/Serious Adverse Event"	4545913002	"hair thinning"	61	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516287661	""	""	""	NA	"Hair thinning"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Hypotrichosis"	""	""	""	""	""	""	""	""	""	""	""	""
"2402"	"DN-101 Protocol No. 011-007"	"084"	"084-0001"	5	9	"Adverse Event/Serious Adverse Event"	3389276001	"insomnia"	14	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499709909	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"2403"	"DN-101 Protocol No. 011-007"	"084"	"084-0001"	5	9	"Adverse Event/Serious Adverse Event"	4545964002	"intermittent edema of penis and scrotum"	149	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516287872	""	""	""	NA	"Edema of penis"	"Reproductive system and breast disorders"	"Reproductive tract disorders NEC"	"Reproductive tract signs and symptoms NEC"	"Oedema genital"	""	""	""	""	""	""	""	""	""	""	""	""
"2404"	"DN-101 Protocol No. 011-007"	"084"	"084-0001"	5	9	"Adverse Event/Serious Adverse Event"	2872080001	"right upper extremity DVT"	11	42	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	19	NA	NA	12	14	"Ultrasoud of right upper extremity. EKG was done showing normal sinus rhythm without any acute ST-T wave changes.; Labs-WBC=2.1, Hgb=10.5, INR=1.0, and electrolytes normal."	""	""	2	2	2	NA	2	2	NA	2	"Patient had a PICC line in place for receiving vancomycin IV, status post urosepsis. He received his vancomycin from 10:00 to 11:30. At 13:00 he noticed redness and swelling of his right forearm. No"	"other symptoms. Came to ER. Right upper extremity ultrasound was done showing DVT in the right subclavian, basilic, axillary and brachial veins. Patient was given a 100 mg of Lovenox subcutaneous."	"PICC line was removed without any incident. Patient was admitted for further observation."	""	""	""	""	""	""	""	""	NA	NA	""	1484514945	""	""	""	NA	"DVT"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"2405"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	2602318003	"alopecia"	29	495	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473795349	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2406"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4118030001	"Altered Taste"	NA	495	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511533891	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2407"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4118117001	"Back Pain"	437	495	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511537284	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2408"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4118051001	"Cough"	178	392	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511534460	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2409"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	2635966001	"fatigue"	8	495	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470856760	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2410"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	2638800001	"Febrile Neutropenia"	37	44	NA	4	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	47	NA	NA	37	44	"August 4/06, Neutrophils=0.1, WBC=0.7. Patient was seen back in clinic on Aug 24/06, Neutrophil = 3.7, and rechallenged with Docetaxel with at a reduced dose of 60 mg/m2."	""	""	2	1	2	NA	2	2	NA	0	"pt felt generally unwell and had a fever of 38.4 C.  He was admitted on Aug 4/06 and treated with IV antibiotics Ceftazidine 500 mg q4h iv.  A blood culture from August 4/06 grew Coagulase Negative"	"Staphylococcus.  Aug 7/06 patients WBC=2.3 and Neutrophils= 1.3.  He slowly improved and was discharged August 11/06.  He went home and continues on antibiotic treatment of Rocephin q 24h iv,"	"starting Aug 12/06 for 5 days.	Rechallenged at a reduced dose of 60 mg/m2 of Docetaxel on August 24/06."	""	""	""	""	""	""	""	""	NA	NA	""	1471209549	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2411"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4118406001	"Hydronephrosis"	422	422	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	561	NA	NA	422	423	"Creatinine levels on 2006-JUL-27 was 124 umol/L (120 ULN);Urea levenls on 2006-JUL-27 was 11.5 mmol/L (7.0 ULN);;Creatinine levels on 2007-AUG-15 was 199 umol/l (120 ULN);Urea levels on 2007-AUG-15"	"was 14.8 mmol/L (7.0 ULN)"	""	2	2	2	NA	2	2	NA	2	"Subject has had known history of hydronephrosis (as per CT scan of 23JUNE2006).  In order to prevent worsening of condition nephrostomy was performed on 24UG2007"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511546139	""	""	""	NA	"Hydronephrosis"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal obstructive disorders"	"Hydronephrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"2412"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	2636005001	"hypertension"	8	8	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470857678	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"2413"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4440564002	"hypopotassemia"	422	495	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515594078	""	""	""	NA	"Hypopotassemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2414"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	2635978001	"insomnia"	8	NA	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470857149	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"2415"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	3777466001	"Large bowel obstruction"	441	443	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	456	NA	NA	441	450	"abdominal x-ray on Sept 12/07 showed bowel obstruction"	""	""	2	2	2	2	2	2	2	2	"Colostomy done on Sept 14/07."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506538576	""	""	""	NA	"Large bowel obstruction"	"Gastrointestinal disorders"	"Gastrointestinal stenosis and obstruction"	"Large intestinal stenosis and obstruction"	"Large intestinal obstruction"	""	""	""	""	""	""	""	""	""	""	""	""
"2416"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	2635997001	"mood changes"	8	495	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470857555	""	""	""	NA	"Mood swings"	"Psychiatric disorders"	"Mood disorders and disturbances NEC"	"Fluctuating mood symptoms"	"Mood swings"	""	""	""	""	""	""	""	""	""	""	""	""
"2417"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4118057001	"Nail Changes"	150	495	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511534713	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2418"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4440287002	"open sore"	462	495	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515593079	""	""	""	NA	"Ulcer"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"2419"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4118069001	"Penile Edema"	7	495	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511535690	""	""	""	NA	"Edema of penis"	"Reproductive system and breast disorders"	"Reproductive tract disorders NEC"	"Reproductive tract signs and symptoms NEC"	"Oedema genital"	""	""	""	""	""	""	""	""	""	""	""	""
"2420"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	2679249001	"pneumonia"	37	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473796118	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"2421"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4118128001	"Rectal Pain"	314	495	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511537612	""	""	""	NA	"Rectal pain"	"Gastrointestinal disorders"	"Anal and rectal conditions NEC"	"Anal and rectal pains"	"Proctalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2422"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	2837362001	"Shortness of Breath"	NA	495	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482338986	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2423"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	2837284001	"Shortness of breath"	37	NA	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482338667	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2424"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4118045001	"Sore Throat"	161	203	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511534355	""	""	""	NA	"Sore throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2425"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	2635991001	"stomach ache"	12	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470857478	""	""	""	NA	"Stomach ache"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"2426"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4118072001	"Suprapubic Edema"	76	495	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511535794	""	""	""	NA	"Localized edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Localised oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"2427"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	2679220001	"tachycardia"	37	NA	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"increased metropolol"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473795733	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"2428"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4118098001	"Urinary Tract Infection"	NA	NA	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511536626	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2429"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4118111001	"Watery eyes"	171	495	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511536961	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2430"	"DN-101 Protocol No. 011-007"	"086"	"086-0001"	5	9	"Adverse Event/Serious Adverse Event"	4118108001	"Worsening of vision in right eye"	161	495	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511536828	""	""	""	NA	"Visual disturbance"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Visual disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"2431"	"DN-101 Protocol No. 011-007"	"086"	"086-0002"	5	9	"Adverse Event/Serious Adverse Event"	3505293003	"alopecia"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509652716	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2432"	"DN-101 Protocol No. 011-007"	"086"	"086-0002"	5	9	"Adverse Event/Serious Adverse Event"	3990839001	"altered taste"	9	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509645978	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2433"	"DN-101 Protocol No. 011-007"	"086"	"086-0002"	5	9	"Adverse Event/Serious Adverse Event"	3992286001	"blurry vision"	23	NA	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509651671	""	""	""	NA	"Blurry vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"2434"	"DN-101 Protocol No. 011-007"	"086"	"086-0002"	5	9	"Adverse Event/Serious Adverse Event"	3991716001	"shortness of breath"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509648762	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2435"	"DN-101 Protocol No. 011-007"	"086"	"086-0004"	5	9	"Adverse Event/Serious Adverse Event"	3532577003	"alopecia"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505316402	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2436"	"DN-101 Protocol No. 011-007"	"086"	"086-0004"	5	9	"Adverse Event/Serious Adverse Event"	3682266001	"altered taste"	2	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505316068	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2437"	"DN-101 Protocol No. 011-007"	"086"	"086-0004"	5	9	"Adverse Event/Serious Adverse Event"	4360359001	"cough"	100	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514757393	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2438"	"DN-101 Protocol No. 011-007"	"086"	"086-0004"	5	9	"Adverse Event/Serious Adverse Event"	3682485001	"generalized muscle ache"	2	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505316764	""	""	""	NA	"Generalized muscle aches"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2439"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	5	9	"Adverse Event/Serious Adverse Event"	2568036003	"abscess gum line"	443	450	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516557725	""	""	""	NA	"Abscess gum"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Dental and oral soft tissue infections"	"Gingival abscess"	""	""	""	""	""	""	""	""	""	""	""	""
"2440"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	5	9	"Adverse Event/Serious Adverse Event"	2595912001	"Alopecia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466602388	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2441"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	5	9	"Adverse Event/Serious Adverse Event"	4572439002	"broken tooth"	443	450	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516557599	""	""	""	NA	"Tooth fracture"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Site specific injuries NEC"	"Tooth fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"2442"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	5	9	"Adverse Event/Serious Adverse Event"	4572543002	"elevated serum creatinine"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516558088	""	""	""	NA	"Blood creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2443"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	5	9	"Adverse Event/Serious Adverse Event"	2587530001	"Extravasation injury of right hand"	19	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465402264	""	""	""	NA	"Extravasation"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Extravasation"	""	""	""	""	""	""	""	""	""	""	""	""
"2444"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	5	9	"Adverse Event/Serious Adverse Event"	2595626001	"Fatigue"	14	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466523677	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2445"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	5	9	"Adverse Event/Serious Adverse Event"	2595513001	"Hyperpigmentation of right hand"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466516208	""	""	""	NA	"Hyperpigmentation skin"	"Skin and subcutaneous tissue disorders"	"Pigmentation disorders"	"Hyperpigmentation disorders"	"Skin hyperpigmentation"	""	""	""	""	""	""	""	""	""	""	""	""
"2446"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	5	9	"Adverse Event/Serious Adverse Event"	2595519001	"Numbness in right hand"	19	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466516599	""	""	""	NA	"Numbness in hand"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"2447"	"DN-101 Protocol No. 011-007"	"087"	"087-0001"	5	9	"Adverse Event/Serious Adverse Event"	2595629001	"Urinary Frequency/Urgency"	19	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466524195	""	""	""	NA	"Urinary frequency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"2448"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2778415003	"Bilateral hip pain"	164	166	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493761295	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2449"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	3155957001	"Bilateral wrist pain"	164	166	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493761214	""	""	""	NA	"Wrist pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2450"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	3241861001	"Chest Pain, non cardiac"	183	209	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Metoprolol increased"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495727460	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2451"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2816041001	"Chest Pain, non-cardiac"	12	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481240861	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2452"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	3070285001	"Constipation"	140	262	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491758575	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2453"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2939939001	"Fatigue"	86	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487091571	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2454"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2904810001	"Febrile Neutropenia"	82	85	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	84	NA	NA	83	85	"1/30/07- chest xray. 1/30/07, 1/31/07, 2/1/07- Hematology/Coagulation. 1/30/07- Chemisty, Urinalysis, and blood cultures."	""	""	2	2	2	2	2	2	2	2	"Patient was admitted to the hospital with Neutopenic Fever. Patient was cultured and started on broad spectrum antibiotics and supported with fluids. He was dismissed and told to stay on Levaquin for"	"several more days and to follow up with Dr. Bjorling in one week."	""	""	""	""	""	""	""	""	""	NA	NA	""	1485908229	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2455"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2988025001	"Heartburn"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489004649	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2456"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	3070267001	"Hematuria"	104	181	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Coumadin and ASA discontinued"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491758199	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"2457"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2816064001	"Leg Pain"	12	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481241120	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2458"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	3043713001	"Neutropenia"	127	146	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490806674	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2459"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2862676001	"Neutropenia"	62	68	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Radiation Tx held"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484004142	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2460"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2860267001	"Neutropenia"	40	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Held radiation therapy."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483919268	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2461"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2833063001	"Numbness to legs and abdomen"	33	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482183988	""	""	""	NA	"Numbness"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"2462"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2963833001	"Paroxysmal Atrial Fibrillation"	103	104	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	107	NA	NA	103	104	"Adenosine Stress Test, Echocardiogram, Hematology/Coagulation, Chemistry, and EKG."	""	""	2	2	2	2	2	2	2	2	"Patient presented to the ER with  palpitations and chest pressure, also has history of coronary artery disease. Found to be in atrial fibrillation with rapid ventricular response and spontaneously"	"converted after 20mg of Diltiazam was given IV. Went home and was later sent back to ER due to chest pain and palpitations. He was then admitted for 24 hour observation. Started on Metoprolol and"	"Coumadin. Check serial cardiac enzymes. Discharged the next day 2/20/07."	""	""	""	""	""	""	""	""	NA	NA	""	1487883284	""	""	""	NA	"Paroxysmal atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"2463"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2862682001	"Sinus Infection"	50	59	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484004277	""	""	""	NA	"Sinus infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Sinusitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2464"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2833026001	"Strep Throat"	25	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482183740	""	""	""	NA	"Streptococcal sore throat"	"Infections and infestations"	"Bacterial infectious disorders"	"Streptococcal infections"	"Pharyngitis streptococcal"	""	""	""	""	""	""	""	""	""	""	""	""
"2465"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	3473666001	"Urinary Infection"	258	293	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501540099	""	""	""	NA	"Urinary infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2466"	"DN-101 Protocol No. 011-007"	"088"	"088-0001"	5	9	"Adverse Event/Serious Adverse Event"	2988011001	"Urinary Retention"	83	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Catheter"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489004530	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"2467"	"DN-101 Protocol No. 011-007"	"089"	"089-0002"	5	9	"Adverse Event/Serious Adverse Event"	3035551003	"ALOPECIA"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501111978	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2468"	"DN-101 Protocol No. 011-007"	"089"	"089-0002"	5	9	"Adverse Event/Serious Adverse Event"	3406236001	"DRY MOUTH"	70	110	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499814265	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"2469"	"DN-101 Protocol No. 011-007"	"089"	"089-0004"	5	9	"Adverse Event/Serious Adverse Event"	3274834003	"Alopecia"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499785591	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2470"	"DN-101 Protocol No. 011-007"	"089"	"089-0004"	5	9	"Adverse Event/Serious Adverse Event"	3399158001	"FATIGUE"	11	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499786949	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2471"	"DN-101 Protocol No. 011-007"	"089"	"089-0004"	5	9	"Adverse Event/Serious Adverse Event"	3399068001	"HEAD ACHE"	6	6	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499786569	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"2472"	"DN-101 Protocol No. 011-007"	"089"	"089-0004"	5	9	"Adverse Event/Serious Adverse Event"	3398752001	"INSOMNIA"	11	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499785845	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"2473"	"DN-101 Protocol No. 011-007"	"089"	"089-0004"	5	9	"Adverse Event/Serious Adverse Event"	4336104001	"Intermittent GERD"	151	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513884457	""	""	""	NA	"GERD"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Gastrooesophageal reflux disease"	""	""	""	""	""	""	""	""	""	""	""	""
"2474"	"DN-101 Protocol No. 011-007"	"089"	"089-0004"	5	9	"Adverse Event/Serious Adverse Event"	3659685001	"LOWER BACK PAIN"	83	100	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505079841	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2475"	"DN-101 Protocol No. 011-007"	"089"	"089-0004"	5	9	"Adverse Event/Serious Adverse Event"	3399543001	"Neutopenia"	11	25	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499788075	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2476"	"DN-101 Protocol No. 011-007"	"089"	"089-0004"	5	9	"Adverse Event/Serious Adverse Event"	4335523001	"Neutropenia"	124	126	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513881244	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2477"	"DN-101 Protocol No. 011-007"	"089"	"089-0004"	5	9	"Adverse Event/Serious Adverse Event"	4335584001	"Peripheral Neuropathy"	151	174	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513881536	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2478"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	2819038003	"Alopecia"	28	308	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484167428	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2479"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	3812214001	"Bloody Nasal Discharge"	71	94	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507133595	""	""	""	NA	"Nose bleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"2480"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	3115529001	"Constipation"	31	121	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492953132	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2481"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	3818321001	"Dysgeusia"	175	252	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507216497	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2482"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	3818159001	"Epiphora"	133	364	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507214852	""	""	""	NA	"Epiphora"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2483"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	3115502001	"Fatigue"	113	308	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492952874	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2484"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	3812286001	"Finger Numbness"	112	308	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507133854	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"2485"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	2995317001	"Jaw Tenderness"	71	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489422363	""	""	""	NA	"Jaw pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Pain in jaw"	""	""	""	""	""	""	""	""	""	""	""	""
"2486"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	3809969001	"Leg Pain"	29	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507123946	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2487"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	3818150001	"Nail Discoloration"	70	308	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507214394	""	""	""	NA	"Nail discoloration"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"2488"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	4815704002	"Pain - Left Groin"	364	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518032481	""	""	""	NA	"Groin pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Soft tissue disorders NEC"	"Groin pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2489"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	3818307001	"Pain: Left Thigh"	175	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507216278	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2490"	"DN-101 Protocol No. 011-007"	"091"	"091-0002"	5	9	"Adverse Event/Serious Adverse Event"	5296938002	"Weight Loss"	224	252	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523805023	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2491"	"DN-101 Protocol No. 011-007"	"092"	"092-0001"	5	9	"Adverse Event/Serious Adverse Event"	2791412003	"back spasms"	8	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496933344	""	""	""	NA	"Muscle spasms"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"2492"	"DN-101 Protocol No. 011-007"	"092"	"092-0001"	5	9	"Adverse Event/Serious Adverse Event"	2856005001	"Constipation"	7	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483638547	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2493"	"DN-101 Protocol No. 011-007"	"092"	"092-0001"	5	9	"Adverse Event/Serious Adverse Event"	3592786001	"Hot flashes"	170	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504025244	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"2494"	"DN-101 Protocol No. 011-007"	"092"	"092-0001"	5	9	"Adverse Event/Serious Adverse Event"	3274081001	"nail changes"	98	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496933441	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2495"	"DN-101 Protocol No. 011-007"	"092"	"092-0001"	5	9	"Adverse Event/Serious Adverse Event"	3274089001	"pain- left hip"	98	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496933595	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2496"	"DN-101 Protocol No. 011-007"	"092"	"092-0001"	5	9	"Adverse Event/Serious Adverse Event"	4607722002	"pain- skull"	384	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516720895	""	""	""	NA	"Pain bone"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2497"	"DN-101 Protocol No. 011-007"	"092"	"092-0001"	5	9	"Adverse Event/Serious Adverse Event"	3274096001	"pain-left heel"	66	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496933679	""	""	""	NA	"Pain in heel"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2498"	"DN-101 Protocol No. 011-007"	"092"	"092-0001"	5	9	"Adverse Event/Serious Adverse Event"	3274103001	"pain-lumbar"	176	183	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496933754	""	""	""	NA	"Lumbar pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2499"	"DN-101 Protocol No. 011-007"	"092"	"092-0001"	5	9	"Adverse Event/Serious Adverse Event"	4607773002	"perpheral neruopathies"	170	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516720988	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2500"	"DN-101 Protocol No. 011-007"	"092"	"092-0001"	5	9	"Adverse Event/Serious Adverse Event"	3274084001	"rash"	36	85	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496933524	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"2501"	"DN-101 Protocol No. 011-007"	"092"	"092-0002"	5	9	"Adverse Event/Serious Adverse Event"	2925109003	"abdomen bloating and discomfort"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505070546	""	""	""	NA	"Abdominal bloating"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Abdominal distension"	""	""	""	""	""	""	""	""	""	""	""	""
"2502"	"DN-101 Protocol No. 011-007"	"092"	"092-0002"	5	9	"Adverse Event/Serious Adverse Event"	3657989001	"fatigue"	115	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505071243	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2503"	"DN-101 Protocol No. 011-007"	"092"	"092-0002"	5	9	"Adverse Event/Serious Adverse Event"	3657647001	"hair thinning"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505069913	""	""	""	NA	"Hair thinning"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Hypotrichosis"	""	""	""	""	""	""	""	""	""	""	""	""
"2504"	"DN-101 Protocol No. 011-007"	"092"	"092-0002"	5	9	"Adverse Event/Serious Adverse Event"	3657826001	"hypersensitivity to Taxotere"	79	79	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505070690	""	""	""	NA	"Drug hypersensitivity"	"Immune system disorders"	"Allergic conditions"	"Allergies to foods, food additives, drugs and other chemicals"	"Drug hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"2505"	"DN-101 Protocol No. 011-007"	"092"	"092-0002"	5	9	"Adverse Event/Serious Adverse Event"	3657762001	"hypersensitivity to Taxotere"	51	51	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505070400	""	""	""	NA	"Drug hypersensitivity"	"Immune system disorders"	"Allergic conditions"	"Allergies to foods, food additives, drugs and other chemicals"	"Drug hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"2506"	"DN-101 Protocol No. 011-007"	"092"	"092-0002"	5	9	"Adverse Event/Serious Adverse Event"	3657920001	"left forearm abrasion"	90	113	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505070976	""	""	""	NA	"Abrasion NOS"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Non-site specific injuries NEC"	"Excoriation"	""	""	""	""	""	""	""	""	""	""	""	""
"2507"	"DN-101 Protocol No. 011-007"	"092"	"092-0002"	5	9	"Adverse Event/Serious Adverse Event"	3657675001	"numbness/tingling fingertips"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505070055	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"2508"	"DN-101 Protocol No. 011-007"	"092"	"092-0004"	5	9	"Adverse Event/Serious Adverse Event"	3513841003	"Alopecia"	72	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516729758	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2509"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	2788383003	"Constipation"	64	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499017119	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2510"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3014278001	"Degenerative Joint Disease - Right Knee"	117	128	NA	3	1	1	NA	NA	NA	NA	1	1	NA	7	1	1	1	"Imaging, Toradal, Naproxen, Pepcid, Morphine, Oxycontin Controlled Release given in the hospital.  Meeting with Ortho Surgeon.  Total Right Knee Replacement done on 3/26/07."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	121	NA	NA	119	128	"03/19  MRI of Lumbar Spine, Two Right Knee Views, Venous Evaluation and Whole Body Scan. Therapy and Surgery Evaluation by Dr. Sydney - Ortho Surgeon; 3/21 PSA 8.2"	""	""	2	2	2	2	2	2	2	2	"Patient came in for a follow up visit with Dr. Heather Mannuel.  His PSA level PSA is 8.2.;MRI of Lumbar Spine -There are diffuse osseous metastatic lessions throughout the T12,L1, L3, L4, L5"	"vertebral bodies.  There is also compression fracture of L4 with slight buckling of posterior cortex of this vertebral body toward the central spinal canal.  Multilevel spondylotic changes"	"throughtout the lumbar spine and diffuse fatty infiltration throughout the bone marrow in lower throacic, lumbar and upper sacral region are noted.Whole Body Bone Scan-;Findings are consistent with"	"osseous metastases at T12 and L3 and L4.  Degenerative changes of knees/shoulders.;Two Views of Right knees -;There are sever degenerative changes noted with joint space narrowing of the medial"	"compartment with small degenerative osteophytes noted.;Lower Extremity Venous Evaluation -;No evidence of venous valvular insufficiency"	""	""	""	""	""	""	NA	NA	""	1490108407	""	""	""	NA	"Degenerative joint disease"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Osteoarthropathies"	"Osteoarthritis"	""	""	""	""	""	""	""	""	""	""	""	""
"2511"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3683725001	"Edema"	247	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505321290	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"2512"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3683581001	"Fatigue"	247	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505320815	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2513"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	4608941002	"Hematuria"	311	311	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516723211	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"2514"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3351395001	"Knee Pain"	64	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499016939	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2515"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3683427001	"Neuropathy - Fingers"	261	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505320190	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2516"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3813463001	"Osteonecrosis"	120	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507139187	""	""	""	NA	"Osteonecrosis"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone disorders NEC"	"Osteonecrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"2517"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3351468001	"Pain - Elbow"	119	179	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499017338	""	""	""	NA	"Pain in elbow"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2518"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3351455001	"Pain - Extremities"	92	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499017243	""	""	""	NA	"Pain of extremities"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2519"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3351163001	"Pain - Knee/Leg Both"	11	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499015021	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2520"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3351498001	"Pain - Right Knee"	179	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499017579	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2521"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3683210001	"Pain - Shingles Pain/Generalized Body"	247	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505319530	""	""	""	NA	"Post herpetic neuralgia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Post herpetic neuralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2522"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3410358001	"Shingles"	228	233	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Patient was hospitalized from 7/7/07 - 7/11/07. Nausea and Vomitting resolved with bowel movement.  Patients pain was addressed with Con Meds"	0	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"Patient was admitted for Severe pain associated with Shingles accompanied with Nausea and Vomitting which was secondary to Shingles."	234	NA	NA	229	233	"Abdominal X-Ray 07/07/2007"	""	""	2	2	2	2	2	2	2	2	"Patient had severe pain associated with Shingles.  Nausea and Vomitting was secondary to this.	The patient was admitted on 7/7/07 and xray was done and Con Meds were given.  Patient was released in"	"Fair condition on 7/11/2007."	""	""	""	""	""	""	""	""	""	NA	NA	""	1499875168	""	""	""	NA	"Shingles"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes zoster"	""	""	""	""	""	""	""	""	""	""	""	""
"2523"	"DN-101 Protocol No. 011-007"	"093"	"093-0003"	5	9	"Adverse Event/Serious Adverse Event"	3351176001	"Shortness of Breath"	11	13	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499015235	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2524"	"DN-101 Protocol No. 011-007"	"094"	"094-0002"	5	9	"Adverse Event/Serious Adverse Event"	3072797003	"fatigue"	71	113	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500834303	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2525"	"DN-101 Protocol No. 011-007"	"094"	"094-0002"	5	9	"Adverse Event/Serious Adverse Event"	4058579001	"hot flashes"	71	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510687055	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"2526"	"DN-101 Protocol No. 011-007"	"094"	"094-0002"	5	9	"Adverse Event/Serious Adverse Event"	3241345001	"leg edema"	30	155	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Pt. advised to keep legs elevated above heart when possible."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495719102	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2527"	"DN-101 Protocol No. 011-007"	"094"	"094-0002"	5	9	"Adverse Event/Serious Adverse Event"	4058856001	"urinary tract infection"	127	134	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510687604	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2528"	"DN-101 Protocol No. 011-007"	"094"	"094-0002"	5	9	"Adverse Event/Serious Adverse Event"	3596027001	"urinary tract infection"	98	113	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504040242	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2529"	"DN-101 Protocol No. 011-007"	"094"	"094-0003"	5	9	"Adverse Event/Serious Adverse Event"	3466788003	"cough"	15	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506281301	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2530"	"DN-101 Protocol No. 011-007"	"094"	"094-0003"	5	9	"Adverse Event/Serious Adverse Event"	4791343002	"fatigue"	99	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"pt has already been discontinued from docetaxel and prednisone due to disease progression PRIOR to the onset of this event"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517927919	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2531"	"DN-101 Protocol No. 011-007"	"094"	"094-0003"	5	9	"Adverse Event/Serious Adverse Event"	4028840001	"persistent sputum production"	77	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510261530	""	""	""	NA	"Sputum increased"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2532"	"DN-101 Protocol No. 011-007"	"094"	"094-0003"	5	9	"Adverse Event/Serious Adverse Event"	4866314002	"shortness of breath"	173	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518538682	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2533"	"DN-101 Protocol No. 011-007"	"094"	"094-0003"	5	9	"Adverse Event/Serious Adverse Event"	4791469002	"swelling of abdomen"	99	173	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"pt already discontinued from prednisone and docetaxel due to metastatic disease PRIOR to this event"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517928352	""	""	""	NA	"Swelling abdomen"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Abdominal distension"	""	""	""	""	""	""	""	""	""	""	""	""
"2534"	"DN-101 Protocol No. 011-007"	"094"	"094-0003"	5	9	"Adverse Event/Serious Adverse Event"	4791443002	"swelling of lower extremities"	99	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"pt already discontinued from prednisone/docetaxel due to disease progression PRIOR to onset of this event"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517928240	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2535"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2625246003	"Acute Renal Insufficiency"	245	250	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalization, IV fluids"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	247	NA	NA	245	250	"3-26-07: Creatinine: 3.9 mg/dL; 3-27-07: Creatinine: 4.2 mg/dL; 3-28-07: Creatinine: 5.1 mg/dL; 3-29-07: Creatinine: 5.2 mg/dL; 3-30-07: Creatinine: 4.9 mg/dL; 3-31-07: Creatinine: 3.9 mg/dL"	""	""	2	2	2	NA	2	2	NA	2	"Subject was admitted to local institution in-patient facility on 3-26-07 due to grade 2 acute renal insufficiency. Subject presented with grade 3 diarrhea, grade 3 dehydration. Diarrhea is thought to"	"be related to docetaxel, which resulted in dehydration, resulting in acute renal insufficiency. ;More information will be provided in a follow up report. Subject received 2 1 L boluses of normal"	"saline in ER and continued to receive aggressive hydration on the floor, 200 cc/hr of normal saline, which was decreased 75 cc/hr after 3 days. Urninalysis did not show eosinophils. Subjects diovan"	"was discontinued at time of discharge secondary to patient's acute renal failure and elavated creatinine."	""	""	""	""	""	""	""	NA	NA	""	1490714835	""	""	""	NA	"Acute renal insufficiency"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure acute"	""	""	""	""	""	""	""	""	""	""	""	""
"2536"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2740576001	"Alkaline Phosphatase- Increased"	44	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476893163	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2537"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2782204001	"ALT- High"	107	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479655711	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2538"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	3033479001	"Cough"	238	280	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490631317	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2539"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	3352937001	"Cranial Neuropathy, nerve XII"	343	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalization"	2	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	343	NA	NA	343	347	"7/3/07: MRI of brain; 7/3/07: C Spine MRI"	""	""	2	2	2	2	2	2	2	2	"Subject presented in clinic today with dysphagia, grade 2, and neurologic disturbance. MRI of the brain without evidence of intraparenchymal or intracranial metastases. The C-spine MRI showed"	"multiple osteoblastic metastases in cervical vertabrae and clivus as well as no evidence of spinal cord compression and some question of possible dural enhancement. Patient has elected to undergo"	"palliation of his symptoms and no longer wishes to receive therapy."	""	""	""	""	""	""	""	""	NA	NA	""	1499028195	""	""	""	NA	"Cranial neuropathy"	"Nervous system disorders"	"Cranial nerve disorders (excl neoplasms)"	"Cranial nerve disorders NEC"	"Cranial neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2540"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	3037145001	"Dehydration"	245	250	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalization, IV fluids"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	247	NA	NA	245	250	"Subject had elevated creatinine at time of admission and during in patient stay. Subject's creatinine peaked at 5.2 mg/dL on 3-29-07 but fell to 3.9 mg/dL at time of discharge."	""	""	2	2	2	NA	2	2	NA	2	"Subject was admitted to local institution's in-patient facility on 3-26-07 after presenting with grade 3 diarrhea related to docetaxel, grade 3 dehydration as a result of the diarrhea and grade 2"	"acute renal insufficiency as a result of the dehydration. Subject received 2 1 L boluses of normal saline in the ER and continued to receive aggressive hydration while on the floor, receving 200"	"cc/hour normal saline, which was decreased to 75 cc/hour after 3 days. Subjects po intake improved to greater than 2 L per day. Subject's urine output was greater than 3 L daily during his final 3"	"days of in-patient stay."	""	""	""	""	""	""	""	NA	NA	""	1490715283	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"2541"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	3033549001	"Diarrhea"	245	245	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"IV Fluids; Hospitalization"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	-119	NA	NA	245	250	"3-26-07: Serum creatinine: 3.9 mg/dL; 3-27-07: Serum creatinine: 4.2 mg/dL; 3-26-07: Urinalysis: Protein +1, otherwise normal; 3-26-07: Chest x-ray: Normal; 3-27-07: Renal ultrasound"	""	""	2	2	2	NA	2	2	NA	2	"Subject was admitted to local institution on 3-26-07 for grade 3 diarrhea, grade 3 dehydration, and grade 2 acute renal insufficiency. Subject reported having watery diarrhea 4-5 x/day for the past 3"	"days. Subject received IV fluids. Subject received two 1 L boluses of normal saline in the ER and aggressive hydration on the floor at 200 cc/hr of 0.9% normal saline. This was later decreased to 75"	"cc per hour. Subject received 1 dose of imodium at time of admission which resolved the diarrhea. Subject did not have episodes of diarrhea during hospital stay."	""	""	""	""	""	""	""	""	NA	NA	""	1490632169	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2542"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	3352892001	"Dysphagia"	343	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalization"	2	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	343	NA	NA	343	347	"7-2-07: Swallow Study"	""	""	2	2	2	2	2	2	2	2	"Subject had complaints of ongoing dysphagia for the past week. Subject presented in clinic today for MD appt and swallow study. After being seen by the MD, it was decided that patient would be"	"admitted for grade 2 dysphagia. Swallow study revealed delay in the oral phase of swallowing with pulling in the vallecula and pyriform sinuses w/ episodes of penetration and silent aspiration."	"G-tube offered to subject but was denied by subject at this time. Subject prescribed dilaudid. Home hospice was also recommended by MD until residential hospice is initiated."	""	""	""	""	""	""	""	""	NA	NA	""	1499027825	""	""	""	NA	"Dysphagia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Dysphagia"	""	""	""	""	""	""	""	""	""	""	""	""
"2543"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	3127898001	"Dyspnea"	266	280	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493135080	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2544"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2740590001	"Elevated Alkaline Phosphatase"	65	86	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476893289	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2545"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2968121001	"Fatigue"	217	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488207976	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2546"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2780893001	"Fatigue"	107	149	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479402247	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2547"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2873455001	"Fatigue"	175	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484583331	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2548"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2873423001	"GGT- High"	175	266	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484583115	""	""	""	NA	"GGT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Gamma-glutamyltransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2549"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2782200001	"GGT-High"	107	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479655645	""	""	""	NA	"GGT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Gamma-glutamyltransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2550"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2707071001	"Hair loss/alopecia"	65	280	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475602550	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2551"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2968149001	"Hemoglobin- Low"	217	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488208304	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2552"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2740382001	"Hemoglobin-Low"	86	149	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476889629	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2553"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2740367001	"Hemoglobin-Low"	44	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476889527	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2554"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2873418001	"Hyperglycemia"	175	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484583007	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2555"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	3033419001	"Hyperglycemia"	238	254	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490630978	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2556"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2919671001	"Hyperglycemia"	196	238	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486418579	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2557"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2740397001	"Hyperglycemia"	44	175	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476889754	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2558"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2740418001	"Hypophosphatemia"	44	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476890019	""	""	""	NA	"Hypophosphatemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Phosphorus metabolism disorders"	"Hypophosphataemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2559"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2782188001	"LDH- High"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479655556	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2560"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2740432001	"Leukopenia"	53	65	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476890151	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2561"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2740441001	"Leukopenia"	74	86	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476890273	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2562"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2809854001	"Lymphopenia"	128	217	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481126281	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2563"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2968115001	"Lymphopenia"	217	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488207902	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2564"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2780905001	"Neuropathy"	107	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479402592	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2565"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2740466001	"Neutropenia"	53	65	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476890680	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2566"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2740451001	"Neutropenia"	74	86	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476890409	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2567"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2739406001	"Pain- Thigh"	44	107	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476825705	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2568"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2739398001	"Pain-Back"	44	266	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476825594	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2569"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2739403001	"Pain-Rib cage"	44	107	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476825648	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2570"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2968146001	"Peripheral Edema"	217	329	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488208229	""	""	""	NA	"Peripheral edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2571"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	3127894001	"Pleural effusion, non-malignant"	266	280	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493135025	""	""	""	NA	"Pleural effusion"	"Respiratory, thoracic and mediastinal disorders"	"Pleural disorders"	"Pneumothorax and pleural effusions NEC"	"Pleural effusion"	""	""	""	""	""	""	""	""	""	""	""	""
"2572"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	3127918001	"Post-nasal Drip"	266	280	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493135404	""	""	""	NA	"Posterior nasal drip"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Postnasal drip"	""	""	""	""	""	""	""	""	""	""	""	""
"2573"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	3804866001	"Right leg weakness"	431	432	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	436	NA	NA	431	432	"CT scan and MRI both negative for spinal cord compression. Patient had improvement of symptoms with 10 mg of Decadron. Patient will taper off accordingly."	""	""	2	2	2	2	2	2	2	2	"Patient is currently in follow up. Patient presented to ER with right leg weakness and paresthesias with subjective weakness on exam. Initial CT scan was negative for cord compression. Subsequent MRI"	"was also negative for cord compression, however show increase in bony disease. Patient's condition did improve with 10mg of Decadron. Patient was discharged in stable condition and will taper off of"	"Decadron accordingly. Patient followed-up in the clinic with PI of this study on 10/1/07."	""	""	""	""	""	""	""	""	NA	NA	""	1507055084	""	""	""	NA	"Weakness of limbs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"2574"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2626552001	"Spinal Cord Compression"	4	8	NA	3	2	NA	1	NA	NA	NA	2	NA	1	4	NA	NA	1	"Radiation therapy for a total of 10 sessions, receiving a total dose of 3000 cGy"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	4	NA	NA	4	6	"MRI: showed spinal cord compression, positive in T4, T8, and T11 regions"	""	""	2	2	2	NA	2	2	NA	2	"Subject was admitted to hospital for spinal cord compression on the same day he was randomized to this study. Spinal cord compression will be considered a baseline SRE. Subject has not received any"	"protocol treatment prior to SAE. ;;The morning of 7/28/06 subject had severe pain in both legs, right hip, and from the lower back around to the front of the abdomen in a band-like pattern. An MRI of"	"the T and L spine was ordered and showed intrathecal extension of soft tissue at the T8 level with radiographic cord compression. It was decided to start steroid therapy, begin prompt radiation"	"therapy. ;;Subject had 10 sessions of radiation therapy and received dexamethasone 4mg every 6 hours, which was tappered off per radiation oncology."	""	""	""	""	""	""	""	NA	NA	""	1469738883	""	""	""	NA	"Spinal cord compression"	"Nervous system disorders"	"Spinal cord and nerve root disorders"	"Spinal cord and nerve root disorders NEC"	"Spinal cord compression"	""	""	""	""	""	""	""	""	""	""	""	""
"2575"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2780898001	"Taste Alteration"	107	280	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479402331	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2576"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2982254001	"Thrush"	221	229	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488902534	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"2577"	"DN-101 Protocol No. 011-007"	"096"	"096-0001"	5	9	"Adverse Event/Serious Adverse Event"	2968129001	"Thrush"	199	206	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488208077	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"2578"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2868184003	"Alkaline Phosphatase- High"	19	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484584690	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2579"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2921396001	"Alopecia"	40	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486483152	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2580"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3076927001	"Arthralgia- Right Thigh"	103	187	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491921104	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2581"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2873612001	"BiCarb- Low"	19	103	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484584481	""	""	""	NA	"Blood bicarbonate low"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood bicarbonate decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2582"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3221216001	"Bicarbonate- Low"	124	187	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495135572	""	""	""	NA	"Blood bicarbonate low"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood bicarbonate decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2583"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3221145001	"Bilirubin-High"	124	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495135355	""	""	""	NA	"Raised bilirubin"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Blood bilirubin increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2584"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2873601001	"BUN- High"	19	61	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484584406	""	""	""	NA	"BUN increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood urea increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2585"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3034038001	"Cough"	82	103	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490637436	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2586"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3221884001	"Dry skin"	124	145	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495137056	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"2587"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3288531001	"Dyspnea"	166	166	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497451558	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2588"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2968600001	"Dyspnea"	53	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488215301	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2589"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3034062001	"Edema- bilateral ankles"	82	103	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490637565	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2590"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2968333001	"Fatigue"	53	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488210982	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2591"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3221130001	"Hemoglobin- Low"	124	187	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495135290	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2592"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2968382001	"Hemoglobin-Low"	50	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488211300	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2593"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3220923001	"Hyperglycemia"	124	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495134805	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2594"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2873628001	"Hyperglycemia"	19	124	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484584589	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2595"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3288460001	"Hyperglycemia"	166	187	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497450242	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2596"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3234938001	"Hyperglycemia"	145	166	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495550645	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2597"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3384559001	"Hyperglycemia"	187	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499694834	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2598"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3288478001	"Hypocalcemia"	166	187	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497450505	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2599"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3034007001	"Hypomagnesemia"	82	124	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490636952	""	""	""	NA	"Hypomagnesemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Magnesium metabolism disorders"	"Hypomagnesaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2600"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3221208001	"Hyponatremia"	124	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495135506	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2601"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3034001001	"Hyponatremia"	82	103	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490636885	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2602"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3076787001	"Hypophosphatemia"	103	124	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491920134	""	""	""	NA	"Hypophosphatemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Phosphorus metabolism disorders"	"Hypophosphataemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2603"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3235001001	"Infected carbuncle"	134	145	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495551336	""	""	""	NA	"Carbuncle"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Carbuncle"	""	""	""	""	""	""	""	""	""	""	""	""
"2604"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2873598001	"LDH- High"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484584351	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2605"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2968669001	"Leukopenia"	28	28	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488217622	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2606"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2968859001	"Leukopenia"	50	50	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488221441	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2607"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3288469001	"Lymphopenia"	166	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497450358	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2608"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3221016001	"Lymphopenia"	124	145	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495134999	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2609"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2873592001	"Lymphopenia"	19	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484584298	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2610"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3076709001	"Lymphopenia"	103	124	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491919678	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2611"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2921366001	"Lymphopenia"	50	103	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486483059	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2612"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3234951001	"Lymphopenia"	145	166	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495550779	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2613"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3288546001	"Myalgia"	147	187	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497451698	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2614"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3076901001	"Nail changes"	103	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491920867	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2615"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2968354001	"Neuropathy- Fingertips"	61	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488211113	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2616"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3221793001	"Neuropathy- Fingertips"	124	187	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495136843	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2617"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2968672001	"Neutropenia"	28	28	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488217687	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2618"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2968864001	"Neutropenia"	50	50	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488221505	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2619"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3076886001	"Oral Mucositis"	85	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491920776	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2620"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3234988001	"Peripheral edema- bilaterally"	124	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495551233	""	""	""	NA	"Edema peripheral"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2621"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	2921420001	"Rash: Hyperpigmentation w/ scaling on right medial wrist"	27	61	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486483340	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"2622"	"DN-101 Protocol No. 011-007"	"096"	"096-0004"	5	9	"Adverse Event/Serious Adverse Event"	3076793001	"Tachycardia"	82	166	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491920197	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"2623"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	2653653003	"alopecia"	76	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478547727	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2624"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	2765211001	"anemia"	41	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478546662	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2625"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	4143373001	"cellulitis"	129	205	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511895232	""	""	""	NA	"Cellulitis"	"Infections and infestations"	"Bacterial infectious disorders"	"Bacterial infections NEC"	"Cellulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2626"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	3110493001	"cough"	76	83	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492702309	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2627"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	3110588001	"elevated blood sugar"	104	167	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492703104	""	""	""	NA	"Blood sugar increased"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2628"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	2766426001	"fever"	68	68	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478623096	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"2629"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	2928079001	"left tibial ORIF pathological"	177	225	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"rod place in tibia"	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	178	NA	NA	177	185	"doppler of LLU shows no DVT,; s/p/ tibial iron rod placement for acue fracture proximal tibial shaft whish appeare to be pathologic"	""	""	2	2	2	NA	2	2	NA	2	"patient came to emergency room with severe pain.Xray taken showed possible leg fracture. Admitted to hospital for pain control and evaluation.."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486654293	""	""	""	NA	"Pathological fracture"	"Musculoskeletal and connective tissue disorders"	"Fractures"	"Pathological fractures and complications"	"Pathological fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"2630"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	3110468001	"mild erythema left shin"	150	205	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492702106	""	""	""	NA	"Erythema"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"2631"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	3190072001	"mucositis, oral"	272	287	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	272	NA	NA	272	287	"discharge summary not available"	""	""	2	2	2	NA	2	0	NA	2	"Patient came to hospital ER with neutropenic fever and mucositis.  Admitted; Non compliant with neupogen; Disccharge summary not available"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494797391	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2632"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	3664997001	"nail changes"	246	296	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505151569	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2633"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	3656462001	"neuropathy hands and feet"	378	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505066146	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2634"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	2765217001	"neutropenia"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478546902	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2635"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	3190051001	"neutropenic fever"	272	287	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	272	NA	NA	272	287	"cbc with diff and chemistry.  All liver enzymes are elevated.  wbc of 0.7"	""	""	2	2	2	NA	2	2	NA	2	"patient came to ER at hospital with fever and mucositis.;Admitted with neutropenic fever;Non compliance with neupogen;startd Cefepine, neupogen and hydrocortisone stress dose in view of neutropenic"	"fever and impending sepsis;Patient was stabalized and discharged."	""	""	""	""	""	""	""	""	""	NA	NA	""	1494796965	""	""	""	NA	"Neutropenic fever"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2636"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	3110546001	"nosocomial pneumonia"	177	185	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492702719	""	""	""	NA	"Nosocomial pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"2637"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	2765220001	"pain in leg"	48	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478547197	""	""	""	NA	"Pain in leg"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2638"	"DN-101 Protocol No. 011-007"	"097"	"097-0001"	5	9	"Adverse Event/Serious Adverse Event"	3031203001	"swelling left lower leg"	129	237	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490581171	""	""	""	NA	"Swelling of legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2639"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	2902679003	"alopecia"	71	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505070093	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2640"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	3654106001	"back pain"	179	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505056199	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2641"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	3654059001	"bilateral parasthesia below knees"	145	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505056015	""	""	""	NA	"Paresthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"2642"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	4711142002	"cough"	328	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517346329	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2643"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	3657645001	"dry eyes"	71	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505069906	""	""	""	NA	"Dry eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Dry eye"	""	""	""	""	""	""	""	""	""	""	""	""
"2644"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	3657703001	"dyspnea on exertion"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505070143	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"2645"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	4144060001	"elevated creatinine"	179	186	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"withheld zometa"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511897227	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2646"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	3031419001	"erythema, macropapular rash on face and back"	53	NA	1	1	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490587446	""	""	""	NA	"Erythematous rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Rash erythematous"	""	""	""	""	""	""	""	""	""	""	""	""
"2647"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	4710671002	"fall secondary to parasthesia (bilat below knees)"	238	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517345820	""	""	""	NA	"Paresthesia lower limb"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"2648"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	3657740001	"fatigue"	137	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505070314	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2649"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	3654221001	"hip pain"	218	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505056633	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2650"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	4144111001	"left rib pain secondary to fall"	260	314	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511897364	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2651"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	4144090001	"nose and face bruising secondary to fall"	238	260	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511897300	""	""	""	NA	"Bruising of face"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"2652"	"DN-101 Protocol No. 011-007"	"097"	"097-0003"	5	9	"Adverse Event/Serious Adverse Event"	3657666001	"runny nose"	71	81	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505070002	""	""	""	NA	"Runny nose"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2653"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	2894099003	"Alopecia"	91	190	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502220110	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2654"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901161002	"Carbon Monoxide diffusion Capacity"	201	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518999144	""	""	""	NA	"Carbon monoxide diffusing capacity decreased"	"Investigations"	"Respiratory and pulmonary investigations (excl blood gases)"	"Respiratory and pulmonary function diagnostic procedures"	"Carbon monoxide diffusing capacity decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2655"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3556688001	"Carbon Monoxide Diffusion Capacity"	141	175	NA	2	0	NA	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"Pulmonary Function tests"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503330979	""	""	""	NA	"Carbon monoxide diffusing capacity decreased"	"Investigations"	"Respiratory and pulmonary investigations (excl blood gases)"	"Respiratory and pulmonary function diagnostic procedures"	"Carbon monoxide diffusing capacity decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2656"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901147002	"Carbon monoxide diffusion capacity"	176	200	NA	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518998838	""	""	""	NA	"Carbon monoxide diffusing capacity decreased"	"Investigations"	"Respiratory and pulmonary investigations (excl blood gases)"	"Respiratory and pulmonary function diagnostic procedures"	"Carbon monoxide diffusing capacity decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2657"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3101368001	"Chest pain, non-cardiac"	14	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"EKG, Adenosine Stress Test"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492540979	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2658"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3048645001	"Chronic low back pain"	8	90	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490904803	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2659"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3101472001	"constipation"	14	163	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492541242	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2660"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3675105001	"cough"	180	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505243299	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2661"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3048619001	"cough"	16	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490904494	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2662"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3556691001	"Dry Throat"	154	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503331063	""	""	""	NA	"Dry throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dry throat"	""	""	""	""	""	""	""	""	""	""	""	""
"2663"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3101416001	"Dyspepsia"	14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492541120	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2664"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3631650001	"Dyspnea"	147	153	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Pulmonary Function Tests"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504640908	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2665"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3675039001	"Dyspnea"	176	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	5	1	NA	1	"Pulmonary Function Tests"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505242993	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2666"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3631674001	"Dyspnea"	154	175	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Pulmonary Function Tests"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504641018	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2667"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3556646001	"dyspnea"	134	139	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Pulmonary function tests done"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503330491	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2668"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3631608001	"Dyspnea"	140	146	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Pulmonary Function Tests"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504640787	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2669"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3048610001	"dyspnea"	8	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490904204	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2670"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901141002	"Fatigue"	176	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518998685	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2671"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3101742001	"Fatigue"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492541969	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2672"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3101680001	"headache"	16	27	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492541768	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"2673"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3048592001	"headache"	8	15	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490903907	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"2674"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3101866001	"heart palpitations"	14	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"EKG and ER visit"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492542335	""	""	""	NA	"Palpitations"	"Cardiac disorders"	"Cardiac disorder signs and symptoms"	"Cardiac signs and symptoms NEC"	"Palpitations"	""	""	""	""	""	""	""	""	""	""	""	""
"2675"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3614416001	"Heartburn"	14	156	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504209897	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2676"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3508141001	"hoarseness"	91	190	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502220518	""	""	""	NA	"Hoarseness"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dysphonia"	""	""	""	""	""	""	""	""	""	""	""	""
"2677"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3556664001	"hotflashes"	134	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503330716	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"2678"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3101781001	"hypertension"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492542093	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"2679"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	5292252002	"hypokalemia"	296	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523546030	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2680"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3675091001	"Infection, unknown ANC, ear infection"	180	190	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505243215	""	""	""	NA	"Ear infection NOS"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Ear infections"	"Ear infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2681"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3556677001	"Injection IV site reaction"	114	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503330827	""	""	""	NA	"Injection site reaction"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Injection site reaction"	""	""	""	""	""	""	""	""	""	""	""	""
"2682"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901165002	"Intermittent cough"	219	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518999210	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2683"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3101815001	"intermittent headache"	28	337	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492542210	""	""	""	NA	"Intermittent headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"2684"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901310002	"Intermittent Left Flank Pain"	379	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"urinalysis & urine for culture negative"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519001396	""	""	""	NA	"Flank pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Flank pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2685"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3099281001	"intermittent night sweats"	8	337	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492526325	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"2686"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901208002	"Intermittent Pain bilateral Groin Region"	337	379	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518999782	""	""	""	NA	"Groin pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Soft tissue disorders NEC"	"Groin pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2687"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901205002	"Intermittent Pain Lumbar spine"	337	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518999727	""	""	""	NA	"Lumbar pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2688"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901181002	"Intermittent Pain Lumbar Spine"	282	336	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Ct Chest/Abd/Pelvis negative Bone Scan positive"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518999408	""	""	""	NA	"Lumbar pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2689"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901303002	"Left costovetebrael angle tenderness"	379	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"urinalysis & urine for culture negative"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519001270	""	""	""	NA	"Costovertebral angle tenderness"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Costovertebral angle tenderness"	""	""	""	""	""	""	""	""	""	""	""	""
"2690"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3675060001	"Left Ear Pain"	180	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505243099	""	""	""	NA	"Ear pain"	"Ear and labyrinth disorders"	"Aural disorders NEC"	"Ear disorders NEC"	"Ear pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2691"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901177002	"Left Hip Pain"	282	336	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"CT Chest/Abdomen/Pelvis neg. Bone scan positive"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518999318	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2692"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901198002	"Left Hip Pain"	337	379	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518999646	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2693"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3508106001	"low back pain chronic"	91	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502220311	""	""	""	NA	"Chronic back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2694"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3112393001	"neutropenia"	58	72	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492719439	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2695"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3522957001	"pruritus"	114	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502655610	""	""	""	NA	"Pruritus"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Pruritus NEC"	"Pruritus"	""	""	""	""	""	""	""	""	""	""	""	""
"2696"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3522948001	"Rash at IV site"	114	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502655528	""	""	""	NA	"Infusion site rash"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion site rash"	""	""	""	""	""	""	""	""	""	""	""	""
"2697"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3101710001	"Rib cage pain"	14	72	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492541873	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2698"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901192002	"Right Flank Pain"	337	379	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518999587	""	""	""	NA	"Flank pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Flank pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2699"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	4901184002	"Right Flank Pain"	330	336	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"MRI Lumbar spine+; CT Chest/Abd/Pelvis negative; urine for urinalysis & culture neg. Bone scan +"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518999503	""	""	""	NA	"Flank pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Flank pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2700"	"DN-101 Protocol No. 011-007"	"098"	"098-0001"	5	9	"Adverse Event/Serious Adverse Event"	3112361001	"sinus drainage"	37	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492719189	""	""	""	NA	"Nasal sinus discharge"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Paranasal sinus hypersecretion"	""	""	""	""	""	""	""	""	""	""	""	""
"2701"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	2835018003	"ANEMIA"	90	171	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504020389	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2702"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	3591763001	"BILATERAL PEDAL EDEMA"	66	90	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504019142	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2703"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	3069498001	"BILATERAL PEDAL EDEMA"	45	66	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491601506	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2704"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	4683293002	"BILATERAL PEDAL EDEMA"	90	171	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517248704	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2705"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	4700546002	"DRY MOUTH"	73	171	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517325750	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"2706"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	3069435001	"DYSPNEA"	52	171	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491598463	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2707"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	3069504001	"FATIGUE"	52	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491601651	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2708"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	3592229001	"FATIGUE"	97	171	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504021778	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2709"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	3069469001	"HEARTBURN"	31	31	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491600511	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2710"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	3069466001	"INCREASING BACK PAIN"	24	171	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491600051	""	""	""	NA	"Back pain aggravated"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2711"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	4714283002	"INCREASING BONE PAIN"	97	171	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517349843	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2712"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	4700379002	"Leukopenia"	52	171	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517325533	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2713"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	4713779002	"MILD  ERYTHEMA RIGHT THIGH"	90	171	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517349407	""	""	""	NA	"Erythema"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"2714"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	3069447001	"RHONCHI"	3	171	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491598962	""	""	""	NA	"Rhonchi"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Lower respiratory tract signs and symptoms"	"Rhonchi"	""	""	""	""	""	""	""	""	""	""	""	""
"2715"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	3069441001	"WEIGHT LOSS"	73	171	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491598602	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2716"	"DN-101 Protocol No. 011-007"	"099"	"099-0002"	5	9	"Adverse Event/Serious Adverse Event"	3591997001	"WEIGHT LOSS"	24	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504020473	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2717"	"DN-101 Protocol No. 011-007"	"104"	"104-0002"	5	9	"Adverse Event/Serious Adverse Event"	2707732003	"Abdominal Tightness"	38	NA	1	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499352490	""	""	""	NA	"Abdominal discomfort"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Abdominal discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"2718"	"DN-101 Protocol No. 011-007"	"104"	"104-0002"	5	9	"Adverse Event/Serious Adverse Event"	3367950001	"Aniexty"	39	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499352804	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"2719"	"DN-101 Protocol No. 011-007"	"104"	"104-0002"	5	9	"Adverse Event/Serious Adverse Event"	2953067001	"FATIGUE"	46	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487517156	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2720"	"DN-101 Protocol No. 011-007"	"104"	"104-0002"	5	9	"Adverse Event/Serious Adverse Event"	3368091001	"Head Cold"	157	164	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499353618	""	""	""	NA	"Head cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2721"	"DN-101 Protocol No. 011-007"	"104"	"104-0002"	5	9	"Adverse Event/Serious Adverse Event"	4968592002	"LEG SWELLING"	46	67	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519676626	""	""	""	NA	"Swelling of legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2722"	"DN-101 Protocol No. 011-007"	"104"	"104-0002"	5	9	"Adverse Event/Serious Adverse Event"	4887311002	"NEUTROPENIA"	53	65	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518713379	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2723"	"DN-101 Protocol No. 011-007"	"104"	"104-0002"	5	9	"Adverse Event/Serious Adverse Event"	5263040002	"SHORTNESS OF BREATH"	15	NA	1	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522927265	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2724"	"DN-101 Protocol No. 011-007"	"104"	"104-0002"	5	9	"Adverse Event/Serious Adverse Event"	3368075001	"Tachycardia"	136	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499353515	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"2725"	"DN-101 Protocol No. 011-007"	"104"	"104-0003"	5	9	"Adverse Event/Serious Adverse Event"	2901577003	"1+ BILATERAL ANKLE EDEMA"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517242333	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2726"	"DN-101 Protocol No. 011-007"	"104"	"104-0003"	5	9	"Adverse Event/Serious Adverse Event"	3367859001	"Fatigue"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499350845	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2727"	"DN-101 Protocol No. 011-007"	"104"	"104-0003"	5	9	"Adverse Event/Serious Adverse Event"	4680185002	"MINOR BACK PAIN"	62	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517242905	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2728"	"DN-101 Protocol No. 011-007"	"104"	"104-0003"	5	9	"Adverse Event/Serious Adverse Event"	4679829002	"MINOR BONE  PAIN"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517242257	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2729"	"DN-101 Protocol No. 011-007"	"104"	"104-0003"	5	9	"Adverse Event/Serious Adverse Event"	3367852001	"Urinary Tract Infection"	82	98	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499350672	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2730"	"DN-101 Protocol No. 011-007"	"104"	"104-0005"	5	9	"Adverse Event/Serious Adverse Event"	3426370003	"ACID REFLUX"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521639810	""	""	""	NA	"Acid reflux (oesophageal)"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Gastrooesophageal reflux disease"	""	""	""	""	""	""	""	""	""	""	""	""
"2731"	"DN-101 Protocol No. 011-007"	"104"	"104-0005"	5	9	"Adverse Event/Serious Adverse Event"	5175854002	"ALOPECIA"	52	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521639733	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2732"	"DN-101 Protocol No. 011-007"	"104"	"104-0005"	5	9	"Adverse Event/Serious Adverse Event"	3621163001	"HEADACHE"	24	59	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504547099	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"2733"	"DN-101 Protocol No. 011-007"	"104"	"104-0005"	5	9	"Adverse Event/Serious Adverse Event"	4648234002	"NUMBNESS OF FINGERS AND FINGER NAILS"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517012115	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"2734"	"DN-101 Protocol No. 011-007"	"104"	"104-0005"	5	9	"Adverse Event/Serious Adverse Event"	4648228002	"THICKNESS ON SOLE OF FEET"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517012003	""	""	""	NA	"Skin thickening"	"Skin and subcutaneous tissue disorders"	"Cornification and dystrophic skin disorders"	"Skin hyperplasias and hypertrophies"	"Skin hypertrophy"	""	""	""	""	""	""	""	""	""	""	""	""
"2735"	"DN-101 Protocol No. 011-007"	"104"	"104-0007"	5	9	"Adverse Event/Serious Adverse Event"	3449357003	"BACK DISCOMFORT"	112	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518708821	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2736"	"DN-101 Protocol No. 011-007"	"104"	"104-0007"	5	9	"Adverse Event/Serious Adverse Event"	4887130002	"CONSTIPATION"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518711881	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2737"	"DN-101 Protocol No. 011-007"	"104"	"104-0007"	5	9	"Adverse Event/Serious Adverse Event"	4887152002	"FATIGUE"	50	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518711945	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2738"	"DN-101 Protocol No. 011-007"	"104"	"104-0007"	5	9	"Adverse Event/Serious Adverse Event"	3580796001	"HIP PAIN"	25	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503867205	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2739"	"DN-101 Protocol No. 011-007"	"104"	"104-0007"	5	9	"Adverse Event/Serious Adverse Event"	4886596002	"INCREASING PAIN NOS"	112	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518709277	""	""	""	NA	"Pain aggravated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2740"	"DN-101 Protocol No. 011-007"	"104"	"104-0007"	5	9	"Adverse Event/Serious Adverse Event"	5344242002	"Neutropenia"	41	NA	1	4	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1525714618	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2741"	"DN-101 Protocol No. 011-007"	"104"	"104-0007"	5	9	"Adverse Event/Serious Adverse Event"	3580749001	"NEUTROPENIA"	20	28	NA	4	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503866899	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2742"	"DN-101 Protocol No. 011-007"	"104"	"104-0007"	5	9	"Adverse Event/Serious Adverse Event"	4886632002	"SHORTNESS OF BREATH"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518709596	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2743"	"DN-101 Protocol No. 011-007"	"104"	"104-0008"	5	9	"Adverse Event/Serious Adverse Event"	3672710003	"Alopecia"	70	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519764781	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2744"	"DN-101 Protocol No. 011-007"	"104"	"104-0008"	5	9	"Adverse Event/Serious Adverse Event"	4152365001	"ALOPECIA"	48	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511974029	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2745"	"DN-101 Protocol No. 011-007"	"104"	"104-0008"	5	9	"Adverse Event/Serious Adverse Event"	4984126002	"INCREASE INTESTINAL GAS"	48	89	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519766699	""	""	""	NA	"Gas"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Flatulence"	""	""	""	""	""	""	""	""	""	""	""	""
"2746"	"DN-101 Protocol No. 011-007"	"104"	"104-0008"	5	9	"Adverse Event/Serious Adverse Event"	4152446001	"NEUROPATHY SENSORY"	27	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511974350	""	""	""	NA	"Sensory peripheral neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2747"	"DN-101 Protocol No. 011-007"	"104"	"104-0008"	5	9	"Adverse Event/Serious Adverse Event"	4152602001	"PARESTHESA"	27	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511974873	""	""	""	NA	"Paresthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"2748"	"DN-101 Protocol No. 011-007"	"104"	"104-0008"	5	9	"Adverse Event/Serious Adverse Event"	4237211001	"Right side pain, under arm"	27	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513004897	""	""	""	NA	"Flank pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Flank pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2749"	"DN-101 Protocol No. 011-007"	"106"	"106-0002"	5	9	"Adverse Event/Serious Adverse Event"	3095956003	"anemia"	52	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497995995	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2750"	"DN-101 Protocol No. 011-007"	"106"	"106-0002"	5	9	"Adverse Event/Serious Adverse Event"	3808732001	"bilateral ankle edema"	98	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507076191	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2751"	"DN-101 Protocol No. 011-007"	"106"	"106-0002"	5	9	"Adverse Event/Serious Adverse Event"	3624149001	"constipation"	121	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504564996	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2752"	"DN-101 Protocol No. 011-007"	"106"	"106-0002"	5	9	"Adverse Event/Serious Adverse Event"	3308384001	"constipation"	31	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497995819	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2753"	"DN-101 Protocol No. 011-007"	"106"	"106-0002"	5	9	"Adverse Event/Serious Adverse Event"	3907728001	"fatigue"	189	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508452220	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2754"	"DN-101 Protocol No. 011-007"	"106"	"106-0002"	5	9	"Adverse Event/Serious Adverse Event"	3308400001	"fatigue"	41	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497995903	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2755"	"DN-101 Protocol No. 011-007"	"106"	"106-0002"	5	9	"Adverse Event/Serious Adverse Event"	3447486001	"rash"	74	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500842923	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"2756"	"DN-101 Protocol No. 011-007"	"106"	"106-0003"	5	9	"Adverse Event/Serious Adverse Event"	3276986003	"Bone Pain"	15	164	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513110309	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2757"	"DN-101 Protocol No. 011-007"	"106"	"106-0003"	5	9	"Adverse Event/Serious Adverse Event"	3571878001	"Constipation"	25	79	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503526642	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2758"	"DN-101 Protocol No. 011-007"	"106"	"106-0003"	5	9	"Adverse Event/Serious Adverse Event"	4257370001	"Dehydration"	18	18	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513109704	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"2759"	"DN-101 Protocol No. 011-007"	"106"	"106-0003"	5	9	"Adverse Event/Serious Adverse Event"	3314265001	"Nausea"	14	164	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	1	104	NA	NA	NA	1	NA	1	1	"Patient hospitalized for severe nausea"	16	NA	NA	15	25	"Urinalysis performed on 6/21/07 to rule out urinary tract infection.  Test was negative.  CBC, CMP performed routinely from 6/20/07 to 6/30/07, no significant findings."	""	""	2	2	2	2	1	2	2	2	"On 2007-06-19 (Prednison started on 2007-06-14 & Docetaxel given on 2007-06-15) patient began having problems sleeping and difficulty controlling nausea, diarrhea, vomiting, and joint pain.  Patient"	"prescribed stronger pain medication and re-instructed on how to take anti-nausea meds. Also given medication for insomnia.  On 6/20/07, the patient's condition began declining secondary to an"	"inability to eat as a result of inability to control nausea and vomiting and oral thrush, and continued diarrhea.  Patient admitted for IV fluids, IV antibiotics (possible infection/low grade fever),"	"and pain control."	""	""	""	""	""	""	""	NA	NA	""	1498084988	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"2760"	"DN-101 Protocol No. 011-007"	"106"	"106-0003"	5	9	"Adverse Event/Serious Adverse Event"	3571923001	"Oral Thrush"	15	25	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503527172	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"2761"	"DN-101 Protocol No. 011-007"	"106"	"106-0003"	5	9	"Adverse Event/Serious Adverse Event"	3791233001	"urinary tract infection"	15	24	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506886869	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2762"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	2939989003	"Bilateral Leg Weakness (calf and knee)"	133	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505664493	""	""	""	NA	"Weakness of limbs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"2763"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	3690946001	"cellulitis bilateral lower extremities"	189	225	NA	3	3	1	1	NA	NA	NA	1	1	NA	7	1	1	1	"Hospitalized for IV anitbiotics;; 9/18/07 update:  Vancomycin over 10 days, then d/c; Transfer to ICU; Incision & drainage rt leg abscess; Pt continues in ICU;"	3	0	NA	0	24	NA	NA	NA	1	1	NA	NA	""	218	NA	NA	189	225	"08/16/07 CT Head or Brain w/o contrast;; 9/18/07 update:  OP report; consult note; CXR;"	""	""	2	2	2	NA	2	2	NA	2	"Patient seen in emergency room for right leg and left foot cellulitis, worsening despite PO antibiotics.  Patient also hypotensive.  Pt afebrile and not neutropenic.  Pt admitted for IV antibiotic"	"therapy.  Pt also given IVF bolus for hypotension, which resolved.  Pt has history of multiple chronic medical problems.;9/18/07 update:  Pt received ATB;  pt condition deteriorated, transferred to"	"ICU;  abscess developed, pt underwent drainage of rt leg abscess  with wound packing at ICU bedside;;Event is possibly related to protocol treatment."	""	""	""	""	""	""	""	""	NA	NA	""	1505411578	""	""	""	NA	"Cellulitis"	"Infections and infestations"	"Bacterial infectious disorders"	"Bacterial infections NEC"	"Cellulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2764"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	3842722001	"Cellulitis, Left Leg"	173	189	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507657564	""	""	""	NA	"Cellulitis of leg"	"Infections and infestations"	"Bacterial infectious disorders"	"Bacterial infections NEC"	"Cellulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2765"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	4910876002	"delirium"	205	206	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519078993	""	""	""	NA	"Delirium"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Deliria"	"Delirium"	""	""	""	""	""	""	""	""	""	""	""	""
"2766"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	3032781001	"DYSPNEA ON EXERTION"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"OXYGEN AT NIGHT"	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490627925	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"2767"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	3694687001	"Fatigue"	82	175	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505663710	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2768"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	4910919002	"head laceration"	342	342	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"stiches in er"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519079124	""	""	""	NA	"Laceration of head"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Skin laceration"	""	""	""	""	""	""	""	""	""	""	""	""
"2769"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	4101134001	"headache"	92	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511202698	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"2770"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	3694741001	"Leg Pain, Bilaterally (calf and knee)"	133	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505664051	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"2771"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	3694719001	"Nail Bed Discoloration"	113	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505663941	""	""	""	NA	"Discoloration nail"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"2772"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	3694768001	"Neuropathy in all toes"	133	175	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505664205	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2773"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	3411423001	"Pitting Edema to groin"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499881700	""	""	""	NA	"Pitting edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Pitting oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"2774"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	5005388002	"severe peripheral vascular disease"	189	225	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519903086	""	""	""	NA	"Peripheral vascular disease"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Peripheral vascular disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2775"	"DN-101 Protocol No. 011-007"	"108"	"108-0002"	5	9	"Adverse Event/Serious Adverse Event"	3842651001	"Skin Peeling, Left Thumb and Wrist"	10	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507657218	""	""	""	NA	"Skin peeling"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Exfoliative conditions"	"Skin exfoliation"	""	""	""	""	""	""	""	""	""	""	""	""
"2776"	"DN-101 Protocol No. 011-007"	"108"	"108-0004"	5	9	"Adverse Event/Serious Adverse Event"	3248857003	"Bilateral Ankle Edema"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504021993	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2777"	"DN-101 Protocol No. 011-007"	"108"	"108-0004"	5	9	"Adverse Event/Serious Adverse Event"	3592576001	"Fatigue"	9	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504023948	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2778"	"DN-101 Protocol No. 011-007"	"108"	"108-0004"	5	9	"Adverse Event/Serious Adverse Event"	3592608001	"Pain, Intermittent RUQ"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504024117	""	""	""	NA	"RUQ pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"2779"	"DN-101 Protocol No. 011-007"	"108"	"108-0004"	5	9	"Adverse Event/Serious Adverse Event"	3595097001	"Pain, Right Hip"	74	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504035251	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2780"	"DN-101 Protocol No. 011-007"	"108"	"108-0004"	5	9	"Adverse Event/Serious Adverse Event"	3592414001	"Taste Alteration"	9	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504022824	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2781"	"DN-101 Protocol No. 011-007"	"108"	"108-0005"	5	9	"Adverse Event/Serious Adverse Event"	3301404003	"Abdominal Bloating"	22	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505827159	""	""	""	NA	"Abdominal bloating"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Abdominal distension"	""	""	""	""	""	""	""	""	""	""	""	""
"2782"	"DN-101 Protocol No. 011-007"	"108"	"108-0005"	5	9	"Adverse Event/Serious Adverse Event"	3709077001	"Decreased WBC"	22	37	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505830871	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2783"	"DN-101 Protocol No. 011-007"	"108"	"108-0005"	5	9	"Adverse Event/Serious Adverse Event"	4046504001	"fatigue"	82	101	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510599479	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2784"	"DN-101 Protocol No. 011-007"	"108"	"108-0005"	5	9	"Adverse Event/Serious Adverse Event"	4046692001	"LDH elevated"	100	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510600097	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2785"	"DN-101 Protocol No. 011-007"	"108"	"108-0005"	5	9	"Adverse Event/Serious Adverse Event"	3709193001	"Low Hemoglobin"	78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505831355	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2786"	"DN-101 Protocol No. 011-007"	"108"	"108-0005"	5	9	"Adverse Event/Serious Adverse Event"	3709043001	"Mucositis oral"	35	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505830671	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2787"	"DN-101 Protocol No. 011-007"	"108"	"108-0005"	5	9	"Adverse Event/Serious Adverse Event"	3710285001	"Taste Alteration"	80	101	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505834928	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2788"	"DN-101 Protocol No. 011-007"	"108"	"108-0006"	5	9	"Adverse Event/Serious Adverse Event"	3748104003	"abscess peri-colonic"	76	83	NA	4	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	140	NA	NA	76	83	"ct  scan abdomen & pelvis   11-28-2007"	""	""	2	2	2	NA	2	2	NA	2	"Patient had fatigue & abdominal pain went to e.r. ct scan revealved abscess pericolonic."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517254541	""	""	""	NA	"Abdominal abscess"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Abdominal abscess"	""	""	""	""	""	""	""	""	""	""	""	""
"2789"	"DN-101 Protocol No. 011-007"	"108"	"108-0006"	5	9	"Adverse Event/Serious Adverse Event"	5069382002	"anorexia"	57	142	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520532048	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"2790"	"DN-101 Protocol No. 011-007"	"108"	"108-0006"	5	9	"Adverse Event/Serious Adverse Event"	4937075002	"diarrhea"	57	142	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519303889	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2791"	"DN-101 Protocol No. 011-007"	"108"	"108-0006"	5	9	"Adverse Event/Serious Adverse Event"	4937077002	"fatigue"	49	55	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519304008	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2792"	"DN-101 Protocol No. 011-007"	"108"	"108-0006"	5	9	"Adverse Event/Serious Adverse Event"	4937072002	"syncope"	17	17	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519303680	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"2793"	"DN-101 Protocol No. 011-007"	"108"	"108-0006"	5	9	"Adverse Event/Serious Adverse Event"	5069629002	"weakness"	57	142	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520532680	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2794"	"DN-101 Protocol No. 011-007"	"109"	"109-0002"	5	9	"Adverse Event/Serious Adverse Event"	3122917003	"alopecia"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497819753	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2795"	"DN-101 Protocol No. 011-007"	"109"	"109-0002"	5	9	"Adverse Event/Serious Adverse Event"	4321519001	"common cold"	91	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513729631	""	""	""	NA	"Common cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2796"	"DN-101 Protocol No. 011-007"	"109"	"109-0002"	5	9	"Adverse Event/Serious Adverse Event"	4321714001	"dry skin"	196	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513730439	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"2797"	"DN-101 Protocol No. 011-007"	"109"	"109-0002"	5	9	"Adverse Event/Serious Adverse Event"	4321558001	"fatigue"	9	93	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513729822	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2798"	"DN-101 Protocol No. 011-007"	"109"	"109-0002"	5	9	"Adverse Event/Serious Adverse Event"	4640370002	"fingers nail infection"	152	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516900849	""	""	""	NA	"Nail infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Nail infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2799"	"DN-101 Protocol No. 011-007"	"109"	"109-0002"	5	9	"Adverse Event/Serious Adverse Event"	4835444002	"fluid retention"	205	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518138439	""	""	""	NA	"Fluid retention"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume increased"	"Fluid retention"	""	""	""	""	""	""	""	""	""	""	""	""
"2800"	"DN-101 Protocol No. 011-007"	"109"	"109-0002"	5	9	"Adverse Event/Serious Adverse Event"	3924213001	"High Blood Pressure"	9	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508800114	""	""	""	NA	"Blood pressure high"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"2801"	"DN-101 Protocol No. 011-007"	"109"	"109-0002"	5	9	"Adverse Event/Serious Adverse Event"	4321646001	"loose stools"	154	240	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513730123	""	""	""	NA	"Loose stools"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2802"	"DN-101 Protocol No. 011-007"	"109"	"109-0002"	5	9	"Adverse Event/Serious Adverse Event"	4321509001	"loss of appetite"	15	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513729534	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"2803"	"DN-101 Protocol No. 011-007"	"109"	"109-0002"	5	9	"Adverse Event/Serious Adverse Event"	4321670001	"peripheral neuropathy"	175	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513730266	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2804"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	2604892003	"altered mental status"	202	203	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521581730	""	""	""	NA	"Mental status changes"	"Psychiatric disorders"	"Psychiatric disorders NEC"	"Mental disorders NEC"	"Mental status changes"	""	""	""	""	""	""	""	""	""	""	""	""
"2805"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	3297174001	"bilateral lower extremity edema"	153	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497805952	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2806"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	3297133001	"bone pain"	-180	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497805264	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2807"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	5301114002	"bronchitis"	200	205	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523890844	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2808"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	4929709002	"constipation"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519235863	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2809"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	5301107002	"dehydration"	200	202	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523890778	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"2810"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	4929686002	"hypokalemia"	317	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519235800	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2811"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	5301084002	"hyponatremia"	200	323	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523890645	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2812"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	3297161001	"insomnia"	19	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497805588	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"2813"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	4929838002	"low hemoglobin"	170	289	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519236321	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2814"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	4930486002	"neutropenia"	202	205	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	596	NA	NA	202	205	"ANC = 0.4 with temp of 97.6 in the ER. ; Blood cultrues negative ; respiratory culture moderate strptococcus pneuminiae; urinary culture +"	""	""	2	2	2	NA	2	2	2	2	"Admitted with altered mental status assocoated wtth UTI and bronchitis"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519237786	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2815"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	4929776002	"urinary frequency"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519235981	""	""	""	NA	"Urinary frequency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"2816"	"DN-101 Protocol No. 011-007"	"110"	"110-0002"	5	9	"Adverse Event/Serious Adverse Event"	5169887002	"UTI"	202	207	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521581811	""	""	""	NA	"UTI"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2817"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	2942022003	"Fatigue"	150	160	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509386269	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2818"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	3966065001	"Fatigue"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509386365	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2819"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	3297064001	"Leukopenia"	30	35	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497804682	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2820"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	2969100001	"Leukopenia"	10	14	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488225258	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2821"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	3165841001	"Low grade temps"	46	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494197114	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"2822"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	4954523002	"Myalgia"	303	352	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519597615	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2823"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	3966053001	"Myalgia"	150	160	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509386317	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2824"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	3297059001	"Neutropenia"	30	35	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497804601	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2825"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	2969096001	"Neutropenia"	10	14	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488225166	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2826"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	4954531002	"Periscapular tenderness"	352	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519597657	""	""	""	NA	"Back discomfort"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"2827"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	3966108001	"Sciatica/Low back pain"	212	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509386565	""	""	""	NA	"Sciatica"	"Nervous system disorders"	"Spinal cord and nerve root disorders"	"Lumbar spinal cord and nerve root disorders"	"Sciatica"	""	""	""	""	""	""	""	""	""	""	""	""
"2828"	"DN-101 Protocol No. 011-007"	"110"	"110-0005"	5	9	"Adverse Event/Serious Adverse Event"	3966086001	"Weight Gain"	170	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509386491	""	""	""	NA	"Weight gain"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2829"	"DN-101 Protocol No. 011-007"	"110"	"110-0007"	5	9	"Adverse Event/Serious Adverse Event"	3322577003	"Alopecia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515436613	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2830"	"DN-101 Protocol No. 011-007"	"110"	"110-0007"	5	9	"Adverse Event/Serious Adverse Event"	3627318001	"hemorrage other- epistaxis"	32	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504628290	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"2831"	"DN-101 Protocol No. 011-007"	"110"	"110-0007"	5	9	"Adverse Event/Serious Adverse Event"	3627298001	"Hemorrhage other- hemoptysis"	32	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504628203	""	""	""	NA	"Hemoptysis"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Haemoptysis"	""	""	""	""	""	""	""	""	""	""	""	""
"2832"	"DN-101 Protocol No. 011-007"	"110"	"110-0007"	5	9	"Adverse Event/Serious Adverse Event"	4774348002	"Hyperglycemia"	16	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517847459	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2833"	"DN-101 Protocol No. 011-007"	"110"	"110-0007"	5	9	"Adverse Event/Serious Adverse Event"	3627348001	"Insomnia"	15	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504628431	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"2834"	"DN-101 Protocol No. 011-007"	"110"	"110-0007"	5	9	"Adverse Event/Serious Adverse Event"	4407479002	"Nose Bleeds"	60	142	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515436569	""	""	""	NA	"Nose bleeds"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"2835"	"DN-101 Protocol No. 011-007"	"110"	"110-0007"	5	9	"Adverse Event/Serious Adverse Event"	4407523002	"Right hip pain"	184	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515436659	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2836"	"DN-101 Protocol No. 011-007"	"110"	"110-0009"	5	9	"Adverse Event/Serious Adverse Event"	3497115003	"Alopecia"	19	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504635257	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2837"	"DN-101 Protocol No. 011-007"	"110"	"110-0009"	5	9	"Adverse Event/Serious Adverse Event"	3629566001	"Fatigue"	9	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504634869	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2838"	"DN-101 Protocol No. 011-007"	"110"	"110-0009"	5	9	"Adverse Event/Serious Adverse Event"	3949105001	"Fatigue"	17	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509057426	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2839"	"DN-101 Protocol No. 011-007"	"110"	"110-0009"	5	9	"Adverse Event/Serious Adverse Event"	4408083002	"Fatigue"	73	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515437981	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2840"	"DN-101 Protocol No. 011-007"	"110"	"110-0009"	5	9	"Adverse Event/Serious Adverse Event"	3629637001	"Flatus"	21	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504635082	""	""	""	NA	"Flatus"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Flatulence"	""	""	""	""	""	""	""	""	""	""	""	""
"2841"	"DN-101 Protocol No. 011-007"	"110"	"110-0009"	5	9	"Adverse Event/Serious Adverse Event"	3629657001	"Hoarseness"	9	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504635131	""	""	""	NA	"Hoarseness"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dysphonia"	""	""	""	""	""	""	""	""	""	""	""	""
"2842"	"DN-101 Protocol No. 011-007"	"110"	"110-0009"	5	9	"Adverse Event/Serious Adverse Event"	3629679001	"Urinary Incontinence"	22	23	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504635200	""	""	""	NA	"Urinary incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"2843"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	3551708003	"Bilateral side pain (musculoskeletal)"	91	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519852853	""	""	""	NA	"Musculoskeletal pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2844"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	3615684001	"Fatigue"	17	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504216590	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2845"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	3615693001	"Generalized Bone Pain"	15	15	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504216658	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2846"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	3615698001	"Headache (left temple)"	15	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504216717	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"2847"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	3967986001	"Headache (left temple/skull)"	55	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509393027	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"2848"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	3967952001	"Headache (left temple/top of skull)"	42	55	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509392923	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"2849"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	5166933002	"Hyperlacrimation"	118	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521576018	""	""	""	NA	"Lacrimation increased"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2850"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	4999933002	"Low back pain"	118	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519852950	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2851"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	3615676001	"Myalgia"	17	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504216548	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2852"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	4999951002	"Nail changes"	160	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519852995	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2853"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	3967973001	"Numbness patches- left cheek"	47	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509392978	""	""	""	NA	"Numbness in face"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Hypoaesthesia facial"	""	""	""	""	""	""	""	""	""	""	""	""
"2854"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	4999863002	"Pain left hip"	NA	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519852734	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2855"	"DN-101 Protocol No. 011-007"	"110"	"110-0010"	5	9	"Adverse Event/Serious Adverse Event"	5166983002	"Peripheral Neuropathy"	118	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521576245	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2856"	"DN-101 Protocol No. 011-007"	"110"	"110-0011"	5	9	"Adverse Event/Serious Adverse Event"	3658001003	"Alopecia"	33	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512947590	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2857"	"DN-101 Protocol No. 011-007"	"110"	"110-0011"	5	9	"Adverse Event/Serious Adverse Event"	4435600002	"Decreased Hemoglobin"	42	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515538511	""	""	""	NA	"Decreased hemoglobin"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2858"	"DN-101 Protocol No. 011-007"	"110"	"110-0011"	5	9	"Adverse Event/Serious Adverse Event"	4983279002	"Extravasation"	35	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Taxotere stopped. cold pack applied."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519763992	""	""	""	NA	"Extravasation"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Extravasation"	""	""	""	""	""	""	""	""	""	""	""	""
"2859"	"DN-101 Protocol No. 011-007"	"110"	"110-0011"	5	9	"Adverse Event/Serious Adverse Event"	4982418002	"Nausea"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519760186	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"2860"	"DN-101 Protocol No. 011-007"	"110"	"110-0011"	5	9	"Adverse Event/Serious Adverse Event"	3799410001	"neutropenia"	28	31	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506979979	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2861"	"DN-101 Protocol No. 011-007"	"110"	"110-0011"	5	9	"Adverse Event/Serious Adverse Event"	3799390001	"neutropenia"	21	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506979879	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2862"	"DN-101 Protocol No. 011-007"	"110"	"110-0011"	5	9	"Adverse Event/Serious Adverse Event"	4233433001	"Neutropenia"	32	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512947444	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2863"	"DN-101 Protocol No. 011-007"	"110"	"110-0012"	5	9	"Adverse Event/Serious Adverse Event"	3696148003	"Chills"	55	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515436188	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"2864"	"DN-101 Protocol No. 011-007"	"110"	"110-0012"	5	9	"Adverse Event/Serious Adverse Event"	3949472001	"Hypersensitivity reaction"	13	13	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509059388	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"2865"	"DN-101 Protocol No. 011-007"	"110"	"110-0012"	5	9	"Adverse Event/Serious Adverse Event"	4407369002	"Infusion reaction"	55	55	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515436285	""	""	""	NA	"Infusion related reaction"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion related reaction"	""	""	""	""	""	""	""	""	""	""	""	""
"2866"	"DN-101 Protocol No. 011-007"	"110"	"110-0012"	5	9	"Adverse Event/Serious Adverse Event"	4407328002	"Pain-lower back"	97	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515436232	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2867"	"DN-101 Protocol No. 011-007"	"110"	"110-0013"	5	9	"Adverse Event/Serious Adverse Event"	3697855003	"fatigue"	92	141	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520463920	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2868"	"DN-101 Protocol No. 011-007"	"110"	"110-0013"	5	9	"Adverse Event/Serious Adverse Event"	4923650002	"hyperglycemia"	36	NA	1	1	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519171664	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2869"	"DN-101 Protocol No. 011-007"	"110"	"110-0014"	5	9	"Adverse Event/Serious Adverse Event"	3749073003	"Alopecia"	22	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513206406	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2870"	"DN-101 Protocol No. 011-007"	"110"	"110-0014"	5	9	"Adverse Event/Serious Adverse Event"	4273980001	"Altered taste"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513206472	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2871"	"DN-101 Protocol No. 011-007"	"110"	"110-0014"	5	9	"Adverse Event/Serious Adverse Event"	4273948001	"Athralgia"	11	15	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513206287	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2872"	"DN-101 Protocol No. 011-007"	"110"	"110-0014"	5	9	"Adverse Event/Serious Adverse Event"	4274032001	"Hemorrhage/nose bleed"	36	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513206679	""	""	""	NA	"Nose bleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"2873"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	3854168003	"Abdominal Distention"	24	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514914126	""	""	""	NA	"Abdominal distension"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Abdominal distension"	""	""	""	""	""	""	""	""	""	""	""	""
"2874"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4365460001	"Abdominal pain"	21	24	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514913840	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2875"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4365661001	"Alopecia"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514915159	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2876"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4944101002	"Anxiety"	26	26	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519338366	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"2877"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4966178002	"Colitis"	77	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519671465	""	""	""	NA	"Colitis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Colitis (excl infective)"	"Colitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2878"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4966211002	"Colitis"	30	72	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519671515	""	""	""	NA	"Colitis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Colitis (excl infective)"	"Colitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2879"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	3941025001	"Colitis with Diarrhea"	24	29	NA	4	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	40	NA	NA	NA	1	NA	1	NA	""	27	NA	NA	26	29	"CT Abd/Pelvis 10/23/07- most consistant with inflammatory colitis, grade 4 neutropenia- 10/22/07"	""	""	2	2	2	NA	2	2	NA	2	"Lower abdominal pain for 3-4 days.  Admitted to hospital for treatment of colitis and neutropenia."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508964857	""	""	""	NA	"Colitis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Colitis (excl infective)"	"Colitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2880"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4409083002	"Fatigue"	77	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515440116	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2881"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4365645001	"Fever"	NA	26	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514915081	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"2882"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	5282364002	"Hypokalemia"	28	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523375052	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2883"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4365534001	"Neutropenia"	24	28	NA	4	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514914176	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2884"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4365688001	"Rash- hand/foot"	78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514915388	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"2885"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4365668001	"Rash- hand/foot skin"	40	60	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514915204	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"2886"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4365674001	"Rash- hand/foot skin"	60	78	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514915254	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"2887"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4966102002	"Recurrent  C. Diff Colitis"	73	76	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	151	NA	NA	73	76	"Leukocytosis: WBC = 15.5 K/uL; CDiff stool toxin = negative"	""	""	2	2	2	NA	2	2	NA	2	"Recurrent C.Diff colitis diagnosed aftr patient admitted to hospital with complaint of LUQ abdominal pain and leukocytosis."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519671299	""	""	""	NA	"C.difficile colitis"	"Infections and infestations"	"Bacterial infectious disorders"	"Clostridia infections"	"Clostridium difficile colitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2888"	"DN-101 Protocol No. 011-007"	"110"	"110-0015"	5	9	"Adverse Event/Serious Adverse Event"	4365513001	"Tachycardia"	24	25	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514914067	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"2889"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	2628998003	"Anemia"	328	328	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513637657	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2890"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	2704410001	"Bright Red Blood Per Rectum"	44	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475449197	""	""	""	NA	"Hemorrhage rectum"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Intestinal haemorrhages"	"Rectal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"2891"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	4305619001	"Constipation"	11	378	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513635886	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2892"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	4274635001	"Death from Liver Failure"	357	376	NA	5	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	4	0	NA	0	12	NA	NA	1	1	NA	NA	NA	""	506	376	0	357	376	"CT Scan"	""	""	2	2	2	NA	2	2	NA	2	"Patient admitted to hospital due to fever and altered mental status. Disease was determined to be from the sepsis and not mental status due to normal CT scan. Patient was given antibiotics, and later"	"succumbed to liver failure soon after."	""	""	""	""	""	""	""	""	""	NA	NA	""	1513212470	""	""	""	NA	"Failure liver"	"Hepatobiliary disorders"	"Hepatic and hepatobiliary disorders"	"Hepatic failure and associated disorders"	"Hepatic failure"	""	""	""	""	""	""	""	""	""	""	""	""
"2893"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	4304503001	"Dizzyness"	76	118	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513632291	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"2894"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	4305953001	"Eye infection"	324	328	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513637756	""	""	""	NA	"Eye infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Eye and eyelid infections"	"Eye infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2895"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	2704362001	"Fatigue"	13	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475447548	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2896"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	2704389001	"Fecal Incontinence"	64	83	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475448768	""	""	""	NA	"Fecal incontinence"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Faecal incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"2897"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	5127466002	"Frequent Urination Leaking through Rectum"	51	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521154972	""	""	""	NA	"Ureteric fistula"	"Renal and urinary disorders"	"Ureteric disorders"	"Ureteric disorders NEC"	"Ureteric fistula"	""	""	""	""	""	""	""	""	""	""	""	""
"2898"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	4305811001	"Gastronintestinal bleeding"	354	376	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513637057	""	""	""	NA	"Bleeding gastrointestinal"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"2899"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	2816121001	"Hyperglycemia"	9	376	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481241978	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2900"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	5127506002	"Increasing Fatigue"	337	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521155138	""	""	""	NA	"Fatigue aggravated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2901"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	4305906001	"Neutropenia"	337	339	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513637460	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2902"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	2640251001	"Neutropenic Fever"	17	21	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	17	NA	NA	17	21	"AUG/11/2006 Hematology"	""	""	2	1	0	NA	2	0	NA	0	"Patient was hospitalized with Neutropenic Fever (Grade 3) on Aug/11/2006 confirmed by blood work and a rectal temperature of 102. Patient hospitalized and given IV fluids with 1000mg Vancomycin and"	"Filgrastim 480 mcg. Additional lab tests and blood cultures pending. Patient will be treated with antibiotics and growth factor."	""	""	""	""	""	""	""	""	""	NA	NA	""	1471291017	""	""	""	NA	"Neutropenic fever"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2903"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	4305736001	"Productive cough"	11	44	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513636372	""	""	""	NA	"Productive cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2904"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	2726697001	"Rectovesical Fistula"	64	NA	1	1	3	1	1	NA	NA	NA	2	NA	1	2	NA	1	NA	""	1	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	84	NA	NA	83	88	"OCT/16/2006 Sigmoid end-colostomy and suprapubic catheter placement"	""	""	2	2	2	NA	2	0	NA	0	"Pt was admitted OCT/16/2006 for elective diverting sigmoid end-colostomy and suprapubic catheter placement for treatment of his rectovesical fistula, a complication likely related to multiple"	"previous local therapies (cryo, xrt, etc.). The surgeries were performed with no complications."	""	""	""	""	""	""	""	""	""	NA	NA	""	1476313380	""	""	""	NA	"Rectovesical fistula"	"Gastrointestinal disorders"	"Gastrointestinal conditions NEC"	"Gastrointestinal fistulae"	"Enterovesical fistula"	""	""	""	""	""	""	""	""	""	""	""	""
"2905"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	5298584002	"Sepsis"	357	376	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523824849	""	""	""	NA	"Sepsis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Sepsis, bacteraemia and viraemia"	"Sepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"2906"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	4304709001	"Sleep disturbance"	76	376	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513632857	""	""	""	NA	"Sleep disturbance"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Sleep disorders NEC"	"Sleep disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2907"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	5127492002	"Unsteady Gait"	337	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521155089	""	""	""	NA	"Unsteady gait"	"General disorders and administration site conditions"	"General system disorders NEC"	"Gait disturbances"	"Gait disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"2908"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	4305402001	"Urinary Tract Infection"	108	376	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513635115	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2909"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	4274559001	"Urosepsis"	294	300	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	506	NA	NA	294	300	"CBC, CMP, UA, Blood cultures, CXR all done upon admission"	""	""	2	2	2	NA	2	2	NA	2	"1. SEPSIS DUE TO PROTEUS MIRABILIS DUE TO URINARY SOURCE;2. MITRAL VALVE REPLACEMENT;;Patient presented to the ED initially for abnormally high fever, was found to be septic and admitted to the"	"hospital. Urine samples showed that he had 10 to 5 Proteus mirabilis with the same susceptibilities to all antimicrobial agents. Patient was given Levoflaxin."	""	""	""	""	""	""	""	""	""	NA	NA	""	1513211964	""	""	""	NA	"Urosepsis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Sepsis, bacteraemia and viraemia"	"Urosepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"2910"	"DN-101 Protocol No. 011-007"	"111"	"111-0001"	5	9	"Adverse Event/Serious Adverse Event"	4304803001	"Wound infections"	108	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513633134	""	""	""	NA	"Wound infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Wound infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2911"	"DN-101 Protocol No. 011-007"	"112"	"112-0005"	5	9	"Adverse Event/Serious Adverse Event"	3533945003	"alopecia"	37	170	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506013075	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2912"	"DN-101 Protocol No. 011-007"	"112"	"112-0005"	5	9	"Adverse Event/Serious Adverse Event"	3923096001	"common cold"	70	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508787148	""	""	""	NA	"Common cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2913"	"DN-101 Protocol No. 011-007"	"112"	"112-0005"	5	9	"Adverse Event/Serious Adverse Event"	4660245002	"dyspnea worsening"	91	126	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517165368	""	""	""	NA	"Dyspnea exacerbated"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exacerbated"	""	""	""	""	""	""	""	""	""	""	""	""
"2914"	"DN-101 Protocol No. 011-007"	"112"	"112-0005"	5	9	"Adverse Event/Serious Adverse Event"	3801579001	"pain lt side lower back"	55	107	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507042764	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2915"	"DN-101 Protocol No. 011-007"	"112"	"112-0005"	5	9	"Adverse Event/Serious Adverse Event"	4660500002	"worsening edema"	105	170	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517165937	""	""	""	NA	"Edema aggravated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"2916"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	3244435003	"Alopecia"	14	185	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500928641	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2917"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	3451083001	"Dry Mouth"	14	54	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500928541	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"2918"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	3451116001	"Fatigue"	35	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500928899	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2919"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	4404763002	"Heartburn"	185	185	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515427709	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2920"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	4408796002	"Heartburn"	152	153	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515439530	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2921"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	4404859002	"Heartburn"	206	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515428010	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2922"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	3471312001	"Mood Alteration: Anxiety"	14	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501527316	""	""	""	NA	"Anxious mood"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"2923"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	4099593001	"Neuropathy: Peripheral"	99	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511194698	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2924"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	3451065001	"Pain Whole Body Aches"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500928318	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2925"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	3451150001	"Pulmonary: Other: Head Cold"	52	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500929150	""	""	""	NA	"Head cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2926"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	4099550001	"Pulmonary:Other:Head Cold"	112	134	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511194499	""	""	""	NA	"Head cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2927"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	3586728001	"Rhinitis"	74	81	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503941363	""	""	""	NA	"Rhinitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Rhinitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2928"	"DN-101 Protocol No. 011-007"	"113"	"113-0001"	5	9	"Adverse Event/Serious Adverse Event"	3451104001	"Taste Alteration"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500928793	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2929"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2621127003	"Acute Renal Failure"	353	357	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV fluids"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501000944	""	""	""	NA	"Acute renal failure"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure acute"	""	""	""	""	""	""	""	""	""	""	""	""
"2930"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	4985632002	"Adrenal insufficiency"	353	357	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519774954	""	""	""	NA	"Adrenal insufficiency"	"Endocrine disorders"	"Adrenal gland disorders"	"Adrenal cortical hypofunctions"	"Adrenal insufficiency"	""	""	""	""	""	""	""	""	""	""	""	""
"2931"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2870233001	"Alopecia"	173	299	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484271656	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"2932"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3454551001	"Anemia"	353	356	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501003905	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2933"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3454556001	"Anemia"	356	357	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501003971	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2934"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3365855001	"Anxiety"	335	357	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499287437	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"2935"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3365966001	"Bruising"	321	357	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499288110	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"2936"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2841271001	"Cognitive Disturbance"	136	173	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482452397	""	""	""	NA	"Cognitive disturbance"	"Nervous system disorders"	"Mental impairment disorders"	"Mental impairment (excl dementia and memory loss)"	"Cognitive disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2937"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3365921001	"Confusion"	335	357	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499287715	""	""	""	NA	"Confusion"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Confusion and disorientation"	"Confusional state"	""	""	""	""	""	""	""	""	""	""	""	""
"2938"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2841268001	"Cough"	117	152	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482452211	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"2939"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2637530001	"Dyspepsia"	7	14	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1470961322	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"2940"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2841274001	"Dyspnea"	137	173	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482452467	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"2941"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3255501001	"Dysuria"	299	357	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496273997	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"2942"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3255480001	"Dysuria"	294	298	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496273902	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"2943"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3280901001	"Elevated Alkaline Phosphatase"	256	354	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497286925	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2944"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3280727001	"Elevated GGT"	320	357	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497283901	""	""	""	NA	"GGT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Gamma-glutamyltransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2945"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3366101001	"Elevated Lactate dehydrogenase"	17	357	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499289926	""	""	""	NA	"Lactate dehydrogenase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"2946"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2642694001	"Epistaxis"	17	19	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471452775	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"2947"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2642698001	"Fatigue"	19	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471452857	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2948"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2717760001	"Fatigue"	47	338	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476139064	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2949"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3365785001	"Fatigue"	339	357	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499286880	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2950"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3417595001	"Fever Induced Coma"	355	357	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	2	NA	1	NA	NA	NA	NA	NA	""	357	NA	NA	353	357	"7/11/07 CT Brain:  moderate diffuse atrophy, no evidence of acute hemorrhage or hematoma.  7/12/07 EEG:  Abnormal"	""	""	2	2	2	NA	2	2	NA	2	"Patient went into coma due to temperature up to 108 F (due to febrile neutropenia)."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499980761	""	""	""	NA	"Coma"	"Nervous system disorders"	"Neurological disorders NEC"	"Coma states"	"Coma"	""	""	""	""	""	""	""	""	""	""	""	""
"2951"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2667164001	"Flu-like symptoms"	32	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473176520	""	""	""	NA	"Flu-like symptoms"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Influenza like illness"	""	""	""	""	""	""	""	""	""	""	""	""
"2952"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	4912449002	"Hypocalcemia"	353	357	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519088753	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2953"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3280723001	"Hyponatremia"	320	357	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497283824	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2954"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	5002796002	"Hyponatremia"	353	356	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519865580	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"2955"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3085015001	"Left Hip Pain"	241	357	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492100255	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2956"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3280701001	"Leukopenia"	12	17	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497283643	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2957"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3365806001	"Lower Back Pain"	342	357	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499287049	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2958"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3085012001	"Lower Back Pain"	194	341	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492100183	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2959"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3255542001	"Lower extremity cellulitis"	263	291	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496274365	""	""	""	NA	"Cellulitis"	"Infections and infestations"	"Bacterial infectious disorders"	"Bacterial infections NEC"	"Cellulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2960"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3454501001	"Metabolic Acidosis"	353	357	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501003442	""	""	""	NA	"Metabolic acidosis"	"Metabolism and nutrition disorders"	"Acid-base disorders"	"Metabolic acidoses (excl diabetic acidoses)"	"Metabolic acidosis"	""	""	""	""	""	""	""	""	""	""	""	""
"2961"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	5002761002	"Muscle spasms"	342	346	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519865182	""	""	""	NA	"Muscle spasms"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"2962"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3365959001	"Muscle weakness - lower extremity"	321	357	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499288004	""	""	""	NA	"Lower extremities weakness of"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"2963"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2769622001	"Nail Change"	89	353	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1478730136	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2964"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3280636001	"Neutropenia"	12	17	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497283009	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2965"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3416641001	"Neutropenic Sepsis"	353	357	NA	5	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	4	0	NA	0	12	NA	NA	1	1	NA	NA	NA	""	357	357	0	353	357	"(7/9/07) ANC = 0.4 on admission, fever up to 108 F, negative chest xray, negative urine, blood and sputum cultures."	""	""	2	2	2	NA	2	2	NA	2	"Patient was admitted with fever, hypotension, confusion, in respiratory distress requiring intubation.	Started on vancomycin, cefepime, fluconazole, neupogen and received blood transfusions."	"Despite all supportive care pateint died of overwhelming neutropenic sepsis."	""	""	""	""	""	""	""	""	""	NA	NA	""	1499974589	""	""	""	NA	"Neutropenic sepsis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Sepsis, bacteraemia and viraemia"	"Neutropenic sepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"2966"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3365902001	"Peripheral sensory neuropathy"	336	357	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499287644	""	""	""	NA	"Peripheral sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2967"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3255464001	"Upper Respiratory Infection"	294	311	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496273746	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2968"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3365869001	"Worsened depression"	342	357	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499287507	""	""	""	NA	"Depression worsened"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"2969"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2717863001	"Worsened peripheral edema"	68	110	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476141136	""	""	""	NA	"Peripheral edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2970"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	3255446001	"Worsened peripheral edema"	244	357	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496273505	""	""	""	NA	"Peripheral edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2971"	"DN-101 Protocol No. 011-007"	"115"	"115-0001"	5	9	"Adverse Event/Serious Adverse Event"	2679609001	"Worsened Peripheral edema"	47	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473801983	""	""	""	NA	"Peripheral edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"2972"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	3017422003	"abdominal pain (middle upper)"	45	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496805444	""	""	""	NA	"Abdominal pain upper"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"2973"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	3949584001	"Bilateral femur pain"	104	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509076231	""	""	""	NA	"Pain femoral"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2974"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	5275345002	"Constipation"	130	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523231197	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2975"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	3269119001	"Fatigue"	52	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496804403	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"2976"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	5275379002	"gastritis"	108	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523231535	""	""	""	NA	"Gastritis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Gastritis (excl infective)"	"Gastritis"	""	""	""	""	""	""	""	""	""	""	""	""
"2977"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	3120386001	"Hematuria"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492997601	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"2978"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	4304678001	"Low Hemoglobin - 79"	252	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"transfuse 2 units of blood"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513632752	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"2979"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	3373455001	"Middle lower back pain"	115	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499387279	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2980"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	3269169001	"Nail changes"	73	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496805660	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"2981"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	4289529001	"Pain Upper Left scapular"	155	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513540939	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2982"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	3373461001	"Right lateral abdominal discomfort"	58	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499387410	""	""	""	NA	"Abdominal discomfort"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Abdominal discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"2983"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	4289473001	"Right sided groin pain"	171	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513540794	""	""	""	NA	"Groin pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Soft tissue disorders NEC"	"Groin pain"	""	""	""	""	""	""	""	""	""	""	""	""
"2984"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	4289428001	"Upper Respiratiory Infection"	176	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513540605	""	""	""	NA	"Infection upper respiratory"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2985"	"DN-101 Protocol No. 011-007"	"116"	"116-0001"	5	9	"Adverse Event/Serious Adverse Event"	3641675001	"urinary tract infection"	108	178	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504731642	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"2986"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	3180812003	"atrial fibrilation"	137	138	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	140	NA	NA	137	138	"ecg- atrial fibrilation with rate 137 beats/min; cardiac enzymes as folllows: CK 28 30-200;					     TROPONIN 1- 0.02"	""	""	0	0	0	NA	0	0	NA	0	"PT PRESENTED TO EMERGENCY ROOM ON SEPTEMBER 15TH  WITH WEAKNESSS, FATIGUE AND A FLUTTERING FEELING IN HIS CHEST . ATRIAL FIBRILLATION. FAST VENTRICULAR RESPONSE. VITAL SIGNS REVEAL BP  134/59, PULSE"	"130-140.; ECG AS ABOVE REVEALS AT. FIB."	""	""	""	""	""	""	""	""	""	NA	NA	""	1505774622	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"2987"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	3640138001	"Constipation"	104	108	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504723272	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2988"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	3635959001	"constipation"	57	79	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504662009	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"2989"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	3663348001	"febrile neutropenia"	130	134	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"tazocin antibiotic"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	133	NA	NA	130	134	"hematology: wbc 0.58 2007 09 08;		    neut 0.10; electrolytes: sodium 125"	""	""	2	2	2	2	2	2	2	2	"subject completed cycle 6 on 2007-08-29. presented to emergency on 2007 09 08 with fever,chills,mild cough and hoarsness of voice. Hospitalized and iv antibioics initiated"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505143187	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"2990"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	3269396001	"Hot flashes"	22	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496812302	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"2991"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	4293091001	"Hypertension"	138	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513553331	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"2992"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	3640224001	"Insomnia"	99	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504723924	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"2993"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	4293060001	"Mucositis (oral - clilnical examination)"	16	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513553088	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"2994"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	4293071001	"Neuropathy-sensory"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513553194	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"2995"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	3635894001	"Rectal Pain"	64	79	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504661681	""	""	""	NA	"Rectal pain"	"Gastrointestinal disorders"	"Anal and rectal conditions NEC"	"Anal and rectal pains"	"Proctalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"2996"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	3346852001	"Taste alteration (Dysgeusia)"	17	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498783942	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"2997"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	3640191001	"Toe Nail discoloration"	103	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504723631	""	""	""	NA	"Discoloration nail"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"2998"	"DN-101 Protocol No. 011-007"	"116"	"116-0002"	5	9	"Adverse Event/Serious Adverse Event"	3640108001	"Tooth pain"	103	117	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504723093	""	""	""	NA	"Tooth pain"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Dental pain and sensation disorders"	"Toothache"	""	""	""	""	""	""	""	""	""	""	""	""
"2999"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2564548003	"allergic rhinitis"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466607700	""	""	""	NA	"Allergic rhinitis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal congestion and inflammations"	"Rhinitis allergic"	""	""	""	""	""	""	""	""	""	""	""	""
"3000"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2579486001	"Alopecia"	14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464278389	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3001"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2596141001	"anemia"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612095	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3002"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	4736171002	"Anxiety"	132	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517436978	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"3003"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2579490001	"arthralgia"	16	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464278467	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3004"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2573653001	"arthralgia"	10	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463423817	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3005"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	4735233002	"bilateral pulmonary emboli"	397	400	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	644	NA	NA	397	400	"Chest X-ray, EKG w/ finding of atrial fibrillation w/ nonspecific inferolateral T-wave changes, CT-chest confirmed bilateral pulmonary emboli, worse in right lung"	""	""	2	2	2	NA	2	2	NA	2	"Patient admitted under presumed diagnosis of pneumonia and begun on IV Levaquin and azithromycin. D-dimer level did return elevated at 3.01. SubQ lovenox was begun and CT chest performed with results"	"reported above. Filter was placed after consultation with all involved parties (patient, wife, Dr. Niedermeyer and Dr. Greco)."	""	""	""	""	""	""	""	""	""	NA	NA	""	1517434303	""	""	""	NA	"Embolism pulmonary"	"Respiratory, thoracic and mediastinal disorders"	"Pulmonary vascular disorders"	"Pulmonary thrombotic and embolic conditions"	"Pulmonary embolism"	""	""	""	""	""	""	""	""	""	""	""	""
"3006"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2721097001	"crepitus of right wrist"	131	194	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476214797	""	""	""	NA	"Crepitations NOS"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Crepitations"	""	""	""	""	""	""	""	""	""	""	""	""
"3007"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2817780001	"decreased albumin"	181	216	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481488249	""	""	""	NA	"Albumin decreased"	"Investigations"	"Protein and chemistry analyses NEC"	"Protein analyses NEC"	"Blood albumin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3008"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2817787001	"decreased globulin"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481488311	""	""	""	NA	"Globulin decreased"	"Investigations"	"Protein and chemistry analyses NEC"	"Protein analyses NEC"	"Globulins decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3009"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664822001	"dizziness"	76	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101461	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"3010"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2583525001	"Dry Eyes"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465157636	""	""	""	NA	"Dry eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Dry eye"	""	""	""	""	""	""	""	""	""	""	""	""
"3011"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2720535001	"edema-pedal"	123	132	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476210554	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3012"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664762001	"elevated cholesterol"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101022	""	""	""	NA	"High cholesterol"	"Investigations"	"Lipid analyses"	"Cholesterol analyses"	"Blood cholesterol increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3013"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2573693001	"fatigue"	10	12	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463424592	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3014"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2596015001	"fatigue"	52	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466607115	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3015"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2596018001	"fatigue"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466607183	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3016"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2583491001	"fatigue"	13	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465156942	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3017"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2579511001	"Fever"	15	17	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464279496	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3018"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2579514001	"groin hernia"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"patient encouraged to wear girdle"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1464279643	""	""	""	NA	"Hernia inguinal"	"Gastrointestinal disorders"	"Abdominal hernias and other abdominal wall conditions"	"Inguinal hernias"	"Inguinal hernia"	""	""	""	""	""	""	""	""	""	""	""	""
"3019"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2573672001	"insomnia"	8	11	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463424330	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3020"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2817751001	"left pedal edema"	132	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481487828	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3021"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664880001	"leukopenia"	84	181	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101828	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3022"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664965001	"leukopenia"	98	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473102482	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3023"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2596150001	"leukopenia"	34	41	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612383	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3024"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2596153001	"leukopenia"	55	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612440	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3025"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664988001	"leukopenia"	105	126	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473102639	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3026"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2596144001	"lymphopenia"	27	41	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612229	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3027"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2596147001	"lymphopenia"	48	55	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612294	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3028"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2844466001	"neuropathy"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482946441	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3029"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2573820001	"neutropenia"	13	21	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1463425865	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3030"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2596156001	"neutropenia"	55	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466612530	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3031"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664975001	"neutropenia"	105	126	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473102563	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3032"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664957001	"neutropenia"	98	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473102415	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3033"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2583529001	"neutropenia"	34	41	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1465157985	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3034"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664859001	"neutropenia"	77	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101649	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3035"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2720416001	"neutropenia"	119	126	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476209802	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3036"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2721048001	"non-cardiac left chest pain"	132	133	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476214654	""	""	""	NA	"Non-cardiac chest pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3037"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664944001	"nose bleed"	85	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473102297	""	""	""	NA	"Nose bleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"3038"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664936001	"nose bleed"	82	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473102216	""	""	""	NA	"Nose bleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"3039"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2721079001	"shortness of breath"	132	133	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476214726	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3040"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2817790001	"shortness of breath"	161	194	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481488409	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3041"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2596290001	"skin sensitivity"	42	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466614613	""	""	""	NA	"Increased skin sensitivity"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hyperaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"3042"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664805001	"taste changes"	70	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101367	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"3043"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664870001	"thrombocytopenia"	77	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101710	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3044"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	4735328002	"upper respitory tract infection"	397	400	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517434589	""	""	""	NA	"Upper respiratory tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3045"	"DN-101 Protocol No. 011-007"	"117"	"117-0001"	5	9	"Adverse Event/Serious Adverse Event"	2664845001	"weight loss"	77	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473101562	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3046"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2585834003	"Anemia"	328	330	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	582	NA	NA	328	330	"CBC done 4/25/07. HGB - 8.6, HCT-25.5, WBC- 2.9."	""	""	2	2	2	NA	2	2	NA	2	"Patient recently began to decline, with increasing pain, worsening anemia and increasing PSA. He was admitted to the hospital related to decreased HCT	for transfusion. Received total of 3 units"	"PRBCs and improved. Hospice suggested. Discharged home on 4/27/07"	""	""	""	""	""	""	""	""	""	NA	NA	""	1515087076	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3047"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2595071001	"anemia"	7	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1466434378	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3048"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661500001	"anemia"	32	33	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472743533	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3049"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661470001	"arthralgia"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472742703	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3050"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2716434001	"chills"	103	104	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122344	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"3051"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	4384665001	"Constipation"	NA	323	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Prune juice"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515087816	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3052"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661560001	"constipation"	60	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744704	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3053"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661557001	"cough"	65	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744600	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3054"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2716441001	"fatgue"	105	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122506	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3055"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661544001	"fatigue"	30	103	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744432	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3056"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2716438001	"fatigue"	103	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122439	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3057"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661580001	"fever"	81	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744846	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3058"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2716431001	"fever"	103	104	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122250	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3059"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2603447001	"fever"	31	34	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	36	NA	NA	31	34	"See faxed lab results from 03/JUL/2006 and 05/JUL/2006."	""	""	2	2	2	NA	2	2	NA	2	"Patient presented to ER with fever of 102, etiolgy unknown, on 02/JUL/2006.  He was admitted to hospital for observation.  He recieved levaquin  and two units of blood for his anemia.  He was"	"discharged 05/JUL/2006."	""	""	""	""	""	""	""	""	""	NA	NA	""	1467899346	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3060"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661551001	"fever"	65	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744519	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3061"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661538001	"indigestion"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744272	""	""	""	NA	"Indigestion"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"3062"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2716453001	"leukopenia"	105	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122652	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3063"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661716001	"leukopenia"	84	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472747159	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3064"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661591001	"nasal congestion"	81	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744948	""	""	""	NA	"Nasal congestion"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal congestion and inflammations"	"Nasal congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"3065"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661627001	"neutropenia"	84	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472745188	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3066"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2716444001	"neutropenia"	105	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122577	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3067"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661489001	"pain- back"	28	34	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472743195	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3068"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661541001	"pain- back"	57	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744358	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3069"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2716428001	"peripheral neuropathy"	98	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122127	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3070"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2788572001	"pneumonia"	176	181	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	179	NA	NA	176	181	"Chest x-ray PA and lateral on 11/24/06 findings: new lilateral bibasilar infiltrates and minimal pleural fluid present bilaterally. 11/24/06 labs: WBC 1.64, RBC 3.64, HGB 11.0, HCT 35.0, sodium 136,"	"BUN 39, and creatinine 1.9  11-26-06 labs: WBC 7.59, RBC 2.77, HGB 8.6, HCT 26.4"	""	2	2	2	NA	2	2	NA	2	"the patient was admitted to the hospital on 11-24-06 for shortness of breath and fever.  chest x-ray showed pneumonia.	He had grade 3 leukopenia and grade 1 anemia.  he recieved 2 units of packed"	"red blood cells.  He currently remains in the hospital.  Patient discharged from hospital 11/29/06.  Per discharge summary, patient also presented with chills and cough.  Patient was started on"	"levaquin and diflucan.	He was also given mild hydration because of his renal toxicity.  Patient was quite weak and required physical therapy. after discharge he will recieve physical therapy."	""	""	""	""	""	""	""	""	NA	NA	""	1480277175	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"3071"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661475001	"shortness of breath"	9	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472742793	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3072"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661608001	"sweats"	81	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472745120	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"3073"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2716471001	"thrombocytopenia"	105	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476122805	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3074"	"DN-101 Protocol No. 011-007"	"117"	"117-0002"	5	9	"Adverse Event/Serious Adverse Event"	2661529001	"thrombocytopenia"	57	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472744099	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3075"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2614756003	"alopecia"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473002077	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3076"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2731515001	"ambulation difficulty"	73	98	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476391258	""	""	""	NA	"Walking difficulty"	"General disorders and administration site conditions"	"General system disorders NEC"	"Gait disturbances"	"Difficulty in walking"	""	""	""	""	""	""	""	""	""	""	""	""
"3077"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2662904001	"anemia"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473002013	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3078"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5068745002	"Anemia"	202	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520530365	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3079"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5069014002	"Arthalgias"	542	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520531181	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3080"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2731409001	"balance difficulty"	73	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476390763	""	""	""	NA	"Balance difficulty"	"Nervous system disorders"	"Neurological disorders NEC"	"Cerebellar coordination and balance disturbances"	"Balance disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"3081"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2723895001	"constipation"	85	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476290054	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3082"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2723816001	"constipation"	41	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289605	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3083"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5068406002	"constipation"	189	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520529114	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3084"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5062697002	"Dehydration"	83	83	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520458225	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"3085"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5067634002	"Dehydration"	94	94	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520527208	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"3086"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5068771002	"dizziness"	384	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"Hydration"	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520530479	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"3087"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2731360001	"double vision"	73	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476390286	""	""	""	NA	"Double vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Diplopia"	""	""	""	""	""	""	""	""	""	""	""	""
"3088"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	4272788001	"elevated LDH"	94	189	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513201173	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3089"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	4272876001	"Elevated phosphorus"	94	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513201517	""	""	""	NA	"Blood phosphorus increased"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood phosphorus increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3090"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2723886001	"fatigue"	77	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289986	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3091"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5071107002	"headache"	420	426	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520538747	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"3092"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5068051002	"Hypotension"	103	112	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520527999	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"3093"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2662910001	"insomnia"	42	52	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473002145	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3094"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2723830001	"insomnia"	75	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289665	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3095"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5068840002	"Knee Pain"	454	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520530745	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3096"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5068982002	"Left jaw pain"	542	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520531082	""	""	""	NA	"Jaw pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Pain in jaw"	""	""	""	""	""	""	""	""	""	""	""	""
"3097"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5068548002	"leg weakness"	377	384	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520529805	""	""	""	NA	"Weakness of limbs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"3098"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2662901001	"leukopenia"	17	24	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473001935	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3099"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2723863001	"leukopenia"	77	87	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289845	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3100"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5068646002	"lightheadedness"	342	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520530099	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"3101"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2731387001	"malaise"	83	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476390643	""	""	""	NA	"Malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"3102"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2723875001	"neutropenia"	77	87	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289910	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3103"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2662895001	"neutropenia"	17	24	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473001860	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3104"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5068290002	"Neutropenia"	103	112	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520528644	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3105"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5063010002	"oral thrush"	103	113	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520458875	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"3106"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5071123002	"Respitory infection"	447	454	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520538805	""	""	""	NA	"Respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3107"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5068485002	"substernal chest tightness"	279	286	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520529528	""	""	""	NA	"Chest tightness"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Chest discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"3108"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5068133002	"Tachycardia"	103	112	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520528175	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"3109"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2662888001	"trigeminal neuralgia"	17	52	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473001698	""	""	""	NA	"Trigeminal neuralgia"	"Nervous system disorders"	"Cranial nerve disorders (excl neoplasms)"	"Trigeminal disorders"	"Trigeminal neuralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3110"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2723798001	"trigeminal neuralgia"	57	73	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476289459	""	""	""	NA	"Trigeminal neuralgia"	"Nervous system disorders"	"Cranial nerve disorders (excl neoplasms)"	"Trigeminal disorders"	"Trigeminal neuralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3111"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	5068897002	"Upper calf pain"	489	503	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520530891	""	""	""	NA	"Calf pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"3112"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2745454001	"urosepsis"	103	113	NA	4	1	1	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Hospitalized 10/22/06 through 11/1/06.  Patient returned to clinic 1/16/07 no further treatment after hospitalization."	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	104	NA	NA	103	113	"WBC on 10/22/2006 at 660.  ECG revealed tachycardia with a complete RBBB and left axis deviation."	""	""	2	2	2	NA	2	2	2	2	"Pt admitted to hospital 10/22/2006, complaining of abdominal discomfort, fever and chills. Pt presented with tachycardia and hypotension, likely related to underlying neutropenic fever. Pts cardizem"	"was discontinued, he was treated with fluids and placed on neutropenic precautions Pt treated with zithromax 500mg IV qd along with Rocephin 1 gram IV qd.  Pt remains in hospital as of 10/23/2006."	"Patient discharged from hospital 11/1/06 and transferred to an inpatient rehabilition center.  He returned home around thanksgiving and recieved outpatient rehab.  He did not return to the clinic"	"until 1/16/07.	He was taken off study due to taxotere being withheld greater than 4 weeks."	""	""	""	""	""	""	""	NA	NA	""	1477241048	""	""	""	NA	"Urosepsis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Sepsis, bacteraemia and viraemia"	"Urosepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"3113"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2731354001	"weakness"	69	NA	1	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476390199	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3114"	"DN-101 Protocol No. 011-007"	"117"	"117-0004"	5	9	"Adverse Event/Serious Adverse Event"	2662892001	"weight loss"	17	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473001789	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3115"	"DN-101 Protocol No. 011-007"	"117"	"117-0006"	5	9	"Adverse Event/Serious Adverse Event"	2869305003	"Alopecia"	92	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517349086	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3116"	"DN-101 Protocol No. 011-007"	"117"	"117-0006"	5	9	"Adverse Event/Serious Adverse Event"	4712941002	"Dyspnea"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517348607	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3117"	"DN-101 Protocol No. 011-007"	"117"	"117-0006"	5	9	"Adverse Event/Serious Adverse Event"	4712798002	"fatigue"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517348476	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3118"	"DN-101 Protocol No. 011-007"	"117"	"117-0006"	5	9	"Adverse Event/Serious Adverse Event"	4713198002	"Left groin pain"	78	92	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517348858	""	""	""	NA	"Groin pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Soft tissue disorders NEC"	"Groin pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3119"	"DN-101 Protocol No. 011-007"	"117"	"117-0006"	5	9	"Adverse Event/Serious Adverse Event"	3058656001	"tumor pain"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491334109	""	""	""	NA	"Tumor pain"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Cancer-related morbidities"	"Oncologic complications and emergencies"	"Cancer pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3120"	"DN-101 Protocol No. 011-007"	"117"	"117-0007"	5	9	"Adverse Event/Serious Adverse Event"	2911970003	"anemia"	115	174	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498579533	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3121"	"DN-101 Protocol No. 011-007"	"117"	"117-0007"	5	9	"Adverse Event/Serious Adverse Event"	3672286001	"dry skin"	97	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505231717	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"3122"	"DN-101 Protocol No. 011-007"	"117"	"117-0007"	5	9	"Adverse Event/Serious Adverse Event"	3672200001	"fatigue"	97	174	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505231459	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3123"	"DN-101 Protocol No. 011-007"	"117"	"117-0007"	5	9	"Adverse Event/Serious Adverse Event"	3672147001	"fatigue"	55	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505231341	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3124"	"DN-101 Protocol No. 011-007"	"117"	"117-0007"	5	9	"Adverse Event/Serious Adverse Event"	3061848001	"fever"	59	61	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"antibiotic Levaquin given"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491403988	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3125"	"DN-101 Protocol No. 011-007"	"117"	"117-0007"	5	9	"Adverse Event/Serious Adverse Event"	4266587001	"nocturia"	202	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513183991	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"3126"	"DN-101 Protocol No. 011-007"	"117"	"117-0007"	5	9	"Adverse Event/Serious Adverse Event"	3061763001	"thrombocytopenia"	45	55	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491403073	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3127"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	3164223003	"Alopecia"	224	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518989887	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3128"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	4900283002	"back pain"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518989412	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3129"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	3529155001	"ecchymosis"	98	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502734960	""	""	""	NA	"Ecchymosis"	"Skin and subcutaneous tissue disorders"	"Skin vascular abnormalities"	"Purpura and related conditions"	"Ecchymosis"	""	""	""	""	""	""	""	""	""	""	""	""
"3130"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	3529063001	"fatigue"	56	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502734534	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3131"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	3523880001	"hyperglycemia"	13	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502660435	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3132"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	5297105002	"insomnia"	48	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523807255	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3133"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	4900256002	"intermittent numbness in left arm"	140	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518989084	""	""	""	NA	"Numbness of upper arm"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"3134"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	3529019001	"left ear seborrheic keratosis"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502734345	""	""	""	NA	"Seborrheic keratosis"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Cutaneous neoplasms benign"	"Skin neoplasms benign"	"Seborrhoeic keratosis"	""	""	""	""	""	""	""	""	""	""	""	""
"3135"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	3726916001	"leukopenia"	133	182	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505936038	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3136"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	4900316002	"Leukopenia"	196	203	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518989750	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3137"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	3340080001	"leukopenia"	24	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498685743	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3138"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	3340070001	"neutropenia"	20	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498685688	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3139"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	3340097001	"oral mucositis"	35	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"recommended salt in soda"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498685897	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3140"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	3529113001	"paresthesia in hands"	98	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502734729	""	""	""	NA	"Paresthesia hand"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"3141"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	4900265002	"right finger curling"	140	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518989286	""	""	""	NA	"Finger deformity"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)"	"Extremity deformities"	"Finger deformity"	""	""	""	""	""	""	""	""	""	""	""	""
"3142"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	4741827002	"Shingles"	172	195	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517498543	""	""	""	NA	"Shingles"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes zoster"	""	""	""	""	""	""	""	""	""	""	""	""
"3143"	"DN-101 Protocol No. 011-007"	"117"	"117-0010"	5	9	"Adverse Event/Serious Adverse Event"	4741857002	"UTI"	179	195	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517498623	""	""	""	NA	"UTI"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3144"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	3182819003	"Depression"	436	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523458322	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"3145"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	4686749002	"dysgusia"	329	338	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517256227	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"3146"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	4686576002	"Fatigue"	320	380	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517255827	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3147"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	5057197002	"leukopenia"	343	346	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520444848	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3148"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	5287583002	"multiple duodenal ulcers"	344	375	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523463399	""	""	""	NA	"Duodenal ulcer"	"Gastrointestinal disorders"	"Gastrointestinal ulceration and perforation"	"Duodenal ulcers and perforation"	"Duodenal ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"3149"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	4686805002	"nail bed changes"	401	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517256337	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"3150"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	3232733001	"neurally mediated syncope"	300	302	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"pt admitted for testing evaluation, MRI brain-negative, given IV fluids for hydration"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	302	NA	NA	300	302	"MRI brain-negative; chest x-ray- negative; EKG- normal;"	""	""	2	2	2	2	2	2	2	2	"Pt was admitted to hospital after experiencing a couple of episode of fainting after nausea and vomiting.  Patient has history of fainting and hypertension. Current medication is metaprolol."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495486809	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"3151"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	3691220001	"Neutropenia"	325	329	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505415313	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3152"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	5056376002	"night sweats head and neck"	498	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520441935	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"3153"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	4687644002	"Oral moniliasis"	346	365	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517258190	""	""	""	NA	"Oral moniliasis"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"3154"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	5056489002	"Right hip pain"	527	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520442206	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3155"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	5056406002	"Right plantar foot pain"	562	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520442019	""	""	""	NA	"Foot pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"3156"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	3357672001	"syncopal episode"	343	346	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	344	NA	NA	343	346	"on admission, glucose 161 and WBC 1.5. Cardiac enzymes within normal limits."	""	""	2	2	2	NA	2	2	NA	2	"patient experienced a syncopal episode on 7/2/07.  He was admitted to the hospital  and is being evaluated by a neurologist. MRI of Head was normal.  CT of abdomen revealed a retrocecal appendix"	"extending to the infrerior liver edge, this was felt to be a nonspecific finding.  He was placed on Neupogen and levaquin. Gallbladder ultrasound was negative.  Upper endoscopy showed multiple"	"duodenal ulcerations.  he was started on prilosec. patient discharged 7/5/07."	""	""	""	""	""	""	""	""	NA	NA	""	1499107382	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"3157"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	5057053002	"syncope"	405	406	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520444177	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"3158"	"DN-101 Protocol No. 011-007"	"117"	"117-0011"	5	9	"Adverse Event/Serious Adverse Event"	3878793001	"Vasovagal Syncope"	432	436	NA	3	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	449	NA	NA	432	436	"CBC - 10/3/07 - increasing white count secondary to steroid therapy, not infectious episode.; Echo - 10/01/07 - negative"	""	""	2	2	2	NA	2	2	NA	2	"Patient admitted after experiencing severe syncopal episodes.  Admitted to coronary care unit, intial bradycardia caused concern that patient might be candidate for a pacemaker. Pacemaker ruled"	"out.;;Received normal saline 500ml per IV bolus for hypotension, Zoloft and midodrine.;;Discharged to home on 10/3/07 and followed up with Dr. Mainwaring"	""	""	""	""	""	""	""	""	""	NA	NA	""	1508163722	""	""	""	NA	"Syncope vasovagal"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope vasovagal"	""	""	""	""	""	""	""	""	""	""	""	""
"3159"	"DN-101 Protocol No. 011-007"	"117"	"117-0013"	5	9	"Adverse Event/Serious Adverse Event"	3420672003	"Asthenia"	35	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517343197	""	""	""	NA	"Asthenia"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3160"	"DN-101 Protocol No. 011-007"	"117"	"117-0013"	5	9	"Adverse Event/Serious Adverse Event"	4708965002	"Edema"	126	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517343320	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"3161"	"DN-101 Protocol No. 011-007"	"117"	"117-0013"	5	9	"Adverse Event/Serious Adverse Event"	5069337002	"Mouth sores"	113	126	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520531948	""	""	""	NA	"Sores mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3162"	"DN-101 Protocol No. 011-007"	"117"	"117-0013"	5	9	"Adverse Event/Serious Adverse Event"	4708636002	"Myalgia"	21	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517342878	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3163"	"DN-101 Protocol No. 011-007"	"117"	"117-0013"	5	9	"Adverse Event/Serious Adverse Event"	4708819002	"Neutropenia"	21	35	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517343099	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3164"	"DN-101 Protocol No. 011-007"	"117"	"117-0013"	5	9	"Adverse Event/Serious Adverse Event"	4708412002	"Pain - extremities"	18	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517342567	""	""	""	NA	"Pain of extremities"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"3165"	"DN-101 Protocol No. 011-007"	"117"	"117-0013"	5	9	"Adverse Event/Serious Adverse Event"	4708481002	"Sore mouth"	21	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517342674	""	""	""	NA	"Sore mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Oral soft tissue pain and paraesthesia"	"Oral pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3166"	"DN-101 Protocol No. 011-007"	"117"	"117-0014"	5	9	"Adverse Event/Serious Adverse Event"	3492067003	"alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506373654	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3167"	"DN-101 Protocol No. 011-007"	"117"	"117-0014"	5	9	"Adverse Event/Serious Adverse Event"	3760971001	"arthralgia"	7	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506372357	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3168"	"DN-101 Protocol No. 011-007"	"117"	"117-0014"	5	9	"Adverse Event/Serious Adverse Event"	3761255001	"dry cough"	35	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506373538	""	""	""	NA	"Dry cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3169"	"DN-101 Protocol No. 011-007"	"117"	"117-0014"	5	9	"Adverse Event/Serious Adverse Event"	3761283001	"dry skin"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506373706	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"3170"	"DN-101 Protocol No. 011-007"	"117"	"117-0014"	5	9	"Adverse Event/Serious Adverse Event"	3761039001	"hyperglycemia"	28	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506372622	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3171"	"DN-101 Protocol No. 011-007"	"117"	"117-0014"	5	9	"Adverse Event/Serious Adverse Event"	3761268001	"lower extremity swelling"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506373604	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3172"	"DN-101 Protocol No. 011-007"	"117"	"117-0014"	5	9	"Adverse Event/Serious Adverse Event"	3760985001	"myalgia"	7	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506372422	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3173"	"DN-101 Protocol No. 011-007"	"117"	"117-0015"	5	9	"Adverse Event/Serious Adverse Event"	3522557003	"Anemia"	46	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509480960	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3174"	"DN-101 Protocol No. 011-007"	"117"	"117-0015"	5	9	"Adverse Event/Serious Adverse Event"	3686496001	"Arthralgia"	9	14	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505333084	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3175"	"DN-101 Protocol No. 011-007"	"117"	"117-0015"	5	9	"Adverse Event/Serious Adverse Event"	4358388001	"Bilateral Edema"	27	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514733878	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"3176"	"DN-101 Protocol No. 011-007"	"117"	"117-0015"	5	9	"Adverse Event/Serious Adverse Event"	3686397001	"Fatigue"	8	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505332553	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3177"	"DN-101 Protocol No. 011-007"	"117"	"117-0015"	5	9	"Adverse Event/Serious Adverse Event"	3686471001	"Myalgias"	9	14	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505332970	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3178"	"DN-101 Protocol No. 011-007"	"117"	"117-0015"	5	9	"Adverse Event/Serious Adverse Event"	4393635002	"Nail bed changes"	132	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515337558	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"3179"	"DN-101 Protocol No. 011-007"	"117"	"117-0015"	5	9	"Adverse Event/Serious Adverse Event"	3976986001	"Tremors"	47	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509481077	""	""	""	NA	"Tremor"	"Nervous system disorders"	"Movement disorders (incl Parkinsonism)"	"Tremor (excl congenital)"	"Tremor"	""	""	""	""	""	""	""	""	""	""	""	""
"3180"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	2914029003	"Achilles Tear"	216	300	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Physical Therapy"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505146904	""	""	""	NA	"Achilles tendon rupture"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Muscle, tendon and ligament injuries"	"Tendon rupture"	""	""	""	""	""	""	""	""	""	""	""	""
"3181"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3411523001	"Anemia"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499882380	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3182"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	5119846002	"Chills"	118	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521125446	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"3183"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3411183001	"Constipation"	91	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499880209	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3184"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	4193872001	"Dyspnea"	174	237	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512488019	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3185"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3609129001	"Fatigue"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504183715	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3186"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3609111001	"Fatigue"	49	69	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504183591	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3187"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3055000001	"Fever"	33	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491247106	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3188"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3411810001	"Fever"	118	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499884252	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3189"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3411692001	"Hot Flashes"	104	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499883631	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"3190"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3411866001	"Nail Changes"	153	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499884700	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"3191"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3595240001	"Occlusive thrombus in bilateral posterior tibial veins"	153	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504035843	""	""	""	NA	"Thrombosis"	"Vascular disorders"	"Embolism and thrombosis"	"Non-site specific embolism and thrombosis"	"Thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"3192"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3476437001	"Peripheral Edema"	153	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501601341	""	""	""	NA	"Peripheral edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3193"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3149779001	"Rales at both lung bases"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493648271	""	""	""	NA	"Rales"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Lower respiratory tract signs and symptoms"	"Rales"	""	""	""	""	""	""	""	""	""	""	""	""
"3194"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3054987001	"Rash on right forearm"	27	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491246942	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"3195"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	4194525001	"Shoulder Pain"	174	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512490019	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3196"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3054994001	"Skin breakdown"	28	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491247040	""	""	""	NA	"Skin breakdown"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"3197"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	4194363001	"Skin Tag"	195	216	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512489318	""	""	""	NA	"Skin tags"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Cutaneous neoplasms benign"	"Skin neoplasms benign"	"Acrochordon"	""	""	""	""	""	""	""	""	""	""	""	""
"3198"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3411883001	"Tearing"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499884949	""	""	""	NA	"Lacrimation"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3199"	"DN-101 Protocol No. 011-007"	"118"	"118-0001"	5	9	"Adverse Event/Serious Adverse Event"	3054977001	"Wooziness"	26	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491246832	""	""	""	NA	"Wooziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"3200"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	2758073003	"abdominal pain"	301	335	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518544832	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3201"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3002342001	"alopecia"	24	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489604208	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3202"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3991849001	"bladder infection"	367	370	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509649152	""	""	""	NA	"Bladder infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Cystitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3203"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3002582001	"chill"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489606641	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"3204"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3898768001	"cholecystitis"	332	342	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	356	NA	NA	332	349	"laparoscopic cholecystectomy with intraoperative cholangiogram."	""	""	2	2	2	NA	2	2	NA	2	"Patient presented to the emergency room and was admitted into the hospital on 9/24/07 because of refractory and recurrent nausea and vomiting.	Patient also complained of grade 3 abdominal pain and"	"intermittent grade 2 dyspnea for about 4 weeks which has coincided with abdominal pain. The doctor states that patient's dyspnea is likely a combination deconditioning, asthma, and pulmonary"	"metastatic disease.;Patient does have a history of kidney stones.  He also has a history of polycystic kidney which is probably causing the kidney stones.  history of Polycystic kidney was noted on"	"8/20/1985.  allopurinol is already on the conmed page."	""	""	""	""	""	""	""	NA	NA	""	1508342547	""	""	""	NA	"Cholecystitis"	"Hepatobiliary disorders"	"Gallbladder disorders"	"Cholecystitis and cholelithiasis"	"Cholecystitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3205"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3002629001	"dyspnea"	55	148	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489607188	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3206"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	4868125002	"dyspnea"	301	370	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518543808	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3207"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3002598001	"fatigue"	55	75	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489606826	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3208"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3142884001	"fatigue"	129	151	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493567639	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3209"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3016867001	"fever"	90	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490127607	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3210"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	2965215001	"fever"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488122916	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3211"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3016771001	"fungal infection"	55	101	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490127045	""	""	""	NA	"Fungal infection"	"Infections and infestations"	"Fungal infectious disorders"	"Fungal infections NEC"	"Fungal infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3212"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3901645001	"hemorrhage, GI (rectum)"	342	348	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508356097	""	""	""	NA	"GI hemorrhage"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"3213"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	4383758001	"high alkaline phosphatase"	347	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515083626	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3214"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3901839001	"high alkaline phosphatase"	298	326	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508356841	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3215"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3901897001	"high alkaline phosphatase"	327	346	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508357046	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3216"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3016828001	"infection (catheter related)"	102	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490127336	""	""	""	NA	"Catheter related infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Catheter related infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3217"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3002624001	"infection (catheter related)"	48	102	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489607085	""	""	""	NA	"Catheter related infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Catheter related infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3218"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3142864001	"infection(cath related)"	74	102	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493567424	""	""	""	NA	"Catheter related infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Catheter related infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3219"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	2864160001	"insomnia"	4	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484080251	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3220"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	4385997001	"low hemoglobin"	403	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515093804	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3221"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3016735001	"muscle weakness"	76	151	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490126900	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"3222"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3002647001	"myalgia"	40	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489607378	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3223"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3142895001	"nail changes"	151	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493567801	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"3224"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	4272450001	"nausea"	406	412	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	412	NA	NA	406	412	"please see event description."	""	""	2	2	2	2	2	2	2	2	"Patient was admitted into the hospital on 12/7/07 for weakness, nausea and vomiting.  He a right uper quadrant ultrasound done on 12/9/07 which was normal. He also had a head CT to rule out any"	"central reason for nausea and vomiting.  The patient's iron and C.Diff. toxin were also checked to rule out any infectious reason for nausea and vomiting. He was given zofran in the emergency room ."	"A KUB was also done and showed no acute findings.  Patient was discharged to a nursing and rehabilitation center and will be followed by Hospice."	""	""	""	""	""	""	""	""	NA	NA	""	1513200058	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"3225"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3896863001	"nausea"	329	342	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	356	NA	NA	332	349	"cholecystectomy with intraoperative cholangiogram (9/27/2007)"	""	""	2	2	2	NA	2	2	NA	2	"Patient presented to the emergency room and was admitted into the hospital on 9/24/07 because of refractory and recurrent nausea and vomiting.	Patient also complained of grade 3 abdominal pain and"	"intermittent grade 2 dyspnea for about 4 weeks which has coincided with abdominal pain. The doctor states that patient's dyspnea is likely a combination deconditioning, asthma, and pulmonary"	"metastatic disease."	""	""	""	""	""	""	""	""	NA	NA	""	1508330241	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"3226"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3892225001	"nausea"	298	305	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	355	NA	NA	298	305	"esophagogastroduodenoscopy (8/23/07) to exclude significant mucosal disease of the upper GI tract. Biopsies were obtained with this procedure to r/o cancer and H.pylori.   UGI(single) (8/22/07) which"	"showed poor gastric distention. , Ultrasound of abdomen (8/22/07) revealed cholelithiasis.Gallbladder emptying study(8/24/07)-abnormal gallbladder ejection fraction.  Gastric emptying 8/27/07 -normal"	""	2	2	2	NA	2	2	NA	2	"Patient presented to our office for a routine visit.  Patient complained of grade 2 nausea, vomiting, and weakness. The doctor thought it was best to have the patient admitted into the hospital for"	"hydration and obtain a gastroenterology consult for further evaluation and treatment of nausea and vomiting."	""	""	""	""	""	""	""	""	""	NA	NA	""	1508269050	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"3227"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3324473001	"shortness of breath"	234	244	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	241	NA	NA	235	244	"CT Chest on 2007-06-19 and 2007-06-22. CT scan states \"the lung fields reveal no evidence of infiltrate or pulmonary edema. No acute cardiopulmonary process is identified.\""	""	""	2	2	2	NA	2	2	NA	2	"Patient completed study on 5/29/07. Completed 10 cylcles. On 6/19/07 he arrived at the hospital with grade 3 weakness, shortness of breath (suspicious of pneumonia), and grade 3 urinary tract"	"infection. He was admitted for IV antibiotic therapy and supportive care."	""	""	""	""	""	""	""	""	""	NA	NA	""	1498485797	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3228"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3320522001	"urinary tract infection"	235	244	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	235	NA	NA	235	244	"urine culture done on 6/19/07 and 6/24/07 both showed multiple species of questionable significane--repeat culture if clinically indicated.  ;urinalysis done on 6/24/07 showed cloudy appearance, spec"	"grav. showed 1.012, PH= 5.5, blood= moderate, RBC=21-50, WBC = 11-20, bacteria= few."	""	2	2	2	NA	2	2	NA	2	"Patient completed study on 5/29/07 (cycle 10). On 6/19/07 he arrived at the hospita with grade 3 weakness, pneumonia, and an urinary tract infection.  He was admitted for IV antibiotic therapy and"	"supportive care."	""	""	""	""	""	""	""	""	""	NA	NA	""	1498408517	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3229"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	4272620001	"vomiting"	406	412	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	412	NA	NA	406	412	"Please see note below"	""	""	2	2	2	NA	2	2	2	2	"Patient admitted into the hospital for severe weakness, nausea and vomiting.  A CT head was done to rule out central reason for nausea and vomiting. KUB was also done. Iron studies and C.Diff. toxin"	"were done to rule out infectious reason for nausea and vomiting.  Patient is being discharged to a nursing and rehabilitaion center and will be followed by Hospice."	""	""	""	""	""	""	""	""	""	NA	NA	""	1513200654	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"3230"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3892563001	"vomiting"	298	300	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	-1836	NA	NA	298	305	"Abdominal ultrasound (8/22/2007)-revealed cholelithiasis. UGI (single) 8/22/07- revealed sliding hiatal hernia. Esophagogastroduodenoscopy 8/23/2007. Impression was that chronic nausea and vomiting"	"likely secondary to gastroparesis and underlying disease. Gastric Biopsy (823/07). Gallbladder emptying study (8/24/07). Gastric emptying on 8/27/07."	""	2	2	2	NA	2	2	NA	2	"Patient presented to our office for a routine visit.  Patient complained of grade 2 nausea, vomiting and weakness.  The doctor thought it was best to have the patient admitted into the hospital for"	"hydration and obtain a gastroenterology constult for further evaluation and treatment of nausea and vomiting."	""	""	""	""	""	""	""	""	""	NA	NA	""	1508270347	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"3231"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3898532001	"vomiting"	332	342	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	356	NA	NA	332	349	"laparoscopic cholecystectomy with intraoperative cholangiogram (9/27/07)"	""	""	2	2	2	NA	2	2	NA	2	"Patient presented to the emergency room and was admitted into the hospital on 9/24/07 because of refractory and recurrent nausea and vomiting.	Patient also complained of grade 3 abdominal pain and"	"intermittent grade 2 dyspnea for about 4 weeks which has coincided with abdominal pain. The doctor states that patient's dyspnea is likely a combination deconditioning, asthma, and pulmonary"	"metastatic disease."	""	""	""	""	""	""	""	""	NA	NA	""	1508341571	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"3232"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3892653001	"weakness"	298	305	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508270855	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3233"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	3320463001	"weakness"	235	244	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	241	NA	NA	235	244	"hematolgy done 6/1907 and 6/20/07- WBC=high RBC=low; chemistry done on 6/19/07, 6/20/07,6/21/07"	""	""	2	2	2	2	2	2	NA	2	"Patient completed study on 5/29/07. On 6/19/07 he arrived at the hospital with grade 3 weakness, pneumonia, and urinary tract infection. He was admitted for IV antibiotic therapy and supportive care."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498407721	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3234"	"DN-101 Protocol No. 011-007"	"119"	"119-0002"	5	9	"Adverse Event/Serious Adverse Event"	4268267001	"weakness"	406	412	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	412	NA	NA	406	412	"Chest x-ray- showed no acute pulmonary disease."	""	""	2	2	2	2	2	2	2	2	"Patient admitted into hospital on 12/7/2007 for severe weakness, nausea and vomiting.  Patient discharged to nursing and rehabilitation center and will be followed by Hospice."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513188475	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3235"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	5	9	"Adverse Event/Serious Adverse Event"	2788285003	"Abdominal Pain"	40	41	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482173998	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3236"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	5	9	"Adverse Event/Serious Adverse Event"	3602730001	"Anemia"	197	211	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504114858	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3237"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	5	9	"Adverse Event/Serious Adverse Event"	3602796001	"Cough"	195	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504115056	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3238"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	5	9	"Adverse Event/Serious Adverse Event"	3168287001	"Diverticulitis"	195	204	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	196	NA	NA	195	204	"WBC 6.9x10-3, Hemoglobin 14.6g/dl, Hematocrit 44.0g, Creatinine .9mg/dl, glucose 257mg/dl.; Vital sounds: Temp99.1, Pulse 104, BP 116/62 Pain 3."	""	""	2	2	2	2	2	2	2	2	"Patient came on May 6-07 to ER, three days ago started with right lower quadrant pain.	Performed Abdomino Pelvic CT and finding of Diverticulitis.;;May 15th 2007 patient was discharge from Hema-onco"	"ward. F/U in August."	""	""	""	""	""	""	""	""	""	NA	NA	""	1494264382	""	""	""	NA	"Diverticulitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Diverticulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3239"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	5	9	"Adverse Event/Serious Adverse Event"	3023486001	"hyperkalemia"	81	123	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490291499	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3240"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	5	9	"Adverse Event/Serious Adverse Event"	3603186001	"hypomagnesemia"	197	199	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504116225	""	""	""	NA	"Hypomagnesemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Magnesium metabolism disorders"	"Hypomagnesaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3241"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	5	9	"Adverse Event/Serious Adverse Event"	3023463001	"leukocytosis"	50	169	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490291317	""	""	""	NA	"Leukocytosis"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukocytoses NEC"	"Leukocytosis"	""	""	""	""	""	""	""	""	""	""	""	""
"3242"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	5	9	"Adverse Event/Serious Adverse Event"	3014502001	"Neuropathy"	109	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490109828	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3243"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	5	9	"Adverse Event/Serious Adverse Event"	3602641001	"neutropenia"	197	211	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504114525	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3244"	"DN-101 Protocol No. 011-007"	"120"	"120-0001"	5	9	"Adverse Event/Serious Adverse Event"	3014521001	"pericecal abcess"	129	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490110033	""	""	""	NA	"Abscess intestinal"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Abscess intestinal"	""	""	""	""	""	""	""	""	""	""	""	""
"3245"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	2576175003	"Bronchitis"	396	442	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502045913	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3246"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	3492874001	"Bronchitis"	232	240	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502042741	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3247"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	2694058001	"Constipation"	114	135	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1474831718	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3248"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	3492893001	"Cough"	232	268	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502042943	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3249"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	3493403001	"Cough"	396	442	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502045789	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3250"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	3871382001	"Depression"	470	512	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508086105	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"3251"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	2621587001	"Fatigue"	35	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"IV hydration"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1469475985	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3252"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	2654431001	"Fatigue"	93	114	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472415832	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3253"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	2705772001	"Fever"	131	135	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475523424	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3254"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	4388827001	"Infection- urinary"	586	591	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515105136	""	""	""	NA	"Urinary infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3255"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	3871455001	"Memory Impairment"	512	533	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Head CT"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508086479	""	""	""	NA	"Memory impairment"	"Nervous system disorders"	"Mental impairment disorders"	"Memory loss (excl dementia)"	"Memory impairment"	""	""	""	""	""	""	""	""	""	""	""	""
"3256"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	2653824001	"Neuropathy- sensory"	93	232	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472403371	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3257"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	4387172001	"Neuropathy- sensory (numbness in fingertips)"	561	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515098156	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3258"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	3492959001	"Night Sweats"	324	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502043499	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"3259"	"DN-101 Protocol No. 011-007"	"121"	"121-0001"	5	9	"Adverse Event/Serious Adverse Event"	3871171001	"Weight loss"	413	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508084692	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3260"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2845998003	"alkaline phosphatate increase intermittent"	14	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485373606	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3261"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	3045528001	"anemia"	77	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490824812	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3262"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	4308105001	"CHEST CONGESTION WITH PRODUCTIVE COUGH"	210	217	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"CHEST X-RAY"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513689019	""	""	""	NA	"Pulmonary congestion"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Pulmonary oedemas"	"Pulmonary congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"3263"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2896357001	"constipation"	20	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485378311	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3264"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2973912001	"cough"	69	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488401377	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3265"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	4307953001	"COUGH"	111	147	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513686415	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3266"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2896421001	"decreased hemoglobin"	21	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485378892	""	""	""	NA	"Decreased hemoglobin"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3267"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2896296001	"dehydration"	21	27	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"given I.V. fluids on 01/09/2007 and 01/12/2007."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485377884	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"3268"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	3503141001	"dehydration"	210	210	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502193310	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"3269"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	4308001001	"EDEMA BILATERAL ANKLES"	168	189	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513687460	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3270"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	3154551001	"edema limb"	119	147	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493748669	""	""	""	NA	"Edema limbs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3271"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	3761904001	"elevated creatinine"	266	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506382596	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3272"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2896380001	"fatigue"	21	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485378610	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3273"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2895851001	"hypercalcemia"	21	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"I.V. FLUIDS ADMINISTERED ON 01/09/2007 AND 01/12/2007 IN THE OUTPATIENT CLINIC."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485374688	""	""	""	NA	"Hypercalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypercalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3274"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2895768001	"hyperglycemia"	14	287	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Instructed to avoid high concentrated sweets and sodas"	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485373116	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3275"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	3761893001	"hyperglycemia"	266	NA	1	1	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506382458	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3276"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	3403891001	"hypertension"	127	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499803613	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"3277"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	4308013001	"HYPERTENSION"	169	189	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513687621	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"3278"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2895798001	"hypoalbuminemia"	14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"started on oral Ensure supplement for increase caloric intake"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485373371	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3279"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2895848001	"hyponatremia"	14	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Instructed patient in increasing fluids by mouth to 6- 8 glasses a day."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485374397	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3280"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2896117001	"HYPOTENSION"	21	27	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"I.V. fluids administered in out patient clinic on 01/09/2007 and 01/12/2007."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485376940	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"3281"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	3503108001	"Hypotension"	210	210	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502193097	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"3282"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2895833001	"increased Creatinine"	14	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"I.V. fluids were administered in outpatient treatment on 01/09/2007 and 01/12/2007"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485374000	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3283"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	4308075001	"LEFT CHESTPAIN RIB CAGE"	208	217	NA	1	0	NA	NA	NA	NA	NA	1	1	NA	5	1	NA	1	"CHEST X-RAY"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513688517	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3284"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	4307934001	"LEUKOPENIA"	42	49	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513685771	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3285"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2896191001	"leukopenia without fever"	21	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Instructions on infection control prevention and face masks provided to patient."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485377299	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3286"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	4307958001	"NAILBED CHANGES DARKENING"	147	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513686686	""	""	""	NA	"Nail discolouration"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"3287"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	4307930001	"NEUTOPENIA"	42	49	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513685549	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3288"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2896217001	"neutropenia without fever"	21	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Instructions given to patient and his son on neutorpenic precautions."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485377456	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3289"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	3154530001	"pulmonary infiltrates ( BRONCHITIS)"	119	147	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"chest x-ray PA/LAT"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493748384	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3290"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	4308133001	"SWELLING UPPER LEFT ARM"	252	266	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"FLOW STUDY DONE 08/28/2007.WAS NORMAL WITH NO SIGN OF THROMBUS"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513689434	""	""	""	NA	"Swelling arm"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3291"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2973866001	"upper pulmonary sinus congestion"	69	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488401188	""	""	""	NA	"Sinus congestion"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Sinus congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"3292"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2896439001	"Urinary Incontinence"	21	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485379052	""	""	""	NA	"Urinary incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"3293"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	4029671001	"urinary incontinence"	64	147	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510272129	""	""	""	NA	"Urinary incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"3294"	"DN-101 Protocol No. 011-007"	"123"	"123-0001"	5	9	"Adverse Event/Serious Adverse Event"	2896405001	"weight loss"	21	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485378788	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3295"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	2971515003	"alkaline phosphatase"	28	150	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492383910	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3296"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	3022618001	"altered mental status"	11	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490283542	""	""	""	NA	"Mental status changes"	"Psychiatric disorders"	"Psychiatric disorders NEC"	"Mental disorders NEC"	"Mental status changes"	""	""	""	""	""	""	""	""	""	""	""	""
"3297"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	3091239001	"constipation"	45	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492384050	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3298"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	3165935001	"edema limb fluid retention lower legs"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494198796	""	""	""	NA	"Edema lower limb"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3299"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	3091257001	"fatigue"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492384241	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3300"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	4360419001	"hematuria"	264	288	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"referral to urologist"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514757885	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"3301"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	3091194001	"hemoglobin"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492383683	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3302"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	3091212001	"hyperglycemia intermittent"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492383810	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3303"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	3293515001	"INSOMNIA"	112	141	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497553972	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3304"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	3370806001	"LEUkopenia"	133	140	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499367510	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3305"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	3165938001	"nail changes darking of curticles"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494199045	""	""	""	NA	"Nail discoloration"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"3306"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	3091247001	"neuropathy sensory"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492384146	""	""	""	NA	"Sensory peripheral neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3307"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	3370851001	"neutropenia"	133	140	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499367727	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3308"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	4371018001	"non insulin dependent diabetes"	272	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514987445	""	""	""	NA	"Diabetes mellitus non-insulin-dependent"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Diabetes mellitus (incl subtypes)"	"Diabetes mellitus non-insulin-dependent"	""	""	""	""	""	""	""	""	""	""	""	""
"3309"	"DN-101 Protocol No. 011-007"	"123"	"123-0002"	5	9	"Adverse Event/Serious Adverse Event"	3370756001	"WEIGHT LOSS"	133	236	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499367297	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3310"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	3149382003	"CONSTIPATION"	89	110	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508705002	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3311"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	3293634001	"CONSTIPATION/ intermittent"	44	189	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497555317	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3312"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	3503377001	"distention /abdominal bloating"	89	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502196347	""	""	""	NA	"Distention"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Abdominal distension"	""	""	""	""	""	""	""	""	""	""	""	""
"3313"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	4293462001	"edema of lower legs"	125	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513555423	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3314"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	3369878001	"fatigue"	66	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499363496	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3315"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	3503382001	"headache frontal INTERMITTENT"	99	180	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502196427	""	""	""	NA	"Frontal headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"3316"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	3369922001	"heartburn"	27	229	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499363708	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"3317"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	3293625001	"HYPERGLYCEMIA/ intermittent"	62	230	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497555234	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3318"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	3503370001	"insomnia"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502196256	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3319"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	4293500001	"muscle pain"	126	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513555655	""	""	""	NA	"Muscle pain"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3320"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	5282673002	"peripheral neuropathy"	146	272	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523379091	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3321"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	3165837001	"sinus allergies"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494197083	""	""	""	NA	"Allergic sinusitis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Allergic sinusitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3322"	"DN-101 Protocol No. 011-007"	"123"	"123-0003"	5	9	"Adverse Event/Serious Adverse Event"	3369951001	"taste alteration"	65	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499363826	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"3323"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	3311184003	"Acute Diverticulitis"	120	138	NA	4	2	NA	1	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508435381	""	""	""	NA	"Acute diverticulitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Diverticulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3324"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	3607547001	"anemia"	13	277	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504137304	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3325"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	4812020002	"Cardiac arrhythmias tachycardia/ Atrial fib intermittent"	121	138	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518019555	""	""	""	NA	"Cardiac arrhythmia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Arrhythmia"	""	""	""	""	""	""	""	""	""	""	""	""
"3326"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502700001	"constipation intermittent"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502188756	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3327"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	4812522002	"diarrhea"	103	105	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	117	NA	NA	103	106	"stool for clostridium Difficile Toxin screen 09/28/2007 was negative."	""	""	2	2	2	2	2	2	2	2	"Patient had reported to nursing staff  at the nursing home patient resides in on 09/21/2007 of loose stools and was medicated with Immmodium and stool softners and laxatives placed on hold. On"	"09/24/2007 patient had no further diarrhea since 09/21/2007.Patient admitted to hospital 09/25/2007 with Urinary Tract Infection and diarrhea of less than 5 stools in 24 hours. Patient given I. V."	"FLUIDS for hydartion for greater than 24 hours and one does of Immodium with diarrhea resolved on 09/27/2007."	""	""	""	""	""	""	""	""	NA	NA	""	1518021382	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3328"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	3607539001	"fatigue"	56	182	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504137202	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3329"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	3833588001	"Hyperglycemia"	105	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507569325	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3330"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	3833595001	"hypocalcemia"	105	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507569417	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3331"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	3833560001	"hypoglycemia"	103	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	117	NA	NA	103	106	"BLOOD GLUCOSE 09/25/2007 = 58, FSBS= 51 MG/DL"	""	""	2	2	2	2	2	2	2	2	"PATIENT GIVEN ONE AMP OF DEXTROSE 50% TO IMPROVE BLOOD SUGAR. Patient is an Insulin dependent diabetic and had received his morning dose of Insulin but had not eaten due to diarrhea and abdominal"	"pain and blood sugar dropped on 09/25/2007. Patient placed on I.V. fluids of D5NS AT 75 CC/HOUR then switched to Normal saline at 75cc/hour after Blood sugar increased to 09/27/2007=191 mg/dl.Patient"	"controlled with Insulin sliding scale while in hospital."	""	""	""	""	""	""	""	""	NA	NA	""	1507569119	""	""	""	NA	"Hypoglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hypoglycaemic conditions NEC"	"Hypoglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3332"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	3833433001	"Infection with normal ANC ( URINARY TRACT INFECTION)"	103	116	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"PATIENT HOSPITALIZED 09/25/2007-0928/2007 AND GIVEN I.V. ANTIBIOTICS/ FLUIDS"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	117	NA	NA	103	106	"URINE CULTURE AND SENSITIVITY 09/25/2007 LAST UPDATED 09/27/2007, Escherichia coli > 100,000 CFU/ML, STOOL CULTURE NEGATIVE FOR C. difficile toxins A/B 09/28/2007, Grade 2 hypoglycemia 51mg/dl"	"09/25/2007, Grade 2 hyperglycemia 217 mg/dl, CT of Brain neg."	""	2	2	2	2	2	2	2	2	"Patient sent to ER from nursing home with complaint of weakness, diarrhea, abdominal pain. FSBS 51 and patient given one amp of Dextrose 50%.Patient found with Urinary Tract infection and"	"hospitalized for I.V. antibiotics and fluids. Diarrhea resolved with one dose of immodium by 09/27/2007.Patient discharged home on oral antibiotics which were completed on 10/08/2007. His mental"	"status improved with antibiotics and re-hydration.Hypocalcemia Grade 1 8.1 09/27/2007,Hypophosphatemia Grade 2 =2.4 09/27/2007."	""	""	""	""	""	""	""	""	NA	NA	""	1507568244	""	""	""	NA	"Infection urinary tract"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3333"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	3999770001	"infection with normal ANC incisional wound"	129	138	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	127	NA	NA	121	138	"URINE CULTURE POSITIVE FOR CANDIDA ALBICANS 10/21/2007 AND WOUND CULTURE OF ABDOMEN POSITIVE FOR E.COLI. BLOOD CULTURES 10/21/2007 SHOWED NO GROWTH AFTER 5 DAYS."	""	""	2	2	0	2	0	2	2	2	"Patient developed urinary and abdominal post operative wound infection.Patient treated with I.V. antibiotics from 10/22/2007- 10/30/2007."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509926569	""	""	""	NA	"Wound infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Wound infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3334"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	3906127001	"perforation,G.I. left colon"	120	138	NA	4	2	NA	1	NA	NA	NA	2	NA	1	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	127	NA	NA	121	138	"Surgical pathology of left colon Acute Diverticulosis with rupture and mesenteric abscess 10/13/2007.10/12/2007 WBC 9.7,HGB 9.7,SEG 92.1, NA+ 131,glucose 169,Calcium 7.3,Albumin 2.7,Corrected Calcium"	"= 8.34"	""	2	2	2	2	2	2	2	2	"Patient presented to the Emergency center on day 4 of Cycle 6 of the Control Arm of Docetaxel 75mg/m2 and prednisone 5 mg twice daily last given on 10/10/2007, with complaint of acute abdominal pain"	"and vomiting x2. Chest x-ray and Abdominal x-ray revealed free air.Patient was taken for exploratory surgery. Post operative diagnosis is perforated  diverticulitis with peritonitis.Patient resected"	"and colostomy created.Patient was admitted to SICU , intubated in critical condition.Chest x-ray revealed bilateral pulmonary infiltrates on 10/13/2007. Patient developed wound infection, and urinary"	"yeast infection during hospital stay. Patient discharged on 10/30/2007. Treatment Cycle #7 due 10/31/2007 and  with held  due to perforated colon until post hospital assessment 11/13/2007.However,"	"study closed prior to that visit on 11/05/2007 and termination visit completed on 11/13/2007."	""	""	""	""	""	""	NA	NA	""	1508433907	""	""	""	NA	"Colon perforation"	"Gastrointestinal disorders"	"Gastrointestinal ulceration and perforation"	"Intestinal ulcers and perforation NEC"	"Large intestine perforation"	""	""	""	""	""	""	""	""	""	""	""	""
"3335"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	3607550001	"peripheral neuropathy"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504137397	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3336"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	4667441002	"pulmonary infitrates"	120	152	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517179617	""	""	""	NA	"Pulmonary infiltration"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Parenchymal lung disorders NEC"	"Lung infiltration"	""	""	""	""	""	""	""	""	""	""	""	""
"3337"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	4667648002	"urinary yeast infection"	129	138	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517180308	""	""	""	NA	"Urinary tract yeast infection"	"Infections and infestations"	"Fungal infectious disorders"	"Fungal infections NEC"	"Urinary tract infection fungal"	""	""	""	""	""	""	""	""	""	""	""	""
"3338"	"DN-101 Protocol No. 011-007"	"123"	"123-0004"	5	9	"Adverse Event/Serious Adverse Event"	3607553001	"weight loss"	75	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504137488	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3339"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	3425312003	"abdominal pain"	24	27	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"x-rays"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	29	NA	NA	25	27	"abdominal x-ray-non-obstsructed non-specific bowel gas pattern.Moderate residual stool throughout colon."	""	""	2	2	2	2	2	2	2	2	"presented to emergency room with complaints of epigastric abdominal pain. Denied nausea,vomiting, and diarrhea. History of chronic constipation. Temperature 101. Blood cultures and urine cultures"	"negative.. Admited for pain management. Discharged on 08/06/07 with reduction in abdominal pain. No further temp. elevation."	""	""	""	""	""	""	""	""	""	NA	NA	""	1502240402	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3340"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	4889207002	"Back Pain"	176	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518721874	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3341"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	4889431002	"Bone Metastasis Left Hip"	86	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	2	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	220	NA	NA	86	88	"Left hip spot film revealed no fracture"	""	""	2	2	2	NA	2	2	NA	2	"Admitted to hospital for planned surgery for left hip prophylactic fixation. History of bone mets to left hip."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518722926	""	""	""	NA	"Bone metastases"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Metastases"	"Metastases to specified sites"	"Metastases to bone"	""	""	""	""	""	""	""	""	""	""	""	""
"3342"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	3833267001	"constipation"	24	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507566753	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3343"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	3785943001	"dehydration"	24	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506636577	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"3344"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	3785875001	"dehydration"	34	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506636041	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"3345"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	3528631001	"Dry Mouth"	24	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502732513	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"3346"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	3785657001	"fatigue"	35	NA	1	2	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506634546	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3347"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	3533408001	"Febrile Neutropenia"	33	40	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502808250	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3348"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	3510872001	"fever"	24	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502240553	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3349"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	4889079002	"fever"	173	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518721595	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3350"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	4082536001	"Hemorriods"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510861416	""	""	""	NA	"Hemorrhoids"	"Gastrointestinal disorders"	"Gastrointestinal vascular conditions"	"Haemorrhoids and gastrointestinal varices (excl oesophageal)"	"Haemorrhoids"	""	""	""	""	""	""	""	""	""	""	""	""
"3351"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	4080152001	"increased bone pain"	20	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510848425	""	""	""	NA	"Bone pain aggravated"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3352"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	3833244001	"indigestion"	24	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507566642	""	""	""	NA	"Indigestion"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"3353"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	4889133002	"Non productive Cough"	57	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518721751	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3354"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	3533500001	"oral mucositis"	33	40	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502809356	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3355"	"DN-101 Protocol No. 011-007"	"124"	"124-0001"	5	9	"Adverse Event/Serious Adverse Event"	3437317001	"Swollen area around eyes"	9	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500493937	""	""	""	NA	"Eyes swollen"	"Eye disorders"	"Eye disorders NEC"	"Ocular disorders NEC"	"Eye swelling"	""	""	""	""	""	""	""	""	""	""	""	""
"3356"	"DN-101 Protocol No. 011-007"	"124"	"124-0003"	5	9	"Adverse Event/Serious Adverse Event"	3655442003	"chemo induced anemia"	103	104	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"2 units packed red blood cells"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518721361	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3357"	"DN-101 Protocol No. 011-007"	"124"	"124-0003"	5	9	"Adverse Event/Serious Adverse Event"	4065540001	"chemotherapy skin extravasation"	32	53	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510754372	""	""	""	NA	"Infusion site extravasation"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion site extravasation"	""	""	""	""	""	""	""	""	""	""	""	""
"3358"	"DN-101 Protocol No. 011-007"	"124"	"124-0003"	5	9	"Adverse Event/Serious Adverse Event"	3862462001	"fatigue"	60	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507820878	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3359"	"DN-101 Protocol No. 011-007"	"124"	"124-0003"	5	9	"Adverse Event/Serious Adverse Event"	4887088002	"low vitamin D deficiency"	136	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518711771	""	""	""	NA	"Vitamin D decreased"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Vitamin analyses"	"Vitamin D decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3360"	"DN-101 Protocol No. 011-007"	"124"	"124-0003"	5	9	"Adverse Event/Serious Adverse Event"	3862479001	"neutropenia"	60	74	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507821018	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3361"	"DN-101 Protocol No. 011-007"	"124"	"124-0003"	5	9	"Adverse Event/Serious Adverse Event"	4065528001	"neutropenia"	88	95	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510754289	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3362"	"DN-101 Protocol No. 011-007"	"124"	"124-0003"	5	9	"Adverse Event/Serious Adverse Event"	3862486001	"neutropenia"	46	53	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507821103	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3363"	"DN-101 Protocol No. 011-007"	"124"	"124-0003"	5	9	"Adverse Event/Serious Adverse Event"	3862427001	"orthostatic hypotension"	38	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507820531	""	""	""	NA	"Orthostatic hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Orthostatic hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"3364"	"DN-101 Protocol No. 011-007"	"124"	"124-0003"	5	9	"Adverse Event/Serious Adverse Event"	4886961002	"sinusitis"	136	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518711397	""	""	""	NA	"Sinusitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Sinusitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3365"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	5	9	"Adverse Event/Serious Adverse Event"	2614744003	"alopecia"	27	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476715510	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3366"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	5	9	"Adverse Event/Serious Adverse Event"	2831120001	"anxiety"	104	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482160628	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"3367"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	5	9	"Adverse Event/Serious Adverse Event"	4762382002	"Depression"	286	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517770000	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"3368"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	5	9	"Adverse Event/Serious Adverse Event"	3005478001	"insomnia"	202	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489691939	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3369"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	5	9	"Adverse Event/Serious Adverse Event"	3089261001	"intermittent heartburn"	241	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492367449	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"3370"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	5	9	"Adverse Event/Serious Adverse Event"	3089308001	"left hip pain, intermittent"	175	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492368033	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3371"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	5	9	"Adverse Event/Serious Adverse Event"	3089275001	"low back pain, intermittent"	175	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492367580	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3372"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	5	9	"Adverse Event/Serious Adverse Event"	4762771002	"Neutropenia"	427	432	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517770814	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3373"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	5	9	"Adverse Event/Serious Adverse Event"	2899582001	"Pain right hip"	175	246	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485720313	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3374"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	5	9	"Adverse Event/Serious Adverse Event"	4762476002	"Rash"	404	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517770194	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"3375"	"DN-101 Protocol No. 011-007"	"125"	"125-0001"	5	9	"Adverse Event/Serious Adverse Event"	2736191001	"right hip numbness"	69	83	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476719439	""	""	""	NA	"Numbness"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"3376"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	2696089003	"alopecia"	93	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516566449	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3377"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	2882025001	"anemia"	107	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484771025	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3378"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	3106517001	"arm pressure/pain"	9	9	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619434	""	""	""	NA	"Pain in arm"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"3379"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	3106511001	"back pain"	9	9	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619359	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3380"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	4575178002	"cellulitis"	244	311	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516566606	""	""	""	NA	"Cellulitis"	"Infections and infestations"	"Bacterial infectious disorders"	"Bacterial infections NEC"	"Cellulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3381"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	3370977001	"Fatigue"	248	NA	1	2	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499368179	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3382"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	3106592001	"fluid retention"	178	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492620268	""	""	""	NA	"Fluid retention"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume increased"	"Fluid retention"	""	""	""	""	""	""	""	""	""	""	""	""
"3383"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	3106530001	"hyperglycemia - intermittent"	16	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619524	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3384"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	3106577001	"intermittent cough"	135	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492620065	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3385"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	3106573001	"intermittent headache"	135	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619979	""	""	""	NA	"Intermittent headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"3386"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	4340102001	"Intermittent left hip pain"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514131347	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3387"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	4575337002	"Intermittent leg cramps"	37	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516566884	""	""	""	NA	"Cramps leg"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"3388"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	3106560001	"left hand extravasation"	93	114	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619784	""	""	""	NA	"Extravasation"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Extravasation"	""	""	""	""	""	""	""	""	""	""	""	""
"3389"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	3106547001	"lightheadedness"	61	62	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619663	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"3390"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	3106581001	"neuropathy in heels"	135	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492620159	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3391"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	2881991001	"neutropenia"	58	63	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484770863	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3392"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	4554520002	"radiating pain down face & neck on right side"	396	399	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	122	NA	NA	396	399	"we have no data, just dotor progress note from ptient verbally informing him of hospitalization"	""	""	0	0	0	NA	0	0	NA	0	"pt had a pain on right side of face and neck and went to ER and was admitted."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516305219	""	""	""	NA	"Facial pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Facial pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3393"	"DN-101 Protocol No. 011-007"	"125"	"125-0005"	5	9	"Adverse Event/Serious Adverse Event"	3106505001	"rib pain"	93	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492619229	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3394"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	2701470003	"anemia"	398	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516647710	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3395"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	2832586001	"cough"	44	50	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482180360	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3396"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	2832404001	"distal testicular pain"	14	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482178510	""	""	""	NA	"Testicular pain"	"Reproductive system and breast disorders"	"Testicular and epididymal disorders"	"Testicular and epididymal disorders NEC"	"Testicular pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3397"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	3089886001	"drainage rt eye"	127	132	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492372113	""	""	""	NA	"Discharge eye"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Ocular infections, inflammations and associated manifestations"	"Eye discharge"	""	""	""	""	""	""	""	""	""	""	""	""
"3398"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	2832395001	"dull ache anterior thighs"	14	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482178428	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"3399"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	3089821001	"fatigue"	87	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492371533	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3400"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	4593026002	"generalized pain"	335	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516647835	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3401"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	2832381001	"headache"	10	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482178251	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"3402"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	2832673001	"hyperglycemia"	17	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482180841	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3403"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	3090047001	"intermittent general malaise"	87	174	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492373489	""	""	""	NA	"General malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"3404"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	3090027001	"intermittent lower extremity edema"	111	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492373370	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3405"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	2832611001	"intermittent neutropenia"	13	98	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482180459	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3406"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	3089801001	"intermittent pain rt mid back to rt mid rib"	87	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492371383	""	""	""	NA	"Musculoskeletal pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3407"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	2832389001	"lower left side back pain"	13	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482178335	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3408"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	2832376001	"muscle pain"	10	16	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482178166	""	""	""	NA	"Muscle pain"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3409"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	2832418001	"rectal itching"	14	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482178579	""	""	""	NA	"Discomfort rectal"	"Gastrointestinal disorders"	"Anal and rectal conditions NEC"	"Anal and rectal disorders NEC"	"Anal discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"3410"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	3674624001	"sensory neuropathy"	174	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505240692	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3411"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	3090499001	"URI"	13	17	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492376454	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3412"	"DN-101 Protocol No. 011-007"	"125"	"125-0006"	5	9	"Adverse Event/Serious Adverse Event"	3090509001	"URI"	94	98	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492376522	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3413"	"DN-101 Protocol No. 011-007"	"125"	"125-0009"	5	9	"Adverse Event/Serious Adverse Event"	2764999003	"Fatigue"	45	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485354041	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3414"	"DN-101 Protocol No. 011-007"	"125"	"125-0009"	5	9	"Adverse Event/Serious Adverse Event"	3685797001	"Left Hip Fracture due to fall"	248	252	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	329	NA	NA	248	252	"X-Rays-left femoral neck hip fracture, Echocardiogram-normal left ventricular systolic function, CBC, CMP within normal range-6/24-6/28/07"	""	""	2	2	2	2	2	2	2	2	"Pt was hospitalized on 6/24/07 for a left femoral neck hip fracture. Left hip (cemented hemiarthroplasty) was performed on 6/25/07. On 6/28/07 pt was discharged."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505330107	""	""	""	NA	"Hip fracture"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Lower limb fractures and dislocations"	"Hip fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"3415"	"DN-101 Protocol No. 011-007"	"125"	"125-0009"	5	9	"Adverse Event/Serious Adverse Event"	2894510001	"mild Alopecia"	85	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485353794	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3416"	"DN-101 Protocol No. 011-007"	"125"	"125-0009"	5	9	"Adverse Event/Serious Adverse Event"	2988663001	"Mild Bone Pain"	106	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489010374	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3417"	"DN-101 Protocol No. 011-007"	"125"	"125-0009"	5	9	"Adverse Event/Serious Adverse Event"	2894550001	"Neutropenia"	29	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485354171	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3418"	"DN-101 Protocol No. 011-007"	"125"	"125-0009"	5	9	"Adverse Event/Serious Adverse Event"	2894559001	"Neutropenia"	50	53	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485354368	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3419"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	2828712003	"Alopecia"	29	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499871491	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3420"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3664465001	"Bilateral Lower Extremity Edema/Swelling"	120	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505147731	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3421"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3409929001	"Constipation"	15	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499871198	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3422"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3666214001	"Dysuria"	92	99	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505158691	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"3423"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3076798001	"edema lower extremities"	92	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491920307	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3424"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3409940001	"Intermittant Fatigue"	57	190	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499871622	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3425"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3665670001	"Intermittant Urinary Tract Infection"	34	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505155570	""	""	""	NA	"Infection urinary tract"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3426"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3665851001	"Leg Edema"	50	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505156573	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3427"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3409956001	"Lesion, Left Forearm"	92	106	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499871869	""	""	""	NA	"Skin lesion"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin lesion"	""	""	""	""	""	""	""	""	""	""	""	""
"3428"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3664559001	"Nail Changes"	141	148	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505148447	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"3429"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3664505001	"Neutropenia"	127	141	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505148042	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3430"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	2895252001	"Neutropenia"	15	22	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485366240	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3431"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	2901273001	"Neutropenia"	36	50	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485802322	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3432"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3665884001	"Neutropenia"	57	64	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505156807	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3433"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3666246001	"Neutropenia"	106	120	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505158837	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3434"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3410036001	"Peripheral Neuropathy"	141	190	NA	2	0	NA	NA	NA	NA	NA	3	1	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499872598	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3435"	"DN-101 Protocol No. 011-007"	"125"	"125-0011"	5	9	"Adverse Event/Serious Adverse Event"	3665553001	"Sore throat"	16	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505154864	""	""	""	NA	"Sore throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3436"	"DN-101 Protocol No. 011-007"	"125"	"125-0013"	5	9	"Adverse Event/Serious Adverse Event"	2837031003	"Constipation"	126	142	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497971347	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3437"	"DN-101 Protocol No. 011-007"	"125"	"125-0013"	5	9	"Adverse Event/Serious Adverse Event"	2901438001	"Dyspepsia"	30	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485803786	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"3438"	"DN-101 Protocol No. 011-007"	"125"	"125-0013"	5	9	"Adverse Event/Serious Adverse Event"	3305678001	"Fatigue, Intermittent"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497971717	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3439"	"DN-101 Protocol No. 011-007"	"125"	"125-0013"	5	9	"Adverse Event/Serious Adverse Event"	4488805002	"hip pain"	276	311	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516024898	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3440"	"DN-101 Protocol No. 011-007"	"125"	"125-0013"	5	9	"Adverse Event/Serious Adverse Event"	4488940002	"hyperglycemia, intermittant"	10	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516025626	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3441"	"DN-101 Protocol No. 011-007"	"125"	"125-0013"	5	9	"Adverse Event/Serious Adverse Event"	3305085001	"Intermittant Back pain"	30	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497964217	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3442"	"DN-101 Protocol No. 011-007"	"125"	"125-0013"	5	9	"Adverse Event/Serious Adverse Event"	3672916001	"Rapid Heart Beat"	63	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505233609	""	""	""	NA	"Heartbeats increased"	"Investigations"	"Cardiac and vascular investigations (excl enzyme tests)"	"Heart rate and pulse investigations"	"Heart rate increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3443"	"DN-101 Protocol No. 011-007"	"125"	"125-0013"	5	9	"Adverse Event/Serious Adverse Event"	3305777001	"Sweating"	119	126	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497972229	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"3444"	"DN-101 Protocol No. 011-007"	"125"	"125-0013"	5	9	"Adverse Event/Serious Adverse Event"	4488965002	"worsening anemia"	281	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516025777	""	""	""	NA	"Anemia aggravated"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3445"	"DN-101 Protocol No. 011-007"	"125"	"125-0017"	5	9	"Adverse Event/Serious Adverse Event"	2873046003	"cerebrovascular accident"	246	247	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	319	NA	NA	246	247	"MRI brain, carotid studies, echo, PT/PTT all on 2007-09-14 all normal/negative except PT 17.1"	""	""	2	2	2	NA	2	2	NA	2	"2007-05-17 pt. off study per his decision. 2007-09-13 pt. experienced left sided weakness and impaired swallowing, presented to clinic 2007-09-14 and sent to ER, where admitted.  Neurologist dictates"	"TIA during hospitalization, and lacunar infarct on 2007-09-18."	""	""	""	""	""	""	""	""	""	NA	NA	""	1511727506	""	""	""	NA	"Cerebrovascular accident"	"Nervous system disorders"	"Central nervous system vascular disorders"	"Central nervous system haemorrhages and cerebrovascular accidents"	"Cerebrovascular accident"	""	""	""	""	""	""	""	""	""	""	""	""
"3446"	"DN-101 Protocol No. 011-007"	"125"	"125-0017"	5	9	"Adverse Event/Serious Adverse Event"	4979470002	"Nail Changes"	70	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519749613	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"3447"	"DN-101 Protocol No. 011-007"	"125"	"125-0017"	5	9	"Adverse Event/Serious Adverse Event"	2898688001	"neutropenia"	14	21	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485707889	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3448"	"DN-101 Protocol No. 011-007"	"125"	"125-0017"	5	9	"Adverse Event/Serious Adverse Event"	4979506002	"Tearing"	126	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519749825	""	""	""	NA	"Lacrimation"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3449"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	2897308003	"anemia"	39	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490286352	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3450"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	3023005001	"anemia"	11	53	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490285563	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3451"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	3705249001	"Constipation"	144	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505765477	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3452"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	3022970001	"dry lips"	12	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490285337	""	""	""	NA	"Dry lips"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Lip dry"	""	""	""	""	""	""	""	""	""	""	""	""
"3453"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	3095142001	"fatigue"	60	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492451617	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3454"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	3705368001	"Hot Flashes"	144	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505765950	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"3455"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	3705171001	"Hydronephrosis"	144	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505765004	""	""	""	NA	"Hydronephrosis"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal obstructive disorders"	"Hydronephrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"3456"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	3023002001	"lower abdominal pain-intermittent"	41	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490285474	""	""	""	NA	"Abdominal pain lower"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain lower"	""	""	""	""	""	""	""	""	""	""	""	""
"3457"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	3023030001	"neutropenia"	25	32	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490286156	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3458"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	3023024001	"neutropenia"	18	25	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490286082	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3459"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	3705338001	"Pain, lower abdomen"	144	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505765842	""	""	""	NA	"Abdominal pain lower"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain lower"	""	""	""	""	""	""	""	""	""	""	""	""
"3460"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	4593114002	"pain. lower back"	144	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516648016	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3461"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	3022989001	"taste change"	12	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490285410	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"3462"	"DN-101 Protocol No. 011-007"	"125"	"125-0018"	5	9	"Adverse Event/Serious Adverse Event"	4763684002	"Weakness"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517773457	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3463"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	2972813003	"fatigue"	168	175	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511294819	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3464"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	4110487001	"fatigue"	217	NA	1	3	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511295620	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3465"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	3244525001	"Fatigue"	105	126	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496069373	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3466"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	4857411002	"intermittent constipation"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518468823	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3467"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	3018333001	"Lower Back Pain"	32	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490192339	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3468"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	4110649001	"Neuropathy"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511296567	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3469"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	4762454002	"neutropenia"	28	35	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517770162	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3470"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	4762909002	"neutropenia"	182	196	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517771164	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3471"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	4762576002	"neutropenia"	49	56	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517770423	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3472"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	3674594001	"neutropenia"	154	161	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505240576	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3473"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	4762743002	"neutropenia"	98	105	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517770746	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3474"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	4762708002	"neutropenia"	91	98	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517770671	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3475"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	4762526002	"neutropenia"	35	42	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517770322	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3476"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	4762674002	"neutropenia"	77	84	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517770609	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3477"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	4762887002	"neutropenia"	112	126	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517771072	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3478"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	4762630002	"neutropenia"	56	63	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517770538	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3479"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	3674586001	"neutropenia"	133	140	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505240512	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3480"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	3399672001	"neutropenia"	70	77	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499788489	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3481"	"DN-101 Protocol No. 011-007"	"125"	"125-0022"	5	9	"Adverse Event/Serious Adverse Event"	3674684001	"neutropenia"	203	217	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505240887	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3482"	"DN-101 Protocol No. 011-007"	"125"	"125-0029"	5	9	"Adverse Event/Serious Adverse Event"	3797740003	"Constipation"	18	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508856467	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3483"	"DN-101 Protocol No. 011-007"	"125"	"125-0029"	5	9	"Adverse Event/Serious Adverse Event"	4157067001	"neutropenia"	43	50	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511989791	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3484"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	2589083003	"alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471798998	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3485"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	2954187001	"anemia"	162	237	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487535797	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3486"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	3043600001	"anxiety"	293	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490805843	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"3487"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	3171779001	"diverticulosis"	142	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494349667	""	""	""	NA	"Diverticulosis"	"Gastrointestinal disorders"	"Diverticular disorders"	"Diverticula"	"Diverticulum"	""	""	""	""	""	""	""	""	""	""	""	""
"3488"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	2852114001	"Fatigue"	135	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483548301	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3489"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	2646323001	"fatigue"	43	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1471799217	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3490"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	2739255001	"GI Bleed"	140	153	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	141	NA	NA	140	142	"10/17/06 HGB 9.3, HCT 27.8.  10/18/06 Colonoscopy showed cecum normal, ascending, transverse, descending, and sigmoid colon were normal except for diverticulosis, the rectum was normal, internal"	"hemorrhoids."	""	2	2	2	NA	2	2	NA	2	"Admitted again on 10-17-06 due to another episode of bright red blood per rectum the morning of 10-17-06.  Denies any abdominal pain, nausea or vomitting.  Denies melena.  Admitted to hospital for"	"evaluation and colonoscopy.  Colonoscopy done on 10-18-06 Showed diverticulosis and internal hemorrhoids.  10-30-06  Patient seen in clinic today, reports no more bleeding note.  To receive cycle 7"	"day 2 docetaxel today."	""	""	""	""	""	""	""	""	NA	NA	""	1476823586	""	""	""	NA	"GI bleed"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"3491"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	2725398001	"GI Bleed"	135	153	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	4	NA	NA	1	"patient admitted for work-up"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	135	NA	NA	135	138	"10-12-06 HGB 9.9, HCT 30.6"	""	""	2	2	2	NA	2	2	NA	2	"Seen in clinic, reported excessive alcohol consumption for the last 2 weeks, none in 3 days.  Reports bright red blood in bowels movements intermittently over the course of the past week.  Very"	"unsteady on feet, HR 128, BP 152/94.  Admitted to hospital with possible GI Bleed for further work-up."	""	""	""	""	""	""	""	""	""	NA	NA	""	1476300177	""	""	""	NA	"GI bleed"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"3492"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608079001	"hyperglycemia"	14	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Decadron to be decreased to 4mg with start of Cycle 6"	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468354284	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3493"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	4591160002	"hyponatremia"	393	396	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516644014	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3494"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608097001	"Insomnia"	17	99	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468355614	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3495"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	2852182001	"insomnia"	174	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483548723	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3496"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	3171793001	"internal hemorrhoids"	141	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494349734	""	""	""	NA	"Internal hemorrhoids"	"Gastrointestinal disorders"	"Gastrointestinal vascular conditions"	"Haemorrhoids and gastrointestinal varices (excl oesophageal)"	"Haemorrhoids"	""	""	""	""	""	""	""	""	""	""	""	""
"3497"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	2673640001	"right leg pain"	94	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473363624	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"3498"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	4459152002	"supraventricular tachycardia"	393	396	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	24	NA	NA	NA	1	1	NA	NA	""	591	NA	NA	393	396	"NA = 128, blodd sugar= 162, cardiac enzymes were negative. Echocardiogram ordered."	""	""	2	2	2	NA	2	2	NA	2	"06/27/07 Presented to ER with weakness and changes in behavior.  In the ER patient was in supraventricular tachycardia with a rate of 130 with either flutter or atrial tachycardia.  CT scan of the"	"brain obtained and negative. Family reports patient had a binge-drinking event . UTI was noted while in the hospital.	This was treated with IV lavaquin. On 6/30 patient in sinue rhythm and feeling"	"better.  Discharged form hospital."	""	""	""	""	""	""	""	""	NA	NA	""	1515678156	""	""	""	NA	"Supraventricular tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Supraventricular tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"3499"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	2608087001	"unrinary incontinence"	21	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468354609	""	""	""	NA	"Incontinence urinary"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"3500"	"DN-101 Protocol No. 011-007"	"126"	"126-0001"	5	9	"Adverse Event/Serious Adverse Event"	4732073002	"UTI"	393	396	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517426430	""	""	""	NA	"UTI"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3501"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2593558003	"alopecia"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1468955958	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3502"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2884826001	"dry cough"	169	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484859251	""	""	""	NA	"Dry cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3503"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2837799001	"edema"	172	175	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482344188	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"3504"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2884851001	"face flush"	92	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484859558	""	""	""	NA	"Flushing of face"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"3505"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	3397372001	"face swollen"	92	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499781473	""	""	""	NA	"Swelling of face"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Swelling face"	""	""	""	""	""	""	""	""	""	""	""	""
"3506"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2884808001	"fatigue"	70	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484858715	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3507"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2884819001	"Fatigue"	134	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484858921	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3508"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2884801001	"finger skin infection"	176	192	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484858602	""	""	""	NA	"Skin infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Skin infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3509"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2837831001	"neuropathy"	169	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482344799	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3510"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2884765001	"night sweats"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484858094	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"3511"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2884836001	"right ankle swelling"	197	218	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484859381	""	""	""	NA	"Ankle swelling"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint swelling"	""	""	""	""	""	""	""	""	""	""	""	""
"3512"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2884789001	"skin rash on neck"	169	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484858402	""	""	""	NA	"Neck rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"3513"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2837804001	"upper respiratory infection"	168	176	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482344346	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3514"	"DN-101 Protocol No. 011-007"	"126"	"126-0002"	5	9	"Adverse Event/Serious Adverse Event"	2884776001	"watery eyes"	176	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484858230	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3515"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	5	9	"Adverse Event/Serious Adverse Event"	2693911003	"Alopecia"	57	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484852253	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3516"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	5	9	"Adverse Event/Serious Adverse Event"	2884210001	"edema, legs"	33	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484851613	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3517"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	5	9	"Adverse Event/Serious Adverse Event"	2796096001	"fatigue"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480536247	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3518"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	5	9	"Adverse Event/Serious Adverse Event"	2884261001	"hot flashes"	33	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484851891	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"3519"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	5	9	"Adverse Event/Serious Adverse Event"	2868872001	"insomnia"	57	204	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484242608	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3520"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	5	9	"Adverse Event/Serious Adverse Event"	3336802001	"lesion left groin, possible infection"	232	246	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498664716	""	""	""	NA	"Skin lesion"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin lesion"	""	""	""	""	""	""	""	""	""	""	""	""
"3521"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	5	9	"Adverse Event/Serious Adverse Event"	2884394001	"Sinus Drainage"	57	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484854218	""	""	""	NA	"Nasal sinus discharge"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Paranasal sinus hypersecretion"	""	""	""	""	""	""	""	""	""	""	""	""
"3522"	"DN-101 Protocol No. 011-007"	"126"	"126-0003"	5	9	"Adverse Event/Serious Adverse Event"	2834595001	"watery eyes"	33	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1482260362	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3523"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	2871837003	"anemia"	42	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488902058	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3524"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	2982228001	"anemia"	32	33	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488902191	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3525"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3496761001	"anemia"	5	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502119417	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3526"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	2982192001	"anemia"	39	40	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488901896	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3527"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	2983821001	"anemia"	25	31	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488913779	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3528"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3032866001	"arthritis"	67	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490628274	""	""	""	NA	"Arthritis"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Arthropathies NEC"	"Arthritis"	""	""	""	""	""	""	""	""	""	""	""	""
"3529"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3496828001	"Cough with associated wheezing"	46	130	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502119970	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3530"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3164124001	"Dry Eyes"	88	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494180215	""	""	""	NA	"Dry eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Dry eye"	""	""	""	""	""	""	""	""	""	""	""	""
"3531"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3032839001	"dry mouth"	5	88	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490628139	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"3532"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3453613001	"Edema to lower extremities"	105	179	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500995864	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3533"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3171994001	"elevated Creatinine"	25	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494351615	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3534"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3496784001	"fatigue"	32	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502119691	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3535"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	4594210002	"GI bleed"	347	350	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	376	NA	NA	347	350	"Hgb on admission was 4.8, Hct was 14.3; Endoscopy was performed and patient was found to have a 1.5 cm flat ulcer on the gastric side of the gastrojejunostomy and duodenal stenosis."	""	""	2	2	2	NA	2	2	NA	2	"Patient presented to the ER on 12/24/07 with complaints of shortness of breath.  At that time HGB was noted to be 4.8.	See above for Endoscopy report.  Patient was treated with IV fluids and"	"transfused with a total of four units of packed Red blood cells.  He was treated with Nexium 40 mg po bid and Carafate one gram one hour before meals and at bedtime. It was noted in the discharge"	"summary, the GI bleed was most likely related to nonsteroidal antiinflammatory use of Aleve.  Patient was instruced to discontinue use. Patient's hemoglobin at time of discharge on 12/27/07 was 8.8."	"He was scheduled for a follow-up EGD in four to six weeks.  Hemoglogin at office visit with oncologist on 1/22/08 was 10.5"	""	""	""	""	""	""	""	NA	NA	""	1516649797	""	""	""	NA	"GI bleed"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"3536"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3496768001	"hematuria"	12	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502119527	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"3537"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3233292001	"hematuria"	130	159	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	131	NA	NA	130	132	"Admission CBC on 5/21/07- WBC 14.4, Hct 25.3, HGB 7.8; Admission Chemistry on 5/21/07- K 5.5, Crea 2.5"	""	""	2	2	2	2	2	2	2	2	"Patient admitted to the hospital after developing hematuria with clot retention at home resulting in the placement of a Foley catheter.  PAtient was requiring multiple irrigations prior to admission,"	"and therefore was admitted to the hospital for continuous bladder irrigation as well as cystoscopy and clot evacuation with possible cauterization.  Admission orders included continuous IV fluids,"	"contiuation of home medications, continuous bladder irrigation, plans for pending cystoscopy, and the transfusion of two units of packed red blood cells."	""	""	""	""	""	""	""	""	NA	NA	""	1495508942	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"3538"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	2983984001	"hot flashes"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488914756	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"3539"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	2982146001	"hyperglycemia"	25	41	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"reduced decadron from 8 mg to 4 mg"	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488901461	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3540"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	4463111002	"hyperglycemia"	214	263	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515693311	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3541"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	4463040002	"hyperglycemia"	67	95	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515692968	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3542"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	4463072002	"hyperglycemia"	109	176	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515693169	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3543"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	4466322002	"hyperkalemia"	25	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515701191	""	""	""	NA	"Hyperkalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hyperkalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3544"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	4466274002	"increased BUN levels"	25	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515701063	""	""	""	NA	"BUN increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood urea increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3545"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3496776001	"itching"	5	5	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502119638	""	""	""	NA	"Itching"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Pruritus NEC"	"Pruritus"	""	""	""	""	""	""	""	""	""	""	""	""
"3546"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	4459113002	"light headed"	34	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515677524	""	""	""	NA	"Light-headed"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"3547"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3164184001	"mouth sores"	109	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494180471	""	""	""	NA	"Sores mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3548"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	2983949001	"night sweats"	25	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488914552	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"3549"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3453665001	"pain to the supra-pubic region"	125	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500996578	""	""	""	NA	"Pubic pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Pubic pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3550"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3496839001	"renal insufficiency"	105	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502120067	""	""	""	NA	"Renal insufficiency"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure"	""	""	""	""	""	""	""	""	""	""	""	""
"3551"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	2983995001	"shortness of breath"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488914838	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3552"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3496810001	"sinus drainage"	42	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502119876	""	""	""	NA	"Nasal sinus discharge"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Paranasal sinus hypersecretion"	""	""	""	""	""	""	""	""	""	""	""	""
"3553"	"DN-101 Protocol No. 011-007"	"126"	"126-0004"	5	9	"Adverse Event/Serious Adverse Event"	3453646001	"urinary retention"	125	179	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500996398	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"3554"	"DN-101 Protocol No. 011-007"	"126"	"126-0005"	5	9	"Adverse Event/Serious Adverse Event"	2939382003	"Bilateral edema lower extremities"	119	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502194820	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3555"	"DN-101 Protocol No. 011-007"	"126"	"126-0005"	5	9	"Adverse Event/Serious Adverse Event"	3470254001	"bruising"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501521850	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"3556"	"DN-101 Protocol No. 011-007"	"126"	"126-0005"	5	9	"Adverse Event/Serious Adverse Event"	3470247001	"cold sore on lip"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501521784	""	""	""	NA	"Cold sores lip"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes simplex"	""	""	""	""	""	""	""	""	""	""	""	""
"3557"	"DN-101 Protocol No. 011-007"	"126"	"126-0005"	5	9	"Adverse Event/Serious Adverse Event"	3164954001	"Constipation"	9	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494187112	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3558"	"DN-101 Protocol No. 011-007"	"126"	"126-0005"	5	9	"Adverse Event/Serious Adverse Event"	3164697001	"fatigue"	9	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494185223	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3559"	"DN-101 Protocol No. 011-007"	"126"	"126-0005"	5	9	"Adverse Event/Serious Adverse Event"	3470330001	"Hemipositive stools"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501522270	""	""	""	NA	"Blood in stool"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Haematochezia"	""	""	""	""	""	""	""	""	""	""	""	""
"3560"	"DN-101 Protocol No. 011-007"	"126"	"126-0005"	5	9	"Adverse Event/Serious Adverse Event"	3505704001	"hip injury"	119	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502212460	""	""	""	NA	"Hip injury"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Limb injuries NEC (incl traumatic amputation)"	"Joint injury"	""	""	""	""	""	""	""	""	""	""	""	""
"3561"	"DN-101 Protocol No. 011-007"	"126"	"126-0005"	5	9	"Adverse Event/Serious Adverse Event"	3470287001	"Hot flashes"	49	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501522072	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"3562"	"DN-101 Protocol No. 011-007"	"126"	"126-0005"	5	9	"Adverse Event/Serious Adverse Event"	3503258001	"Sacral pain"	133	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502195047	""	""	""	NA	"Sacral pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Sacral pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3563"	"DN-101 Protocol No. 011-007"	"126"	"126-0005"	5	9	"Adverse Event/Serious Adverse Event"	3470307001	"Urinary frequency"	70	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501522138	""	""	""	NA	"Urinary frequency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"3564"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3415722003	"arrhythmia"	83	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"ekg, referred to cardiologist"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508694530	""	""	""	NA	"Arrhythmia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Arrhythmia"	""	""	""	""	""	""	""	""	""	""	""	""
"3565"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	4484458002	"BUN elevated"	132	175	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515969303	""	""	""	NA	"BUN increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood urea increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3566"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	4484527002	"Changes in vision"	132	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515969751	""	""	""	NA	"Visual disturbance"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Visual disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"3567"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3912438001	"constipation"	90	147	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508696381	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3568"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	4484625002	"Cough"	148	158	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515970261	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3569"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	4484469002	"Creatinine elevated"	132	175	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515969419	""	""	""	NA	"Creatinine high"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3570"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	4484587002	"Dizziness when standing"	132	147	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515970112	""	""	""	NA	"Dizzy on standing"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness postural"	""	""	""	""	""	""	""	""	""	""	""	""
"3571"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3912038001	"dyspnea"	83	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508694447	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3572"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	4484504002	"Dyspnea"	104	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515969645	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3573"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3912483001	"dyspnea"	97	103	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"supplemental oxygen"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508696564	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3574"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3912113001	"edema"	90	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508694725	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"3575"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3912010001	"fatigue"	69	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508694325	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3576"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3611563001	"High Blood Pressure"	48	68	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504197692	""	""	""	NA	"Blood pressure high"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"3577"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3466574001	"Hot flashes"	6	131	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501440088	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"3578"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3466567001	"Insomnia"	6	131	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501440025	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3579"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3611615001	"mild headaches"	48	68	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504197971	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"3580"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	4484568002	"Myalgia"	111	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515970035	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3581"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3533083001	"night sweats"	7	131	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502804722	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"3582"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	4484493002	"Nose bleed"	48	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515969557	""	""	""	NA	"Nose bleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"3583"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3611629001	"palpitations"	48	68	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504198024	""	""	""	NA	"Palpitations"	"Cardiac disorders"	"Cardiac disorder signs and symptoms"	"Cardiac signs and symptoms NEC"	"Palpitations"	""	""	""	""	""	""	""	""	""	""	""	""
"3584"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	3892068001	"Pulmonary embolism"	97	111	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Oxygen supplementation"	0	0	NA	0	24	NA	NA	NA	1	1	NA	NA	""	98	NA	NA	97	103	"10/16/07 CT scan of chest obtained due to shortness of breath, showed \"saddle\" pulmonary embolus present spanning the right and left pulmonary arteries with thrombus within the bilateral lower lobar"	"abd subsegmental pukmonary arteries.;10/17/07 bilateral venous doppler for lower extremities performed, results not available.	;10/17/07 ECHO performed, results not available."	""	2	2	2	NA	2	2	NA	2	"10/16/07 patient presented to clinic for routine lab visit.  C/O shortness of breath, especially dyspnea on excertion.	Pulse/Ox Sat fell to 86% on room air with ambulation, recovered to 93% with"	"rest.	Vital signs showed: BP 128/52, HR 50-80's and irregular, respirations 20 and labored. Patient complained of progressive shortness of breath over several days.	Denied sputum production, blood"	"in sputum, fever, or pleuritic chest pain.  Physical exam showed mild bilateral pedal edema, pitting and nontender.  Patient sent for CT of chest which revealed a \"saddle\" pulmonary embolus.	Patient"	"admitted to the hospital on 10/16/07 for IV heparin, EKG, oxygen supplementation, and decisions regarding possible thrombolysis."	""	""	""	""	""	""	""	NA	NA	""	1508268480	""	""	""	NA	"Pulmonary embolism"	"Respiratory, thoracic and mediastinal disorders"	"Pulmonary vascular disorders"	"Pulmonary thrombotic and embolic conditions"	"Pulmonary embolism"	""	""	""	""	""	""	""	""	""	""	""	""
"3585"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	4484452002	"Skin cancer, face"	139	141	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515969171	""	""	""	NA	"Skin cancer"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Skin neoplasms malignant and unspecified"	"Skin neoplasms malignant and unspecified (excl melanoma)"	"Skin cancer"	""	""	""	""	""	""	""	""	""	""	""	""
"3586"	"DN-101 Protocol No. 011-007"	"126"	"126-0009"	5	9	"Adverse Event/Serious Adverse Event"	4484553002	"Watery eyes"	132	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515969828	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3587"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	2663088003	"Acid Indigestion"	379	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515619386	""	""	""	NA	"Acid indigestion"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"3588"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3368148001	"anemia"	21	105	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499353999	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3589"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3370945001	"anemia"	119	147	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499368066	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3590"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3371165001	"anemia"	147	154	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499368916	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3591"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3371192001	"Anemia"	154	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499369031	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3592"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3368519001	"Anemia"	105	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499355299	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3593"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	4479480002	"Atrial fibrillatiion"	303	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515951851	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"3594"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	4479403002	"black tarry stools"	161	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515951407	""	""	""	NA	"Tarry stools"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Melaena"	""	""	""	""	""	""	""	""	""	""	""	""
"3595"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	4479456002	"change in taste"	203	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515951629	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"3596"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3371246001	"constipation"	56	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499369316	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3597"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	4454056002	"Diarrhea"	133	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515619480	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3598"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3371009001	"elevated alkaline phosphatase"	119	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499368288	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3599"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3764188001	"elevated creatinine"	99	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506436130	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3600"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	4479466002	"fainted(loss consiousness)"	221	221	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515951769	""	""	""	NA	"Faint"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"3601"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3371261001	"Fatigue"	56	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499369372	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3602"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3371269001	"GERD"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499369434	""	""	""	NA	"GERD"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Gastrooesophageal reflux disease"	""	""	""	""	""	""	""	""	""	""	""	""
"3603"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3370981001	"hyperglycemia"	119	140	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499368192	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3604"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3371051001	"Hyperglycemia"	140	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499368451	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3605"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3368117001	"Hyperglycemia"	21	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499353839	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3606"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3368448001	"Hyperglycemia"	99	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499355054	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3607"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3368439001	"Hyperglycemia"	77	99	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499354987	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3608"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3371206001	"Hyperglycemia"	161	182	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499369106	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3609"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3368196001	"Hyperglycemia"	35	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499354193	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3610"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3371228001	"Hypoalbuminemia"	182	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499369232	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3611"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3371085001	"Hypoalbuminemia"	140	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499368604	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3612"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3371028001	"Hyponatremia"	119	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499368364	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3613"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	4479581002	"increased serum creatinine"	385	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515952220	""	""	""	NA	"Increased serum creatinine"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3614"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3368250001	"leukopenia"	42	49	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499354352	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3615"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3368487001	"leukopenia"	105	112	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499355183	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3616"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3368168001	"leukopenia"	21	37	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499354072	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3617"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3368418001	"neutropenia"	42	49	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499354914	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3618"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	3370913001	"neutropenia"	105	112	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499367928	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3619"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	4479510002	"nocturia"	364	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515951983	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"3620"	"DN-101 Protocol No. 011-007"	"127"	"127-0003"	5	9	"Adverse Event/Serious Adverse Event"	4479649002	"weakness of legs"	168	443	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515952446	""	""	""	NA	"Weakness of limbs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"3621"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	2691801003	"anemia"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506887284	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3622"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3733261001	"arthalgias"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505996965	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3623"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4067098001	"back pain mid and lower"	357	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510759792	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3624"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4067034001	"back stiffness"	168	189	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510759648	""	""	""	NA	"Back stiffness"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal stiffness"	""	""	""	""	""	""	""	""	""	""	""	""
"3625"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4611483002	"BIG TOE TENDER"	133	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516729742	""	""	""	NA	"Pain in toe"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"3626"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3733350001	"bilateral extremity edema"	140	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505997938	""	""	""	NA	"Edema extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3627"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3814165001	"Conduction abnormality(complete heartblock)"	246	250	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	24	NA	NA	NA	1	1	NA	NA	""	381	NA	NA	246	250	"None"	""	""	2	2	2	NA	2	2	NA	2	"Pt was driving his car and became woozy at a stoplight. He pulled over and stopped.  He passed out, his wife called EMS. He was transfered to an ER, where his blood pressure was 80/40 and his heart"	"rate was 26.  From ER, he went to cath lab where he had a pacemaker inserted.  Dismissed  follwoing day.  Being followed by a cardiologist."	""	""	""	""	""	""	""	""	""	NA	NA	""	1507143428	""	""	""	NA	"Atrioventricular block complete"	"Cardiac disorders"	"Cardiac arrhythmias"	"Cardiac conduction disorders"	"Atrioventricular block complete"	""	""	""	""	""	""	""	""	""	""	""	""
"3628"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3733286001	"Constipation"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505997223	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3629"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4067131001	"cough intermittent"	357	361	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510759887	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3630"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3733308001	"decreased ANC"	56	61	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505997592	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3631"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4611378002	"DRY HEAVES"	58	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516729367	""	""	""	NA	"Dry heaves"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Retching"	""	""	""	""	""	""	""	""	""	""	""	""
"3632"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066708001	"dyspnea"	133	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510758823	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3633"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066941001	"dyspnea"	168	175	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510759398	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3634"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066848001	"edema bilateral ankles"	154	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510759163	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3635"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066875001	"epistaxis"	154	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510759222	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"3636"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3733805001	"Fatigue"	168	217	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505999738	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3637"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066575001	"fatigue"	217	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510758189	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3638"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3733225001	"Fatigue"	7	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505996663	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3639"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4615390002	"FELL IN SHOWER"	189	189	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516738812	""	""	""	NA	"Fall"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Non-site specific injuries NEC"	"Fall"	""	""	""	""	""	""	""	""	""	""	""	""
"3640"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3733233001	"groin pain"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505996731	""	""	""	NA	"Groin pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Soft tissue disorders NEC"	"Groin pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3641"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4067059001	"hay fever"	287	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510759705	""	""	""	NA	"Hay fever"	"Immune system disorders"	"Allergic conditions"	"Atopic disorders"	"Seasonal allergy"	""	""	""	""	""	""	""	""	""	""	""	""
"3642"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066799001	"headache"	137	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510759054	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"3643"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066923001	"hot flashes"	154	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510759342	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"3644"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791482001	"Hyperglycemia"	154	217	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506888514	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3645"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791472001	"Hyperglycemia"	137	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506888445	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3646"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791257001	"Hyperglycemia"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506887054	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3647"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791300001	"Hyperglycemia"	49	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506887350	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3648"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791248001	"Hyponatremia"	28	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506886978	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3649"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4611408002	"INSOMNIA"	91	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516729493	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3650"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4611497002	"INTERMITTENT SHARP PAIN IN LOW ABDOMEN"	140	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516729818	""	""	""	NA	"Abdominal pain lower"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain lower"	""	""	""	""	""	""	""	""	""	""	""	""
"3651"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066824001	"joint swelling rt foot"	137	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510759107	""	""	""	NA	"Joint swelling"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint swelling"	""	""	""	""	""	""	""	""	""	""	""	""
"3652"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791403001	"leukopenia"	99	102	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506887991	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3653"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791430001	"Leukopenia"	119	133	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506888132	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3654"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791365001	"Leukopenia"	77	99	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506887857	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3655"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791520001	"Leukopenia"	182	189	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506888752	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3656"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791511001	"Leukopenia"	161	168	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506888692	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3657"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791328001	"Leukopenia"	56	63	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506887538	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3658"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791232001	"Leukopenia"	14	21	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506886863	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3659"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791289001	"Leukopenia"	35	42	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506887228	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3660"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3733334001	"nail changes"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505997857	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"3661"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3733314001	"neuropathy"	73	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505997740	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3662"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3733851001	"neuropathy"	196	287	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506000002	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3663"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791277001	"Neutopenia"	35	42	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506887142	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3664"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3722211001	"neutropenia"	137	141	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505923898	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3665"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791415001	"neutropenia"	99	102	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506888049	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3666"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791538001	"Neutropenia"	182	189	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506888846	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3667"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791494001	"Neutropenia"	161	168	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506888607	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3668"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791381001	"Neutropenia"	77	79	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506887918	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3669"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3791220001	"Neutropenia"	14	21	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506886800	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3670"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066901001	"night sweats"	154	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510759285	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"3671"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066775001	"pain lower abdomen"	137	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510759000	""	""	""	NA	"Abdominal pain lower"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain lower"	""	""	""	""	""	""	""	""	""	""	""	""
"3672"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066623001	"pain rt hip"	133	135	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510758363	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3673"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3391604001	"peripheral  neuropathy"	196	NA	1	3	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499717460	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3674"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3352400001	"peripheral neuropathy"	154	195	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499024150	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3675"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3722085001	"sinus discharge"	352	357	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505923599	""	""	""	NA	"Nasal sinus discharge"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Paranasal sinus disorders (excl infections and neoplasms)"	"Paranasal sinus hypersecretion"	""	""	""	""	""	""	""	""	""	""	""	""
"3676"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3733305001	"sinus infection"	44	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505997435	""	""	""	NA	"Sinus infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Sinusitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3677"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4611430002	"TASTE CHANGES"	112	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516729565	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"3678"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066696001	"tenderness rt big toenail"	133	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510758774	""	""	""	NA	"Nail pain"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onychalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3679"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	3733302001	"weakness"	42	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505997346	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3680"	"DN-101 Protocol No. 011-007"	"127"	"127-0004"	5	9	"Adverse Event/Serious Adverse Event"	4066671001	"weakness upper and lower extremitiy"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510758665	""	""	""	NA	"Weakness in extremity"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"3681"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	2697091003	"Anemia"	20	414	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499269586	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3682"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363610001	"Anemia"	13	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499269339	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3683"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363753001	"AST elevated"	111	131	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499270615	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3684"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	2944123001	"constipation"	7	414	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487168902	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3685"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363618001	"Decreased ANC"	13	27	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499269445	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3686"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363704001	"Decreased ANC"	83	90	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499270255	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3687"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363643001	"Decreased ANC"	27	34	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499269702	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3688"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	4468357002	"decreased appetite"	300	414	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515705826	""	""	""	NA	"Appetite decreased NOS"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"3689"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3776952001	"dizziness"	111	113	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506536769	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"3690"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	4468293002	"dry mouth"	132	414	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515705653	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"3691"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	4617757002	"DYSURIA"	188	197	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516743384	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"3692"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3777047001	"edema of lower extremities"	27	414	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506536967	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3693"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	2944160001	"edema Right lower extremity"	48	414	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487169512	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3694"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363653001	"Elevated Alkaline Phosphatase"	27	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499269762	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3695"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363746001	"Elevated Alkaline Phosphate"	111	114	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499270533	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3696"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3777001001	"hair loss"	69	414	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506536879	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3697"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	4482117002	"hot flashes"	90	414	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515960842	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"3698"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363669001	"hyperglycemia"	27	38	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499269911	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3699"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363676001	"Hyperglycemia"	37	68	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499270012	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3700"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363724001	"Hyperglycemia"	90	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499270362	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3701"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363741001	"Hyponatremia"	90	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499270460	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3702"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363663001	"hyponatremia"	27	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499269848	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3703"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	4482061002	"Intermittent chills"	131	414	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515960625	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"3704"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	4617662002	"LEFT BLURRY EYE"	69	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516743099	""	""	""	NA	"Blurring of eyes"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"3705"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	4617796002	"LEG WEAKNESS"	139	146	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516743465	""	""	""	NA	"Weakness of limbs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"3706"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363604001	"leukopenia"	13	20	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499269223	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3707"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363691001	"leukopenia"	83	99	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499270155	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3708"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363623001	"leukopenia"	20	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499269513	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3709"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	4468069002	"Neuropathy in feet"	209	414	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515705318	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3710"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	4468144002	"thinning hair"	132	414	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515705419	""	""	""	NA	"Hair thinning"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Hypotrichosis"	""	""	""	""	""	""	""	""	""	""	""	""
"3711"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	3363797001	"Urinary tract infection"	55	85	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499271169	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3712"	"DN-101 Protocol No. 011-007"	"127"	"127-0005"	5	9	"Adverse Event/Serious Adverse Event"	4483926002	"Urinary tract infection"	139	147	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515965961	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3713"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	2703225003	"alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505907966	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3714"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3727569001	"anemia"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505937804	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3715"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	2950217001	"Angina pectoris"	70	76	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	6	NA	1	1	"CABG"	0	0	NA	0	16	NA	NA	NA	NA	1	NA	NA	""	142	NA	NA	70	76	"Pt had a stress test that was positive, followed by a cardiac catheterization.	Those studies confirmed the presence of severe triple-vessel coronary artery disease. Cardiac surgery was advised."	"Surgery performed 12/15/06"	""	2	2	2	NA	2	0	NA	0	"Pt complained of chest tightness on 12/6/06 when exerting himself. Pt went to see cardiologist and eventually underwent triple bypass surgery. Pt is on cardiac rehab at the present time."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487265003	""	""	""	NA	"Angina pectoris"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"3716"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	4624216002	"BONE ACHES"	14	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516805675	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3717"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3718866001	"constipation"	35	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505909735	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3718"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3727876001	"decreased anc"	42	49	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505938575	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3719"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3727833001	"decreased anc"	35	42	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505938464	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3720"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3727628001	"decreased anc"	14	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505937944	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3721"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3727516001	"Decreased WBC"	35	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505937643	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3722"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3727364001	"Decreased WBC"	14	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505937244	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3723"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3727468001	"Decreased WBC"	21	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505937524	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3724"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3727716001	"decresed anc"	21	28	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505938179	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3725"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3728133001	"elevated alkaline phosphatase"	28	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505939229	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3726"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3718686001	"fatigue"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505908104	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3727"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3727978001	"hyperglycemia"	28	70	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505938812	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3728"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3728012001	"hyperglycemia"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505938933	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3729"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3728092001	"hyponatremia"	28	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505939087	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3730"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3719159001	"infection left thumb"	35	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505911719	""	""	""	NA	"Infected thumb"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Localised infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3731"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	4624222002	"MOUTH TENDERNESS"	9	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516805727	""	""	""	NA	"Tender mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Oral soft tissue pain and paraesthesia"	"Oral pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3732"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	3719338001	"oral mucositis"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"salt water rinses"	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505912505	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"3733"	"DN-101 Protocol No. 011-007"	"127"	"127-0006"	5	9	"Adverse Event/Serious Adverse Event"	4624235002	"TINGLING IN TOES"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516805925	""	""	""	NA	"Tingling"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"3734"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	2747604003	"ANEMIA"	207	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506892783	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3735"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792026001	"ANEMIA"	34	207	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506892406	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3736"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3403713001	"cerebral mass per CT scan of the head"	216	218	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	265	NA	NA	216	218	"CT of the head done 5/7/07 showed a blastic metastases in the skull base extending into the clivus and a 1.2 cm enhancing lesion in the right occipital lobe with moderate surrounding vasogenic edema."	""	""	0	0	2	NA	2	2	NA	0	"Subject was hospitalized from 5/23/07 to 5/25/07 for removal of brain tumor. Subject continued on Taxotere/Cisplatin and Avastin, however Prednisone was permanently discontinued."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499802895	""	""	""	NA	"Brain mass"	"Nervous system disorders"	"Structural brain disorders"	"Structural brain disorders NEC"	"Brain mass"	""	""	""	""	""	""	""	""	""	""	""	""
"3737"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3793374001	"CONSTIPATION"	27	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506944911	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3738"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	4625759002	"CRANIAL NERVE PALSY"	48	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516812827	""	""	""	NA	"Cranial nerve palsies multiple"	"Nervous system disorders"	"Cranial nerve disorders (excl neoplasms)"	"Cranial nerve disorders NEC"	"Cranial nerve palsies multiple"	""	""	""	""	""	""	""	""	""	""	""	""
"3739"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	4625737002	"CYST ON PITUITARY"	27	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516812708	""	""	""	NA	"Pituitary cyst"	"Endocrine disorders"	"Hypothalamus and pituitary gland disorders"	"Pituitary neoplasms"	"Pituitary cyst"	""	""	""	""	""	""	""	""	""	""	""	""
"3740"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	4512432002	"decreased appetite"	307	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516130824	""	""	""	NA	"Appetite decreased NOS"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"3741"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	4512614002	"difficulty hearing"	405	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516131121	""	""	""	NA	"Hearing impaired"	"Ear and labyrinth disorders"	"Hearing disorders"	"Hearing losses"	"Hearing impaired"	""	""	""	""	""	""	""	""	""	""	""	""
"3742"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792238001	"DOUBLE VISION"	153	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506893839	""	""	""	NA	"Double vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Diplopia"	""	""	""	""	""	""	""	""	""	""	""	""
"3743"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792203001	"DOUBLE VISION"	27	132	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506893556	""	""	""	NA	"Double vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Diplopia"	""	""	""	""	""	""	""	""	""	""	""	""
"3744"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792013001	"ELEVATED ALKALINE PHOSPHATASE"	6	90	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506892295	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3745"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792067001	"ELEVATED ALKALINE PHOSPHATASE"	90	200	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506892614	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3746"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792119001	"ELEVATED ALKALINE PHOSPHATASE"	200	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506892848	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3747"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3793371001	"FATIGUE"	27	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506944848	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3748"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3793380001	"FATIGUE"	195	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506945129	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3749"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	4994230002	"fluid retention"	228	228	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519831877	""	""	""	NA	"Fluid retention"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume increased"	"Fluid retention"	""	""	""	""	""	""	""	""	""	""	""	""
"3750"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	4512573002	"heartburn"	307	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516131043	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"3751"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792020001	"HYPERGLYCEMIA"	6	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506892349	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3752"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792047001	"HYPERGLYCEMIA"	69	111	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506892531	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3753"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792032001	"HYPERGLYCEMIA"	48	69	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506892470	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3754"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792084001	"HYPERGLYCEMIA"	174	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506892678	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3755"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792096001	"HYPONATREMIA"	195	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506892726	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3756"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	4512872002	"increased discomfort to upper extremity"	132	153	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516131470	""	""	""	NA	"Discomfort"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"3757"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792192001	"INTERMITTENT HEADACHES"	27	132	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506893486	""	""	""	NA	"Intermittent headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"3758"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792249001	"NIGHT INTERMITTENT SWEATS"	153	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506893888	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"3759"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792211001	"PAIN IN  LOWER EXTREMITIES"	132	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506893644	""	""	""	NA	"Pain of lower extremities"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"3760"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3792175001	"PAIN, Right hip"	6	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506893297	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3761"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3722950001	"Pulmonary Embolism"	286	288	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	336	NA	NA	286	288	"CT scan of chest on 8/1/07 showed an pulmonary embolism."	""	""	2	2	2	NA	2	2	NA	0	"Pulmonary embolism was diagnosed and therefore hospitalized.  Was given Coumadin and condition improved."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505926462	""	""	""	NA	"Pulmonary embolism"	"Respiratory, thoracic and mediastinal disorders"	"Pulmonary vascular disorders"	"Pulmonary thrombotic and embolic conditions"	"Pulmonary embolism"	""	""	""	""	""	""	""	""	""	""	""	""
"3762"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	4512659002	"shortness of breathe"	286	321	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516131200	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3763"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	4625749002	"SHOULDER PAIN"	111	195	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516812769	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3764"	"DN-101 Protocol No. 011-007"	"127"	"127-0007"	5	9	"Adverse Event/Serious Adverse Event"	3793377001	"SKIN RASH"	15	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506944973	""	""	""	NA	"Skin rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"3765"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	2932344003	"alopecia"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505164124	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3766"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3358593001	"Anemia"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499115746	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3767"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3358518001	"Anemia"	16	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499115318	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3768"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3669974001	"CONSTIPATION"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505221259	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3769"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	4073377001	"cough"	161	175	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510781792	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"3770"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	4073269001	"depression"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510781422	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"3771"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3363166001	"Elevated alanine transferase (ALT)"	112	116	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499261914	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3772"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3667204001	"fatigue"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505164016	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3773"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3669999001	"HEARTBURN"	77	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505221766	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"3774"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	4073754001	"hot flashes"	85	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510782957	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"3775"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3358599001	"Hyperglycemia"	70	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499115831	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3776"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3363155001	"Hyperglycemia"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499261760	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3777"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3358540001	"Hyperglycemia"	28	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499115459	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3778"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3667030001	"leukopenia"	140	154	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505162622	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3779"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3667037001	"leukopenia"	161	175	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505162816	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3780"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3667023001	"leukopenia"	126	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505162374	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3781"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3358563001	"leukopenia"	25	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499115531	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3782"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3358588001	"leukopenia"	63	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499115680	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3783"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3363090001	"leukopenia"	98	112	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499260775	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3784"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3358533001	"leukopenia"	16	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499115385	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3785"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3358603001	"leukopenia"	77	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499115899	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3786"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3363087001	"leukopenia"	84	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499260411	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3787"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3667166001	"leukopenia"	182	189	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505163653	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3788"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3669630001	"NAIL CHANGES"	112	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505215918	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"3789"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3363099001	"neutropenia"	84	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499260964	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3790"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3666930001	"neutropenia"	161	168	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505161916	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3791"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3358578001	"neutropenia"	25	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499115608	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3792"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3666792001	"neutropenia"	140	147	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505161232	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3793"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3363230001	"neutropenia"	119	126	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499262891	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3794"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3667092001	"neutropenia"	182	189	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505163167	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3795"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3363126001	"neutropenia"	98	112	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499261369	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3796"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	4073254001	"shortness of breath"	112	122	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510781347	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"3797"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	4073246001	"sleep disturbance"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510781287	""	""	""	NA	"Sleep disturbance"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Sleep disorders NEC"	"Sleep disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"3798"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	4072452001	"swollen left thumb"	119	132	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510777515	""	""	""	NA	"Swollen thumb"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3799"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3667152001	"thrombocytopenia"	182	189	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505163565	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3800"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3363093001	"thrombocytopenia"	98	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499260888	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3801"	"DN-101 Protocol No. 011-007"	"127"	"127-0009"	5	9	"Adverse Event/Serious Adverse Event"	3667027001	"thrombocytopenia"	140	147	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505162521	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3802"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	2994752003	"anemia"	78	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506515987	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3803"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	4462934002	"bilateral edema of feet"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515692644	""	""	""	NA	"Foot edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3804"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	4454908002	"chills due to antibiotic reaction"	104	104	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515621854	""	""	""	NA	"Allergic reaction to antibiotics"	"Immune system disorders"	"Allergic conditions"	"Allergies to foods, food additives, drugs and other chemicals"	"Drug hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"3805"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3274140001	"constipation"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496934328	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3806"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	5091159002	"elevated alt"	338	352	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520887070	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3807"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	5091090002	"elevated alt"	313	331	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520886786	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3808"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773523001	"elevated ALT (alanine transferase)"	196	224	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506518405	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3809"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	5091301002	"elevated ast"	338	352	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520887640	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3810"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	5091247002	"elevated ast"	295	331	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520887486	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3811"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	5091230002	"elevated ast"	252	295	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520887414	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3812"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773467001	"Elevated AST (Aspartate transferase)"	133	234	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506518177	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3813"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	4463124002	"Fatigue"	69	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515693361	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3814"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3238527001	"febrile neutropenia"	77	79	NA	4	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	78	NA	NA	77	79	"ANC 0.4(1.5-8.8)grade 4; WBC 1.3(4.0-11.0)grade 3"	""	""	2	2	2	NA	2	2	NA	2	"DS recieved treatment with Taxotere on May 16. In clinic for a CBC check on 5/23/07.  Pt reported that he was week and had a temperature of 100.2 on 5/22/07.  Blood count resulted in hospitaliztion"	"and the start of IV antibiotics and Neupogen.;Pt remains in hospital.;;Pt was discharged on 5/25/07"	""	""	""	""	""	""	""	""	""	NA	NA	""	1495639460	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3815"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	4462980002	"hair thinning"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515692779	""	""	""	NA	"Hair thinning"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Hypotrichosis"	""	""	""	""	""	""	""	""	""	""	""	""
"3816"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772968001	"hyperglycemia"	84	175	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506516355	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3817"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772653001	"hyperglycemia"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506513377	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3818"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3988848001	"Hyperglycemia"	214	316	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509638121	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3819"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	5087239002	"hyperglycemia"	317	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520871408	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3820"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773424001	"hyperglycemia"	175	224	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506518056	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3821"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772666001	"hyperglycemia"	49	77	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506513670	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3822"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	5090745002	"hypocalcemia"	317	331	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520885520	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3823"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772957001	"hypokalemia"	84	112	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506516288	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3824"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	5090665002	"hypokalemia"	331	338	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520885258	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3825"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772785001	"hyponatremia"	70	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506515146	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3826"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	5087366002	"hyponatremia"	317	331	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520871902	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3827"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772649001	"increased alkaline phosphatase"	28	49	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506513308	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3828"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772661001	"increased alkaline phosphatase"	49	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506513562	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3829"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3988943001	"Increased Alkaline Phosphatase"	224	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509638475	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3830"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772644001	"increased alt"	28	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506513240	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3831"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3517364001	"itchy rash due to antibiotic"	105	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502379737	""	""	""	NA	"Itchy rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Pruritus NEC"	"Rash pruritic"	""	""	""	""	""	""	""	""	""	""	""	""
"3832"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773553001	"leukopenia"	203	217	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506518517	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3833"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772997001	"leukopenia"	98	112	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506516493	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3834"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3770843001	"leukopenia"	14	21	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506461505	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3835"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773482001	"leukopenia"	182	189	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506518235	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3836"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773399001	"leukopenia"	168	175	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506517985	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3837"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772810001	"leukopenia"	77	79	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506515323	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3838"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773188001	"leukopenia"	140	147	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506517283	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3839"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773135001	"leukopenia"	120	126	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506517125	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3840"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773379001	"leukopenia"	161	168	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506517933	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3841"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772680001	"leukopenia"	56	63	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506513950	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3842"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	5087434002	"low calcium"	313	317	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520872167	""	""	""	NA	"Calcium low"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood calcium decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3843"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	4983704002	"mild swelling in legs"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519765259	""	""	""	NA	"Swelling of legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3844"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	4463244002	"Myaligas"	26	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515693702	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3845"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3988884001	"Neutropenia"	210	224	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509638271	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3846"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772798001	"neutropenia"	77	79	NA	4	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506515247	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3847"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772631001	"neutropenia"	21	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506513072	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3848"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772669001	"neutropenia"	56	63	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506513739	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3849"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773116001	"neutropenia"	120	126	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506517053	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3850"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3770807001	"neutropenia"	14	21	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506461385	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3851"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773365001	"neutropenia"	161	168	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506517881	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3852"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773511001	"neutropenia"	182	189	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506518338	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3853"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773298001	"neutropenia"	147	154	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506517639	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3854"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773206001	"neutropenia"	140	147	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506517344	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3855"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772684001	"neutropenia"	63	70	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506514073	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3856"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772931001	"neutropenia"	79	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506516115	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3857"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3772656001	"neutropenia"	35	42	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506513442	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3858"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3773025001	"neutropenia"	98	112	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506516589	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3859"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	4463173002	"numbness of fingers and toes"	175	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515693502	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"3860"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3603152001	"pain in right hip"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504116114	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3861"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3603137001	"Peripheral neuropathy of feet"	91	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504116042	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3862"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3989012001	"peripheral neuropathy to feet"	196	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509638822	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"3863"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	4454887002	"shaking due to antibiotic  reaction"	104	104	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515621753	""	""	""	NA	"Allergic reaction to antibiotics"	"Immune system disorders"	"Allergic conditions"	"Allergies to foods, food additives, drugs and other chemicals"	"Drug hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"3864"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	4463101002	"shaking hands"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515693278	""	""	""	NA	"Shaking of hands"	"Nervous system disorders"	"Movement disorders (incl Parkinsonism)"	"Tremor (excl congenital)"	"Tremor"	""	""	""	""	""	""	""	""	""	""	""	""
"3865"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	4463199002	"Tingling of fingers and toes"	175	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515693589	""	""	""	NA	"Tingling"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"3866"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	4462970002	"Weakness"	26	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515692726	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3867"	"DN-101 Protocol No. 011-007"	"127"	"127-0010"	5	9	"Adverse Event/Serious Adverse Event"	3603042001	"Weakness(Neuropathy motor)"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504115726	""	""	""	NA	"Motor peripheral neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral motor neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3868"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3030343003	"Anemia"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504550505	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3869"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622374001	"Decreased ANC"	56	63	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504553618	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3870"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622574001	"Decreased ANC"	98	119	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504554432	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3871"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622613001	"Decreased ANC"	126	140	NA	3	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504554589	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3872"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622517001	"Decreased ANC"	77	84	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504554175	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3873"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622427001	"Decreased ANC"	63	70	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504553793	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3874"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3621951001	"Decreased ANC"	42	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504551315	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3875"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3714373001	"decreased anc"	168	168	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505851087	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3876"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3621677001	"Decreased ANC"	14	21	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504549511	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3877"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622638001	"Decreased WBC"	126	140	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504554706	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3878"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3714322001	"decreased wbc"	168	175	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505850895	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3879"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622405001	"Decreased WBC"	56	63	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504553705	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3880"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622449001	"Decreased WBC"	63	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504553882	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3881"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622532001	"Decreased WBC"	77	84	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504554243	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3882"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3621920001	"Decreased WBC"	42	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504551170	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3883"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3621822001	"Decreased WBC"	14	21	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504550430	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3884"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	4464341002	"Fatigie"	26	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515696770	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3885"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	4464176002	"fatigue"	91	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515696460	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3886"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622829001	"fatigue"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504555562	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3887"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	4464244002	"hair loss(balding)"	217	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515696598	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3888"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3714072001	"headache"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505850169	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"3889"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3621881001	"Hyperglycemia"	28	70	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504550972	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3890"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3714179001	"hyperglycemia"	161	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505850494	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3891"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622479001	"Hyperglycemia"	91	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504554008	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3892"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622543001	"Hyperglycemia"	119	140	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504554306	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3893"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622494001	"Hyponatremia"	91	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504554072	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3894"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3621907001	"Hypopnatremia"	28	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504551093	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3895"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3621857001	"Increased alkaline phos"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504550886	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3896"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	4464090002	"Intermittent nausea"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515696280	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"3897"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	4464397002	"left hip pain"	217	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515696844	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3898"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	4464287002	"left shoulder pain"	140	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515696682	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3899"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	4464457002	"left shoulder pain"	196	217	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515696948	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3900"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3405831001	"Mild fatigue"	26	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499811575	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3901"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	4464597002	"mild headaches"	50	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515697197	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"3902"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	4464036002	"Sleep apnea"	27	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515696202	""	""	""	NA	"Sleep apnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Sleep apnoea syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"3903"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3621967001	"Thrombocytopenia"	56	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504551433	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3904"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	3622592001	"thrombocytopenia"	126	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504554514	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3905"	"DN-101 Protocol No. 011-007"	"127"	"127-0011"	5	9	"Adverse Event/Serious Adverse Event"	4464146002	"tongue sores"	77	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515696400	""	""	""	NA	"Sore tongue"	"Gastrointestinal disorders"	"Tongue conditions"	"Tongue signs and symptoms"	"Glossodynia"	""	""	""	""	""	""	""	""	""	""	""	""
"3906"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3522024003	"anemia"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505931884	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3907"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3588550001	"Back pain"	6	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503950786	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3908"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3719039001	"constipation"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505911078	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3909"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3719172001	"decreased ANC"	20	22	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505911790	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3910"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3719080001	"decreased ANC"	13	20	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505911367	""	""	""	NA	"Absolute neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3911"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3725411001	"Decreased WBC"	41	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505931995	""	""	""	NA	"WBC decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3912"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3719307001	"Heartburn"	34	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505912356	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"3913"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3719147001	"hyperglycemia"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505911681	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3914"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3719118001	"hyponatremia"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505911553	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3915"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3725197001	"Muscle aches"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505931623	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"3916"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3719187001	"neutropenia"	34	NA	1	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505911879	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3917"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3719224001	"neutropenia"	34	41	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505912092	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3918"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3725772001	"numbness inside of mouth"	34	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505932793	""	""	""	NA	"Numbness mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Oral soft tissue signs and symptoms"	"Hypoaesthesia oral"	""	""	""	""	""	""	""	""	""	""	""	""
"3919"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3719054001	"right leg cramps"	13	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505911243	""	""	""	NA	"Cramps leg"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"3920"	"DN-101 Protocol No. 011-007"	"127"	"127-0013"	5	9	"Adverse Event/Serious Adverse Event"	3719093001	"thrombocytopenia"	13	20	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505911449	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3921"	"DN-101 Protocol No. 011-007"	"128"	"128-0001"	5	9	"Adverse Event/Serious Adverse Event"	3039470003	"alopecia"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499783692	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3922"	"DN-101 Protocol No. 011-007"	"128"	"128-0001"	5	9	"Adverse Event/Serious Adverse Event"	5144024002	"fatigue"	112	198	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521467903	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3923"	"DN-101 Protocol No. 011-007"	"128"	"128-0001"	5	9	"Adverse Event/Serious Adverse Event"	3209692001	"fatigue"	14	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495034396	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3924"	"DN-101 Protocol No. 011-007"	"128"	"128-0001"	5	9	"Adverse Event/Serious Adverse Event"	3588294001	"GI Bleed"	104	108	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	7	1	1	1	"transfusion"	0	1	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	155	NA	NA	104	108	"Hemoglobin on admission was 7.8, transfused 4 units PRBC.; EGD done 07/10/2007 Barrett's esophagus, esophageal reflux, ulcers and hiatal hernia"	""	""	2	2	2	NA	2	2	2	2	"Patient admitted to hospital wit GI bleed.  Had black tarry stools for several daysand presented to ED with hgb of 7.8.  Patient had upper endoscopywhich showed barrett's esophagus.  Patient also had"	"ulcers in middle third of the esophagus and lower third of the esophagus and espohageal reflux.  Event not related to docetaxel.  Related to history of GI reflux and possible predinsone therapy."	""	""	""	""	""	""	""	""	""	NA	NA	""	1503948924	""	""	""	NA	"GI bleed"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"3925"	"DN-101 Protocol No. 011-007"	"128"	"128-0001"	5	9	"Adverse Event/Serious Adverse Event"	3398087001	"hemoglobinemia"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499783912	""	""	""	NA	"Hemoglobinemia"	"Blood and lymphatic system disorders"	"Haemolyses and related conditions"	"Haemolyses NEC"	"Haemoglobinaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3926"	"DN-101 Protocol No. 011-007"	"128"	"128-0001"	5	9	"Adverse Event/Serious Adverse Event"	3211464001	"Intermittent toe cramps"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495042466	""	""	""	NA	"Cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"3927"	"DN-101 Protocol No. 011-007"	"128"	"128-0001"	5	9	"Adverse Event/Serious Adverse Event"	3211568001	"lymphopenia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495042874	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3928"	"DN-101 Protocol No. 011-007"	"128"	"128-0001"	5	9	"Adverse Event/Serious Adverse Event"	3545667001	"pneumonia"	122	125	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	144	NA	NA	122	125	"requested records from local hospital"	""	""	2	2	2	NA	2	2	NA	2	"found out on 08/13/2007 that patient had been admitted to local hospital for elevated temp. and pneunomia.  Diagnosis per ct scsn according to patient.  Patient stated he was treated with antibiotics"	"and was hospitalized for 3 days.  Patient was released and feels back to normal in one week after event per patient.  Records have been requested from local hospital. ;Additional information to add."	"Patient presented to local hospital with grade 3 febrile neutropenia a symptom of the pneunomia."	""	""	""	""	""	""	""	""	NA	NA	""	1502995260	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"3929"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	2590631003	"alkaline phosphatase"	7	356	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475714872	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3930"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3379328001	"alkaline phosphatase"	357	407	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499628524	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3931"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3376961001	"ALT,SGPT"	357	407	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499618049	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3932"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	4609971002	"blurred vision"	332	385	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516725621	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"3933"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	4601077002	"constipation"	196	407	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516668593	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"3934"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3063629001	"dizziness, intermittent"	117	407	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491416044	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"3935"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3190291001	"dyseusia"	130	407	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494798885	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"3936"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3063439001	"fatigue"	113	352	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491415305	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3937"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3376933001	"fatigue"	353	407	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499617863	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3938"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	2710906001	"hemoglobin"	91	356	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475714762	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3939"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3379308001	"hemoglobin"	357	407	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499628466	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3940"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3379370001	"hemoglobin(per CTC and SOP)"	279	299	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499628771	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3941"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	4601037002	"hives on face"	98	99	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516668453	""	""	""	NA	"Hives"	"Skin and subcutaneous tissue disorders"	"Angioedema and urticaria"	"Urticarias"	"Urticaria"	""	""	""	""	""	""	""	""	""	""	""	""
"3942"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	2710897001	"hyperglycemia"	29	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475714411	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3943"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	2710900001	"hypoalbuminemia"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475714560	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3944"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	2701707001	"hyponatremia"	7	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475174668	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3945"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3063891001	"insomnia"	120	407	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491417050	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"3946"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	4601610002	"low back pain"	303	407	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516671250	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3947"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	4600990002	"mood alteration, depression"	253	407	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516668272	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"3948"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	4610033002	"neuropathy, cranial, CN-V"	332	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516725794	""	""	""	NA	"Cranial neuropathy"	"Nervous system disorders"	"Cranial nerve disorders (excl neoplasms)"	"Cranial nerve disorders NEC"	"Cranial neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3949"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3190385001	"neuropathy, sensory, lower lip."	298	407	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494799314	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"3950"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3063667001	"pain, low back"	204	302	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491416183	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"3951"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3063413001	"pain, R groin to leg"	113	352	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491415193	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"3952"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	2710940001	"rash on back"	97	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475715585	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"3953"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	4601009002	"rash on buttock"	71	110	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516668347	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"3954"	"DN-101 Protocol No. 011-007"	"130"	"130-0002"	5	9	"Adverse Event/Serious Adverse Event"	3376994001	"weight loss"	225	407	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499618255	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3955"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	2618792003	"alopecia"	30	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475189769	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3956"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070849001	"AST,SGOT"	122	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491768654	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3957"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	2702663001	"asthenia-muscle weakness"	19	28	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475189541	""	""	""	NA	"Asthenia"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3958"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070686001	"blurred vision"	112	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491766353	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"3959"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	5298814002	"fever"	127	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523825992	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"3960"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070674001	"hallucinations"	125	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491766235	""	""	""	NA	"Hallucinations"	"Psychiatric disorders"	"Disturbances in thinking and perception"	"Perception disturbances"	"Hallucination"	""	""	""	""	""	""	""	""	""	""	""	""
"3961"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070629001	"headache"	124	130	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491765763	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"3962"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	2702653001	"headaches, intermittent"	14	123	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475189407	""	""	""	NA	"Intermittent headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"3963"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070765001	"hematuria"	128	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491767030	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"3964"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070695001	"hemoglobin"	122	125	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491766526	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3965"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	4612924002	"hemoglobin"	128	128	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516733713	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3966"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	4611418002	"hemoglobin"	126	126	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516729525	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3967"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	4612852002	"hemoglobin"	126	126	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516733442	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3968"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	2776566001	"hemorrhage, CNS (subdural hematoma)"	124	130	NA	5	0	NA	NA	NA	NA	NA	0	NA	NA	7	1	1	1	"hospitalization"	4	0	NA	0	60	NA	NA	1	1	1	1	NA	""	128	130	0	125	130	"CT of Brain, labs. Operation on 11/13/2006 for left frontoparietal craniotomy for evacuation of subacute subdural hematoma with placement of subdural drain."	""	""	2	2	2	2	2	2	2	2	"patient is in follow up phase.;;by history from neurosurgeon, patient suffered a fall on Saturday, Nov 11,2006 due to instability from parkinison's diasease (medical history).  Struck head but"	"acutely ok. Later that evening, patient had onset of severe headache. Went to ER here at St Joseph's hospital in Tucson. CT/MRI showed subdural hematoma.  There was progressive alteration of mental"	"status.  Patient was transfered to Phoenix hospital for treatment. Operation performed. Patient released on 11/17/2006 to home hospice. Patient died at home."	""	""	""	""	""	""	""	""	NA	NA	""	1479228984	""	""	""	NA	"Hemorrhage subdural"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Cerebral injuries NEC"	"Subdural haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"3969"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070861001	"hyperglycemia"	126	127	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491768784	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3970"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070872001	"hypernatremia"	127	130	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491768967	""	""	""	NA	"Hypernatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hypernatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3971"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	5298826002	"hypertension"	126	130	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523826058	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"3972"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070881001	"hypoalbuminemia"	127	130	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491769075	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3973"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070903001	"hypokalemia"	127	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491769250	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3974"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070865001	"hypophosphatemia"	127	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491768861	""	""	""	NA	"Hypophosphatemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Phosphorus metabolism disorders"	"Hypophosphataemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3975"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	4610907002	"muscle weakness"	28	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516728044	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"3976"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070799001	"neutrophils"	21	34	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491767400	""	""	""	NA	"Neutrophil count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3977"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	3070742001	"thrombocytopenia"	122	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491766773	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"3978"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	2702648001	"urininary tract infection"	14	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475189298	""	""	""	NA	"Infection urinary tract"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"3979"	"DN-101 Protocol No. 011-007"	"130"	"130-0003"	5	9	"Adverse Event/Serious Adverse Event"	2702686001	"vitreous hemorrage"	34	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1475189917	""	""	""	NA	"Vitreous hemorrhage"	"Eye disorders"	"Retina, choroid and vitreous haemorrhages and vascular disorders"	"Choroid and vitreous haemorrhages and vascular disorders"	"Vitreous haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"3980"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	2715083003	"excessive tearing"	85	269	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491163650	""	""	""	NA	"Excess tears"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3981"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	2883069001	"fatigue"	18	29	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484778642	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3982"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	4184322001	"fatigue"	359	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512412495	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3983"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	3052197001	"fatigue"	96	154	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491163400	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3984"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	2883084001	"flushing"	35	37	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484778742	""	""	""	NA	"Flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"3985"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	3052701001	"flushing"	162	166	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491167197	""	""	""	NA	"Flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"3986"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	2883057001	"flushing"	17	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484778475	""	""	""	NA	"Flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"3987"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	4184219001	"hematuria"	359	383	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512412312	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"3988"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	4184256001	"hematuria"	383	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512412384	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"3989"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	2883098001	"hematuria"	43	359	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484778826	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"3990"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	3052346001	"hemoglobin"	16	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491164212	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3991"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	3052704001	"hemoglobin"	56	224	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491167299	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"3992"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	3052337001	"hyperglycemia"	16	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491164125	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3993"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	3052709001	"hyperglycemia"	35	240	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491167426	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3994"	"DN-101 Protocol No. 011-007"	"130"	"130-0004"	5	9	"Adverse Event/Serious Adverse Event"	3190202001	"hyponatremia"	224	240	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494798197	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"3995"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	2754100003	"alopecia"	204	234	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499733497	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"3996"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	3394082001	"creatinine"	126	412	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499733574	""	""	""	NA	"Creatinine high"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3997"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	3394071001	"excessive tearing"	204	248	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499733419	""	""	""	NA	"Excess tears"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"3998"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	2899396001	"fatigue"	44	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485717942	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"3999"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	2899423001	"fatigue"	85	248	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485718150	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4000"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	2899403001	"fatigue"	67	69	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485718017	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4001"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	2899452001	"hyperglycemia"	22	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485718377	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4002"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	2899469001	"hypoalbuminemia"	42	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485718561	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4003"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	2899485001	"hypoalbuminemia"	84	105	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485718649	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4004"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	3394068001	"hypoalbuminemia"	168	189	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499733229	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4005"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	3394087001	"hypocalcemia"	189	210	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499733640	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4006"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	2899496001	"Left foot neuropathy sensory"	97	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485718810	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4007"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	3112914001	"nail changes"	114	248	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492725068	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4008"	"DN-101 Protocol No. 011-007"	"130"	"130-0005"	5	9	"Adverse Event/Serious Adverse Event"	3523707001	"UTI"	278	323	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502659545	""	""	""	NA	"UTI"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4009"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	2825540003	"alopecia"	38	215	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491340797	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4010"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3858369001	"back pain"	137	314	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507756432	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4011"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	4202446001	"back pain"	314	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512515609	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4012"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	4202422001	"back pain, L 10th rib"	110	136	NA	2	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512515491	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4013"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3059757001	"constipation, intermittent"	50	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491341142	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4014"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3063243001	"creatinine"	82	110	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491414496	""	""	""	NA	"Creatinine high"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4015"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3059629001	"creatinine"	19	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491340391	""	""	""	NA	"Creatinine high"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4016"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3380864001	"fatigue"	152	203	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499636437	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4017"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3059743001	"fatigue"	62	151	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491341025	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4018"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3188469001	"flushing, facial"	153	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494788573	""	""	""	NA	"Facial flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"4019"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3059841001	"hematuria"	103	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491342229	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"4020"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3380898001	"hemoglobin"	131	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499636673	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4021"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3059737001	"hyperglycemia"	40	243	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491340910	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4022"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3059591001	"hyperglycemia"	19	39	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491340302	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4023"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3059658001	"hypoalbuminemia"	19	81	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491340541	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4024"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	4202356001	"hypoalbuminemia"	82	109	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512515050	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4025"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	4202364001	"hypoalbuminemia"	110	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512515126	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4026"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3855653001	"left leg weakness"	295	309	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507747620	""	""	""	NA	"Weakness of limbs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4027"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3524790001	"numbness in fingers"	131	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502667365	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4028"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3524794001	"numbness on toes & feet"	131	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502667456	""	""	""	NA	"Numbness in toes"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4029"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3063195001	"pain, back, 10th rib"	96	110	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491414325	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4030"	"DN-101 Protocol No. 011-007"	"130"	"130-0006"	5	9	"Adverse Event/Serious Adverse Event"	3858352001	"sore throat"	311	334	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507756364	""	""	""	NA	"Sore throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4031"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	2830874003	"akaline phosphatase"	44	171	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485893726	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4032"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	3393974001	"alkaline phosphatase"	172	221	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499731569	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4033"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	2903822001	"alopecia"	59	331	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485894315	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4034"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	4190101001	"back pain"	331	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512427773	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4035"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	4190123001	"dehydration"	343	343	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512427929	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"4036"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	2903704001	"fatigue"	45	60	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485892546	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4037"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	4190068001	"fatigue"	366	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512427542	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4038"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	3393953001	"fatigue, intermittent"	121	366	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499731279	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4039"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	3393980001	"hemoglobin, intermittent"	214	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499731743	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4040"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	2903784001	"hyperglycemia"	44	64	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485893931	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4041"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	2903809001	"hyperglycemia, intermittent"	65	259	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485894184	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4042"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	2903794001	"hypoalbuminemia"	44	88	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485894036	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4043"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	3393977001	"hypoalbuminemia, intermittent"	214	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499731669	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4044"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	2903761001	"hypocalcemia"	65	88	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485893635	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4045"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	3393967001	"hyponatremia"	172	193	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499731467	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4046"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	2903749001	"hyponatremia"	44	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485893372	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4047"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	4750275002	"insomnia"	NA	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517525495	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4048"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	4190113001	"sweats"	331	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512427857	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4049"	"DN-101 Protocol No. 011-007"	"130"	"130-0007"	5	9	"Adverse Event/Serious Adverse Event"	3807703001	"weight loss"	207	366	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507065923	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4050"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3223521003	"alkaline phosphatase"	152	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512929230	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4051"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3665178001	"atrial fibrillation"	92	112	NA	3	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505152463	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"4052"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3519005001	"back pain"	58	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502397603	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4053"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	4750072002	"depression"	153	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517525003	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"4054"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3518889001	"dizziness"	90	99	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502396365	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"4055"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3786496001	"dizziness"	99	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506640140	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"4056"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3855907001	"dysguesia"	145	223	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507748291	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4057"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3393447001	"dysquesia"	35	145	NA	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499725985	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4058"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3381648001	"dysquesia"	14	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499646093	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4059"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3519016001	"fatigue"	67	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502398027	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4060"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3381651001	"fatigue"	42	43	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499646151	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4061"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	4228397001	"hemoglobin"	152	217	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512928966	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4062"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3665009001	"hemoglobin"	96	152	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505151648	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4063"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3664968001	"hemoglobin"	91	96	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505151417	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4064"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3519024001	"hoarse voice"	67	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502398177	""	""	""	NA	"Hoarse voice"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dysphonia"	""	""	""	""	""	""	""	""	""	""	""	""
"4065"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3381657001	"hoarse voice"	39	46	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499646215	""	""	""	NA	"Hoarse voice"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dysphonia"	""	""	""	""	""	""	""	""	""	""	""	""
"4066"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3519027001	"hoarse voice"	72	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502398256	""	""	""	NA	"Hoarse voice"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dysphonia"	""	""	""	""	""	""	""	""	""	""	""	""
"4067"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3786514001	"hypoalbuminemia"	125	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506640239	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4068"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3664920001	"hypoalbuminemia"	104	125	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505151164	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4069"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3519034001	"hypoalbuminemia"	63	104	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502398732	""	""	""	NA	"Hypoalbuminemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoalbuminaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4070"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3664938001	"hypocalcemia"	104	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505151242	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4071"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3665082001	"hypotension"	92	223	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505152081	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"4072"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3664904001	"mouth infection"	91	97	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505151070	""	""	""	NA	"Oral infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Dental and oral soft tissue infections"	"Oral infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4073"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3381645001	"mucositis,oral"	14	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499646018	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4074"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3515428001	"neutropenic fever"	91	99	NA	3	1	1	NA	NA	NA	NA	1	1	NA	5	1	NA	1	"hospitalized"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	91	NA	NA	91	99	"chest x-ray, lab tests. serial blood cultures, 2-D echocardiogram, Urinalysis, telemetry, CT of abd& pelvis"	""	""	2	2	1	NA	1	2	NA	2	"Pt experienced fever of 101.5 on evening of 8/8/07 with  nausea and weakness. He was admitted to UMC after being evaluated in ER.  Blood cultures obtained and showed he was neutropenic.   Pt was in"	"atrial fibrillation. Pt was put on IV antibiotics and given 2 untis of PRBC for anemia. Blood cultures and UA were negative. A-fib became complicated with hypotension.  Pt was treated with IV fluid"	"boluses and IV diltiazem.  Pt stabilized and discharged with instructions to follow up with his Cardiologist and Oncologist."	""	""	""	""	""	""	""	""	NA	NA	""	1502325436	""	""	""	NA	"Neutropenic fever"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4075"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3664995001	"oral thrush"	97	100	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505151556	""	""	""	NA	"Oral thrush"	"Infections and infestations"	"Fungal infectious disorders"	"Candida infections"	"Oral candidiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"4076"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3381639001	"pain, abdominal cramp"	14	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499645926	""	""	""	NA	"Abdominal crampy pains"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4077"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3786479001	"vision changes"	92	223	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506640063	""	""	""	NA	"Visual disturbances"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Visual disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"4078"	"DN-101 Protocol No. 011-007"	"130"	"130-0008"	5	9	"Adverse Event/Serious Adverse Event"	3518912001	"weakness"	90	NA	1	2	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502396482	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4079"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	2832712003	"Alopecia"	23	185	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484254545	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4080"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3697322001	"Anemia"	221	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505683250	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4081"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3214312001	"Back Skin Thermal Burns"	141	185	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495054438	""	""	""	NA	"Thermal burn"	"Injury, poisoning and procedural complications"	"Injuries by physical agents"	"Thermal burns"	"Thermal burn"	""	""	""	""	""	""	""	""	""	""	""	""
"4082"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3065964001	"Bone/Joint pain"	73	136	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491432371	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4083"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	2869752001	"Bruising"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484254828	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"4084"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3687351001	"Constipation"	225	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505336191	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4085"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3697589001	"Dyspepsia"	249	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505684972	""	""	""	NA	"Dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"4086"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3307916001	"Fatigue"	162	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497992157	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4087"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	2909415001	"Flu Symptoms"	45	94	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486075292	""	""	""	NA	"Flu symptoms"	"Infections and infestations"	"Viral infectious disorders"	"Influenza viral infections"	"Influenza"	""	""	""	""	""	""	""	""	""	""	""	""
"4088"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3697467001	"Hypocalcemia"	221	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505684196	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4089"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3697398001	"Hypokalemia"	221	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505683946	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4090"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3596623001	"Hypotension"	225	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504042210	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"4091"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3596526001	"Incomplete Tetraplegia"	217	NA	1	4	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	2	0	NA	0	2	NA	1	NA	NA	NA	NA	NA	""	254	NA	NA	217	NA	"Various radiological reports since time of hospital admission"	""	""	0	0	0	NA	0	0	2	2	"Subject admitted  to hospital for increased neck/back pain and paralysis, underwent emergent C-4 laminectomy with C3-6 posterior cervical fusion on or about 7/16/07.  Radiological studies showed"	"probable metastatic tumors throughout the spine with cervical areas causing severe spinal stenosis.  Subject was transferred to Southern Arizona VA Health Care System on 7/20/07 and remained"	"inpatient since then.  Adverse events related to disease progresssion not related to study treatments."	""	""	""	""	""	""	""	""	NA	NA	""	1504041869	""	""	""	NA	"Tetraplegia"	"Nervous system disorders"	"Movement disorders (incl Parkinsonism)"	"Paralysis and paresis (excl cranial nerve)"	"Quadriplegia"	""	""	""	""	""	""	""	""	""	""	""	""
"4092"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3697495001	"Insomnia"	226	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505684319	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4093"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3697515001	"Nausea"	231	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505684432	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"4094"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3596761001	"Neck Pain"	213	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504043031	""	""	""	NA	"Neck pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Neck pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4095"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3009521001	"Peripheral Neuropathy"	80	185	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489964250	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4096"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3165421001	"Right Paraspinal Soft Tissue Pain"	115	NA	1	4	1	1	NA	NA	NA	NA	1	1	NA	5	1	NA	1	"Radiation Therapy to Right Paraspinal Area"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494193484	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4097"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3307958001	"Shortness of Breath"	162	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497992387	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4098"	"DN-101 Protocol No. 011-007"	"131"	"131-0001"	5	9	"Adverse Event/Serious Adverse Event"	3697547001	"Urinary Tract Infeciton"	241	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505684696	""	""	""	NA	"Infection urinary tract"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4099"	"DN-101 Protocol No. 011-007"	"131"	"131-0005"	5	9	"Adverse Event/Serious Adverse Event"	3645246003	"Acute Hypersensitivity Reactions"	51	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Docetaxel dose infusion time interrupted., infusion time 45 minutes."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507151769	""	""	""	NA	"Hypersensitivity reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"4100"	"DN-101 Protocol No. 011-007"	"131"	"131-0005"	5	9	"Adverse Event/Serious Adverse Event"	3815752001	"Fatigue"	32	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507151300	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4101"	"DN-101 Protocol No. 011-007"	"131"	"131-0005"	5	9	"Adverse Event/Serious Adverse Event"	3815777001	"Generalized Pain"	32	38	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507151474	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4102"	"DN-101 Protocol No. 011-007"	"131"	"131-0005"	5	9	"Adverse Event/Serious Adverse Event"	3815743001	"Hair Loss"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507151185	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4103"	"DN-101 Protocol No. 011-007"	"131"	"131-0005"	5	9	"Adverse Event/Serious Adverse Event"	3933018001	"Insomnia"	60	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508883514	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4104"	"DN-101 Protocol No. 011-007"	"131"	"131-0005"	5	9	"Adverse Event/Serious Adverse Event"	3815764001	"Taste Alterations"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507151381	""	""	""	NA	"Taste altered"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4105"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	2763956003	"Dizziness"	239	285	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508862592	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"4106"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	2997413001	"Fatigue"	112	116	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489510050	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4107"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	2969557001	"Fatigue"	91	95	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488240404	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4108"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	2969537001	"Fatigue"	29	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488240165	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4109"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	2823436001	"Fatigue"	8	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481669156	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4110"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	2969548001	"Fatigue"	50	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488240255	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4111"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	3095572001	"Fatigue"	133	213	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492453995	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4112"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	2969552001	"Fatigue"	71	76	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488240332	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4113"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	3928092001	"Fatigue"	249	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508862472	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4114"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	3095597001	"Nail changes"	134	164	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492454089	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4115"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	3271734001	"Nail changes"	165	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496865765	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4116"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	3928116001	"Pedal edema"	249	311	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508862549	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4117"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	3928146001	"Right hip pain"	302	308	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508862651	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4118"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	3271771001	"Taste change"	184	229	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496866054	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4119"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	3271748001	"Tearing in eyes"	160	185	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496865886	""	""	""	NA	"Tearing eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4120"	"DN-101 Protocol No. 011-007"	"133"	"133-0001"	5	9	"Adverse Event/Serious Adverse Event"	2969564001	"Upper respiratory tract infection"	103	108	NA	1	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488240552	""	""	""	NA	"Upper respiratory tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4121"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	2819357003	"Agitation"	238	287	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508870086	""	""	""	NA	"Agitation"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Agitation"	""	""	""	""	""	""	""	""	""	""	""	""
"4122"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3928897001	"Collapsed vertebra"	232	287	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508866858	""	""	""	NA	"Collapsed vertebra"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Spinal fractures and dislocations"	"Spinal compression fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"4123"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3929705001	"Confusion"	235	287	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508870049	""	""	""	NA	"Confusion"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Confusion and disorientation"	"Confusional state"	""	""	""	""	""	""	""	""	""	""	""	""
"4124"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3929736001	"Constipation"	234	287	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508870133	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4125"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	2978769001	"Facial redness"	3	4	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488758755	""	""	""	NA	"Redness facial"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"4126"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	2978829001	"Fatigue"	24	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488759937	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4127"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	2978860001	"Fatigue"	47	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488760379	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4128"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3393469001	"Fatigue"	171	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499726217	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4129"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3393454001	"Hypersensitivity reaction to Docetaxel"	149	149	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499726047	""	""	""	NA	"Drug hypersensitivity"	"Immune system disorders"	"Allergic conditions"	"Allergies to foods, food additives, drugs and other chemicals"	"Drug hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"4130"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3137944001	"Hypersensitivity reaction to Docetaxel"	128	128	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493313444	""	""	""	NA	"Drug hypersensitivity"	"Immune system disorders"	"Allergic conditions"	"Allergies to foods, food additives, drugs and other chemicals"	"Drug hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"4131"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3137851001	"Hypersensitivity reaction to Docetaxel"	107	107	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493311221	""	""	""	NA	"Drug hypersensitivity"	"Immune system disorders"	"Allergic conditions"	"Allergies to foods, food additives, drugs and other chemicals"	"Drug hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"4132"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	2978765001	"Hypersensitivity reaction to Docetaxel"	2	2	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488758679	""	""	""	NA	"Drug hypersensitivity"	"Immune system disorders"	"Allergic conditions"	"Allergies to foods, food additives, drugs and other chemicals"	"Drug hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"4133"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	2978826001	"Hypersensitivity reaction to Docetaxel"	23	23	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488759797	""	""	""	NA	"Drug hypersensitivity"	"Immune system disorders"	"Allergic conditions"	"Allergies to foods, food additives, drugs and other chemicals"	"Drug hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"4134"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3393473001	"Hypersensitivity reaction to Docetaxel"	191	191	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499726268	""	""	""	NA	"Drug hypersensitivity"	"Immune system disorders"	"Allergic conditions"	"Allergies to foods, food additives, drugs and other chemicals"	"Drug hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"4135"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3393460001	"Nail changes"	150	287	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499726153	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4136"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	4835558002	"Pain - back"	132	225	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518140307	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4137"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3393423001	"Pain left rib"	132	225	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499725804	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4138"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3929771001	"Pain, lower back and sacral region"	279	287	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508870229	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4139"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3929812001	"Pneumonia"	286	287	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508870385	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"4140"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3928794001	"Rib pain"	225	233	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508866253	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4141"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3513074001	"Rib pain"	234	241	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	240	NA	NA	234	241	"No relevant tests"	""	""	2	2	2	NA	2	2	NA	2	"Patient complaint of severe rib pain not controlled with Oxycodone at home.  Patient was admitted to hospital for pain control.  Patient was discharged Aug 10/07"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502299219	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4142"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3928764001	"Right shoulder pain"	225	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508866075	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4143"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	3928806001	"Right shoulder pain"	238	287	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508866309	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4144"	"DN-101 Protocol No. 011-007"	"133"	"133-0003"	5	9	"Adverse Event/Serious Adverse Event"	2978777001	"Upper respiratory tract infection"	10	16	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488758831	""	""	""	NA	"Upper respiratory tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4145"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	2969402003	"Abdominal pain - left lower quadrant"	280	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513033152	""	""	""	NA	"Abdominal pain lower"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain lower"	""	""	""	""	""	""	""	""	""	""	""	""
"4146"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3366988001	"Back pain"	112	138	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499299269	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4147"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3497055001	"Back Pain"	139	230	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502121521	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4148"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3366991001	"Constipation"	112	258	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499299475	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4149"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3837537001	"Cough"	196	230	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507596265	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4150"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3346136001	"Deep vein thrombosis"	129	135	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	132	NA	NA	129	135	"INR 26Jun2007 1.2; Right leg venous doppler study 26Jun2007 -Deep vein thrombus in the proximal thigh and groin level of the right leg"	""	""	2	2	2	NA	2	2	NA	2	"Patient presented to the Emergency with increased swelling in his right thigh and calf and progressive weakness in his right leg. DVT was confirmed on Doppler study.  Patient was treated with low"	"molecular weight Heparin and warfarin.	Patient was discharged from hospital on July 1/07"	""	""	""	""	""	""	""	""	""	NA	NA	""	1498772142	""	""	""	NA	"Deep vein thrombosis"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4151"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3837535001	"Fatigue"	196	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507596198	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4152"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3837614001	"Hypotension"	166	167	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507598029	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"4153"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3837540001	"Infection - Left elbow"	176	186	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507596341	""	""	""	NA	"Localized infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Localised infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4154"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3366950001	"Left lower quadrant pain"	79	105	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499298763	""	""	""	NA	"Left lower quadrant pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain lower"	""	""	""	""	""	""	""	""	""	""	""	""
"4155"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3837533001	"Nail Changes"	196	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507596142	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4156"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3366922001	"Nail changes"	69	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499298514	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4157"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3497075001	"Nail Infection - Left 3rd finger"	145	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502121607	""	""	""	NA	"Nail infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Nail infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4158"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3837549001	"Neuropathy - feet"	223	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507596767	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4159"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3366994001	"Nocturia"	106	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499299636	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"4160"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3366976001	"Taste changes"	83	258	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499299013	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4161"	"DN-101 Protocol No. 011-007"	"133"	"133-0009"	5	9	"Adverse Event/Serious Adverse Event"	3102793001	"Upper respiratory tract infection"	17	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492545977	""	""	""	NA	"Upper respiratory tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4162"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3075302003	"Alopecia"	120	279	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502124938	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4163"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381901001	"Dry Skin"	22	279	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499648570	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"4164"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381941001	"Fatigue"	61	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499648886	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4165"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381894001	"Fatigue"	22	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499648499	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4166"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381924001	"Fatigue"	54	54	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499648731	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4167"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381950001	"Hot flashes"	34	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499648937	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"4168"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	4861269002	"Musculoskeletal pain"	279	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518489509	""	""	""	NA	"Musculoskeletal pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4169"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	4247102001	"Myalgia"	208	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513035787	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4170"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381979001	"Nail changes"	79	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499649252	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4171"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381982001	"Peripheral neuropathy"	79	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499649312	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4172"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381967001	"Right thigh hematoma - dog bite"	76	93	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499649128	""	""	""	NA	"Dog bite"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Non-site specific injuries NEC"	"Animal bite"	""	""	""	""	""	""	""	""	""	""	""	""
"4173"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381927001	"Sore throat"	39	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499648774	""	""	""	NA	"Sore throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4174"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381934001	"Taste change"	61	72	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499648833	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4175"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381908001	"Taste change"	40	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499648624	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4176"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381977001	"Taste change"	79	93	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499649213	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4177"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3381888001	"Taste change"	22	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499648464	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4178"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3497524001	"Taste changes"	103	115	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502124865	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4179"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3933625001	"Taste changes"	164	172	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508890671	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4180"	"DN-101 Protocol No. 011-007"	"133"	"133-0010"	5	9	"Adverse Event/Serious Adverse Event"	3933630001	"Taste changes"	184	188	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508890722	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4181"	"DN-101 Protocol No. 011-007"	"133"	"133-0012"	5	9	"Adverse Event/Serious Adverse Event"	3240293003	"Alopecia"	18	222	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502139364	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4182"	"DN-101 Protocol No. 011-007"	"133"	"133-0012"	5	9	"Adverse Event/Serious Adverse Event"	4860997002	"back pain"	227	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518487716	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4183"	"DN-101 Protocol No. 011-007"	"133"	"133-0012"	5	9	"Adverse Event/Serious Adverse Event"	3500175001	"Fatigue"	55	62	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502139476	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4184"	"DN-101 Protocol No. 011-007"	"133"	"133-0012"	5	9	"Adverse Event/Serious Adverse Event"	3500155001	"Muscle aches"	6	9	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502139427	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4185"	"DN-101 Protocol No. 011-007"	"133"	"133-0012"	5	9	"Adverse Event/Serious Adverse Event"	4248191001	"Nail changes"	177	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513041083	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4186"	"DN-101 Protocol No. 011-007"	"133"	"133-0012"	5	9	"Adverse Event/Serious Adverse Event"	3846558001	"Sensory neuropathy - toes"	78	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507677605	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4187"	"DN-101 Protocol No. 011-007"	"133"	"133-0012"	5	9	"Adverse Event/Serious Adverse Event"	3500195001	"Taste changes"	27	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502139543	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4188"	"DN-101 Protocol No. 011-007"	"133"	"133-0012"	5	9	"Adverse Event/Serious Adverse Event"	3500117001	"Taste Changes"	6	12	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502139326	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4189"	"DN-101 Protocol No. 011-007"	"133"	"133-0012"	5	9	"Adverse Event/Serious Adverse Event"	3500211001	"Taste changes"	55	62	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502139577	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4190"	"DN-101 Protocol No. 011-007"	"133"	"133-0012"	5	9	"Adverse Event/Serious Adverse Event"	4248185001	"Teary eyes"	136	222	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513041046	""	""	""	NA	"Teary eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4191"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3270681003	"Alopecia"	165	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513044060	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4192"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3510954001	"Constipation"	23	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502242876	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4193"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3510951001	"Dry skin"	47	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502242634	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"4194"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3510938001	"Fatigue"	23	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502242421	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4195"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3510945001	"Fatigue"	47	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502242467	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4196"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3418055001	"Febrile neutropenia"	49	53	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	50	NA	NA	49	53	"July 12/07: Neutorphil 0.03 giga/L; Fever 38.3; July 16/07:  Neutrophil 1.4 gig/L;"	""	""	2	2	2	NA	2	2	NA	2	"12 Jul 2007 Patient admitted to hospital with fever (38.3) and neutropenic.  Patient is treated with Imipenem initially  then switched to oral antibiotics with Amoxiciillin/Clavulin.	Patient's"	"neutorpenia recovered and was afebrile at discharge"	""	""	""	""	""	""	""	""	""	NA	NA	""	1499993159	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4197"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3939645001	"Nail changes"	124	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508959798	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4198"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	4248428001	"Nail changes"	154	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513043950	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4199"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3939603001	"Peripheral Edema - left leg"	114	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508959653	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4200"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3939510001	"Sensory neuropathy - feet"	114	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508959353	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4201"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3607982001	"Sensory neuropathy - feet"	65	114	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504147204	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4202"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3510947001	"Sensory neuropathy - finger tips"	47	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502242536	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4203"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3510949001	"Taste changes"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502242579	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4204"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	3939501001	"Teary eyes"	109	160	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508959296	""	""	""	NA	"Teary eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4205"	"DN-101 Protocol No. 011-007"	"133"	"133-0013"	5	9	"Adverse Event/Serious Adverse Event"	4248430001	"Teary eyes"	160	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513044022	""	""	""	NA	"Teary eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4206"	"DN-101 Protocol No. 011-007"	"133"	"133-0014"	5	9	"Adverse Event/Serious Adverse Event"	3322498003	"Confusion"	32	62	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518484226	""	""	""	NA	"Confusion"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Confusion and disorientation"	"Confusional state"	""	""	""	""	""	""	""	""	""	""	""	""
"4207"	"DN-101 Protocol No. 011-007"	"133"	"133-0014"	5	9	"Adverse Event/Serious Adverse Event"	4860664002	"Confusion"	25	32	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518483697	""	""	""	NA	"Confusion"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Confusion and disorientation"	"Confusional state"	""	""	""	""	""	""	""	""	""	""	""	""
"4208"	"DN-101 Protocol No. 011-007"	"133"	"133-0014"	5	9	"Adverse Event/Serious Adverse Event"	4924298002	"Deep Vein Thrombosis"	32	62	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	247	NA	NA	25	62	"July 20, 2007 left leg Doppler revealed deep venous thromboiss"	""	""	2	2	2	NA	2	2	NA	2	"Patient was originally hospitalized on July 13/07 for pneumonia.  While in hospital, patient was sent to another hospital for further investigation of his swelling leg and confusion.	Doppler study"	"done July 20/07 confirmed Deep vein thrombosis.  Patient died Aug 19/07 of progressive disease"	""	""	""	""	""	""	""	""	""	NA	NA	""	1519180726	""	""	""	NA	"Deep vein thrombosis"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4209"	"DN-101 Protocol No. 011-007"	"133"	"133-0014"	5	9	"Adverse Event/Serious Adverse Event"	3429444001	"Pneumonia"	25	62	NA	3	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	29	NA	NA	25	62	"CXR - pneumonia"	""	""	2	2	2	NA	2	2	NA	2	"Patient complaint of fever and was admitted to hospital on Jul 13/07.  Chest X-ray confirmed pneumonia.  Patient was treated with IV antibiotics.  Patient was transferred to another hospital on Jul"	"20/07 to investigate for DVT and confusion.  Patient subsequently died of progressive disease on Aug 19/07"	""	""	""	""	""	""	""	""	""	NA	NA	""	1500336477	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"4210"	"DN-101 Protocol No. 011-007"	"133"	"133-0014"	5	9	"Adverse Event/Serious Adverse Event"	3559218001	"Prostate Cancer Disease Progression"	59	62	NA	5	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	4	0	NA	0	4	NA	NA	1	NA	NA	NA	NA	""	64	62	0	32	62	"Aug 16/07 Biopsy Left cervical lymph node  - small cell carcinoma (PI stated that this is not a new cancer, but just a changed histology from his original prostate cancer)"	""	""	2	2	2	NA	2	2	2	2	"Patient was originally admitted to hospital on July 13/07 with fever and confusion.  He was diagnosed with pneumonia was treated with antibiotics.  While in hospital he became increasingly confused"	"and complaint of left leg pain and swelling.  Patient was transferred to another hospital on Jul 20/07 to have further investigations.	Patient  was diagnosed to have Deep vein thrombosis and was"	"started on tinzaparin injections.  While in hospital, left neck lymphadenopathy was noted and a biopsy of the left cervical lymph node was done which confirmed malignancy.  Patient died Aug 19/07 of"	"progressive disease"	""	""	""	""	""	""	""	NA	NA	""	1503355236	""	""	""	NA	"Progression of pre-existing cancer"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Miscellaneous and site unspecified neoplasms malignant and unspecified"	"Neoplasms malignant site unspecified NEC"	"Malignant neoplasm progression"	""	""	""	""	""	""	""	""	""	""	""	""
"4211"	"DN-101 Protocol No. 011-007"	"133"	"133-0014"	5	9	"Adverse Event/Serious Adverse Event"	3614306001	"Swelling and pain - right leg"	11	62	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504209318	""	""	""	NA	"Swelling of legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4212"	"DN-101 Protocol No. 011-007"	"133"	"133-0014"	5	9	"Adverse Event/Serious Adverse Event"	4860738002	"Urinary tract infection"	38	NA	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518484418	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4213"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3377749003	"Alopecia"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504213195	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4214"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3940985001	"Cough"	58	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508964740	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4215"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3941016001	"Fatigue"	69	80	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508964838	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4216"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3941110001	"Fatigue"	92	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508965090	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4217"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3940973001	"Fatigue"	48	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508964692	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4218"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3941114001	"Fatigue"	105	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508965126	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4219"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3941064001	"Fatigue"	81	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508964983	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4220"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3614958001	"Fatigue"	8	14	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504213149	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4221"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3614988001	"Fatigue"	28	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504213291	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4222"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3614992001	"Insomnia"	25	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504213331	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4223"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3941044001	"Insomnia"	68	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508964909	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4224"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3614978001	"Mid back pain"	7	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504213249	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4225"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	4860062002	"Nail changes"	88	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518479403	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4226"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3614951001	"Taste change"	11	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504213110	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4227"	"DN-101 Protocol No. 011-007"	"133"	"133-0015"	5	9	"Adverse Event/Serious Adverse Event"	3940954001	"Taste changes"	49	54	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508964651	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4228"	"DN-101 Protocol No. 011-007"	"133"	"133-0016"	5	9	"Adverse Event/Serious Adverse Event"	3423346003	"Alopecia"	27	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505317967	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4229"	"DN-101 Protocol No. 011-007"	"133"	"133-0016"	5	9	"Adverse Event/Serious Adverse Event"	3941656001	"Alopecia"	97	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508967237	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4230"	"DN-101 Protocol No. 011-007"	"133"	"133-0016"	5	9	"Adverse Event/Serious Adverse Event"	3682925001	"Arthritis"	15	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505318609	""	""	""	NA	"Arthritis"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Arthropathies NEC"	"Arthritis"	""	""	""	""	""	""	""	""	""	""	""	""
"4231"	"DN-101 Protocol No. 011-007"	"133"	"133-0016"	5	9	"Adverse Event/Serious Adverse Event"	4859730002	"Fatigue"	168	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518478351	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4232"	"DN-101 Protocol No. 011-007"	"133"	"133-0016"	5	9	"Adverse Event/Serious Adverse Event"	4253953001	"Nail changes"	102	149	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513099464	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4233"	"DN-101 Protocol No. 011-007"	"133"	"133-0016"	5	9	"Adverse Event/Serious Adverse Event"	4859739002	"Nail changes"	149	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518478398	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4234"	"DN-101 Protocol No. 011-007"	"133"	"133-0016"	5	9	"Adverse Event/Serious Adverse Event"	4253963001	"Watery eyes"	128	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513099497	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4235"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3537213003	"Alopecia"	51	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507673823	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4236"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	4858726002	"Atrial Fibrillation"	158	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518474080	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"4237"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3969934001	"Atrial Fibrillation"	109	158	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	110	NA	NA	109	117	"ECG confirmed atrial fibrillation"	""	""	2	2	2	NA	2	2	NA	2	"Patient was taken off study on Oct 24/07 due to docetaxel related pneumonitis.	Patient was hospitalized on Oct 29/07 for shortness of breath.	Patient was found to have cardiac failure due to Atrial"	"fibrillation.  Patient's condition improved and returned to sinus rhythm with medication.  Patient was discharged on Nov 5/07"	""	""	""	""	""	""	""	""	""	NA	NA	""	1509406117	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"4238"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3944462001	"Bilateral ankle edema"	99	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509032131	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4239"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3846221001	"Cellulitis - right arm"	42	50	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507673701	""	""	""	NA	"Cellulitis of arm"	"Infections and infestations"	"Bacterial infectious disorders"	"Bacterial infections NEC"	"Cellulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4240"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	4928678002	"Congestive heart failure"	117	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519232639	""	""	""	NA	"Congestive heart failure"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"4241"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	4928600002	"Congestive heart failure"	109	117	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	224	NA	NA	109	117	"Oct 29/07 Troponin I - 0.64 ug/L (likely consistent with heart failure); Oct 30/07 BNP - 905 pg/ml (strongly supports CHF)"	""	""	2	2	2	NA	2	2	NA	2	"Patient was admitted to hospital on Oct 29/07 with congestive heart failure secondary to rapid atrial fibrillation.   Patient's condition improved with medication and was discharged on Nov 6/07"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519232443	""	""	""	NA	"Congestive heart failure"	"Cardiac disorders"	"Heart failures"	"Heart failures NEC"	"Cardiac failure congestive"	""	""	""	""	""	""	""	""	""	""	""	""
"4242"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3944424001	"Cough"	90	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509031994	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4243"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3846215001	"Dehydration"	45	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507673638	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"4244"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3944474001	"Docetaxel induced pneumonitis"	104	110	NA	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509032175	""	""	""	NA	"Pneumonitis"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Lower respiratory tract inflammatory and immunologic conditions"	"Pneumonitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4245"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3846246001	"Fatigue"	58	60	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507673911	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4246"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3846230001	"Fatigue"	44	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507673780	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4247"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3846207001	"Rectal bleeding"	42	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507673576	""	""	""	NA	"Rectal bleeding"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Intestinal haemorrhages"	"Rectal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"4248"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	4859088002	"Right hip pain"	166	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518476005	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4249"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3944440001	"Shortness of breath"	94	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509032056	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4250"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	4858684002	"Shortness of breath"	116	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518473973	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4251"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	4858189002	"Shortness of breath"	109	116	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518471929	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4252"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3846241001	"Taste Change"	60	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507673867	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4253"	"DN-101 Protocol No. 011-007"	"133"	"133-0017"	5	9	"Adverse Event/Serious Adverse Event"	3846184001	"Taste Change"	40	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507673471	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4254"	"DN-101 Protocol No. 011-007"	"133"	"133-0018"	5	9	"Adverse Event/Serious Adverse Event"	3676636003	"Fatigue"	18	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513115811	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4255"	"DN-101 Protocol No. 011-007"	"133"	"133-0018"	5	9	"Adverse Event/Serious Adverse Event"	4259601001	"Sensory neuropthy - lower extremities"	18	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513115574	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4256"	"DN-101 Protocol No. 011-007"	"133"	"133-0020"	5	9	"Adverse Event/Serious Adverse Event"	3900175003	"Fatigue"	11	18	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513192763	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4257"	"DN-101 Protocol No. 011-007"	"133"	"133-0020"	5	9	"Adverse Event/Serious Adverse Event"	4269833001	"Nausea"	32	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513192920	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"4258"	"DN-101 Protocol No. 011-007"	"133"	"133-0021"	5	9	"Adverse Event/Serious Adverse Event"	3921775003	"Alopecia"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513184242	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4259"	"DN-101 Protocol No. 011-007"	"133"	"133-0021"	5	9	"Adverse Event/Serious Adverse Event"	4266679001	"Myalgia"	8	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513184204	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4260"	"DN-101 Protocol No. 011-007"	"133"	"133-0021"	5	9	"Adverse Event/Serious Adverse Event"	4856300002	"Nail changes"	63	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518464808	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4261"	"DN-101 Protocol No. 011-007"	"133"	"133-0021"	5	9	"Adverse Event/Serious Adverse Event"	4856317002	"sensory neuropathy - fingers"	63	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518464851	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4262"	"DN-101 Protocol No. 011-007"	"133"	"133-0021"	5	9	"Adverse Event/Serious Adverse Event"	4856331002	"Watery eyes"	67	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518464894	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4263"	"DN-101 Protocol No. 011-007"	"134"	"134-0001"	5	9	"Adverse Event/Serious Adverse Event"	2817309003	"Anginal chest pain"	91	229	NA	2	0	NA	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513003138	""	""	""	NA	"Anginal pain"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"4264"	"DN-101 Protocol No. 011-007"	"134"	"134-0001"	5	9	"Adverse Event/Serious Adverse Event"	4236797001	"Constipation"	81	229	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513003246	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4265"	"DN-101 Protocol No. 011-007"	"134"	"134-0001"	5	9	"Adverse Event/Serious Adverse Event"	4919222002	"hypertension"	131	131	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519153497	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"4266"	"DN-101 Protocol No. 011-007"	"134"	"134-0001"	5	9	"Adverse Event/Serious Adverse Event"	4236503001	"Leg Weakness"	49	229	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"MRI of spine"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513002209	""	""	""	NA	"Weakness of limbs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4267"	"DN-101 Protocol No. 011-007"	"134"	"134-0001"	5	9	"Adverse Event/Serious Adverse Event"	4236603001	"management of prostate cancer disease progression"	71	229	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Physiotherapy, occupational therapy, palliative radiaton to metastastatic areas"	2	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	371	NA	NA	122	176	"2007-04-06 Xray, 2007-04-10 CT scan head & spine,  2007-04-11 CT scan chest, 2007-04-12 bone scintigraphy, 2007-04-12 CT scan thoracic spine, 2007-04-15 Xray chest, 2007-04-15 CT chest, 2007-04-22"	"Xray abdomen, 2007-04-06 EKG, 2007-04-06 through 2007-05-30 daily blood chemistry and hematology"	""	2	2	2	NA	2	2	NA	2	"Subject was admitted into hospital for palliative pain management resulting from bone metastases.  Subject was transferred to Trillium palliative care center on 2007-05-30 where he later died on"	"2007-07-22 as a result of disease progression."	""	""	""	""	""	""	""	""	""	NA	NA	""	1513002635	""	""	""	NA	"Progression of pre-existing cancer"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Miscellaneous and site unspecified neoplasms malignant and unspecified"	"Neoplasms malignant site unspecified NEC"	"Malignant neoplasm progression"	""	""	""	""	""	""	""	""	""	""	""	""
"4268"	"DN-101 Protocol No. 011-007"	"134"	"134-0001"	5	9	"Adverse Event/Serious Adverse Event"	4918768002	"nausea"	132	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519152210	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"4269"	"DN-101 Protocol No. 011-007"	"134"	"134-0001"	5	9	"Adverse Event/Serious Adverse Event"	4919273002	"urinary tract infection"	132	144	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519153590	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4270"	"DN-101 Protocol No. 011-007"	"134"	"134-0002"	5	9	"Adverse Event/Serious Adverse Event"	3512530003	"Chest tightness"	28	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512999360	""	""	""	NA	"Chest tightness"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Chest discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"4271"	"DN-101 Protocol No. 011-007"	"134"	"134-0002"	5	9	"Adverse Event/Serious Adverse Event"	3727715001	"dyspnea"	28	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505938175	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4272"	"DN-101 Protocol No. 011-007"	"134"	"134-0002"	5	9	"Adverse Event/Serious Adverse Event"	3873087001	"headache"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508095713	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"4273"	"DN-101 Protocol No. 011-007"	"134"	"134-0002"	5	9	"Adverse Event/Serious Adverse Event"	4236097001	"Mouth soreness"	NA	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512999102	""	""	""	NA	"Sore mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Oral soft tissue pain and paraesthesia"	"Oral pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4274"	"DN-101 Protocol No. 011-007"	"134"	"134-0002"	5	9	"Adverse Event/Serious Adverse Event"	4144897001	"numb tongue"	73	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511899144	""	""	""	NA	"Numbness of tongue"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Oral soft tissue signs and symptoms"	"Hypoaesthesia oral"	""	""	""	""	""	""	""	""	""	""	""	""
"4275"	"DN-101 Protocol No. 011-007"	"134"	"134-0003"	5	9	"Adverse Event/Serious Adverse Event"	3777417003	"constipation"	97	102	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518551243	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4276"	"DN-101 Protocol No. 011-007"	"134"	"134-0003"	5	9	"Adverse Event/Serious Adverse Event"	4870786002	"insomnia"	91	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518551100	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4277"	"DN-101 Protocol No. 011-007"	"134"	"134-0003"	5	9	"Adverse Event/Serious Adverse Event"	4310560001	"non ST elevation mycardial infarction"	97	103	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hospitalization"	0	0	NA	0	56	NA	NA	NA	1	1	1	NA	""	100	NA	NA	97	103	"patient underwent multiple blood tests"	""	""	2	2	2	NA	2	2	NA	2	"patient was admitted under cardiology service for \"acute coronary syndrome/non sestemic t elevated myocardial infarction. An angiogram was done on Dec 18 2007 which showed a severe LV dysfunction,"	"three vessel cornary aftery disease and left main disease with saccular aneurysms of the proximal branch of the LAD. It was decided to manage the symptoms only and he was given heparin and pain"	"medications and was discharged on 22 December 2007."	""	""	""	""	""	""	""	""	NA	NA	""	1513702230	""	""	""	NA	"Non ST segment elevation myocardial infarction"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Acute myocardial infarction"	""	""	""	""	""	""	""	""	""	""	""	""
"4278"	"DN-101 Protocol No. 011-007"	"134"	"134-0003"	5	9	"Adverse Event/Serious Adverse Event"	4231584001	"Syncope"	90	92	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	91	NA	NA	91	92	"various blood work was orderd and an echocardiogram was done - LV diastolic function is abnormal and mild left atrial dilatation was found - otherwise normal echo"	""	""	2	2	2	NA	2	2	NA	2	"Admitted under cardiology service for Syncope afer being found on the floor of the patients room.Patient was discharged on Dec 11 2007 and told to stop Atenolol medication."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512939685	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"4279"	"DN-101 Protocol No. 011-007"	"134"	"134-0003"	5	9	"Adverse Event/Serious Adverse Event"	4904677002	"urinary tract infection"	99	102	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519055632	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4280"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	2646040003	"Alkalosis"	362	364	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	417	NA	NA	362	364	"Labs: pH, ART= 7.61; pCO2, ART=15"	""	""	2	2	2	NA	2	2	NA	2	"Patient admitted to hospital with increasing dyspnea and hematuria for the 2 weeks prior to admission.	Upon admission, patient was found to have respiratory and metabolic alkalosis.	Patient was"	"treated w/ fluids and diamox and his alkalosis returned to baseline by discharge.  All most likely secondary to his obstructive uropathy (patient had nephrostomy tubes placed on 5/15/07).  Patient"	"was discharged on 8/1/07 in stable condition."	""	""	""	""	""	""	""	""	NA	NA	""	1506213624	""	""	""	NA	"Alkalosis"	"Metabolism and nutrition disorders"	"Acid-base disorders"	"Metabolic alkaloses"	"Alkalosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4281"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	2816146001	"Alopecia"	43	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481242248	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4282"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	2816149001	"Blurred vision"	48	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481242310	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"4283"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3745889001	"CNS ischemia"	355	NA	1	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	417	NA	NA	355	356	"Unable to obtain any diagnostic testing done on patient due to patient being admitted to outside hospital but per our physician records here, patient states they only started him on oral aspirin and"	"was discharged home."	""	2	2	2	NA	2	2	NA	2	"Patient admitted to hospital on 7/23/07 for experiencing a CVA and was started on oral aspirin and was discharged. No further information to be reported."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506214956	""	""	""	NA	"Ischemia cerebrovascular"	"Nervous system disorders"	"Central nervous system vascular disorders"	"Central nervous system haemorrhages and cerebrovascular accidents"	"Cerebral ischaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4284"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3368934001	"Constipation"	272	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499357309	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4285"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3368910001	"Distension"	251	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499357111	""	""	""	NA	"Distension NOS"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Abdominal distension"	""	""	""	""	""	""	""	""	""	""	""	""
"4286"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3021362001	"Dyspnea"	226	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218998	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4287"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3745857001	"dyspnea"	348	364	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	417	NA	NA	362	364	"Labs: pH, ART= 7.61; pCO2, ART=15"	""	""	2	2	2	NA	2	2	NA	2	"Patient admitted to hospital with increasing dyspnea(grade 2) and hematuria (grade 2) for the 2 weeks prior to admission.  Upon admission, patient was found to have grade 3 respiratory and metabolic"	"alkalosis.  Patient was treated w/ fluids and diamox and his acidosis returned to baseline by discharge.  All most likely secondary to his obstructive uropathy (patient had nephrostomy tubes placed"	"on 5/15/07).  Patient was discharged on 8/1/07 in stable condition."	""	""	""	""	""	""	""	""	NA	NA	""	1506213820	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4288"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	2816171001	"Fatigue"	83	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481242634	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4289"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	2816155001	"Fatigue"	51	62	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1481242383	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4290"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	2725427001	"Heartburn/Dyspepsia"	26	26	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476300329	""	""	""	NA	"Heartburn-like dyspepsia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"4291"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3021321001	"Hot flashes"	110	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218565	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"4292"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	2725404001	"Insomnia"	21	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476300209	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4293"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3021354001	"Neutrophils (low)"	159	167	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218812	""	""	""	NA	"Neutrophils reduced"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4294"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	2725391001	"Neutrophils (low)"	29	34	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476300128	""	""	""	NA	"Neutrophils reduced"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"Neutrophil count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4295"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	4955522002	"Non-pathological SRE: Fracture (left maxillary)"	309	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	1	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	572	NA	NA	309	313	"CT of head on 6/07/07 showing fractures of the left orbital floor and anterior left maxillary sinus wall.; CT of the facial bones on 6/07/07 showing the same fractures."	""	""	2	2	2	NA	2	2	NA	2	"Patient had a syncopal episode while in the restroom and fell down.  He obtained left maxillary fractures. Patient underwent repair of left orbital blowout fracture using a trasnorbital approach and"	"medipore implant performed on 6/8/07 before being discharged in stable condition on 6/11/07.After work up in hospital, it was presumed patient had syncope secondary to orthostatic hypotension."	"Patient was discharged on 6/11/07 in stable condition with left maxillary fracture recovering with sequale."	""	""	""	""	""	""	""	""	NA	NA	""	1519603262	""	""	""	NA	"Fractured maxilla"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Skull fractures, facial bone fractures and dislocations"	"Jaw fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"4296"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	4983165002	"Obstruction, GU-ureter"	484	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	1	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	574	NA	NA	484	490	"Left ureteral stent change done on 12/5/07."	""	""	2	2	2	NA	2	2	NA	2	"Patient admitted to hospital for hematuria on 11/29/07 due to prostate cancer.	Bladder irrigation was initiated.  Shortly after patient developed urinary retention due to left ureteral obstruction."	"Left ureteral stent change performed.  Patient discharged on 12/5/07 in stable condition."	""	""	""	""	""	""	""	""	""	NA	NA	""	1519763498	""	""	""	NA	"Ureter obstruction"	"Renal and urinary disorders"	"Ureteric disorders"	"Ureteric disorders NEC"	"Ureteric obstruction"	""	""	""	""	""	""	""	""	""	""	""	""
"4297"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3021365001	"Pain-back"	211	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490219097	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4298"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	2725471001	"Pain-NOS"	23	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476300605	""	""	""	NA	"Pain NOS"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4299"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	4983143002	"Renal-Other (hematuria)"	484	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	1	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	209	NA	NA	484	490	"Cystooscopy, left ureteral stent change performed on 12/05/2007"	""	""	2	2	2	NA	2	2	NA	2	"Patient admitted to hospital for hematuria on 11/29/07 due to prostate cancer.	Bladder irrigation was initiated.  Shortly after patient developed urinary retention due to left ureteral obstruction."	"Left ureteral stent change performed.  Patient discharged on 12/5/07 in stable condition."	""	""	""	""	""	""	""	""	""	NA	NA	""	1519763156	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"4300"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3021357001	"Rhinitis"	208	231	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218900	""	""	""	NA	"Rhinitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Rhinitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4301"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3691898001	"Syncope"	309	309	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient was admitted to hospital."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	408	NA	NA	309	313	"CT of head on 6/07/07 showing fractures of the left orbital floor and anterior left maxillary sinus wall.; CT of the facial bones on 6/07/07 showing the same fractures."	""	""	2	2	2	2	2	2	2	2	"Patient had a syncopal episode while in the restroom and fell down.  He obtained left maxillary fractures. Patient underwent repair of left orbital blowout fracture using a trasnorbital approach and"	"medipore implant performed on 6/8/07 before being discharged in stable condition on 6/11/07.  After work up in hospital, it was presumed patient had syncope secondary to orthostatic hypotension."	"Upon admission, patients bloodpressure readings were 121/88 to 144/78.	While in hospital, patient was also found to have a UTI and was given a course of antibiotics.	Patient was discharged on"	"6/11/07 in stable condition."	""	""	""	""	""	""	""	NA	NA	""	1505422201	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"4302"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3021317001	"Taste alteration"	94	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218488	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4303"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3021309001	"Urinary frequency/urgency"	104	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218379	""	""	""	NA	"Urinary frequency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"4304"	"DN-101 Protocol No. 011-007"	"136"	"136-0001"	5	9	"Adverse Event/Serious Adverse Event"	3021343001	"Vascular-other (vein discoloration on left forearm)"	129	210	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490218708	""	""	""	NA	"Vein discoloration"	"Vascular disorders"	"Vascular disorders NEC"	"Non-site specific vascular disorders NEC"	"Vein discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"4305"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	2758274003	"Alopecia"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486413929	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4306"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	4059841001	"Bilateral knee weakness"	223	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510689890	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4307"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	3640473001	"Blurred vision"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504725325	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"4308"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	2919116001	"Blurring of Eyes"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Told patient to see his PCP for eye exam"	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486414292	""	""	""	NA	"Blurring of eyes"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"4309"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	4059736001	"constipation"	375	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510689604	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4310"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	3640828001	"cough with productive sputum"	158	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504727270	""	""	""	NA	"Productive cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4311"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	3023830001	"Dehydration"	147	151	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient was hospitalized"	0	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"patient hospitalized for syncope and dehydration"	148	NA	NA	147	151	"3/22/07 CMP, Ca+, Mg+, P, blood cult, UA/CS, occult blood, D dif., sputum cult; 3/23/07, 3/25/07  CBC with D, basic 7"	""	""	2	2	2	2	2	2	2	2	"Patient was taken to the Emergency Room on 3/22/07 after being noted by son of being dizzy and with unsteady gait.  Admitting diagnosis recorded was syncope and dehydration."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490295177	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"4312"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	3640499001	"Diabetes"	75	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504725702	""	""	""	NA	"Diabetes"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Diabetes mellitus (incl subtypes)"	"Diabetes mellitus"	""	""	""	""	""	""	""	""	""	""	""	""
"4313"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	2917674001	"Gynecomastia"	8	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486399662	""	""	""	NA	"Gynecomastia"	"Reproductive system and breast disorders"	"Breast disorders"	"Breast disorders NEC"	"Gynaecomastia"	""	""	""	""	""	""	""	""	""	""	""	""
"4314"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	3640484001	"Hypertension"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504725479	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"4315"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	2984680001	"Incontinence"	96	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488919962	""	""	""	NA	"Incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"4316"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	2984687001	"Low Back Pain"	96	139	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488920061	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4317"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	4059776001	"muscle stiffness"	375	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510689741	""	""	""	NA	"Muscle stiffness"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal stiffness"	""	""	""	""	""	""	""	""	""	""	""	""
"4318"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	2919134001	"Nocturia/Urgency"	33	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486414413	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"4319"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	3054834001	"Syncope"	158	161	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"Patient hospitalized"	0	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"Patient admitted to UH for Syncope on 4/2/2007 @ 2016.  Various Tests being performed.  Patient is still in hospital as of 4/5/2007.  At this time, discharge date unknown."	159	NA	NA	158	161	"CBC, Chem 7, Mg+, Phos, TSH, Bl2, Folate, RPR, CT Head"	""	""	2	2	2	2	2	2	2	2	"Patient complaining of weakness.  Son had father brought to ER on 4/2/2007.  Admission diagnosis is Syncope."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491244670	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"4320"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	3023804001	"Syncope"	147	151	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient admitted to hospital"	0	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"hospitalized for Syncope and Dehydration"	147	NA	NA	147	151	"CMP, Ca+, Mg+, P, Blood cult, UA/CS, occult blood, C.dif, sputum cult (3/22/07), 3/25/07 cbc with diff, basic 7,"	""	""	2	2	2	2	2	2	2	2	"Patient was taken to ER on 3/22/07 after being noted by son of being dizzy and with unsteady gait. Admitting diagnosis recorded was syncope and dehydration."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490294886	""	""	""	NA	"Syncope"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope"	""	""	""	""	""	""	""	""	""	""	""	""
"4321"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	4059674001	"Urinary frequency"	375	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510689406	""	""	""	NA	"Urinary frequency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"4322"	"DN-101 Protocol No. 011-007"	"137"	"137-0002"	5	9	"Adverse Event/Serious Adverse Event"	3640854001	"UTI"	158	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504727417	""	""	""	NA	"UTI"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4323"	"DN-101 Protocol No. 011-007"	"137"	"137-0003"	5	9	"Adverse Event/Serious Adverse Event"	3700174003	"Alopecia"	11	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507748020	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4324"	"DN-101 Protocol No. 011-007"	"137"	"137-0003"	5	9	"Adverse Event/Serious Adverse Event"	3981068001	"hematuria"	41	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509553813	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"4325"	"DN-101 Protocol No. 011-007"	"137"	"137-0003"	5	9	"Adverse Event/Serious Adverse Event"	4419107002	"Hyperpigmentation near infusion site"	68	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515510590	""	""	""	NA	"Infusion site hyperpigmentation"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion site discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"4326"	"DN-101 Protocol No. 011-007"	"137"	"137-0003"	5	9	"Adverse Event/Serious Adverse Event"	4419172002	"Hyperpigmentation of the nailbed"	68	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515510765	""	""	""	NA	"Nail pigmentation"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail pigmentation"	""	""	""	""	""	""	""	""	""	""	""	""
"4327"	"DN-101 Protocol No. 011-007"	"137"	"137-0003"	5	9	"Adverse Event/Serious Adverse Event"	3981011001	"nocturia"	41	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509553548	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"4328"	"DN-101 Protocol No. 011-007"	"137"	"137-0003"	5	9	"Adverse Event/Serious Adverse Event"	3855857001	"pain (generalized)"	11	22	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507748188	""	""	""	NA	"Generalized aching"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4329"	"DN-101 Protocol No. 011-007"	"137"	"137-0003"	5	9	"Adverse Event/Serious Adverse Event"	4419574002	"Rash on buttocks"	11	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515511412	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"4330"	"DN-101 Protocol No. 011-007"	"137"	"137-0003"	5	9	"Adverse Event/Serious Adverse Event"	3855638001	"rash on mandible"	11	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507747585	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"4331"	"DN-101 Protocol No. 011-007"	"137"	"137-0003"	5	9	"Adverse Event/Serious Adverse Event"	4270802001	"Urinary Retention"	89	89	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient went to the Emergency Room seeking urological intervention."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513195363	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"4332"	"DN-101 Protocol No. 011-007"	"138"	"138-0001"	5	9	"Adverse Event/Serious Adverse Event"	3040262003	"alopecia"	26	NA	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494785116	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4333"	"DN-101 Protocol No. 011-007"	"138"	"138-0001"	5	9	"Adverse Event/Serious Adverse Event"	3498123001	"fatigue"	117	123	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502130508	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4334"	"DN-101 Protocol No. 011-007"	"138"	"138-0001"	5	9	"Adverse Event/Serious Adverse Event"	3137749001	"right eye irritation"	5	6	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493309571	""	""	""	NA	"Eye irritation"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Ocular infections, inflammations and associated manifestations"	"Eye irritation"	""	""	""	""	""	""	""	""	""	""	""	""
"4335"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	3139654003	"alopecia"	33	233	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497474551	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4336"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	3270933001	"constipation"	20	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496857076	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4337"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	3291275001	"delerium"	45	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497475199	""	""	""	NA	"Delirium"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Deliria"	"Delirium"	""	""	""	""	""	""	""	""	""	""	""	""
"4338"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	3291251001	"fatigue"	56	223	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497474432	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4339"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	3290455001	"fatigue"	45	55	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497467461	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4340"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	3270942001	"fatigue"	19	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496857187	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4341"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	4291646001	"fatigue"	224	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513547967	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4342"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	3792537001	"hypertension"	151	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506896943	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"4343"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	3792525001	"neuropathy - sensory - tingling left toes"	80	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506896794	""	""	""	NA	"Peripheral sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4344"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	3291257001	"pain - joints"	45	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497474721	""	""	""	NA	"Aching joints"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4345"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	3391706001	"taste changes"	62	230	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499717859	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4346"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	4291722001	"viral infection - flu"	224	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513548157	""	""	""	NA	"Flu"	"Infections and infestations"	"Viral infectious disorders"	"Influenza viral infections"	"Influenza"	""	""	""	""	""	""	""	""	""	""	""	""
"4347"	"DN-101 Protocol No. 011-007"	"139"	"139-0002"	5	9	"Adverse Event/Serious Adverse Event"	3291261001	"weakness - musculoskeletal"	45	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497474961	""	""	""	NA	"Muscular weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4348"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3210884003	"acute viral respiratory illness"	89	105	NA	1	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501094495	""	""	""	NA	"Respiratory tract infection viral"	"Infections and infestations"	"Viral infectious disorders"	"Viral infections NEC"	"Respiratory tract infection viral"	""	""	""	""	""	""	""	""	""	""	""	""
"4349"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3459990001	"allergic reaction"	49	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"infusion interupted for 15 minutes"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501095013	""	""	""	NA	"Allergic reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"4350"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3308643001	"alopecia"	43	225	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497998733	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4351"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3667013001	"blurred vision"	140	141	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505162278	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"4352"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	4366705001	"cancer pain"	228	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514920313	""	""	""	NA	"Cancer pain"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Cancer-related morbidities"	"Oncologic complications and emergencies"	"Cancer pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4353"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3388518001	"edema - lower leg"	61	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499707621	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4354"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3922760001	"facial flushing"	141	142	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508785741	""	""	""	NA	"Facial flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"4355"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3922721001	"facial flushing"	161	162	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508785554	""	""	""	NA	"Facial flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"4356"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3666953001	"fatigue"	123	130	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505162038	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4357"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3570429001	"forehead abrasion"	116	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503511020	""	""	""	NA	"Abrasion NOS"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Non-site specific injuries NEC"	"Excoriation"	""	""	""	""	""	""	""	""	""	""	""	""
"4358"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3922675001	"hyperglycemia"	140	160	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508785380	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4359"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3308646001	"nail changes"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497998845	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4360"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3570444001	"Post Nasal Drip"	91	225	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503511169	""	""	""	NA	"Postnasal drip"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Postnasal drip"	""	""	""	""	""	""	""	""	""	""	""	""
"4361"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3459878001	"taste alteration"	73	86	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501093892	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4362"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	3570475001	"taste alteration"	101	225	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503512093	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4363"	"DN-101 Protocol No. 011-007"	"139"	"139-0004"	5	9	"Adverse Event/Serious Adverse Event"	4297502001	"vomiting"	238	239	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"IV fluids"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	242	NA	NA	239	240	"abdominal x-ray"	""	""	2	2	2	NA	2	2	NA	2	"Malaise times 3 weeks, vomiting times 1 day.  Patient presented to emergency department on December 15 2007 with deydration and malaise.  IV fluids and IV Zofran given.  Abdominal x-ray showed no"	"explanation for vomiting.  Patient discharged on December 16 2007."	""	""	""	""	""	""	""	""	""	NA	NA	""	1513613501	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"4364"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3230990003	"Alopecia"	78	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501528331	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4365"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3311233001	"alopecia"	49	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498062193	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4366"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3796802001	"bilateral ankle edema"	141	144	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506966119	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4367"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3796819001	"bilateral ankle edema"	145	181	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506966199	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4368"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3311204001	"constipation"	33	38	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498061969	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4369"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3311300001	"dizziness"	34	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498062626	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"4370"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3392859001	"dizziness"	70	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499721983	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"4371"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3553479001	"edema ankle edema"	111	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503257380	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4372"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3795327001	"fatigue"	140	148	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506957897	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4373"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3311217001	"fatigue"	37	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498062092	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4374"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3471419001	"fatigue"	77	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501527924	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4375"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3915403001	"fatigue"	160	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508710875	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4376"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3392800001	"fatigue"	57	62	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499721786	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4377"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3311345001	"hemmorroids"	33	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498063001	""	""	""	NA	"Hemorrhoids"	"Gastrointestinal disorders"	"Gastrointestinal vascular conditions"	"Haemorrhoids and gastrointestinal varices (excl oesophageal)"	"Haemorrhoids"	""	""	""	""	""	""	""	""	""	""	""	""
"4378"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3392919001	"hyperglycemia"	76	76	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499722343	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4379"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3640492001	"leg muscle weakness"	124	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504725584	""	""	""	NA	"Weakness of limbs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4380"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3553418001	"leg muscle weakness"	97	100	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503257163	""	""	""	NA	"Weakness of limbs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4381"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3392882001	"muscle weakness"	56	66	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499722089	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4382"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3311331001	"muscle weakness"	34	42	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498062863	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4383"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3471537001	"muscle weakness - leg"	77	89	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501528626	""	""	""	NA	"Weakness of limbs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4384"	"DN-101 Protocol No. 011-007"	"139"	"139-0005"	5	9	"Adverse Event/Serious Adverse Event"	3915425001	"neuropathy - tingling bilateral feet"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508711046	""	""	""	NA	"Peripheral sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4385"	"DN-101 Protocol No. 011-007"	"139"	"139-0007"	5	9	"Adverse Event/Serious Adverse Event"	3866509003	"Abdominal Bloating"	16	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510691950	""	""	""	NA	"Abdominal bloating"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Abdominal distension"	""	""	""	""	""	""	""	""	""	""	""	""
"4386"	"DN-101 Protocol No. 011-007"	"139"	"139-0007"	5	9	"Adverse Event/Serious Adverse Event"	4060744001	"herpes infection"	32	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510692296	""	""	""	NA	"Herpes infection"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes virus infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4387"	"DN-101 Protocol No. 011-007"	"139"	"139-0007"	5	9	"Adverse Event/Serious Adverse Event"	4060504001	"hypotension"	16	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510691677	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"4388"	"DN-101 Protocol No. 011-007"	"139"	"139-0007"	5	9	"Adverse Event/Serious Adverse Event"	4060665001	"oral infection"	16	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510692080	""	""	""	NA	"Oral infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Dental and oral soft tissue infections"	"Oral infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4389"	"DN-101 Protocol No. 011-007"	"139"	"139-0007"	5	9	"Adverse Event/Serious Adverse Event"	4060986001	"urinary frequency"	16	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510692761	""	""	""	NA	"Urinary frequency"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"4390"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	5	9	"Adverse Event/Serious Adverse Event"	2880562003	"agitation"	11	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491366111	""	""	""	NA	"Agitation"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Agitation"	""	""	""	""	""	""	""	""	""	""	""	""
"4391"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	5	9	"Adverse Event/Serious Adverse Event"	5305958002	"bronchitis"	21	31	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523983561	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4392"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	5	9	"Adverse Event/Serious Adverse Event"	3060706001	"constipation"	11	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491365932	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4393"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	5	9	"Adverse Event/Serious Adverse Event"	3060650001	"dyspnea"	11	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491365357	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4394"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	5	9	"Adverse Event/Serious Adverse Event"	2961241001	"low hemoglobin"	11	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487786848	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4395"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	5	9	"Adverse Event/Serious Adverse Event"	2907175001	"Muscle weakness - (Patient fall)"	11	31	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"patient hospitalized"	5	1	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	14	NA	NA	11	20	"CBC, Chemistries, Chest x-ray"	""	""	2	2	2	2	2	2	2	2	"Patient developed weakness and fell at home.  Patient was admitted to hospital to evaluate.  No fractures or other injury from fall.  Family and patient considering placement in assisted living"	"situation due to patients weakness.  Plan to continue on study at this time."	""	""	""	""	""	""	""	""	""	NA	NA	""	1485981333	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4396"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	5	9	"Adverse Event/Serious Adverse Event"	2961181001	"neutropenia"	11	13	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487785977	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4397"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	5	9	"Adverse Event/Serious Adverse Event"	2961011001	"prostate cancer (progressive)"	31	31	NA	5	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	4	0	NA	0	4	NA	NA	1	NA	NA	NA	NA	""	35	31	0	NA	NA	"N/A"	""	""	2	2	2	NA	2	2	NA	2	"Patient and family decided to go off study 2/8/2007 after patient continued to become progressively weaker and did not show any signs of improvement.  This lack of improvement suggested progressive"	"cancer per the treating investigator and so the family opted to discontinue treatment.	The patient passed away at home with hospice on 2/18/2007."	""	""	""	""	""	""	""	""	""	NA	NA	""	1487783144	""	""	""	NA	"Progression of pre-existing cancer"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Miscellaneous and site unspecified neoplasms malignant and unspecified"	"Neoplasms malignant site unspecified NEC"	"Malignant neoplasm progression"	""	""	""	""	""	""	""	""	""	""	""	""
"4398"	"DN-101 Protocol No. 011-007"	"140"	"140-0001"	5	9	"Adverse Event/Serious Adverse Event"	2961223001	"thrombocytopenia"	12	31	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487786635	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4399"	"DN-101 Protocol No. 011-007"	"140"	"140-0002"	5	9	"Adverse Event/Serious Adverse Event"	2983189003	"alopecia"	43	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504837406	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4400"	"DN-101 Protocol No. 011-007"	"140"	"140-0002"	5	9	"Adverse Event/Serious Adverse Event"	3648049001	"fatigue"	64	253	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504837808	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4401"	"DN-101 Protocol No. 011-007"	"140"	"140-0002"	5	9	"Adverse Event/Serious Adverse Event"	4815764002	"gynecomastia"	330	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518032609	""	""	""	NA	"Gynecomastia"	"Reproductive system and breast disorders"	"Breast disorders"	"Breast disorders NEC"	"Gynaecomastia"	""	""	""	""	""	""	""	""	""	""	""	""
"4402"	"DN-101 Protocol No. 011-007"	"140"	"140-0002"	5	9	"Adverse Event/Serious Adverse Event"	4815728002	"hot flashes"	330	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518032530	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"4403"	"DN-101 Protocol No. 011-007"	"140"	"140-0002"	5	9	"Adverse Event/Serious Adverse Event"	3648069001	"insomnia"	106	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504839610	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4404"	"DN-101 Protocol No. 011-007"	"140"	"140-0002"	5	9	"Adverse Event/Serious Adverse Event"	3056859001	"taste alteration"	2	253	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491319527	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4405"	"DN-101 Protocol No. 011-007"	"140"	"140-0002"	5	9	"Adverse Event/Serious Adverse Event"	3648055001	"tearing"	148	253	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504838996	""	""	""	NA	"Lacrimation"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4406"	"DN-101 Protocol No. 011-007"	"140"	"140-0002"	5	9	"Adverse Event/Serious Adverse Event"	5177607002	"wheezes (left lung)"	330	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521648343	""	""	""	NA	"Wheezes"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Wheezing"	""	""	""	""	""	""	""	""	""	""	""	""
"4407"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	2801848003	"acid reflux (mild GERD)"	4	66	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492979432	""	""	""	NA	"Acid reflux (oesophageal)"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Gastrooesophageal reflux disease"	""	""	""	""	""	""	""	""	""	""	""	""
"4408"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3547976001	"Alopecia"	24	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503082638	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4409"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3118943001	"aphthous ulcer behind the lower gum"	126	171	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492980261	""	""	""	NA	"Aphthous ulcer"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Aphthous stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4410"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3118868001	"blurred vision"	57	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492979648	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"4411"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3118919001	"dry cough"	78	108	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492980139	""	""	""	NA	"Dry cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4412"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3388714001	"Eccymosis (on arms)"	129	227	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499708294	""	""	""	NA	"Ecchymosis"	"Skin and subcutaneous tissue disorders"	"Skin vascular abnormalities"	"Purpura and related conditions"	"Ecchymosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4413"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3520028001	"fatigue"	98	171	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502564316	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4414"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3520007001	"fatigue"	66	69	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502563346	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4415"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3520052001	"fatigue"	210	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502565194	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4416"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3118904001	"fatigue"	46	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492980025	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4417"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3520013001	"increased incontinence"	4	171	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502563535	""	""	""	NA	"Incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"4418"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3388572001	"nail changes on hands"	171	192	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499707781	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4419"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3118792001	"Night Sweat"	18	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492978942	""	""	""	NA	"Night sweat"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"4420"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3333483001	"nocturia"	130	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498608860	""	""	""	NA	"Nocturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"4421"	"DN-101 Protocol No. 011-007"	"141"	"141-0001"	5	9	"Adverse Event/Serious Adverse Event"	3388672001	"peripheral neuropathy"	129	129	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499708187	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4422"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	2881904003	"anemia"	113	118	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"blood transfusion"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503092735	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4423"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3541955001	"bruising"	84	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502927750	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"4424"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3119982001	"fatigue"	63	73	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492992098	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4425"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542069001	"fatigue"	105	119	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502930593	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4426"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542061001	"fatigue"	73	105	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502930541	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4427"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3119943001	"fatigue"	2	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492991763	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4428"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542018001	"fatigue"	42	47	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502929931	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4429"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	4781253002	"glucose intolerance"	2	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517862125	""	""	""	NA	"Glucose intolerance"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Glucose tolerance impaired"	""	""	""	""	""	""	""	""	""	""	""	""
"4430"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3206934001	"hepatic hemmorage"	118	119	NA	5	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	4	0	NA	0	12	NA	NA	1	1	NA	NA	NA	""	118	119	0	118	119	"hematacrit 16.2, platelets 37 (2007 - 05 - 16)"	""	""	2	2	2	2	2	2	2	2	"The patient presented to the ED this morning with profound fatigue.  Patient found to have hematocrit of 16.2.	Patient is being transfused.;;The patient died in hospital, 17 May 2007.;;PI requested"	"an autopsy but the family declined."	""	""	""	""	""	""	""	""	""	NA	NA	""	1494976653	""	""	""	NA	"Hepatic hemorrhage"	"Hepatobiliary disorders"	"Hepatic and hepatobiliary disorders"	"Hepatic vascular disorders"	"Hepatic haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"4431"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542001001	"increased alkaline phosphatase"	105	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502929687	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4432"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542122001	"increased ALT"	91	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502931537	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4433"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3541976001	"increased AST"	91	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502928655	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4434"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3373317001	"increased AST (AST = 103 U/L)"	62	91	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499384823	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4435"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542075001	"increased back pain"	84	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502930679	""	""	""	NA	"Back pain aggravated"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4436"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542082001	"increased back pain"	105	119	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"pallitive radiation therapy"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502930801	""	""	""	NA	"Back pain aggravated"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4437"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	4147335001	"Nausea"	118	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511907601	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"4438"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3541990001	"Platelet < 100 K/ul"	118	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502929412	""	""	""	NA	"Platelets decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"Platelet analyses"	"Platelet count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4439"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3541970001	"platelets  < 100 K/ul"	84	91	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502928236	""	""	""	NA	"Platelets decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"Platelet analyses"	"Platelet count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4440"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3541980001	"platelets < 50 K/ul"	113	118	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"transfusion"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502929109	""	""	""	NA	"Platelets decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"Platelet analyses"	"Platelet count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4441"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3541978001	"platelets < 75 K/ul"	105	113	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502929001	""	""	""	NA	"Platelets decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"Platelet analyses"	"Platelet count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4442"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542095001	"shortness of breath"	105	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502930973	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4443"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542109001	"tachycardia"	103	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502931274	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"4444"	"DN-101 Protocol No. 011-007"	"141"	"141-0003"	5	9	"Adverse Event/Serious Adverse Event"	3119948001	"upset stomach"	2	41	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492991821	""	""	""	NA	"Upset stomach"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Stomach discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"4445"	"DN-101 Protocol No. 011-007"	"141"	"141-0006"	5	9	"Adverse Event/Serious Adverse Event"	2984907003	"altered taste"	141	245	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503110713	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4446"	"DN-101 Protocol No. 011-007"	"141"	"141-0006"	5	9	"Adverse Event/Serious Adverse Event"	3548593001	"back pain"	127	162	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"ice pack"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503110597	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4447"	"DN-101 Protocol No. 011-007"	"141"	"141-0006"	5	9	"Adverse Event/Serious Adverse Event"	4501314002	"decreased Albumin"	34	54	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"stopped pravachol"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516057066	""	""	""	NA	"Albumin decreased"	"Investigations"	"Protein and chemistry analyses NEC"	"Protein analyses NEC"	"Blood albumin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4448"	"DN-101 Protocol No. 011-007"	"141"	"141-0006"	5	9	"Adverse Event/Serious Adverse Event"	3548602001	"fatigue"	141	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503110904	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4449"	"DN-101 Protocol No. 011-007"	"141"	"141-0006"	5	9	"Adverse Event/Serious Adverse Event"	3548608001	"heart murmur"	162	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503111081	""	""	""	NA	"Heart murmur"	"Investigations"	"Cardiac and vascular investigations (excl enzyme tests)"	"Cardiac auscultatory investigations"	"Cardiac murmur"	""	""	""	""	""	""	""	""	""	""	""	""
"4450"	"DN-101 Protocol No. 011-007"	"141"	"141-0006"	5	9	"Adverse Event/Serious Adverse Event"	4501296002	"increased Alk phos"	34	54	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"stopped pravachol"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516056978	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4451"	"DN-101 Protocol No. 011-007"	"141"	"141-0006"	5	9	"Adverse Event/Serious Adverse Event"	4501278002	"increased ALT"	33	54	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"stopped pravachol"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516056881	""	""	""	NA	"ALT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Alanine aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4452"	"DN-101 Protocol No. 011-007"	"141"	"141-0006"	5	9	"Adverse Event/Serious Adverse Event"	3148277001	"increased AST"	33	54	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"discontinued pravachol 2007-03-30"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493595238	""	""	""	NA	"AST increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4453"	"DN-101 Protocol No. 011-007"	"141"	"141-0006"	5	9	"Adverse Event/Serious Adverse Event"	3548605001	"nocturnal restless legs"	NA	203	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503111013	""	""	""	NA	"Legs restless"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Restless legs syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"4454"	"DN-101 Protocol No. 011-007"	"141"	"141-0006"	5	9	"Adverse Event/Serious Adverse Event"	3548599001	"occasional constipation"	141	162	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503110792	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4455"	"DN-101 Protocol No. 011-007"	"141"	"141-0007"	5	9	"Adverse Event/Serious Adverse Event"	2985011003	"alopecia"	NA	294	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516137614	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4456"	"DN-101 Protocol No. 011-007"	"141"	"141-0007"	5	9	"Adverse Event/Serious Adverse Event"	3144706001	"Atrial Fibrillation"	27	27	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"admitted to hospital and observed overnight. spontaneously reverted to normal sinus rhythm and discharged within 23 hours."	0	0	NA	0	16	NA	NA	NA	NA	1	NA	NA	""	28	NA	NA	27	27	"Unknown."	""	""	0	0	0	NA	0	0	NA	0	"Subject experienced Atrial Fibrillation. Taxotere and Prednisone were not abated during this time.;;He was admitted to an outside Hospital with atrial;fibrillation and was found to have a heart rate"	"of 180 beats per minute.;He was admitted and observed overnight, but spontaneously reverted to normal sinus rhythm.  He was discharged with metoprolol 25 mg daily to taken p.r.n. for palpitations."	""	""	""	""	""	""	""	""	""	NA	NA	""	1493576506	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"4457"	"DN-101 Protocol No. 011-007"	"141"	"141-0007"	5	9	"Adverse Event/Serious Adverse Event"	3144812001	"Chest pain, non cardiac"	33	33	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"had an EKG and blood test done...negative for MI. Stress test performed, outcome=negative."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493576943	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4458"	"DN-101 Protocol No. 011-007"	"141"	"141-0007"	5	9	"Adverse Event/Serious Adverse Event"	3548639001	"chest tighness with pain radiating to arms during infusion"	29	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503113792	""	""	""	NA	"Chest pain with radiation to left arm"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4459"	"DN-101 Protocol No. 011-007"	"141"	"141-0007"	5	9	"Adverse Event/Serious Adverse Event"	3548633001	"chest tightness with pain radiating to elbows during infusion"	8	8	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503113660	""	""	""	NA	"Chest tightness"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Chest discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"4460"	"DN-101 Protocol No. 011-007"	"141"	"141-0007"	5	9	"Adverse Event/Serious Adverse Event"	3548643001	"elevated glucose"	133	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503113887	""	""	""	NA	"Glucose high"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4461"	"DN-101 Protocol No. 011-007"	"141"	"141-0007"	5	9	"Adverse Event/Serious Adverse Event"	3548630001	"facial flushing during infusion"	8	8	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503113584	""	""	""	NA	"Facial flushing"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"4462"	"DN-101 Protocol No. 011-007"	"141"	"141-0007"	5	9	"Adverse Event/Serious Adverse Event"	4515938002	"fatigue"	91	294	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516137938	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4463"	"DN-101 Protocol No. 011-007"	"141"	"141-0007"	5	9	"Adverse Event/Serious Adverse Event"	4515910002	"nail changes"	252	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516137783	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4464"	"DN-101 Protocol No. 011-007"	"141"	"141-0007"	5	9	"Adverse Event/Serious Adverse Event"	4516004002	"sore elbow due to fall"	185	252	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516138093	""	""	""	NA	"Elbow injury"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Limb injuries NEC (incl traumatic amputation)"	"Joint injury"	""	""	""	""	""	""	""	""	""	""	""	""
"4465"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	3165024003	"cold symptoms"	167	224	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519157674	""	""	""	NA	"Cold symptoms"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4466"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	3333222001	"Ecchymosis on forearms"	62	146	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498604033	""	""	""	NA	"Ecchymosis"	"Skin and subcutaneous tissue disorders"	"Skin vascular abnormalities"	"Purpura and related conditions"	"Ecchymosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4467"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	4920857002	"Edema on ankles, lower extremity"	62	224	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519157373	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4468"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	3548884001	"extravasation of right hand"	83	83	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503124211	""	""	""	NA	"Extravasation"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Extravasation"	""	""	""	""	""	""	""	""	""	""	""	""
"4469"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	4920831002	"fatigue"	104	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519157217	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4470"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	3333206001	"Hair Thinning"	41	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498603836	""	""	""	NA	"Hair thinning"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Hypotrichosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4471"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	3333201001	"infusion site reaction-Hives"	20	20	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498603723	""	""	""	NA	"Infusion site hives"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion site urticaria"	""	""	""	""	""	""	""	""	""	""	""	""
"4472"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	4920766002	"numbness in hand-from knuckles to wrist"	83	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519156954	""	""	""	NA	"Numbness in hand"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4473"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	4920864002	"pale skin"	83	83	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519157429	""	""	""	NA	"Pale skin"	"Vascular disorders"	"Vascular disorders NEC"	"Site specific vascular disorders NEC"	"Pallor"	""	""	""	""	""	""	""	""	""	""	""	""
"4474"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	4920821002	"peeling dry skin on right hand"	83	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519157151	""	""	""	NA	"Skin peeling"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Exfoliative conditions"	"Skin exfoliation"	""	""	""	""	""	""	""	""	""	""	""	""
"4475"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	4920880002	"peripheral neuropathy-feet"	146	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519157609	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4476"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	4920870002	"peripheral neuropathy-hands tingling"	83	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519157501	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4477"	"DN-101 Protocol No. 011-007"	"141"	"141-0010"	5	9	"Adverse Event/Serious Adverse Event"	4920800002	"Right hand swollen"	83	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519157032	""	""	""	NA	"Hand swelling"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4478"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3240063003	"alopecia"	21	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503211405	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4479"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3549474001	"altered taste"	21	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503212744	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4480"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3549425001	"anemia"	9	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503210614	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4481"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	4717014002	"anxiety"	107	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517354407	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"4482"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	4717231002	"bilateral plural effusions"	103	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517355176	""	""	""	NA	"Effusion pleural"	"Respiratory, thoracic and mediastinal disorders"	"Pleural disorders"	"Pneumothorax and pleural effusions NEC"	"Pleural effusion"	""	""	""	""	""	""	""	""	""	""	""	""
"4483"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	4715914002	"edema"	72	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517352187	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"4484"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	5036200002	"elevated creatinine"	105	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520293633	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4485"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	4716305002	"elevated creatinine"	104	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517352867	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4486"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3549666001	"elevated potassium"	63	69	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503216740	""	""	""	NA	"Potassium increased"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood potassium increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4487"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3549451001	"eyelid swelling, right lower"	39	104	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503211792	""	""	""	NA	"Swelling of eyelid"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Lid, lash and lacrimal infections, irritations and inflammations"	"Eyelid oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"4488"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3549435001	"fatigue"	9	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503211232	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4489"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3261449001	"febrile neutropenia"	9	13	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	11	NA	NA	9	13	"02 jun 07 WBC = 0.8 K/uL, ANC = 0.04 K/uL; 04 jun 07 WBC = 2.0 K/uL, ANC = 0.39 K/u/L; 06 jun 07 WBC = 18.6 K/ul, ANC = 14.5K/ul"	""	""	2	1	2	2	2	2	2	0	"Patient had body aches for 2 days before presenting to the ED on Saturday 02 Jun 07; he did not take temp at home.;also noted to have nonspecific URI symptoms, rhinorrhea, sore throat with marked"	"aphagia, diffuse myalgias.;Admitted due to neutropenia; given 1 L bolus IV fluids, cefepime 2g q12h, Neupogen, pantoprazole;;The day after, he presented with pain in his nose, found to have a lesion"	"in his right nostril. sent for viral cultures which were negative at the time of discharge. However, the lesion did continue in rare numbers of methicillin-resistant Staphylococcus aureus. He was"	"started on vancomycin in addition to the cefepime that was started as empiric treatment for his neutropenic fever. The patient received a total of 3 doses of filgrastim 480 mcg start day of"	"admission. The day of discharge WBC 18.6. afebrile throughout hospital stay. At discharge, given Bactroban cream applied each nostril BID for 5 days for MRSA infection;;Patient was discharged home on"	"06 Jun 2007."	""	""	""	""	""	NA	NA	""	1496611366	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4490"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3549441001	"mild cough"	21	60	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503211516	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4491"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	4713395002	"Multi-Resistant Staphyloccus Aureus"	10	16	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517349061	""	""	""	NA	"Methicillin-resistant staphylococcal aureus infection"	"Infections and infestations"	"Bacterial infectious disorders"	"Staphylococcal infections"	"Staphylococcal infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4492"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	4711672002	"non-cardiac chest pain"	42	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517347112	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4493"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3549462001	"pain, left side of neck"	42	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503212279	""	""	""	NA	"Pain neck"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Neck pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4494"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3549457001	"productive cough"	60	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503212136	""	""	""	NA	"Productive cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4495"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3648581001	"pulmonary embolism"	105	109	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	107	NA	NA	105	109	"CT showed single tiny embolism in the basal segment of the right lower lobe with small bilateral pleural effusions"	""	""	2	2	2	NA	2	2	NA	2	"patient had extremity swelling.  patient presented to the ER and was admitted for PE. Discharged on anti-coagulation therapy"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504890901	""	""	""	NA	"Pulmonary embolism"	"Respiratory, thoracic and mediastinal disorders"	"Pulmonary vascular disorders"	"Pulmonary thrombotic and embolic conditions"	"Pulmonary embolism"	""	""	""	""	""	""	""	""	""	""	""	""
"4496"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3549465001	"right groin pain"	63	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503212346	""	""	""	NA	"Groin pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Soft tissue disorders NEC"	"Groin pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4497"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3549468001	"right hand swelling"	63	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503212522	""	""	""	NA	"Hand swelling"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4498"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	4717442002	"sinus tachycardia"	106	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517355922	""	""	""	NA	"Sinus tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Sinus tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"4499"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3549471001	"skin lesions, right hand"	63	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503212587	""	""	""	NA	"Skin lesion"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin lesion"	""	""	""	""	""	""	""	""	""	""	""	""
"4500"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	4922247002	"upper respiratory infection"	63	90	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519163734	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4501"	"DN-101 Protocol No. 011-007"	"141"	"141-0011"	5	9	"Adverse Event/Serious Adverse Event"	3489710001	"viral infection"	69	72	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	71	NA	NA	69	72	"CBC, chemistry, chest x ray 01 aug 2007"	""	""	2	2	2	2	2	2	2	2	"pt was admitted the evening of 01 aug 07 complaining of cough and fever.  Patient's was found to have low ANC and was given neuprogin.	chest x -ray did not show infitrate. patient was treated with"	"IV antibiotics.;;It is very likely that the patient had a viral infection versus pneumonia"	""	""	""	""	""	""	""	""	""	NA	NA	""	1501790633	""	""	""	NA	"Viral infection"	"Infections and infestations"	"Viral infectious disorders"	"Viral infections NEC"	"Viral infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4502"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2594462003	"Anemia"	14	141	NA	1	2	NA	1	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472057558	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4503"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2650805001	"Atrial fibrillation"	16	19	NA	3	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	16	NA	NA	15	20	"Sodium	130 mmol/L; BUN  28 mg/dL; Creatinine 2.1  mg/dL; WBC count  0.9 K/uL; Hemoglobin  12.9 g/dL; Neutrophil ABS.  0.14 K/uL; BNP 262 pg/mL"	""	""	2	2	2	NA	2	2	NA	2	"Subject went to clinic for blood draw on 6/27/2006 per protocol and was found to have a fever.	Subject also complained of weakness and diarrhea for the past 3 days.  Neutrophil, ABS 0.14 K/uL"	"Diagnosed with neutropenia and admitted to hospital for continued observation and hydration.  Patient was also admitted to MICU for atrial fibrillation and tachycardia, which required cardizem drip."	"He was also hypotensive and required NS boluses (totaling 2100 ml), after which the blood pressure responded slowly.  Patient was then diagnosed with acute renal failure in which an ultrasound was"	"done showing bilateral hydronephrosis.	His toxicities resolved and he was discharged on 7/3/2006."	""	""	""	""	""	""	""	NA	NA	""	1472060304	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"4504"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2650595001	"Bilateral Hydronephrosis"	14	141	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Foley catheter placed and changed monthly with follow up to Urology."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472055202	""	""	""	NA	"Bilateral hydronephrosis"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal obstructive disorders"	"Hydronephrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4505"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2650462001	"Dehydration"	14	20	NA	3	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	15	NA	NA	15	20	"Sodium	130 mmol/L; BUN  28 mg/dL; Creatinine 2.1  mg/dL; WBC count  0.9 K/uL; Hemoglobin  12.9 g/dL; Neutrophil ABS.  0.14 K/uL; BNP 262 pg/mL"	""	""	2	1	2	NA	2	2	NA	0	"Subject went to clinic for blood draw on 6/27/2006 per protocol and was found to have a fever.	Subject also complained of weakness and diarrhea for the past 3 days.  Neutrophil, ABS 0.14 K/uL"	"Diagnosed with neutropenia and admitted to hospital for continued observation and hydration.  Patient was also admitted to MICU for atrial fibrillation and tachycardia, which required cardizem drip."	"Patient was then diagnosed with acute renal failure in which an ultrasound was done showing bilateral hydronephrosis.  His toxicities resolved and he was discharged on 7/3/2006."	""	""	""	""	""	""	""	""	NA	NA	""	1472052845	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"4506"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2650529001	"Elevated Creatinine"	14	17	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472053608	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4507"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2599765001	"Febrile Neutropenia"	14	20	NA	4	2	NA	1	NA	NA	NA	2	NA	1	5	1	NA	1	"Subject given IV fluids for hydration and admitted for continued observation.  Subject also given Cefepime 2g IVPB"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	15	NA	NA	15	20	"Sodium	130 mmol/L; BUN  28 mg/dL; Creatinine 2.1  mg/dL; WBC count  0.9 K/uL; Hemoglobin  12.9 g/dL; Neutrophil ABS.  0.14 K/uL; BNP 262 pg/mL"	""	""	2	1	2	NA	2	2	NA	0	"Subject went to clinic for blood draw on 6/27/2006 per protocol and was found to have a fever.	Subject also complained of weakness and diarrhea for the past 3 days.  Neutrophil, ABS 0.14 K/uL"	"Diagnosed with neutropenia and admitted to hospital for continued observation and hydration.  Patient was also admitted to MICU for atrial fibrillation and tachycardia, which required cardizem drip."	"Patient was then diagnosed with acute renal failure in which an ultrasound was done showing bilateral hydronephrosis.  His toxicities resolved and he was discharged on 7/3/2006."	""	""	""	""	""	""	""	""	NA	NA	""	1467128616	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4508"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2650774001	"Hyponatremia"	14	15	NA	1	2	NA	1	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472057715	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4509"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2650921001	"Hypotension"	16	16	NA	2	2	NA	1	NA	NA	NA	2	NA	1	5	1	NA	1	"2100 ml NS boluses given."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472061859	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"4510"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2650719001	"Leukopenia"	14	17	NA	4	2	NA	1	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472057017	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4511"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2663119001	"Lower GI Bleeding"	76	141	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Blood transfusion 2 units of pRBCs.  Colonoscopy performed to evaluate bleeding."	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473083874	""	""	""	NA	"Lower gastrointestinal hemorrhage"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Lower gastrointestinal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"4512"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2659029001	"Neutropenia"	75	91	NA	4	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	78	NA	NA	75	91	"ANC 0.57 K/uL (8/27/2006); 0.24 K/uL (8/28/2006); HGB 8.9 g/dl; WBC 1.1 K/uL; Blood cultures positive for Gram(+) cocci"	""	""	2	2	2	NA	2	2	NA	2	"Patient presented to the Emergency Room on 8/27/2006 complaining of weakness and nausea without vomiting.  He reports being too weak to walk and falling at home while in the bathroom.  Urinalysis"	"done was found abnormal and his ANC was 0.57 K/uL.  He was started on Ciprofloxacin.  On 8/28/2006 he developed a fever and chills, so he was switched to Cefepime and Vancomycin.  He was also started"	"on Neupogen since his ANC dropped to 0.27 K/uL.  ;;Lower GI Bleeding:  On 8/28/2006 patient had an episode of bright red blood per rectum about 100 ml.  His hemoglobin dropped and he was transfused 2"	"units of PRBCs."	""	""	""	""	""	""	""	NA	NA	""	1472585201	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4513"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	2650848001	"Tachycardia"	16	16	NA	3	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472060894	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"4514"	"DN-101 Protocol No. 011-007"	"142"	"142-0001"	5	9	"Adverse Event/Serious Adverse Event"	5245578002	"Uninary Tract Infection"	75	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522756096	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4515"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	2597835003	"Abdominal Pain"	40	44	NA	2	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472413869	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4516"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4657094002	"Abdominal Pain"	26	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517158298	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4517"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	2654282001	"Acute Renal Insufficiency"	40	42	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472413739	""	""	""	NA	"Acute renal insufficiency"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure acute"	""	""	""	""	""	""	""	""	""	""	""	""
"4518"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4659925002	"Anorexia"	47	75	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517164485	""	""	""	NA	"Anorexia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"4519"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	3225522001	"Back Pain"	218	221	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	330	NA	NA	218	221	"Spinal CT showed no spinal cord compression."	""	""	2	2	2	2	2	2	2	2	"Patient presented to the Emergency Room complaining of sever back pain preventing him from moving around.  Patient was admitted and given Oramorph 30 mg PO Q12hr ATC, and morphine sulfate PRN.  Pain"	"controlled by Oramorph and patient discharged on 1/29/2007.  CT of spinal while inpatient showed no spinal cord compression."	""	""	""	""	""	""	""	""	""	NA	NA	""	1495203886	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4520"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	3225528001	"Back Pain"	245	246	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Radiation treatment for pain management."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	331	NA	NA	245	246	"Hemoglobin 10.4  g/dL"	""	""	2	2	2	2	2	2	2	2	"Patient admitted due to uncontrolled back pain.  Received Morphine and radiation treatment for pain management and discharged."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495204657	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4521"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4659982002	"Benign Positional Vertigo"	92	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517164603	""	""	""	NA	"Benign positional vertigo"	"Ear and labyrinth disorders"	"Inner ear and VIIIth cranial nerve disorders"	"Inner ear signs and symptoms"	"Vertigo positional"	""	""	""	""	""	""	""	""	""	""	""	""
"4522"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4553065002	"Chemo induced Anemia"	553	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516302349	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4523"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	2634208001	"Dehydration"	42	44	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	47	NA	NA	43	44	"Creatinine 1.5 mg/dL; WBC 2.7 K/uL; Neutrophil, ABS. 1.30 K/uL"	""	""	2	2	2	NA	2	2	NA	0	"Patient presents to the Emergency Room complaining of nausea, vomiting and intermittent episodes of diarrhea for several days.	He was seen by his primary oncologist on 8/1/06 and advised that he"	"should be admitted to the hospital, but he refused.  Two days after, with persistent nausea and vomiting, he agrees to hospital admission.  The patient was admitted for dehydration and started on IV"	"fluids with 1 liter bolus of normal saline.  He was also given Phenergan 25 mg IV for his nausea.  All other medications, including Prednisone, were withheld while hospitalized.;;Creatinine 1.5 mg/dL"	"Acute renal insufficiency likely secondary to prostate cancer.	Renal ultrasound showed no hydronephrosis or acute process.  Creatinine improved with IV fluids to 1.1 mg/dL."	""	""	""	""	""	""	""	NA	NA	""	1470686787	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"4524"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4135108001	"Dysgeusia"	509	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511813077	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4525"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4660011002	"Edema Bilateral Lower Extremities"	152	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517164665	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4526"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4552646002	"Fatigue"	544	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516301640	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4527"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4140114001	"Heaviness in legs"	487	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511871174	""	""	""	NA	"Heaviness in limbs"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Sensation of heaviness"	""	""	""	""	""	""	""	""	""	""	""	""
"4528"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4163396001	"Hemmorage, GU Urinary NOS"	522	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512073032	""	""	""	NA	"Haemorrhage urinary tract"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Haemorrhage urinary tract"	""	""	""	""	""	""	""	""	""	""	""	""
"4529"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4660090002	"Immobility of left arm due to muscle weakness"	260	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517164863	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4530"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4659860002	"Intermittent Diarrhea"	42	44	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517164284	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4531"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4140087001	"Lower Extremity Edema"	487	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511870689	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4532"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	2654184001	"Nausea"	40	44	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	47	NA	NA	43	44	"Creatinine 1.5 mg/dL; WBC 2.7 K/uL; Neutrophil, ABS. 1.30 K/uL"	""	""	2	2	2	NA	2	0	NA	0	"Patient presents to the Emergency Room complaining of nausea, vomiting and intermittent episodes of diarrhea for several days.	He was seen by his primary oncologist on 8/1/06 and advised that he"	"should be admitted to the hospital, but he refused.  Two days after, with persistent nausea and vomiting, he agrees to hospital admission.  The patient was admitted for dehydration and started on IV"	"fluids with 1 liter bolus of normal saline.  He was also given Phenergan 25 mg IV for his nausea.  All other medications, including Prednisone, were withheld while hospitalized.;;Creatinine 1.5 mg/dL"	"Acute renal insufficiency likely secondary to prostate cancer.	Renal ultrasound showed no hydronephrosis or acute process.  Creatinine improved with IV fluids to 1.1 mg/dL."	""	""	""	""	""	""	""	NA	NA	""	1472412305	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"4533"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	2654240001	"Neutropenia"	11	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1472412940	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4534"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4553109002	"Pain in right arm/shoulder"	553	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516302428	""	""	""	NA	"Painful R arm"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"4535"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4660049002	"Peripheral Neuropathy"	194	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517164739	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4536"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	2654176001	"Vomiting"	40	44	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	47	NA	NA	43	44	"Creatinine 1.5 mg/dL; WBC 2.7 K/uL; Neutrophil, ABS. 1.30 K/uL"	""	""	2	2	2	NA	2	2	NA	0	"Patient presents to the Emergency Room complaining of nausea, vomiting and intermittent episodes of diarrhea for several days.	He was seen by his primary oncologist on 8/1/06 and advised that he"	"should be admitted to the hospital, but he refused.  Two days after, with persistent nausea and vomiting, he agrees to hospital admission.  The patient was admitted for dehydration and started on IV"	"fluids with 1 liter bolus of normal saline.  He was also given Phenergan 25 mg IV for his nausea.  All other medications, including Prednisone, were withheld while hospitalized.;;Creatinine 1.5 mg/dL"	"Acute renal insufficiency likely secondary to prostate cancer.	Renal ultrasound showed no hydronephrosis or acute process.  Creatinine improved with IV fluids to 1.1 mg/dL."	""	""	""	""	""	""	""	NA	NA	""	1472412121	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"4537"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4660066002	"Weakness Right Upper Extremities"	260	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517164788	""	""	""	NA	"Weakness in extremity"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4538"	"DN-101 Protocol No. 011-007"	"142"	"142-0002"	5	9	"Adverse Event/Serious Adverse Event"	4659953002	"Weight Loss"	47	75	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517164543	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4539"	"DN-101 Protocol No. 011-007"	"142"	"142-0003"	5	9	"Adverse Event/Serious Adverse Event"	2619306003	"Alopecia"	33	402	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473163947	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4540"	"DN-101 Protocol No. 011-007"	"142"	"142-0003"	5	9	"Adverse Event/Serious Adverse Event"	2666516001	"Constipation"	21	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1473163782	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4541"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	2675801003	"Anemia"	107	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516821421	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4542"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	4630229002	"Constipation"	119	124	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516824544	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4543"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	2881513001	"Dehydration"	115	117	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	150	NA	NA	115	117	"Neutrophil, ABS.  0.42 K/uL  (2006-12-14);			   0.20 K/uL  (2006-12-15); Hemoglobin	10.1 g/dL (2006-12-14); Positive Urinalysis"	""	""	2	2	2	NA	2	2	NA	2	"The patient was admitted through the Emergency Room after an episode of hypotension (60/40).  IV fluids were given for dehydration.  He had a positive urinalysis, which later grew E. Coli resistant"	"to ampicillin and cipro.  Also, his neutrophil count was 0.42 K/uL.  He was given Bactrim for 7 days and is to follow up with Urology as an outpatient.  He also had one episode of hemorrhoidal"	"bleeding and is to follow up with an appointment in colorectal surgery."	""	""	""	""	""	""	""	""	NA	NA	""	1484768288	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"4544"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	4629081002	"Dehydration"	130	130	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516821469	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"4545"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	4628196002	"Discomfort in sacral region"	72	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516819839	""	""	""	NA	"Sacral pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Sacral pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4546"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	4628088002	"Dysgeusia"	65	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516819525	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4547"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	4627907002	"Fatigue"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516819141	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4548"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	5245605002	"Hemorrage, GI Rectum"	117	117	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522757639	""	""	""	NA	"Hemorrhage rectum"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Intestinal haemorrhages"	"Rectal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"4549"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	2798968001	"Left hip fracture. pathologic"	85	93	NA	3	2	NA	1	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	105	NA	NA	88	93	"X-ray"	""	""	2	2	0	NA	2	2	NA	0	"The patient presented to the emergency room on 11/17/2006 complaining of left hip pain and lower extremity pain.  X-ray revealed left intertrochanteric hip fracture.  Open reduction and internal"	"fixation of left hip fracture performed on 11/18/2006.	Patient discharged on 11/22/2006."	""	""	""	""	""	""	""	""	""	NA	NA	""	1480861371	""	""	""	NA	"Pathological fracture of hip"	"Musculoskeletal and connective tissue disorders"	"Fractures"	"Pathological fractures and complications"	"Pathological fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"4550"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	4628724002	"Lower Extremity Pain"	104	107	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516820729	""	""	""	NA	"Pain of lower extremities"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"4551"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	4628503002	"Lower extremity swelling"	104	107	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516820418	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4552"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	4345154001	"Mild Dysuria"	485	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514386120	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"4553"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	2881601001	"Neutropenia"	115	127	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	150	NA	NA	115	117	"Neutrophil, ABS.  0.42 K/uL  (2006-12-14);			   0.20 K/uL  (2006-12-15); Hemoglobin	10.1 g/dL (2006-12-14); Positive Urinalysis"	""	""	2	2	2	NA	2	2	NA	2	"The patient was admitted through the Emergency Room after an episode of hypotension (60/40).  IV fluids were given for dehydration.  He had a positive urinalysis, which later grew E. Coli resistant"	"to ampicillin and cipro.  Also, his neutrophil count was 0.42 K/uL.  He was given Bactrim for 7 days and is to follow up with Urology as an outpatient.  He also had one episode of hemorrhoidal"	"bleeding and is to follow up with an appointment in colorectal surgery."	""	""	""	""	""	""	""	""	NA	NA	""	1484768975	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4554"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	3404860001	"Proctitis"	175	252	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499806432	""	""	""	NA	"Proctitis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Rectal inflammations NEC"	"Proctitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4555"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	4345142001	"Urinary Incontinence"	485	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514385980	""	""	""	NA	"Urinary incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"4556"	"DN-101 Protocol No. 011-007"	"142"	"142-0004"	5	9	"Adverse Event/Serious Adverse Event"	2881569001	"Urinary Tract Infection"	115	117	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	150	NA	NA	115	117	"Neutrophil, ABS.  0.42 K/uL  (2006-12-14);			   0.20 K/uL  (2006-12-15); Hemoglobin	10.1 g/dL (2006-12-14); Positive Urinalysis"	""	""	2	2	2	NA	2	2	NA	2	"The patient was admitted through the Emergency Room after an episode of hypotension (60/40).  IV fluids were given for dehydration.  He had a positive urinalysis, which later grew E. Coli resistant"	"to ampicillin and cipro.  Also, his neutrophil count was 0.42 K/uL.  He was given Bactrim for 7 days and is to follow up with Urology as an outpatient.  He also had one episode of hemorrhoidal"	"bleeding and is to follow up with an appointment in colorectal surgery."	""	""	""	""	""	""	""	""	NA	NA	""	1484768774	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4557"	"DN-101 Protocol No. 011-007"	"142"	"142-0007"	5	9	"Adverse Event/Serious Adverse Event"	3115283003	"Acute Renal Failure"	96	99	NA	3	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	131	NA	NA	96	99	"07/24/07 Cat scan lumbar spine, MRI L spine, T spine and C spine.;07/26/07 Bone Scan;07/24/07 CBC, Chemical profile,  ;07/25/07 CBC, Chemical profile;07/26/07 CBC, Chemical profile;07/25/07"	"EKG;07/26/07 Blood transfusion"	""	2	2	2	0	0	2	2	2	"on 07/23/07 pt complained of lower extremity weakness, back pain and shoulder pain. Pt also complained of increased frequency nocturia, hesitancy and dysuria. Patient PSA level had increased. MRI"	"showed diffuse osseous metastatic lesion  and worsening epidural metastases.;Due to the rising PSA and progressive, diffuse metastatic disease, pt was removed from study. There was no relationship to"	"study drugs."	""	""	""	""	""	""	""	""	NA	NA	""	1503953441	""	""	""	NA	"Acute renal failure"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure acute"	""	""	""	""	""	""	""	""	""	""	""	""
"4558"	"DN-101 Protocol No. 011-007"	"142"	"142-0007"	5	9	"Adverse Event/Serious Adverse Event"	3577053001	"Anemia"	20	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503761947	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4559"	"DN-101 Protocol No. 011-007"	"142"	"142-0007"	5	9	"Adverse Event/Serious Adverse Event"	3577042001	"Lower Back Pain"	52	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Radiation Therapy 6/25/2007-7/2/2007"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503761494	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4560"	"DN-101 Protocol No. 011-007"	"142"	"142-0007"	5	9	"Adverse Event/Serious Adverse Event"	3577039001	"Lower Extremity Edema"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503761068	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4561"	"DN-101 Protocol No. 011-007"	"142"	"142-0010"	5	9	"Adverse Event/Serious Adverse Event"	3350540003	"Depression"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514391342	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"4562"	"DN-101 Protocol No. 011-007"	"142"	"142-0010"	5	9	"Adverse Event/Serious Adverse Event"	4346179001	"Dysgeusia"	181	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514391812	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4563"	"DN-101 Protocol No. 011-007"	"142"	"142-0010"	5	9	"Adverse Event/Serious Adverse Event"	4346081001	"Fatigue"	139	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514391486	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4564"	"DN-101 Protocol No. 011-007"	"142"	"142-0010"	5	9	"Adverse Event/Serious Adverse Event"	4346125001	"Hyperkeratosis of distal left lower extremity"	92	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514391629	""	""	""	NA	"Hyperkeratosis"	"Skin and subcutaneous tissue disorders"	"Cornification and dystrophic skin disorders"	"Hyperkeratoses"	"Hyperkeratosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4565"	"DN-101 Protocol No. 011-007"	"142"	"142-0010"	5	9	"Adverse Event/Serious Adverse Event"	4346104001	"Increased pain in Distal Left Lower Extremity"	159	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514391561	""	""	""	NA	"Pain of lower extremities"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"4566"	"DN-101 Protocol No. 011-007"	"142"	"142-0010"	5	9	"Adverse Event/Serious Adverse Event"	4346154001	"Slightly elevated blood sugar"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514391735	""	""	""	NA	"Blood sugar increased"	"Investigations"	"Metabolic, nutritional and blood gas investigations"	"Carbohydrate tolerance analyses (incl diabetes)"	"Blood glucose increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4567"	"DN-101 Protocol No. 011-007"	"142"	"142-0011"	5	9	"Adverse Event/Serious Adverse Event"	3565083003	"Erectile Dysfunction"	24	45	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513876121	""	""	""	NA	"Erectile dysfunction"	"Reproductive system and breast disorders"	"Sexual function and fertility disorders"	"Erection and ejaculation conditions and disorders"	"Erectile dysfunction"	""	""	""	""	""	""	""	""	""	""	""	""
"4568"	"DN-101 Protocol No. 011-007"	"142"	"142-0011"	5	9	"Adverse Event/Serious Adverse Event"	4334139001	"Exertional Dyspnea"	87	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513876442	""	""	""	NA	"Exertional dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"4569"	"DN-101 Protocol No. 011-007"	"142"	"142-0011"	5	9	"Adverse Event/Serious Adverse Event"	4334176001	"Heartburn"	101	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513876534	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"4570"	"DN-101 Protocol No. 011-007"	"142"	"142-0011"	5	9	"Adverse Event/Serious Adverse Event"	4334077001	"minimal parathesis of fingers and toes"	87	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513876322	""	""	""	NA	"Paresthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4571"	"DN-101 Protocol No. 011-007"	"142"	"142-0011"	5	9	"Adverse Event/Serious Adverse Event"	4334215001	"Persistent tingling in lower extremities"	108	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513876600	""	""	""	NA	"Tingling of extremity"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4572"	"DN-101 Protocol No. 011-007"	"142"	"142-0011"	5	9	"Adverse Event/Serious Adverse Event"	4334112001	"Tingling in hands and feet"	87	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513876399	""	""	""	NA	"Tingling feet/hands"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4573"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	2684853003	"Acute Renal Failure"	246	248	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509489017	""	""	""	NA	"Acute renal failure"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure acute"	""	""	""	""	""	""	""	""	""	""	""	""
"4574"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	2792205001	"Alopecia"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480375864	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4575"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	3406359001	"Ankle Edema"	235	248	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499817494	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4576"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	2792214001	"Calf Cramps"	43	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480376263	""	""	""	NA	"Cramps calf"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"4577"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	2999597001	"Calf Cramps"	98	100	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489539208	""	""	""	NA	"Cramps calf"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"4578"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	3215497001	"dehydration"	246	248	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hospitalization"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	248	NA	NA	246	248	"5/15/07 - Cortrosyn stimul cortisol ; 5/15/07 - Brain MRI; 5/15/07 - CBC and CMP; 5/15/07 - MRI of the C- Spine"	""	""	2	2	2	2	2	2	2	2	"Hospital admission on 5/15/07 with N&V, r/o CNS mets, and ? adrenal insufficiency.  Brain MRI revealed extensive mets to skull but no intracranial pathology. Cortisol normal.	Per Dr. Mendelson,"	"event is not related to study drug."	""	""	""	""	""	""	""	""	""	NA	NA	""	1495061193	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"4579"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	2792208001	"Dizzinesss"	43	NA	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480376045	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"4580"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	2722291001	"Hypertension"	9	10	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1476227043	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"4581"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	3406431001	"Increased hot flashes"	217	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499820241	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"4582"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	3406339001	"Increased Pain (Shoulder, Knee, Back, sternal)"	229	248	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499817255	""	""	""	NA	"Musculoskeletal pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4583"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	2792285001	"Insomnia"	57	248	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480377988	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4584"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	3072176001	"intermittent Anemia"	22	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491789811	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4585"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	2999581001	"Lightheadedness"	8	8	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489538194	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"4586"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	2999588001	"Moody (Change in Mood)"	86	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489538651	""	""	""	NA	"Mood change"	"Psychiatric disorders"	"Mood disorders and disturbances NEC"	"Emotional and mood disturbances NEC"	"Mood altered"	""	""	""	""	""	""	""	""	""	""	""	""
"4587"	"DN-101 Protocol No. 011-007"	"144"	"144-0001"	5	9	"Adverse Event/Serious Adverse Event"	3406423001	"Pain in skull"	246	248	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499820062	""	""	""	NA	"Pain bone"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4588"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	5	9	"Adverse Event/Serious Adverse Event"	3107964003	"Alopecia"	26	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495496220	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4589"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	5	9	"Adverse Event/Serious Adverse Event"	3634548001	"Constipation"	74	80	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504651660	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4590"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	5	9	"Adverse Event/Serious Adverse Event"	3431784001	"dehydration"	91	94	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"Hospital admission"	0	1	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	93	NA	NA	92	94	"Serum sodium 123 mmol/L"	""	""	2	2	2	NA	2	2	NA	2	"70 yo male with metastatic prostate cancer in for C5 Taxotere infusion complained of increasing muscle weakness and \"unsteadiness\" since last treatment.  Labs drawn on 7/16/07 revealed serum sodium"	"123.  Patient admitted to hospital for dehydration and correction of serum sodium."	""	""	""	""	""	""	""	""	""	NA	NA	""	1500398928	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"4591"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	5	9	"Adverse Event/Serious Adverse Event"	3634513001	"Fatigue"	29	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504651559	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4592"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	5	9	"Adverse Event/Serious Adverse Event"	3634598001	"indigestion"	73	94	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504651926	""	""	""	NA	"Indigestion"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"4593"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	5	9	"Adverse Event/Serious Adverse Event"	3634373001	"Metallic Taste"	35	90	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504650862	""	""	""	NA	"Taste metallic"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4594"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	5	9	"Adverse Event/Serious Adverse Event"	3233161001	"Muscle Cramps"	15	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495495356	""	""	""	NA	"Muscle cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"4595"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	5	9	"Adverse Event/Serious Adverse Event"	3634309001	"Muscle Spasm  - Shoulders"	29	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504650501	""	""	""	NA	"Muscle spasm"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"4596"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	5	9	"Adverse Event/Serious Adverse Event"	3634587001	"Muscle Weakness"	73	94	NA	3	2	NA	1	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504651832	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4597"	"DN-101 Protocol No. 011-007"	"144"	"144-0002"	5	9	"Adverse Event/Serious Adverse Event"	3233208001	"Tingling Tops of Feet"	26	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495496607	""	""	""	NA	"Tingling"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4598"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	2787766003	"Blood - Low Hemoglobin"	159	178	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517171808	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4599"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	4658578002	"Blood - Neutropenia"	276	293	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517161165	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4600"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	4664423002	"Blood Low Hemoglobin"	276	323	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517172455	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4601"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	4664462002	"Blood Low Hemoglobin"	323	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517172519	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4602"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	4664135002	"Blood Low Hemoglobin"	178	276	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517172015	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4603"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	3010795001	"blood-low hemoglobin"	10	159	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490023621	""	""	""	NA	"Hemoglobin low"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4604"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	4092160001	"Constitutional - Fatigue"	12	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511120539	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4605"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	3010821001	"constitutional-fatigue"	108	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490023725	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4606"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	4938721002	"Mouth Sores"	66	157	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519319007	""	""	""	NA	"Sores mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4607"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	4659198002	"Musculoskeletal - back pain"	348	351	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Patient hospitalized for pain control"	0	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"patient was hospitalized for pain control"	348	NA	NA	348	351	"CT lumbar spine performed which demostrated multiple sclerotic lesions"	""	""	2	2	2	NA	2	2	NA	2	"Patient was seen in office for severe low back pain radiating into left leg.  Admitted to hospital for pain control with IV meds"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517162616	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4608"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	3274387001	"neuropathy of feet"	157	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496938216	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4609"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	4938755002	"Pain - back"	351	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519319162	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4610"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	3010772001	"pulmonary-upper respiratory infection"	91	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490023530	""	""	""	NA	"Infection upper respiratory"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4611"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	2928548001	"skin - alopecia"	45	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486658004	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4612"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	4938738002	"Sore throat"	91	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519319073	""	""	""	NA	"Sore throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4613"	"DN-101 Protocol No. 011-007"	"145"	"145-0003"	5	9	"Adverse Event/Serious Adverse Event"	4938831002	"Taxotere burn on arm"	267	314	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519319460	""	""	""	NA	"Infusion site burning"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion site pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4614"	"DN-101 Protocol No. 011-007"	"145"	"145-0005"	5	9	"Adverse Event/Serious Adverse Event"	3504874003	"Back Pain"	42	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Infusion was started and stopped.  Con Med noted was increased Decadron."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510243446	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4615"	"DN-101 Protocol No. 011-007"	"145"	"145-0005"	5	9	"Adverse Event/Serious Adverse Event"	4941852002	"Back Pain"	63	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Infusion was started and stopped.  Con Med noted was increased Decadron."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519328190	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4616"	"DN-101 Protocol No. 011-007"	"145"	"145-0005"	5	9	"Adverse Event/Serious Adverse Event"	4941873002	"Back Pain"	21	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Infusion was started and stopped.  Con Med noted was increased Decadron."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519328236	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4617"	"DN-101 Protocol No. 011-007"	"145"	"145-0005"	5	9	"Adverse Event/Serious Adverse Event"	4942012002	"Cough"	112	184	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519328912	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4618"	"DN-101 Protocol No. 011-007"	"145"	"145-0005"	5	9	"Adverse Event/Serious Adverse Event"	4537152002	"Hand Foot Syndrome"	82	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516222234	""	""	""	NA	"Hand and foot syndrome"	"Skin and subcutaneous tissue disorders"	"Skin and subcutaneous tissue disorders NEC"	"Skin and subcutaneous conditions NEC"	"Palmar-plantar erythrodysaesthesia syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"4619"	"DN-101 Protocol No. 011-007"	"145"	"145-0006"	5	9	"Adverse Event/Serious Adverse Event"	3562940003	"anemia"	28	41	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516204632	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4620"	"DN-101 Protocol No. 011-007"	"145"	"145-0006"	5	9	"Adverse Event/Serious Adverse Event"	4527696002	"anemia"	42	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516204944	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4621"	"DN-101 Protocol No. 011-007"	"145"	"145-0006"	5	9	"Adverse Event/Serious Adverse Event"	3748577001	"Decreased Urinary Output"	35	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506271211	""	""	""	NA	"Urine output decreased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Urinary tract function analyses NEC"	"Urine output decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4622"	"DN-101 Protocol No. 011-007"	"145"	"145-0006"	5	9	"Adverse Event/Serious Adverse Event"	3748570001	"Dyspnea"	33	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506271120	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4623"	"DN-101 Protocol No. 011-007"	"145"	"145-0006"	5	9	"Adverse Event/Serious Adverse Event"	3748544001	"Fatigue"	35	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506270970	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4624"	"DN-101 Protocol No. 011-007"	"145"	"145-0006"	5	9	"Adverse Event/Serious Adverse Event"	3748588001	"Lower Extremity Edema"	28	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506271291	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4625"	"DN-101 Protocol No. 011-007"	"145"	"145-0006"	5	9	"Adverse Event/Serious Adverse Event"	4528375002	"mild crackles at lung base"	35	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516206164	""	""	""	NA	"Crackles lung"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Lower respiratory tract signs and symptoms"	"Rales"	""	""	""	""	""	""	""	""	""	""	""	""
"4626"	"DN-101 Protocol No. 011-007"	"145"	"145-0006"	5	9	"Adverse Event/Serious Adverse Event"	4940706002	"Pain in Ribcage and Back"	112	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519325372	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4627"	"DN-101 Protocol No. 011-007"	"145"	"145-0006"	5	9	"Adverse Event/Serious Adverse Event"	3640964001	"paroxysmal Atrial Tachycardia"	18	19	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	21	NA	NA	19	20	"CBC 09-04-07, Chem Profile, 09-04-07, EKG 09-04-07, Troponins 09-04-07"	""	""	2	2	2	NA	2	2	NA	2	"Patient went to primary care doctor with weakness and increased pulse.	He was not having any symptoms of angina or congestive heart failure. Upon admission patietn was given 6 mg of Adenocard with"	"conversion to a sinus rhytm. Patient was diagnosed with paroxysmal atrial tachycardia and placed on metoprolol 50 mg bid."	""	""	""	""	""	""	""	""	""	NA	NA	""	1504727851	""	""	""	NA	"Paroxysmal atrial tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"4628"	"DN-101 Protocol No. 011-007"	"146"	"146-0002"	5	9	"Adverse Event/Serious Adverse Event"	2984515003	"ALOPECIA"	128	234	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506960640	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4629"	"DN-101 Protocol No. 011-007"	"146"	"146-0002"	5	9	"Adverse Event/Serious Adverse Event"	4336616001	"ANXIETY"	154	159	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513887078	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"4630"	"DN-101 Protocol No. 011-007"	"146"	"146-0002"	5	9	"Adverse Event/Serious Adverse Event"	3546698001	"EDEMA FEET, ANKLES, CALVES"	134	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503002210	""	""	""	NA	"Edema lower limb"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4631"	"DN-101 Protocol No. 011-007"	"146"	"146-0002"	5	9	"Adverse Event/Serious Adverse Event"	4219470001	"HYPERLACRIMATION"	204	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512671528	""	""	""	NA	"Lacrimation increased"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4632"	"DN-101 Protocol No. 011-007"	"146"	"146-0002"	5	9	"Adverse Event/Serious Adverse Event"	3795902001	"HYPERPIGMENTATION - HANDS AND FOREARMS"	190	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506960488	""	""	""	NA	"Hyperpigmentation skin"	"Skin and subcutaneous tissue disorders"	"Pigmentation disorders"	"Hyperpigmentation disorders"	"Skin hyperpigmentation"	""	""	""	""	""	""	""	""	""	""	""	""
"4633"	"DN-101 Protocol No. 011-007"	"146"	"146-0002"	5	9	"Adverse Event/Serious Adverse Event"	3795992001	"MYALGIA"	103	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506960990	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4634"	"DN-101 Protocol No. 011-007"	"146"	"146-0002"	5	9	"Adverse Event/Serious Adverse Event"	3795880001	"NAIL CHANGES"	190	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506960359	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4635"	"DN-101 Protocol No. 011-007"	"146"	"146-0002"	5	9	"Adverse Event/Serious Adverse Event"	3976594001	"NEUTROPENIA"	150	152	NA	2	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509479359	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4636"	"DN-101 Protocol No. 011-007"	"146"	"146-0002"	5	9	"Adverse Event/Serious Adverse Event"	3546669001	"SEPSIS - CELLULITIS LEFT ARM"	150	159	NA	3	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	3	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	165	NA	NA	150	165	"JULY 23-07: ANC 0.60. JULY 25-07: ANC 08.30. JULY 26-07: WBC 17.30  JULY 31-07- WBC 12.50 ;CHEST XRAY REVEALED	MULTIPLE OSETEOBLASTIC LESIONS IDENTIFIED WITHIN THE CLAVICLES, SCAPULAE AND RIBS"	"BILATERALLY IN KEEPING WITH METASTATIC DISEASE. THE LUNGS ARE MILDLY HYPERINFLATED IN KEEPING WITH COPD."	""	2	2	1	NA	1	2	NA	2	"SUBJECT ADMITTED TO HOSPITAL WITH SWOLLEN LEFT UPPER ARM.  PICC LINE REMOVED.  TIP CULTURED WITH OUTCOME OF STAPHYLOCOCCUS AUREUS GROWTH.  BLOOD CULTURES  REVEALED S. AUREUS. IV ANTIBIOTICS"	"STARTED.;NEW PICC LINE INSERTED JULY 30-07 IV ANTIBIOTICS TO CONTINUE AT HOME AFTER DISCHARGE ON AUGUST 1, 2007."	""	""	""	""	""	""	""	""	""	NA	NA	""	1503001846	""	""	""	NA	"Sepsis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Sepsis, bacteraemia and viraemia"	"Sepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"4637"	"DN-101 Protocol No. 011-007"	"146"	"146-0002"	5	9	"Adverse Event/Serious Adverse Event"	3546120001	"TASTE ALTERATION"	81	162	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502997147	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4638"	"DN-101 Protocol No. 011-007"	"146"	"146-0002"	5	9	"Adverse Event/Serious Adverse Event"	4336078001	"WORSENING LOW BACK PAIN"	180	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513884223	""	""	""	NA	"Back pain aggravated"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4639"	"DN-101 Protocol No. 011-007"	"146"	"146-0004"	5	9	"Adverse Event/Serious Adverse Event"	3230377003	"ALOPECIA"	18	100	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500226150	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4640"	"DN-101 Protocol No. 011-007"	"146"	"146-0004"	5	9	"Adverse Event/Serious Adverse Event"	3804811001	"ATRIAL FIBRILLATION"	23	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"HOLOR MONITOR AND ECHOCARDIOGRAM"	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507054959	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"4641"	"DN-101 Protocol No. 011-007"	"146"	"146-0004"	5	9	"Adverse Event/Serious Adverse Event"	3420656001	"FEBRILE NEUTROPENIA"	51	54	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	70	NA	NA	51	57	"ANC JUNE 27,2007 = 0.03 X 10^9/L; ANC JUNE 30,2007 = 2.00 X 10^9/L; TEMPERATURES >38.3 ARE DOCUMENTED"	""	""	2	2	2	NA	2	2	NA	2	"SUBJECT ADMITTED TO HOSPITAL WITH FEBRILE NEUTROPENIA.	IV ANTIBIOTICS, PIPERCILLIN AND GENTAMYCIN WERE GIVEN PLUS POTASSIUM CHLORIDE SUPPLEMENT X 2.  (K = 3.0 ON JUNE 27,2007 AND 3.5 ON JUNE"	"30,2007).  aLLCULTURES WERE NEGATIVE.  ;SUBJECT ALSO PRESENTED WITH DIARRHEA GRADE 2 X 3 DAYS."	""	""	""	""	""	""	""	""	""	NA	NA	""	1500218825	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4642"	"DN-101 Protocol No. 011-007"	"146"	"146-0004"	5	9	"Adverse Event/Serious Adverse Event"	4220452001	"HYPOKALEMIA"	51	53	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512677393	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4643"	"DN-101 Protocol No. 011-007"	"146"	"146-0004"	5	9	"Adverse Event/Serious Adverse Event"	3421382001	"WORSENING ABDOMINAL CRAMPING"	19	25	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500226953	""	""	""	NA	"Abdominal cramp"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4644"	"DN-101 Protocol No. 011-007"	"146"	"146-0004"	5	9	"Adverse Event/Serious Adverse Event"	3253979001	"WORSENING DIARRHEA"	19	27	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	22	NA	NA	22	30	"ABSOLUTE NEUTROPHILS 0.08 UNITS X 10^9/L ON 2007-05-29. ABSOLUTE NEUTROPHIL COUNT 0.03 UNITS X10^/L ON 2007-05-31"	""	""	2	2	2	2	2	2	2	2	"RECEIVED CALL ON MAY 29,2007 THAT SUBJECT HAD BEEN HAVING WORSENING DIARRHEA SINCE MAY 26, 2007.  THIS WAS ACCOMPANIED BY ANEXORIA, SOME NAUSEA AND ONE EPIDSODE OF VOMITING, FOLLOWED BY ABDOMINAL"	"DISTENTION AND PAIN.  NECESSARY TO WEAR ATTENDS DUE TO THE EXPLOSIVE NATURE OF THIS EVENT.  SUBJECT BECOMING INCREASINGLY WEAK. TAKING ONLY ENSURE.;SUBJECT TAKEN TO EMERGENCY BY THE FAMILY AND"	"ADMITTED. TREATED WITH IV HYDRATION AND ANTIBIOTICS, CIPRO AND FLAGYL.;INVESTIGATOR IMPRESSION IS DIARRHEA RELATED TO CHEMOTHERAPY.  RULE OUT NEUTROPENIC COLITIS."	""	""	""	""	""	""	""	""	NA	NA	""	1496259008	""	""	""	NA	"Diarrhea aggravated"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4645"	"DN-101 Protocol No. 011-007"	"146"	"146-0004"	5	9	"Adverse Event/Serious Adverse Event"	3421296001	"WORSENING FATIGUE"	19	25	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500226332	""	""	""	NA	"Fatigue aggravated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4646"	"DN-101 Protocol No. 011-007"	"146"	"146-0004"	5	9	"Adverse Event/Serious Adverse Event"	3805057001	"WORSENING INSOMNIA"	65	117	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507055571	""	""	""	NA	"Insomnia exacerbated"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4647"	"DN-101 Protocol No. 011-007"	"149"	"149-0001"	5	9	"Adverse Event/Serious Adverse Event"	3171356003	"allergic reaction"	14	14	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"pt. said he felt funny, chemo IV turned off immediately, benadryl (25mg IV given), chemo withheld until 5/14/07 and infused at a slower rate."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499267546	""	""	""	NA	"Allergic reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"4648"	"DN-101 Protocol No. 011-007"	"149"	"149-0001"	5	9	"Adverse Event/Serious Adverse Event"	3363587001	"muscle weakness/generalized"	19	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499268817	""	""	""	NA	"Generalized muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4649"	"DN-101 Protocol No. 011-007"	"149"	"149-0001"	5	9	"Adverse Event/Serious Adverse Event"	5293699002	"urinary tract infection"	32	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523559375	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4650"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	2933704003	"anemia"	307	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517440839	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4651"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3065550001	"arthralgia (intermittent)"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491425963	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4652"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	4736942002	"atrial fibrillation"	238	243	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517439636	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"4653"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3065780001	"bradycardia"	27	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491427924	""	""	""	NA	"Bradycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Bradycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"4654"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3065617001	"constipation"	9	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491426365	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4655"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799518001	"constipation"	125	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506981591	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4656"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799561001	"cough"	167	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506982034	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4657"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3065737001	"cough"	13	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491427406	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4658"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799498001	"decreased sensitivity to touch in hands"	90	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506980906	""	""	""	NA	"Paresthesia hand"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4659"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799502001	"edema--feet"	87	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506981020	""	""	""	NA	"Foot edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4660"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3065758001	"elevated transaminases (SGOT)"	6	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"stop cozaar"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491427610	""	""	""	NA	"SGOT increased"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Aspartate aminotransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4661"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799544001	"exersional dyspnea"	147	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506981811	""	""	""	NA	"Exercise dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"4662"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3201262001	"fatigue"	48	125	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494953872	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4663"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799506001	"fingernail changes"	111	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506981117	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4664"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799450001	"flu"	55	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506980213	""	""	""	NA	"Flu"	"Infections and infestations"	"Viral infectious disorders"	"Influenza viral infections"	"Influenza"	""	""	""	""	""	""	""	""	""	""	""	""
"4665"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3065593001	"heartburn (intermittent)"	12	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hospital bed  with raised head"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491426183	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"4666"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799515001	"hip pain"	111	167	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506981316	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4667"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3065534001	"insomnia (intermittent)"	6	69	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491425827	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4668"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799512001	"low back pain"	111	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506981242	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4669"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3065565001	"myalgia (intermittent)"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491426057	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4670"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3065664001	"phlebitis"	11	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"port implanted"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491426646	""	""	""	NA	"Phlebitis"	"Vascular disorders"	"Vascular inflammations"	"Phlebitis NEC"	"Phlebitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4671"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799464001	"runny nose"	55	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506980333	""	""	""	NA	"Runny nose"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4672"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799550001	"sinusitis"	154	167	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506981894	""	""	""	NA	"Sinusitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Sinusitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4673"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799558001	"sore throat"	154	167	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506981966	""	""	""	NA	"Sore throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4674"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799526001	"stiff neck"	125	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506981668	""	""	""	NA	"Stiff neck"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal stiffness"	""	""	""	""	""	""	""	""	""	""	""	""
"4675"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799477001	"stuffy nose"	55	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506980458	""	""	""	NA	"Nasal stuffiness"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal congestion and inflammations"	"Nasal congestion"	""	""	""	""	""	""	""	""	""	""	""	""
"4676"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799534001	"taste changes"	118	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506981735	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4677"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3799489001	"upper back pain"	90	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506980646	""	""	""	NA	"Upper back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4678"	"DN-101 Protocol No. 011-007"	"150"	"150-0002"	5	9	"Adverse Event/Serious Adverse Event"	3065768001	"ventricular bigeminy"	27	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491427745	""	""	""	NA	"Ventricular bigeminy"	"Cardiac disorders"	"Cardiac arrhythmias"	"Ventricular arrhythmias and cardiac arrest"	"Ventricular extrasystoles"	""	""	""	""	""	""	""	""	""	""	""	""
"4679"	"DN-101 Protocol No. 011-007"	"150"	"150-0003"	5	9	"Adverse Event/Serious Adverse Event"	3612219003	"alopecia"	18	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507582096	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4680"	"DN-101 Protocol No. 011-007"	"150"	"150-0003"	5	9	"Adverse Event/Serious Adverse Event"	3836071001	"bilateral leg aches"	5	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507582006	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"4681"	"DN-101 Protocol No. 011-007"	"150"	"150-0003"	5	9	"Adverse Event/Serious Adverse Event"	4819158002	"fatigue"	108	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518042764	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4682"	"DN-101 Protocol No. 011-007"	"150"	"150-0003"	5	9	"Adverse Event/Serious Adverse Event"	4109026001	"left shoulder pain"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511287816	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4683"	"DN-101 Protocol No. 011-007"	"150"	"150-0003"	5	9	"Adverse Event/Serious Adverse Event"	4109054001	"left shoulder tingling"	14	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511287931	""	""	""	NA	"Tingling"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4684"	"DN-101 Protocol No. 011-007"	"150"	"150-0003"	5	9	"Adverse Event/Serious Adverse Event"	3835733001	"neutropenia"	12	17	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507580365	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4685"	"DN-101 Protocol No. 011-007"	"150"	"150-0003"	5	9	"Adverse Event/Serious Adverse Event"	3835716001	"pedal edema"	31	52	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507580276	""	""	""	NA	"Pedal edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4686"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	2800309003	"confusion"	197	202	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500313847	""	""	""	NA	"Confusion"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Confusion and disorientation"	"Confusional state"	""	""	""	""	""	""	""	""	""	""	""	""
"4687"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	2868187001	"constipation"	15	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484231240	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4688"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	2982552001	"cough"	64	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488906204	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4689"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	2982602001	"dehydration"	64	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488906529	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"4690"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	2868291001	"Depression"	15	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484234498	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"4691"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	3075236001	"dry mucosa"	111	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491858744	""	""	""	NA	"Mucosal dryness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Mucosal findings abnormal"	"Mucosal dryness"	""	""	""	""	""	""	""	""	""	""	""	""
"4692"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	3075230001	"exertional dyspnea"	106	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491858653	""	""	""	NA	"Exertional dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"4693"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	3425827001	"Fever"	194	202	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500308939	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"4694"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	3137493001	"Generalized Malaise"	132	139	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493307054	""	""	""	NA	"General malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"4695"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	2868258001	"Hair loss"	31	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484233153	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4696"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	3426648001	"hypokalemia"	197	202	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500313697	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4697"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	3426606001	"Hyponatremia"	197	202	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500313552	""	""	""	NA	"Hyponatremia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Sodium imbalance"	"Hyponatraemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4698"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	2982606001	"insomnia"	44	51	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488906674	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4699"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	3137487001	"Intermitant leucocytosis"	147	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493306954	""	""	""	NA	"Leukocytosis"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukocytoses NEC"	"Leukocytosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4700"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	2982392001	"Intermitant leukopenia"	37	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488904541	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4701"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	2868221001	"Left leg Swelling"	37	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484232068	""	""	""	NA	"Swelling of legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4702"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	3137484001	"neutropenia (pancytopenia)"	139	147	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493306854	""	""	""	NA	"Pancytopenia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Marrow depression and hypoplastic anaemias"	"Pancytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4703"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	2982514001	"post nasal drip"	64	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488905922	""	""	""	NA	"Postnasal drip"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Postnasal drip"	""	""	""	""	""	""	""	""	""	""	""	""
"4704"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	3426450001	"Prostate Cancer progression"	197	238	NA	5	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	4	0	NA	0	12	NA	NA	1	1	NA	NA	NA	""	230	238	0	197	202	"CT chest without contrast"	""	""	0	2	0	2	2	0	2	0	"Patient had cancer progression as per CT and PSA increase. Chemotherapy regimen to be changed. Patient taken off study treatmenty phase. Patient condition continued to deteriorate. Head MRI showed"	"brain metastasis. Patient died."	""	""	""	""	""	""	""	""	""	NA	NA	""	1500312851	""	""	""	NA	"Progression of pre-existing cancer"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Miscellaneous and site unspecified neoplasms malignant and unspecified"	"Neoplasms malignant site unspecified NEC"	"Malignant neoplasm progression"	""	""	""	""	""	""	""	""	""	""	""	""
"4705"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	3426522001	"sepsis"	197	202	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Hospitalization"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	197	NA	NA	197	202	"Blood culture 06/13/07"	""	""	2	2	2	NA	2	2	NA	2	"Patient was admited to the hospital with fever and chills, blood cultures were positive for pseudomona aeruginosa. Patien was treated with IV antibiotics and was discgraged from the hospital afted"	"the condition improved."	""	""	""	""	""	""	""	""	""	NA	NA	""	1500313264	""	""	""	NA	"Sepsis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Sepsis, bacteraemia and viraemia"	"Sepsis"	""	""	""	""	""	""	""	""	""	""	""	""
"4706"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	5400662002	"severe chills"	216	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1527623062	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"4707"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	4433077002	"urinary difficulties"	106	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515533636	""	""	""	NA	"Urination difficulty"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"4708"	"DN-101 Protocol No. 011-007"	"151"	"151-0001"	5	9	"Adverse Event/Serious Adverse Event"	4433005002	"worsening gastric reflux"	127	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515533526	""	""	""	NA	"Esophageal reflux aggravated"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Gastrooesophageal reflux disease"	""	""	""	""	""	""	""	""	""	""	""	""
"4709"	"DN-101 Protocol No. 011-007"	"154"	"154-0001"	5	9	"Adverse Event/Serious Adverse Event"	2734817003	"Anemia"	27	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507135073	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4710"	"DN-101 Protocol No. 011-007"	"154"	"154-0001"	5	9	"Adverse Event/Serious Adverse Event"	3812799001	"Bruising"	153	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507135224	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"4711"	"DN-101 Protocol No. 011-007"	"154"	"154-0001"	5	9	"Adverse Event/Serious Adverse Event"	3812741001	"Constipation"	24	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507134998	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4712"	"DN-101 Protocol No. 011-007"	"154"	"154-0001"	5	9	"Adverse Event/Serious Adverse Event"	3812780001	"Fatigue"	69	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507135143	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4713"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3045387003	"anemia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499363083	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4714"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3433334001	"Atrial fibrillation"	59	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500414605	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"4715"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3816705001	"Conjunctivitis of the right eye"	183	207	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507160562	""	""	""	NA	"Conjunctivitis"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Conjunctival infections, irritations and inflammations"	"Conjunctivitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4716"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	4692907002	"Constipation"	16	53	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517271298	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4717"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3195059001	"Deep Vein Thrombosis - Right Leg"	56	59	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	57	NA	NA	-674	59	"2007-05-17;- blood pressure 111/67;- respirations 18;- pulse 85-99;- afebrile;- hemoglobin 11.4, MCV 87;- INR 2 with PTT of 46;- may start anticoagulation anywhere from 9-12 months;- to start"	"amiodarone 200 mg once a day"	""	2	2	2	2	2	2	2	2	"This SAE was reported to me on 5-15-07. I spoke with a family member of the patient and he said the patient experienced right leg swelling on 5-14-07 and subsequently saw his physician. A DVT study"	"ultrasound was completed and the patient was found to have a DVT in the right leg from the proximal SFV to the popliteal vein. The patient was hospitalized on 5-14-07 at around 17:00. The family"	"\"thinks he is receiving heparin\". The family states that the plan is for the patient to be in the hospital for 3-4 days and then discharged on Coumadin for six months.  This is all preliminary"	"information.  Per Dr. Shiba, Principal Investigator, he states that this event is unlikely related to any drug therapy but rather to the patient's underlying disease."	""	""	""	""	""	""	""	NA	NA	""	1494874389	""	""	""	NA	"Deep vein thrombosis leg"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4718"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3739345001	"Dysuria"	158	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506019078	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"4719"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3369579001	"dysuria"	32	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499361804	""	""	""	NA	"Dysuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"4720"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3739453001	"Fatigue"	179	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506019360	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4721"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3515479001	"Lightheadedness"	135	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502328872	""	""	""	NA	"Lightheadedness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"4722"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3739473001	"Neuropathy"	179	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506019438	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4723"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3369807001	"neuropathy"	74	178	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499363211	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4724"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3369720001	"rash"	53	95	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499362767	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"4725"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3369668001	"rectal burning"	32	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499362435	""	""	""	NA	"Burning rectal"	"Gastrointestinal disorders"	"Anal and rectal conditions NEC"	"Anal and rectal disorders NEC"	"Anal discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"4726"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3739305001	"Renal stones"	144	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506018983	""	""	""	NA	"Renal stone"	"Renal and urinary disorders"	"Urolithiases"	"Renal lithiasis"	"Nephrolithiasis"	""	""	""	""	""	""	""	""	""	""	""	""
"4727"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	4058894001	"Sensory Neuropathy"	208	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510687651	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4728"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3816688001	"Sensory Neuropathy"	180	NA	1	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507160479	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4729"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	4058785001	"Swelling of Right Leg"	53	59	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510687507	""	""	""	NA	"Swelling of legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4730"	"DN-101 Protocol No. 011-007"	"154"	"154-0002"	5	9	"Adverse Event/Serious Adverse Event"	3739406001	"Vertigo"	97	185	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506019225	""	""	""	NA	"Vertigo"	"Ear and labyrinth disorders"	"Inner ear and VIIIth cranial nerve disorders"	"Inner ear signs and symptoms"	"Vertigo"	""	""	""	""	""	""	""	""	""	""	""	""
"4731"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	2765586003	"EDEMA"	228	266	NA	2	1	1	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498502692	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"4732"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	3084812001	"elevated creatinine"	161	169	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"CMP WILL BE REPEATED ON 4-16-2007, FAX REPORT TO UROLOGIST AND HE WILL SET UP RENAL SONOGRAM RESULTS OF CMP FOR 4-16-07 WILL BE FAXED TO UROLOGIST"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492098317	""	""	""	NA	"Creatinine increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4733"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	2967105001	"hemorrhage, gu,bladder"	98	102	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"referral to urologist"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488143118	""	""	""	NA	"Bladder hemorrhage"	"Renal and urinary disorders"	"Bladder and bladder neck disorders (excl calculi)"	"Bladder disorders NEC"	"Urinary bladder haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"4734"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	4588170002	"hypercholestrolemia"	111	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516637264	""	""	""	NA	"Hypercholesterolemia"	"Metabolism and nutrition disorders"	"Lipid metabolism disorders"	"Elevated cholesterol"	"Hypercholesterolaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4735"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	3326155001	"INFECTION BLADDER"	128	138	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498502547	""	""	""	NA	"Infection bladder"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Cystitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4736"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	3325879001	"infection in left foot"	224	241	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498500774	""	""	""	NA	"Foot infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Localised infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4737"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	2870972001	"insomnia"	67	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484494485	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4738"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	2797556001	"Joint Pain"	17	23	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480617542	""	""	""	NA	"Joint pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4739"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	2797532001	"neutropenia"	17	32	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1480617318	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4740"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	2967096001	"neutropenia"	102	109	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488142975	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4741"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	2967117001	"obstruction GU"	116	116	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488143316	""	""	""	NA	"Urinary obstruction unspecified"	"Renal and urinary disorders"	"Genitourinary tract disorders NEC"	"Genital and urinary tract disorders NEC"	"Urinary tract obstruction"	""	""	""	""	""	""	""	""	""	""	""	""
"4742"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	2870993001	"obstruction, gu, bladder"	70	73	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484494997	""	""	""	NA	"Bladder obstruction"	"Renal and urinary disorders"	"Bladder and bladder neck disorders (excl calculi)"	"Bladder disorders NEC"	"Bladder obstruction"	""	""	""	""	""	""	""	""	""	""	""	""
"4743"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	2870985001	"pain, sinus"	67	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484494648	""	""	""	NA	"Sinus pain"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Sinus headache"	""	""	""	""	""	""	""	""	""	""	""	""
"4744"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	3008760001	"perforation, GU-urethra"	105	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Urologist is managing this problem"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489951906	""	""	""	NA	"Urethral perforation"	"Renal and urinary disorders"	"Urethral disorders (excl calculi)"	"Urethral disorders NEC"	"Urethral perforation"	""	""	""	""	""	""	""	""	""	""	""	""
"4745"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	3326172001	"SPASM BLADDER"	133	138	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498502610	""	""	""	NA	"Bladder spasm"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Bladder spasm"	""	""	""	""	""	""	""	""	""	""	""	""
"4746"	"DN-101 Protocol No. 011-007"	"155"	"155-0001"	5	9	"Adverse Event/Serious Adverse Event"	3459436001	"swelling left arm"	260	309	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"venous doppler to r/o dvt."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501089094	""	""	""	NA	"Swelling arm"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4747"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	2793723003	"anemia"	48	48	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516834441	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4748"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4760011002	"back pain"	363	370	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517761649	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4749"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	2852027001	"c-diff colitis"	40	56	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"obtain stool specimen, admitted to hospital, started on flagyl."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	48	NA	NA	48	56	"1.Positive stool specimen for C-Diff collected 02/01/2007; 2.Abnormal Chemistry Panel 02/01/2007 and on admission 04/01/2007 indicating dehydration; 3.Abnormal U/A indicating uti"	""	""	2	2	2	NA	2	2	NA	2	"Patient was seen by urologist for cystitis on 17/12/2006 and placed on Augmentin 500mg po bid. On 28/12/2006 patient was in clinic for cycle 2 of Docetaxel and had complaints of diarrhea related to"	"abx. Chemo was given according to schedule and orders. Pt started to experience exacerbation of the diarrhea with nausea and fever. He stated he had some blood in stools but that predated the chemo."	"Lab work proved the patient was not neutropenic and the doctor suspected this to be gastroenteritis or c-diff infection. He was placed on Flagyl. Blood Cultures were collected and the stool sample"	"and urine sample were brought to clinic on 03/01/2007. The patient remained somewhat stable at home on po fluids, flagyl, until the morning of 04/01/2007 when he became dizzy and fell. The wife"	"called 911 and the patient was taken to the ER. It was determined that he had dehydration requiring IV fluids and hospitalization. Pt discharged on January 12, 2007"	""	""	""	""	""	""	NA	NA	""	1483547370	""	""	""	NA	"C.difficile colitis"	"Infections and infestations"	"Bacterial infectious disorders"	"Clostridia infections"	"Clostridium difficile colitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4750"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4585775002	"Cough"	280	291	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516631428	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4751"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	2851868001	"cystitis/psudomonas"	22	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Patient was seen by urologist on 12/17/2006 for complaints of hematuria, after he had provided a specimen the patient was put on augmentin 500 mg po bid starting on 12/17/06 for 10 days."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483546589	""	""	""	NA	"Cystitis pseudomonal"	"Infections and infestations"	"Bacterial infectious disorders"	"Pseudomonal infections"	"Cystitis pseudomonal"	""	""	""	""	""	""	""	""	""	""	""	""
"4752"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4632492002	"dehydration"	46	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516832863	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"4753"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	5144343002	"DVT left femoral"	95	96	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521469636	""	""	""	NA	"Deep venous thrombosis femoral"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4754"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	3325282001	"ecchymosis both arms"	199	341	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498495792	""	""	""	NA	"Ecchymosis"	"Skin and subcutaneous tissue disorders"	"Skin vascular abnormalities"	"Purpura and related conditions"	"Ecchymosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4755"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4585862002	"Fatigue"	48	56	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516631691	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4756"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4585763002	"Fever"	280	285	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516631369	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"4757"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4516911002	"fever"	400	411	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	400	NA	NA	400	411	"Ct scans. Indium body scan."	""	""	2	2	2	2	2	2	2	2	"Patient was admitted to hospital with fever. During this hospitalization the patient had an indium scan which showed uptake throughout the bone marrow. He was started on antiobiotic therapy with"	"Zyvox and Amikacin. He was discharged and referred to hospice. Patient will complete 9 cycles of radiation while on hospice."	""	""	""	""	""	""	""	""	""	NA	NA	""	1516139905	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"4758"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4633029002	"fever"	44	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516835056	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"4759"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4575533002	"fever"	363	370	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	363	NA	NA	363	370	"CT Scan of Abdomen, Blood Cultures, Indium Scan, Blood Transfusion, Antibiotic Therapy, ECHO Cardiogram"	""	""	2	2	2	NA	2	2	NA	2	"Patient was admitted with 103 temperature, low back pain and chills. CT Scan showed no evidence of pneumonia. ECHO Cardiogram showed no vegitative growth. Patient's Port-A-Cath was removed in hopes"	"of being the source of infection. Patient was discharged home in good condition."	""	""	""	""	""	""	""	""	""	NA	NA	""	1516567310	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"4760"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	3057489001	"hemoglobin decreased"	95	385	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491328087	""	""	""	NA	"Hemoglobin decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"Red blood cell analyses"	"Haemoglobin decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4761"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4585966002	"Hoarseness"	40	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516631941	""	""	""	NA	"Hoarseness"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dysphonia"	""	""	""	""	""	""	""	""	""	""	""	""
"4762"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	3554096001	"neutropenic fever"	265	268	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	265	NA	NA	265	268	"Lab, blood cultures"	""	""	2	2	2	NA	2	2	2	2	"PT CAME TO CLINIC ON 8/8/07 FOR CBC AND IT SHOWED ANC ON 500. ON 8/9/2007 PT BECAME FEBRILE AND CAME TO CLINIC, HE WAS ADMITTED TO HOSPITAL FOR IV ABX AND FLUIDS. HE WAS DISCHARGED ON 8/12 WITH GOOD"	"COUNTS AND NO FEVER, DISCHARGE SUMMARY PENDING."	""	""	""	""	""	""	""	""	""	NA	NA	""	1503261888	""	""	""	NA	"Neutropenic fever"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4763"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4585948002	"Nose Bleed"	40	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516631898	""	""	""	NA	"Nose bleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"4764"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4516568002	"pain, right quadrant"	387	397	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	387	NA	NA	387	398	"Cystoscopy. Replacement of bilateral ureteral stents."	""	""	2	2	2	NA	2	2	NA	2	"Patient admitted to hospital with right upper quadrant pain. No discharge summary is available at this time."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516139220	""	""	""	NA	"Pain right upper quadrant"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"4765"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4585917002	"Renal Failure"	48	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516631820	""	""	""	NA	"Renal failure"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure"	""	""	""	""	""	""	""	""	""	""	""	""
"4766"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4585690002	"Skin Fragility"	199	312	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516630942	""	""	""	NA	"Skin fragility"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin fragility"	""	""	""	""	""	""	""	""	""	""	""	""
"4767"	"DN-101 Protocol No. 011-007"	"155"	"155-0002"	5	9	"Adverse Event/Serious Adverse Event"	4585888002	"Weakness"	46	73	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516631751	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4768"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	2917064003	"bilateral ankle edema"	324	352	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521401439	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4769"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138125002	"bilateral shins red/burning"	324	352	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521401362	""	""	""	NA	"Skin reaction"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin reaction"	""	""	""	""	""	""	""	""	""	""	""	""
"4770"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138247002	"cough"	107	111	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521401657	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4771"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138289002	"fatigue"	51	72	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521401773	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4772"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	3293240001	"hyperglycemia"	135	303	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"dexamethasone decreased to 4mg as pre med for chemo"	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497550702	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4773"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138197002	"hyperpigmentation neck/fingernails"	282	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521401512	""	""	""	NA	"Hyperpigmentation skin"	"Skin and subcutaneous tissue disorders"	"Pigmentation disorders"	"Hyperpigmentation disorders"	"Skin hyperpigmentation"	""	""	""	""	""	""	""	""	""	""	""	""
"4774"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138450002	"hypokalemia"	177	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521402243	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4775"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	3086059001	"hypokalemia"	72	93	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492121471	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4776"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138112002	"neuropathy fingers"	310	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521401297	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4777"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138542002	"neutropenia"	184	191	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521402572	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4778"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138555002	"neutropenia"	226	233	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521402614	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4779"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	2953031001	"neutropenia"	16	23	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487516670	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4780"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138530002	"neutropenia"	163	170	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521402528	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4781"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138471002	"neutropenia"	58	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521402302	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4782"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138482002	"neutropenia"	122	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521402345	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4783"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138564002	"neutropenia"	247	254	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521402653	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4784"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138513002	"neutropenia"	142	149	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521402471	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4785"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138033002	"polyphagia"	156	177	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521401015	""	""	""	NA	"Polyphagia"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Hyperphagia"	""	""	""	""	""	""	""	""	""	""	""	""
"4786"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138053002	"polyuria"	156	177	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521401115	""	""	""	NA	"Polyuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Polyuria"	""	""	""	""	""	""	""	""	""	""	""	""
"4787"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138360002	"rash fungal"	16	352	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521401988	""	""	""	NA	"Fungal rash"	"Infections and infestations"	"Fungal infectious disorders"	"Fungal infections NEC"	"Fungal rash"	""	""	""	""	""	""	""	""	""	""	""	""
"4788"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138221002	"right ingrown toe nail"	198	219	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521401602	""	""	""	NA	"Ingrown toe nail"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Ingrowing nail"	""	""	""	""	""	""	""	""	""	""	""	""
"4789"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	2953025001	"uticaria on neck/shoulders"	16	352	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487516520	""	""	""	NA	"Urticaria"	"Skin and subcutaneous tissue disorders"	"Angioedema and urticaria"	"Urticarias"	"Urticaria"	""	""	""	""	""	""	""	""	""	""	""	""
"4790"	"DN-101 Protocol No. 011-007"	"155"	"155-0004"	5	9	"Adverse Event/Serious Adverse Event"	5138085002	"watery eyes"	240	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521401217	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4791"	"DN-101 Protocol No. 011-007"	"155"	"155-0010"	5	9	"Adverse Event/Serious Adverse Event"	3350301003	"DEHYDRATION"	38	50	NA	5	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	4	0	NA	0	12	NA	NA	1	1	NA	NA	NA	""	39	50	2	38	48	"CBC, CMP, U/A ON 08/06/2007"	""	""	2	2	2	NA	2	2	NA	2	"PT HAD CYCLE 2 OF DOCETAXEL ON 7/27/2007 ON 8/6/07 THE PATIENT WAS ADMITTED TO HOSPITAL FOR WHAT APPEARS TO BE DEHYDRATION SECONDARY TO DIARRHEA, HOWEVER SEVERAL TESTS ARE BEING ORDERED TO ASSESS THE"	"CONDITION OF THE PATIENT.;;DISCHARGE SUMMARY FROM HOSPITALIZATION DATED 8/16/2007 STATES THE PATIENT'S DEHYDRATION LEAD TO WEAKNESS AND ANOREXIA THE DIARRRHEA HE HAD DID RESOLVE HOWEVER BECAUSE OF"	"THE PATIENT'S CONDITION IT WAS DECIDED TO TRANSFER THE PATIENT TO THE INPATIENT UNIT AT WICHITA FALLS SO TO BE CLOSER TO HIS DAUGHTER AND FAMILY. PATIENT EXPIRED ON 8/18/2007 AT THE INPATIENT HOSPICE"	"UNIT."	""	""	""	""	""	""	""	NA	NA	""	1502141717	""	""	""	NA	"Dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"4792"	"DN-101 Protocol No. 011-007"	"155"	"155-0010"	5	9	"Adverse Event/Serious Adverse Event"	5268048002	"Diarrhea"	38	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522962979	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4793"	"DN-101 Protocol No. 011-007"	"155"	"155-0010"	5	9	"Adverse Event/Serious Adverse Event"	4688593002	"high BUN"	38	50	NA	3	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517260047	""	""	""	NA	"BUN increased"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood urea increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4794"	"DN-101 Protocol No. 011-007"	"155"	"155-0010"	5	9	"Adverse Event/Serious Adverse Event"	4688361002	"high creatinine"	38	50	NA	3	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517259591	""	""	""	NA	"Creatinine high"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4795"	"DN-101 Protocol No. 011-007"	"155"	"155-0010"	5	9	"Adverse Event/Serious Adverse Event"	4688545002	"high magnesium"	38	50	NA	3	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517259937	""	""	""	NA	"Magnesium high"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood magnesium increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4796"	"DN-101 Protocol No. 011-007"	"155"	"155-0010"	5	9	"Adverse Event/Serious Adverse Event"	3421717001	"joint pain"	13	17	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500229535	""	""	""	NA	"Joint pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4797"	"DN-101 Protocol No. 011-007"	"155"	"155-0010"	5	9	"Adverse Event/Serious Adverse Event"	4687907002	"neutropenia"	35	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517258833	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4798"	"DN-101 Protocol No. 011-007"	"155"	"155-0012"	5	9	"Adverse Event/Serious Adverse Event"	3813371003	"Anemia"	64	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521665517	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4799"	"DN-101 Protocol No. 011-007"	"155"	"155-0012"	5	9	"Adverse Event/Serious Adverse Event"	5184448002	"Cold intolerance"	29	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521665297	""	""	""	NA	"Cold intolerance"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Temperature intolerance"	""	""	""	""	""	""	""	""	""	""	""	""
"4800"	"DN-101 Protocol No. 011-007"	"155"	"155-0012"	5	9	"Adverse Event/Serious Adverse Event"	5184353002	"Constipation"	50	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521665106	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4801"	"DN-101 Protocol No. 011-007"	"155"	"155-0012"	5	9	"Adverse Event/Serious Adverse Event"	5184323002	"Fatigue"	8	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521665055	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4802"	"DN-101 Protocol No. 011-007"	"155"	"155-0012"	5	9	"Adverse Event/Serious Adverse Event"	5184543002	"Mucousitis / Stomatitis"	64	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521665482	""	""	""	NA	"Stomatitis"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4803"	"DN-101 Protocol No. 011-007"	"155"	"155-0012"	5	9	"Adverse Event/Serious Adverse Event"	5184497002	"Neuropathy"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521665411	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4804"	"DN-101 Protocol No. 011-007"	"155"	"155-0012"	5	9	"Adverse Event/Serious Adverse Event"	5184420002	"Pain-back"	8	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521665249	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4805"	"DN-101 Protocol No. 011-007"	"155"	"155-0012"	5	9	"Adverse Event/Serious Adverse Event"	5184399002	"Pain-joints"	8	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521665205	""	""	""	NA	"Aching joints"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4806"	"DN-101 Protocol No. 011-007"	"155"	"155-0012"	5	9	"Adverse Event/Serious Adverse Event"	5184376002	"Pain-legs"	8	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521665163	""	""	""	NA	"Pain legs"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"4807"	"DN-101 Protocol No. 011-007"	"155"	"155-0012"	5	9	"Adverse Event/Serious Adverse Event"	5184470002	"Shortness of breath"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521665337	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4808"	"DN-101 Protocol No. 011-007"	"155"	"155-0012"	5	9	"Adverse Event/Serious Adverse Event"	5184485002	"Weakness"	8	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521665374	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4809"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	2744899003	"Cough"	103	109	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485377126	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4810"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	3537667001	"Fall"	303	303	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalized after falling. Nursing home sent pt to ER after fall and pt was admitted for further testing."	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	308	NA	NA	303	314	"CXR: Pneumonia, End-stage Prostate Cancer 8/21/2007"	""	""	2	2	2	NA	2	2	NA	2	"8/10/07 Took Ativan, fell and struck his chin, requiring steri strips.	;Hospitalization was for further evaluation to rule out sepsis.;See additional SAE of Pneumonia which developed while an"	"inpatient and prolonged this hospitalization."	""	""	""	""	""	""	""	""	""	NA	NA	""	1502834250	""	""	""	NA	"Fall"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Non-site specific injuries NEC"	"Fall"	""	""	""	""	""	""	""	""	""	""	""	""
"4811"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	3496616001	"Fecal Impaction"	292	297	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	299	NA	NA	293	297	"Multiple abdomen 8/1/07, Ultrasound Abdomen 8/1/07, CT Abdomen/pelvis 8/2/07, Chemistry 7/31/07, CBC 7/31/07"	""	""	2	2	2	NA	2	2	NA	2	"Patient went to local emergency room with complaints of abdominal pain.  Diagnosed with Fecal impaction and Urinary Tract Infection.  Immediately treated to remove fecal impaction.  Treated with"	"antibiotics for Urinary Tract Infection.  Abdomial studies also found significant metastises to the liver."	""	""	""	""	""	""	""	""	""	NA	NA	""	1502118483	""	""	""	NA	"Fecal impaction"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Faecal abnormalities NEC"	"Faecaloma"	""	""	""	""	""	""	""	""	""	""	""	""
"4812"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	3584313001	"Mental Status change/Confusion"	303	314	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalization.  Not an SAE, but related to the SAE hospitalization for the FALL."	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503929717	""	""	""	NA	"Mental confusion"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Confusion and disorientation"	"Confusional state"	""	""	""	""	""	""	""	""	""	""	""	""
"4813"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	2972658001	"Mucositis, oral"	140	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488383099	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4814"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	4662178002	"Pneumonia"	305	315	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"Pneumonia developed during hospitalization for Fall."	308	NA	NA	303	314	"Series of chest x-rays"	""	""	2	2	2	NA	2	2	NA	2	"Pneumonia developed during hospitalization from fall"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517169011	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"4815"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	2991966001	"Pruritis/Itching"	148	152	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489325622	""	""	""	NA	"Itching"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Pruritus NEC"	"Pruritus"	""	""	""	""	""	""	""	""	""	""	""	""
"4816"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	2945491001	"Upper Respiratory Infection"	127	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1487178632	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4817"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	2896205001	"Upper Respiratory Infection"	103	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485377358	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4818"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	3372195001	"Urinary Tract Infection"	264	293	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499373645	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4819"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	3496652001	"Urinary Tract Infection"	293	297	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	299	NA	NA	293	297	"Urinalysis with culture and sensitivity"	""	""	2	2	2	NA	2	2	NA	2	"Upon visit to emergency room with complaints of abdominal pain, patient was diagnosed with a urinary tract infection (in addition to a fecal impaction).  Treated with IV antibiotics.	Continues to"	"have an indwelling catheter."	""	""	""	""	""	""	""	""	""	NA	NA	""	1502118828	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4820"	"DN-101 Protocol No. 011-007"	"156"	"156-0001"	5	9	"Adverse Event/Serious Adverse Event"	3160989001	"Worsening of Urinary Retention"	198	315	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493925033	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"4821"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	2799095003	"Anemia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485110687	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4822"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	2886604001	"Anxiety"	49	NA	1	2	2	NA	1	NA	NA	NA	0	NA	NA	5	1	NA	1	"Prednisone decreased to daily on 1/24/2007.  Initial adverse event recorded/initiated on 1/17/2007 when con med added."	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485110751	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"4823"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	4684324002	"Cough"	41	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517251001	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4824"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	4682208002	"Dizziness"	35	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517246686	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"4825"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	4684376002	"Dysphagia"	341	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517251163	""	""	""	NA	"Dysphagia"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Dysphagia"	""	""	""	""	""	""	""	""	""	""	""	""
"4826"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	4681496002	"Fatigue"	70	NA	1	3	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"Admitted to Hospice"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517245470	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4827"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	2854406001	"Fatigue"	34	69	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Flomax, Norvasc, and ASA discontinued due to dizziness and stomach irritation."	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483565560	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4828"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	2897401001	"Insomnia"	55	70	NA	2	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485458135	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4829"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	2897406001	"Labored Breathing"	55	70	NA	2	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485458221	""	""	""	NA	"Labored breathing"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4830"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	3358572001	"Pain/Musculoskeletal"	167	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499115587	""	""	""	NA	"Musculoskeletal pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4831"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	3171141001	"Pain/musculoskeletal"	122	167	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Patient is on follow-up and is no longer on any study medication due to PI's decision"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494343960	""	""	""	NA	"Musculoskeletal pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4832"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	2886515001	"Pedal/Ankle Edema"	43	57	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485110087	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4833"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	4682519002	"Unsteady Gait"	68	NA	1	3	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"Pt requested Hospice"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517247237	""	""	""	NA	"Unsteady gait"	"General disorders and administration site conditions"	"General system disorders NEC"	"Gait disturbances"	"Gait disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"4834"	"DN-101 Protocol No. 011-007"	"156"	"156-0002"	5	9	"Adverse Event/Serious Adverse Event"	2890399001	"Weight Loss"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485207969	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"4835"	"DN-101 Protocol No. 011-007"	"157"	"157-0002"	5	9	"Adverse Event/Serious Adverse Event"	2786733003	"Common Cold - nasopharyngitis"	23	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509288737	""	""	""	NA	"Common cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4836"	"DN-101 Protocol No. 011-007"	"157"	"157-0002"	5	9	"Adverse Event/Serious Adverse Event"	4534990002	"Discomfort in knees and other joints"	NA	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516218081	""	""	""	NA	"Discomfort in joints"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"4837"	"DN-101 Protocol No. 011-007"	"157"	"157-0002"	5	9	"Adverse Event/Serious Adverse Event"	3953903001	"Epistaxis (intermittent)"	65	NA	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509287168	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"4838"	"DN-101 Protocol No. 011-007"	"157"	"157-0002"	5	9	"Adverse Event/Serious Adverse Event"	3953920001	"Hematochezia"	65	307	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Consult  with GI specialist Dr. Washke"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509287305	""	""	""	NA	"Hematochezia"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Haematochezia"	""	""	""	""	""	""	""	""	""	""	""	""
"4839"	"DN-101 Protocol No. 011-007"	"157"	"157-0002"	5	9	"Adverse Event/Serious Adverse Event"	3954188001	"insonmia"	23	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509288806	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4840"	"DN-101 Protocol No. 011-007"	"157"	"157-0002"	5	9	"Adverse Event/Serious Adverse Event"	3953668001	"Left prepatellar bursitis"	23	170	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509285114	""	""	""	NA	"Prepatellar bursitis"	"Musculoskeletal and connective tissue disorders"	"Synovial and bursal disorders"	"Bursal disorders"	"Bursitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4841"	"DN-101 Protocol No. 011-007"	"157"	"157-0002"	5	9	"Adverse Event/Serious Adverse Event"	3954077001	"Mouth sores"	23	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509288255	""	""	""	NA	"Sores mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4842"	"DN-101 Protocol No. 011-007"	"157"	"157-0006"	5	9	"Adverse Event/Serious Adverse Event"	3259961003	"Aches and pains"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515525040	""	""	""	NA	"Ache"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4843"	"DN-101 Protocol No. 011-007"	"157"	"157-0006"	5	9	"Adverse Event/Serious Adverse Event"	3955751001	"Alopecia"	30	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509295177	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4844"	"DN-101 Protocol No. 011-007"	"157"	"157-0006"	5	9	"Adverse Event/Serious Adverse Event"	3955543001	"Fatigue"	7	9	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509294488	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4845"	"DN-101 Protocol No. 011-007"	"157"	"157-0006"	5	9	"Adverse Event/Serious Adverse Event"	4005614001	"Metallic taste in mouth"	140	165	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509996375	""	""	""	NA	"Taste metallic"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4846"	"DN-101 Protocol No. 011-007"	"157"	"157-0006"	5	9	"Adverse Event/Serious Adverse Event"	4428963002	"Pain in both thumbs"	147	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515527137	""	""	""	NA	"Pain in thumb"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"4847"	"DN-101 Protocol No. 011-007"	"157"	"157-0006"	5	9	"Adverse Event/Serious Adverse Event"	3955827001	"Paresthesias (sole of feet)"	72	198	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509295571	""	""	""	NA	"Paresthesia foot"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4848"	"DN-101 Protocol No. 011-007"	"157"	"157-0006"	5	9	"Adverse Event/Serious Adverse Event"	4005674001	"Runny nose"	140	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509996566	""	""	""	NA	"Runny nose"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Rhinorrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4849"	"DN-101 Protocol No. 011-007"	"157"	"157-0006"	5	9	"Adverse Event/Serious Adverse Event"	4427756002	"Swelling of feet"	198	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Doppler Ultrasound"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515525309	""	""	""	NA	"Swelling of feet"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4850"	"DN-101 Protocol No. 011-007"	"157"	"157-0006"	5	9	"Adverse Event/Serious Adverse Event"	3955513001	"Swollen left ankle"	7	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Doppler"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509294395	""	""	""	NA	"Ankles swollen"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint swelling"	""	""	""	""	""	""	""	""	""	""	""	""
"4851"	"DN-101 Protocol No. 011-007"	"157"	"157-0006"	5	9	"Adverse Event/Serious Adverse Event"	3955802001	"Watery eyes"	72	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Artificial tears"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509295442	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4852"	"DN-101 Protocol No. 011-007"	"157"	"157-0007"	5	9	"Adverse Event/Serious Adverse Event"	3644871003	"Constipation"	72	86	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516126257	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4853"	"DN-101 Protocol No. 011-007"	"157"	"157-0007"	5	9	"Adverse Event/Serious Adverse Event"	3923251001	"Dryness of lips"	47	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508788551	""	""	""	NA	"Dryness of lips"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Lip dry"	""	""	""	""	""	""	""	""	""	""	""	""
"4854"	"DN-101 Protocol No. 011-007"	"157"	"157-0007"	5	9	"Adverse Event/Serious Adverse Event"	4510542002	"Fatigue"	47	72	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516126507	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4855"	"DN-101 Protocol No. 011-007"	"157"	"157-0007"	5	9	"Adverse Event/Serious Adverse Event"	4510901002	"Head pain on left side behind ear"	117	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516127230	""	""	""	NA	"Head pain"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"4856"	"DN-101 Protocol No. 011-007"	"157"	"157-0007"	5	9	"Adverse Event/Serious Adverse Event"	4508269002	"Weakness"	62	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516120815	""	""	""	NA	"Weakness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4857"	"DN-101 Protocol No. 011-007"	"157"	"157-0007"	5	9	"Adverse Event/Serious Adverse Event"	4508175002	"Worsening back pain"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516120588	""	""	""	NA	"Back pain aggravated"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4858"	"DN-101 Protocol No. 011-007"	"159"	"159-0004"	5	9	"Adverse Event/Serious Adverse Event"	3224247003	"abdominal bloating"	49	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510445606	""	""	""	NA	"Abdominal bloating"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Abdominal distension"	""	""	""	""	""	""	""	""	""	""	""	""
"4859"	"DN-101 Protocol No. 011-007"	"159"	"159-0004"	5	9	"Adverse Event/Serious Adverse Event"	4032217001	"abdominal pain"	28	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510445508	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4860"	"DN-101 Protocol No. 011-007"	"159"	"159-0004"	5	9	"Adverse Event/Serious Adverse Event"	5194835002	"alopecia"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521757539	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4861"	"DN-101 Protocol No. 011-007"	"159"	"159-0004"	5	9	"Adverse Event/Serious Adverse Event"	4032214001	"dizziness"	26	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510445152	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"4862"	"DN-101 Protocol No. 011-007"	"159"	"159-0004"	5	9	"Adverse Event/Serious Adverse Event"	5194905002	"excessive gas"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521757847	""	""	""	NA	"Gas"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Flatulence"	""	""	""	""	""	""	""	""	""	""	""	""
"4863"	"DN-101 Protocol No. 011-007"	"159"	"159-0004"	5	9	"Adverse Event/Serious Adverse Event"	5194854002	"heartburn"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521757620	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"4864"	"DN-101 Protocol No. 011-007"	"159"	"159-0004"	5	9	"Adverse Event/Serious Adverse Event"	5194912002	"hot flashes"	28	49	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521757938	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"4865"	"DN-101 Protocol No. 011-007"	"159"	"159-0004"	5	9	"Adverse Event/Serious Adverse Event"	4032211001	"infusion reaction"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"infusion stopped, restarted at slower rate"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510445064	""	""	""	NA	"Infusion related reaction"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion related reaction"	""	""	""	""	""	""	""	""	""	""	""	""
"4866"	"DN-101 Protocol No. 011-007"	"159"	"159-0004"	5	9	"Adverse Event/Serious Adverse Event"	5194731002	"insomnia"	21	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521756851	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4867"	"DN-101 Protocol No. 011-007"	"159"	"159-0004"	5	9	"Adverse Event/Serious Adverse Event"	5194940002	"neutropenia, intermittent"	20	175	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521758480	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4868"	"DN-101 Protocol No. 011-007"	"159"	"159-0004"	5	9	"Adverse Event/Serious Adverse Event"	5194760002	"pain, right side of abdomen"	49	73	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521757045	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4869"	"DN-101 Protocol No. 011-007"	"159"	"159-0004"	5	9	"Adverse Event/Serious Adverse Event"	4032205001	"Stinging on IV site"	7	7	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"cold pack palced on IV site"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510444877	""	""	""	NA	"Infusion site stinging"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion site pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4870"	"DN-101 Protocol No. 011-007"	"159"	"159-0005"	5	9	"Adverse Event/Serious Adverse Event"	3913634003	"alopecia"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516304175	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4871"	"DN-101 Protocol No. 011-007"	"159"	"159-0005"	5	9	"Adverse Event/Serious Adverse Event"	4554816002	"Anemia"	50	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516305735	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4872"	"DN-101 Protocol No. 011-007"	"159"	"159-0005"	5	9	"Adverse Event/Serious Adverse Event"	4554559002	"bloating"	64	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516305290	""	""	""	NA	"Bloating"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Abdominal distension"	""	""	""	""	""	""	""	""	""	""	""	""
"4873"	"DN-101 Protocol No. 011-007"	"159"	"159-0005"	5	9	"Adverse Event/Serious Adverse Event"	4554496002	"Heartburn"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516305183	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"4874"	"DN-101 Protocol No. 011-007"	"159"	"159-0005"	5	9	"Adverse Event/Serious Adverse Event"	4554094002	"Intermittent Fatigue"	29	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516304450	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4875"	"DN-101 Protocol No. 011-007"	"159"	"159-0005"	5	9	"Adverse Event/Serious Adverse Event"	4553999002	"Nosebleed"	64	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516304271	""	""	""	NA	"Nosebleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"4876"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	3970171003	"alopecia"	47	66	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517353251	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4877"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716508002	"anxiety"	66	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517353329	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"4878"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4691047002	"blurry vision"	7	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517264356	""	""	""	NA	"Blurry vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"4879"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716535002	"chills"	66	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517353384	""	""	""	NA	"Chills"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"4880"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4715409002	"cough"	26	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517351328	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4881"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716329002	"cracking skin"	26	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517352909	""	""	""	NA	"Skin chapped"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Skin injuries and mechanical dermatoses"	"Skin chapped"	""	""	""	""	""	""	""	""	""	""	""	""
"4882"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716373002	"depression"	26	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517353004	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"4883"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716402002	"depression"	66	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517353058	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"4884"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716295002	"dry skin"	26	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517352848	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"4885"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4715872002	"Generalized body pain"	47	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517352114	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4886"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4690773002	"heartburn"	26	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517263816	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"4887"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716038002	"increased fatigue"	66	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517352432	""	""	""	NA	"Fatigue aggravated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4888"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716683002	"leg weakness"	66	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517353648	""	""	""	NA	"Weakness of limbs"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"4889"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716811002	"loose teeth"	40	55	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517353894	""	""	""	NA	"Loose tooth"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Dental disorders NEC"	"Loose tooth"	""	""	""	""	""	""	""	""	""	""	""	""
"4890"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716625002	"neuropathy"	66	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517353543	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4891"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4708960002	"neutropenia, intermittent"	20	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517343314	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4892"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4715960002	"Pain, head"	27	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517352296	""	""	""	NA	"Pain head"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"4893"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716094002	"Pain, lower back"	6	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517352525	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4894"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716709002	"painful joints"	66	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517353700	""	""	""	NA	"Painful joints"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4895"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4707882002	"shortness of breath"	26	NA	1	3	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517341894	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4896"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716252002	"skin sores"	26	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517352785	""	""	""	NA	"Skin ulcer"	"Skin and subcutaneous tissue disorders"	"Skin and subcutaneous tissue disorders NEC"	"Skin and subcutaneous tissue ulcerations"	"Skin ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"4897"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4715467002	"sore throat"	25	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517351412	""	""	""	NA	"Sore throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4898"	"DN-101 Protocol No. 011-007"	"159"	"159-0006"	5	9	"Adverse Event/Serious Adverse Event"	4716201002	"unsteady gait"	26	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517352716	""	""	""	NA	"Unsteady gait"	"General disorders and administration site conditions"	"General system disorders NEC"	"Gait disturbances"	"Gait disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"4899"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	2829603003	"atrophicgenetalia"	133	374	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511212917	""	""	""	NA	"Senile genital atrophy"	"Reproductive system and breast disorders"	"Menopause and related conditions"	"Menopausal effects on the genitourinary tract"	"Senile genital atrophy"	""	""	""	""	""	""	""	""	""	""	""	""
"4900"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	4103040001	"decreasing appetite"	113	374	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511212454	""	""	""	NA	"Decreased appetite"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"4901"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	4103211001	"fatigue"	133	374	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511212976	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4902"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	4103124001	"gynecomastia"	133	374	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511212757	""	""	""	NA	"Gynecomastia"	"Reproductive system and breast disorders"	"Breast disorders"	"Breast disorders NEC"	"Gynaecomastia"	""	""	""	""	""	""	""	""	""	""	""	""
"4903"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	4103263001	"hand-foot syndrome"	147	374	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511213076	""	""	""	NA	"Hand and foot syndrome"	"Skin and subcutaneous tissue disorders"	"Skin and subcutaneous tissue disorders NEC"	"Skin and subcutaneous conditions NEC"	"Palmar-plantar erythrodysaesthesia syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"4904"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	2971576001	"Paresthesia, left hand"	58	374	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488315097	""	""	""	NA	"Paresthesia hand"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4905"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	2971606001	"Paresthesia, right side of face"	64	67	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488316052	""	""	""	NA	"Facial paresthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4906"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	2904814001	"worsening Anemia"	49	374	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485908374	""	""	""	NA	"Anemia aggravated"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4907"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	4102985001	"worsening bone pain"	113	374	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511212232	""	""	""	NA	"Bone pain aggravated"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4908"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	4103100001	"worsening constipation"	113	374	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511212616	""	""	""	NA	"Constipation aggravated"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4909"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	4103148001	"worsening depression"	133	374	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511212828	""	""	""	NA	"Depression worsened"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"4910"	"DN-101 Protocol No. 011-007"	"161"	"161-0001"	5	9	"Adverse Event/Serious Adverse Event"	2872541001	"worsening Night sweats"	14	374	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484522332	""	""	""	NA	"Night sweats"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Night sweats"	""	""	""	""	""	""	""	""	""	""	""	""
"4911"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	2903639003	"Bilateral leg muscle aches"	22	26	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490045825	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4912"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	4021887001	"dyspnea"	156	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510170774	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4913"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	4021632001	"dyspnea, only upon exertion"	93	155	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510169497	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"4914"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	4021906001	"edema, bilateral legs"	156	NA	1	1	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510170861	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4915"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	3140112001	"Fatigue"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493333365	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4916"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	4021687001	"loss of taste"	93	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510169714	""	""	""	NA	"Loss of taste"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Ageusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4917"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	3140075001	"Loss of taste"	27	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493333184	""	""	""	NA	"Loss of taste"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Ageusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4918"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	3373318001	"mucositis, right side of mouth"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499384824	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4919"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	4021731001	"numbness, bilateral feet"	93	155	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510169924	""	""	""	NA	"Numbness in feet"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4920"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	4021923001	"numbness, fingers and soles of feet"	156	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510170954	""	""	""	NA	"Numbness in fingers"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4921"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	3380631001	"numbness, fingertips of right hand"	42	155	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499635009	""	""	""	NA	"Numbness in hand"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"4922"	"DN-101 Protocol No. 011-007"	"161"	"161-0002"	5	9	"Adverse Event/Serious Adverse Event"	3140191001	"urinary Incontinence-intermittent"	41	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493333763	""	""	""	NA	"Incontinence urinary"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"4923"	"DN-101 Protocol No. 011-007"	"161"	"161-0004"	5	9	"Adverse Event/Serious Adverse Event"	3841392003	"anemia"	96	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520448602	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4924"	"DN-101 Protocol No. 011-007"	"161"	"161-0004"	5	9	"Adverse Event/Serious Adverse Event"	5057887002	"blood tinged and nasal discharge"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520447806	""	""	""	NA	"Nasal mucus blood tinged"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"4925"	"DN-101 Protocol No. 011-007"	"161"	"161-0004"	5	9	"Adverse Event/Serious Adverse Event"	5057981002	"frontal headache"	12	30	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520448088	""	""	""	NA	"Frontal headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"4926"	"DN-101 Protocol No. 011-007"	"161"	"161-0004"	5	9	"Adverse Event/Serious Adverse Event"	5057948002	"increase bruisability over arms"	30	54	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520447997	""	""	""	NA	"Bruising of arm"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"4927"	"DN-101 Protocol No. 011-007"	"161"	"161-0004"	5	9	"Adverse Event/Serious Adverse Event"	5058089002	"loose bowel movements"	90	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520448467	""	""	""	NA	"Loose bowel"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4928"	"DN-101 Protocol No. 011-007"	"161"	"161-0004"	5	9	"Adverse Event/Serious Adverse Event"	5058075002	"myalgia"	90	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520448398	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4929"	"DN-101 Protocol No. 011-007"	"161"	"161-0004"	5	9	"Adverse Event/Serious Adverse Event"	4010493001	"neutropenia"	13	18	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510071499	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4930"	"DN-101 Protocol No. 011-007"	"161"	"161-0004"	5	9	"Adverse Event/Serious Adverse Event"	5058152002	"neutropenia"	54	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520448666	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4931"	"DN-101 Protocol No. 011-007"	"161"	"161-0004"	5	9	"Adverse Event/Serious Adverse Event"	3996113001	"neutropenia"	8	9	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"labs repeated on 10/12/07"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509904888	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4932"	"DN-101 Protocol No. 011-007"	"161"	"161-0004"	5	9	"Adverse Event/Serious Adverse Event"	5058027002	"suprabubic and pelvic pain"	47	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520448249	""	""	""	NA	"Pelvic pain"	"Reproductive system and breast disorders"	"Reproductive tract disorders NEC"	"Reproductive tract signs and symptoms NEC"	"Pelvic pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4933"	"DN-101 Protocol No. 011-007"	"161"	"161-0004"	5	9	"Adverse Event/Serious Adverse Event"	5058043002	"uri"	47	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520448314	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4934"	"DN-101 Protocol No. 011-007"	"164"	"164-0001"	5	9	"Adverse Event/Serious Adverse Event"	2960164003	"Alopecia"	50	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507067693	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4935"	"DN-101 Protocol No. 011-007"	"164"	"164-0001"	5	9	"Adverse Event/Serious Adverse Event"	3792418001	"Altered Taste"	92	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506895408	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4936"	"DN-101 Protocol No. 011-007"	"164"	"164-0001"	5	9	"Adverse Event/Serious Adverse Event"	3807001001	"Arm Bruised - Right & Left"	190	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507062295	""	""	""	NA	"Bruising of arm"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"4937"	"DN-101 Protocol No. 011-007"	"164"	"164-0001"	5	9	"Adverse Event/Serious Adverse Event"	3792430001	"Bilateral Blurred Vision"	191	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506895831	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"4938"	"DN-101 Protocol No. 011-007"	"164"	"164-0001"	5	9	"Adverse Event/Serious Adverse Event"	3792398001	"Fatigue"	92	NA	1	3	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"Patient discontinued from study due to this AE, PI concurred."	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506895112	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4939"	"DN-101 Protocol No. 011-007"	"164"	"164-0001"	5	9	"Adverse Event/Serious Adverse Event"	3792448001	"Lack of Appetite (secondary to Altered Taste)"	92	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506896124	""	""	""	NA	"Appetite decreased NOS"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"4940"	"DN-101 Protocol No. 011-007"	"164"	"164-0001"	5	9	"Adverse Event/Serious Adverse Event"	3792424001	"Leukocytosis, intermittent"	113	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506895635	""	""	""	NA	"Leukocytosis"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukocytoses NEC"	"Leukocytosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4941"	"DN-101 Protocol No. 011-007"	"164"	"164-0001"	5	9	"Adverse Event/Serious Adverse Event"	3792378001	"Rash - Upper Extremities"	61	189	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506894883	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"4942"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3030697003	"Altered Taste"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505312640	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"4943"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3682445001	"Bilateral Dry Eyes (Conjuctivities)"	123	200	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505316632	""	""	""	NA	"Conjunctivitis"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Conjunctival infections, irritations and inflammations"	"Conjunctivitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4944"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3800504001	"Constipation, intermittent (post Chemo treatment)"	54	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507037859	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4945"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3681678001	"Dizziness"	55	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505313459	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"4946"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3920138001	"Edema in Extremities"	200	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508774511	""	""	""	NA	"Edema extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4947"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3681611001	"Fatigue"	35	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505313037	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4948"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3681513001	"Flu-Like Symptoms"	15	19	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505312384	""	""	""	NA	"Flu-like symptoms"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Influenza like illness"	""	""	""	""	""	""	""	""	""	""	""	""
"4949"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3800521001	"Fungal Infection right mid fingernail"	131	169	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507038050	""	""	""	NA	"Fungal infection of nail"	"Infections and infestations"	"Fungal infectious disorders"	"Fungal infections NEC"	"Onychomycosis"	""	""	""	""	""	""	""	""	""	""	""	""
"4950"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3800538001	"Insomnia"	96	101	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507038193	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"4951"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3681572001	"Mouth Sores"	16	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505312850	""	""	""	NA	"Sores mouth"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4952"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3681627001	"Muscle Aches, intermittent"	35	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505313163	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4953"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3919988001	"Peripheral Neuropathy"	200	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508774150	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4954"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3681530001	"Poor Appetite"	15	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505312485	""	""	""	NA	"Appetite decreased NOS"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"4955"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3920093001	"Right Knee Pain"	200	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508774401	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4956"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3920002001	"Shortness Of Breath"	200	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508774209	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"4957"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3920121001	"tachycardia"	200	NA	1	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508774455	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"4958"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3681903001	"Urethra Yeast Infection"	122	157	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505314210	""	""	""	NA	"Urethral infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urethritis"	""	""	""	""	""	""	""	""	""	""	""	""
"4959"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3920029001	"Watering Eyes"	200	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508774265	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"4960"	"DN-101 Protocol No. 011-007"	"164"	"164-0004"	5	9	"Adverse Event/Serious Adverse Event"	3800526001	"Worsening of Headaches (post chemo treatment)"	54	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507038124	""	""	""	NA	"Headache aggravated"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"4961"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	3119360003	"alopecia"	172	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517255203	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4962"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	4686271002	"anemia"	150	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517255288	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4963"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	4686150002	"arrhythmia"	193	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517255041	""	""	""	NA	"Arrhythmia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Arrhythmia"	""	""	""	""	""	""	""	""	""	""	""	""
"4964"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	3681466001	"Bilateral hip Pain"	122	235	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505311970	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4965"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	4686047002	"constipation"	193	214	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517254791	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4966"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	3799066001	"Constipation - worsening from Baseline"	21	24	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506977908	""	""	""	NA	"Constipation aggravated"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4967"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	3681348001	"Diverticulitis"	21	40	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505310792	""	""	""	NA	"Diverticulitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Diverticulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"4968"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	3681414001	"Dyspnea (with activity only)"	47	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505311526	""	""	""	NA	"Dyspnea exertional"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea exertional"	""	""	""	""	""	""	""	""	""	""	""	""
"4969"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	3921381001	"Edema"	152	235	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508778739	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"4970"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	3681411001	"Fatigue"	47	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505311394	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"4971"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	4686336002	"leukopenia"	164	171	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517255399	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4972"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	4686197002	"motor neuropathy"	214	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517255146	""	""	""	NA	"Motor peripheral neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral motor neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"4973"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	4686299002	"neutropenia"	164	171	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517255344	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4974"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	3681419001	"Urinary Frequency worsening from baseline"	68	152	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505311655	""	""	""	NA	"Urinary frequency aggravated"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"4975"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	3681299001	"Urinary Tract Infection"	20	30	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505310579	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"4976"	"DN-101 Protocol No. 011-007"	"164"	"164-0005"	5	9	"Adverse Event/Serious Adverse Event"	3921442001	"Wheezing"	152	235	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508778944	""	""	""	NA	"Wheezing"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Wheezing"	""	""	""	""	""	""	""	""	""	""	""	""
"4977"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	2979987003	"anemia"	29	244	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504705797	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4978"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	3630868001	"arthralgia"	181	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504638556	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4979"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	3974612001	"bilateral lower extremity edema"	192	202	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509471494	""	""	""	NA	"Edema of lower extremities"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"4980"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	4431246002	"cataract of left eye"	NA	230	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515530601	""	""	""	NA	"Left cataract"	"Eye disorders"	"Anterior eye structural change, deposit and degeneration"	"Cataract conditions"	"Cataract"	""	""	""	""	""	""	""	""	""	""	""	""
"4981"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	3631345001	"depression"	155	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504639892	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"4982"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	3121945001	"muscle cramping of feet"	31	245	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493043163	""	""	""	NA	"Cramp muscle"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"4983"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	3181081001	"neutropenia"	63	244	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494519585	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"4984"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	3289635001	"right paravertebral pain"	49	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497459139	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"4985"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	4441675002	"severe left leg pain"	242	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515597277	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"4986"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	3630127001	"subtle left hip fracture related to injury"	98	272	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504636888	""	""	""	NA	"Hip fracture"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Lower limb fractures and dislocations"	"Hip fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"4987"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	3121781001	"urinary retention"	7	7	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"foley catheter insertion for that day"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493042270	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"4988"	"DN-101 Protocol No. 011-007"	"165"	"165-0001"	5	9	"Adverse Event/Serious Adverse Event"	3630432001	"worsening hoarseness"	70	92	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504637554	""	""	""	NA	"Hoarseness"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dysphonia"	""	""	""	""	""	""	""	""	""	""	""	""
"4989"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3245624003	"aching joints"	69	125	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506966391	""	""	""	NA	"Aching joints"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"4990"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3979877001	"alopecia"	26	191	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509547413	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"4991"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3796965001	"anemia"	12	152	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506966897	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"4992"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3482699001	"constipation"	57	59	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501682699	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"4993"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3797071001	"cough"	128	152	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506967564	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"4994"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3981009001	"decreased concentration"	152	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509553542	""	""	""	NA	"Mental concentration decreased"	"Nervous system disorders"	"Mental impairment disorders"	"Mental impairment (excl dementia and memory loss)"	"Disturbance in attention"	""	""	""	""	""	""	""	""	""	""	""	""
"4995"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3956378001	"dry mouth"	135	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509298498	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"4996"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3797095001	"early satiety"	111	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506967682	""	""	""	NA	"Early satiety"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Early satiety"	""	""	""	""	""	""	""	""	""	""	""	""
"4997"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3796890001	"equilibrium off"	69	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506966491	""	""	""	NA	"Equilibrium trouble"	"Nervous system disorders"	"Neurological disorders NEC"	"Cerebellar coordination and balance disturbances"	"Balance disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"4998"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3482692001	"gas / bloating"	60	191	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501682608	""	""	""	NA	"Bloating"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Flatulence, bloating and distension"	"Abdominal distension"	""	""	""	""	""	""	""	""	""	""	""	""
"4999"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3482656001	"heart burn"	33	47	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501682401	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"5000"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3797132001	"hoarseness"	129	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506967799	""	""	""	NA	"Hoarseness"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dysphonia"	""	""	""	""	""	""	""	""	""	""	""	""
"5001"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3980960001	"increased anxiety"	152	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509553282	""	""	""	NA	"Anxiety"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Anxiety"	""	""	""	""	""	""	""	""	""	""	""	""
"5002"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3980915001	"increased confusion"	152	161	NA	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509553148	""	""	""	NA	"Confusion aggravated"	"Psychiatric disorders"	"Deliria (incl confusion)"	"Confusion and disorientation"	"Confusional state"	""	""	""	""	""	""	""	""	""	""	""	""
"5003"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3482677001	"increased fatigue"	51	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501682530	""	""	""	NA	"Fatigue aggravated"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5004"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3797014001	"left upper quadrant pain"	111	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506967126	""	""	""	NA	"Left upper quadrant pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"5005"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3979950001	"malaise"	69	94	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509548072	""	""	""	NA	"Malaise"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Malaise"	""	""	""	""	""	""	""	""	""	""	""	""
"5006"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3980081001	"neuropathy"	152	NA	1	2	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509549255	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"5007"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3796997001	"neuropathy"	69	152	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506967028	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"5008"	"DN-101 Protocol No. 011-007"	"165"	"165-0002"	5	9	"Adverse Event/Serious Adverse Event"	3956510001	"tremors"	134	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509299035	""	""	""	NA	"Tremor"	"Nervous system disorders"	"Movement disorders (incl Parkinsonism)"	"Tremor (excl congenital)"	"Tremor"	""	""	""	""	""	""	""	""	""	""	""	""
"5009"	"DN-101 Protocol No. 011-007"	"165"	"165-0003"	5	9	"Adverse Event/Serious Adverse Event"	3264485003	"abdominal pain"	51	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502300401	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5010"	"DN-101 Protocol No. 011-007"	"165"	"165-0003"	5	9	"Adverse Event/Serious Adverse Event"	3513242001	"hip pain"	51	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502300492	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5011"	"DN-101 Protocol No. 011-007"	"165"	"165-0003"	5	9	"Adverse Event/Serious Adverse Event"	3436405001	"intermittant constipation"	32	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500486137	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5012"	"DN-101 Protocol No. 011-007"	"165"	"165-0003"	5	9	"Adverse Event/Serious Adverse Event"	3436389001	"taste changes"	32	192	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500486030	""	""	""	NA	"Taste changed"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5013"	"DN-101 Protocol No. 011-007"	"170"	"170-0002"	5	9	"Adverse Event/Serious Adverse Event"	3301506003	"abdominal pain"	97	100	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hospitalization, endoscopy, echocardiogram"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	148	NA	NA	97	100	"esophagogastroduodenoscopy 08/31/2007 revealed mild antral gastritis and mild distal esophagitis"	""	""	2	2	2	NA	2	2	NA	2	"presented to ER with abdominal pain x 3-4 days. Patient with history of gastritis esophageal erosion and prostate cancer. Pain was intermittent. GI consult. EGD performed which revealed mild"	"antralgastritis and mild distal esophagitis.Medications were mildly modified to correct."	""	""	""	""	""	""	""	""	""	NA	NA	""	1508329673	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5014"	"DN-101 Protocol No. 011-007"	"170"	"170-0002"	5	9	"Adverse Event/Serious Adverse Event"	3896857001	"atrial fibrillation"	131	134	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hospitalization, chest xray for cardiac  risk stratification"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	148	NA	NA	131	134	"CIP's, chest xray for cardiac risk stratification, nuclear stress test revealed no evidence of ischemia, venous access placement on 10/03/2007"	""	""	2	2	2	NA	2	2	NA	0	"Patient presented for out patient venous access placement and developed chest discomfort with atrial fribrillation.Discomfort resolved with nitro and morphine. Patient was admitted for Cardiac Injury"	"Profile and cardiac risk stratification."	""	""	""	""	""	""	""	""	""	NA	NA	""	1508330164	""	""	""	NA	"Atrial fibrillation"	"Cardiac disorders"	"Cardiac arrhythmias"	"Supraventricular arrhythmias"	"Atrial fibrillation"	""	""	""	""	""	""	""	""	""	""	""	""
"5015"	"DN-101 Protocol No. 011-007"	"170"	"170-0002"	5	9	"Adverse Event/Serious Adverse Event"	3920925001	"billiary dyskinesia"	147	148	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	153	NA	NA	147	148	"laproscopic cholecystetomy, amylase elevated at 158, lipase within normal limits."	""	""	2	2	2	2	2	2	2	2	"Patient admitted overnight for laproscopic cholecystetomy due to recurrent nausea, vomiting and abdominal discomfort. Final diagnosis biliary dyskinesia."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508777037	""	""	""	NA	"Biliary dyskinesia"	"Hepatobiliary disorders"	"Gallbladder disorders"	"Gallbladder disorders NEC"	"Biliary dyskinesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5016"	"DN-101 Protocol No. 011-007"	"170"	"170-0002"	5	9	"Adverse Event/Serious Adverse Event"	3784524001	"epigastric abdominal pain"	63	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"was seen by his gastroenterologist, abdominal ultrasound"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506626335	""	""	""	NA	"Epigastric pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"5017"	"DN-101 Protocol No. 011-007"	"170"	"170-0002"	5	9	"Adverse Event/Serious Adverse Event"	3784303001	"hiccups"	27	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506624661	""	""	""	NA	"Hiccups"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Lower respiratory tract signs and symptoms"	"Hiccups"	""	""	""	""	""	""	""	""	""	""	""	""
"5018"	"DN-101 Protocol No. 011-007"	"170"	"170-0002"	5	9	"Adverse Event/Serious Adverse Event"	4136474001	"hypokalemia"	97	100	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511817211	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5019"	"DN-101 Protocol No. 011-007"	"170"	"170-0002"	5	9	"Adverse Event/Serious Adverse Event"	3896837001	"left ankle pain"	125	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"plain films\xray"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508329892	""	""	""	NA	"Pain ankle"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5020"	"DN-101 Protocol No. 011-007"	"170"	"170-0002"	5	9	"Adverse Event/Serious Adverse Event"	3784396001	"left sided flank pain"	27	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506625222	""	""	""	NA	"Flank pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Flank pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5021"	"DN-101 Protocol No. 011-007"	"170"	"170-0002"	5	9	"Adverse Event/Serious Adverse Event"	4136558001	"leukopenia"	97	100	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511817360	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5022"	"DN-101 Protocol No. 011-007"	"171"	"171-0001"	5	9	"Adverse Event/Serious Adverse Event"	3493184003	"Cardiac Arrest"	12	12	NA	5	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	4	0	NA	0	4	NA	NA	1	NA	NA	NA	NA	""	15	12	0	NA	NA	"None - Pt was found unresponsive at home in the bathroom"	""	""	2	2	2	NA	2	2	NA	2	"Office received call froma afamily member on Wednesday 8/16/2007 stating that the pt expired on 8/13/2007.  ;;The pt was found unresponsive by his wife in the bathroom. 911 was called and the EMT"	"explained to the family that this was a vasovagal syncope resulting in cardiac arrest and the pt was pronounced dead at the scene at home."	""	""	""	""	""	""	""	""	""	NA	NA	""	1517762093	""	""	""	NA	"Cardiac arrest"	"Cardiac disorders"	"Cardiac arrhythmias"	"Ventricular arrhythmias and cardiac arrest"	"Cardiac arrest"	""	""	""	""	""	""	""	""	""	""	""	""
"5023"	"DN-101 Protocol No. 011-007"	"171"	"171-0001"	5	9	"Adverse Event/Serious Adverse Event"	3541013001	"Vasovagal Syncope"	12	NA	1	4	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	0	16	NA	NA	NA	NA	1	NA	NA	""	15	NA	NA	NA	NA	"None - Pt found unresponsive at home in the bathroom"	""	""	2	2	2	NA	2	2	NA	2	"Office received a call from family member on Wednesday 8/16/2007 stating the pt expired on 8/13/2007. We cannot get any further information at this time.  Family is not responding to phone calls"	"today.	The pt spoke with a nurse here on Monday stating he was constipated only and otherwise fine. Pt was given instructions on constipation management and advised to call if not better in 24"	"hrs.;;Pt was foung unresponsive by his wife in the bathroom.  (11 was called and the EMT explained to the family that this was a Vasovagal syncope attack resulting in cardiac arrest and the pt was"	"pronouned dead at the home."	""	""	""	""	""	""	""	NA	NA	""	1502909344	""	""	""	NA	"Syncope vasovagal"	"Nervous system disorders"	"Neurological disorders NEC"	"Disturbances in consciousness NEC"	"Syncope vasovagal"	""	""	""	""	""	""	""	""	""	""	""	""
"5024"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	5	9	"Adverse Event/Serious Adverse Event"	2961623003	"alopecia"	27	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510846712	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5025"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	5	9	"Adverse Event/Serious Adverse Event"	3643900001	"bowel dysfunction"	9	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504795162	""	""	""	NA	"Bowel dysfunction"	"Gastrointestinal disorders"	"Gastrointestinal conditions NEC"	"Gastrointestinal disorders NEC"	"Intestinal functional disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5026"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	5	9	"Adverse Event/Serious Adverse Event"	3089372001	"bronchitis"	54	58	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hospitalized"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	55	NA	NA	54	58	"Sputum sent for culture."	""	""	2	2	2	NA	2	2	NA	2	"Pt presented to ER with cough with plegm.  Admitted to hospital with bronchitis +/- pneumonia."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492368583	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5027"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	5	9	"Adverse Event/Serious Adverse Event"	3643818001	"cheek redness"	7	9	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504794555	""	""	""	NA	"Redness"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"5028"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	5	9	"Adverse Event/Serious Adverse Event"	4316920001	"decreased calcium"	55	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513715381	""	""	""	NA	"Calcium decreased"	"Investigations"	"Water, electrolyte and mineral investigations"	"Mineral and electrolyte analyses"	"Blood calcium decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5029"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	5	9	"Adverse Event/Serious Adverse Event"	3089321001	"fatigue"	48	NA	1	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492368104	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5030"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	5	9	"Adverse Event/Serious Adverse Event"	3089406001	"febrile neutropenia"	54	58	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"hospitalized"	0	0	NA	1	40	NA	NA	NA	1	NA	1	NA	""	55	NA	NA	54	58	"CBC 04/15/07  WBC=1.3 ANC=494"	""	""	2	2	2	NA	2	2	NA	2	"Pt presented to ER with cough.	CBC revealed neutropenia.  Pt was hospitalized."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492368939	""	""	""	NA	"Febrile neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Febrile neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5031"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	5	9	"Adverse Event/Serious Adverse Event"	3089330001	"hiccups"	48	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492368176	""	""	""	NA	"Hiccups"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Lower respiratory tract signs and symptoms"	"Hiccups"	""	""	""	""	""	""	""	""	""	""	""	""
"5032"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	5	9	"Adverse Event/Serious Adverse Event"	4079810001	"hip pain"	97	127	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510846914	""	""	""	NA	"Pain in hip"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5033"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	5	9	"Adverse Event/Serious Adverse Event"	3089352001	"insomnia"	48	127	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492368328	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5034"	"DN-101 Protocol No. 011-007"	"173"	"173-0001"	5	9	"Adverse Event/Serious Adverse Event"	4079786001	"intermittent nausea"	99	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510846830	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"5035"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	3563041003	"acute apendicitis"	143	146	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	7	1	1	1	"SCT held for 1 cycle"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	146	NA	NA	146	149	"no additional relevant information"	""	""	2	2	2	NA	2	2	NA	2	"On his restaging CT scan of 18 DEC 2007 there was evidence of acute appendicitis with inflammatory enlargment of the appendix and surrounding periappendicieal inflammation.  There was no localized"	"abscess or perforation.  The patient stated that he was feeling somewhat unwell for a few days with a low grade fever, chills, loss of appetite, nausea and some low grade lower abdominal pain.  The"	"patient was admitted on 18 DEC 2007 and had an appendectomy on the same day.  His surgery was uncomplicated."	""	""	""	""	""	""	""	""	NA	NA	""	1518458713	""	""	""	NA	"Acute appendicitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Appendicitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5036"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	4221264001	"alopecia"	44	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512681264	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5037"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	4221391001	"Blurred vision"	32	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512681898	""	""	""	NA	"Blurred vision"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Vision blurred"	""	""	""	""	""	""	""	""	""	""	""	""
"5038"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	4221291001	"Fatigue"	32	46	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512681406	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5039"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	4221350001	"heartburn"	41	42	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512681618	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"5040"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	4927727002	"hives"	174	174	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519229321	""	""	""	NA	"Hives"	"Skin and subcutaneous tissue disorders"	"Angioedema and urticaria"	"Urticarias"	"Urticaria"	""	""	""	""	""	""	""	""	""	""	""	""
"5041"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	4221611001	"Irritability"	33	35	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512683275	""	""	""	NA	"Irritability"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Irritability"	""	""	""	""	""	""	""	""	""	""	""	""
"5042"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	4221652001	"Lymphopenia"	112	167	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512683651	""	""	""	NA	"Lymphopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Lymphopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5043"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	4221596001	"Myalgia"	32	34	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512683155	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5044"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	4221624001	"Palpitations"	32	32	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512683383	""	""	""	NA	"Palpitations"	"Cardiac disorders"	"Cardiac disorder signs and symptoms"	"Cardiac signs and symptoms NEC"	"Palpitations"	""	""	""	""	""	""	""	""	""	""	""	""
"5045"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	4221639001	"Rectal Bleeding"	42	74	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512683516	""	""	""	NA	"Rectal bleeding"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Intestinal haemorrhages"	"Rectal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"5046"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	4221359001	"skin irritation"	30	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"docetaxel rate decreased"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512681741	""	""	""	NA	"Skin irritation"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermatitis and eczema"	"Skin irritation"	""	""	""	""	""	""	""	""	""	""	""	""
"5047"	"DN-101 Protocol No. 011-007"	"180"	"180-0002"	5	9	"Adverse Event/Serious Adverse Event"	4221379001	"voice changes"	33	44	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512681819	""	""	""	NA	"Voice alteration"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dysphonia"	""	""	""	""	""	""	""	""	""	""	""	""
"5048"	"DN-101 Protocol No. 011-007"	"181"	"181-0002"	5	9	"Adverse Event/Serious Adverse Event"	3244930003	"Alopecia"	27	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502818542	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5049"	"DN-101 Protocol No. 011-007"	"181"	"181-0002"	5	9	"Adverse Event/Serious Adverse Event"	4388308001	"Constipation"	222	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515102222	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5050"	"DN-101 Protocol No. 011-007"	"181"	"181-0002"	5	9	"Adverse Event/Serious Adverse Event"	3534955001	"fatigue"	69	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502818656	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5051"	"DN-101 Protocol No. 011-007"	"181"	"181-0002"	5	9	"Adverse Event/Serious Adverse Event"	3379230001	"hyperglycemia, intermitten"	27	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499628060	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5052"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	2858542003	"alterations in taste"	133	252	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509468146	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5053"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	3251782001	"ankle pain"	70	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496240902	""	""	""	NA	"Pain ankle"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5054"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	2889149001	"arthralgias"	10	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485192019	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5055"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	3080852001	"fatigue"	28	252	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492023975	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5056"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	2889164001	"flu- like syndrome"	10	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485192287	""	""	""	NA	"Flu like symptoms"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Influenza like illness"	""	""	""	""	""	""	""	""	""	""	""	""
"5057"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	2977818001	"intermittent arthralgias"	31	252	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488735823	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5058"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	2977815001	"intermittent flu like syndrome"	31	252	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488735745	""	""	""	NA	"Flu like symptoms"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Influenza like illness"	""	""	""	""	""	""	""	""	""	""	""	""
"5059"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	2977828001	"intermittent myalgias"	31	252	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488735976	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5060"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	3782414001	"left necrosis of jaw"	232	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"discontinued zometa"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506615091	""	""	""	NA	"Aseptic necrosis of jaw"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone disorders NEC"	"Osteonecrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5061"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	2889155001	"myalgias"	10	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1485192190	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5062"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	3251788001	"nail changes"	118	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496240977	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5063"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	2977801001	"nosebleeds"	12	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488735486	""	""	""	NA	"Nosebleed"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"5064"	"DN-101 Protocol No. 011-007"	"184"	"184-0001"	5	9	"Adverse Event/Serious Adverse Event"	3599182001	"upper respiratory tract symptoms"	175	188	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504099680	""	""	""	NA	"Upper respiratory tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5065"	"DN-101 Protocol No. 011-007"	"184"	"184-0004"	5	9	"Adverse Event/Serious Adverse Event"	3675721003	"decrease appetite"	29	66	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512506947	""	""	""	NA	"Appetite decreased NOS"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Decreased appetite"	""	""	""	""	""	""	""	""	""	""	""	""
"5066"	"DN-101 Protocol No. 011-007"	"184"	"184-0004"	5	9	"Adverse Event/Serious Adverse Event"	4199826001	"fatigue"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512506800	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5067"	"DN-101 Protocol No. 011-007"	"184"	"184-0004"	5	9	"Adverse Event/Serious Adverse Event"	4210213001	"Nausea"	7	66	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512586072	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"5068"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3206029003	"alopecia"	26	181	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499194138	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5069"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3863665001	"bruising"	123	200	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507828128	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"5070"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3361459001	"diaphoresis"	39	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499202001	""	""	""	NA	"Diaphoresis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5071"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3729687001	"diaphoresis"	50	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505946163	""	""	""	NA	"Diaphoresis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5072"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	4872590002	"dry mouth"	239	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518557030	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"5073"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3729821001	"dyspnea"	71	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505946792	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5074"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3728936001	"fatigue"	50	203	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505942173	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5075"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3361347001	"Fatigue"	9	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499194729	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5076"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3361445001	"fatigue"	29	43	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499201655	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5077"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3863686001	"hot flashes"	123	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507828242	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"5078"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	4873170002	"muscle weakness"	228	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518559428	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"5079"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3361397001	"muscle weakness - extremity-lower (thighs)"	36	43	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499200154	""	""	""	NA	"Muscle weakness lower limb"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"5080"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3728846001	"muscle weakness -thighs(bilaterally)"	50	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505941743	""	""	""	NA	"Muscle weakness"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle weakness conditions"	"Muscular weakness"	""	""	""	""	""	""	""	""	""	""	""	""
"5081"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3361438001	"nail changes"	29	177	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499201578	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5082"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3361413001	"neuropathy: sensory (thighs)"	36	43	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499200862	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"5083"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3729626001	"neuropathy: sensory (thighs)"	50	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505945821	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"5084"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	4873223002	"pain - low back"	207	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518559537	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5085"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	4427914002	"pain - low back"	189	206	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515525617	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5086"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3729581001	"Pain - musculoskeletal - thighs (bilaterally)"	50	227	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505945625	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"5087"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3361360001	"Pain - musculoskeletal - thighs (bilaterally)"	36	43	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499195305	""	""	""	NA	"Pain in thigh"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"5088"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	4873331002	"pain - right shoulder"	244	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518560014	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5089"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3361432001	"taste alteration"	29	37	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499201480	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5090"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3863647001	"taste alteration"	123	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507828051	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5091"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3361350001	"taste alteration"	9	23	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499194812	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5092"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	4873240002	"urinary retention"	247	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518559594	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"5093"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	4448674002	"urinary retention"	186	215	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515608833	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"5094"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	3863620001	"urinary retention"	105	177	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507827976	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"5095"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	4873304002	"urinary retention"	216	246	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518559889	""	""	""	NA	"Urinary retention"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary retention"	""	""	""	""	""	""	""	""	""	""	""	""
"5096"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	4872624002	"weight loss"	207	248	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518557169	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5097"	"DN-101 Protocol No. 011-007"	"186"	"186-0002"	5	9	"Adverse Event/Serious Adverse Event"	4873359002	"weight loss"	249	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518560102	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5098"	"DN-101 Protocol No. 011-007"	"188"	"188-0001"	5	9	"Adverse Event/Serious Adverse Event"	3300962003	"fatigue"	15	23	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498670772	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5099"	"DN-101 Protocol No. 011-007"	"188"	"188-0001"	5	9	"Adverse Event/Serious Adverse Event"	3619061001	"hematuria"	78	81	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504528967	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"5100"	"DN-101 Protocol No. 011-007"	"188"	"188-0001"	5	9	"Adverse Event/Serious Adverse Event"	3454613001	"hypocalcemia"	29	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501004436	""	""	""	NA	"Hypocalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypocalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5101"	"DN-101 Protocol No. 011-007"	"188"	"188-0001"	5	9	"Adverse Event/Serious Adverse Event"	3671602001	"insomnia"	88	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505229246	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5102"	"DN-101 Protocol No. 011-007"	"188"	"188-0001"	5	9	"Adverse Event/Serious Adverse Event"	3832283001	"joint pain"	115	117	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"changed zometa to week following taxotere infusion"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507559012	""	""	""	NA	"Joint pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5103"	"DN-101 Protocol No. 011-007"	"188"	"188-0001"	5	9	"Adverse Event/Serious Adverse Event"	3832421001	"neuropathy left big toe"	115	134	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	3	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507559907	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5104"	"DN-101 Protocol No. 011-007"	"188"	"188-0001"	5	9	"Adverse Event/Serious Adverse Event"	3926652001	"neuropathy left foot"	134	NA	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508856001	""	""	""	NA	"Neuropathy peripheral"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5105"	"DN-101 Protocol No. 011-007"	"188"	"188-0001"	5	9	"Adverse Event/Serious Adverse Event"	3330640001	"neutropenia"	15	23	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498586182	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5106"	"DN-101 Protocol No. 011-007"	"189"	"189-0001"	5	9	"Adverse Event/Serious Adverse Event"	3293070003	"Bilateral Ankle Swelling"	38	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505863419	""	""	""	NA	"Ankle swelling"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint swelling"	""	""	""	""	""	""	""	""	""	""	""	""
"5107"	"DN-101 Protocol No. 011-007"	"189"	"189-0001"	5	9	"Adverse Event/Serious Adverse Event"	4829208002	"Bilateral hand lesions"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518116065	""	""	""	NA	"Skin lesion"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin lesion"	""	""	""	""	""	""	""	""	""	""	""	""
"5108"	"DN-101 Protocol No. 011-007"	"189"	"189-0001"	5	9	"Adverse Event/Serious Adverse Event"	3716831001	"Blood in stools"	49	53	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505870026	""	""	""	NA	"Blood stool"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Haematochezia"	""	""	""	""	""	""	""	""	""	""	""	""
"5109"	"DN-101 Protocol No. 011-007"	"189"	"189-0001"	5	9	"Adverse Event/Serious Adverse Event"	3716802001	"Bruises easily after venipuncture"	20	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505864866	""	""	""	NA	"Bruising"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Skin injuries NEC"	"Contusion"	""	""	""	""	""	""	""	""	""	""	""	""
"5110"	"DN-101 Protocol No. 011-007"	"189"	"189-0001"	5	9	"Adverse Event/Serious Adverse Event"	3716812001	"Fatigue"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505865365	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5111"	"DN-101 Protocol No. 011-007"	"189"	"189-0001"	5	9	"Adverse Event/Serious Adverse Event"	3716809001	"Hand Cramps"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505865274	""	""	""	NA	"Cramp in hand"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"5112"	"DN-101 Protocol No. 011-007"	"189"	"189-0001"	5	9	"Adverse Event/Serious Adverse Event"	3486753001	"Hematoma Right Forearm"	14	19	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501719282	""	""	""	NA	"Hematoma"	"Vascular disorders"	"Vascular haemorrhagic disorders"	"Haemorrhages NEC"	"Haematoma"	""	""	""	""	""	""	""	""	""	""	""	""
"5113"	"DN-101 Protocol No. 011-007"	"189"	"189-0001"	5	9	"Adverse Event/Serious Adverse Event"	3716782001	"Increased Right Rib Pain"	84	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505864396	""	""	""	NA	"Rib pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5114"	"DN-101 Protocol No. 011-007"	"189"	"189-0001"	5	9	"Adverse Event/Serious Adverse Event"	3716806001	"Leg Cramps"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505865203	""	""	""	NA	"Leg cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"5115"	"DN-101 Protocol No. 011-007"	"189"	"189-0001"	5	9	"Adverse Event/Serious Adverse Event"	3716775001	"Parasthesia Left Foot"	63	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505864312	""	""	""	NA	"Paresthesia foot"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5116"	"DN-101 Protocol No. 011-007"	"189"	"189-0001"	5	9	"Adverse Event/Serious Adverse Event"	3716758001	"Parasthesia Right Foot"	63	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505864146	""	""	""	NA	"Paresthesia foot"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5117"	"DN-101 Protocol No. 011-007"	"199"	"199-0001"	5	9	"Adverse Event/Serious Adverse Event"	3892947003	"dysgeusia"	13	44	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514302891	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5118"	"DN-101 Protocol No. 011-007"	"199"	"199-0001"	5	9	"Adverse Event/Serious Adverse Event"	4341426001	"fatigue"	10	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514303168	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5119"	"DN-101 Protocol No. 011-007"	"199"	"199-0001"	5	9	"Adverse Event/Serious Adverse Event"	4341742001	"Generalized pain"	3	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514308713	""	""	""	NA	"General body pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5120"	"DN-101 Protocol No. 011-007"	"199"	"199-0001"	5	9	"Adverse Event/Serious Adverse Event"	4344417001	"Neutropenia"	10	22	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514381094	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5121"	"DN-101 Protocol No. 011-007"	"199"	"199-0001"	5	9	"Adverse Event/Serious Adverse Event"	4345979001	"Sinusitis"	58	68	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1514391154	""	""	""	NA	"Sinusitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Sinusitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5122"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	5	9	"Adverse Event/Serious Adverse Event"	2762410004	"Anemia"	48	55	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"2 erothrycyte concentrates given on 22.12.06"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483352448	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5123"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	5	9	"Adverse Event/Serious Adverse Event"	2772590001	"constipation"	9	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479122508	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5124"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	5	9	"Adverse Event/Serious Adverse Event"	3013746001	"dyspnoe"	114	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490092420	""	""	""	NA	"Dyspnoea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5125"	"DN-101 Protocol No. 011-007"	"501"	"501-0001"	5	9	"Adverse Event/Serious Adverse Event"	2772593001	"fatigue"	9	13	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1479122663	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5126"	"DN-101 Protocol No. 011-007"	"501"	"501-0005"	5	9	"Adverse Event/Serious Adverse Event"	3291907003	"deep vein thrombosis"	74	105	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	218	NA	NA	74	105	"physical examination"	""	""	2	2	2	2	2	2	2	2	"leukopenia and deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516371133	""	""	""	NA	"Deep vein thrombosis"	"Vascular disorders"	"Embolism and thrombosis"	"Peripheral embolism and thrombosis"	"Deep vein thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5127"	"DN-101 Protocol No. 011-007"	"501"	"501-0005"	5	9	"Adverse Event/Serious Adverse Event"	3328166001	"leukopenia"	11	45	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	12	NA	NA	11	17	"lab data from 26.6.07"	""	""	2	2	2	2	2	2	2	2	"During routine blood testing his leukocytes were at 0.4 x 10^9/L, during his hospital stay rose to 1.5 till discharge."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498559389	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5128"	"DN-101 Protocol No. 011-007"	"501"	"501-0005"	5	9	"Adverse Event/Serious Adverse Event"	3591206001	"leukopenia"	74	75	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	75	NA	NA	74	105	"lab values show leukopenia grade 4 on 28th, grade 3 on 29th of August 2007,grade 1 on 20th of September."	""	""	2	2	2	NA	2	2	NA	2	"patient was admitted with leukopenia and deep vein thrombosis, now unter heparine infusion"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504007067	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5129"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	2898233003	"Difficulties of breathing"	199	258	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503560375	""	""	""	NA	"Difficulty breathing"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5130"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	3003658001	"Dysgeusia"	15	258	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489661003	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5131"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	3341155001	"Fatigue"	141	290	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498723055	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5132"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	3198056001	"Fatigue"	77	79	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494923226	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5133"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	2974771001	"Fatigue"	35	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488447270	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5134"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	3061176001	"Fatigue"	57	61	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491383983	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5135"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	3952336001	"Headache"	259	305	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509269815	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"5136"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	3608467001	"Itchiness Back"	220	258	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504170312	""	""	""	NA	"Itchy"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Pruritus NEC"	"Pruritus"	""	""	""	""	""	""	""	""	""	""	""	""
"5137"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	3262194001	"Lacrimation"	101	290	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496649535	""	""	""	NA	"Lacrimation"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5138"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	3341173001	"Loss of appetite"	141	258	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498723168	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5139"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	3009966001	"Nykturie"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490008423	""	""	""	NA	"Nycturia"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary tract signs and symptoms NEC"	"Nocturia"	""	""	""	""	""	""	""	""	""	""	""	""
"5140"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	3262204001	"Paresthesia Feed"	99	290	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496649646	""	""	""	NA	"Paresthesia generalized"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5141"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	3572606001	"Sleep Disorder"	13	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503560043	""	""	""	NA	"Sleep disorder"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Sleep disorders NEC"	"Sleep disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5142"	"DN-101 Protocol No. 011-007"	"503"	"503-0003"	5	9	"Adverse Event/Serious Adverse Event"	3952358001	"Swelling right Leg"	245	290	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Duplex sonography on 05.10.2007: no thrombosis"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509270046	""	""	""	NA	"Swelling of legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5143"	"DN-101 Protocol No. 011-007"	"504"	"504-0004"	5	9	"Adverse Event/Serious Adverse Event"	3481489003	"bone pain"	25	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516483310	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5144"	"DN-101 Protocol No. 011-007"	"504"	"504-0004"	5	9	"Adverse Event/Serious Adverse Event"	4565952002	"dyspnea"	25	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516483688	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5145"	"DN-101 Protocol No. 011-007"	"504"	"504-0004"	5	9	"Adverse Event/Serious Adverse Event"	3723922001	"fatigue"	30	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505928437	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5146"	"DN-101 Protocol No. 011-007"	"504"	"504-0004"	5	9	"Adverse Event/Serious Adverse Event"	4565930002	"myospasm"	25	37	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516483477	""	""	""	NA	"Muscle spasm"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"5147"	"DN-101 Protocol No. 011-007"	"504"	"504-0005"	5	9	"Adverse Event/Serious Adverse Event"	3487235003	"acute pancreatitis"	26	53	NA	3	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	48	NA	NA	26	53	"WBC 1,6; hemoglobin 5.3 mmol/l; CT"	""	""	0	0	0	NA	2	2	NA	2	"hospital letter: acute Pancreatitis"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505137263	""	""	""	NA	"Acute pancreatitis"	"Gastrointestinal disorders"	"Exocrine pancreas conditions"	"Acute and chronic pancreatitis"	"Pancreatitis acute"	""	""	""	""	""	""	""	""	""	""	""	""
"5148"	"DN-101 Protocol No. 011-007"	"504"	"504-0005"	5	9	"Adverse Event/Serious Adverse Event"	4755544002	"anemia"	43	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	40	NA	NA	NA	1	NA	1	NA	""	48	NA	NA	26	53	"blood count"	""	""	0	0	0	NA	0	2	NA	2	"anemia due to cancer"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517682271	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5149"	"DN-101 Protocol No. 011-007"	"504"	"504-0005"	5	9	"Adverse Event/Serious Adverse Event"	4755570002	"diabetes mellitus"	26	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517684212	""	""	""	NA	"Diabetes mellitus"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Diabetes mellitus (incl subtypes)"	"Diabetes mellitus"	""	""	""	""	""	""	""	""	""	""	""	""
"5150"	"DN-101 Protocol No. 011-007"	"504"	"504-0005"	5	9	"Adverse Event/Serious Adverse Event"	4755566002	"leukopenia"	30	37	NA	3	0	NA	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	48	NA	NA	26	53	"blood count"	""	""	0	0	0	NA	1	2	NA	2	"due to cancer therapy"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517683861	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5151"	"DN-101 Protocol No. 011-007"	"504"	"504-0005"	5	9	"Adverse Event/Serious Adverse Event"	4755560002	"pleural effusion"	26	53	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	48	NA	NA	26	53	"x-ray"	""	""	0	0	0	NA	0	2	NA	2	"air hunger"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517683408	""	""	""	NA	"Pleural effusion"	"Respiratory, thoracic and mediastinal disorders"	"Pleural disorders"	"Pneumothorax and pleural effusions NEC"	"Pleural effusion"	""	""	""	""	""	""	""	""	""	""	""	""
"5152"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	5	9	"Adverse Event/Serious Adverse Event"	2818450003	"Bone Pain"	201	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516630445	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5153"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	5	9	"Adverse Event/Serious Adverse Event"	2871672001	"fever"	60	60	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484507905	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5154"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	5	9	"Adverse Event/Serious Adverse Event"	4585175002	"Leucopenia"	79	80	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516629472	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5155"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	5	9	"Adverse Event/Serious Adverse Event"	2871644001	"leucopenia"	60	62	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	62	NA	NA	60	62	"Hb 7.97 mmol/L; Leucocytes 1.1 Gpt/L"	""	""	2	2	2	NA	2	2	NA	2	"Patient was admitted to hospital because of episode of fever (max. 38.4 degree centigrade) At hospital Leucopenia was diagnosed and antibiotic therapy initiated."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484507633	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5156"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	5	9	"Adverse Event/Serious Adverse Event"	3115748001	"leucopenia"	122	123	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492954602	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5157"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	5	9	"Adverse Event/Serious Adverse Event"	2999917001	"Leucopenia"	36	43	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489571645	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5158"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	5	9	"Adverse Event/Serious Adverse Event"	2851775001	"Leucopenia"	37	43	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1483545885	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5159"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	5	9	"Adverse Event/Serious Adverse Event"	2999921001	"Leucopenia"	99	114	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489571817	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5160"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	5	9	"Adverse Event/Serious Adverse Event"	3467824001	"neuropathy sensory"	199	NA	1	1	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"local irradiation therapy lumbar spine"	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501487454	""	""	""	NA	"Sensory peripheral neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"5161"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	5	9	"Adverse Event/Serious Adverse Event"	3467821001	"progressive back pain due to spinal cord compression"	191	218	NA	3	2	NA	1	NA	NA	NA	2	NA	1	5	1	NA	1	"local radiation therapy lumbar spine"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	259	NA	NA	201	218	"Hb 7,68 mmol/l; CT Spine 01.06.2007: Metastases complete spine, fracture vertebra 8, narrowing of spinal canal."	""	""	2	2	0	NA	0	2	NA	2	"Progressive pain caused admission to hospital. Pain medication was changed, CT spine and MRI spine revealed osteoblastic metastases and narrowing of spinal canal. Radiation therapy was applied"	"07.06.2007 until 19.06.2007."	""	""	""	""	""	""	""	""	""	NA	NA	""	1501487137	""	""	""	NA	"Spinal cord compression"	"Nervous system disorders"	"Spinal cord and nerve root disorders"	"Spinal cord and nerve root disorders NEC"	"Spinal cord compression"	""	""	""	""	""	""	""	""	""	""	""	""
"5162"	"DN-101 Protocol No. 011-007"	"505"	"505-0001"	5	9	"Adverse Event/Serious Adverse Event"	3467921001	"Urinary tract infection"	201	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	5	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501491652	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5163"	"DN-101 Protocol No. 011-007"	"505"	"505-0002"	5	9	"Adverse Event/Serious Adverse Event"	3010626003	"lekocytopeniea"	42	47	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511956132	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5164"	"DN-101 Protocol No. 011-007"	"505"	"505-0002"	5	9	"Adverse Event/Serious Adverse Event"	4150259001	"leukocytopenia"	147	162	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511956905	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5165"	"DN-101 Protocol No. 011-007"	"505"	"505-0002"	5	9	"Adverse Event/Serious Adverse Event"	4150262001	"leukocytopenia"	166	174	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511957019	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5166"	"DN-101 Protocol No. 011-007"	"505"	"505-0002"	5	9	"Adverse Event/Serious Adverse Event"	4150256001	"leukocytopenia"	124	131	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511956736	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5167"	"DN-101 Protocol No. 011-007"	"505"	"505-0002"	5	9	"Adverse Event/Serious Adverse Event"	4150275001	"leukocytopenia"	208	215	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511957237	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5168"	"DN-101 Protocol No. 011-007"	"505"	"505-0002"	5	9	"Adverse Event/Serious Adverse Event"	4150247001	"leukocytopenia"	84	91	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511956441	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5169"	"DN-101 Protocol No. 011-007"	"505"	"505-0002"	5	9	"Adverse Event/Serious Adverse Event"	4150243001	"leukocytopenia"	61	78	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511956299	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5170"	"DN-101 Protocol No. 011-007"	"505"	"505-0002"	5	9	"Adverse Event/Serious Adverse Event"	3114911001	"leukocytopenia"	19	28	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492943255	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5171"	"DN-101 Protocol No. 011-007"	"505"	"505-0002"	5	9	"Adverse Event/Serious Adverse Event"	4150250001	"leukocytopenia"	103	112	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511956555	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5172"	"DN-101 Protocol No. 011-007"	"505"	"505-0002"	5	9	"Adverse Event/Serious Adverse Event"	4150265001	"leukocytopeniea"	187	197	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511957107	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5173"	"DN-101 Protocol No. 011-007"	"505"	"505-0002"	5	9	"Adverse Event/Serious Adverse Event"	4150382001	"periorbital edem"	224	239	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511959238	""	""	""	NA	"Edema periorbital"	"Skin and subcutaneous tissue disorders"	"Angioedema and urticaria"	"Angioedemas"	"Periorbital oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5174"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	5	9	"Adverse Event/Serious Adverse Event"	3061274003	"back pain"	66	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501493871	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5175"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	5	9	"Adverse Event/Serious Adverse Event"	3211564001	"Colon diverticulum bleeding"	37	42	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	50	NA	NA	37	42	"Platelets 81 GPt/l (04.05.2007); TPZ 38% (04.05.2007)"	""	""	2	2	2	NA	2	2	NA	2	"Patient was admitted because of rectal bleeding on May 3rd, 2007 to hospital close to his home. A coloscopy was performed which showed diverticula in the colon. Bleeding from a diverticulum was"	"identified as the reason. Also thrombocytopenia was found. Bleeding stopped after thromocytes had risen and medication with coumarine derivatives was stopped and patient received low molecular weight"	"heparine."	""	""	""	""	""	""	""	""	NA	NA	""	1495042868	""	""	""	NA	"Diverticulitis of colon with hemorrhage"	"Gastrointestinal disorders"	"Diverticular disorders"	"Diverticulum inflammations"	"Diverticulitis intestinal haemorrhagic"	""	""	""	""	""	""	""	""	""	""	""	""
"5176"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	5	9	"Adverse Event/Serious Adverse Event"	3467972001	"Diarrhea"	66	69	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	141	NA	NA	66	69	"Hb 7,55 mmol/l; Leucocytes 17,8 Gpt/l; Potassium 3,67 mmol/l"	""	""	0	0	0	NA	2	2	NA	2	"Patient was admitted to hospital becuause of diarrhea and pain. In hospital diarrhea was becoming less and patient could be discharged on 4.6.2007.; ; Ultrasound was without abnomalities."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501493762	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5177"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	5	9	"Adverse Event/Serious Adverse Event"	4151045001	"edema"	9	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511968038	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5178"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	5	9	"Adverse Event/Serious Adverse Event"	3849096001	"heartburn"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507725429	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"5179"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	5	9	"Adverse Event/Serious Adverse Event"	3229913001	"Leucopenia"	36	43	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495443104	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5180"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	5	9	"Adverse Event/Serious Adverse Event"	4150867001	"leukocytopenia"	16	20	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511966493	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5181"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	5	9	"Adverse Event/Serious Adverse Event"	3468004001	"pathological distruktion lumbar vertebrae"	91	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"radiation lumbar spine; orthesis"	2	0	NA	0	10	NA	1	NA	1	NA	NA	NA	""	126	NA	NA	91	113	"Hb 6.68 mmol/l; PSA 0.12 ng/ml"	""	""	2	2	2	NA	0	2	NA	2	"Patient complained about progressive lumbar pain. Patietn was admitted to hospital, new destruction was diagnosed in lumbar vertebrae 1 and 5. CT scan showed in addition reduction of pulmonary and"	"retroperitoneal metastases. Chemotherapy was finished because of side effects and progressive bone metastases."	""	""	""	""	""	""	""	""	""	NA	NA	""	1501495714	""	""	""	NA	"Pathologic fracture of vertebrae"	"Musculoskeletal and connective tissue disorders"	"Fractures"	"Pathological fractures and complications"	"Pathological fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"5182"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	5	9	"Adverse Event/Serious Adverse Event"	4150953001	"swelling tongue"	30	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511967378	""	""	""	NA	"Edema tongue"	"Gastrointestinal disorders"	"Tongue conditions"	"Tongue signs and symptoms"	"Tongue oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5183"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	5	9	"Adverse Event/Serious Adverse Event"	3229893001	"thrombocytopenia"	38	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495442867	""	""	""	NA	"Thrombocytopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5184"	"DN-101 Protocol No. 011-007"	"505"	"505-0003"	5	9	"Adverse Event/Serious Adverse Event"	4150823001	"weight loss"	9	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511965938	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5185"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2780546003	"acampsia"	60	60	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489931593	""	""	""	NA	"Joint stiffness"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint stiffness"	""	""	""	""	""	""	""	""	""	""	""	""
"5186"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	3007210001	"acampsia total"	57	57	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489929519	""	""	""	NA	"Joint stiffness"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint stiffness"	""	""	""	""	""	""	""	""	""	""	""	""
"5187"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	3007226001	"aching muscles"	64	129	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489930009	""	""	""	NA	"Muscle ache"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5188"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2879541001	"alopecia"	32	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484737781	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5189"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2927478001	"Anaemia"	61	63	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Transfusion of erythrocytes"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	93	NA	NA	61	63	"Haemoglobin 8,4 g/dl (2007-01-08); Erythrocytes 2,7 T/l (2007-01-08); Heamoglobin 10,1 g/dl (2007-01-09)"	""	""	2	2	2	NA	2	2	NA	2	"Chronic anaemia as a result of metastatic tumor disease.; After chemotherapy reduction of Hb-concentration."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486642082	""	""	""	NA	"Anaemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5190"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2879532001	"bone pain"	15	129	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484737267	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5191"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	4545842002	"depression"	26	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516287419	""	""	""	NA	"Depression"	"Psychiatric disorders"	"Depressed mood disorders and disturbances"	"Depressive disorders"	"Depression"	""	""	""	""	""	""	""	""	""	""	""	""
"5192"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2879588001	"epistaxis"	42	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484741320	""	""	""	NA	"Epistaxis"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"5193"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2879529001	"herpes simplex"	36	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484736560	""	""	""	NA	"Herpes simplex"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes simplex"	""	""	""	""	""	""	""	""	""	""	""	""
"5194"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2879594001	"joint numbness"	45	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484741799	""	""	""	NA	"Numbness"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Hypoaesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5195"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2927485001	"loss of weight"	13	34	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486642337	""	""	""	NA	"Loss of weight"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5196"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	3556009001	"monoparesis left leg"	16	26	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	286	NA	NA	20	26	"MRI spine 2006-11-30:multiple filiae"	""	""	2	2	2	NA	2	2	NA	2	"paresis due to pain"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503324050	""	""	""	NA	"Monoparesis"	"Nervous system disorders"	"Movement disorders (incl Parkinsonism)"	"Paralysis and paresis (excl cranial nerve)"	"Monoparesis"	""	""	""	""	""	""	""	""	""	""	""	""
"5197"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2879535001	"myalgia"	32	129	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484737436	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5198"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	3007340001	"neuropathia sensoric"	65	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489931893	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"5199"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	3007076001	"neuropathia sensoric"	97	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489924873	""	""	""	NA	"Sensory neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Peripheral sensory neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"5200"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	3007069001	"paraesthesia"	97	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489924739	""	""	""	NA	"Paraesthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5201"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2879526001	"rhagaden in the corner of the mouth"	12	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484736314	""	""	""	NA	"Rhagades"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin fissures"	""	""	""	""	""	""	""	""	""	""	""	""
"5202"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	3007040001	"spinal cord compression"	99	119	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	7	1	1	1	"radiation of BWS"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	103	NA	NA	99	119	"MRI vertebral column from 16.02.2007"	""	""	0	0	0	NA	0	0	NA	0	"laminectomie 19.02.2007, after surgery clear recovery; radiation of BWS"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489924115	""	""	""	NA	"Spinal cord compression"	"Nervous system disorders"	"Spinal cord and nerve root disorders"	"Spinal cord and nerve root disorders NEC"	"Spinal cord compression"	""	""	""	""	""	""	""	""	""	""	""	""
"5203"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	3007178001	"sweeting"	57	57	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1489928741	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5204"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2879605001	"tachykardia"	54	129	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484741990	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"5205"	"DN-101 Protocol No. 011-007"	"506"	"506-0001"	5	9	"Adverse Event/Serious Adverse Event"	2879591001	"xerostomia"	52	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1484741610	""	""	""	NA	"Xerostomia"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"5206"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	2858015003	"alopecia"	118	276	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495697635	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5207"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	2969946001	"bone pain"	17	17	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488292641	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5208"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3241545001	"bronchitis"	126	140	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495721478	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5209"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3240792001	"bronchitis"	108	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495698530	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5210"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3348300001	"coated throat"	161	182	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498979815	""	""	""	NA	"Throat irritation"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Throat irritation"	""	""	""	""	""	""	""	""	""	""	""	""
"5211"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363311001	"cough"	170	170	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499263595	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"5212"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3348278001	"distaste for fish"	150	150	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498979391	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5213"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363507001	"disturbance of equilibrium"	170	182	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499266117	""	""	""	NA	"Equilibrium trouble"	"Nervous system disorders"	"Neurological disorders NEC"	"Cerebellar coordination and balance disturbances"	"Balance disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5214"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363470001	"dizziness"	170	170	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499265004	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"5215"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3076141001	"dry skin"	77	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491912520	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"5216"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363194001	"face turned red"	162	162	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499262382	""	""	""	NA	"Face red"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"5217"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363236001	"face turned red"	169	169	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499262958	""	""	""	NA	"Face red"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"5218"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3458311001	"face turned red"	185	186	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501070212	""	""	""	NA	"Face red"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Erythemas"	"Erythema"	""	""	""	""	""	""	""	""	""	""	""	""
"5219"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3550571001	"fatigue"	220	220	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503233999	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5220"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3240989001	"fatigue"	140	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495702503	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5221"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3076130001	"fatigue"	84	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491912144	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5222"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3031705001	"fatigue"	75	75	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490615160	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5223"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3348254001	"fatigue"	143	143	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498979003	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5224"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3348230001	"hot flashes face"	140	141	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498978535	""	""	""	NA	"Hot flushes facial"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"5225"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3240940001	"insomnia"	119	119	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495701560	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5226"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3240729001	"insomnia"	102	102	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495697228	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5227"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3348245001	"insomnia"	141	141	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498978875	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5228"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3550518001	"insomnia"	204	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503233243	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5229"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363296001	"insomnia"	170	170	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499263465	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5230"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363209001	"insomnia"	162	162	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499262540	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5231"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3240992001	"inspiration dragging pain thoracal left"	140	161	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495702716	""	""	""	NA	"Thoracic pain"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5232"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3458620001	"leukopenia"	199	276	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501073816	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5233"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	4078338001	"leukopenia"	64	70	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510842308	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5234"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3367291001	"leukopenia"	170	182	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499328991	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5235"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3943327001	"neutropenia"	64	70	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509003891	""	""	""	NA	"Neutropenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Neutropenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5236"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3240722001	"pain back"	106	107	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495696788	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5237"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363289001	"pain bone"	168	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499263350	""	""	""	NA	"Pain bone"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5238"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3348261001	"pain bone"	143	143	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498979150	""	""	""	NA	"Pain bone"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5239"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3075940001	"pain in the back"	95	96	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491907489	""	""	""	NA	"Pain back"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5240"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363265001	"pain mandible"	168	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499263177	""	""	""	NA	"Pain jaw"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Pain in jaw"	""	""	""	""	""	""	""	""	""	""	""	""
"5241"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3348466001	"pain skeleton"	170	182	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498982089	""	""	""	NA	"Skeletal pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5242"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	2972733001	"pain stomach"	37	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488384003	""	""	""	NA	"Pain stomach"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"5243"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3031690001	"pain stomach"	70	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490614822	""	""	""	NA	"Pain stomach"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"5244"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3550505001	"pain testes"	182	182	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503232503	""	""	""	NA	"Pain in testis"	"Reproductive system and breast disorders"	"Testicular and epididymal disorders"	"Testicular and epididymal disorders NEC"	"Testicular pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5245"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3348313001	"pain throat"	170	182	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498980024	""	""	""	NA	"Pain throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5246"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3075988001	"raw nasal mucosa"	98	118	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491908894	""	""	""	NA	"Nasal mucosal disorder"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Nasal mucosal disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5247"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3348421001	"sputum in the morning"	170	182	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498981703	""	""	""	NA	"Sputum"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"5248"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363381001	"swallowing difficulties"	170	170	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499264192	""	""	""	NA	"Swallowing difficult"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Dysphagia"	""	""	""	""	""	""	""	""	""	""	""	""
"5249"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3031666001	"sweating"	58	59	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490614229	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5250"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3240983001	"sweating"	126	126	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495702317	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5251"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3240716001	"swelling, redness left eye"	104	104	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495696630	""	""	""	NA	"Eye swelling"	"Eye disorders"	"Eye disorders NEC"	"Ocular disorders NEC"	"Eye swelling"	""	""	""	""	""	""	""	""	""	""	""	""
"5252"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3458332001	"taste disorder"	185	191	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501070371	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5253"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3348268001	"taste disorder"	144	146	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498979292	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5254"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3550515001	"taste disorder"	205	208	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503233105	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5255"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3076013001	"taste disorder"	98	276	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491909524	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5256"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363226001	"taste disorder"	165	166	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499262821	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5257"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3240976001	"taste disorder"	121	128	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495702028	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5258"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	2972743001	"taste disorder"	40	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488384230	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5259"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363220001	"unfirm on the legs"	163	163	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499262701	""	""	""	NA	"Unsteady gait"	"General disorders and administration site conditions"	"General system disorders NEC"	"Gait disturbances"	"Gait disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"5260"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	4076887001	"worsening in hearing"	182	203	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510833658	""	""	""	NA	"Hearing decreased"	"Ear and labyrinth disorders"	"Hearing disorders"	"Hearing losses"	"Hypoacusis"	""	""	""	""	""	""	""	""	""	""	""	""
"5261"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3363492001	"worsening in hearing"	170	182	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499265673	""	""	""	NA	"Hearing decreased"	"Ear and labyrinth disorders"	"Hearing disorders"	"Hearing losses"	"Hypoacusis"	""	""	""	""	""	""	""	""	""	""	""	""
"5262"	"DN-101 Protocol No. 011-007"	"506"	"506-0003"	5	9	"Adverse Event/Serious Adverse Event"	3076135001	"xerostomia"	77	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491912420	""	""	""	NA	"Xerostomia"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"5263"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3026428003	"alopecia"	26	33	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495712315	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5264"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3241135001	"alopecia"	48	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495713640	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5265"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	4053416001	"bone pain"	213	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510671215	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5266"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3817414001	"bone pain"	176	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507201972	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5267"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502471001	"bone pain"	118	138	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502185860	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5268"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3429915001	"bone pain"	97	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500383044	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5269"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3241086001	"chapped lips"	22	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495712223	""	""	""	NA	"Chapped lips"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Oral soft tissue disorders NEC"	"Chapped lips"	""	""	""	""	""	""	""	""	""	""	""	""
"5270"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3342000001	"common cold"	95	95	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498728072	""	""	""	NA	"Common cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5271"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	4053351001	"common cold"	204	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510670862	""	""	""	NA	"Common cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5272"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341513001	"common cold"	67	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498725377	""	""	""	NA	"Common cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5273"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3429970001	"common cold"	99	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500383835	""	""	""	NA	"Common cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5274"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3430153001	"dermal changes"	96	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500385308	""	""	""	NA	"Skin disorder NOS"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5275"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341455001	"dermal changes"	65	68	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498725082	""	""	""	NA	"Skin disorder NOS"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5276"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	4544598002	"dibetes mellitus"	97	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516282669	""	""	""	NA	"Diabetes mellitus"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Diabetes mellitus (incl subtypes)"	"Diabetes mellitus"	""	""	""	""	""	""	""	""	""	""	""	""
"5277"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502306001	"dizziness"	125	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502183530	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"5278"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341729001	"dizziness"	85	86	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498726727	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"5279"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341557001	"eye irritation"	69	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498725595	""	""	""	NA	"Eye irritation"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Ocular infections, inflammations and associated manifestations"	"Eye irritation"	""	""	""	""	""	""	""	""	""	""	""	""
"5280"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341636001	"eye irritation"	77	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498726066	""	""	""	NA	"Eye irritation"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Ocular infections, inflammations and associated manifestations"	"Eye irritation"	""	""	""	""	""	""	""	""	""	""	""	""
"5281"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341976001	"falling down from cherrytree"	93	93	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498727977	""	""	""	NA	"Falling down"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Non-site specific injuries NEC"	"Fall"	""	""	""	""	""	""	""	""	""	""	""	""
"5282"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502320001	"fatigue"	139	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502183931	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5283"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341393001	"fatigue"	16	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498724675	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5284"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3342053001	"furuncle"	76	95	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498728462	""	""	""	NA	"Furuncle"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Skin structures and soft tissue infections"	"Furuncle"	""	""	""	""	""	""	""	""	""	""	""	""
"5285"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3817360001	"gingivitis"	167	172	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507200360	""	""	""	NA	"Gingivitis"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Gingival disorders NEC"	"Gingivitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5286"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502257001	"haematoma"	139	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502182817	""	""	""	NA	"Haematoma"	"Vascular disorders"	"Vascular haemorrhagic disorders"	"Haemorrhages NEC"	"Haematoma"	""	""	""	""	""	""	""	""	""	""	""	""
"5287"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3693027001	"headache"	145	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505639594	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"5288"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502275001	"headache"	125	126	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502183250	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"5289"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341844001	"heatwaves"	89	89	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498727384	""	""	""	NA	"Hot flashes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"5290"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	4524127002	"herniated vertebral disk"	265	273	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	302	NA	NA	265	273	"interlaminar windowing"	""	""	2	2	2	2	2	2	2	2	"interlaminar windowing"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516198174	""	""	""	NA	"Intervertebral disc herniation"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders)"	"Intervertebral disc disorders NEC"	"Intervertebral disc protrusion"	""	""	""	""	""	""	""	""	""	""	""	""
"5291"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341427001	"huskiness"	64	68	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498724913	""	""	""	NA	"Hoarseness"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Dysphonia"	""	""	""	""	""	""	""	""	""	""	""	""
"5292"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3241138001	"hypertension"	34	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495713753	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"5293"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341631001	"hypertension"	75	79	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498725978	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"5294"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3241065001	"hypertension"	13	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495711053	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"5295"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341810001	"hypertension"	88	88	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498727268	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"5296"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3241144001	"hypertension"	48	58	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495713874	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"5297"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3817402001	"incontinence"	163	164	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507201604	""	""	""	NA	"Incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"5298"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3429995001	"incontinence"	101	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500384042	""	""	""	NA	"Incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"5299"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341714001	"incontinence"	82	82	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498726594	""	""	""	NA	"Incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"5300"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341899001	"inflammation eye"	93	93	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498727576	""	""	""	NA	"Eye inflammation"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Ocular infections, inflammations and associated manifestations"	"Eye inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"5301"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	4053466001	"inflammation of both eyes"	218	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510671460	""	""	""	NA	"Eye inflammation"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Ocular infections, inflammations and associated manifestations"	"Eye inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"5302"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3693042001	"inflammation of the eyes"	157	183	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505640266	""	""	""	NA	"Eye inflammation"	"Eye disorders"	"Ocular infections, irritations and inflammations"	"Ocular infections, inflammations and associated manifestations"	"Eye inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"5303"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	4041238001	"inflammation of the throat"	42	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510572478	""	""	""	NA	"Pharyngeal inflammation"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Pharyngeal disorders (excl infections and neoplasms)"	"Pharyngeal inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"5304"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3342562001	"inflammation of the throat"	77	81	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498731838	""	""	""	NA	"Pharyngeal inflammation"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Pharyngeal disorders (excl infections and neoplasms)"	"Pharyngeal inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"5305"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3693035001	"inflammation of the throat"	149	151	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505639953	""	""	""	NA	"Pharyngeal inflammation"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Pharyngeal disorders (excl infections and neoplasms)"	"Pharyngeal inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"5306"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3342573001	"inflammation of the throat"	93	93	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498731899	""	""	""	NA	"Pharyngeal inflammation"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Pharyngeal disorders (excl infections and neoplasms)"	"Pharyngeal inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"5307"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3342535001	"inflammation of the throat"	61	63	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498731728	""	""	""	NA	"Pharyngeal inflammation"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Pharyngeal disorders (excl infections and neoplasms)"	"Pharyngeal inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"5308"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	4033829001	"inflammation of the throat"	189	191	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510497678	""	""	""	NA	"Pharyngeal inflammation"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Pharyngeal disorders (excl infections and neoplasms)"	"Pharyngeal inflammation"	""	""	""	""	""	""	""	""	""	""	""	""
"5309"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341769001	"inflammaton nose inside"	85	86	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498727056	""	""	""	NA	"Nasal mucosal disorder"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Nasal mucosal disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5310"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3429909001	"insomnia"	97	97	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500382828	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5311"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	4033042001	"insomnia"	183	183	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510485973	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5312"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3241071001	"insomnia"	13	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495711322	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5313"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	4053457001	"insomnia"	215	215	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510671381	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5314"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502533001	"intensity of hearing decreased"	34	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502186526	""	""	""	NA	"Hearing decreased"	"Ear and labyrinth disorders"	"Hearing disorders"	"Hearing losses"	"Hypoacusis"	""	""	""	""	""	""	""	""	""	""	""	""
"5315"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502549001	"intensity of seeing"	34	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502186620	""	""	""	NA	"Visual disturbance"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Visual disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"5316"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	4041186001	"muscular cramps"	37	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510571983	""	""	""	NA	"Muscle cramps"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"5317"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3430120001	"nail deformation"	104	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500385072	""	""	""	NA	"Nail deformation"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5318"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502250001	"nail deformation"	139	238	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502182217	""	""	""	NA	"Nail deformation"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5319"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3692981001	"neuropathia"	160	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505637426	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"5320"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3241077001	"obstipation"	16	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495711820	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5321"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	4041196001	"obstipation"	38	38	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510572155	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5322"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3817328001	"onycholyse"	183	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507199927	""	""	""	NA	"Onycholysis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onycholysis"	""	""	""	""	""	""	""	""	""	""	""	""
"5323"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502394001	"pain mandible"	139	159	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502185137	""	""	""	NA	"Pain jaw"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Pain in jaw"	""	""	""	""	""	""	""	""	""	""	""	""
"5324"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3429927001	"pain throat"	99	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500383180	""	""	""	NA	"Pain throat"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Upper respiratory tract signs and symptoms"	"Pharyngolaryngeal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5325"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502497001	"paresthesia"	143	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502186136	""	""	""	NA	"Paresthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5326"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502265001	"peptic esophagitis"	117	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502182992	""	""	""	NA	"Esophagitis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Oesophagitis (excl infective)"	"Oesophagitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5327"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3430026001	"shortness of breath"	104	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500384278	""	""	""	NA	"Shortness of breath"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5328"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3693016001	"strain ankle right"	142	142	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505639364	""	""	""	NA	"Strain"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Muscle, tendon and ligament injuries"	"Muscle strain"	""	""	""	""	""	""	""	""	""	""	""	""
"5329"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341259001	"taste disorder"	36	238	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498723633	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5330"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3502383001	"taste disorder"	125	238	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502185015	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5331"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3241074001	"taste disorder"	14	14	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495711514	""	""	""	NA	"Taste abnormality"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5332"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3241068001	"tightness breast left"	13	13	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495711235	""	""	""	NA	"Breast tension"	"Reproductive system and breast disorders"	"Breast disorders"	"Breast signs and symptoms"	"Breast discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"5333"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	4041210001	"white tongue"	40	40	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510572270	""	""	""	NA	"Tongue white"	"Gastrointestinal disorders"	"Tongue conditions"	"Tongue signs and symptoms"	"Tongue discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"5334"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3692990001	"white tongue"	143	143	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505637883	""	""	""	NA	"Tongue white"	"Gastrointestinal disorders"	"Tongue conditions"	"Tongue signs and symptoms"	"Tongue discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"5335"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341279001	"white tongue"	60	60	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498723811	""	""	""	NA	"Tongue white"	"Gastrointestinal disorders"	"Tongue conditions"	"Tongue signs and symptoms"	"Tongue discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"5336"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3817405001	"white tongue"	162	165	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507201717	""	""	""	NA	"Tongue white"	"Gastrointestinal disorders"	"Tongue conditions"	"Tongue signs and symptoms"	"Tongue discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"5337"	"DN-101 Protocol No. 011-007"	"506"	"506-0004"	5	9	"Adverse Event/Serious Adverse Event"	3341679001	"white tongue"	78	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498726426	""	""	""	NA	"Tongue white"	"Gastrointestinal disorders"	"Tongue conditions"	"Tongue signs and symptoms"	"Tongue discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"5338"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	2817051003	"anemia"	226	324	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486328482	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5339"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	3092144001	"asthenia"	87	108	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492415596	""	""	""	NA	"Asthenia"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5340"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	4371755001	"bad general condition"	305	329	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	388	NA	NA	305	311	"Hemoglobin level (12.10.07): 8.8 g/dl, creatinine 1.56 mg/dl, alkaline phosphatase 1087 U/L, LDH 738 U/L"	""	""	2	2	2	NA	2	2	NA	2	"patient was admitted to hospital in bad general condition and with worsening pain. Due to the limited prognosis of the patient palliative therapy was introduced. patient was discharged on 18.10.07"	"with slightly improved general condition."	""	""	""	""	""	""	""	""	""	NA	NA	""	1514992325	""	""	""	NA	"Reduced general condition"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"General physical health deterioration"	""	""	""	""	""	""	""	""	""	""	""	""
"5341"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	3692534001	"bone pain"	276	324	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"CT-scan"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	278	NA	NA	277	278	"HB 7,1 mg/dl 13.09.2007"	""	""	0	0	0	NA	2	0	NA	0	"bone pain by metastases"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505587120	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5342"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	2914242001	"bone pain"	24	66	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486327914	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5343"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	3909446001	"bronchitis"	192	220	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508663448	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5344"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	3126321001	"dyspnea"	108	276	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493114445	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5345"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	3126289001	"edema"	108	276	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493114198	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5346"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	2914032001	"hair loss"	3	276	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486326663	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5347"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	2914263001	"hyperglycemia"	45	45	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Cancelation of Dexamthasone 3 hours before Docetaxel"	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486328075	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5348"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	3126314001	"hyperglycemia"	129	129	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493114353	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5349"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	3342784001	"leucopenia"	192	199	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498733656	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5350"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	2914068001	"leukopenia"	10	16	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486326968	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5351"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	3092201001	"neuropathy"	108	276	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492416376	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"5352"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	3456490001	"Phlegmone"	222	245	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	226	NA	NA	226	245	"CRP about 480"	""	""	0	0	0	NA	2	0	NA	0	"Phlegmone at the right leg. After introduction of antibiotic therapy the phlegmone was reduced. Furthermore a renal tube was inserted because of urinary obstruction. After that renal function"	"improved."	""	""	""	""	""	""	""	""	""	NA	NA	""	1501013970	""	""	""	NA	"Phlegmon"	"Infections and infestations"	"Bacterial infectious disorders"	"Bacterial infections NEC"	"Cellulitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5353"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	3262365001	"tachycardia"	129	170	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496653981	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"5354"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	3909426001	"tasting disorder"	108	276	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508663071	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5355"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	4438643002	"thrombosis left leg"	NA	324	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515580768	""	""	""	NA	"Thrombosis leg"	"Vascular disorders"	"Embolism and thrombosis"	"Non-site specific embolism and thrombosis"	"Thrombosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5356"	"DN-101 Protocol No. 011-007"	"507"	"507-0003"	5	9	"Adverse Event/Serious Adverse Event"	3334599001	"trombopenia"	192	199	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498640211	""	""	""	NA	"Thrombopenia"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Thrombocytopenias"	"Thrombocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5357"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	5	9	"Adverse Event/Serious Adverse Event"	2827491003	"anemia"	43	45	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515408353	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5358"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	5	9	"Adverse Event/Serious Adverse Event"	4838604002	"Ascites"	42	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518340389	""	""	""	NA	"Ascites"	"Gastrointestinal disorders"	"Peritoneal and retroperitoneal conditions"	"Peritoneal and retroperitoneal disorders"	"Ascites"	""	""	""	""	""	""	""	""	""	""	""	""
"5359"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	5	9	"Adverse Event/Serious Adverse Event"	4437956002	"bad general condition"	45	48	NA	3	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	129	NA	NA	45	48	"x-ray of abdomen: coprostase, no ileus. ; blood test: creatinine 2,21 mg/dl, leucocytes 26.050/_l"	""	""	2	2	2	2	2	2	2	2	"patient was admitted to hospital in bad general condition and suspicion of an ileus. after medical stimulation of the bowels condition improved. Furthermore a permanent venous access was implanted."	"patient was discharged after 3 days with improved general condition"	""	""	""	""	""	""	""	""	""	NA	NA	""	1515572673	""	""	""	NA	"Reduced general condition"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"General physical health deterioration"	""	""	""	""	""	""	""	""	""	""	""	""
"5360"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	5	9	"Adverse Event/Serious Adverse Event"	3127059001	"bone pain"	45	71	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493126518	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5361"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	5	9	"Adverse Event/Serious Adverse Event"	2974994001	"Ileus"	58	71	NA	5	1	1	NA	NA	NA	NA	1	1	NA	2	NA	1	NA	""	4	0	NA	0	12	NA	NA	1	1	NA	NA	NA	""	75	71	0	58	71	"To date we do not have any further information."	""	""	2	2	2	2	2	2	2	2	"Patient was admitted to hospital on 13-02-07 with ileus, on 14.02.07 an operation with building of an artificial anus done. The patient died suddenly on the 26.02.07. To date we do not have any"	"further information because the patient was operated in a different hospital."	""	""	""	""	""	""	""	""	""	NA	NA	""	1488460264	""	""	""	NA	"Ileus"	"Gastrointestinal disorders"	"Gastrointestinal stenosis and obstruction"	"Gastrointestinal stenosis and obstruction NEC"	"Ileus"	""	""	""	""	""	""	""	""	""	""	""	""
"5362"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	5	9	"Adverse Event/Serious Adverse Event"	3126500001	"pain left shoulder"	22	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493116347	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5363"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	5	9	"Adverse Event/Serious Adverse Event"	4402608002	"renal impairment"	42	71	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515408220	""	""	""	NA	"Renal impairment"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal impairment"	""	""	""	""	""	""	""	""	""	""	""	""
"5364"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	5	9	"Adverse Event/Serious Adverse Event"	4402451002	"subileus"	41	43	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	387	NA	NA	41	43	"Ultrasound (27.01.07): Ascites, Urinary obstruction in both kidneys with concomitant renal impairment."	""	""	2	2	2	NA	2	2	NA	2	"Patient was admitted to hospital with abdominal pain and koprostasis. After introducing medical treatment he opened the bowels on 28.01.07. On 28.01.07 docetaxel was continued as scheduled and"	"patient was discharged on 29.01.07."	""	""	""	""	""	""	""	""	""	NA	NA	""	1515405674	""	""	""	NA	"Subileus"	"Gastrointestinal disorders"	"Gastrointestinal stenosis and obstruction"	"Gastrointestinal stenosis and obstruction NEC"	"Subileus"	""	""	""	""	""	""	""	""	""	""	""	""
"5365"	"DN-101 Protocol No. 011-007"	"507"	"507-0004"	5	9	"Adverse Event/Serious Adverse Event"	3127052001	"subileus"	45	48	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	129	NA	NA	45	48	"x-ray of abdomen: coprostase, no ileus. ; blood test: creatinine 2,21 mg/dl, leucocytes 26.050/_l"	""	""	2	2	2	2	2	2	2	2	"patient was admitted to hospital in bad general condition and suspicion of an ileus. after medical stimulation of the bowels condition improved. Furthermore a permanent venous access was implanted."	"patient was discharged after 3 days with improved general condition"	""	""	""	""	""	""	""	""	""	NA	NA	""	1493126274	""	""	""	NA	"Subileus"	"Gastrointestinal disorders"	"Gastrointestinal stenosis and obstruction"	"Gastrointestinal stenosis and obstruction NEC"	"Subileus"	""	""	""	""	""	""	""	""	""	""	""	""
"5366"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	5	9	"Adverse Event/Serious Adverse Event"	2867838003	"alopecia"	21	270	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492430111	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5367"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	5	9	"Adverse Event/Serious Adverse Event"	4458295002	"anemia"	28	87	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515665917	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5368"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	5	9	"Adverse Event/Serious Adverse Event"	4458305002	"anemia"	108	270	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515666131	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5369"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	5	9	"Adverse Event/Serious Adverse Event"	4458238002	"back pain"	332	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515665037	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5370"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	5	9	"Adverse Event/Serious Adverse Event"	3334657001	"dyspnoe"	92	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498642178	""	""	""	NA	"Dyspnoea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5371"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	5	9	"Adverse Event/Serious Adverse Event"	4458339002	"elevated alkaline phosphatase"	270	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515666499	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5372"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	5	9	"Adverse Event/Serious Adverse Event"	4458330002	"elevated LDH"	92	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515666448	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5373"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	5	9	"Adverse Event/Serious Adverse Event"	2966464001	"high serum alkaline phosphatase"	28	154	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1488137813	""	""	""	NA	"Serum alkaline phosphatase elevated"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5374"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	5	9	"Adverse Event/Serious Adverse Event"	3353877001	"nail changes"	175	332	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499066936	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5375"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	5	9	"Adverse Event/Serious Adverse Event"	3895909001	"pain (right leg)"	50	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508321461	""	""	""	NA	"Leg pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"5376"	"DN-101 Protocol No. 011-007"	"507"	"507-0006"	5	9	"Adverse Event/Serious Adverse Event"	3353842001	"tasting disorder"	133	270	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499065710	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5377"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	5	9	"Adverse Event/Serious Adverse Event"	2883211003	"dry mucosa"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493120406	""	""	""	NA	"Mucosal dryness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Mucosal findings abnormal"	"Mucosal dryness"	""	""	""	""	""	""	""	""	""	""	""	""
"5378"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	5	9	"Adverse Event/Serious Adverse Event"	3126786001	"hypertension"	66	101	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493120654	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"5379"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	5	9	"Adverse Event/Serious Adverse Event"	3126665001	"incontinence"	10	17	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"pelvic floor exercises"	3	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493119416	""	""	""	NA	"Incontinence"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"5380"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	5	9	"Adverse Event/Serious Adverse Event"	3126774001	"leucopenia"	59	66	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493120503	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5381"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	5	9	"Adverse Event/Serious Adverse Event"	3126755001	"leucopenia"	17	24	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493120332	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5382"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	5	9	"Adverse Event/Serious Adverse Event"	3126821001	"nail changes"	80	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"cooling of hands during infusion of docetaxel"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493121104	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5383"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	5	9	"Adverse Event/Serious Adverse Event"	3126661001	"rash"	10	11	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493119304	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"5384"	"DN-101 Protocol No. 011-007"	"507"	"507-0007"	5	9	"Adverse Event/Serious Adverse Event"	3126671001	"tasting disorder"	10	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493119499	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5385"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	5	9	"Adverse Event/Serious Adverse Event"	2991875003	"anemia"	29	218	NA	3	NA	NA	NA	0	NA	NA	0	NA	NA	1	1	NA	NA	""	0	NA	0	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513607145	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5386"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	5	9	"Adverse Event/Serious Adverse Event"	3237319001	"bad general condition"	71	218	NA	4	NA	NA	NA	1	1	NA	1	1	NA	1	1	NA	NA	""	0	NA	0	1	8	NA	NA	NA	1	NA	NA	NA	""	73	NA	NA	71	74	"will be entered"	""	""	2	2	1	2	1	2	2	2	"Patient was admitted to hospital with edema of the legs, scrotum and penis. He was unable to void. Furthermore he complains about bone pain and his general condition was bad.;Therefore treatment was"	"discontinued for unknown time."	""	""	""	""	""	""	""	""	""	NA	NA	""	1495601466	""	""	""	NA	"Reduced general condition"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"General physical health deterioration"	""	""	""	""	""	""	""	""	""	""	""	""
"5387"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	5	9	"Adverse Event/Serious Adverse Event"	4295740001	"laceration of scalp"	45	71	NA	2	NA	NA	NA	0	NA	NA	0	NA	NA	2	NA	1	NA	""	0	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513605860	""	""	""	NA	"Laceration"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Non-site specific injuries NEC"	"Laceration"	""	""	""	""	""	""	""	""	""	""	""	""
"5388"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	5	9	"Adverse Event/Serious Adverse Event"	3162245001	"loss of appetite"	10	31	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494148705	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5389"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	5	9	"Adverse Event/Serious Adverse Event"	3162257001	"neuropathy"	17	218	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494148994	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"5390"	"DN-101 Protocol No. 011-007"	"507"	"507-0011"	5	9	"Adverse Event/Serious Adverse Event"	4089110001	"prostate cancer disease progression"	218	218	NA	5	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	4	NA	0	0	4	NA	NA	1	NA	NA	NA	NA	""	252	218	0	NA	NA	"There have only been PSA evaluating tests"	""	""	2	2	2	2	2	2	2	2	"Paient died because of prostate cancer disease progression at home. Informed by wife by telefone"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511109610	""	""	""	NA	"Progression of pre-existing cancer"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Miscellaneous and site unspecified neoplasms malignant and unspecified"	"Neoplasms malignant site unspecified NEC"	"Malignant neoplasm progression"	""	""	""	""	""	""	""	""	""	""	""	""
"5391"	"DN-101 Protocol No. 011-007"	"507"	"507-0012"	5	9	"Adverse Event/Serious Adverse Event"	3009691003	"accident - knee"	112	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513610276	""	""	""	NA	"Knee injury"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Limb injuries NEC (incl traumatic amputation)"	"Joint injury"	""	""	""	""	""	""	""	""	""	""	""	""
"5392"	"DN-101 Protocol No. 011-007"	"507"	"507-0012"	5	9	"Adverse Event/Serious Adverse Event"	3132649001	"appetite loss"	28	268	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493222104	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5393"	"DN-101 Protocol No. 011-007"	"507"	"507-0012"	5	9	"Adverse Event/Serious Adverse Event"	4296282001	"elevated serum LDH"	48	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513609588	""	""	""	NA	"Serum LDH raised"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5394"	"DN-101 Protocol No. 011-007"	"507"	"507-0012"	5	9	"Adverse Event/Serious Adverse Event"	3132643001	"hair loss"	28	268	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493222056	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5395"	"DN-101 Protocol No. 011-007"	"507"	"507-0012"	5	9	"Adverse Event/Serious Adverse Event"	4296470001	"leucocytosis"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513610082	""	""	""	NA	"Leucocytosis NOS"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukocytoses NEC"	"Leukocytosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5396"	"DN-101 Protocol No. 011-007"	"507"	"507-0012"	5	9	"Adverse Event/Serious Adverse Event"	3745730001	"nail changes"	154	NA	1	3	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"patient was admitted to surgical and dermatologic department"	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506195852	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5397"	"DN-101 Protocol No. 011-007"	"507"	"507-0012"	5	9	"Adverse Event/Serious Adverse Event"	3334925001	"nose bleeding"	48	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498647169	""	""	""	NA	"Bleeding nose"	"Respiratory, thoracic and mediastinal disorders"	"Upper respiratory tract disorders (excl infections)"	"Nasal disorders NEC"	"Epistaxis"	""	""	""	""	""	""	""	""	""	""	""	""
"5398"	"DN-101 Protocol No. 011-007"	"507"	"507-0012"	5	9	"Adverse Event/Serious Adverse Event"	4296213001	"paresthesia"	268	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513609356	""	""	""	NA	"Paresthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5399"	"DN-101 Protocol No. 011-007"	"507"	"507-0012"	5	9	"Adverse Event/Serious Adverse Event"	3132653001	"tasting disorder"	7	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493222150	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5400"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	5	9	"Adverse Event/Serious Adverse Event"	3035957003	"anemia"	71	119	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515600376	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5401"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	5	9	"Adverse Event/Serious Adverse Event"	4443387002	"anemia"	163	232	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515600785	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5402"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	5	9	"Adverse Event/Serious Adverse Event"	3334996001	"anemia"	8	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498647840	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5403"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	5	9	"Adverse Event/Serious Adverse Event"	3456747001	"bone pain"	115	127	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"diagnostic by CT-scan"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	121	NA	NA	119	122	"CT-scan"	""	""	2	2	2	0	2	2	NA	2	"no skeletal fracture was observed; pain medication introduced"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501015100	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5404"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	5	9	"Adverse Event/Serious Adverse Event"	3132797001	"bone pain"	11	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493222952	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5405"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	5	9	"Adverse Event/Serious Adverse Event"	4095868001	"fatigue"	71	238	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511165166	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5406"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	5	9	"Adverse Event/Serious Adverse Event"	4442651002	"gastric and duodenal ulceration"	221	228	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	290	NA	NA	221	228	"Gastroscopy: Gastric and duodenal ulceration as the most likely sourca of bleeding. ; Colonoscopy: several small intestinal adenomas. no source of bleeding."	""	""	2	2	2	2	2	2	2	2	"patient was admitted to hospital with acute gastrointestinal bleeding. after blood transfusion hemoglobin levels were stable. gastroscopy revealed gastric and duodenal ulceration as the source of"	"bleeding."	""	""	""	""	""	""	""	""	""	NA	NA	""	1515599139	""	""	""	NA	"Duodenal ulcer"	"Gastrointestinal disorders"	"Gastrointestinal ulceration and perforation"	"Duodenal ulcers and perforation"	"Duodenal ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"5407"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	5	9	"Adverse Event/Serious Adverse Event"	3132789001	"hair loss"	8	255	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493222901	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5408"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	5	9	"Adverse Event/Serious Adverse Event"	3555146001	"neuropathy"	127	NA	1	1	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1503306843	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"5409"	"DN-101 Protocol No. 011-007"	"507"	"507-0013"	5	9	"Adverse Event/Serious Adverse Event"	3895495001	"pain lower back"	29	33	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508316490	""	""	""	NA	"Low back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5410"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	3118198003	"anemia"	35	190	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515674489	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5411"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	4043028001	"dyspnoe"	165	190	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510588369	""	""	""	NA	"Dyspnoea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5412"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	4042982001	"edema"	182	190	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510588177	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5413"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	4120861001	"fatigue"	77	190	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511689592	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5414"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	4120854001	"hair loss"	14	190	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511689467	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5415"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	5313974002	"infection by pseudomas"	175	181	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1524381704	""	""	""	NA	"Pseudomonas infection"	"Infections and infestations"	"Bacterial infectious disorders"	"Pseudomonal infections"	"Pseudomonas infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5416"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	3908621001	"Leukopenia"	190	190	NA	4	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	3	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	190	NA	NA	190	190	"Laboratory results: leucocytes 0.59/nl, hemoglobin 8.1 mg/dl, thrombocytes 79.000"	""	""	2	2	2	2	2	2	2	2	"Patient was admitted to hospital in bad general condition. Patient was somnolent, had gross edema and dyspnoe. Patient and relatives did not want any further investigation and treatment. Best"	"supportive care was given. Patient died a few ours after admission to hospital."	""	""	""	""	""	""	""	""	""	NA	NA	""	1508538692	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5417"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	3934502001	"leukopenia"	165	169	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	165	NA	NA	165	181	"Leucocytes 0.81 x E9/lw a neupogentherapy was administered"	""	""	2	2	2	2	2	2	2	2	"Patient was hospitalized with reduced general condition as an emergency"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508930213	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5418"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	4043045001	"loss of appetite"	35	129	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510588475	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5419"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	4839099002	"mucositis"	161	181	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518344686	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5420"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	3934511001	"oesophagitis"	161	181	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	3	1	1	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	165	NA	NA	165	181	"gastro-oesophagoscopy"	""	""	2	2	2	2	2	2	2	2	"patient was hospitalized as an emergency in a bad general condition. oesophagitis was diagnosed, pseudomonas aeruginosa and pneumocystis carinii were found and treated accordingly"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508930952	""	""	""	NA	"Oesophagitis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Oesophagitis (excl infective)"	"Oesophagitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5421"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	4043092001	"paresthesia"	182	190	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510588620	""	""	""	NA	"Paresthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5422"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	4043065001	"tasting disorder"	182	190	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510588542	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5423"	"DN-101 Protocol No. 011-007"	"507"	"507-0014"	5	9	"Adverse Event/Serious Adverse Event"	5174282002	"voiding disorder"	172	190	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521620163	""	""	""	NA	"Difficulty voiding"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Dysuria"	""	""	""	""	""	""	""	""	""	""	""	""
"5424"	"DN-101 Protocol No. 011-007"	"507"	"507-0015"	5	9	"Adverse Event/Serious Adverse Event"	3118213003	"bad general condition"	43	52	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	58	NA	NA	43	52	"clinical examination (04.06.07): patient in bad general condition, erysipelas at the right upper limb. ; laboratory data (04.06.07): abnormal: hemoglobin 11.1 mg/dl, thrombocytes 167/nl"	""	""	2	2	2	NA	2	2	NA	2	"massive worsening of general condition, inflammation of viggo-point"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497510697	""	""	""	NA	"Reduced general condition"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"General physical health deterioration"	""	""	""	""	""	""	""	""	""	""	""	""
"5425"	"DN-101 Protocol No. 011-007"	"507"	"507-0015"	5	9	"Adverse Event/Serious Adverse Event"	4925950002	"diarrhea"	58	64	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	309	NA	NA	58	64	"no data available as patient was treated in another hospital"	""	""	0	0	0	NA	0	0	NA	0	"patient was admitted to another hospital due to nausea, diarrhea and vomiting"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519212037	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5426"	"DN-101 Protocol No. 011-007"	"507"	"507-0015"	5	9	"Adverse Event/Serious Adverse Event"	4673333002	"diarrhea"	18	35	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	4	NA	NA	1	"patient was admitted to another hospital"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	150	NA	NA	21	35	"we were informed that patient was admitted to another hospital with acute diarrhea and worsening general condition. Ulcers of the rectum were diagnosed, we have no further information"	""	""	2	2	2	NA	2	2	2	2	"patient was admitted to another hospital with acute diarrhea and worsening general condition. Ulcers of the rectum were diagnosed, we have no further information"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517224899	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5427"	"DN-101 Protocol No. 011-007"	"507"	"507-0015"	5	9	"Adverse Event/Serious Adverse Event"	4988207002	"erysipelas right upper limb"	43	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519806426	""	""	""	NA	"Erysipelas"	"Infections and infestations"	"Bacterial infectious disorders"	"Streptococcal infections"	"Erysipelas"	""	""	""	""	""	""	""	""	""	""	""	""
"5428"	"DN-101 Protocol No. 011-007"	"507"	"507-0015"	5	9	"Adverse Event/Serious Adverse Event"	4894803002	"nausea"	58	64	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	306	NA	NA	58	64	"no further information, patient was treated in another hospital"	""	""	2	2	2	NA	2	2	NA	2	"patient was admitted to another hospital due to vomiting, nausea and diarrhea,"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518953164	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"5429"	"DN-101 Protocol No. 011-007"	"507"	"507-0015"	5	9	"Adverse Event/Serious Adverse Event"	3225543001	"Nausea"	18	35	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"Patient was admitted to another hospital"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	31	NA	NA	21	35	"We were informed by another hospital that the patient was admitted with acute diarrhea, nausea, vomitting and worsening of general condition. Up to now we only know that ulcers of the rectum were"	"diagnosed. We do not have any additional information so far."	""	2	2	2	NA	2	2	NA	2	"We were informed by another hospital that the patient was admitted with acute diarrhea, nausea, vomitting and worsening of general condition. Up to now we only know that ulcers of the rectum were"	"diagnosed. We do not have any additional information so far."	""	""	""	""	""	""	""	""	""	NA	NA	""	1495219661	""	""	""	NA	"Nausea"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Nausea"	""	""	""	""	""	""	""	""	""	""	""	""
"5430"	"DN-101 Protocol No. 011-007"	"507"	"507-0015"	5	9	"Adverse Event/Serious Adverse Event"	5296135002	"obstipation"	43	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523791092	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5431"	"DN-101 Protocol No. 011-007"	"507"	"507-0015"	5	9	"Adverse Event/Serious Adverse Event"	5240098002	"rectum ulcer"	18	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1522661106	""	""	""	NA	"Rectal ulcer"	"Gastrointestinal disorders"	"Gastrointestinal ulceration and perforation"	"Anal and rectal ulcers and perforation"	"Rectal ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"5432"	"DN-101 Protocol No. 011-007"	"507"	"507-0015"	5	9	"Adverse Event/Serious Adverse Event"	4673267002	"vomiting"	18	35	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	5	1	NA	1	"patient was admitted to another hospital"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	150	NA	NA	21	35	"we were informed by another hospital that patient was admitted with acute vomiting and worsening general condition. Ulcers of rectum were diagnosed. We have no further information"	""	""	2	2	2	NA	2	2	NA	2	"we were informed that patient was admitted to another hospital with acute vomiting and worsened general condition. Ulcers of the rectum were diagnosed. We have no further information"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517224097	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"5433"	"DN-101 Protocol No. 011-007"	"507"	"507-0015"	5	9	"Adverse Event/Serious Adverse Event"	4925989002	"vomiting"	58	64	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	309	NA	NA	58	64	"no further information available as patient was admitted to another hospital"	""	""	0	0	0	0	0	0	NA	0	"patient was admitted to another hospital due to vomiting nausea and diarrhea"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519212496	""	""	""	NA	"Vomiting"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Nausea and vomiting symptoms"	"Vomiting"	""	""	""	""	""	""	""	""	""	""	""	""
"5434"	"DN-101 Protocol No. 011-007"	"507"	"507-0018"	5	9	"Adverse Event/Serious Adverse Event"	3169931003	"alopecia"	85	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504003764	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5435"	"DN-101 Protocol No. 011-007"	"507"	"507-0018"	5	9	"Adverse Event/Serious Adverse Event"	4275755001	"appetite loss"	147	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513255959	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5436"	"DN-101 Protocol No. 011-007"	"507"	"507-0018"	5	9	"Adverse Event/Serious Adverse Event"	4275721001	"edema"	169	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513255484	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5437"	"DN-101 Protocol No. 011-007"	"507"	"507-0018"	5	9	"Adverse Event/Serious Adverse Event"	4275743001	"excessive tearing"	169	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513255786	""	""	""	NA	"Excess tears"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5438"	"DN-101 Protocol No. 011-007"	"507"	"507-0018"	5	9	"Adverse Event/Serious Adverse Event"	3994289001	"hematoma injection site"	43	64	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509876322	""	""	""	NA	"Hematoma injection site"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Injection site haematoma"	""	""	""	""	""	""	""	""	""	""	""	""
"5439"	"DN-101 Protocol No. 011-007"	"507"	"507-0018"	5	9	"Adverse Event/Serious Adverse Event"	3591181001	"nail disorder"	106	169	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504004001	""	""	""	NA	"Nail disorder"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5440"	"DN-101 Protocol No. 011-007"	"507"	"507-0018"	5	9	"Adverse Event/Serious Adverse Event"	3591178001	"neuropathy"	106	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504003915	""	""	""	NA	"Neuropathy"	"Nervous system disorders"	"Peripheral neuropathies"	"Peripheral neuropathies NEC"	"Neuropathy"	""	""	""	""	""	""	""	""	""	""	""	""
"5441"	"DN-101 Protocol No. 011-007"	"507"	"507-0018"	5	9	"Adverse Event/Serious Adverse Event"	3591175001	"tasting disorder"	106	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504003846	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5442"	"DN-101 Protocol No. 011-007"	"507"	"507-0018"	5	9	"Adverse Event/Serious Adverse Event"	4275854001	"tooth pain"	106	127	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513256961	""	""	""	NA	"Tooth pain"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Dental pain and sensation disorders"	"Toothache"	""	""	""	""	""	""	""	""	""	""	""	""
"5443"	"DN-101 Protocol No. 011-007"	"507"	"507-0019"	5	9	"Adverse Event/Serious Adverse Event"	3175154003	"back pain"	154	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"x-ray"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510572845	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5444"	"DN-101 Protocol No. 011-007"	"507"	"507-0019"	5	9	"Adverse Event/Serious Adverse Event"	4487045002	"fatigue"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516003076	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5445"	"DN-101 Protocol No. 011-007"	"507"	"507-0019"	5	9	"Adverse Event/Serious Adverse Event"	3314664001	"hairloss"	28	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498118753	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5446"	"DN-101 Protocol No. 011-007"	"507"	"507-0019"	5	9	"Adverse Event/Serious Adverse Event"	3809165001	"nail disorder"	91	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507107680	""	""	""	NA	"Nail disorder"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5447"	"DN-101 Protocol No. 011-007"	"507"	"507-0019"	5	9	"Adverse Event/Serious Adverse Event"	4277632001	"paresthesia"	217	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513268353	""	""	""	NA	"Paresthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5448"	"DN-101 Protocol No. 011-007"	"507"	"507-0019"	5	9	"Adverse Event/Serious Adverse Event"	4277610001	"sjoegren syndrome"	196	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513268242	""	""	""	NA	"Sjoegren's syndrome"	"Musculoskeletal and connective tissue disorders"	"Connective tissue disorders (excl congenital)"	"Connective tissue disorders (excl LE)"	"Sjogren's syndrome"	""	""	""	""	""	""	""	""	""	""	""	""
"5449"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	3359291003	"abdominal pain"	12	17	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510406774	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5450"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4031061001	"abdominal pain"	96	108	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510408215	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5451"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4031070001	"appetite loss"	93	96	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510408520	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5452"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4031088001	"bad general condition"	93	96	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510408764	""	""	""	NA	"Reduced general condition"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"General physical health deterioration"	""	""	""	""	""	""	""	""	""	""	""	""
"5453"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4051287001	"bad general condition"	114	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510657743	""	""	""	NA	"Reduced general condition"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"General physical health deterioration"	""	""	""	""	""	""	""	""	""	""	""	""
"5454"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4051349001	"bad smelling stools"	114	141	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510658096	""	""	""	NA	"Feces abnormal smell of"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Faecal abnormalities NEC"	"Abnormal faeces"	""	""	""	""	""	""	""	""	""	""	""	""
"5455"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4505319002	"elevated LDH"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516095252	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5456"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4051371001	"gastric pain"	30	51	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510658213	""	""	""	NA	"Gastric pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"5457"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4051318001	"gerneralized pain"	114	128	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510657897	""	""	""	NA	"Generalised aching"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5458"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4031030001	"hair loss"	30	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510407172	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5459"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4505341002	"hyperglykemia"	9	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516095350	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5460"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4031058001	"hypotension"	94	99	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510408111	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"5461"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4031037001	"loss of appetite"	51	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510407337	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5462"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4031020001	"loss of appetite"	12	17	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510406870	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5463"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4051332001	"obstipation"	114	141	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510658016	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5464"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4031067001	"obstipation"	93	96	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"clyster"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510408460	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5465"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4031084001	"pollakisuria"	96	108	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510408699	""	""	""	NA	"Pollakiuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Pollakiuria"	""	""	""	""	""	""	""	""	""	""	""	""
"5466"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4051301001	"tasting disorder"	114	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510657804	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5467"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4031079001	"tasting disorder"	93	99	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510408608	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5468"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4031010001	"tasting disorder"	12	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510406620	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5469"	"DN-101 Protocol No. 011-007"	"507"	"507-0023"	5	9	"Adverse Event/Serious Adverse Event"	4031034001	"tasting disorder"	51	54	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510407276	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5470"	"DN-101 Protocol No. 011-007"	"507"	"507-0026"	5	9	"Adverse Event/Serious Adverse Event"	3444905003	"duodenal ulceration"	14	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516120821	""	""	""	NA	"Duodenal ulcer"	"Gastrointestinal disorders"	"Gastrointestinal ulceration and perforation"	"Duodenal ulcers and perforation"	"Duodenal ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"5471"	"DN-101 Protocol No. 011-007"	"507"	"507-0026"	5	9	"Adverse Event/Serious Adverse Event"	3848523001	"esophagitis"	14	32	NA	4	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	3	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	51	NA	NA	14	32	"HP-test, PPI-therapy, antimykotic therapy"	""	""	2	2	2	2	2	2	2	2	"patient was admitted to another hospital. After medical treatment general condition had improved and patient was discharged. We received first information regarding the cours of the patient on"	"September fifth, 2007"	""	""	""	""	""	""	""	""	""	NA	NA	""	1507717568	""	""	""	NA	"Esophagitis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Oesophagitis (excl infective)"	"Oesophagitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5472"	"DN-101 Protocol No. 011-007"	"507"	"507-0026"	5	9	"Adverse Event/Serious Adverse Event"	3625241001	"leucopenia"	14	32	NA	4	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	51	NA	NA	14	32	"30.07.07: leukocytes 0.68/nl,"	""	""	2	2	2	2	2	2	2	2	"patient was admitted to another hospital with acute neutropenia and esophagitis. After medical treatment general condition improved and the patient was discharged on 17.08.07. We received the first"	"information regarding the course of the patient on 05.09.07. Therefore SAE report is late."	""	""	""	""	""	""	""	""	""	NA	NA	""	1504609359	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5473"	"DN-101 Protocol No. 011-007"	"507"	"507-0026"	5	9	"Adverse Event/Serious Adverse Event"	4508247002	"urinary tract infection"	14	32	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516120740	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5474"	"DN-101 Protocol No. 011-007"	"507"	"507-0027"	5	9	"Adverse Event/Serious Adverse Event"	3487393003	"cold"	39	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516520439	""	""	""	NA	"Cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5475"	"DN-101 Protocol No. 011-007"	"507"	"507-0027"	5	9	"Adverse Event/Serious Adverse Event"	4566688002	"cold"	149	151	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516520629	""	""	""	NA	"Cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5476"	"DN-101 Protocol No. 011-007"	"507"	"507-0027"	5	9	"Adverse Event/Serious Adverse Event"	4064221001	"hair loss"	28	37	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510737944	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5477"	"DN-101 Protocol No. 011-007"	"507"	"507-0027"	5	9	"Adverse Event/Serious Adverse Event"	4566682002	"nail changes"	112	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"cooling of hands during infusion"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516520512	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5478"	"DN-101 Protocol No. 011-007"	"507"	"507-0027"	5	9	"Adverse Event/Serious Adverse Event"	4064264001	"streaming eyes"	58	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510738991	""	""	""	NA	"Tearing eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5479"	"DN-101 Protocol No. 011-007"	"507"	"507-0027"	5	9	"Adverse Event/Serious Adverse Event"	4064228001	"tasting disorder"	35	37	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510738259	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5480"	"DN-101 Protocol No. 011-007"	"507"	"507-0027"	5	9	"Adverse Event/Serious Adverse Event"	4064255001	"tasting disorder"	73	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510738862	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5481"	"DN-101 Protocol No. 011-007"	"507"	"507-0027"	5	9	"Adverse Event/Serious Adverse Event"	4064241001	"tasting disorder"	53	59	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510738386	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5482"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	3525507003	"abdominal pain"	124	130	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	124	NA	NA	124	130	"hematology (11.12.07): hemoglobin 8.6 g/dl,"	""	""	2	2	2	2	2	2	2	2	"Patient was admitted to hospital with severe abdominal pain. After optimizing palliative therapy general condition improved and the patient was discharged on 17.12.07"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512985636	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5483"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	3978729001	"abdominal pain"	83	96	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	84	NA	NA	83	96	"X-Ray of abdomen (31.10.07): constipation; coloscopy (07.11.07): no evidence of bleeding; gastroscopy (06.11.07): gastritis, no bleeding"	""	""	2	2	2	2	2	2	2	2	"Patient presented with abdominal pain a few hours after last application of docetaxel on the 31.10.07. He did not open the bowels for a couple of days and reported on dark brown/black stools. Because"	"of the severity of pain and the risk of gastrointestinal bleeding he was admitted to hospital."	""	""	""	""	""	""	""	""	""	NA	NA	""	1509517213	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5484"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	5270854002	"anaemia"	85	86	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523181840	""	""	""	NA	"Anaemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5485"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	4066665001	"edema"	83	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510758643	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5486"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	4581290002	"elevation of gamma GT"	77	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516615501	""	""	""	NA	"Gamma GT raised"	"Investigations"	"Hepatobiliary investigations"	"Liver function analyses"	"Gamma-glutamyltransferase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5487"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	4581330002	"elevation of ldh"	41	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516615631	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5488"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	4066654001	"gastritis"	89	96	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510758591	""	""	""	NA	"Gastritis"	"Gastrointestinal disorders"	"Gastrointestinal inflammatory conditions"	"Gastritis (excl infective)"	"Gastritis"	""	""	""	""	""	""	""	""	""	""	""	""
"5489"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	4581612002	"hyperglykemia"	41	105	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516616800	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5490"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	4581640002	"hyperglykemia"	108	NA	1	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516616886	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5491"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	4581065002	"hypoproteinemia"	91	101	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516613110	""	""	""	NA	"Hypoproteinemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoproteinaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5492"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	4581367002	"leucopenia"	96	101	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516615768	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5493"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	3869935001	"loss of appetite"	62	83	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508060370	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5494"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	3869941001	"obstipation"	41	86	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508060553	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5495"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	4104364001	"pain upper spine"	101	112	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	104	NA	NA	100	112	"X-ray (18.11.07): no evidence of pathologic fracture of any vertebral body"	""	""	2	2	2	2	2	2	2	2	"Patient was admitted to hospital with pain in the upper spine and suspicion of pathologic fracture of a vetrebral body. Furthermore a nephrostoma was placed 19.11.07 on the right and on 23.11.07 on"	"the left side because of urinray obstruction.  After that general condition improved and the patient was discharged on 29.11.07."	""	""	""	""	""	""	""	""	""	NA	NA	""	1511244060	""	""	""	NA	"Pain in spine"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5496"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	3869938001	"tasting disorder"	62	83	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508060464	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5497"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	4581574002	"thrombocytosis"	62	125	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516616653	""	""	""	NA	"Thrombocytosis"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Secondary thrombocythaemias"	"Thrombocythaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5498"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	4581543002	"thrombocytosis"	20	41	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516616545	""	""	""	NA	"Thrombocytosis"	"Blood and lymphatic system disorders"	"Platelet disorders"	"Secondary thrombocythaemias"	"Thrombocythaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5499"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	5295345002	"urinary tract infection"	102	120	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523734329	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5500"	"DN-101 Protocol No. 011-007"	"507"	"507-0028"	5	9	"Adverse Event/Serious Adverse Event"	4580914002	"urinary tract infection"	41	62	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516611493	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5501"	"DN-101 Protocol No. 011-007"	"507"	"507-0031"	5	9	"Adverse Event/Serious Adverse Event"	3668850003	"anemia"	37	99	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516537577	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5502"	"DN-101 Protocol No. 011-007"	"507"	"507-0031"	5	9	"Adverse Event/Serious Adverse Event"	4989076002	"bronchitis"	36	83	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519811638	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5503"	"DN-101 Protocol No. 011-007"	"507"	"507-0031"	5	9	"Adverse Event/Serious Adverse Event"	4568202002	"elevation of alkaline phosphatase"	5	99	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516537716	""	""	""	NA	"Alkaline phosphatase increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood alkaline phosphatase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5504"	"DN-101 Protocol No. 011-007"	"507"	"507-0031"	5	9	"Adverse Event/Serious Adverse Event"	4568210002	"elevation of LDH"	42	99	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516537762	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5505"	"DN-101 Protocol No. 011-007"	"507"	"507-0031"	5	9	"Adverse Event/Serious Adverse Event"	4568498002	"hyperglykemia"	5	8	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516540222	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5506"	"DN-101 Protocol No. 011-007"	"507"	"507-0031"	5	9	"Adverse Event/Serious Adverse Event"	4568507002	"hyperglykemia"	41	56	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516540277	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5507"	"DN-101 Protocol No. 011-007"	"507"	"507-0031"	5	9	"Adverse Event/Serious Adverse Event"	4568179002	"hypoproteinemia"	34	99	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516537651	""	""	""	NA	"Hypoproteinemia"	"Metabolism and nutrition disorders"	"Protein and amino acid metabolism disorders NEC"	"Protein metabolism disorders NEC"	"Hypoproteinaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5508"	"DN-101 Protocol No. 011-007"	"507"	"507-0031"	5	9	"Adverse Event/Serious Adverse Event"	4568151002	"leucopenia"	34	36	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516537497	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5509"	"DN-101 Protocol No. 011-007"	"507"	"507-0031"	5	9	"Adverse Event/Serious Adverse Event"	4989049002	"mucositis"	34	83	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519811564	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5510"	"DN-101 Protocol No. 011-007"	"507"	"507-0031"	5	9	"Adverse Event/Serious Adverse Event"	4989095002	"obstipation"	36	83	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519811726	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5511"	"DN-101 Protocol No. 011-007"	"507"	"507-0031"	5	9	"Adverse Event/Serious Adverse Event"	4567905002	"open wound of spine surgery"	75	82	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	-229	NA	NA	75	82	"Clinical examination (21.11.07): open wound of spine surgery."	""	""	2	2	2	NA	2	2	NA	2	"Patient was re-admitted to hospital from rehablilitation because of an open wound. The wound was reoperated on 22.11.07 and 28.11.07."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516535169	""	""	""	NA	"Open wound"	"Injury, poisoning and procedural complications"	"Injuries NEC"	"Non-site specific injuries NEC"	"Open wound"	""	""	""	""	""	""	""	""	""	""	""	""
"5512"	"DN-101 Protocol No. 011-007"	"507"	"507-0031"	5	9	"Adverse Event/Serious Adverse Event"	3917653001	"pathologic fracture of spine"	34	60	NA	4	3	1	1	NA	NA	NA	1	1	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	46	NA	NA	34	60	"X-Ray: pathologic fracture of lumbar spine with instability"	""	""	2	2	2	2	2	2	2	2	"Patient was admitted to hospital on 11.10.07 with back pain and immoblility since 2 days. After diagnosis of pathologic fracture patient underwent spondylodesis of L1-L5 and laminektomy L2-L4 on"	"13.10.07. Docetaxel was witheld on 24.10.07 due to the reduced general condition and in order to avoid delay of recovery from surgery. Since the patient receives dexamethasone 8mg 3 times per day for"	"the prevention of spinal edema post surgery prednisone was stopped and will be introduced again after stopping dexamethasone. The treatment was stopped on 30.10.07 because the patient needed"	"neurologic rehabilitation first an was therefore discharged on 06.11.07."	""	""	""	""	""	""	""	NA	NA	""	1508761375	""	""	""	NA	"Pathologic fracture of vertebrae"	"Musculoskeletal and connective tissue disorders"	"Fractures"	"Pathological fractures and complications"	"Pathological fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"5513"	"DN-101 Protocol No. 011-007"	"507"	"507-0032"	5	9	"Adverse Event/Serious Adverse Event"	3698103003	"alopecia"	31	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508311680	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5514"	"DN-101 Protocol No. 011-007"	"507"	"507-0032"	5	9	"Adverse Event/Serious Adverse Event"	4567066002	"elevation of LDH"	57	78	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516524516	""	""	""	NA	"LDH increased"	"Investigations"	"Enzyme investigations NEC"	"Tissue enzyme analyses NEC"	"Blood lactate dehydrogenase increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5515"	"DN-101 Protocol No. 011-007"	"507"	"507-0032"	5	9	"Adverse Event/Serious Adverse Event"	4567069002	"leucopenia"	15	36	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516524613	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5516"	"DN-101 Protocol No. 011-007"	"507"	"507-0032"	5	9	"Adverse Event/Serious Adverse Event"	4567084002	"nail changes"	99	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"cooling    hands during infusion"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516524797	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5517"	"DN-101 Protocol No. 011-007"	"507"	"507-0032"	5	9	"Adverse Event/Serious Adverse Event"	4567062002	"paresthesia"	99	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516524445	""	""	""	NA	"Paresthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5518"	"DN-101 Protocol No. 011-007"	"507"	"507-0032"	5	9	"Adverse Event/Serious Adverse Event"	3925691001	"tasting disorder"	15	19	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508841110	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5519"	"DN-101 Protocol No. 011-007"	"508"	"508-0001"	5	9	"Adverse Event/Serious Adverse Event"	2900243003	"leucocytopenia"	28	127	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499850219	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5520"	"DN-101 Protocol No. 011-007"	"508"	"508-0001"	5	9	"Adverse Event/Serious Adverse Event"	4216143001	"Pathalogical Bone Fracture of Lower Extremity (SRE)"	239	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	239	NA	NA	239	NA	"information by telephone by his wife. We got no more information. Patient is not hospitalized at our center."	""	""	0	2	2	NA	2	2	NA	2	"pathologic bone fracture of the lower extremity. It is unknown if this event is related to bone metastasis or to osteoporosis."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512651684	""	""	""	NA	"Pathological fracture"	"Musculoskeletal and connective tissue disorders"	"Fractures"	"Pathological fractures and complications"	"Pathological fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"5521"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	2943359003	"dysgeusia"	76	91	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502804627	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5522"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	3994788001	"Leucopenia"	234	240	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509892436	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5523"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	3619164001	"Leucopenia"	188	196	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504529777	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5524"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	3350305001	"Leucopenia"	115	137	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499007766	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5525"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	3994783001	"Leucopenia"	209	216	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509892318	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5526"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	4674170002	"leucopenia"	308	309	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517227854	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5527"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	3258640001	"Leucopenia"	66	73	NA	4	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496578181	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5528"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	3533035001	"Leucopenia"	146	150	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502804335	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5529"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	3258735001	"Leucopenia"	94	105	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496580327	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5530"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	3619147001	"Leucopenia"	164	181	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504529693	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5531"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	4674115002	"leucopenia"	281	293	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517227715	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5532"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	4674148002	"leucopenia"	300	304	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517227795	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5533"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	3092651001	"Leukopenia"	27	30	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492422511	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5534"	"DN-101 Protocol No. 011-007"	"509"	"509-0001"	5	9	"Adverse Event/Serious Adverse Event"	3092671001	"Leukopenia"	45	51	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492422910	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5535"	"DN-101 Protocol No. 011-007"	"509"	"509-0005"	5	9	"Adverse Event/Serious Adverse Event"	3061079003	"leucopenia"	61	67	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517233462	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5536"	"DN-101 Protocol No. 011-007"	"509"	"509-0005"	5	9	"Adverse Event/Serious Adverse Event"	4675738002	"leucopenia"	123	126	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517233779	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5537"	"DN-101 Protocol No. 011-007"	"509"	"509-0005"	5	9	"Adverse Event/Serious Adverse Event"	4676082002	"leucopenia"	186	207	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517235051	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5538"	"DN-101 Protocol No. 011-007"	"509"	"509-0005"	5	9	"Adverse Event/Serious Adverse Event"	4675700002	"leucopenia"	81	88	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517233640	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5539"	"DN-101 Protocol No. 011-007"	"509"	"509-0005"	5	9	"Adverse Event/Serious Adverse Event"	3384715001	"Leucopenia"	25	39	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499695232	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5540"	"DN-101 Protocol No. 011-007"	"509"	"509-0005"	5	9	"Adverse Event/Serious Adverse Event"	4675718002	"leucopenia"	102	109	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517233709	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5541"	"DN-101 Protocol No. 011-007"	"509"	"509-0005"	5	9	"Adverse Event/Serious Adverse Event"	3157006001	"Radius fracture (surgery 2007-05-03) not an SRE"	26	39	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	3	1	1	NA	""	3	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	35	NA	NA	35	39	"control x-ray after surgery"	""	""	0	0	0	NA	0	0	NA	0	"Patient tumbled on his way home. By falling down he leaned on his left arm. Result of this aktion, was an fracture of his left radius ."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493810611	""	""	""	NA	"Radius fracture"	"Injury, poisoning and procedural complications"	"Bone and joint injuries"	"Upper limb fractures and dislocations"	"Radius fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"5542"	"DN-101 Protocol No. 011-007"	"511"	"511-0001"	5	9	"Adverse Event/Serious Adverse Event"	2763427004	"eye problems; cataracta corticonuclearis"	157	167	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"eye operation in ITN PPV with Endo-Lako and Gastamponade; (this is no concomitant medication)"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	463	NA	NA	161	167	"Visus LA -0.5 -0.5x114grad/0.4"	""	""	2	2	2	NA	2	2	NA	2	"eye operation; Cataractia corticonuclearis; Endo-Lako"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517257049	""	""	""	NA	"Cataract nuclear"	"Eye disorders"	"Anterior eye structural change, deposit and degeneration"	"Cataract conditions"	"Cataract nuclear"	""	""	""	""	""	""	""	""	""	""	""	""
"5543"	"DN-101 Protocol No. 011-007"	"511"	"511-0001"	5	9	"Adverse Event/Serious Adverse Event"	3407434001	"Leukopenia"	203	211	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499845982	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5544"	"DN-101 Protocol No. 011-007"	"511"	"511-0001"	5	9	"Adverse Event/Serious Adverse Event"	3407416001	"Leukopenia"	231	251	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499845821	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5545"	"DN-101 Protocol No. 011-007"	"511"	"511-0001"	5	9	"Adverse Event/Serious Adverse Event"	3407381001	"Leukopenia"	182	182	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499845488	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5546"	"DN-101 Protocol No. 011-007"	"511"	"511-0001"	5	9	"Adverse Event/Serious Adverse Event"	3407387001	"Leukopenia"	157	169	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499845559	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5547"	"DN-101 Protocol No. 011-007"	"511"	"511-0001"	5	9	"Adverse Event/Serious Adverse Event"	3407373001	"Leukopenia"	49	49	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499845192	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5548"	"DN-101 Protocol No. 011-007"	"511"	"511-0003"	5	9	"Adverse Event/Serious Adverse Event"	2885635003	"haematuria"	33	41	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508617544	""	""	""	NA	"Haematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"5549"	"DN-101 Protocol No. 011-007"	"511"	"511-0003"	5	9	"Adverse Event/Serious Adverse Event"	4659112002	"heartburn"	185	191	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517162450	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"5550"	"DN-101 Protocol No. 011-007"	"511"	"511-0003"	5	9	"Adverse Event/Serious Adverse Event"	3908856001	"heartburn"	76	78	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508617774	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"5551"	"DN-101 Protocol No. 011-007"	"511"	"511-0003"	5	9	"Adverse Event/Serious Adverse Event"	3908837001	"loss of appetite"	17	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508617249	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5552"	"DN-101 Protocol No. 011-007"	"511"	"511-0005"	5	9	"Adverse Event/Serious Adverse Event"	2989091003	"allergic reaction"	38	41	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507711678	""	""	""	NA	"Allergic reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"5553"	"DN-101 Protocol No. 011-007"	"511"	"511-0005"	5	9	"Adverse Event/Serious Adverse Event"	3848393001	"bronchitis"	189	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507716598	""	""	""	NA	"Bronchitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5554"	"DN-101 Protocol No. 011-007"	"511"	"511-0005"	5	9	"Adverse Event/Serious Adverse Event"	3847963001	"dry mouth"	38	41	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507711548	""	""	""	NA	"Dry mouth"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Dry mouth"	""	""	""	""	""	""	""	""	""	""	""	""
"5555"	"DN-101 Protocol No. 011-007"	"511"	"511-0005"	5	9	"Adverse Event/Serious Adverse Event"	3847989001	"leucopenia"	90	92	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507711946	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5556"	"DN-101 Protocol No. 011-007"	"511"	"511-0005"	5	9	"Adverse Event/Serious Adverse Event"	3847985001	"oral mucositis"	59	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507711833	""	""	""	NA	"Mucositis oral"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5557"	"DN-101 Protocol No. 011-007"	"511"	"511-0006"	5	9	"Adverse Event/Serious Adverse Event"	3113949003	"Leucocytes deceased"	143	210	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517166561	""	""	""	NA	"Leukocyte count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5558"	"DN-101 Protocol No. 011-007"	"511"	"511-0006"	5	9	"Adverse Event/Serious Adverse Event"	4660743002	"Leucozytes decreased"	38	125	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517166485	""	""	""	NA	"Leukocyte count decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5559"	"DN-101 Protocol No. 011-007"	"511"	"511-0006"	5	9	"Adverse Event/Serious Adverse Event"	4660809002	"loss of appetite"	210	216	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517166651	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5560"	"DN-101 Protocol No. 011-007"	"511"	"511-0006"	5	9	"Adverse Event/Serious Adverse Event"	3848534001	"lost taste"	11	19	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507718050	""	""	""	NA	"Loss of taste"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Ageusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5561"	"DN-101 Protocol No. 011-007"	"511"	"511-0006"	5	9	"Adverse Event/Serious Adverse Event"	3848538001	"pimples"	11	19	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507718189	""	""	""	NA	"Pimples"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Acnes"	"Acne"	""	""	""	""	""	""	""	""	""	""	""	""
"5562"	"DN-101 Protocol No. 011-007"	"511"	"511-0006"	5	9	"Adverse Event/Serious Adverse Event"	4660909002	"watery eyes"	210	216	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517166835	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5563"	"DN-101 Protocol No. 011-007"	"511"	"511-0007"	5	9	"Adverse Event/Serious Adverse Event"	3175671003	"nail disorder"	196	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516307197	""	""	""	NA	"Nail disorder"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5564"	"DN-101 Protocol No. 011-007"	"511"	"511-0007"	5	9	"Adverse Event/Serious Adverse Event"	4555578002	"skin disorder"	196	230	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516307356	""	""	""	NA	"Skin disorder"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Skin disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5565"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3141707003	"allergic reaction, face redness"	8	27	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	16	NA	NA	8	10	"no tests"	""	""	2	2	2	NA	2	2	NA	2	"Patient got redness on his face 8 hours after the end of infusion. Pat. got Dimetinden 2x 1 mg per day"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494405643	""	""	""	NA	"Allergic reaction"	"Immune system disorders"	"Allergic conditions"	"Allergic conditions NEC"	"Hypersensitivity"	""	""	""	""	""	""	""	""	""	""	""	""
"5566"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3986967001	"Alopecia"	50	272	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509615201	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5567"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3179750001	"burning flank pain"	11	21	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494489372	""	""	""	NA	"Flank pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Flank pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5568"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	4008651001	"common cold"	190	192	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510043583	""	""	""	NA	"Common cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5569"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	4392612002	"dry eye syndrome"	207	238	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515325452	""	""	""	NA	"Dry eye syndrome"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Keratoconjunctivitis sicca"	""	""	""	""	""	""	""	""	""	""	""	""
"5570"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	4392549002	"edema"	217	272	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515324623	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5571"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3970688001	"edema"	165	176	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509443348	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5572"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3787752001	"edema"	113	120	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506842516	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5573"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3382529001	"fever"	74	75	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499672640	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5574"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3382770001	"headache"	74	74	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499676896	""	""	""	NA	"Headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"5575"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3348298001	"leukopenia"	57	64	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498979770	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5576"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3179687001	"leukopenia"	16	21	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494488612	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5577"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3668922001	"leukopenia"	127	135	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505206479	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5578"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542984001	"leukopenia"	98	105	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502959817	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5579"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542975001	"leukopenia"	77	84	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502959501	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5580"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542981001	"myalgia"	95	98	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502959731	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5581"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3237412001	"pain in the neck"	19	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495614091	""	""	""	NA	"Pain neck"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Neck pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5582"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3179723001	"polymyalgia"	11	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494489023	""	""	""	NA	"Polymyalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Polymyalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5583"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3970702001	"prickel hands and feet"	164	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509443475	""	""	""	NA	"Tingling feet/hands"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5584"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3237421001	"prickel in hands and legs"	19	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495614444	""	""	""	NA	"Prickling of hand"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5585"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3542978001	"urinarytract infection"	77	84	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502959638	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5586"	"DN-101 Protocol No. 011-007"	"513"	"513-0003"	5	9	"Adverse Event/Serious Adverse Event"	3237407001	"vesicular eczema face, neck and hands"	17	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1495613303	""	""	""	NA	"Eczema vesicular"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermatitis and eczema"	"Eczema vesicular"	""	""	""	""	""	""	""	""	""	""	""	""
"5587"	"DN-101 Protocol No. 011-007"	"514"	"514-0001"	5	9	"Adverse Event/Serious Adverse Event"	3435090003	"Arthralgia left foot"	61	72	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505056654	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5588"	"DN-101 Protocol No. 011-007"	"514"	"514-0001"	5	9	"Adverse Event/Serious Adverse Event"	4078416001	"arthralgia, mtp joint big toe"	136	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510842551	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5589"	"DN-101 Protocol No. 011-007"	"514"	"514-0001"	5	9	"Adverse Event/Serious Adverse Event"	3654121001	"hair loss"	47	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505056322	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5590"	"DN-101 Protocol No. 011-007"	"514"	"514-0001"	5	9	"Adverse Event/Serious Adverse Event"	4078322001	"Leucocytosis"	93	156	NA	1	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510842260	""	""	""	NA	"Leucocytosis NOS"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukocytoses NEC"	"Leukocytosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5591"	"DN-101 Protocol No. 011-007"	"514"	"514-0001"	5	9	"Adverse Event/Serious Adverse Event"	4078387001	"sweating"	136	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510842437	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5592"	"DN-101 Protocol No. 011-007"	"515"	"515-0001"	5	9	"Adverse Event/Serious Adverse Event"	2910083003	"hypertension with RR 209/108 mmHg HF:108"	90	90	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Nitrendipin 5 mg- ; 20 min post Nitrendipinr- RR: 152/82 HF: 95"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494356250	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"5593"	"DN-101 Protocol No. 011-007"	"515"	"515-0001"	5	9	"Adverse Event/Serious Adverse Event"	4702331002	"pain in bone"	279	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517330206	""	""	""	NA	"Pain bone"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5594"	"DN-101 Protocol No. 011-007"	"515"	"515-0001"	5	9	"Adverse Event/Serious Adverse Event"	3948917001	"pain in legs"	253	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509056135	""	""	""	NA	"Pain legs"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Pain in extremity"	""	""	""	""	""	""	""	""	""	""	""	""
"5595"	"DN-101 Protocol No. 011-007"	"515"	"515-0001"	5	9	"Adverse Event/Serious Adverse Event"	4702136002	"urinary tract infection"	139	145	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517329748	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5596"	"DN-101 Protocol No. 011-007"	"515"	"515-0001"	5	9	"Adverse Event/Serious Adverse Event"	3187415001	"urinary tract infection"	48	50	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494784569	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5597"	"DN-101 Protocol No. 011-007"	"515"	"515-0001"	5	9	"Adverse Event/Serious Adverse Event"	3187456001	"urinary tract infection"	83	88	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494784689	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5598"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	2964464003	"caugh"	12	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493119928	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"5599"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	3869171001	"circulatory disorder in foots"	157	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"use of cooling gloves during docetaxel infusion"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507975671	""	""	""	NA	"Circulatory disorder peripheral"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Peripheral vascular disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5600"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	3869178001	"common cold"	197	204	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507976450	""	""	""	NA	"Common cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5601"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	3126734001	"diminuation of taste"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493120157	""	""	""	NA	"Taste diminished"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Hypogeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5602"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	3294700001	"dry mucosa"	51	71	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497606057	""	""	""	NA	"Mucosal dryness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Mucosal findings abnormal"	"Mucosal dryness"	""	""	""	""	""	""	""	""	""	""	""	""
"5603"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	3294710001	"dry skin on hands,fingers and lips"	92	NA	1	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497606826	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"5604"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	3383413001	"hyposalivation"	12	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499685631	""	""	""	NA	"Saliva decreased"	"Gastrointestinal disorders"	"Salivary gland conditions"	"Oral dryness and saliva altered"	"Aptyalism"	""	""	""	""	""	""	""	""	""	""	""	""
"5605"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	5008095002	"leukopenia"	161	183	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519922388	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5606"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	3367295001	"leukopenia"	121	121	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499329087	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5607"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	3113205001	"Leukopenia"	57	69	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492771254	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5608"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	3294718001	"loosening of fingernails"	99	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"cooling gloves during docetaxel infusion"	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497607770	""	""	""	NA	"Onycholysis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onycholysis"	""	""	""	""	""	""	""	""	""	""	""	""
"5609"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	3168679001	"loss of hair"	29	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494271067	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5610"	"DN-101 Protocol No. 011-007"	"515"	"515-0003"	5	9	"Adverse Event/Serious Adverse Event"	4648843002	"onchyolysis"	218	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517058720	""	""	""	NA	"Onycholysis"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onycholysis"	""	""	""	""	""	""	""	""	""	""	""	""
"5611"	"DN-101 Protocol No. 011-007"	"515"	"515-0004"	5	9	"Adverse Event/Serious Adverse Event"	2964470003	"common cold"	49	56	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519141583	""	""	""	NA	"Common cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5612"	"DN-101 Protocol No. 011-007"	"515"	"515-0004"	5	9	"Adverse Event/Serious Adverse Event"	3950705001	"edema in lower legs"	189	254	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509134657	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5613"	"DN-101 Protocol No. 011-007"	"515"	"515-0004"	5	9	"Adverse Event/Serious Adverse Event"	4915990002	"fatique"	189	254	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519141651	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5614"	"DN-101 Protocol No. 011-007"	"515"	"515-0004"	5	9	"Adverse Event/Serious Adverse Event"	4916036002	"flush in face"	56	126	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519141764	""	""	""	NA	"Flushing of face"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Flushing"	""	""	""	""	""	""	""	""	""	""	""	""
"5615"	"DN-101 Protocol No. 011-007"	"515"	"515-0004"	5	9	"Adverse Event/Serious Adverse Event"	3950666001	"increased lacrimation"	168	254	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509134279	""	""	""	NA	"Lacrimation increased"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5616"	"DN-101 Protocol No. 011-007"	"515"	"515-0004"	5	9	"Adverse Event/Serious Adverse Event"	4916170002	"ischalgia"	226	254	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519142202	""	""	""	NA	"Lumbago"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5617"	"DN-101 Protocol No. 011-007"	"515"	"515-0004"	5	9	"Adverse Event/Serious Adverse Event"	4681935002	"leucopenia"	56	79	NA	4	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517246322	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5618"	"DN-101 Protocol No. 011-007"	"515"	"515-0004"	5	9	"Adverse Event/Serious Adverse Event"	3167949001	"loss of hair"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494261572	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5619"	"DN-101 Protocol No. 011-007"	"515"	"515-0004"	5	9	"Adverse Event/Serious Adverse Event"	4916088002	"nail-changes"	126	254	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519141911	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5620"	"DN-101 Protocol No. 011-007"	"515"	"515-0004"	5	9	"Adverse Event/Serious Adverse Event"	3950694001	"sensory disturbance in legs"	189	254	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509134486	""	""	""	NA	"Sensory disturbance"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Sensory disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"5621"	"DN-101 Protocol No. 011-007"	"515"	"515-0004"	5	9	"Adverse Event/Serious Adverse Event"	4916136002	"urinary tract infection"	196	226	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519142096	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5622"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	3026451003	"constipation"	194	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519922953	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5623"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	5008294002	"constipation"	20	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519922839	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5624"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	3426421001	"decompensated cardiac insufficiency, valvular aortic stenosis"	106	117	NA	4	2	NA	1	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	118	NA	NA	106	117	"ECG (electrocardiogram)"	""	""	2	2	2	NA	2	2	2	2	"decompensated cardiac insufficiency,NYHA IV"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500312701	""	""	""	NA	"Aortic stenosis"	"Vascular disorders"	"Arteriosclerosis, stenosis, vascular insufficiency and necrosis"	"Aortic necrosis and vascular insufficiency"	"Aortic stenosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5625"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	5008419002	"dyspnea"	106	117	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519923357	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5626"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	5008443002	"edema"	106	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519923429	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5627"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	5008312002	"fatique"	166	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519922905	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5628"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	3804758001	"gastric complaints"	174	187	NA	1	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507054791	""	""	""	NA	"Gastric irritation"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal signs and symptoms NEC"	"Stomach discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"5629"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	5008490002	"insomnia"	131	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519923558	""	""	""	NA	"Insomnia"	"Psychiatric disorders"	"Sleep disorders and disturbances"	"Disturbances in initiating and maintaining sleep"	"Insomnia"	""	""	""	""	""	""	""	""	""	""	""	""
"5630"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	5008398002	"nail changes"	177	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519923291	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5631"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	3075563001	"paroxysmal atrium arrhythmia"	10	15	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	20	NA	NA	10	15	"ECG,atrium-flutter"	""	""	2	2	2	NA	2	2	NA	2	"paroxysmal atrium arrhythmia"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1491861200	""	""	""	NA	"Paroxysmal arrhythmia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Paroxysmal arrhythmia"	""	""	""	""	""	""	""	""	""	""	""	""
"5632"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	5008341002	"sweating"	166	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519923075	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5633"	"DN-101 Protocol No. 011-007"	"515"	"515-0005"	5	9	"Adverse Event/Serious Adverse Event"	5008463002	"watery eyes"	208	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519923498	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5634"	"DN-101 Protocol No. 011-007"	"515"	"515-0007"	5	9	"Adverse Event/Serious Adverse Event"	3076265003	"alopecia"	27	237	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519926714	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5635"	"DN-101 Protocol No. 011-007"	"515"	"515-0007"	5	9	"Adverse Event/Serious Adverse Event"	3867792001	"arteriosclerosis stenosans due to diabetes mellitus"	183	188	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	183	188	"duplex sonography 2007-10-01; echocardiography 2007-10-11; angiography 2007-10-12; percutan transluminal angioplasty 2007-10-12"	""	""	0	0	0	NA	0	0	NA	0	"arteriosclerosis stenosans with diabetic foot syndrome and neuropathic disease with ulcus on left foot; reason:Complication of diabetes mellitus-no connection with chemotherapy"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507899373	""	""	""	NA	"Arteriosclerosis"	"Vascular disorders"	"Arteriosclerosis, stenosis, vascular insufficiency and necrosis"	"Non-site specific necrosis and vascular insufficiency NEC"	"Arteriosclerosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5636"	"DN-101 Protocol No. 011-007"	"515"	"515-0007"	5	9	"Adverse Event/Serious Adverse Event"	5009451002	"fatique"	49	70	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519926779	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5637"	"DN-101 Protocol No. 011-007"	"515"	"515-0007"	5	9	"Adverse Event/Serious Adverse Event"	3295153001	"leukopenia"	35	44	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497619494	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5638"	"DN-101 Protocol No. 011-007"	"515"	"515-0007"	5	9	"Adverse Event/Serious Adverse Event"	3295161001	"leukopenia"	56	61	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497619662	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5639"	"DN-101 Protocol No. 011-007"	"515"	"515-0007"	5	9	"Adverse Event/Serious Adverse Event"	5009468002	"lumboischalgia"	84	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519926857	""	""	""	NA	"Lumboischialgia"	"Nervous system disorders"	"Spinal cord and nerve root disorders"	"Lumbar spinal cord and nerve root disorders"	"Sciatica"	""	""	""	""	""	""	""	""	""	""	""	""
"5640"	"DN-101 Protocol No. 011-007"	"515"	"515-0007"	5	9	"Adverse Event/Serious Adverse Event"	5009484002	"urinary tract infection"	133	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519926927	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5641"	"DN-101 Protocol No. 011-007"	"515"	"515-0007"	5	9	"Adverse Event/Serious Adverse Event"	5009406002	"vertigo"	15	15	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519926584	""	""	""	NA	"Vertigo"	"Ear and labyrinth disorders"	"Inner ear and VIIIth cranial nerve disorders"	"Inner ear signs and symptoms"	"Vertigo"	""	""	""	""	""	""	""	""	""	""	""	""
"5642"	"DN-101 Protocol No. 011-007"	"515"	"515-0007"	5	9	"Adverse Event/Serious Adverse Event"	3295135001	"weight loss"	6	333	NA	2	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497618067	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5643"	"DN-101 Protocol No. 011-007"	"515"	"515-0007"	5	9	"Adverse Event/Serious Adverse Event"	5009392002	"weigt less"	176	237	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519926496	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5644"	"DN-101 Protocol No. 011-007"	"515"	"515-0008"	5	9	"Adverse Event/Serious Adverse Event"	3157031003	"iron deficiency anemia"	101	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520679412	""	""	""	NA	"Iron deficiency anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemia deficiencies"	"Iron deficiency anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5645"	"DN-101 Protocol No. 011-007"	"515"	"515-0008"	5	9	"Adverse Event/Serious Adverse Event"	3453838001	"makrohaematuria"	85	94	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	86	NA	NA	87	94	"histology: urocystitis"	""	""	0	0	0	NA	0	0	0	0	"diagnostic tutur because of macrohaematuria"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500997756	""	""	""	NA	"Haematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"5646"	"DN-101 Protocol No. 011-007"	"515"	"515-0008"	5	9	"Adverse Event/Serious Adverse Event"	3675428001	"prearranged hospitalization because of implantation of portcathetersystem"	130	134	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	6	NA	1	1	"implantation of a portkathetersystem inguinal right side"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	135	NA	NA	129	134	"prearrenged hospitalisation"	""	""	0	0	0	0	0	0	0	0	"prearrenged hospitalisation to implantation of a portkathetersystem inguinal right side"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505244976	""	""	""	NA	"Catheter placement"	"Surgical and medical procedures"	"Therapeutic procedures and supportive care NEC"	"Therapeutic procedures NEC"	"Catheter placement"	""	""	""	""	""	""	""	""	""	""	""	""
"5647"	"DN-101 Protocol No. 011-007"	"515"	"515-0008"	5	9	"Adverse Event/Serious Adverse Event"	5073924002	"urinary tract infection"	39	NA	1	1	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520679138	""	""	""	NA	"Urinary tract infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5648"	"DN-101 Protocol No. 011-007"	"515"	"515-0012"	5	9	"Adverse Event/Serious Adverse Event"	3708242003	"back pain"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521379810	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5649"	"DN-101 Protocol No. 011-007"	"515"	"515-0012"	5	9	"Adverse Event/Serious Adverse Event"	3959011001	"hypotonic dehydration"	40	44	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	40	NA	NA	40	44	"X-Ray of chest 2007-10-30; Laboratory investigations"	""	""	0	0	0	NA	0	0	0	0	"dyspnoe,exsiccosis,increased creatinine"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509316203	""	""	""	NA	"Hypotonic dehydration"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Total fluid volume decreased"	"Dehydration"	""	""	""	""	""	""	""	""	""	""	""	""
"5650"	"DN-101 Protocol No. 011-007"	"515"	"515-0012"	5	9	"Adverse Event/Serious Adverse Event"	3949813001	"loss of hair"	21	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509115364	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5651"	"DN-101 Protocol No. 011-007"	"515"	"515-0012"	5	9	"Adverse Event/Serious Adverse Event"	5074004002	"non-cardiac chest pain"	30	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1520681684	""	""	""	NA	"Chest pain (non-cardiac)"	"General disorders and administration site conditions"	"General system disorders NEC"	"Pain and discomfort NEC"	"Non-cardiac chest pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5652"	"DN-101 Protocol No. 011-007"	"515"	"515-0014"	5	9	"Adverse Event/Serious Adverse Event"	3809791003	"diarrhoe"	5	6	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516713536	""	""	""	NA	"Diarrhoea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5653"	"DN-101 Protocol No. 011-007"	"515"	"515-0014"	5	9	"Adverse Event/Serious Adverse Event"	4605891002	"loss of appetite"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516713622	""	""	""	NA	"Appetite lost"	"Metabolism and nutrition disorders"	"Appetite and general nutritional disorders"	"Appetite disorders"	"Anorexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5654"	"DN-101 Protocol No. 011-007"	"515"	"515-0014"	5	9	"Adverse Event/Serious Adverse Event"	4605904002	"loss of taste"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516713775	""	""	""	NA	"Loss of taste"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Ageusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5655"	"DN-101 Protocol No. 011-007"	"515"	"515-0014"	5	9	"Adverse Event/Serious Adverse Event"	4605839002	"metallic taste"	12	20	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516713419	""	""	""	NA	"Taste metallic"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5656"	"DN-101 Protocol No. 011-007"	"515"	"515-0014"	5	9	"Adverse Event/Serious Adverse Event"	4605896002	"muscle pain"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516713703	""	""	""	NA	"Muscle pain"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5657"	"DN-101 Protocol No. 011-007"	"518"	"518-0001"	5	9	"Adverse Event/Serious Adverse Event"	3086987003	"Ankle edema"	176	211	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Compression sock"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508762419	""	""	""	NA	"Ankle edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5658"	"DN-101 Protocol No. 011-007"	"518"	"518-0001"	5	9	"Adverse Event/Serious Adverse Event"	3334751001	"Creatinin increase"	25	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498644777	""	""	""	NA	"Creatinine high"	"Investigations"	"Renal and urinary tract investigations and urinalyses"	"Renal function analyses"	"Blood creatinine increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5659"	"DN-101 Protocol No. 011-007"	"518"	"518-0001"	5	9	"Adverse Event/Serious Adverse Event"	3292299001	"Hair Loss"	38	190	NA	1	0	NA	NA	NA	NA	NA	NA	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497533424	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5660"	"DN-101 Protocol No. 011-007"	"518"	"518-0001"	5	9	"Adverse Event/Serious Adverse Event"	3917648001	"Hypertension"	152	152	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508761163	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"5661"	"DN-101 Protocol No. 011-007"	"518"	"518-0001"	5	9	"Adverse Event/Serious Adverse Event"	3917645001	"Hypertension"	109	109	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508761069	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"5662"	"DN-101 Protocol No. 011-007"	"518"	"518-0001"	5	9	"Adverse Event/Serious Adverse Event"	3334767001	"Leukocytes increased"	47	68	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498645337	""	""	""	NA	"Leukocyte count increased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5663"	"DN-101 Protocol No. 011-007"	"518"	"518-0001"	5	9	"Adverse Event/Serious Adverse Event"	3262416001	"Pulmonary Infection"	50	55	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496654856	""	""	""	NA	"Lung infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Lung infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5664"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	2883225003	"Alopecia"	27	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493043576	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5665"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	4323249001	"anemia"	299	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513769903	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5666"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	3732242001	"Bone pain - lumbar spine"	215	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505988049	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5667"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	3527387001	"Bonepain pelvis"	133	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502720568	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5668"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	3461855001	"bonepain right shoulder"	88	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501162609	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5669"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	2920971001	"constipation"	15	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486478258	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5670"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	3122633001	"cuchingoid habitus"	90	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493047430	""	""	""	NA	"Cushingoid"	"Endocrine disorders"	"Adrenal gland disorders"	"Adrenal cortical hyperfunctions"	"Cushingoid"	""	""	""	""	""	""	""	""	""	""	""	""
"5671"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	3732275001	"dentalgia"	225	238	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505988400	""	""	""	NA	"Tooth pain"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Dental pain and sensation disorders"	"Toothache"	""	""	""	""	""	""	""	""	""	""	""	""
"5672"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	3527045001	"Fatigue"	134	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502716254	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5673"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	3527266001	"Granulocytopenia"	147	160	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502718129	""	""	""	NA	"Granulocytopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Granulocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5674"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	3527376001	"Granulocytopenia"	168	174	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502720410	""	""	""	NA	"Granulocytopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Neutropenias"	"Granulocytopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5675"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	3527335001	"Leucocytopenia intermittend"	147	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502719691	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5676"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	3527303001	"Taste alteration"	80	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502718988	""	""	""	NA	"Taste alteration"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5677"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	2920951001	"Urinary incontinence intermittend"	7	48	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1486477938	""	""	""	NA	"Incontinence urinary"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Bladder and urethral symptoms"	"Urinary incontinence"	""	""	""	""	""	""	""	""	""	""	""	""
"5678"	"DN-101 Protocol No. 011-007"	"521"	"521-0002"	5	9	"Adverse Event/Serious Adverse Event"	4323592001	"Worsening physical examination"	225	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513773388	""	""	""	NA	"General physical health deterioration"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"General physical health deterioration"	""	""	""	""	""	""	""	""	""	""	""	""
"5679"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	5	9	"Adverse Event/Serious Adverse Event"	2911848003	"Alopecia"	25	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493034777	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5680"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	5	9	"Adverse Event/Serious Adverse Event"	3383645001	"cushingoid habitus"	113	NA	1	2	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499687647	""	""	""	NA	"Cushingoid"	"Endocrine disorders"	"Adrenal gland disorders"	"Adrenal cortical hyperfunctions"	"Cushingoid"	""	""	""	""	""	""	""	""	""	""	""	""
"5681"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	5	9	"Adverse Event/Serious Adverse Event"	3652082001	"face-edema"	NA	NA	1	2	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505045648	""	""	""	NA	"Face edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Face oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5682"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	5	9	"Adverse Event/Serious Adverse Event"	3121394001	"Fever"	20	24	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493034533	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5683"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	5	9	"Adverse Event/Serious Adverse Event"	3121388001	"grippal infection (with unknown ANC)"	20	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493034059	""	""	""	NA	"Upper respiratory infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Upper respiratory tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5684"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	5	9	"Adverse Event/Serious Adverse Event"	3383508001	"Gynecomastia"	92	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499686426	""	""	""	NA	"Gynecomastia"	"Reproductive system and breast disorders"	"Breast disorders"	"Breast disorders NEC"	"Gynaecomastia"	""	""	""	""	""	""	""	""	""	""	""	""
"5685"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	5	9	"Adverse Event/Serious Adverse Event"	4324138001	"loss of motion shoulder joint both sides"	230	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513779148	""	""	""	NA	"Joint range of motion decreased"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Joint range of motion decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5686"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	5	9	"Adverse Event/Serious Adverse Event"	3121379001	"Myalgia"	10	12	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1493033838	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5687"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	5	9	"Adverse Event/Serious Adverse Event"	4324110001	"Pain Shoulder both sides"	228	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513778861	""	""	""	NA	"Shoulder pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Shoulder pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5688"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	5	9	"Adverse Event/Serious Adverse Event"	3383826001	"periobital edema"	139	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499689285	""	""	""	NA	"Edema periorbital"	"Skin and subcutaneous tissue disorders"	"Angioedema and urticaria"	"Angioedemas"	"Periorbital oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5689"	"DN-101 Protocol No. 011-007"	"521"	"521-0003"	5	9	"Adverse Event/Serious Adverse Event"	3652156001	"submental edema"	NA	NA	1	2	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505046338	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5690"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	5	9	"Adverse Event/Serious Adverse Event"	2977156003	"ague"	237	240	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517164891	""	""	""	NA	"Shivering"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Chills"	""	""	""	""	""	""	""	""	""	""	""	""
"5691"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	5	9	"Adverse Event/Serious Adverse Event"	3105079001	"calf cramp"	44	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492603461	""	""	""	NA	"Cramps calf"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"5692"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	5	9	"Adverse Event/Serious Adverse Event"	3310471001	"cough"	94	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498055522	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"5693"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	5	9	"Adverse Event/Serious Adverse Event"	4674853002	"eczema forearm"	294	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517230671	""	""	""	NA	"Eczema"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermatitis and eczema"	"Eczema"	""	""	""	""	""	""	""	""	""	""	""	""
"5694"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	5	9	"Adverse Event/Serious Adverse Event"	4674930002	"edema lower legs"	220	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517230953	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5695"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	5	9	"Adverse Event/Serious Adverse Event"	4660123002	"hernia surgery"	248	248	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517164986	""	""	""	NA	"Hernia repair"	"Surgical and medical procedures"	"Gastrointestinal therapeutic procedures"	"Hernia repairs"	"Hernia repair"	""	""	""	""	""	""	""	""	""	""	""	""
"5696"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	5	9	"Adverse Event/Serious Adverse Event"	3105076001	"obstipation"	31	53	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492603308	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5697"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	5	9	"Adverse Event/Serious Adverse Event"	3251480001	"obstipation"	67	137	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496236744	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5698"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	5	9	"Adverse Event/Serious Adverse Event"	4674833002	"obstipation"	294	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517230609	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5699"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	5	9	"Adverse Event/Serious Adverse Event"	3424989001	"paresthesia big toe left side"	116	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500301333	""	""	""	NA	"Paresthesia"	"Nervous system disorders"	"Neurological disorders NEC"	"Paraesthesias and dysaesthesias"	"Paraesthesia"	""	""	""	""	""	""	""	""	""	""	""	""
"5700"	"DN-101 Protocol No. 011-007"	"522"	"522-0001"	5	9	"Adverse Event/Serious Adverse Event"	4674971002	"wight loss"	290	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517231133	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5701"	"DN-101 Protocol No. 011-007"	"522"	"522-0004"	5	9	"Adverse Event/Serious Adverse Event"	3006719003	"edema lower leg"	91	147	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500478004	""	""	""	NA	"Leg edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5702"	"DN-101 Protocol No. 011-007"	"522"	"522-0004"	5	9	"Adverse Event/Serious Adverse Event"	3624988001	"edema lower legs"	168	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504603867	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5703"	"DN-101 Protocol No. 011-007"	"522"	"522-0004"	5	9	"Adverse Event/Serious Adverse Event"	3435537001	"nail discoloration"	93	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500478225	""	""	""	NA	"Nail discoloration"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"5704"	"DN-101 Protocol No. 011-007"	"522"	"522-0004"	5	9	"Adverse Event/Serious Adverse Event"	3910865001	"nail lost"	210	210	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508687070	""	""	""	NA	"Nail loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onychomadesis"	""	""	""	""	""	""	""	""	""	""	""	""
"5705"	"DN-101 Protocol No. 011-007"	"522"	"522-0004"	5	9	"Adverse Event/Serious Adverse Event"	4678274002	"obstipation"	295	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517239829	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5706"	"DN-101 Protocol No. 011-007"	"522"	"522-0004"	5	9	"Adverse Event/Serious Adverse Event"	3247289001	"weight loss"	63	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496151276	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5707"	"DN-101 Protocol No. 011-007"	"522"	"522-0004"	5	9	"Adverse Event/Serious Adverse Event"	3247334001	"worsening of hot flashes"	47	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496151786	""	""	""	NA	"Hot flushes aggravated"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"5708"	"DN-101 Protocol No. 011-007"	"522"	"522-0005"	5	9	"Adverse Event/Serious Adverse Event"	3109381003	"backache"	119	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504511998	""	""	""	NA	"Backache"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5709"	"DN-101 Protocol No. 011-007"	"522"	"522-0005"	5	9	"Adverse Event/Serious Adverse Event"	3525866001	"calf cramp"	42	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502699845	""	""	""	NA	"Cramps calf"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"5710"	"DN-101 Protocol No. 011-007"	"522"	"522-0005"	5	9	"Adverse Event/Serious Adverse Event"	3755539001	"edema lower legs"	161	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506348826	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5711"	"DN-101 Protocol No. 011-007"	"522"	"522-0005"	5	9	"Adverse Event/Serious Adverse Event"	3288247001	"hair loss"	28	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497445269	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5712"	"DN-101 Protocol No. 011-007"	"522"	"522-0005"	5	9	"Adverse Event/Serious Adverse Event"	3598271001	"hematoma after infusion"	56	61	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504088335	""	""	""	NA	"Infusion site hematoma"	"General disorders and administration site conditions"	"Administration site reactions"	"Injection and infusion site reactions"	"Infusion site haematoma"	""	""	""	""	""	""	""	""	""	""	""	""
"5713"	"DN-101 Protocol No. 011-007"	"522"	"522-0005"	5	9	"Adverse Event/Serious Adverse Event"	4661222002	"increased Leucocytes (WBC)"	27	34	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517167639	""	""	""	NA	"WBC increased"	"Investigations"	"Haematology investigations (incl blood groups)"	"White blood cell analyses"	"White blood cell count increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5714"	"DN-101 Protocol No. 011-007"	"522"	"522-0005"	5	9	"Adverse Event/Serious Adverse Event"	3247239001	"unspecifid infection"	27	34	NA	1	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1496150631	""	""	""	NA	"Infection NOS"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Infections NEC"	"Infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5715"	"DN-101 Protocol No. 011-007"	"522"	"522-0006"	5	9	"Adverse Event/Serious Adverse Event"	3153380003	"back pain"	220	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1525804344	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5716"	"DN-101 Protocol No. 011-007"	"522"	"522-0006"	5	9	"Adverse Event/Serious Adverse Event"	4096668001	"flu"	180	189	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511174815	""	""	""	NA	"Flu"	"Infections and infestations"	"Viral infectious disorders"	"Influenza viral infections"	"Influenza"	""	""	""	""	""	""	""	""	""	""	""	""
"5717"	"DN-101 Protocol No. 011-007"	"522"	"522-0006"	5	9	"Adverse Event/Serious Adverse Event"	4662582002	"flu"	218	232	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517169476	""	""	""	NA	"Flu"	"Infections and infestations"	"Viral infectious disorders"	"Influenza viral infections"	"Influenza"	""	""	""	""	""	""	""	""	""	""	""	""
"5718"	"DN-101 Protocol No. 011-007"	"522"	"522-0006"	5	9	"Adverse Event/Serious Adverse Event"	4698004002	"knee pain"	218	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517317769	""	""	""	NA	"Knee pain"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5719"	"DN-101 Protocol No. 011-007"	"522"	"522-0006"	5	9	"Adverse Event/Serious Adverse Event"	3917554001	"nail discoloration"	163	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508757899	""	""	""	NA	"Nail discoloration"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail discolouration"	""	""	""	""	""	""	""	""	""	""	""	""
"5720"	"DN-101 Protocol No. 011-007"	"522"	"522-0006"	5	9	"Adverse Event/Serious Adverse Event"	3917540001	"obstipation"	165	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508757833	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5721"	"DN-101 Protocol No. 011-007"	"522"	"522-0007"	5	9	"Adverse Event/Serious Adverse Event"	3156780003	"calf cramp"	40	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497880866	""	""	""	NA	"Cramps calf"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle related signs and symptoms NEC"	"Muscle spasms"	""	""	""	""	""	""	""	""	""	""	""	""
"5722"	"DN-101 Protocol No. 011-007"	"522"	"522-0007"	5	9	"Adverse Event/Serious Adverse Event"	4096878001	"flu"	189	196	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511175861	""	""	""	NA	"Flu"	"Infections and infestations"	"Viral infectious disorders"	"Influenza viral infections"	"Influenza"	""	""	""	""	""	""	""	""	""	""	""	""
"5723"	"DN-101 Protocol No. 011-007"	"522"	"522-0007"	5	9	"Adverse Event/Serious Adverse Event"	3301199001	"hair loss"	36	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497880990	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5724"	"DN-101 Protocol No. 011-007"	"522"	"522-0007"	5	9	"Adverse Event/Serious Adverse Event"	3468153001	"ostealgia tailbone"	73	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1501497994	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5725"	"DN-101 Protocol No. 011-007"	"522"	"522-0009"	5	9	"Adverse Event/Serious Adverse Event"	3275980003	"edema lowe legs"	72	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504095270	""	""	""	NA	"Edema legs"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5726"	"DN-101 Protocol No. 011-007"	"522"	"522-0009"	5	9	"Adverse Event/Serious Adverse Event"	4699671002	"nail disorder"	135	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517323908	""	""	""	NA	"Nail disorder"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5727"	"DN-101 Protocol No. 011-007"	"522"	"522-0009"	5	9	"Adverse Event/Serious Adverse Event"	3598754001	"worsening of diabetes mellitus"	49	154	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504095170	""	""	""	NA	"Diabetes mellitus aggravated"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Diabetes mellitus (incl subtypes)"	"Diabetes mellitus"	""	""	""	""	""	""	""	""	""	""	""	""
"5728"	"DN-101 Protocol No. 011-007"	"522"	"522-0011"	5	9	"Adverse Event/Serious Adverse Event"	3567815003	"dyspnea"	69	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517326863	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5729"	"DN-101 Protocol No. 011-007"	"522"	"522-0011"	5	9	"Adverse Event/Serious Adverse Event"	3693956001	"hair loss"	24	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505657479	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5730"	"DN-101 Protocol No. 011-007"	"522"	"522-0011"	5	9	"Adverse Event/Serious Adverse Event"	4700875002	"hot flushes"	90	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517326482	""	""	""	NA	"Hot flushes"	"Vascular disorders"	"Vascular disorders NEC"	"Peripheral vascular disorders NEC"	"Hot flush"	""	""	""	""	""	""	""	""	""	""	""	""
"5731"	"DN-101 Protocol No. 011-007"	"522"	"522-0011"	5	9	"Adverse Event/Serious Adverse Event"	3693952001	"obstipation"	8	28	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505657377	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5732"	"DN-101 Protocol No. 011-007"	"522"	"522-0011"	5	9	"Adverse Event/Serious Adverse Event"	4701049002	"warery eye"	69	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517326915	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5733"	"DN-101 Protocol No. 011-007"	"522"	"522-0011"	5	9	"Adverse Event/Serious Adverse Event"	4097767001	"Watery eye"	67	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511184011	""	""	""	NA	"Watering eyes"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5734"	"DN-101 Protocol No. 011-007"	"522"	"522-0012"	5	9	"Adverse Event/Serious Adverse Event"	3572532003	"hematoma shoulder right side"	43	68	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508769121	""	""	""	NA	"Hematoma"	"Vascular disorders"	"Vascular haemorrhagic disorders"	"Haemorrhages NEC"	"Haematoma"	""	""	""	""	""	""	""	""	""	""	""	""
"5735"	"DN-101 Protocol No. 011-007"	"523"	"523-0001"	5	9	"Adverse Event/Serious Adverse Event"	2994191003	"Decubitus"	91	NA	1	3	2	NA	1	NA	NA	NA	2	NA	1	2	NA	1	NA	""	1	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	109	125	"none"	""	""	2	2	2	2	2	2	2	2	"Decubitus gluteal left"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498643506	""	""	""	NA	"Decubitus"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Skin injuries and mechanical dermatoses"	"Decubitus ulcer"	""	""	""	""	""	""	""	""	""	""	""	""
"5736"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	5	9	"Adverse Event/Serious Adverse Event"	2935622003	"backache"	228	230	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517209721	""	""	""	NA	"Backache"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5737"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	5	9	"Adverse Event/Serious Adverse Event"	3167308001	"bad cold"	34	38	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494258160	""	""	""	NA	"Cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5738"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	5	9	"Adverse Event/Serious Adverse Event"	3688867001	"change of nails"	67	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505366248	""	""	""	NA	"Nail changes"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5739"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	5	9	"Adverse Event/Serious Adverse Event"	4671044002	"cold extremity"	230	230	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517209810	""	""	""	NA	"Cold extremities"	"General disorders and administration site conditions"	"Body temperature conditions"	"Body temperature perception"	"Peripheral coldness"	""	""	""	""	""	""	""	""	""	""	""	""
"5740"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	5	9	"Adverse Event/Serious Adverse Event"	3167419001	"dysgeusia"	257	270	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494258914	""	""	""	NA	"Dysgeusia"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Dysgeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5741"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	5	9	"Adverse Event/Serious Adverse Event"	3167387001	"heartburn"	44	44	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494258749	""	""	""	NA	"Heartburn"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Dyspeptic signs and symptoms"	"Dyspepsia"	""	""	""	""	""	""	""	""	""	""	""	""
"5742"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	5	9	"Adverse Event/Serious Adverse Event"	3341367001	"Lacrimation"	70	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498724563	""	""	""	NA	"Lacrimation"	"Eye disorders"	"Eye disorders NEC"	"Lacrimal disorders"	"Lacrimation increased"	""	""	""	""	""	""	""	""	""	""	""	""
"5743"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	5	9	"Adverse Event/Serious Adverse Event"	4671053002	"loss in weigth"	258	274	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517210005	""	""	""	NA	"Weight loss"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5744"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	5	9	"Adverse Event/Serious Adverse Event"	4671047002	"tired"	257	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517209911	""	""	""	NA	"Tiredness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5745"	"DN-101 Protocol No. 011-007"	"524"	"524-0001"	5	9	"Adverse Event/Serious Adverse Event"	4671030002	"Toenails stink"	147	170	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517209618	""	""	""	NA	"Nail abnormality NOS"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Nail disorder"	""	""	""	""	""	""	""	""	""	""	""	""
"5746"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	2943304003	"bad cold"	40	43	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494259550	""	""	""	NA	"Cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5747"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	4671462002	"cold"	234	254	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517213618	""	""	""	NA	"Cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5748"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	5345961002	"cold"	253	257	NA	1	NA	NA	NA	0	NA	NA	2	NA	1	0	NA	NA	NA	""	0	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1525769938	""	""	""	NA	"Cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5749"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	4671494002	"cold"	274	289	NA	2	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517213756	""	""	""	NA	"Cold"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Nasopharyngitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5750"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	3036217001	"COPD"	42	58	NA	4	NA	NA	NA	2	NA	1	2	NA	1	5	1	NA	1	"Hospitalisation"	0	0	0	0	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	42	58	"No"	""	""	2	2	2	2	2	2	2	2	"Yesterday a flu, this morning  symptoms like a COPD ad hospitalisation at once."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490705271	""	""	""	NA	"COPD"	"Respiratory, thoracic and mediastinal disorders"	"Bronchial disorders (excl neoplasms)"	"Bronchospasm and obstruction"	"Chronic obstructive pulmonary disease"	""	""	""	""	""	""	""	""	""	""	""	""
"5751"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	3694179001	"diarrhoea"	213	216	NA	2	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	0	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	213	213	"no"	""	""	0	2	0	2	2	0	2	2	"yesterday a diarrhea"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505660246	""	""	""	NA	"Diarrhoea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5752"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	4671454002	"diarrhoea"	185	191	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517213547	""	""	""	NA	"Diarrhoea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5753"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	4671401002	"Edema"	33	NA	1	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517213016	""	""	""	NA	"Edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema"	""	""	""	""	""	""	""	""	""	""	""	""
"5754"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	4671421002	"Fever"	48	55	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517213214	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5755"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	3167561001	"Fever"	40	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494259845	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5756"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	3986753001	"Fever"	260	268	NA	2	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	0	8	NA	NA	NA	1	NA	NA	NA	""	261	NA	NA	260	261	"No relevant Laboratory"	""	""	NA	2	NA	2	2	NA	2	2	"Fever"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509608122	""	""	""	NA	"Fever"	"General disorders and administration site conditions"	"Body temperature conditions"	"Febrile disorders"	"Pyrexia"	""	""	""	""	""	""	""	""	""	""	""	""
"5757"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	5285871002	"hypertension"	42	NA	1	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523456816	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"5758"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	4671428002	"intestinal infection"	53	58	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517213324	""	""	""	NA	"Gastrointestinal infection"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Abdominal and gastrointestinal infections"	"Gastrointestinal infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5759"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	5345973002	"renal insufficiency"	222	NA	1	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1525770470	""	""	""	NA	"Renal insufficiency"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal failure and impairment"	"Renal failure"	""	""	""	""	""	""	""	""	""	""	""	""
"5760"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	3167488001	"Stomach ache"	12	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494259315	""	""	""	NA	"Stomach ache"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"5761"	"DN-101 Protocol No. 011-007"	"524"	"524-0002"	5	9	"Adverse Event/Serious Adverse Event"	4671437002	"swelled feet"	99	NA	1	1	NA	NA	NA	0	NA	NA	0	NA	NA	0	NA	NA	NA	""	5	NA	0	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517213423	""	""	""	NA	"Swelling of feet"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5762"	"DN-101 Protocol No. 011-007"	"524"	"524-0007"	5	9	"Adverse Event/Serious Adverse Event"	3550461003	"Leikopenie"	31	42	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517240717	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5763"	"DN-101 Protocol No. 011-007"	"524"	"524-0007"	5	9	"Adverse Event/Serious Adverse Event"	3988174001	"Tachyarrhytmia"	58	58	NA	5	1	1	NA	NA	NA	NA	1	1	NA	1	1	NA	NA	""	4	0	NA	0	12	NA	NA	1	1	NA	NA	NA	""	73	58	0	58	58	"No"	""	""	2	2	2	NA	1	2	NA	2	"Tachyarhytmia on 2007-10-17 and death"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509633778	""	""	""	NA	"Tachyarrhythmia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachyarrhythmia"	""	""	""	""	""	""	""	""	""	""	""	""
"5764"	"DN-101 Protocol No. 011-007"	"524"	"524-0011"	5	9	"Adverse Event/Serious Adverse Event"	3747038003	"Diarrhea"	22	22	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515600483	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5765"	"DN-101 Protocol No. 011-007"	"524"	"524-0011"	5	9	"Adverse Event/Serious Adverse Event"	4875718002	"Obstipation"	43	43	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1518590008	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5766"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	5	9	"Adverse Event/Serious Adverse Event"	2954979003	"Alopezia"	34	112	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490860838	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5767"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	5	9	"Adverse Event/Serious Adverse Event"	3732855001	"Daily tiredness"	161	230	NA	1	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505993854	""	""	""	NA	"Tiredness"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5768"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	5	9	"Adverse Event/Serious Adverse Event"	3732968001	"Leucopenia"	35	42	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505994561	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5769"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	5	9	"Adverse Event/Serious Adverse Event"	3732978001	"Leucopenia"	77	84	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505994655	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5770"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	5	9	"Adverse Event/Serious Adverse Event"	3733023001	"Leucopenia"	161	168	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505994964	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5771"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	5	9	"Adverse Event/Serious Adverse Event"	3732958001	"Leucopenia"	14	24	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505994434	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5772"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	5	9	"Adverse Event/Serious Adverse Event"	3732990001	"Leucopenia"	98	104	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505994748	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5773"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	5	9	"Adverse Event/Serious Adverse Event"	3732995001	"Leucopenia"	139	150	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505994814	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5774"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	5	9	"Adverse Event/Serious Adverse Event"	3732931001	"loss of fingernails"	210	279	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505994158	""	""	""	NA	"Nail loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Nail and nail bed conditions (excl infections and infestations)"	"Onychomadesis"	""	""	""	""	""	""	""	""	""	""	""	""
"5775"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	5	9	"Adverse Event/Serious Adverse Event"	3045845001	"loss of oral taste perception"	13	230	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1490860732	""	""	""	NA	"Taste loss"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Ageusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5776"	"DN-101 Protocol No. 011-007"	"525"	"525-0002"	5	9	"Adverse Event/Serious Adverse Event"	3732882001	"loss of strength"	161	230	NA	2	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505993969	""	""	""	NA	"Strength loss of"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Asthenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5777"	"DN-101 Protocol No. 011-007"	"525"	"525-0003"	5	9	"Adverse Event/Serious Adverse Event"	3240649003	"Alopezie"	38	176	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498732599	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5778"	"DN-101 Protocol No. 011-007"	"525"	"525-0003"	5	9	"Adverse Event/Serious Adverse Event"	3342835001	"Leucopenia"	17	24	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498733867	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5779"	"DN-101 Protocol No. 011-007"	"525"	"525-0003"	5	9	"Adverse Event/Serious Adverse Event"	3925520001	"Leucopenia"	141	144	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508838766	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5780"	"DN-101 Protocol No. 011-007"	"525"	"525-0003"	5	9	"Adverse Event/Serious Adverse Event"	3408388001	"Leucopenia"	38	44	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499856076	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5781"	"DN-101 Protocol No. 011-007"	"525"	"525-0003"	5	9	"Adverse Event/Serious Adverse Event"	3715579001	"Leucopenia"	80	87	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505854816	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5782"	"DN-101 Protocol No. 011-007"	"525"	"525-0003"	5	9	"Adverse Event/Serious Adverse Event"	3715572001	"Leucopenia"	59	66	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505854711	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5783"	"DN-101 Protocol No. 011-007"	"525"	"525-0003"	5	9	"Adverse Event/Serious Adverse Event"	3925513001	"Leucopenia"	80	83	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508838713	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5784"	"DN-101 Protocol No. 011-007"	"525"	"525-0004"	5	9	"Adverse Event/Serious Adverse Event"	3241045003	"Leucopenia"	112	124	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507838113	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5785"	"DN-101 Protocol No. 011-007"	"525"	"525-0004"	5	9	"Adverse Event/Serious Adverse Event"	3865680001	"Leucopenia"	129	140	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507838237	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5786"	"DN-101 Protocol No. 011-007"	"525"	"525-0004"	5	9	"Adverse Event/Serious Adverse Event"	3643205001	"Leucopenia"	91	98	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504788100	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5787"	"DN-101 Protocol No. 011-007"	"525"	"525-0004"	5	9	"Adverse Event/Serious Adverse Event"	4249919001	"Leucopenia"	153	166	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1513081498	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5788"	"DN-101 Protocol No. 011-007"	"525"	"525-0004"	5	9	"Adverse Event/Serious Adverse Event"	3408276001	"slight oedma of both ankles"	24	77	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499854785	""	""	""	NA	"Peripheral edema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5789"	"DN-101 Protocol No. 011-007"	"525"	"525-0005"	5	9	"Adverse Event/Serious Adverse Event"	3291861003	"Alopecia"	27	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499852037	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5790"	"DN-101 Protocol No. 011-007"	"525"	"525-0005"	5	9	"Adverse Event/Serious Adverse Event"	3407957001	"Leucopenia"	14	20	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499851934	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5791"	"DN-101 Protocol No. 011-007"	"525"	"525-0005"	5	9	"Adverse Event/Serious Adverse Event"	3642885001	"Leucopenia"	35	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504785002	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5792"	"DN-101 Protocol No. 011-007"	"525"	"525-0005"	5	9	"Adverse Event/Serious Adverse Event"	3407954001	"rectal bleeding"	9	10	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499851838	""	""	""	NA	"Rectal bleeding"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Intestinal haemorrhages"	"Rectal haemorrhage"	""	""	""	""	""	""	""	""	""	""	""	""
"5793"	"DN-101 Protocol No. 011-007"	"525"	"525-0007"	5	9	"Adverse Event/Serious Adverse Event"	3516725003	"Paresis of N. abducens right"	6	9	NA	3	2	NA	1	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	0	NA	0	34	NA	1	NA	NA	NA	1	NA	""	7	NA	NA	NA	NA	"CT cranium revealed osteolysis of scull basis"	""	""	0	0	0	NA	0	0	NA	0	"Due to osteolysis of scull basis N. abducens right was paralyzed"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1502975240	""	""	""	NA	"Monoparesis"	"Nervous system disorders"	"Movement disorders (incl Parkinsonism)"	"Paralysis and paresis (excl cranial nerve)"	"Monoparesis"	""	""	""	""	""	""	""	""	""	""	""	""
"5794"	"DN-101 Protocol No. 011-007"	"525"	"525-0007"	5	9	"Adverse Event/Serious Adverse Event"	5280000002	"pathological bone fracture"	6	9	NA	3	2	NA	1	NA	NA	NA	2	NA	1	3	1	1	NA	""	0	0	NA	0	2	NA	1	NA	NA	NA	NA	NA	""	242	NA	NA	NA	NA	"CT cranium revealed osteolysis of scull basis"	""	""	0	0	0	NA	0	0	NA	0	"due to osteolysis of scull basis N. abducens right was paralyzed"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1523308268	""	""	""	NA	"Pathological fracture"	"Musculoskeletal and connective tissue disorders"	"Fractures"	"Pathological fractures and complications"	"Pathological fracture"	""	""	""	""	""	""	""	""	""	""	""	""
"5795"	"DN-101 Protocol No. 011-007"	"525"	"525-0007"	5	9	"Adverse Event/Serious Adverse Event"	3843178001	"peripheral oedema"	61	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507659981	""	""	""	NA	"Peripheral oedema"	"General disorders and administration site conditions"	"General system disorders NEC"	"Oedema NEC"	"Oedema peripheral"	""	""	""	""	""	""	""	""	""	""	""	""
"5796"	"DN-101 Protocol No. 011-007"	"527"	"527-0001"	5	9	"Adverse Event/Serious Adverse Event"	3616571003	"bone pain"	6	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509005772	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5797"	"DN-101 Protocol No. 011-007"	"527"	"527-0001"	5	9	"Adverse Event/Serious Adverse Event"	3943350001	"dizzyness"	6	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509005691	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"5798"	"DN-101 Protocol No. 011-007"	"527"	"527-0001"	5	9	"Adverse Event/Serious Adverse Event"	3943366001	"dry skin"	5	27	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509005972	""	""	""	NA	"Dry skin"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Dermal and epidermal conditions NEC"	"Dry skin"	""	""	""	""	""	""	""	""	""	""	""	""
"5799"	"DN-101 Protocol No. 011-007"	"527"	"527-0001"	5	9	"Adverse Event/Serious Adverse Event"	3943344001	"loss of weight"	6	48	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509005598	""	""	""	NA	"Loss of weight"	"Investigations"	"Physical examination topics"	"Physical examination procedures"	"Weight decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5800"	"DN-101 Protocol No. 011-007"	"528"	"528-0001"	5	9	"Adverse Event/Serious Adverse Event"	3324531003	"diarrhea"	35	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519825941	""	""	""	NA	"Diarrhea"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Diarrhoea (excl infective)"	"Diarrhoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5801"	"DN-101 Protocol No. 011-007"	"528"	"528-0001"	5	9	"Adverse Event/Serious Adverse Event"	4987267002	"fatigue"	35	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519793569	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5802"	"DN-101 Protocol No. 011-007"	"528"	"528-0001"	5	9	"Adverse Event/Serious Adverse Event"	4987204002	"fatigue"	14	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519793032	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5803"	"DN-101 Protocol No. 011-007"	"528"	"528-0001"	5	9	"Adverse Event/Serious Adverse Event"	4987293002	"herpes labialis"	35	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519793913	""	""	""	NA	"Herpes labialis"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes simplex"	""	""	""	""	""	""	""	""	""	""	""	""
"5804"	"DN-101 Protocol No. 011-007"	"528"	"528-0001"	5	9	"Adverse Event/Serious Adverse Event"	3609073001	"Peumonitis"	71	116	NA	2	0	NA	NA	NA	NA	NA	1	1	NA	5	1	NA	1	"Increase dose of the glocucoticoid medication as reaction to the pneumonitis"	3	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	71	NA	NA	71	89	"reduced lunge function, bad blood gases, elevated C-Reactive Protein (8 mg/dl) all on 31.08.2007"	""	""	2	2	2	NA	2	2	NA	2	"10 days ago begin of dyspnea and productive coughing. No report to us as of this morning. Patient is physician himself and increased his prednisone on his own 10-0-10 mg / day. That produced a slight"	"imporovement of symtoms. This morning X-ray of the chest was performed showing pneumonitis. Lungefunktion prooved a poor funktion with a restrictive component and poor blood gases. The last dose was"	"the third dose of docetaxel 21 days ago and today was supposed to be the next dose. First two doses were tolerated well. Today's docetaxel was held back and hospitalization was performed (increased"	"corticoid therapy)."	""	""	""	""	""	""	""	NA	NA	""	1504183265	""	""	""	NA	"Pneumonitis"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Lower respiratory tract inflammatory and immunologic conditions"	"Pneumonitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5805"	"DN-101 Protocol No. 011-007"	"528"	"528-0001"	5	9	"Adverse Event/Serious Adverse Event"	4626101002	"Pneumonia"	109	116	NA	5	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	4	0	NA	1	12	NA	NA	1	1	NA	NA	NA	""	217	116	0	109	116	"acute dyspnea, therefore respiration test on 08.10.07, showed poor pulmonary function, severe pneumonia was diagnosed, that led to hospitalization., initial CRP on 8th of october 12,3 mg/dl"	""	""	0	0	0	2	0	2	2	2	"bad lungue function after initial pneumonitis, see earlier SAE report lead to diagnosis of a severe pneumonia. Immediate inhouse i.v. antibiotics were administered, but the infection unfortunately"	"ended up fatally."	""	""	""	""	""	""	""	""	""	NA	NA	""	1516813866	""	""	""	NA	"Pneumonia"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Pneumonia"	""	""	""	""	""	""	""	""	""	""	""	""
"5806"	"DN-101 Protocol No. 011-007"	"528"	"528-0001"	5	9	"Adverse Event/Serious Adverse Event"	4987277002	"stomatitis"	35	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519793749	""	""	""	NA	"Stomatitis"	"Gastrointestinal disorders"	"Oral soft tissue conditions"	"Stomatitis and ulceration"	"Stomatitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5807"	"DN-101 Protocol No. 011-007"	"528"	"528-0001"	5	9	"Adverse Event/Serious Adverse Event"	4987290002	"tasteless"	35	39	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519793839	""	""	""	NA	"Taste diminished"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Hypogeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5808"	"DN-101 Protocol No. 011-007"	"528"	"528-0001"	5	9	"Adverse Event/Serious Adverse Event"	4987215002	"tasteless"	14	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519793121	""	""	""	NA	"Taste diminished"	"Nervous system disorders"	"Neurological disorders NEC"	"Sensory abnormalities NEC"	"Hypogeusia"	""	""	""	""	""	""	""	""	""	""	""	""
"5809"	"DN-101 Protocol No. 011-007"	"528"	"528-0003"	5	9	"Adverse Event/Serious Adverse Event"	3362811003	"bone pain of the back"	-19	168	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519813325	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5810"	"DN-101 Protocol No. 011-007"	"528"	"528-0003"	5	9	"Adverse Event/Serious Adverse Event"	4380228001	"Hydronephrosis of both kidneys due to Lymphnode metastasis compression"	112	168	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Planning of irradiation in hometown hospital starting in late November 2007"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515056010	""	""	""	NA	"Hydronephrosis"	"Renal and urinary disorders"	"Renal disorders (excl nephropathies)"	"Renal obstructive disorders"	"Hydronephrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5811"	"DN-101 Protocol No. 011-007"	"528"	"528-0003"	5	9	"Adverse Event/Serious Adverse Event"	4989975002	"Liver-Metastasis"	134	168	NA	5	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	4	0	NA	0	116	NA	NA	1	NA	1	1	1	"New metastasis, evaluation of irradiation was performed in an out-patient setting but was considered as not possible by radiologist"	240	168	0	NA	NA	"CT-Imaging of 14.11.07 showed several new liver metastasis"	""	""	2	2	2	NA	2	2	NA	2	"liver metastases in a CT-Checkup, Irradiatio was evaluated but not performed, Patient dies on 18.12.07 in severely pregressing metastatic prostate cancer"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1519814927	""	""	""	NA	"Liver metastases"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Metastases"	"Metastases to specified sites"	"Metastases to liver"	""	""	""	""	""	""	""	""	""	""	""	""
"5812"	"DN-101 Protocol No. 011-007"	"528"	"528-0003"	5	9	"Adverse Event/Serious Adverse Event"	3624926001	"Obstipation"	28	168	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Hospitalization, Enema, Bowel regulation, Diagnostics (New liver metastasis)"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	64	NA	NA	62	64	"Ultrasoundsonography of the abdomen. Diagnosis of new liver metastasis resulting in a progressive disease under Chemotherapy"	""	""	2	2	2	NA	2	2	NA	2	"Abdominal Pain. due to obstipation, Pat. went to hospital near home town. Hospitalization. Diagnosis and treatment of Obstipation. Still ongoing but Obstipation is getting better according to"	"external physician. Diagnosis of newly formed liver metastasis."	""	""	""	""	""	""	""	""	""	NA	NA	""	1504599313	""	""	""	NA	"Obstipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5813"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3025966003	"abdominal pain intermittend"	9	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492944522	""	""	""	NA	"Abdominal pain"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5814"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3114986001	"agitation"	6	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492944181	""	""	""	NA	"Agitation"	"Psychiatric disorders"	"Anxiety disorders and symptoms"	"Anxiety symptoms"	"Agitation"	""	""	""	""	""	""	""	""	""	""	""	""
"5815"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3310568001	"bonepain"	83	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498056308	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5816"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3115109001	"cough"	11	12	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492945366	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"5817"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3598474001	"cough with expectoration"	132	239	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504091178	""	""	""	NA	"Productive cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Productive cough"	""	""	""	""	""	""	""	""	""	""	""	""
"5818"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3114916001	"Dizziness"	6	55	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492943292	""	""	""	NA	"Dizziness"	"Nervous system disorders"	"Neurological disorders NEC"	"Neurological signs and symptoms NEC"	"Dizziness"	""	""	""	""	""	""	""	""	""	""	""	""
"5819"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3114955001	"dyspnea intermittend"	5	90	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492943681	""	""	""	NA	"Dyspnea"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Breathing abnormalities"	"Dyspnoea"	""	""	""	""	""	""	""	""	""	""	""	""
"5820"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3115082001	"fatigue"	13	246	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492945197	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5821"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3114942001	"headaches intermittend"	6	239	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492943514	""	""	""	NA	"Intermittent headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"5822"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3304924001	"infection of urinary tract"	76	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497960087	""	""	""	NA	"Infection urinary tract"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Urinary tract infection"	""	""	""	""	""	""	""	""	""	""	""	""
"5823"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3115125001	"leucopenia"	13	19	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492945559	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5824"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3598549001	"leucopenia"	139	153	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504091808	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5825"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3839423001	"leucopenia"	181	195	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507642548	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5826"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3198626001	"leucopenia"	55	65	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494935225	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5827"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3198614001	"lost of hair"	13	116	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1494935028	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5828"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3114991001	"muscle-and bonepain"	9	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492944374	""	""	""	NA	"Musculoskeletal pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5829"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3839409001	"necrosis lower jaw"	178	269	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"bisphosphanat stopped"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507642159	""	""	""	NA	"Bone necrosis"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone disorders NEC"	"Osteonecrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5830"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3304910001	"sweating intermittend"	50	197	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497959438	""	""	""	NA	"Sweating"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Apocrine and eccrine gland disorders"	"Hyperhidrosis"	""	""	""	""	""	""	""	""	""	""	""	""
"5831"	"DN-101 Protocol No. 011-007"	"529"	"529-0001"	5	9	"Adverse Event/Serious Adverse Event"	3114966001	"urticaria intermittend"	6	196	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1492943811	""	""	""	NA	"Urticaria"	"Skin and subcutaneous tissue disorders"	"Angioedema and urticaria"	"Urticarias"	"Urticaria"	""	""	""	""	""	""	""	""	""	""	""	""
"5832"	"DN-101 Protocol No. 011-007"	"529"	"529-0005"	5	9	"Adverse Event/Serious Adverse Event"	3909447003	"fatigue intermittend"	9	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510669476	""	""	""	NA	"Fatigue"	"General disorders and administration site conditions"	"General system disorders NEC"	"Asthenic conditions"	"Fatigue"	""	""	""	""	""	""	""	""	""	""	""	""
"5833"	"DN-101 Protocol No. 011-007"	"529"	"529-0005"	5	9	"Adverse Event/Serious Adverse Event"	4053359001	"headaches intermittend"	9	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510670922	""	""	""	NA	"Intermittent headache"	"Nervous system disorders"	"Headaches"	"Headaches NEC"	"Headache"	""	""	""	""	""	""	""	""	""	""	""	""
"5834"	"DN-101 Protocol No. 011-007"	"529"	"529-0005"	5	9	"Adverse Event/Serious Adverse Event"	4053384001	"hyperglycemia"	6	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510671059	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5835"	"DN-101 Protocol No. 011-007"	"529"	"529-0005"	5	9	"Adverse Event/Serious Adverse Event"	4097822001	"leucopenia"	12	21	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511184722	""	""	""	NA	"Leucopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5836"	"DN-101 Protocol No. 011-007"	"529"	"529-0005"	5	9	"Adverse Event/Serious Adverse Event"	4053409001	"loss of hair"	15	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510671176	""	""	""	NA	"Hair loss"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5837"	"DN-101 Protocol No. 011-007"	"529"	"529-0005"	5	9	"Adverse Event/Serious Adverse Event"	4053174001	"muscle- and bonepain intermittend"	9	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1510669564	""	""	""	NA	"Musculoskeletal pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Musculoskeletal pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5838"	"DN-101 Protocol No. 011-007"	"603"	"603-0001"	5	9	"Adverse Event/Serious Adverse Event"	3583307003	"Back pain"	55	72	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"We started diclofenac therapy"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516132113	""	""	""	NA	"Back pain"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Back pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5839"	"DN-101 Protocol No. 011-007"	"603"	"603-0001"	5	9	"Adverse Event/Serious Adverse Event"	3661318001	"rash"	8	18	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Claritine, Flonidan, Fenistil gel, Cetirizin, Cutivat cremor refrigerans"	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1505125952	""	""	""	NA	"Rash"	"Skin and subcutaneous tissue disorders"	"Epidermal and dermal conditions"	"Rashes, eruptions and exanthems NEC"	"Rash"	""	""	""	""	""	""	""	""	""	""	""	""
"5840"	"DN-101 Protocol No. 011-007"	"604"	"604-0002"	5	9	"Adverse Event/Serious Adverse Event"	3926987003	"hyperglycemia"	22	36	NA	3	2	NA	1	NA	NA	NA	2	NA	1	5	1	NA	1	"Inzulin-Actrapid 32U"	0	1	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	23	NA	NA	21	36	"Glucose, 14 mmol/L, 2007-10-30"	""	""	2	2	1	NA	2	2	NA	2	"2007.10.29 we are start with prednisolone and 2007.10.30-th befor Dexametesone adminstration the glucose test show G 3 hyperglycemia."	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509443804	""	""	""	NA	"Hyperglycemia"	"Metabolism and nutrition disorders"	"Glucose metabolism disorders (incl diabetes mellitus)"	"Hyperglycaemic conditions NEC"	"Hyperglycaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5841"	"DN-101 Protocol No. 011-007"	"606"	"606-0002"	5	9	"Adverse Event/Serious Adverse Event"	3521593003	"Pain (dental)"	100	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Dental extraction."	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517152824	""	""	""	NA	"Dental discomfort"	"Gastrointestinal disorders"	"Dental and gingival conditions"	"Dental pain and sensation disorders"	"Dental discomfort"	""	""	""	""	""	""	""	""	""	""	""	""
"5842"	"DN-101 Protocol No. 011-007"	"606"	"606-0002"	5	9	"Adverse Event/Serious Adverse Event"	3964621001	"Pain-bone"	26	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"Algopyrin, Demalgon, Mydeton, Losec, Apranax SR"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509381230	""	""	""	NA	"Pain bone"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5843"	"DN-101 Protocol No. 011-007"	"606"	"606-0002"	5	9	"Adverse Event/Serious Adverse Event"	4654482002	"platelets"	120	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"thromocyte and blood transfusion on 2007-12-13"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517152476	""	""	""	NA	"Platelets decreased"	"Investigations"	"Haematology investigations (incl blood groups)"	"Platelet analyses"	"Platelet count decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5844"	"DN-101 Protocol No. 011-007"	"606"	"606-0002"	5	9	"Adverse Event/Serious Adverse Event"	4654374002	"Worsening ECOG"	42	NA	1	2	1	1	NA	NA	NA	NA	1	1	NA	4	NA	NA	1	"Mitoxantron treatment"	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517152168	""	""	""	NA	"Performance status decreased"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Performance status decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5845"	"DN-101 Protocol No. 011-007"	"606"	"606-0003"	5	9	"Adverse Event/Serious Adverse Event"	3830137003	"Bone pain"	70	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517153958	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5846"	"DN-101 Protocol No. 011-007"	"606"	"606-0005"	5	9	"Adverse Event/Serious Adverse Event"	3962934003	"constipation"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517156428	""	""	""	NA	"Constipation"	"Gastrointestinal disorders"	"Gastrointestinal motility and defaecation conditions"	"Gastrointestinal atonic and hypomotility disorders NEC"	"Constipation"	""	""	""	""	""	""	""	""	""	""	""	""
"5847"	"DN-101 Protocol No. 011-007"	"606"	"606-0005"	5	9	"Adverse Event/Serious Adverse Event"	4656447002	"Worsening ECOG"	54	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1517156555	""	""	""	NA	"Performance status decreased"	"General disorders and administration site conditions"	"General system disorders NEC"	"General signs and symptoms NEC"	"Performance status decreased"	""	""	""	""	""	""	""	""	""	""	""	""
"5848"	"DN-101 Protocol No. 011-007"	"610"	"610-0004"	5	9	"Adverse Event/Serious Adverse Event"	3375008003	"hematuria"	162	165	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"control by urologist.Cause of hematuria not known"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516187161	""	""	""	NA	"Hematuria"	"Renal and urinary disorders"	"Urinary tract signs and symptoms"	"Urinary abnormalities"	"Haematuria"	""	""	""	""	""	""	""	""	""	""	""	""
"5849"	"DN-101 Protocol No. 011-007"	"610"	"610-0004"	5	9	"Adverse Event/Serious Adverse Event"	4522386002	"Rhinitis"	148	149	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516187633	""	""	""	NA	"Rhinitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Upper respiratory tract infections"	"Rhinitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5850"	"DN-101 Protocol No. 011-007"	"613"	"613-0002"	5	9	"Adverse Event/Serious Adverse Event"	3207760003	"anemia /hemoglobin 84/"	143	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509543871	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5851"	"DN-101 Protocol No. 011-007"	"613"	"613-0002"	5	9	"Adverse Event/Serious Adverse Event"	4193270001	"anemia/ hemoglobin 58,8/"	199	206	NA	4	0	NA	NA	NA	NA	NA	0	NA	NA	2	NA	1	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	208	NA	NA	200	206	"58,8 g/l"	""	""	2	2	2	NA	2	2	NA	2	"5x transfusion of erymasa, hospitalisation, stopping of docetaxel, normalisation of hemoglobin / 116 g/l/"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1512486359	""	""	""	NA	"Anemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5852"	"DN-101 Protocol No. 011-007"	"613"	"613-0002"	5	9	"Adverse Event/Serious Adverse Event"	3608801001	"hypotension"	68	68	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"discontinuation of antihypertension medication"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504180615	""	""	""	NA	"Hypotension"	"Vascular disorders"	"Decreased and nonspecific blood pressure disorders and shock"	"Vascular hypotensive disorders"	"Hypotension"	""	""	""	""	""	""	""	""	""	""	""	""
"5853"	"DN-101 Protocol No. 011-007"	"613"	"613-0002"	5	9	"Adverse Event/Serious Adverse Event"	3746774001	"pain in bones"	115	NA	1	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1506255064	""	""	""	NA	"Bone pain"	"Musculoskeletal and connective tissue disorders"	"Bone disorders (excl congenital and fractures)"	"Bone related signs and symptoms"	"Bone pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5854"	"DN-101 Protocol No. 011-007"	"613"	"613-0002"	5	9	"Adverse Event/Serious Adverse Event"	3608788001	"pain in neck"	68	75	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1504180349	""	""	""	NA	"Pain neck"	"Musculoskeletal and connective tissue disorders"	"Musculoskeletal and connective tissue disorders NEC"	"Musculoskeletal and connective tissue signs and symptoms NEC"	"Neck pain"	""	""	""	""	""	""	""	""	""	""	""	""
"5855"	"DN-101 Protocol No. 011-007"	"613"	"613-0002"	5	9	"Adverse Event/Serious Adverse Event"	4440920002	"prostata cancer disease progression"	209	242	NA	5	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"hospitalisation for worsening of pain, analgetic treatment in a hospital indicated"	4	0	NA	0	12	NA	NA	1	1	NA	NA	NA	""	244	242	2	209	242	""	""	""	2	2	2	NA	2	2	NA	2	"hospitalisation for worsening of pain, analgetic treatment in a hospital indicated,progression of bone metastases was fatal"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515595258	""	""	""	NA	"Progression of pre-existing cancer"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Miscellaneous and site unspecified neoplasms malignant and unspecified"	"Neoplasms malignant site unspecified NEC"	"Malignant neoplasm progression"	""	""	""	""	""	""	""	""	""	""	""	""
"5856"	"DN-101 Protocol No. 011-007"	"613"	"613-0004"	5	9	"Adverse Event/Serious Adverse Event"	3788923003	"leukopenia"	35	42	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1515584012	""	""	""	NA	"Leukopenia"	"Blood and lymphatic system disorders"	"White blood cell disorders"	"Leukopenias NEC"	"Leukopenia"	""	""	""	""	""	""	""	""	""	""	""	""
"5857"	"DN-101 Protocol No. 011-007"	"616"	"616-0001"	5	9	"Adverse Event/Serious Adverse Event"	3444852003	"cough"	88	91	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509215898	""	""	""	NA	"Cough"	"Respiratory, thoracic and mediastinal disorders"	"Respiratory disorders NEC"	"Coughing and associated symptoms"	"Cough"	""	""	""	""	""	""	""	""	""	""	""	""
"5858"	"DN-101 Protocol No. 011-007"	"616"	"616-0003"	5	9	"Adverse Event/Serious Adverse Event"	3457926003	"exacerbation of bronchitis chronica"	81	90	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1509375513	""	""	""	NA	"Bronchitis chronic"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Lower respiratory tract and lung infections"	"Bronchitis chronic"	""	""	""	""	""	""	""	""	""	""	""	""
"5859"	"DN-101 Protocol No. 011-007"	"616"	"616-0003"	5	9	"Adverse Event/Serious Adverse Event"	3602774001	"non-malignant lung lesion"	30	51	NA	3	0	NA	NA	NA	NA	NA	2	NA	1	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	31	NA	NA	30	51	"Chest X-ray - 01.08.2007; Bronchoscopy - 02.08.2007,24.8.2007,3.9.2007,7.9.2007; cytology and biopsy - 24.8.2007,3.9.2007,7.9.2007 - negative; malignoma"	""	""	2	2	2	NA	2	2	NA	2	"The Chest X-ray showed a leasion on the lung. Bronchoscopy has been performed. The result of the biopsy, cytology didn't help to find the origin of the Chest X-ray finding. The patient has been sent"	"to the hospital for further examination, please;see above in section E1.Patient will go on study treatment."	""	""	""	""	""	""	""	""	""	NA	NA	""	1504115013	""	""	""	NA	"Lung nodule"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Respiratory and mediastinal neoplasms malignant and unspecified"	"Respiratory tract and pleural neoplasms malignancy unspecified NEC"	"Lung neoplasm"	""	""	""	""	""	""	""	""	""	""	""	""
"5860"	"DN-101 Protocol No. 011-007"	"616"	"616-0004"	5	9	"Adverse Event/Serious Adverse Event"	3457940003	"Hypertension"	116	123	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516117132	""	""	""	NA	"Hypertension"	"Vascular disorders"	"Vascular hypertensive disorders"	"Vascular hypertensive disorders NEC"	"Hypertension"	""	""	""	""	""	""	""	""	""	""	""	""
"5861"	"DN-101 Protocol No. 011-007"	"616"	"616-0009"	5	9	"Adverse Event/Serious Adverse Event"	3616365003	"carcinoma rectosigme"	75	NA	1	4	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	2	0	NA	0	72	NA	NA	NA	1	NA	NA	1	"carcinoma rectosigme"	89	NA	NA	75	97	"Anemia -Hb 102 g/l/5.11.2007/; ultrasonography:pankreatopathia, status post cholecystectomy/5.11.2007/"	""	""	0	0	0	2	0	0	2	0	"Patient is hospitalized due to carcinoma rectosigme, it was confirmed irigography and histologically on 26.10.2007.;6.11.2007 paliative operation-sigmoideostomia axialis.Radiotherapy is planned due"	"to inoperabile carcimona of rectosigmae."	""	""	""	""	""	""	""	""	""	NA	NA	""	1511117287	""	""	""	NA	"Carcinoma rectum"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Gastrointestinal neoplasms malignant and unspecified"	"Rectal neoplasms malignant"	"Rectal cancer"	""	""	""	""	""	""	""	""	""	""	""	""
"5862"	"DN-101 Protocol No. 011-007"	"616"	"616-0009"	5	9	"Adverse Event/Serious Adverse Event"	4091199001	"cystitis acuta"	70	75	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511115775	""	""	""	NA	"Acute cystitis"	"Infections and infestations"	"Infections - pathogen class unspecified"	"Urinary tract infections"	"Cystitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5863"	"DN-101 Protocol No. 011-007"	"616"	"616-0013"	5	9	"Adverse Event/Serious Adverse Event"	3624946003	"angina pectoris"	56	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516894890	""	""	""	NA	"Angina pectoris"	"Cardiac disorders"	"Coronary artery disorders"	"Ischaemic coronary artery disorders"	"Angina pectoris"	""	""	""	""	""	""	""	""	""	""	""	""
"5864"	"DN-101 Protocol No. 011-007"	"616"	"616-0013"	5	9	"Adverse Event/Serious Adverse Event"	4101159001	"herpes zoster"	66	91	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511202861	""	""	""	NA	"Herpes zoster"	"Infections and infestations"	"Viral infectious disorders"	"Herpes viral infections"	"Herpes zoster"	""	""	""	""	""	""	""	""	""	""	""	""
"5865"	"DN-101 Protocol No. 011-007"	"616"	"616-0013"	5	9	"Adverse Event/Serious Adverse Event"	4101138001	"palpitation"	56	56	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511202735	""	""	""	NA	"Palpitation"	"Cardiac disorders"	"Cardiac disorder signs and symptoms"	"Cardiac signs and symptoms NEC"	"Palpitations"	""	""	""	""	""	""	""	""	""	""	""	""
"5866"	"DN-101 Protocol No. 011-007"	"616"	"616-0013"	5	9	"Adverse Event/Serious Adverse Event"	4101302001	"stomachache"	8	29	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1511203541	""	""	""	NA	"Stomachache"	"Gastrointestinal disorders"	"Gastrointestinal signs and symptoms"	"Gastrointestinal and abdominal pains (excl oral and throat)"	"Abdominal pain upper"	""	""	""	""	""	""	""	""	""	""	""	""
"5867"	"DN-101 Protocol No. 011-007"	"616"	"616-0014"	5	9	"Adverse Event/Serious Adverse Event"	3753771003	"pneumonitis"	42	51	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	1	1	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	61	NA	NA	42	51	"X-ray - shadow has been found on the lung - left middle lower area; blood sample - leukocytosis (WBC - 3,5Gpt/l) and elevation of creatine 203 umol/l"	""	""	0	0	0	NA	0	0	NA	0	"Patient was hospitalized due to cought, fever and dispnoe. Shadow has been found on the lung - left middle lower area - X-ray. Patient was treated with antibiotics, Unasyn375mg 2X1 /day, control"	"X-ray was made before discharge date and it confirmed regression of infiltration. Patient is in good condition."	""	""	""	""	""	""	""	""	""	NA	NA	""	1511120234	""	""	""	NA	"Pneumonitis"	"Respiratory, thoracic and mediastinal disorders"	"Lower respiratory tract disorders (excl obstruction and infection)"	"Lower respiratory tract inflammatory and immunologic conditions"	"Pneumonitis"	""	""	""	""	""	""	""	""	""	""	""	""
"5868"	"DN-101 Protocol No. 011-007"	"619"	"619-0004"	5	9	"Adverse Event/Serious Adverse Event"	3264843003	"Arthralgia"	23	26	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498381480	""	""	""	NA	"Arthralgia"	"Musculoskeletal and connective tissue disorders"	"Joint disorders"	"Joint related signs and symptoms"	"Arthralgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5869"	"DN-101 Protocol No. 011-007"	"619"	"619-0004"	5	9	"Adverse Event/Serious Adverse Event"	3332398001	"Hypercalcemia"	34	43	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	5	1	NA	1	"- Brain CT is required"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	35	NA	NA	34	43	"Calcium: 3,5"	""	""	2	2	2	2	2	2	2	2	"Mental confusion"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498596540	""	""	""	NA	"Hypercalcemia"	"Metabolism and nutrition disorders"	"Bone, calcium, magnesium and phosphorus metabolism disorders"	"Calcium metabolism disorders"	"Hypercalcaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5870"	"DN-101 Protocol No. 011-007"	"619"	"619-0004"	5	9	"Adverse Event/Serious Adverse Event"	3332441001	"Hypokaliemia"	34	43	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Symphtomatic therapy: 500 ml 0.9 NaCl with 30 mEq KCl + Urbason 40 mg KCl per day during 3 days (IV) + 1000 ml crystalloid solution + 2 ampulles of Lasix"	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498596755	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5871"	"DN-101 Protocol No. 011-007"	"619"	"619-0004"	5	9	"Adverse Event/Serious Adverse Event"	3294404001	"Hypokaliemia"	23	26	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Symphtomatic therapy: 500 ml 5%Glc + 500 ml Hartman solution with 20 mEq KCl (IV)"	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	23	NA	NA	23	26	"Potassium, serum level 2.4"	""	""	2	2	2	NA	2	2	NA	2	"Fatigue, arthralgia, myalgia"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1497564971	""	""	""	NA	"Hypokalemia"	"Metabolism and nutrition disorders"	"Electrolyte and fluid balance conditions"	"Potassium imbalance"	"Hypokalaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5872"	"DN-101 Protocol No. 011-007"	"619"	"619-0004"	5	9	"Adverse Event/Serious Adverse Event"	3418494001	"Myalgia"	23	26	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1500139514	""	""	""	NA	"Myalgia"	"Musculoskeletal and connective tissue disorders"	"Muscle disorders"	"Muscle pains"	"Myalgia"	""	""	""	""	""	""	""	""	""	""	""	""
"5873"	"DN-101 Protocol No. 011-007"	"619"	"619-0004"	5	9	"Adverse Event/Serious Adverse Event"	3414245001	"Prostate cancer disease progression"	44	44	NA	5	1	1	NA	NA	NA	NA	1	1	NA	0	NA	NA	NA	""	4	0	NA	0	4	NA	NA	1	NA	NA	NA	NA	""	44	44	0	NA	NA	"Not applicable"	""	""	2	2	2	2	2	2	2	2	"Previous seriious hypercalcemia and tachycardia with mental confusion"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1499905136	""	""	""	NA	"Progression of pre-existing cancer"	"Neoplasms benign, malignant and unspecified (incl cysts and polyps)"	"Miscellaneous and site unspecified neoplasms malignant and unspecified"	"Neoplasms malignant site unspecified NEC"	"Malignant neoplasm progression"	""	""	""	""	""	""	""	""	""	""	""	""
"5874"	"DN-101 Protocol No. 011-007"	"619"	"619-0004"	5	9	"Adverse Event/Serious Adverse Event"	3332332001	"Tachycardia"	34	43	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	8	NA	NA	NA	1	NA	NA	NA	""	NA	NA	NA	34	43	"ECG results"	""	""	2	2	2	2	2	2	2	2	"Fatigue"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498595957	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"5875"	"DN-101 Protocol No. 011-007"	"619"	"619-0004"	5	9	"Adverse Event/Serious Adverse Event"	3318828001	"Tachycardia"	23	26	NA	2	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1498382005	""	""	""	NA	"Tachycardia"	"Cardiac disorders"	"Cardiac arrhythmias"	"Rate and rhythm disorders NEC"	"Tachycardia"	""	""	""	""	""	""	""	""	""	""	""	""
"5876"	"DN-101 Protocol No. 011-007"	"619"	"619-0005"	5	9	"Adverse Event/Serious Adverse Event"	3276319003	"Alopecia"	112	133	NA	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	0	NA	1	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1516546114	""	""	""	NA	"Alopecia"	"Skin and subcutaneous tissue disorders"	"Skin appendage conditions"	"Alopecias"	"Alopecia"	""	""	""	""	""	""	""	""	""	""	""	""
"5877"	"DN-101 Protocol No. 011-007"	"619"	"619-0005"	5	9	"Adverse Event/Serious Adverse Event"	5136863002	"Disorders with vision"	112	NA	1	1	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1521397395	""	""	""	NA	"Visual disturbance"	"Eye disorders"	"Vision disorders"	"Visual disorders NEC"	"Visual disturbance"	""	""	""	""	""	""	""	""	""	""	""	""
"5878"	"DN-101 Protocol No. 011-007"	"619"	"619-0007"	5	9	"Adverse Event/Serious Adverse Event"	3431078003	"Anaemia"	97	104	NA	3	0	NA	NA	NA	NA	NA	0	NA	NA	4	NA	NA	1	"Blood transfusion: he has been administered with Erythrocits (RBC), see Concomitant Medications"	0	0	NA	1	8	NA	NA	NA	1	NA	NA	NA	""	97	NA	NA	97	104	"Hgb level: 60 g/L"	""	""	2	2	2	NA	2	2	NA	2	"Fatigue, tachypnea, tachycardia"	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1508422257	""	""	""	NA	"Anaemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5879"	"DN-101 Protocol No. 011-007"	"619"	"619-0007"	5	9	"Adverse Event/Serious Adverse Event"	3823146001	"Anaemia"	76	NA	1	3	0	NA	NA	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	1	0	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507406758	""	""	""	NA	"Anaemia"	"Blood and lymphatic system disorders"	"Anaemias nonhaemolytic and marrow depression"	"Anaemias NEC"	"Anaemia"	""	""	""	""	""	""	""	""	""	""	""	""
"5880"	"DN-101 Protocol No. 011-007"	"619"	"619-0008"	5	9	"Adverse Event/Serious Adverse Event"	3661584003	"Melaena"	27	29	NA	2	2	NA	1	NA	NA	NA	0	NA	NA	0	NA	NA	NA	""	0	1	NA	0	0	NA	NA	NA	NA	NA	NA	NA	""	NA	NA	NA	NA	NA	""	""	""	NA	NA	NA	NA	NA	NA	NA	NA	""	""	""	""	""	""	""	""	""	""	""	NA	NA	""	1507451698	""	""	""	NA	"Melaena"	"Gastrointestinal disorders"	"Gastrointestinal haemorrhages NEC"	"Non-site specific gastrointestinal haemorrhages"	"Melaena"	""	""	""	""	""	""	""	""	""	""	""	""
